Pharmaceutical reference substances and impurities 2011/2012 · The 2011/2012 edition of the LGC Standards catalogue ‘Pharmaceutical reference substances and impurities’, replaces

Pharmaceuticalreference substancesand impurities2011/2012

For further information, or if you require substances or materials not currently listed please contact one of our local sales offices.

BrazilTel: +55 12 3302 5880Email: [email protected]

BulgariaTel: +359 (0)2 971 4955Email: [email protected] Countries served: Bulgaria, Macedonia (FYRM)

ChinaTel: +86 10 85324820Email: [email protected] served: China, Hongkong, Macau, Taiwan

Czech RepublicTel: +420 543 529 205Email: [email protected] served: Czech Republic, Slovakia

FinlandTel: +358 (0)2 233 9355 Email: [email protected]

FranceTel: +33 (0)3 88 04 82 82Email: [email protected] served:Algeria, Belgium, France, Ivory Coast,Jordan, Lebanon, Libya, Madagascar,Morocco, Senegal, Syria, Tanzania,Tunesia

GermanyTel: +49 (0)281 9887 0Email: [email protected] Countries served:Austria, Cyprus, Germany, Greece, Israel, Japan, Korea, Singapore, Switzerland, Thailand, Vietnam

HungaryTel: +36 (06) 26 314 891Email: [email protected] served:Croatia, Hungary, Slovenia

IndiaTel: +91 (0)80 6701 2000Email: [email protected] served:Bangladesh, India, Nepal, Pakistan

IrelandTel: +44 (0)7879 556983Email: [email protected]

ItalyTel: +39 02 2412 6830Email: [email protected]

NetherlandsTel: +31 (0)643 775 422 Email: [email protected]

PolandTel: +48 (0)22 751 31 40Email: [email protected] served:Armenia, Azerbaijan, Belarus, Georgia, Kazakhstan, Kyrgizstan, Lithuania, Poland, Slovakia, Tajikistan, Turkmenistan, Ukraine,Uzbekistan

RomaniaTel: +40 364 116890Email: [email protected] served:Moldova, Romania, Serbia

RussiaTel: +7 (812)935 1180Email: [email protected]

SpainTel: +34 (0)93 308 4181Email: [email protected] served:Andorra, Latin America, Portugal, Spain

SwedenTel: +46 (0)33 20 90 60Email: [email protected] served:Denmark, Estonia, Iceland, Latvia,Norway, Sweden

TurkeyTel: +90 216 360 0870Email: [email protected]

Middle EastTel: +971 555 570 664Email: [email protected] served:Egypt, Sudan, UAE, Yemen

United KingdomTel: +44 (0)20 8943 8480Email: [email protected] served:Australia, Brunei, Channel Islands, Ireland, Kenya, Kuwait, Malta, New Zealand,Philippines, Saudi Arabia, South Africa, United Kingdom

USA + CanadaTel: +44 (0)20 8943 8480Email: [email protected]

www.lgcstandards.com

International locations LGCS.indd 1 23/08/2011 16:30:15

Introduction

Global quality management solutions for the laboratory


LGC Standards provides products and services to improve measurement and quality control within your laboratory:

Why choose LGC Standards? Widest range of reference materials from a single source

Expert technical support

Access to knowledge

olGrof

ytilauqlaboarobaleht

meganamyyrota

oitulostnem

s no





Why choose LGC Standards?idest range of W

Why choose LGC Standards?idest range of reference materials fr

Why choose LGC Standards?om a single sourcereference materials fr

om a single source

Expert technical sup

Acce

portExpert technical sup

ess to knowledgAcce

port

www

.lgcstandards.comwww

.lgcstandards.com

New dividers.qxp:Layout 1 21/3/11 14:18 Page 3

Content

Edition 2011/2012 All your needs for pharmaceutical analysis – email [email protected] 1

Content Introduction

Introduction 2

Pharmaceutical impurities 5

Background 7

List of products 9

European Pharmacopoeia 221

ATCC microbiological products 280

Certified liquids for viscosity measurements 282

International commission on pharmaceutical enzymes 283

European Pharmacopoeia reagents 284

WHO International Standards for Antibiotics 289

British Pharmacopoeia 291


Pharmacopée Française 309

Pharmacopoeia Helvetica 311

International Pharmacopeia 312

United States Pharmacopeia and National Formulary 317


Secondary standards 389

Institute of Dyes and Organic products 395

Refractive index CRMs 398

Publications and subscriptions 399

High purity solvents and acids 403

Introduction

2 All your needs for pharmaceutical analysis – email [email protected] Edition 2011/2012

Introduction About LGC Standards LGC Standards has successfully established a global reputation for the production of impurities and working

standards, and as a single source for the supply of pharmacopeia reference materials. Our menu of custom services, including custom synthesis of impurities and metabolites, characterisation, certification, packaging and distribution, adds value to the scientific support we provide to our pharmaceutical customers. Our relationships with the world’s leading pharmacopoeias and their range of Chemical Reference Substances (CRS) and Reference Standards (RS), combined with in-house production of certified reference materials and pharmaceutical impurities, enable us to meet our customers’ specific needs. LGC Standards is also the exclusive European distributor for ATCC cultures and bio products. LGC Standards’ extensive network of sales offices and distribution centres mean we offer the widest range of reference materials from one single source for rapid delivery. Our staff can provide scientific and technical guidance, including shipping and customs advice, in the local language. Our range of products also includes reference materials for clinical and forensic applications, phytochemicals, environmental analysis, physical properties determination, and food and beverage analysis.For more information about our range of services, or to receive any of our catalogues, please refer to our website www.lgcstandards.com or contact your local office.

About LGC LGC Standards is part of LGC. LGC, whose Science and Technology Division acts as the designated UK

National Measurement Institute (NMI) for Chemical and Biochemical measurement, has a long history in the development and validation of analytical methods and the production of reference materials. Many of the analytical methods, which cover the food, environment, industrial, clinical and pharmaceutical sectors, are accredited to ISO/IEC 17025 (Requirements for the competency of testing and calibration laboratories). Full details of the accreditation schedule can be found on the UKAS website www.ukas.com). LGC’s Research and Technology Division is accredited to ISO Guide 34 (General Requirements for the competence of reference materials producers) for the production of reference materials. The measurement capabilities used to produce certified reference materials in its capacity as the UK NMI are verified through participation on key comparison studies organised by the Consultative Committee for the Amount of Substance (CCQM) of the International Weights and Measures Organisation (BIPM). The certificates are recognised by other National Measurement Institutes, under the Mutual Recognition Arrangement. In its role as the NMI, LGC serves on the International Organisation for Standardisation (ISO) Committee for Reference Materials (REMCO), which aims to carry out and encourage a broad international effort for the harmonization, production and application of certified reference materials (CRM’s).

About the catalogue The 2011/2012 edition of the LGC Standards catalogue ‘Pharmaceutical reference substances and

impurities’, replaces the ‘Pharmaceutical reference substances and impurities’ 2010/2011 edition and the newsletter updates. The information provided in this catalogue as regards compendial articles is based on the ‘official’ pharmacopoeial lists and is correct at the time of print. Original descriptions and spellings used by the producers are retained. In some cases additional information has been included to make the lists more convenient to use. The catalogue will be updated with three to four newsletters; these will be downloadable under www.lgcstandards.com. You can also contact your local LGC Standards office and ask to be provided with the newsletters once they are published.

Pharmaceutical reference substances


Pharmaceutical reference substances Certification The products described in this catalogue include pharmacopeial reference substances for use in

pharmaceutical analysis. Pharmacopeial CRSs and RSs should be distinguished from certified reference materials (CRMs), which are produced in conformity with the ISO guides 30 to 35, and supplied with a detailed certification document. Pharmacopeial reference substances are produced for a specific purpose, and the manufacturers follow rigorous protocols to ensure the reference substance is fit for the intended purpose. The ‘certification’ processes follow the basic requirements of the relevant ISO REMCO guides, but are modified by the pharmacopoeias to reflect the particular demands of the associated pharmaceutical monograph. Details are given in the introduction to each section listing the various CRS collections in this catalogue.

Shelf Life, storage and expiry dates Pharmacopeial CRSs and RSs should be purchased when required and not stored for a prolonged period.

Pack sizes are designed to allow a limited number of replicate analyses, as required by Good Analytical Practice, but the opened pack should not be kept for future use. Please check all individual storage temperature requirements and note that the substances should be kept away from humidity and light (unless otherwise stated). Specific lot numbers or letters are allocated to all pharmacopeial reference substances, but no expiry dates are set. New lots are normally prepared well in advance of the expected "sell-out" of the current lot. When a substance is withdrawn from sale because the lot has depleted a final expiry date is given, by which any material from the outgoing lot held by users must be used. This means that for a period of time both lots are ‘official’. Lot information is provided by USP and EP in their literature and is available from LGC Standards. If a material is withdrawn by the producer, then all stocks held by the users are no longer valid and have to be destroyed. Should this occur, LGC Standards will inform all customers who have purchased the withdrawn substance. Please note that such a situation is outside LGC Standards’ control and products are not refundable.

Impurity standards Impurities in a pharmaceutical substance can change the effects and side effects of a drug significantly.

Therefore, it is important to have an accurate detection of these substances. The pharmaceutical monographs regulate the legal definition, the analysis and the limits of impurities of a given substance. An official range of impurity standards is available from the main pharmacopoeias where a CRS or RS is required in the monograph. Over 2700 other impurity standards are listed in the ‘pharmaceutical impurities’ section of this catalogue. These materials are produced by LGC, whose Science and Technology Division acts as the designated UK National Measurement Institute for Chemical and Biochemical Measurements. They are produced at our facility in Luckenwalde near Berlin, Germany and are supplied with a certificate of analysis. Our impurity reference standards are intended for the identification and control of impurities in drug substances and drug preparations, as well as for method development and validation.

Controlled substances A number of the pharmaceutical substances, such as narcotics and tranquillisers, described in this catalogue

are Controlled Substances in their country of origin and are marked ‘Controlled Substance’ against the product description. The purchase, possession and use of Controlled Substances are subject to national and international regulations designed to limit their abuse. It is the responsibility of the customer to obtain any authorisation necessary to both purchase and possess Controlled Substances, complying with the laws of the importing country, before ordering. Customers wishing to obtain Controlled Substances must contact their LGC Standards sales office before ordering, and clarify with the sales specialists the relevant national requirements, the associated charges and consequential delivery times. All orders for Controlled Substances must be provided in writing and signed by an authorised person. The orders must be accompanied with the original import permit and/or possession permit.

Pharmaceutical reference substances


Use, safety and handling Please read any documents supplied with the product before opening or using it. Particular attention must be

paid to instructions referring to pre-mixing, addition of diluent to lyophilised materials and to the minimum size of sample to be used. The latter point is particularly important as it has normally been set by the producer after considering fully the homogeneity testing data obtained as a part of the certification exercise. The use of smaller than recommended samples is one of the most common sources of error. Some pharmaceutical substances are toxic and require special handling. Virtually all pharmaceutical reference substances have a pharmacological and/or biological activity. We therefore recommend that all the products described in this catalogue should be handled as if they were bio-active, toxic or infective, and that opened packs should only be handled by trained laboratory personnel. We also strongly recommend to read the information provided by material safety data sheets coming with our impurity reference standards and the reference standards from major pharmacopoeias. All pharmaceutical reference substances and standards are for laboratory analytical use only and not for use in humans.

General ordering information Prices and delivery procedures are described in the price list that accompanies this catalogue, or are

available from your local LGC Standards office. For products requiring special delivery procedures (cooled shipping, special licensing, Controlled Substances) additional charges may be applied. Please note that once delivered to the customer, reference substances are not returnable. Customers requiring assistance with the purchase, use or application of a particular reference substance should contact LGC Standards where technical staff are available to advise on the use and suitability of the products.

Pharmaceuticalimpurities


Pharmaceutical impurities


Pharmaceutical impurities Background

The pharmacopeial monographs regulate the legal definition but also the analysis and the limits of impurities in a given substance. Impurities in a pharmaceutical substance can change the effects and side effects of a drug significantly. It is therefore important to have an accurate detection of impurities.

The increasing importance of impurity reference materials is also becoming apparent in the registration of drugs, where an exact identification and quantification of susceptible impurities is required for an assured documentation.

A wide range of known impurities is listed in individual pharmacopeial monographs. However, by far not all of these standards are available from the pharmcopoeias. The impurity standards listed below from LGC are filling this gap to a large extent.

Guidelines and limits for impurities have been laid out in compendial monographs, in specifications from the manufacturer internally or in the International Conference on Harmonisation (ICH) Guidelines which have been agreed by Europe, Japan and the United States. The ICH conducted three guidelines on impurity issues:

ICH Q3A (R1): Impurities in New Drug Substances

ICH Q3B (R2): Impurities in New Drug Products

ICH Q3C (R5): Impurity Guidelines for Residual Solvents.

The full wording of the ICH guidelines is available at the official website of the ICH: www.ich.org.

The ICH guidelines on impurities were originally developed for new, original drug substances and products. However, it is now commonly agreed in the three ICH regions – by FDA, EMA and Japanese regulation documents – that these guidelines need to be applied to generic compounds as well, in addition to the pharmacopoeial monographs.

If you want to hear more about the background on impurity testing, please contact your local LGC Standards office and refer to our recently launched campaign “Our 7 truths of impurities and their reference standards” for further valuable information on the subject.

About LGC

The pharmaceutical impurities listed in this section are produced by LGC, whose Research & Technology Division acts as the designated UK National Measurement Institute for Chemical and Biochemical Measurements.

LGC is an independent, science-based service company providing chemical, biochemical and DNA based analytical and diagnostic services, and reference standards. As Europe's largest, independent analytical laboratory, LGC's services include analytical testing, research, consultancy, validation, training and knowledge transfer.

LGC Standards, a division of LGC, provides the most comprehensive source of certified reference materials and standards, pharmaceutical reference substances and impurities, biomaterials, cell lines and high purity solvents to the scientific community worldwide.

LGC Standards has successfully established a global reputation for the production of impurities and working standards, and as a single source for the supply of pharmacopeia reference materials. Our menu of custom services, including custom synthesis of impurities and metabolites, characterisation, certification, packaging and distribution, adds value to the scientific support we provide to our pharmaceutical customers.

For more information about these services, please contact your local LGC Standards office.



Certification

Each product is accompanied by a detailed certificate of analysis, which gives information on the identity and purity, together with the various analytical methods and their conditions. A sample of such a certificate is printed on the following pages.

In the past, we received some inquiries from a few customers wondering why there is no declaration on the certificates of analysis (CofA) for LGC products stating that the substances are fulfilling the specifications for reagents, as described for example in chapter 4 of the European Pharmacopeia.

The LGC impurity standards are thoroughly tested chemical reference substances and are used for reliable identification and quantification of impurities in pharmaceutical ingredients and products. They are also valuable tools for spiking experiments during validation studies of specificity and accuracy of analytical methods.

The abbreviations EP, Pharmeuropa, BP and USP in the article description are indicating that the particular substance is mentioned as an impurity in that particular compendial publication. They do not indicate that certain specification of reagents or drug substances mentioned in the publications are fulfilled. The standards – where they are actually listed as reagents or drug substances – may fulfill this specification, but this is not the intention and is not certified on the CofA.

The production of our 2700+ LGC impurities reference standards follows the principles of ISO Guide 34 "General requirements for the competence of reference materials producers". This applies to new products and new batches of already existing products. In combination with ISO 17025, the ISO Guide 34 principles provide the best approach to the production of reference materials.

Narcotics and drug precursors

Some of the substances described in this section are subject to narcotics respective drug precursors legislation. These are marked as [Controlled Substance] or [Drug Precursors], respectively. Please contact your local LGC Standards office for information on the legal requirements in order to purchase these products.

Delivery time

The majority of products mentioned in this section are available from stock; others may have a delivery time of approximately four weeks. For substances marked with "on request", longer delivery times may apply. For custom synthesis, the time is estimated from previous experience. Customers will be notified if unforeseen complications arise during the synthesis. In the unlikely event that a synthesis does not reach the expected result, LGC Standards reserves the right to cancel the order.



Code Product Price Unit

4-Aminobenzoic Acid MM 0094.00 Imp. B (EP): Benzocaine

H2N

O

O (A) 500 mg

MM 0093.17 Imp. C (EP) as Hydrochloride: Aniline Hydrochloride

H2N

x HCl(B) 100 mg

Acebutolol Hydrochloride MM 0435.00 Acebutolol Hydrochloride O

O

OH HN

NH

O

x HCl

(A) 500 mg

MM 0435.01 Imp. A (EP): N-[3-Acetyl-4-[(2RS)-oxiran-2-ylmethoxy]phenyl]butanamide

O

OO

NH

O

(A) 50 mg

MM 0435.02 Imp. B (EP) as Hydrochloride:N-[3-Acetyl-4-[(2RS)-2-hydroxy-3-[(1-methylethyl)amino]-propoxy]phenyl]acetamide Hydrochloride (Diacetolol Hydrochloride)

O

O

OHHN

NH

O x HCl

(A) 100 mg

MM 0435.03 Imp. C (EP): N-(3-Acetyl-4-hydroxyphenyl)butanamide O

OH

NH

O

(A) 100 mg

MM 0435.04 Imp. D (EP) as Hydrochloride: 1-[5-Amino-2- [(2RS)-2-hydroxy-3-[(1-methylethyl)amino]- propoxy]phenyl]ethanone Dihydrochloride

O

O

OHHN

H2N

x 2 HCl

(A) 50 mg

MM 0435.05 Imp. E (EP) as Hydrochloride: N-[4-[(2RS)-2- Hydroxy-3-[(1-methylethyl)amino]propoxy]- phenyl]butanamide Hydrochloride

O

OHHN

NH

O x HCl

(A) 50 mg

MM 0435.06 Imp. F (EP): N-[3-Acetyl-4-[(2RS)-2,3-dihydroxypropoxy]phenyl]butanamide

O

O

OH

OH

NH

O

(A) 50 mg

MM 0435.07 Imp. G (EP): N,N'-[[(1-Methylethyl)imino]-bis[(2-hydroxypropane-1,3-diyl)oxy(3-acetyl-1,4-phenylene)]]dibutanamide (Acebutolol Biamine)

O

O

OH

N

HN

O

OH

O

O

NH

O

(A) 50 mg

MM 0435.08 Imp. H (EP): N,N'-[(2-Hydroxypropane-1,3-diyl)bis[oxy(3-acetyl-1,4-phenylene)]]di-butanamide

O

O

OH

O

HN

O

O

NH

O

(A) 50 mg

MM 0435.09 Imp. I (EP): N-[3-Acetyl-4-[(2RS)-3-(ethylamino)-2-hydroxypropoxy]phenyl]butanamide

O

O

OHHN

NH

O

(A) 50 mg

MM 0435.10 Imp. J (EP) as Hydrochloride: N-[3-Acetyl-4- [(2RS)-2-hydroxy-3-[(1-methylethyl)amino]- propoxy]phenyl]propanamide Hydrochloride

O

OHN

NH

O

OH

x HCl

(A) 50 mg

MM 0435.11 Imp. K (EP) as Hydrochloride: N-[3-Butanoyl-4-[(2RS)-2-hydroxy-3-[(1-methylethyl)amino]-propoxy]phenyl]butanamide Hydrochloride

O

O

OHHN

NH

O x HCl

(A) 50 mg




Aceclofenac MM 0181.00 Aceclofenac

NH

ClCl

O

O

OH

O (A) 250 mg

MM 0006.20 Imp. A (EP): [2-[(2,6-Dichlorophenyl)amino]phenyl]acetic Acid (Diclofenac)

NH

ClCl

OH

O

(A) 100 mg

MM 0006.10 Imp. B (EP): Methyl [2-[(2,6-Dichlorophenyl)amino]phenyl]acetate (Methyl Ester of Diclofenac) NH

ClCl

O

O

(A) 100 mg

MM 0006.11 Imp. C (EP): Ethyl 2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetate (Ethyl Ester of Diclofenac) NH

ClCl

O

O

(A) 100 mg

MM 0181.01 Imp. D (EP): Methyl [[[2-[(2,6-Dichloro-phenyl)amino]phenyl]acetyl]oxy]acetate (Methyl Ester of Aceclofenac) NH

ClCl

O

O

O

O (A) 100 mg

MM 0181.02 Imp. E (EP): Ethyl [[[2-[(2,6-Dichlorophenyl)amino]-phenyl]acetyl]oxy]acetate (Ethyl Ester of Aceclofenac)

NH

ClCl

O

O

O

O (A) 100 mg

MM 0181.03 Imp. F (EP): ): Benzyl[[[2-[(2,6-Dichlorophenyl)amino]-phenyl]acetyl]oxy]acetate (Benzyl Ester of Aceclofenac)

NH

ClCl

O

O

O

O (A) 100 mg

MM 0181.04 Imp. G (EP): [[[[[2-[(2,6-Dichlorophenyl)amino]phenyl]- acetyl]oxy]acetyl]oxy]acetic Acid (Acetic Aceclofenac)

NH

ClCl

O

O

O

OOH

O

(A) 100 mg

MM 0181.05 Imp. H (EP): [[[[[[[2-[(2,6-Dichlorophenyl)-amino]phenyl]acetyl]oxy]acetyl]oxy]acetyl]- oxy]acetic Acid (Diacetic Aceclofenac)

NH

ClCl

O

O

O

O

O

O

OH

O (A) 50 mg

MM 0006.01 Imp. I (EP):1-(2,6-Dichlorophenyl)-1,3-dihydro-2H-indol-2-one

ClCl

NO

(A) 100 mg

MM 0181.06 Isopropyl [2-[(2,6-Dichlorophenyl)amino]phenyl]acetate (Isopropyl Ester of Diclofenac) NH

ClCl

O

O

(A) 100 mg

Acesulfame Potassium New MM 1093.01 Imp. A (EP): 3-Oxobutanamide (Acetylacetamide)

NH2

O

O

(A) 100 mg

Acetazolamide MM 0648.00 Acetazolamide

N N

S SNH2

HN

O

O O (A) 500 mg

New MM 0648.04 Imp. A (EP): N-(5-Chloro-1,3,4-thiadiazol-2-yl)acetamide

NN

SClHN

O

(A) 50 mg




New MM 0648.01 Imp. B (EP): N-(1,3,4-Thiadiazol-2-yl)acetamide

NN

SHN

O

(A) 50 mg

Acetylcysteine MM 0024.00 N-Acetyl-L-cysteine

HS OH

O

HN

O

(A) 500 mg

MM 0024.03 Imp. A (EP): L-Cystine S OH

O

NH2

SHO

O

NH2 (B) 100 mg

MM 0024.02 Imp. B (EP): L-Cysteine HS OH

O

NH2

(B) 100 mg

MM 0024.04 Imp. C (EP): N,N’-Diacetyl-L-cystine

S OH

O

HN

SHO

O

NH

O

O (A) 100 mg

MM 0024.01 Imp. D (EP): N,S-Diacetyl-L-cysteine S OH

O

HN

O

O (A) 100 mg

MM 0024.05 Sodium 2-Methyl-4,5-dihydro-1,3-thiazol-4-carboxylate N

S

ONa

O (A) 100 mg

MM 0024.06 N-Propionyl-L-cysteine HS OH

O

HN

O

(A) 100 mg

Acetylsalicylic Acid MM 0133.00 Acetylsalicylic Acid O

HO OO (A) 500 mg

MM 0045.01 Imp. A (EP): 4-Hydroxybenzoic Acid HO

OH

O (B) 100 mg

MM 0045.02 Imp. B (EP): 4-Hydroxybenzene-1,3-dicarboxylic Acid (4-Hydroxyisophthalic Acid) HO

OH

O

OH

O (A) 100 mg

MM 0045.00 Imp. C (EP): Salicylic Acid OH

O

OH

(A) 500 mg

MM 0133.01 Imp. D (EP): 2-[[2-(Acetyloxy)benzoyl]oxy]benzoic Acid (Acetylsalicylsalicylic Acid)

O

O

OH

O

O

O

(A) 100 mg

MM 0133.03 Imp. E (EP):2-[(2-Hydroxybenzoyl)oxy]benzoic Acid (Salicylsalicylic Acid)

O

O

OH

O

OH

(A) 100 mg

MM 0133.02 Imp. F (EP): 2-(Acetyloxy)benzoic Anhydride (Acetylsalicylic Anhydride)

O

O

O

O O O

O (A) 100 mg




MM 0133.04 2-(2,4-Dihydroxybenzoyl)benzoic Acid OH

O

O

OH

OH

(A) 100 mg

New MM 0133.08 4-Acetoxyisophthalic Acid O

OH

O

HO

O

O

(A) 50 mg

New MM 0133.09 Acetylsalicylsalicylsalicylic Acid

O

O

O

O

O

O

OH

O (A) 50 mg

N-Acetyltryptophan MM 1267.01 Imp. A (EP): Tryptophan H

N

O

OH

NH2(A) 100 mg

MM 0172.03 Imp. D (EP): (S)-2-Amino-3-(5-hydroxy- 1H-indol-3-yl)propanoic Acid (5-Hydroxy- tryptophan)

HN

O

OH

NH2

HO

(A) 100 mg

Aciclovir MM 0061.00 Aciclovir

N

HN N

N

O

H2NO

OH

(A) 500 mg

MM 0061.01 Imp. A (EP): 2-[(2-Amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl Acetate

N

HN N

N

O

H2NO

O

O

(A) 100 mg

MM 0061.02 Imp. B (EP): 2-Amino-1,7-dihydro-6H-purin-6-one (Guanine)

N

HNHN

N

O

H2N

(B) 100 mg

MM 0061.04 2-[(2-Amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl Benzoate

N

HN N

N

O

H2NO

O

O

(A) 100 mg

MM 0061.06 Imp. F (EP): N-[9-[(2-Hydroxyethoxy)methyl]-6-oxo-6,9-dihydro-1H-purin-2-yl]acetamide

N

HN N

N

O

NH O

OHO

(A) 100 mg

MM 0061.07 Imp. G (EP): 2-[[(2-(Acetylamino)-6-oxo-1,6-dihydro-9H-purin-9-yl]methoxy]ethyl Acetate

N

HN N

N

O

NH O

OO

O(A) 100 mg

MM 0061.08 2-[[2-(Acetylamino)-6-oxo-1,6-dihydro-9H-purin-9-yl]methoxy]ethyl Benzoate

N

HNN

N

O

NH O

OO

O

(A) 100 mg

MM 0061.10 2,6-Dichloropurine

N

N N

NH

Cl

Cl

(B) 100 mg




Adalapene New MM 0681.03 Imp. A (EP): 2,2'-Binaphthalene-6,6'-dicarboxylic Acid

HO

O

O

OH

(A) 50 mg

New MM 0681.01 Imp. C (EP): 1-(2-Methoxyphenyl)tricyclo-

[3.3.1.13,7

]decane

O (A) 50 mg

Adenosine MM 0784.00 Adenosine

N

NN

N

NH2

O

HO

OH OH

(A) 500 mg

New MM 0784.01 Imp. A (EP) as Sulphate: 7H-Purin-6-amine Sulphate (Adenine Sulphate)

NH

NN

N

NH2

2

x H2SO4

(A) 100 mg

New MM 0784.02 Imp. F (EP): 1--D-Ribofuranosylpyrimidine- 2,4(1H,3H)-dione (Uridine)

NO

HO

OH OH

HN

O

O

(A) 100 mg

New MM 0784.03 Imp. G (EP): 9--D-Ribofuranosyl-1,9-dihydro- 6H-purin-6-one (Inosine)

N

NHN

N

O

O

HO

OH OH

(A) 100 mg

New MM 0784.04 Imp. H (EP): 2-Amino-9--D-ribofuranosyl- 1,9-dihydro-6H-purin-6-one (Guanosine)

N

NHN

N

O

O

HO

OH OH

H2N

(A) 100 mg

Adiphenine Hydrochloride MM 1172.00 Adiphenine Hydrochloride

O

O

N

x HCl

(A) 250 mg

Adrenaline Tartrate MM 0614.00 Adrenaline Tartrate

OH

HO

OH HN

HO

OH

OH

OH

O

O

x

(A) 500 mg

MM 0614.02 L-Adrenaline

OH

HO

OH HN

(A) 500 mg

MM 0614.13 Imp. C (EP) as Hydrochloride: 1-(3,4-Di- hydroxyphenyl)-2-(methylamino)ethanone Hydrochloride (Adrenalone Hydrochloride)

HO

OHNHO

x HCl

(A) 100 mg

MM 0614.01 (1R)-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanesulphonic Acid(Adrenaline -Sulphonate)

OH

HO

HN

SO3H (A) 100 mg




Alanine MM 0566.00 Alanine

OH

O

NH2 (A) 500 mg

Albendazole MM 0382.00 Albendazole

N

HN

S

NHO

O (A) 500 mg

MM 0382.01 Imp. A (EP): 5-(Propylsulphanyl)-1H-benzimidazol-2-amine

N

HN

S

NH2

(A) 100 mg

MM 0382.02 Imp. B (EP): Methyl [5-Propylsulphinyl)-1H-benzimidazol-2-yl]carbamate

N

HN

S

NHO

O

O

(A) 100 mg

MM 0382.03 Imp. C (EP): Methyl [5-Propylsulphonyl)-1H-benzimidazol-2-yl]carbamate N

HN

S

NH

O

O

OO

(A) 100 mg

MM 0382.04 Imp. D (EP): 5-(Propylsulphonyl)-1H-benzimidazol-2-amine

N

HN

S

NH2

OO

(A) 100 mg

MM 2500.00 Imp. E (EP): Methyl (1H-Benzimidazol-2-yl)carbamate (Carbendazim)

N

HN

NH

O

O (A) 100 mg

Alfuzosin Hydrochloride MM 0085.04 Imp. B (EP): 2-Chloro-6,7-dimethoxyquinazolin-4-amine

N

NO

O

NH2

Cl (A) 100 mg

New MM 1004.04 Imp. D (EP) as Dihydrochloride: N-(4-Amino-6,7-dimethoxyquinazolin-2-yl)- N-methylpropane-1,3-diamine Dihydrochloride N

NO

O

NH2

N NH2

x 2 HCl

(A) 50 mg

Allobarbital MM 0899.00 Allobarbital [Controlled Substance]

NH

HN OO

O

(A) 100 mg

Allopurinol MM 0034.00 Allopurinol

NH

NNH

N

O (A) 500 mg

MM 0034.01 Imp. A (EP) as Hemisulphate: 5-Amino-1H-pyrazole-4-carboxamide Hemisulphate NH2

NH2NH

N

O

x 1/2 H2SO4

(A) 100 mg

MM 0034.05 Imp. D (EP): Ethyl 5-Amino1H-pyrazole-4-carboxylate O

NH2NH

N

O (A) 100 mg

MM 0034.06 Imp. E (EP): Ethyl 5-(Formylamino)-1H-pyrazole-4-carboxylate O

NH

NH

N

O

O

(A) 100 mg

MM 0034.07 Oxypurinol

NH

NHN

NH

O

O

(A) 100 mg

Alprazolam MM 0028.03 Imp. E (EP): (2-Amino-5-chlorophenyl)phenylmethanone

OCl

NH2 (B) 100 mg




Alverine Citrate MM 0454.00 Alverine Citrate

N

OH

O

OH

O

OHO

OH

x

(A) 250 mg

MM 0454.02 Imp. A (EP): 1-Chloro-3-phenyl-propane Cl

(A) 100 mg

MM 0454.03 Imp. B (EP): 3-Phenylpropan-1-ol OH

(A) 100 mg

MM 0454.04 Imp. C (EP) as Hydrochloride: N-Ethyl- 3-phenylpropan-1-amine Hydrochloride NH

x HCl (A) 100 mg

MM 0454.05 Imp. D (EP) as Hydrochloride: N-(3- Cyclohexylpropyl)-N-ethyl-3-phenylpropan-1-amine Hydrochloride

Nx HCl (A) 100 mg

MM 0454.06 Imp. E (EP) as Hydrochloride: 3-Phenyl- N,N-bis(3-phenylpropyl)propan-1-amine Hydrochloride

N

x HCl

(A) 100 mg

Amantadine Hydrochloride MM 0564.00 Amantadine Hydrochloride NH2

x HCl(A) 500 mg

Ambroxol Hydrochloride MM 0005.00 Ambroxol Hydrochloride

x HCl

Br

NH2

BrNH

OH (A) 500 mg

MM 0005.01 Imp. A (EP): (2-Amino-3,5-dibromophenyl)methanol

Br

NH2

BrOH (A) 100 mg

MM 0005.04 Imp. B (EP) as Hydrochloride: trans-4-(6,8-Dibromo-1,4-dihydroquinazolin-3(2H)-yl)cyclohexanol Hydrochloride

x HCl

Br

NH

BrN

OH (A) 100 mg

MM 0005.03 Imp. C (EP): trans-4-[[(E)-2-Amino-3,5-dibromobenzyliden]amino]cyclohexanol

Br

NH2

BrN

OH (A) 100 mg

MM 0005.05 Imp. D (EP) as Hydrochloride: cis-4-[(2-Amino-3,5-dibromobenzyl)amino]cyclohexanol Hydrochloride

x HCl

Br

NH2

BrNH

OH (A) 100 mg

MM 0005.02 Imp. E (EP): 2-Amino-3,5-dibromobenzaldehyde

Br

NH2

BrO (A) 100 mg

MM 0005.06 trans-4-Aminocyclohexanol Hydrochloride x HCl

H2N

OH (A) 100 mg

MM 0005.07 cis-4-Aminocyclohexanol Hydrochloride x HCl

H2N

OH (A) 100 mg

Amiloride Hydrochloride MM 0560.00 Amiloride Hydrochloride Dihydrate

N

NCl

NH2H2N

NH

O

NH2

NH

x HClx 2 H2O

(A) 500 mg

Aminocaproic Acid MM 0896.00 Aminocaproic Acid

H2NOH

O (A) 500 mg




Amiodarone Hydrochloride MM 0697.00 Amiodarone Hydrochloride O

O

I

I

ON

x HCl

(A) 250 mg

MM 0697.11 Imp. A (EP) as Oxalate: (2-Butylbenzofuran-3-yl)-[4-[2-(diethylamino)ethoxy]- phenyl]methanone Oxalate

O

O

ON

HO O

OHO

x

(A) 100 mg

MM 0697.03 Imp. B (EP) as Hydrochloride: (2-Butylbenzofuran-3-yl)[4-[2-(ethylamino)ethoxy]-3,5- diiodophenyl]methanone Hydrochloride (Desethylamiodarone Hydrochloride)

O

O

I

I

O

HN

x HCl

(D) 100 mg

MM 0697.04 Imp. C (EP) as Hydrochloride: (2-Butylbenzofuran-3-yl)[4-[2-(diethylamino)ethoxy]- 3-iodophenyl]methanone Hydrochloride

O

OI

ON

x HCl

(A) 100 mg

MM 0697.05 Imp. D (EP): (2-Butylbenzofuran-3-yl)(4-hydroxy-3,5-diiodophenyl)methanone

O

O

I

I

OH

(A) 100 mg

MM 0697.06 Imp. E (EP): (2-Butylbenzofuran-3-yl)(4-hydroxyphenyl)methanone

O

O

OH

(A) 100 mg

MM 0697.07 Imp. F (EP): (2-Butylbenzofuran-3-yl)(4-hydroxy-3-iodophenyl)methanone

O

OI

OH

(A) 100 mg

MM 0697.09 Imp. H (EP) as Hydrochloride: 2-Chloro-N,N-diethylethanamine Hydrochloride (2-Chlorotriethylamine Hydrochloride; (2-Chloroethyl)diethylamine Hydrochloride)

ClN

x HCl(C) 100 mg

MM 0697.10 Amiodarone N-Oxide Hydrochloride O

O

I

I

ON

x HClO

(A) 100 mg

Amisulpride MM 0051.01 Imp. A (EP): [(2RS)-1-Ethylpyrrolidin-2-yl]methanamine H2N

N

(A) 100 mg

New MM 0793.03 Imp. C (EP): 4-Amino-N-[[(2RS)-1-ethyl-pyrrolidin- 2-yl]methyl]-5-iodo-2-methoxy-benzamide I

H2N O

NH

O

N

(A) 50 mg

New MM 0793.04 Imp. D (EP): 4-Amino-N-[[(2RS)-1-ethyl-pyrrolidin-2-yl]methyl]-2-methoxy-5-(methylsulphonyl)benzamide S

O O

H2N O

NH

O

N

(A) 50 mg

New MM 0793.05 Imp. E (EP): 4-Amino-5-(ethylsulphonyl)- 2-methoxybenzoic Acid S

O O

H2N O

OH

O (A) 100 mg

Amitraz MM 1018.01 Imp. A (BP): 2,4-Dimethylaniline

(2,4-Xylidine)

NH2 (A) 100 mg

MM 1018.02 Imp. B (BP): Form-2',4'-xylidide HN O (A) 100 mg




Amitriptyline Hydrochloride MM 0062.00 Amitriptyline Hydrochloride

N x HCl

(A) 500 mg

MM 0062.01 Imp. A (EP): 10,11-Dihydro-5H-dibenzo- [a,d][7]annulen-5-one (Dibenzosuberone) O

(B) 100 mg

MM 0062.02 Imp. B (EP) as Hydrochloride: 3-(5H-Dibenzo[a,d][7]annulen-5-ylidene)-N,N-dimethylpropan-1-amine Hydrochloride (Cyclobenzaprine Hydrochloride)

N x HCl

(A) 100 mg

MM 0079.00 Imp. C (EP) as Hydrochloride: 3-(10,11-Dihydro-5H-dibenzo[a,d][7]annulen-5-ylidene)-N-methylpropan-1-amine Hydrochloride (Nortriptyline Hydrochloride)

NH x HCl

(A) 500 mg

MM 0062.03 Imp. D (EP): 5-[3-(Dimethylamino)propyl]-10,11-dihydro-5H-dibenzo[a,d][7]annulen-5-ol OH

N

(A) 100 mg

MM 0062.05 Imp. F (EP): (5EZ,10RS)-5-[3-(Dimethyl-amino)propylidene]- 10,11-dihydro-5H-dibenzo[a,d][7]annulen-10-ol

HO

N(A) 100 mg

MM 0062.14 Imp. G (EP): 10,11-Dihydro-5H-dibenzo[a,d][7]annulen-5-ol (Dibenzosuberol) OH

(A) 100 mg

MM 0062.12 Amitriptyline N-Oxide Hydrochloride

N x HClO

(B) 10 mg

MM 0062.13 10,11-Dihydro-5H-dibenzo[a,d]cycloheptene (Dibenzosuberane) (A) 100 mg

Amlodipine Besilate MM 0383.00 Amlodipine Besilate H

N

O

O

O

O

ONH2

Cl

SO

O

OH

x

(D) 100 mg

MM 0383.06 Amlodipine HN

O

O

O

O

ONH2

Cl

(A) 100 mg

MM 0383.01 Imp. A (EP): 3-Ethyl-5-Methyl (4RS)-4-(2-Chlorophenyl)-2-[[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethoxy]methyl]-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate

HN

O

O

O

O

O

Cl

N

O

O

(D) 100 mg




MM 0383.02 Imp. B (EP): 3-Ethyl 5-Methyl (4RS)-4-(2-Chlorophenyl)-6-methyl-2-[[2-[[2-(methylcarbamoyl)benzoyl]amino]-ethoxy]methyl]-1,4-dihydropyridine-3,5-dicarboxylate

HN

O

O

O

O

O

HN

Cl

O

NH

O(D) 100 mg

MM 0383.03 Ethyl Methyl (4RS)-2,6-Bis[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Dihydrochloride

HN

O

O

O

O

ONH2

Cl

OH2N

x 2 HCl

(D) 100 mg

MM 0383.04 Imp. D (EP): 3-Ethyl-5-Methyl 2-[(2-Aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methylpyridine-3,5-dicarboxylate

N

O

O

O

O

ONH2

Cl

(D) 100 mg

MM 0383.10 Imp. E (EP): Diethyl (4RS)-2-[(2-Amino- ethoxy)methyl]-4-(2-chlorophenyl)-6- methyl-1,4-dihydropyridine-3,5-dicarboxylate

HN

O

O

O

O

ONH2

Cl

on request

New MM 0383.09 Imp. F (EP): Dimethyl (4RS)-2-[(2-Amino- ethoxy)methyl]-4-(2-chlorophenyl)-6- methyl-1,4-dihydropyridine-3,5-dicarboxylate

HN

O

O

O

O

ONH2

Cl

(D) 100 mg

MM 0383.07 Imp. G (EP): Dimethyl 4-(2-Chlorophenyl)- 2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate

HN

O

O

O

OCl

(A) 100 mg

MM 0383.11 Imp. H (EP): 2-[[2-[[(4RS)-4-(2-Chlorophenyl)- 3-(ethoxycarbonyl)-5-(methoxycarbonyl)-6- methyl-1,4-dihydropyridin-2-yl]methoxy]ethyl]- carbamoyl]benzoic Acid

HN

O

O

O

O

O

HN

Cl

OOHO

(D) 100 mg

MM 0383.05 Benzenesulfonic Acid SO

O

OH(B) 100 mg

Amlodipine Maleate MM 0631.00 Amlodipine Maleate H

N

O

O

O

O

ONH2

Cl

O

OH

O

OHx

(D) 100 mg

Amlodipine Mesilate MM 0592.00 Amlodipine Mesilate H

N

O

O

O

O

ONH2

Cl

SHO

xO O

(D) 100 mg

Amodiaquine Dihydrochloride Dihydrate MM 0617.00 Amodiaquine Dihydrochloride Dihydrate NCl

HN

OH

N x 2 HClx 2 H2O

(A) 500 mg

MM 0617.01 4-Acetamido-2-diethylaminomethylphenol

OH

N

O

HN

(A) 100 mg




MM 0617.02 7-Chloro-4-(4-hydroxyphenylamino)quinoline NCl

HN

OH

(A) 100 mg

MM0617.03 4,7-Dichloroquinoline NCl

Cl

(C) 100 mg

MM 0617.04 Monodesethylamodiaquine Dihydrochloride NCl

HN

OH

HNx 2 HCl

(A) 100 mg

Amoxicillin Trihydrate MM 0232.00 Amoxicillin Trihydrate

N

S

OHO

H

O

HN

HO

NH2

O

x 3 H2O

(A) 500 mg

MM 0026.04 Imp. A (EP): (2S,5R,6R)-6-Amino-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]-heptane-2-carboxylic Acid (6-Aminopenicillanic Acid)

N

S

OHO

H

O

H2N

(B) 100 mg

New MM 0232.02 Imp. B (EP): (2S,5R,6R)-6-[[(2S)-2-Amino-2- (4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]-heptane- 2-carboxylic Acid (L-Amoxicillin)

N

S

OHO

H

O

HN

HO

NH2

O

(D) 100 mg

MM 0232.03 Imp. C (EP): (4S)-2-[5-(4-Hydroxyphenyl)-3,6-dioxopiperazin-2-yl]-5,5-dimethyl-thiazolidine-4-carboxylic Acid (Amoxicillin Diketopiperazines) H

N S

HN

OHO

NH

HO

O

O

(A) 100 mg

MM 0232.04 Imp. D (EP) as Sodium Salt:(4S)-2-[[[(2R)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino]carboxymethyl]-5,5-dimethylthiazolidine-4-carboxylic Acid Sodium Salt (Penicilloic Acids of Amoxicillin Sodium Salt)

HN

HO

NH2

O

S

HN

ONaO

OHO

(A) 100 mg

MM 0232.05 Imp. E (EP): (2RS,4S)-2-[[[(2R)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino]methyl]-5,5-dimethylthiazolidine-4-carboxylic Acid (Penilloic Acids of Amoxicillin)

HN

HO

NH2

O

S

HN

OOH (A) 50 mg

MM 0232.06 Imp. F (EP): 3-(4-Hydroxyphenyl)pyrazin-2-ol N

N

HO

HO (A) 100 mg

MM 0232.08 Imp. H (EP): (2R)-2-[(2,2-Dimethylpropanoyl)amino]-2- (4-hydroxyphenyl)acetic Acid

HO

NH

O

O

OH

(A) 100 mg

MM 0232.09 Imp. I (EP): (2R)-2-Amino-2-(4-hydroxyphenyl)acetic Acid

HO

NH2

OH

O

(B) 100 mg

MM 0232.12 (2R)-2-Amino-2-(4-hydroxyphenyl)acetamide

HO

NH2

NH2

O

(A) 100 mg

Ampicillin Sodium MM 0253.00 Ampicillin Sodium

N

S

ONaO

H

O

HN

NH2

O

(A) 500 mg




MM 0253.15 Ampicillin Trihydrate

N

S

OOH

H

O

HN

NH2

O

x 3 H2O

(A) 500 mg


N

S

OHO

H

O

H2N

(B) 100 mg

MM 0253.02 Imp. B (EP): (2S,5R,6R)-6-[[(2S)-2-Amino-2-phenylacetyl]amino]-3,3- dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid (L-Ampicillin)

N

S

OOH

H

O

HN

NH2

O

(A) 100 mg

MM 0253.03 Imp. C (EP): (4S)-2-(3,6-Dioxo-5-phenylpiperazin-2-yl)-5,5-dimethylthiazolidine-4-carboxylic Acid (Diketopiperazines of Ampicillin) H

N S

HN

OOH

NH

O

O

(A) 100 mg

MM 0253.04 Imp. D (EP) as Sodium Salt: (4S)-2-[[[(2R)-2-Amino-2-phenylacetyl]amino]carboxymethyl]-5,5-dimethylthiazolidine-4-carboxylic Acid Sodium Salt (Penicilloic Acids of Ampicillin Sodium Salt)

HN

NH2

O

S

HN

ONaO

OHO

(A) 100 mg

MM 0253.06 Imp. F (EP): (2RS,4S)-2-[[[(2R)-2-Amino-2-phenylacetyl]amino]methyl]-5,5-dimethyl-thiazolidine-4-carboxylic Acid (Penilloic Acids of Ampicillin) H

N

NH2

O

S

HN

OOH (A) 100 mg

MM 0253.08 Imp. H (EP): 3-Phenylpyrazin-2-ol

N

NHO (A) 100 mg

MM 0253.11 Imp. K (EP): (2R)-2-[(2,2-Dimethylpropanoyl)amino]-2-phenylacetic Acid

O

OH

NH

O (A) 100 mg

MM 0253.12 Imp. L (EP): (2R)-2-Amino-2-phenylacetic Acid (D-Phenylglycine)

O

OH

NH2 (B) 100 mg

MM 0253.16 Ampicillin, anhydrous

N

S

OOH

H

O

HN

NH2

O

(A) 500 mg

Androstanolone MM 0565.00 Androstanolone

O

OH (A) 250 mg

Anise Oil MM 0164.01 trans-Anethole

O

(C) 100 mg

MM 0164.02 Estragole

O

(C) 100 mg

MM 0164.03 Anisaldehyde

O

O (C) 100 mg

MM 0164.05 Linalol

HO

(C) 100 mg

MM 0164.06 cis-Anethole

O

(D) 100 mg




Antazoline Hydrochloride MM 0171.00 Antazoline Hydrochloride

NNH

N x HCl

(A) 500 mg

MM 0171.01 Imp. A (EP) as Dihydrochloride: N-(2-Aminoethyl)-2-(benzylphenylamino)acetamide Dihydrochloride

NNH

O

NH2

x 2 HCl

(A) 100 mg

MM 0171.04 Imp. B (Pharmeuropa) as Hydrochloride: 2-(Chloro- methyl)-4,5-dihydro-1H-imidazole Hydrochloride

Cl

NH

N

x HCl(A) 100 mg

MM 0171.03 N-Benzylaniline NH (B) 100 mg

Antazoline Phosphate MM 0561.00 Antazoline Phosphate

N

N

HN

x H3PO4

(A) 500 mg

Apomorphine Hydrochloride MM 0562.00 Apomorphine Hydrochloride Hemihydrate

N

OH

HO

H

x HClx ½ H2O

(A) 250 mg

MM 0037.00 Imp. B (EP) as Hydrochloride Trihydrate: Morphine Hydrochloride Trihydrate [Controlled Substance]

O OHHO

N

x HClx 3 H2O

(A) 250 mg

Aprindine Hydrochloride MM 0467.00 Aprindine Hydrochloride

N

N

HCl

on request

Arginine MM 0568.00 Arginine

OH

O

HNH2N

NH

NH2 (A) 500 mg

Arginine Hydrochloride MM 0569.00 Arginine Hydrochloride

OH

O

HNH2N

NH

NH2

x HCl(A) 500 mg

Articaine Hydrochloride MM 0369.00 Articaine Hydrochloride

HN

NHS

OO

O

x HCl

(A) 100 mg

MM 0369.01 Imp. A (EP) as Hydrochloride: Methyl 3-[[2-(Propylamino)acetyl]amino]-4-methylthiophene-2-carboxylate Hydrochloride (Acetamidoarticaine Hydrochloride)

x HClHN

NHS

OO

O

(A) 100 mg

MM 0369.02 Imp. B (EP) as Hydrochloride: 4-Methyl-3-[[(2RS)-2-(propylamino)propanoyl]amino]thiophene-2-carboxylic Acid Hydrochloride (Articaine Acid Hydrochloride)

x HClHN

NHS

OHO

O

(A) 50 mg

MM 0369.03 Imp. C (EP) as Hydrochloride: 1-Methylethyl 4-Methyl-3-[[(2RS)-2-(propylamino)propanoyl]amino]thiophene-2-carboxylate Hydrochloride (Articaine Isopropyl Ester Hydrochloride)

x HClHN

NHS

OO

O

(A) 100 mg

MM 0369.04 Imp. D (EP) as Hydrochloride: Methyl 3-[[(2RS)-2-(Ethylamino)propanoyl]amino]-4-methylthiophene-2-carboxylate Hydrochloride (Ethylarticaine Hydrochloride)

x HClHN

NHS

OO

O

(B) 10 mg




MM 0369.05 Imp. E (EP) as Hydrochloride: Methyl 4-Methyl-3-[[(2RS)-2-[(1-methylethyl)amino]propanoyl]amino]thiophene-2-carboxylate Hydrochloride (Isopropylarticaine Hydrochloride)

x HClHN

NHS

OO

O

(A) 100 mg

MM 0369.06 Imp. F (EP) as Hydrochloride: 4-Methyl-N-propyl-3-[[(2RS)-2-(propylamino)propanoyl]amino]thiophene-2-carboxamide Hydrochloride (Articaine Acid Propionamide Hydrochloride)

x HClHN

NHS

OHN

O

(A) 50 mg

MM 0369.07 Imp. G (EP) as Hydrochloride: Methyl 3-[[(2RS)-2-(Butylamino)propanoyl]amino]-4-methylthiophene-2-carboxylate Hydrochloride (Butylarticaine Hydrochloride)

x HClHN

NHS

OO

O

(A) 100 mg

MM 0369.08 Imp. H (EP) as Hydrochloride: Methyl 3-[[(2RS)-2-(Dipropylamino)propanoyl]amino]-4-methylthiophene-2-carboxylate Hydrochloride (Dipropylarticaine Hydrochloride)

x HClHN

NS

OO

O

(A) 100 mg

MM 0369.09 Imp. I (EP): Methyl 3-Amino-4-methylthiophene-2-carboxylate (3-Aminoarticaine)

S

NH2

OO (C) 100 mg

MM 0369.10 Imp. J (EP): Methyl 3-[[(2RS)-2-Bromopropanoyl]amino]-4-methylthiophene-2-carboxylate (Bromo Compound)

HN

BrS

OO

O

(B) 10 mg

Ascorbic Acid MM 0166.00 L-Ascorbic Acid

OHO

OH

OHHO

O

(A) 500 mg

Asparagine Monohydrate MM 0765.01 Phenylacetylasparagine

O

H2NOH

O

HN

O (C) 50 mg

Aspartame MM 0314.00 Aspartame H

NO

O

O

NH2

HO

O (A) 500 mg

MM 0314.01 Imp. A (EP): 2-(5-Benzyl-3,6-dioxopiperazin-2-yl)acetic Acid (Diketopiperazine)

NH

O

HN

HO

O

O (A) 100 mg

MM 0314.02 Imp. B (EP): L-Aspartyl-L-phenylalanine HN

OH

O

O

NH2

HO

O (A) 100 mg

MM 0314.03 Imp. C (EP): Phenylalanine H2N

OH

O (B) 100 mg

Aspartic Acid MM 0567.00 Aspartic Acid

OH

O

HO

NH2O (A) 500 mg

New MM 0460.10 Imp. B (Pharmeuropa): (E)-Butenedioic Acid (Fumaric Acid) OH

O

HO

O

(B) 100 mg

New MM 0566.00 Imp. D (Pharmeuropa): (S)-2-Aminopropanoic Acid (Alanine) OH

O

NH2 (A) 500 mg

New MM 0169.00 Imp. F (Pharmeuropa): (2S)-2,5-Diamino-5- oxopentanoic Acid (L-Glutamine) OH

O

NH2

H2N

O

(A) 500 mg




Astemizole MM 0184.00 Astemizole

NN

HN

NO

F(A) 250 mg

MM 0184.13 Desmethyl Astemizole Hydrochloride

N

N

HN

N

OH

F

x HCl

(B) 10 mg

Atenolol MM 0013.00 Atenolol

H2N

OO

OHHN

(A) 500 mg

MM 0013.03 Imp. A (EP): 2-(4-Hydroxyphenyl)acetamide

H2N

OOH (B) 100 mg

MM 0013.05 Imp. B (EP): 2-[4-[(2RS)-2,3-Dihydroxypropoxy)phenyl]acetamide

H2N

OO

OH

OH(A) 100 mg

MM 0013.01 2-[4-[[(2RS)-Oxiran-2-yl]methoxy]phenyl]acetamide

H2N

OO

O (A) 100 mg

MM 0013.06 Imp. D (EP): 2-[4-[(2RS)-3-Chloro-2-hydroxypropoxy]phenyl]acetamide

H2N

OO

OH

Cl(A) 50 mg

MM 0013.07 Imp. E (EP): 2,2'-[(2-Hydroxypropane-1,3- diyl)bis(oxy-4,1-phenylene)]diacetamide

H2N

OO

NH2

OO

OH (A) 50 mg

MM 0013.02 Imp. F (EP): 2,2'-[[(1-Methylethyl)- imino]bis[(2-hydroxypropane-3,1- diyl)oxy-4,1-phenylene]]diacetamide

H2N

OO

OH

N

NH2

OO

OH (A) 50 mg

MM 0013.04 Imp. G (EP): 2-[4-[(2RS)-2-Hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]acetic Acid

HO

OO

OHHN

(A) 50 mg

MM 0013.08 Imp. H (EP): 2-[4-[(2RS)-2-Hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]acetonitrile

O

OHHN

N

(A) 100 mg

New MM 0013.17 Imp. I (EP): 2-[4-[(2RS)-3-(Ethylamino)-2- hydroxypropoxy]phenyl]acetamide

H2N

OO

OHHN

(A) 50 mg

MM 0013.13 4-Hydroxyphenylacetic Acid HO

OOH (B) 100 mg

Atorvastatin Calcium MM 0400.00 Atorvastatin Calcium

N

F

NH

O

O

OOH

OH

-

2

Ca2+

(D) 100 mg

MM 0400.12 Imp. G (EP) as Calcium Salt: (3R,5R)-7-[2-(4-Fluorophenyl)-5-(1-methylethyl)-3-phenyl-4- (phenylcarbamoyl)-1H-pyrrol-1-yl]-5-hydroxy- 3-methoxyheptanoic Acid Calcium Salt (3-O-Methylatorvastatin Calcium Salt)

N

F

NH

O

O

OOH

O

-

2

Ca2+

(D) 100 mg




MM 0400.16 Imp. G (EP) as Lithium Salt: (3R,5R)-7-[2-(4- Fluorophenyl)-5-(1-methylethyl)-3-phenyl-4- (phenylcarbamoyl)-1H-pyrrol-1-yl]-5-hydroxy- 3-methoxyheptanoic Acid Lithium Salt (3-O-Methylatorvastatin Lithium Salt)

N

F

NH

O

O

OLiOH

O

(D) 100 mg

MM 0400.01 Imp. H (EP): (4R,6R)-6-[2-[2-(4-Fluorophenyl)- 5-(1-methylethyl)-3-phenyl-4-(phenylcarbamoyl)- 1H-pyrrol-1-yl]ethyl]-4-hydroxytetrahydro-2H- pyran-2-one (Atorvastatin Lactone)

N

F

NH

O O

OH

O (D) 100 mg

MM 0400.04 1,1-Dimethylethyl (4R-cis)-6-[2-[2-(4-Fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1-H-pyrrol-1-yl]ethyl]-2,2-dimethyl-1,3-dioxane-4-acetate

NNH

O O OO

F

O

(A) 100 mg

MM 0400.05 1,1-Dimethylethyl (4R-cis)-6-Aminoethyl-2,2-dimethyl-1,3-dioxane-4-acetate O

O

O O

H2N

(A) 100 mg

MM 0400.13 1-[2-[(2S)-3,6-Dihydro-6-oxo-2H-pyran-2-yl]-ethyl]-5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1H-pyrrole-3-carboxamide (Atorvastatin eliminated Lactone)

N

F

NH

O O

O (A) 100 mg

Atracurium Besilate MM 0858.13 Imp. J (EP): Methyl Benzenesulphonate

SO

O O (A) 100 mg

Atropine MM 0289.18 Atropine

O

O

N

OH

H

H

H

and enantiomer

(A) 250 mg

MM 0289.00 Atropine Sulphate

O

O

N

OH

H

2and enantiomer

x H2SO4x H2O

H

H (A) 500 mg

MM 0289.01 Imp. A (EP) as Hydrochloride: (1R,3r,5S)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 2-Phenylpropenoate Hydrochloride (Apoatropine Hydrochloride)

O

O

NH

x HCl

H

H (D) 100 mg

MM 0601.03 Imp. C (EP): (2RS)-3-Hydroxy-2-phenylpropanoic Acid (Tropic Acid)

OH

OH

O (A) 100 mg

MM 0546.00 Imp. F (EP) as Hydrobromide Trihydrate: Hyoscine Hydrobromide Trihydrate

ON

OH

H

H

H

O

H

H

x HBrx 3 H2O

O(A) 500 mg

MM 0289.03 Atropic Acid

OH

O (A) 100 mg

Avobenzone MM 0902.00 Avobenzone O O

O

(A) 500 mg




Azelaic Acid MM 0687.00 Azelaic Acid

HO OH

OO (A) 500 mg

Azelastine Hydrochloride MM 0362.00 Azelastine Hydrochloride

N

N

ON

Cl

x HCl

(A) 100 mg

MM 0362.04 Imp. A (EP): Benzoyldiazane (Benzohydrazide) NH

O

NH2

(C) 100 mg

New MM 0362.07 Imp. B (EP) as Dihydrochloride: 1-Benzoyl- 2-[(4RS)-1-methylhexahydro-1H-azepin-4-yl] diazane Dihydrochloride

HN

O

x 2 HClNH

N(A) 100 mg

MM 0362.05 Imp. C (EP): 2-[(4-Chlorophenyl)acetyl]benzoic Acid OH

O

O

Cl

(A) 100 mg

MM 0362.01 Imp. D (EP): 4-(4-Chlorobenzyl)phthalazin-1(2H)-one

N

NH

O

Cl

(A) 100 mg

MM 0362.06 Imp. E (EP) Z-Isomer: (Z)-3-(4-Chlorobenzylidene)-isobenzofuran-1(3H)-one O

O

Cl

(A) 100 mg

MM 0362.03 1-Methylazepan-4-one Hydrochloride

O

N x HCl(A) 100 mg

Azithromycin New MM 1075.00 Azithromycin

O

HO

OH

O

HO

O

O

OOH

N

O

N

O

OH

(A) 100 mg

MM 1075.01 Imp. A (EP): 6-Demethylazithromycin (Azaerythromycin A)

O

HO

OH

O

HO

O

O

O

OH

OO

N

OH

HN (D) 100 mg

Baclofen MM 1235.03 Imp. B (EP): (3RS)-5-Amino-3-(4-chlorophenyl)-

5-oxopentanoic Acid

Cl

OH

O

O

H2N

(A) 100 mg

MM 1235.01 3-(4-Chlorophenyl)glutaric Acid

Cl

OH

O

O

HO

(A) 100 mg




Bambuterol Hydrochloride MM 0773.04 Imp. D (EP): 5-[(1RS)-1-Hydroxyethyl]-1,3-phenylene

Bis(dimethylcarbamate) ON

O

O

OH

O

N

(A) 100 mg

MM 0773.05 Imp. E (EP): 5-Acetyl-1,3-phenylene Bis-(dimethylcarbamate) ON

O

O

O

O

N

(A) 100 mg

Basic Butylated Methacrylate Copolymer MM 0753.01 Imp. A (EP): Butyl Methacrylate O

O

(A) 100 mg

MM 0753.02 Imp. B (EP): Methyl Methacrylate O

O

(A) 100 mg

MM 0753.03 Imp. C (EP): 2-(Dimethylamino)ethyl Methacrylate O

ON

(A) 100 mg

Beclometasone Dipropionate MM 0199.00 Beclometasone Dipropionate

O

HO

O

O

O

Cl

O

O (A) 250 mg

MM 0199.02 Imp. A (EP): 9-Chloro-11,17-dihydroxy-16- methyl-3,20-dioxopregna-1,4-dien-21-yl Propanoate (Beclometasone 21-Propionate)

O

HO

Cl

OH

OO

O (A) 100 mg

MM 0199.06 Imp. B (EP): 21-(Acetyloxy)-9-chloro-11- hydroxy-16-methyl-3,20-dioxopregna-1,4- dien-17-yl Propanoate (Beclometasone 21- Acetate 17-Propionate)

O

HO

Cl

O

OO

O

O

(A) 100 mg

MM 0199.05 Imp. C (EP): 9-Chloro-11-hydroxy-16-methyl- 3,20-dioxo-17-(propanoyloxy)-pregna-1,4-dien- 21-yl Butanoate (Beclometasone 21-Butyrate 17-Propionate)

O

HO

Cl

O

OO

O

O

(A) 100 mg

MM 0199.01 Imp. H (EP): 9-Chloro-11,21-dihydroxy-16- methyl-3,20-dioxopregna-1,4-dien-17-yl Propanoate (Beclometasone 17-Propionate)

O

HO

Cl

O

OOHO (A) 100 mg

MM 0199.03 9-Chloro-11,17,21-trihydroxy-16-methylpregna- 1,4-diene-3,20-dione (Beclometasone)

O

HO

Cl

OH

OOH (A) 100 mg

Benazepril Hydrochloride New MM 1229.00 Benazepril Hydrochloride

N

OOH

O

HN

OO

x HCl

(A) 100 mg




Bendroflumethiazide MM 0674.01 Imp. A (EP): 4-Amino-6-(trifluoromethyl)benzene-1,3-disulphonamide S S

NH2

H2N

O

F

FF

O O

NH2

O (A) 100 mg

Benfluorex Hydrochloride New MM 0278.01 Imp. C (EP): Benzoic Acid

HO

O (B) 100 mg

Benperidol MM 0113.00 Benperidol

F

O

N

NHN

O (A) 100 mg

MM 0113.03 Imp. A (EP): 1-(Piperidin-4-yl)-1,3-dihydro-2H-benzimidazol-2-one

HN

NH

N

O (A) 100 mg

MM 0113.07 4-Chloro-4'-fluorobutyrophenone

F

O

Cl(B) 100 mg

Benzalkonium Chloride MM 0224.00 Benzalkonium Chloride

N

Cl

n

(A) 500 mg

MM 0795.00 Imp. A (EP): Benzyl Alcohol OH

(A) 500 mg

MM 0224.01 Benzyldimethyldodecylammonium Chloride N

Cl

5

(A) 500 mg

MM 0224.02 Benzyldimethyltetradecylammonium Chloride N

Cl

6

(A) 500 mg

MM 0224.03 Benzyldimethylhexadecylammonium Chloride N

Cl

7

(A) 500 mg

Benzbromarone MM 0456.00 Benzbromarone O

O

Br

OH

Br

(A) 500 mg

Benzocaine MM 0094.00 Benzocaine

H2N

O

O (A) 500 mg

MM 0094.01 Benzocaine Acetylsalicylamide

NH

O

O

O

O

O

(C) 50 mg

MM 0094.02 N-Acetylbenzocaine

NH

O

O

O

(A) 100 mg

MM 0094.03 4-Aminobenzoic Acid

H2N

OH

O (B) 100 mg

MM 0094.04 Ethyl 4-Nitrobenzoate

O2N

O

O (B) 100 mg




Benzydamine Hydrochloride MM 0142.00 Benzydamine Hydrochloride

NN

O N

x HCl

(A) 500 mg

MM 0142.04 Imp. C (BP): 1-Benzyl-1H-indazol-3-ol N

N

OH

(A) 100 mg

MM 0142.08 Benzydamine N-Oxide Hydrochloride N

N

O N

x HCl

O

(A) 100 mg

MM 0290.02 1-Chloropropyl(dimethyl)amine Hydrochloride (N,N-Dimethyl-3-chloropropylamine Hydrochloride)

Cl N x HCl (B) 100 mg

Benzyl Alcohol MM 0795.00 Benzyl Alcohol

OH

(A) 500 mg

MM 0795.02 Imp. B (EP): Cyclohexylmethanol OH (A) 100 mg

Benzyl Benzoate MM 0570.00 Benzyl Benzoate

O

O (A) 500 mg

Benzyl Nicotinate MM 0104.00 Benzyl Nicotinate

N O

O (A) 500 mg

MM 0553.00 Nicotinic Acid N OH

O (A) 500 mg

Benzylpenicillin Benzathine MM 0513.00 Benzylpenicillin Benzathine

N

SH

O

OOH

HN

NH

2

x HN

O

(A) 500 mg

MM 0513.02 Imp. A (EP): Monobenzylethylendiamine HNNH2 (C) 100 mg

MM 0160.03 Imp. B (EP): Phenylacetic Acid [Drug Precursor] OH

O

(B) 100 mg

MM 0160.07 Imp. D (EP): (3S,7R,7aR)-5-Benzyl-2,2-dimethyl-2,3,7,7a-tetrahydroimidazo[5,1-b]-thiazole-3,7-dicarboxylic Acid (Penillic Acid of Benzylpenicillin)

N

S

OOH

N

OHO

H

(A) 100 mg

MM 0160.01 Imp. E (EP): (4S)-2-[Carboxy[(phenylacetyl)amino]methyl]-5,5-dimethylthiazolidine-4-carboxylic Acid (Penicilloic Acids of Benzylpenicillin)

HN

S

OOH

HN

OO OH

(A) 100 mg

MM 0160.05 Imp. F (EP): (2RS,4S)-2-[[(Phenylacetyl)amino]methyl]-5,5-dimethylthiazolidine-4-carboxylic Acid (Penilloic Acids of Benzylpenicillin)

HN

S

OOH

HN

O

(A) 100 mg

MM 0513.01 N,N’-Dibenzylethylenediamine Diacetate

HO

Ox

2

HN

NH

(C) 100 mg




Benzylpenicillin Potassium MM 0160.00 Benzylpenicillin Potassium

N

SH

O

NH

O

OOK (A) 250 mg


N

SH

O

H2N

OOH (B) 100 mg

MM 0160.03 Imp. B (EP): Phenylacetic Acid [Drug Precursor] O

OH

(B) 100 mg

MM 0160.07 Imp. D (EP): (3S,7R,7aR)-5-Benzyl-2,2-dimethyl-2,3,7,7a- tetrahydroimidazo[5,1-b]-thiazole-3,7-dicarboxylic Acid (Penillic Acid of Benzylpenicillin)

N

S

OOH

N

OHO

H

(A) 100 mg

MM 0160.01 Imp. E (EP): (4S)-2-[Carboxy[(phenylacetyl)amino]methyl]-5,5-dimethyl-thiazolidine-4-carboxylic Acid (Penicilloic Acids of Benzylpenicillin)

HN

S

OOH

HN

OO OH

(A) 100 mg

MM 0160.05 Imp. F (EP): (2RS,4S)-2-[[(Phenylacetyl)amino]methyl]-5,5-dimethylthiazolidine-4-carboxylic Acid (Penilloic Acids of Benzylpenicillin)

HN

S

OOH

HN

O

(A) 100 mg

Benzylpenicillin Procaine MM 0094.03 Imp. A (EP): 4-Aminobenzoic Acid

OH

H2N

O (B) 100 mg

MM 0160.01 Imp. B (EP): (4S)-2-[Carboxy[(phenyl-acetyl)amino]methyl]- 5,5-dimethyl-thiazolidine-4-carboxylic Acid (Penicilloic Acids of Benzylpenicillin)

HN

S

OOH

HN

OO OH

(A) 100 mg

MM 0160.05 Imp. C (EP): (2RS,4S)-2-[[(Phenylacetyl)-amino]methyl]- 5,5-dimethylthiazolidine-4-carboxylic Acid (Penilloic Acids of Benzylpenicillin)

HN

S

OOH

HN

O

(A) 100 mg

MM 0160.07 Imp. D (EP): (3S,7R,7aR)-5-Benzyl-2,2-dimethyl-2,3,7,7a- tetrahydroimidazo[5,1-b]thiazole-3,7-dicarboxylic Acid (Penillic Acid of Benzylpenicillin)

N

S

OOH

N

OHO

H

(A) 100 mg

MM 0160.03 Imp. E (EP): Phenylacetic Acid [Drug Precursor] OH

O

(B) 100 mg

Betahistine Dihydrochloride MM 0587.00 Betahistine Dihydrochloride N

HN

x 2 HCl(A) 500 mg

MM 0587.01 Imp. A (EP): 2-Ethenylpyridine (2-Vinylpyridine) N (C) 100 mg

MM 0587.02 Imp. B (EP): 2-(Pyridin-2-yl)ethanol (2-(2-Hydroxyethyl)pyridine) N OH (B) 100 mg

MM 0587.03 Imp. C (EP) as Trihydrochloride: N-Methyl-2-(pyridin-2-yl)-N-[2-(pyridin-2-yl)ethyl]ethanamine Trihydrochloride

N N Nx 3 HCl

(A) 100 mg

MM 0587.04 Imp. C (EP) as Trimesilate: N-Methyl-2-(pyridin-2-yl)-N-[2-(pyridin-2-yl)ethyl]ethanamine Trimesilate

N N Nx 3 S

OH

OO(A) 100 mg

Betaine Hydrochloride MM 0611.00 Betaine Hydrochloride

NOH

OCl

(A) 500 mg




Betamethasone MM 0200.00 Betamethasone

O

HO

F

OH

O

OH(A) 250 mg

MM 0213.00 Imp. A (EP): Dexamethasone

O

HO

F

OH

O

OH(A) 250 mg

MM 0200.01 Imp. B (EP): 21-Chloro-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione (Clobetasol)

O

HO

F

OH

O

Cl(A) 100 mg

Betamethasone Acetate MM 0201.00 Betamethasone Acetate

O

O

OHHO

F

O

O (A) 250 mg

MM 0200.00 Imp. A (EP): Betamethasone

O

O

OHHO

F

OH (A) 250 mg

MM 0445.00 Imp. B (EP): Dexamethasone Acetate

O

O

OHHO

F

O

O (A) 250 mg

MM 0201.03 Imp. C (EP): Betamethasone 11,21-Diacetate

O

O

F

OH

O

O

OO (A) 100 mg

Betamethasone Dipropionate MM 0200.00 Imp. A (Pharmeuropa): 9-Fluoro-11,17,21-

trihydroxy-16-methylpregna-1,4-diene-3,20- dione (Betamethasone)

O

HO

F

OH

OOH (A) 250 mg

MM 0202.00 Betamethasone Dipropionate

O

O

OHO

F

O

O

O

(A) 250 mg

MM 0202.04 Imp. C (Pharmeuropa): 9-Fluoro-11,17-dihydroxy- 16-methyl-3,20-dioxopregna-1,4-dien-21-yl Propanoate(Betamethasone 21-Propionate)

O

HO

F

OH

OO

O (A) 100 mg

MM 0199.00 Imp. E (Pharmeuropa): 9-Chloro-11-hydroxy- 16-methyl-3,20-dioxopregna-1,4-diene-17,21- diyl Dipropanoate (Beclometasone Dipropionate)

O

HO

Cl

O

OO

O

O

(A) 250 mg




Betamethasone Sodium Phosphate MM 0303.00 Betamethasone Sodium Phosphate

O

O

OHHO

F

O P

O

ONa

ONaon request

Betamethasone 17-Valerate MM 0203.00 Betamethasone 17-Valerate

O

O

OHO

F

OHO

(A) 250 mg

MM 0200.00 Imp. A (EP): Betamethasone

O

HO

F

OH

OOH (A) 250 mg

Betaxolol Hydrochloride MM 0436.01 Imp. A (EP) as Hydrochloride: (2RS)-

1-(4-Ethylphenoxy)-3-[(1-methylethyl)amino]-propan-2-ol Hydrochloride

O

OHHN x HCl

(A) 50 mg

MM 0027.10 Imp. B (EP): (2RS)-1-[4-(2-Hydroxyethyl)phenoxy]- 3-[(1-methylethyl)amino]propan-2-ol

HO

O

OHHN

(A) 100 mg

MM 0436.03 Imp. C (EP): 2-[[4-[2-(Cyclopropylmethoxy)-ethyl]phenoxy]methyl]oxirane

O

OO

(A) 50 mg

MM 0436.04 Imp. D (EP): 4-[2-(Cyclopropylmethoxy)ethyl]phenol

O

OH (A) 50 mg

MM 0436.05 Imp. E (EP) as Hydrochloride: (2RS)-1-[4-(2-Butoxyethyl)phenoxy]-3-[(1-methylethyl)amino]propan-2-ol Hydrochloride O

O

OHHN

x HCl

(A) 50 mg

New MM 0436.06 1-[4-(2-Cyclobutoxyethyl)phenoxy]-3-(isopropylamino)propan-2-ol Hydrochloride

O

O

OHHN

x HCl

(D) 50 mg

Bezafibrate MM 0063.00 Bezafibrate

Cl

NH

OO

OH

O (A) 500 mg

MM 0063.01 Imp. A (EP): 4-Chloro-N-[2-(4-hydroxyphenyl)ethyl]benzamide (4-Chlorobenzoyltyramine)

Cl

NH

OOH (A) 100 mg

MM 0063.03 Imp. B (EP): 4-Chlorobenzoic Acid

Cl

O

OH

(B) 100 mg

MM 0063.04 Imp. C (EP): Methyl-2-[4-[2-[(4-Chlorobenzoyl)amino]ethyl]phenoxy]- 2-methylpropanoate

Cl

NH

OO

O

O (A) 100 mg

MM 0063.02 Imp. D (EP): Ethyl 2-[4-[2-[(4-Chlorobenzoyl)amino]- ethyl]phenoxy]-2-methylpropanoate

Cl

NH

OO

O

O (A) 100 mg

MM 0063.05 Imp. E (EP): Butyl 2-[4-[2-[(4-Chlorobenzoyl)amino]- ethyl]phenoxy]-2-methylpropanoate

Cl

NH

OO

O

O (A) 100 mg




MM 0063.06 Tyramine H2N

OH (B) 100 mg

MM 0063.07 N,O-Bis-(4-chlorobenzoyl)tyramine

NH

O

O

O

Cl

Cl (A) 100 mg

Bicalutamide MM 0894.00 Bicalutamide F

S

O O

NH

O

OH

N

F

F F

(A) 100 mg

MM 0894.01 N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfinyl]-2-hydroxy-2-methylpropanamide

F

SHN

O

HO

N

F

F FO (A) 50 mg

Bifonazole MM 0318.00 Bifonazole

N

N

(A) 500 mg

MM 0318.01 Imp. A (EP): (RS)-(Biphenyl-4-yl)phenylmethanol

OH

(A) 100 mg

MM 0015.02 Imp. C (EP): 1H-Imidazole (Imidazole)

N

HN (B) 100 mg

MM 0318.03 Imp. D (EP) as Chloride: 1,3-Bis[(biphenyl-4-yl)- phenylmethyl]-1H-imidazolium Chloride

N+

N

Cl-

(D) 100 mg

Bisacodyl MM 0031.00 Bisacodyl

N

O

O

O

O

(A) 500 mg

MM 0031.01 Imp. A (EP): 4,4'-(Pyridin-2-ylmethylene)diphenol

N

HO OH (A) 100 mg

MM 0031.04 Imp. B (EP): 2-[(RS)-(4-Hydroxyphenyl)(pyridin-2-yl)methyl]phenol

N

OH OH (A) 50 mg

MM 0031.02 Imp. C (EP): 4-[(RS)-(4-Hydroxyphenyl)(pyridin-2-yl)methyl]phenyl Acetate

N

HO O

O

(A) 100 mg

MM 0031.03 Imp. E (EP): 2-[(RS)-[4-(Acetyloxy)phenyl](pyridin-2-yl)methyl]phenyl Acetate

N

O

O

O

O

(A) 50 mg

MM 0054.01 4-[(RS)-(4-Hydroxyphenyl)(pyridin-2-yl)-methyl]phenyl Sodium Sulphate (4-[(Pyridin-2-yl)(4-hydroxyphenyl)methyl]phenyl Sodium Sulphate) N

HO OS

ONa

O O

(A) 100 mg




MM 0054.02 2-[(RS)-(Pyridin-2-yl)[4-(sulphonatooxy)- phenyl]methyl]phenyl Disodium Sulphate (2,4'-[(Pyridin-2-yl)methylene]bisphenyl Bis(Sodium Sulphate)) N

O

OS

SNaO

ONa

O O

O O

(D) 50 mg

Bisoprolol Fumarate MM 0460.00 Bisoprolol

O

OH HN

OO

(A) 100 mg

MM 0460.08 Bisoprolol Fumarate O

OHHN

OO

OH

HO

O

O

2

x

(A) 100 mg

MM 0460.01 Imp. A (EP): (RS)-1-(4-Hydroxymethyl- phenoxy)-3-isopropylaminopropan-2-ol O

OHHN

OH

(A) 100 mg

MM 0460.07 Imp. B (EP): (RS)-1-Isopropylamino-3-[4-(2- propoxyethoxymethyl)phenoxy]propan-2-ol O

OHHN

OO

(A) 100 mg

MM 0460.15 Imp. C (EP): (RS)-1-[4-[4-(2-Hydroxy- 3-isopropylaminopropoxy)benzyl]- phenoxy]-3-isopropylaminopropan-2-ol

O

OHHNO

HN

OH (A) 100 mg

MM 0460.21 Imp. G (EP): (2RS)-1-[4-[[(2-Isopropoxy- ethoxy)methoxy]methyl]phenoxy]-3-isopropylaminopropan-2-ol

O

OHHN

O OO

(D) 100 mg

MM 0460.24 Imp. J (Pharmeuropa): (2RS)-3-[4-((2-Isopropoxy- ethoxy)methyl)phenoxy]-1,2-propanediol O

OH

OH

O

O

(A) 100 mg

MM 0460.18 Imp. K (EP): 2-Isopropoxyethyl 4-[[(2RS)- 2-Hydroxy-3-(isopropylamino)propyl]oxy]- benzoate (Bisoprolol Ester)

O

OHHN

O

O

O

(A) 100 mg

MM 0027.24 Imp. L (EP) as Hydrochloride: 4-[[(2RS)-2-Hydroxy-3-(isopropylamino)propyl]oxy]benzaldehyde Hydrochloride (4-[(2RS)-2-Hydroxy-3-[(1-methylethyl)amino]propoxy]-benzaldehyde Hydrochloride)

O

OHHN

O

x HCl

(A) 100 mg

MM 0460.02 Imp. M (Pharmeuropa): 4-[(2-Isopropoxyethoxy)methyl]phenol OH

O

O

(A) 100 mg

MM 0460.25 Imp. N (EP): [(2RS)-1-[4-[(2-Ethoxyethoxy)- methyl]phenoxy]-3-isopropylaminopropan-2-ol O

OHHN

O

O

(A) 100 mg

MM 0460.05 Imp. Q (EP): (2RS)-1-(Isopropylamino)-3-[4-(2- methoxyethoxy)methyl]phenoxypropan-2-ol O

OHHN

O

O

(A) 100 mg

MM 0460.28 Imp. R (EP): (2RS)-1-(Isopropylamino)-3-(4- methylphenoxy)propan-2-ol O

OHHN

(A) 50 mg

MM 0460.14 Imp. S (EP): 4-Hydroxybenzaldehyde OH

O

(C) 100 mg

MM 0460.17 Imp. T (EP): 4-[(3-Isopropyl-2-oxo-1,3-oxazolidin-5- yl)methoxy]benzaldehyde (Bisoprolol Oxazolidinone- benzaldehyde) O N

O

O

O

(A) 50 mg




MM 0460.16 Imp. U (EP): 5-[[4-(Hydroxymethyl)phenoxy]- methyl]-3-isopropyl-1,3-oxazolidin-2-one (Bisoprolol Oxazolidinonebenzylalcohol) O

NO

O

HO

(A) 50 mg

MM 0460.27 (2RS)-4-[2-Hydroxy-3-(isopropylamino)propoxy]- benzoic Acid Hydrochloride O

OHHN

O

HOx HCl

(A) 50 mg

MM 0460.03 2-[4-(2-Isopropoxyethoxymethyl)phenoxymethyl]oxirane O

OO

O (A) 100 mg

MM 0460.06 4-Hydroxybenzyl Alcohol OH

HO

(B) 100 mg

MM 0460.10 Fumaric Acid OH

HO

O

O (B) 100 mg

New MM 0460.23 (2RS)-1-[4-((2-Hydroxyethoxy)methyl)phenoxy]-3-(isopropylamino)-2-propanol O

OHHN

O

HO

(A) 50 mg

Boldenone MM 0864.00 Boldenone

O

OH (A) 100 mg

Brimonidine Tartrate New MM 1324.00 Brimonidine Tartrate

NH

Br

NH

NN

NHO

OH

OH

OH

O

O

x

(A) 100 mg

Bromazepam MM 0064.00 Bromazepam [Controlled Substance]

N

HN

N

O

Br

(A) 100 mg

MM 0064.01 Imp. A (EP): (2-Amino-5-bromophenyl)(pyridin-2-yl)methanone

Br

NH2

O

N

(A) 100 mg

MM 0064.02 Imp. B (EP): N-[4-Bromo-2-(pyridin-2- ylcarbonyl)phenyl]-2-chloroacetamide

Br

NH

O

N

OCl (A) 50 mg

MM 0064.09 Imp. C (EP): 7-Bromo-5-(6-methylpyridin-2-yl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one

N

HN

N

O

Br

(A) 50 mg

MM 0064.04 Imp. D (EP): 3-Amino-6-bromo-4-(pyridin- 2-yl)quinolin-2(1H)-one

Br

HN

N

NH2

O (A) 50 mg

MM 0064.07 Imp. E (EP): 2-Bromo-N-[4-bromo-2-(pyridin- 2-ylcarbonyl)phenyl]acetamide

Br

NH

O

N

OBr (A) 50 mg




Bromhexine Hydrochloride MM 0065.00 Bromhexine Hydrochloride Br

Br

NH2

Nx HCl

(A) 500 mg

MM 0005.01 Imp. A (EP): (2-Amino-3,5-dibromophenyl)methanol

Br

NH2

BrOH (A) 100 mg

MM 0005.02 Imp. B (EP): 2-Amino-3,5-dibromobenzaldehyde

Br

NH2

BrO (A) 100 mg

MM 0065.02 Imp. C (EP): N-(2-Aminobenzyl)-N-methylcyclohexanamine

NH2

N

(A) 100 mg

MM 0065.03 Imp. D (EP) as Dihydrochloride: N-(2-Amino-5-bromobenzyl)-N-methylcyclohexanamine Dihydrochloride

NH2

N

Br

x 2 HCl

(A) 100 mg

MM 0065.01 N-(2-Nitrobenzyl)-N-cyclohexyl-N-methylamine

NO2

N

(A) 100 mg

MM 0065.05 6,8-Dibromo-3-cyclohexyl-3,4-dihydro-2(1H)-quinazolinone Br

Br

HN N

O

(A) 100 mg

MM 0065.09 Bromhexine N-Oxide Br

Br

NH2

N

O

(A) 100 mg

Bromisoval MM 1128.01 Ethyl 2-Bromoisovalerate

Br

O

O (A) 100 mg

Brompheniramine Maleate MM 0060.00 Brompheniramine Maleate O

OH

O

OHx

N

Br

N

(A) 500 mg

MM 0090.00 Imp. A (EP) as Maleate: Chlorphenamine Maleate O

OH

O

OHx

N

Cl

N

(A) 500 mg

MM 1114.00 Imp. B (EP) as Maleate: Dexchlorpheniramine Maleate O

OH

O

OHx

N

Cl

N

(A) 100 mg

MM 0059.01 Imp. C (EP): (3RS)-N,N-Dimethyl-3-phenyl-3-(pyridin-2-yl)- propan-1-amine (Pheniramine) N

N

(A) 100 mg

MM 0059.00 Imp. C (EP) as Maleate: (3RS)-N,N-Dimethyl- 3-phenyl-3-(pyridin-2-yl)propan-1-amine Maleate (Pheniramine Maleate)

O

OH

O

OHx

N

N

(A) 100 mg




MM 0060.12 Brompheniramine N-Oxide N

Br

NO

on request

MM 0060.16 Desmethylbrompheniramine Maleate O

OH

O

OHx

N

Br

NH

(A) 100 mg

Buclizine Hydrochloride MM 0380.04 Imp. A (BP): 1,4-Bis(4-chlorobenzhydryl)piperazine

(1,4-Bis[(4-chlorophenyl)phenylmethyl]piperazine)

N

N

Cl

Cl

(A) 100 mg

MM 0380.09 4-Chlorobenzhydrol OH

Cl (B) 100 mg

MM 0380.10 4-Chlorobenzophenone O

Cl (B) 100 mg

MM 0380.01 1-(4-Chlorobenzhydryl)piperazine((RS)-1-[(4-Chlorophenyl)phenylmethyl]piperazine)

NH

N

Cl (A) 100 mg

Budesonide MM 0204.01 Imp. A (EP): 11,16,17,21-Tetrahydroxy-

pregna-1,4-diene-3,20-dione (16-Hydroxy- prednisolone)

O

HO

OH

O

OH OH

(A) 100 mg

New MM 0204.02 Imp. B (EP): 16,17-[(1RS)-Ethylidenebis(oxy)]- 11,21-dihydroxypregna-1,4-diene-3,20-dione

O

HO

O

OOH

O

(A) 50 mg

Bufexamac MM 0179.00 Bufexamac

O

HN

OH

O

(A) 500 mg

MM 0179.01 Imp. A (EP): 2-(4-Butoxyphenyl)acetic Acid O

OH

O

(A) 100 mg

MM 0179.02 Imp. B (EP): Methyl 2-(4-Butoxyphenyl)acetate O

O

O

(A) 100 mg

MM 0179.03 Imp. C (EP): Butyl 2-(4-Butoxyphenyl)acetate O

O

O

(A) 100 mg

MM 0179.04 Imp. D (EP): 2-(4-Butoxyphenyl)acetamide O

NH2

O

(A) 100 mg

MM 0179.05 4'-Butoxyacetophenone

O

O (A) 100 mg

MM 0179.06 Ethyl 2-(4-Butoxyphenyl)acetate

O

O

O

on request




Buflomedil Hydrochloride MM 0066.00 Buflomedil Hydrochloride

N

OO

OOx HCl

(A) 500 mg

MM 0066.01 Imp. A (EP) as Hydrochloride: 4-(Pyrrolidin-1-yl)-1- (2-hydroxy-4,6-dimethoxyphenyl)butan-1-one Hydrochloride(o-Desmethyl-Buflomedil Hydrochloride)

N

OOH

OOx HCl

(A) 100 mg

MM 0066.02 Imp. B (EP) as Hydrochloride: 4-(Pyrrolidin-1-yl)-1-(4-hydroxy-2,6-dimethoxyphenyl)butan-1-one Hydrochloride(p-Desmethyl-Buflomedil Hydrochloride)

N

OO

OHOx HCl

(A) 100 mg

MM 0066.03 4-(1-Pyrrolidino)butyronitrile N

N (C) 100 mg

MM 0066.05 1,3,5-Trimethoxybenzene O

OO

(C) 100 mg

Bunolol Hydrochloride MM 0642.00 Bunolol Hydrochloride

O

OHHN x HClO

(A) 100 mg

Buphenine Hydrochloride MM 0710.00 Buphenine Hydrochloride

HO

OH

HNx HCl

(A) 500 mg

Bupivacaine Hydrochloride MM 0613.00 Bupivacaine Hydrochloride Monohydrate

HN

O

Nx HClx H2O

(A) 500 mg

MM 0368.03 Imp. A (EP): N-(2,6-Dimethylphenyl)pyridine- 2-carboxamide

HN

O

N

(A) 100 mg

MM 0613.05 Imp. E (EP) as Hydrochloride: 6-(Butylamino)-N-(2,6-dimethylphenyl)hexanamide Hydrochloride

HN

O

NH

x HCl

(A) 50 mg

MM 0102.02 Imp. F (EP): 2,6-Dimethylaniline NH2

(B) 100 mg

MM 0613.07 Bupivacaine N-Oxide HN

O

NO

(A) 100 mg

Bupropion Hydrochloride MM 0745.00 Bupropion Hydrochloride

Cl

OHN

x HCl

(A) 100 mg

MM 0745.02 2-(tert-Butylamino)-4'-chloropropiophenone Hydrochloride OHN

x HCl

Cl

(A) 100 mg

MM 0745.03 2-(tert-Butylamino)-3'-bromopropiophenone Hydrochloride OHN

x HClBr

on request

MM 0745.05 2-(tert-Butylamino)propiophenone Hydrochloride OHN

x HCl

(A) 100 mg

MM 0745.07 1-(3-Chlorophenyl)-1-hydroxy-2-propanone Cl

OH

O(D) 100 mg

MM 0745.08 3-Chloropropiophenone Cl

O (B) 100 mg




Buspirone Hydrochloride MM 0464.00 Buspirone Hydrochloride N

NN

N

N

O

O

x HCl

(A) 500 mg

MM 0464.02 Imp. A (EP) as Dihydrochloride: 2-(Piperazin- 1-yl)pyrimidine Dihydrochloride

HN

N

N

N x 2 HCl

(A) 100 mg

New MM 0464.04 Imp. C (EP): 2,2'-[Butane- 1,4-diylbis(piperazine- 1,4-diyl)]dipyrimidine

N

NN

N

N

N

N

N

(A) 50 mg

New MM 0464.12 Imp. G (EP): 2,2'-(Piperazine-1,4-diyl)dipyrimidine

N

NN

N

N

N

(A) 50 mg

New MM 0464.14 Imp. I (EP): 8-[4-[4-(5-Chloropyrimidin-2- yl)-piperazin-1-yl]butyl]-8-azaspiro [4.5]decane-7,9-dione

N

O

O

N

N

N

N

Cl

(A) 50 mg

MM 0464.08 Imp. K (EP): 8-Azaspiro[4,5]-decane-7,9-dione

NH

O

O

(B) 100 mg

New MM 0464.09 Imp. L (EP): 8-(4-Chlorobutyl)-8-azaspiro[4.5]-decane-7,9-dione

N

O

O

Cl

(A) 50 mg

New MM 0464.16 Imp. M (EP): 8-(4-Bromobutyl)-8-azaspiro[4.5]- decane-7,9-dione

N

O

O

Br

(A) 50 mg

Butalbital MM 0899.00 5,5-Diallybarbituric acid (Allobarbital)

[Controlled Substance] NH

HN OO

O

(A) 100 mg

Butenafine Hydrochloride MM 1041.00 Butenafine Hydrochloride

Nx HCl

on request

Butetamate Citrate MM 0606.00 Butetamate Citrate

O

O

N

x

OH

O

OH

O

OHO

OH

(A) 500 mg

Butyl Parahydroxybenzoate MM 0496.00 Butyl Parahydroxybenzoate

HO

O

O (A) 500 mg

MM 0045.01 Imp. A (EP): 4-Hydroxybenzoic Acid

HO

OH

O (B) 100 mg




MM 0431.00 Imp. B (EP): Methyl 4-Hydroxybenzoate (Methyl Parahydroxybenzoate)

HO

O

O (A) 500 mg

MM 0498.00 Imp. C (EP): Ethyl 4-Hydroxybenzoate (Ethyl Parahydroxybenzoate)

HO

O

O (A) 500 mg

MM 0432.00 Imp. D (EP): Propyl 4-Hydroxybenzoate (Propyl Parahydroxybenzoate)

HO

O

O (A) 500 mg

MM 0496.05 Imp. E (EP): 2-Methylpropyl 4-Hydroxy- benzoate (Isobutyl Parahydroxybenzoate)

HO

O

O (A) 100 mg

Butylhydroxytoluene MM 0679.00 Butylhydroxytoluene

OH

(A) 500 mg

Caffeine MM 0494.00 Caffeine

N

N N

N

O

O

(A) 500 mg

MM 0176.00 Imp. A (EP): Theophylline N

N N

HN

O

O (A) 500 mg

MM 0176.02 Imp. B (EP): N-(6-Amino-1,3-dimethyl-2,4-dioxo- 1,2,3,4-tetrahydropyrimidin-5-yl)formamide N

NO

O

NH2

HN O

(A) 100 mg

MM 0494.03 Imp. C (EP): 1,3,9-Trimethyl-3,9-dihydro- 1H-purine-2,6-dione (Isocaffeine) N

N N

N

O

O

(A) 50 mg

MM 0577.00 Imp. D (EP): Theobromine HN

N N

N

O

O

(A) 500 mg

MM 0494.06 Imp. E (EP) as Nitrate: N,1-Dimethyl-4- (methylamino)-1H-imidazole-5-carboxamide Nitrate (Caffeidine Nitrate)

NH

HN N

N

O

x HNO3

(A) 100 mg

MM 0494.04 Imp. F (EP): 1,7-Dimethyl-3,7-dihydro-1H-purine-2,6-dione (Paraxanthine; 1,7-Dimethylxanthine) N

NNH

N

O

O

(D) 50 mg

Candesartan Cilexetil New MM 0776.00 Candesartan Cilexetil

NH

NN

NN

NO

O

OO

O

O(A) 100 mg

New MM 0776.01 Imp. A (EP): Ethyl 2-Ethoxy-1-[[2'-(1H- tetrazol-5-yl)biphenyl-4-yl]methyl]-1H- benzimidazole-7-carboxylate NH

NN

NN

NO

O

O(A) 100 mg




New MM 0776.09 Imp. G (EP): 2-Ethoxy-1-[[2'-(1H-tetrazol-5-yl)- biphenyl-4-yl]methyl]-1H-benzimidazole-7- carboxylic Acid (Candesartan) NH

NN

NN

NO

O

OH(A) 100 mg

New MM 0776.07 Imp. H (EP): (1RS)-1-[[(Cyclohexyloxy)carbonyl]- oxy]ethyl 2-Ethoxy-1-[[2'-[1-(triphenylmethyl)-1H- tetrazol-5-yl]biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (N-Tritylcandesartan Cilexetil) N

NN

NN

NO

O

OO

O

O(A) 100 mg

New MM 0776.08 Trityl Candesartan

N

NN

NN

NO

O

OH(A) 100 mg

Capecitabine New MM 0992.00 Capecitabine

ON

N

O

HN O

F

O

OH OH

on request

New MM 0992.02 2,3-O-Carbonyl-5-deoxy-5-fluoro-N4-(pentyloxycarbonyl)cytidine

ON

N

O

HN O

F

O

O O

O

(A) 100 mg

Captopril MM 0067.00 Captopril

NHS

OO OH (A) 500 mg

MM 0067.01 Imp. A (EP): 1,1'-[Disulfanediylbis- [(2S)-2-methyl-1-oxopropane-3,1-diyl]- bis[(2S)-pyrrolidine-2-carboxylic] Acid (Captopril Disulfide)

NS

OO OH

N S

OOHO

(A) 100 mg

MM 0067.02 Imp. C (EP): (2RS)-2-Methyl-3-sulfanylpropanoic Acid OHHS

O (A) 100 mg

MM 0067.06 Imp. D (EP): (2RS)-3-Bromo-2-methylpropanoic Acid O

OHBr

(A) 100 mg

MM 0067.08 Imp. E (EP): (2S)-1-[2-Methylpropanoyl]pyrrolidine-2-carboxylic Acid

N

OO OH (A) 100 mg

MM 0067.05 Imp. J (EP) as Hydrate: (2S)-1-[(2S)-3-(Acetylsulfanyl)-2-methylpropanoyl]-pyrrolidine-2-carboxylic Acid Hydrate (Acetylcaptopril Hydrate)

NS

OO OH

Ox H2O

(A) 100 mg

MM 0067.04 Imp. K (Pharmeuropa): (2S)-3-(Acetylthio)-2-methylpropanoic Acid OHS

OO (C) 100 mg

MM 0067.15 Imp. N (EP): 3,3'-Disulfanediylbis[(2S)-2- methylpropanoic] Acid OHS

O

SHO

O

(A) 50 mg

MM 0067.03 Captopril Ethyl Ester

NHS

OO O on request




Carbamazepine MM 0076.00 Carbamazepine O

NH2N

(A) 250 mg

MM 0076.04 Imp. A (EP): 10,11-Dihydro-5H-dibenzo[b,f]-azepine-5-carboxamide (10,11-Dihydrocarbamazepine)

O

NH2N

(A) 100 mg

MM 0076.09 Imp. B (EP): 9-Methylacridine

N

(A) 100 mg

MM 0076.12 Imp. C (EP): (5H-Dibenzo[b,f]azepin-5-yl-carbonyl)urea (N-Carbamoylcarbamazepine)

O

NH

N NH2

O (A) 100 mg

MM 0076.08 Imp. D (EP): 5H-Dibenzo[b,f]azepine (Iminostilbene)

NH

(B) 100 mg

MM 0076.06 Imp. E (EP): 10,11-Dihydro-5H-dibenzo[b,f]-azepine (Iminodibenzyl)

NH

(B) 100 mg

MM 0076.01 Carbamazepine 10,11-Epoxide O

NH2N

O

(A) 100 mg

MM 0076.05 Imp. G (EP): 10-Bromo-5H-dibenzo[b,f]azepine- 5-carboxamide (10-Bromocarbamazepine)

O

NH2N

Br

(A) 100 mg

MM 0076.10 10-Hydroxy-10,11-dihydrocarbamazepine O

NH2N

HO

(A) 100 mg

MM 0076.17 Oxcarbazepine O

NH2N

O

(A) 100 mg

Carbasalate Calcium MM 0133.02 Imp. A (EP): 2-(Acetyloxy)benzoic Anhydride

(Acetylsalicylic Anhydride)

O

O O O

O

O

O

(A) 100 mg

MM 0133.01 Imp. B (EP): 2-[[2-(Acetyloxy)benzoyl]oxy]benzoic Acid (Acetylsalicylsalicylic Acid)

O

OH

O

O

O

O

(A) 100 mg


O

OH

(A) 500 mg




MM 0133.03 Imp. D (EP): 2-[(2-Hydroxybenzoyl)oxy]benzoic Acid (Salicylsalicylic Acid)

O

OH

O

O

OH

(A) 100 mg

Carbendazim MM 2500.00 Carbendazim

N

HN

NH

O

O (A) 100 mg

MM 2500.01 2,3-Diaminophenazine

N

N NH2

NH2

(A) 100 mg

MM 2500.02 2-Amino-3-hydroxyphenazine

N

N NH2

OH

(A) 100 mg

Carbenicillin Sodium MM 0805.00 Carbenicillin Sodium

N

SH

O

NH

O

OONa

ONaO

(A) 250 mg

Carbocisteine MM 0236.00 Carbocisteine

S OH

NH2

O

HO

O

(A) 500 mg

MM 0236.01 (S)-Carboxymethyl-L-cysteine (R/S)-Sulphoxide S OH

NH2

O

HO

O O

(A) 100 mg

MM 0236.02 Lactam of (S)-Carboxymethyl-L-cysteine

OH

O

NH

S

O (A) 100 mg

MM 0236.03 L-Cysteinesulfinic Acid S OH

NH2

O

HO

O

(C) 100 mg

Carisoprodol MM 0782.03 Imp. C (EP): 2-Methyl-2-propylpropane-1,3-diol HO OH (A) 100 mg

Carvedilol MM 0291.00 Carvedilol

O

O

HN

OH

O

HN

(A) 100 mg

MM 0291.02 Imp. B (EP): 1,1'-[[2-(2-Methoxyphenoxy)- ethyl]nitrilo]bis[3-(9H-carbazol-4-yloxy)propan-2-ol]

O

ON

OH

O

HN

OH

O NH

(A) 100 mg

MM 0291.03 Imp. C (EP): (2RS)-1-[Benzyl[2-(2-methoxyphenoxy)- ethyl]amino]-3-(9H-carbazol-4-yloxy)propan-2-ol

O

ON

OH

O

HN

(A) 100 mg

MM 0291.04 Toluene (C) 100 mg




MM 0291.10 4-(2,3-Epoxypropoxy)carbazole O

HN

O (A) 100 mg

MM 0291.11 2-(2-Methoxyphenoxy)ethylamine Hydrochloride O

OH2N

x HCl

(A) 100 mg

Cefaclor MM 0326.00 Cefaclor Monohydrate

N

S

Cl

O OH

O

H

HN

O

NH2x H2O

(A) 100 mg

MM 0253.12 Imp. A (EP): (2R)-2-Amino-2-phenylacetic Acid (D-Phenylglycine)

O

OH

NH2 (B) 100 mg

MM 0253.08 Imp. F (EP): 3-Phenylpyrazin-2-ol

N

N OH (A) 100 mg

Cefadroxil Monohydrate MM 0232.09 Imp. A (EP): (2R)-2-Amino-2-(4-hydroxyphenyl)acetic Acid

HO

NH2

OH

O

(B) 100 mg

MM 0811.01 Imp. B (EP): (6R,7R)-7-Amino-3-methyl-8-oxo- 5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid (7-ADCA; 7-Aminodesacetoxycephalosporanic Acid)

N

S

O OH

O

H2N H

(A) 100 mg

Cefalexin Monohydrate MM 0605.00 Cefalexin Monohydrate

N

H

O

HN

NH2

O

x H2O

S

O OH (A) 500 mg

MM 0253.12 Imp. A (EP): (2R)-2-Amino-2-phenylacetic Acid (D-Phenylglycine)

O

OH

NH2 (B) 100 mg

MM 0811.01 Imp. B (EP): (6R,7R)-7-Amino-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid (7-Aminodesacetoxycephalosporanic Acid; 7-ADCA)

N

S

O OH

O

H2N H

(A) 100 mg

Cefazolin Sodium MM 0238.00 Cefazolin Sodium

N

S

O ONa

OS

S

N

NH

HN

N

NN

N O

(A) 100 mg

MM 0238.05 Imp. E (EP): 5-Methyl-1,3,4-thiadiazol-2-thiol (MMTD)

N

NS

SH (A) 100 mg

MM 0238.08 Imp. H (EP): (6R,7R)-3-[(Acetyloxy)methyl]-7-amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid (7-ACA)

N

S

O OH

OO

HH2N

O (A) 100 mg

Cefetamet MM 0811.01 7-Aminodesacetoxycephalosporanic Aicd

N

S

O OH

O

H2N H

(A) 100 mg




Cefoperazone Sodium MM 0853.03 Imp. C (EP): 1-Methyl-1H-tetrazole-5-thiol

N N

NN

SH (A) 100 mg

MM 0238.08 Imp. E (EP): (6R,7R)-3-[(Acetyloxy)methyl]-7-amino-8-oxo- 5-thia-1-azabicyclo-[4.2.0]oct-2-ene-2-carboxylic Acid (7-ACA)

N

S

O OH

OO

HH2N

O (A) 100 mg

Cefradine MM 0811.01 Imp. A (EP): (6R,7R)-7-Amino-3-methyl-8-oxo-5-thia-

1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid (7-Aminodeacetoxycephalosporanic Acid, 7-ADCA)

N

S

O OH

O

HH2N

(A) 100 mg

Celecoxib New MM 0344.00 Celecoxib

N

SNH2

O O

N

F

FF

on request

New MM 0344.06 Imp. A (Pharmeuropa): 4-[5-(3-Methylphenyl)- 3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide

N

SNH2

O O

N

F

FF

(A) 50 mg

MM 0344.02 4-[5-[4-(Hydroxymethyl)phenyl]-3-(trifluoromethyl)-1H-pyrazol-1-yl]-benzenesulfonamide

N

SNH2

O O

N

F

FF

HO (D) 100 mg

MM 0344.03 4-[1-[4-(Aminosulfonyl)phenyl]-3-(trifluoromethyl)-1H-pyrazol-5-yl]benzoic Acid

N

SNH2

O O

N

F

FF

OHO (D) 100 mg

Celiprolol Hydrochloride MM 0128.00 Celiprolol Hydrochloride O

NH

O

N

O

OHHN

x HCl

(A) 100 mg

MM 0128.01 Imp. A (EP): 1-[5-Amino-2-[(2RS)-3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]phenyl]ethanone

O

H2N

O

OHHN

(A) 100 mg

MM 0128.03 Imp. C (EP): 1-[3-Acetyl-4-[(2RS)-3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]phenyl]-3-(1,1-dimethylethyl)urea

O

NH

O

NH

O

OHHN

(A) 100 mg

MM 0128.10 Imp. D (EP):3-[3-Acetyl-4-[(RS)-3-(diethylamino)-2-hydroxypropoxy]phenyl]-1,1-diethylurea

O

NH

O

N

O

OH

N

(D) 100 mg




MM 0128.05 Imp. E (EP): 1,1'-[[(1,1-Dimethylethyl)-imino]bis[(2-hydroxypropane-1,3-diyl)-oxy(3-acetyl-1,4-phenylene)]]bis(3,3-diethylurea)

O

HN

O

OH

N

O N

OH

O

O

NH

N O

(D) 50 mg

MM 0128.07 Imp. F (EP): 3-(3-Acetyl-4-hydroxyphenyl)-1,1-diethylurea O

NH

O

N

OH

(A) 100 mg

MM 0128.06 Imp. G (EP): 3-[3-Acetyl-4-[[(RS)-oxiranyl]methoxy]phenyl]-1,1-diethylurea

O

NH

O

N

OO

(A) 100 mg

MM 0128.04 Imp. H (EP): 3-[3-Acetyl-4-[(2RS)-3-bromo-2-hydroxypropoxy]phenyl]-1,1-diethylurea (Bromhydrin Compound)

O

NH

O

N

O

OH

Br

(A) 100 mg

MM 0128.11 3-Acetyl-4-hydroxyaniline Hydrochloride O

H2N

OH x HCl

(A) 100 mg

MM 0128.58 5-Acetamido-2-hydroxyacetophenone O

NH

OOH

(A) 100 mg

Cethexonium Bromide MM 0501.01 rac-trans-2-Dimethylaminocyclohexanol Hydrochloride

OH

N

x HCl

and enantiomer

(A) 100 mg

Cetirizine Dihydrochloride MM 0380.00 Cetirizine Dihydrochloride

N

NOCl

x 2 HCl

OH

O (A) 100 mg

MM 0380.01 Imp. A (EP): (RS)-1-[(4-Chlorophenyl)phenylmethyl]piperazine N

NHCl (A) 100 mg

MM 0380.02 Imp. B (EP) as Dihydrochloride: (RS)-2-[4-[(4-Chlorophenyl)phenylmethyl]- piperazin-1-yl]acetic Acid Dihydrochloride

N

NOH

O

Cl

x 2 HCl

(A) 100 mg

MM 0380.03 Imp. C (EP) as Dihydrochloride: (RS)-2-[2-[4-[(2-Chloro-phenyl)phenylmethyl]piperazin-1-yl]ethoxy]acetic Acid Dihydrochloride N

NO

OH

O

Cl x 2 HCl

(A) 100 mg

MM 0380.04 Imp. D (EP): 1,4-Bis[(4-chlorophenyl)-phenylmethyl]piperazine

N

NCl

Cl

(A) 100 mg

MM 0380.05 Imp. E (EP) as Dihydrochloride: (RS)- 2-[2-[2-[4-[(4-Chlorophenyl)phenylmethyl]piperazin-1-yl]ethoxy]ethoxy]- acetic Acid Dihydrochloride (Ethoxycetirizine Dihydrochloride)

N

NOCl

OOH

O

x 2 HCl

(D) 100 mg




MM 0380.06 Imp. F (EP) as Dihydrochloride: [2-[4-[Diphenylmethyl]piperazin-1-yl]ethoxy]acetic Acid Dihydrochloride N

NO

OH

O

x 2 HCl

(A) 100 mg

MM 0380.11 Imp. G (EP) as Dihydrochloride: 2-[4-[(RS)-(4-Chlorophenyl)phenylmethyl]piperazin-1-yl]ethanol Dihydrochloride

N

NOHCl

x 2 HCl

(A) 100 mg

MM 0380.08 Isopropyl Ester of Cetirizine

N

NOCl

O

O (A) 100 mg

MM 0380.09 4-Chlorobenzhydrol OH

Cl

(B) 100 mg

MM 0380.10 4-Chlorobenzophenone O

Cl

(B) 100 mg

MM 0380.13 Cetirizine N-Oxide

N

NO

OH

O

ClO (A) 100 mg

MM 0380.15 Ethyl Ester of Cetirizine Dihydrochloride

N

NOCl

O

O

x 2 HCl

(A) 100 mg

New MM 0380.16 Methyl Ester of Cetirizine Dihydrochloride

N

NO

O

O

Cl

x 2 HCl

(A) 100 mg

New MM 0380.17 3-Chlorocetirizine Dihydrochloride ((RS)-2-[2-[4-[(3-Chlorophenyl)phenylmethyl]piperazin-1-yl]ethoxy]acetic Acid Dihydrochloride) N

NO

OH

O

x 2 HCl

Cl

(A) 100 mg

Chlorambucil MM 0821.00 Chlorambucil OH

ON

Cl

Cl

(A) 500 mg

Chloramphenicol MM 0516.00 Chloramphenicol NO2

NH

OHO

Cl

Cl OH

(A) 500 mg

MM 0516.01 (D)-(-)-threo-2-Amino-1-(4-nitrophenyl)-1,3-propanediol NO2

H2N

OH

OH

(A) 100 mg

Chlordiazepoxide Hydrochloride MM 0028.02 Imp. A (EP): 7-Chloro-5-phenyl-1,3-dihydro-

2H-1,4-benzodiazepin-2-one 4-Oxide (Demoxepam) N

HN

O

OCl

(A) 100 mg




MM 0028.04 Imp. B (EP): 6-Chloro-2-(chloromethyl)-4-phenylquinazoline 3-Oxide

Cl

N

NO

Cl (A) 100 mg

MM 0028.03 Imp. C (EP): (2-Amino-5-chlorophenyl)phenyl-methanone (Aminochlorobenzophenone)

Cl

NH2

O

(B) 100 mg

Chlorhexidine Diacetate MM 0162.00 Chlorhexidine Diacetate

HN

HN

HN

NH

NH

ClNH NH

NH

NH

NHCl

O

OH

x 2

(A) 500 mg

MM 0162.05 4-Chloroaniline NH2

Cl

(B) 100 mg

MM 0162.07 (4-Chlorophenyl)urea HN NH2

ClO

(A) 100 mg

MM 0162.08 (4-Chlorophenyl)guanidine Hydrochloride HN NH2

ClNH

x HCl(C) 50 mg

Chlorhexidine Dihydrochloride MM 0946.00 Chlorhexidine Dihydrochloride

Cl

HN

HN

NH

HN

NH

NH

NH

NH

NH

NHCl

x 2 HCl

(A) 500 mg

Chlormezanone MM 0017.00 Chlormezanone

N

S

O

O OCl (A) 250 mg

MM 0017.02 2-(4-Chlorophenyl)-3-methylperhydro-1,3-thiazin-4-one

N

S

O

Cl on request

MM 0017.03 4-Chlorobenzaldehyde H

ClO (B) 100 mg

Chlorobutanol Hemihydrate MM 0535.00 Chlorobutanol Hemihydrate Cl

ClCl

OHx ½ H2O

(A) 500 mg

Chlorocresol MM 0459.00 Chlorocresol OH

Cl

(A) 500 mg

Chlorphenamine Maleate MM 0090.00 Chlorphenamine Maleate

NN

O

OH

O

OHx

Cl (A) 500 mg

MM 0090.03 Imp. A (EP) as Dihydrochloride: 2-(4-Chlorophenyl)- 4-(dimethylamino)-2-[2-(dimethylamino)ethyl]butanenitrile Dihydrochloride

N N

N

Cl

x 2 HCl

(D) 100 mg




MM 0090.04 Imp. B (EP): N-(Pyridin-2-yl)pyridin-2-amine (2,2'-Dipyridylamine)

HNN

N

(A) 100 mg

MM 0090.13 Imp. C (EP) as Maleate: (3RS)-3-(4-Chloro-phenyl)-N- methyl-3-(pyridin-2-yl)propan-1-amine Maleate

NHN

O

OH

O

OHx

Cl (A) 100 mg

MM 0090.05 Imp. D (EP) as Maleate: (2RS)-2-(4-Chloro-phenyl)-4- (dimethylamino)-2-(pyridin-2-yl)butanenitrile Maleate

NN

N

ClO

OH

O

OHx

(D) 100 mg

MM 0090.11 Chlorphenamine N-Oxide Dihydrochloride

NN

Cl

O

x 2 HCl

(A) 100 mg

Chlorphenoxamine Hydrochloride New MM 1291.00 Chlorphenoxamine Hydrochloride

ON

Cl

x HCl

(A) 100 mg

Chlorpromazine Hydrochloride MM 0420.00 Chlorpromazine Hydrochloride

N

S

Cl

Nx HCl

(A) 500 mg

MM 0420.01 Imp. A (EP): 3-(2-Chloro-10H-phenothiazin- 10-yl)-N,N-dimethylpropan-1-amine S-Oxide (Chlorpromazine Sulfoxide)

N

S

Cl

N

O

(A) 100 mg

MM 0420.06 Imp. B (EP) as Dihydrochloride: N-[3-(2-Chloro- 10H-phenothiazin-10-yl)propyl]-N,N',N'-trimethylpropane-1,3-diamine Dihydrochloride

N

S

Cl

N N

x 2 HCl

(A) 100 mg

MM 0290.00 Imp. C (EP) as Hydrochloride: 3-(10H-Phenothiazin- 10-yl)-N,N-dimethylpropan-1-amine Hydrochloride (Promazine Hydrochloride)

N

S

Nx HCl

(A) 500 mg

MM 0420.07 Imp. D (EP) as Hydrochloride: 3-(2-Chloro-10H-phenothiazin-10-yl)-N-methylpropan-1-amine Hydrochloride (Desmethylchlorpromazine Hydrochloride)

N

S

Cl

NHx HCl

(A) 100 mg

MM 0420.04 Imp. E (EP): 2-Chloro-10H-phenothiazine

NH

S

Cl

(A) 100 mg

MM 0420.02 Chlorpromazine Sulphoxide N-Oxide Maleate

N

S

Cl

NO

O

O

OH

O

OHx

(B) 10 mg




Chlorprothixene Hydrochloride New MM 1321.01 Imp. A (EP): (RS)-2-Chloro-9-[3-(dimethylamino)-

propyl]-9H-thioxanthen-9-ol

S

Cl

N

OH(A) 100 mg

New MM 1321.07 Imp. B (EP) as Hydrochloride: N,N-Dimethyl-3- (9H-thioxanthen-9-ylidene)propan-1-amine Hydrochloride

S

Nx HCl

(A) 50 mg

New MM 1321.05 Imp. E (EP): 2-Chloro-9H-thioxanthen-9-one

S

Cl

O

(A) 100 mg

Chlorquinaldol MM 0390.00 Chlorquinaldol OH

Cl

Cl

N(A) 500 mg

Chlortalidone MM 0297.00 Chlortalidone HN

HO

O

Cl

SH2N

O O(A) 250 mg

Chlortetracycline Hydrochloride MM 0607.00 Chlortetracycline Hydrochloride OH O OH O

NH2

O

OH

OH

N

HH x HCl

Cl OH

(A) 500 mg

MM 0636.00 Imp. B (EP) as Hydrochloride: Demeclocycline Hydrochloride

OH O OH O

NH2

O

OH

OH

N

HH x HCl

Cl OH

(A) 250 mg

MM 0452.00 Tetracycline Hydrochloride OH O OH O

NH2

O

OH

OH

N

HH x HCl

HO

(A) 500 mg

Cholecalciferol MM 0249.02 Imp. B (EP): Cholesta-5,7-dien-3-ol

(7,8-Didehydrocholesterol; Provitamin D3)

HO

(A) 100 mg

Ciclopirox Olamine MM 0418.00 Ciclopirox Olamine

N O

OH

H2NOHx

(A) 250 mg

MM 0418.03 Imp. C (EP): 6-Cyclohexyl-4-methylpyridin-2(1H)-one HN O

(A) 50 mg

Cimetidine Hydrochloride MM 0020.00 Cimetidine

N

NH

NH

S

NHN

N (A) 500 mg




MM 0020.08 Imp. A (EP): 3-Cyano-2-methyl-1-[2- [[(5-methyl-1H-imidazol-4-yl)methyl]- sulphanyl]ethyl]isothiourea

N

SNH

S

NHN

N (A) 100 mg

MM 0020.12 Imp. B (EP): 3-Cyano-2-methyl-1-[2-[[(5-methyl-1H-imidazol-4-yl)methyl]sulphanyl]ethyl]isourea

N

ONH

S

NHN

N (A) 100 mg

MM 0020.03 Imp. C (EP) as Dihydrochloride: 1-[(Methylamino)[[2-[[(5-methyl-1H-imidazol-4-yl)-methyl]sulphanyl]ethyl]amino]methylene]urea Dihydrochloride (Cimetidine Amide Dihydrochloride)

x 2 HClN

NH

NH

S

NHN

NH2O (A) 100 mg

MM 0020.06 Imp. D (EP) as Dihydrochloride:1-Methyl-3-[2-[[(5-methyl-1H-imidazol-4-yl)methyl]sulphanyl]ethyl]guanidine Dihydrochloride

x 2 HCl

NH

NH

NH

S

NHN (A) 100 mg

MM 0020.04 Imp. E (EP): 2-Cyano-1-methyl-3-[2-[[(5-methyl-1H-imidazol-4-yl)methyl]sulphinyl]ethyl]guanidine (Cimetidine Sulphoxide)

N

NH

NH

S

NHN

N

O

(A) 100 mg

MM 0020.15 Imp. G (EP): 2-Cyano-1,3-dimethylguanidine

NH

NH

N

N (A) 100 mg

MM 0020.07 Imp. H (EP): 1,1'-(Disulphanediyldiethylene)bis (2-cyano-3-methylguanidine)

N

HN

HN

SS

N

NH

NH

N

N (A) 100 mg

MM 0020.50 Imp. J (EP) as Dihydrobromide: 2-[[(5-Methyl-1H-imidazol-4-yl)methyl]sulphanyl]ethanamine Dihydrobromide x 2 HBr

NH2S

NHN (A) 100 mg

MM 0020.10 1,1-Dimethyl-3-cyanoguanidine N

HN

NHN

(A) 100 mg

MM 0056.01 Cyanoguanidine H2NHN

NHN

(B) 100 mg

Cinchocaine Hydrochloride MM 0604.00 Cinchocaine Hydrochloride

x HClN

NH

O

NO

(A) 500 mg

MM 0604.02 Imp. B (EP): 2-Hydroxyquinoline-4-carboxylic Acid

N

OH

O

HO(A) 100 mg

MM 0604.05 Cinchocaine N-Oxide

N

NH

O

NO

O

(A) 100 mg

Cinnarizine MM 1038.01 Imp. A (EP): 1-(Diphenylmethyl)piperazine

N

NH (A) 100 mg




MM 1038.03 Imp. B (EP): (Z)-1-(Diphenylmethyl)-4-(3-phenylprop-2-enyl)piperazine

N

N

(A) 100 mg

MM 1038.04 Imp. C (EP): (4-(Diphenylmethyl)-1,1-bis[(E)- 3-phenylprop-2-enyl]piperazinium Chloride N

N+

Cl-

(A) 100 mg

MM 1038.06 Imp. E (EP): 1,4-Bis(diphenylmethyl)piperazine

N

N

(A) 100 mg

Ciprofloxacin Hydrochloride MM 0018.06 Ciprofloxacin Hydrochloride Monohydrate

NN

O

OH

O

HN

F

x HClx H2O

(A) 500 mg

MM 0018.01 Imp. A (EP): 7-Chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid (Fluoroquinolonic Acid) NCl

O

OH

O

F

(A) 100 mg

MM 0018.05 Imp. B (EP): 1-Cyclopropyl-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic Acid (Desfluoro Compound) NN

O

OH

O

HN(A) 100 mg

MM 0018.04 Imp. C (EP): 7-(2-Aminoethylamino)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid (Ethylenediamine Compound)

NHN

O

OH

O

F

H2N

(D) 50 mg

MM 0018.02 Imp. D (EP): 7-Chloro-1-cyclopropyl-4-oxo-6-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic Acid

NCl

O

OH

O

N

HN

(D) 50 mg

MM 0018.03 Imp. E (EP): 1-Cyclopropyl-6-fluoro-7-(piperazin-1-yl)-quinolin-4(1H)-one (Decarboxylated Compound) NN

O

HN

F

(A) 100 mg

MM 0018.10 6-(2-Aminoethylamino)-7-chloro-1-cyclopropyl-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid Hydrochloride NCl

O

OH

O

NH

H2N

x HCl

(D) 100 mg

Citalopram Hydrobromide MM 0242.00 Citalopram Hydrobromide

ON

F

N

x HBr

(A) 250 mg

MM 0242.14 Imp. A (EP): (1RS)-1-[3-(Dimethylamino)- propyl]-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carboxamide (Citalopram- Amide)

ON

F

H2N

O

(A) 100 mg




MM 0242.17 Imp. C (EP): (3RS)-6-Cyano-3-[3-(dimethylamino)propyl]-3-(4-fluorophenyl)isobenzofuran-1(3H)-one

ON

F

N O

(A) 100 mg

MM 0242.09 Imp. D (EP) as Hydrochloride: (1RS)-1-(4-Fluorophenyl)- 1-[3-(methylamino)propyl]-1,3-dihydroisobenzofuran- 5-carbonitrile Hydrochloride (Desmethylcitalopram Hydrochloride)

ONH

F

x HCl

N

(A) 100 mg

MM 0242.12 Imp. E (EP) as Oxalate: 3-[(1RS)-5-Chloro-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-1-yl]-N,N-dimethylpropan-1-amine Oxalate

ON

F

Cl

HO O

OHO

x

(A) 50 mg

New MM 0242.13 Imp. F (EP) as Hydrogen Oxalate: 3-[(1R)-5-Bromo- 1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-1-yl]- N,N-dimethylpropan-1-amine Hydrogen Oxalate

ON

F

Br

HO O

OHO

x(A) 100 mg

Citric Acid Anhydrous MM 0988.00 Citric Acid Anhydrous

O

HO OH

OHO

O OH (A) 250 mg

Citric Acid Monohydrate MM 0575.00 Citric Acid Monohydrate

x H2OO

HO OH

OHO

O OH (A) 500 mg

Clarithromycin MM 0057.00 Clarithromycin

O

O

O

O

O

OH

OH

OO

NHO

O

O

OH

on request

MM 0057.05 Imp. E (EP): 6,11-Di-O-methylerythromycin A O

O

O

OH

O

O

O

O

O

OH

OO

N

OH

(D) 100 mg

Clindamycin Hydrochloride New MM 0259.00 Clindamycin Hydrochloride

O

OH

HO

HN

OH

S

Cl

O

N

x HCl

(A) 100 mg

Clioquinol MM 0312.00 Clioquinol

N

Cl

OH

I(A) 500 mg

MM 0312.01 Imp. A (EP): 5-Chloroquinolin-8-ol N

Cl

OH (B) 100 mg




MM 0312.02 Imp. B (EP): 5,7-Dichloroquinolin-8-ol N

Cl

OH

Cl(B) 100 mg

MM 0312.03 Imp. C (EP): 5,7-Diiodoquinolin-8-ol N

I

OH

I(B) 100 mg

Clobenzorex Hydrochloride MM 0649.00 Clobenzorex Hydrochloride H

N

Cl

x HCl

(A) 500 mg

Clobetasol Propionate MM 0769.00 Clobetasol Propionate

HO

F

O

OOCl

O

(A) 100 mg

MM 0200.01 Imp. G (EP): 21-Chloro-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione (Clobetasol)

HO

F

OH

OCl

O

(A) 100 mg

MM 0202.04 Imp. K (EP):9-Fluoro-11,17-dihydroxy- 16-methyl-3,20-dioxopregna-1,4-dien- 21-yl Propanoate (Betamethasone 21- Propionate) HO

F

OH

OO

O

O (A) 100 mg

Clobutinol Hydrochloride MM 0038.00 Clobutinol Hydrochloride

N

ClOH

x HCl

on request

MM 0038.01 1-Dimethylamino-2-methylbutan-3-one N

O

(A) 100 mg

Clomifene Citrate MM 0650.00 Clomifene Citrate

Cl

ON

OH

O

OH

O

OHO

OH

x

and Z-Isomer

(A) 250 mg

MM 0650.01 Clomifene N-Oxide Hydrochloride

Cl

ON

and Z-Isomer

O

x HCl

(A) 100 mg

MM 0650.03 Desethylclomifene Hydrochloride

Cl

ONH

and Z-Isomer

x HCl

(A) 100 mg

Clomipramine Hydrochloride MM 0545.00 Clomipramine Hydrochloride

N x HClN

Cl (A) 500 mg




MM 0545.01 Imp. A (EP) as Dihydrochloride: N-[3-(3- Chloro-10,11-dihydro-5H-dibenzo[b,f]azepin- 5-yl)propyl]-N,N',N'-trimethylpropane-1,3- diamine Dihydrochloride N

x 2 HCl

N

Cl

N

on request

MM 0077.00 Imp. B (EP) as Hydrochloride: Imipramine Hydrochloride

N x HClN

(A) 500 mg

MM 0545.03 Imp. C (EP) as Hydrochloride: 3-(3-Chloro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine Hydrochloride

N x HClN

Cl (C) 10 mg

MM 0545.04 Imp. D (EP) as Hydrochloride: 3-(3,7-Dichloro- 10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N- dimethylpropan-1-amine Hydrochloride

N x HClN

Cl

Cl

on request

MM 0076.06 Imp. E (EP): 10,11-Dihydro-5H-dibenzo[b,f]-azepine (Iminodibenzyl)

NH

(B) 100 mg

MM 0545.06 Imp. F (EP): 3-Chloro-10,11-dihydro-5H-dibenzo[b,f]azepine

NH

Cl (A) 100 mg

MM 0545.07 Imp. G (EP): 3-Chloro-5-(prop-2-enyl)-10,11-dihydro-5H-dibenzo[b,f]azepine

N

Cl (C) 50 mg

MM 0545.08 Desmethylclomipramine Hydrochloride

NH

x HClN

Cl (A) 100 mg

MM 0545.09 Clomipramine N-Oxide

NN

Cl

O

on request

MM 0545.13 3-Chloro-10-[3(dimethylamino)propyl]-9-acridanone

NN

O

Cl (A) 100 mg

Clonazepam New MM 0945.01 Imp. A (EP): (2-Amino-5-nitrophenyl)(2-

chlorophenyl)methanone O2N

O

Cl

NH2 (A) 100 mg




New MM 0945.02 Imp. B (EP): 3-Amino-4-(2-chlorophenyl)-6-nitroquinolin-2(1H)-one HN O

NH2O2N

Cl

(A) 50 mg

New MM 0945.04 Methylclonazepam

O2N N

NO

Cl

(A) 50 mg

New MM 0945.05 2-Bromo-2'-(2-chlorobenzoyl)-4'-nitroacetanilide

O2NO

Cl

NH

OBr (A) 50 mg

Clonidine Hydrochloride MM 0983.00 Clonidine Hydrochloride

N

Cl

Cl

NH

HN

x HCl

(A) 100 mg

MM 0983.04 Imp. A (EP): 1-Acetylimidazolidin-2-one O N

HN

O

(A) 100 mg

New MM 0983.03 Imp. B (EP): 1-Acetyl-2-[(2,6-dichlorophenyl)amino]-4,5-dihydro-1H-imidazole

NH

Cl

Cl

N

N

O

(A) 50 mg

MM 0006.21 Imp. C (EP): 2,6-Dichloroaniline NH2

Cl

Cl (B) 100 mg

MM 0983.02 1-(2,6-Dichlorophenyl)thiourea

Cl

Cl

NH

NH2

S (A) 100 mg

Clopidogrel Hydrogen Sulphate MM 0455.10 Clopidogrel Hydrogen Sulphate

Cl

N

O

O

S

x H2SO4

(A) 100 mg

MM 0455.13 Imp. B (EP) as Racemate Hydrogen Sulfate: Methyl (2RS)-(2-Chlorophenyl)[4,7-dihydrothieno[2,3-c]pyridin-6(5H)-yl]acetate Hydrogen Sulfate

Cl

N

O

OS

x H2SO4

(A) 100 mg

MM 0455.12 Imp. C (EP) as Hydrogen Sulfate: Methyl (2R)-(2-Chlorophenyl)[6,7-dihydrothieno[3,2-c]- pyridin-5(4H)-yl]acetate Hydrogen Sulfate ((R)-Clopidogrel Hydrogen Sulfate)

Cl

N

O

O

S

x H2SO4

(A) 100 mg

MM 0455.09 Clopidogrel Alcohol

Cl

NOH

S

(D) 100 mg

Clotrimazole MM 0015.00 Clotrimazole

N

N

Cl (A) 500 mg

MM 0015.01 Imp. A (EP): (2-Chlorophenyl)diphenylmethanol

OHCl

(A) 100 mg




MM 0015.10 Imp. B (EP): 1-[(4-Chlorophenyl)diphenylmethyl]-1H-imidazole

N

N

Cl (A) 100 mg

MM 0015.03 Imp. C (EP): 1-Chloro-2-(chlorodiphenylmethyl)benzene

ClCl

(A) 100 mg

MM 0015.02 Imp. D (EP): Imidazole

N

HN (B) 100 mg

MM 0015.06 Imp. E (EP): (2-Chlorophenyl)phenylmethanone (2-Chlorobenzophenone)

Cl O

(A) 100 mg

MM 0015.11 Imp. F (EP): 1-(Triphenylmethyl)-1H-imidazole (Deschloroclotrimazole)

N

N

(A) 100 mg

MM 0015.04 (2-Chlorophenyl)diphenylmethane

Cl

(A) 100 mg

MM 0015.05 (2-Chlorophenyl)diphenylmethyl Ethyl Ether

OCl

(A) 100 mg

MM 0015.07 (2-Chlorophenyl)phenyldichloromethane

Cl Cl Cl

(A) 100 mg

MM 0015.08 (2-Chlorophenyl)trichlormethane Cl

Cl ClCl

(A) 100 mg

MM 0015.09 1-[(2-Chlorophenyl)diphenylmethyl]-1H-pyrazole

NNCl

(C) 50 mg

Cloxacillin Sodium MM 0682.00 Cloxacillin Sodium Monohydrate

NO

S

OONa

H

x H2OHN

O

N

O

Cl (A) 500 mg

MM 0026.04 Imp. C (EP): (2S,5R,6R)-6-Amino-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid (6-Aminopenicillanic Acid)

NO

S

OOH

HH2N

(B) 100 mg

MM 0682.04 Imp. D (EP): 3-(2-Chlorophenyl)-5-methylisoxazole-4-carboxylic Acid N

O

Cl

OH

O

(A) 100 mg

Cloxiquine MM 0391.00 Cloxiquine OH

Cl

N(A) 500 mg

Clozapine MM 0480.00 Clozapine

N

NN

HN

Cl (A) 100 mg




MM 0480.01 Imp. A (EP): 8-Chloro-5,10-dihydro-11H-dibenzo[b,e][1,4]diazepin-11-one O

HN

HN

Cl (A) 100 mg

MM 0480.03 Imp. C (EP): 8-Chloro-11-(piperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine N

NHN

HN

Cl (A) 100 mg

Codeine MM 0442.00 Codeine Phosphate Hemihydrate

[Controlled Substance]

O OHO

N

x ½ H2O

x H3PO4

(A) 100 mg

MM 0004.00 Codeine Monohydrate [Controlled Substance]

O OHO

N

x H2O

(A) 100 mg

MM 0004.03 Imp. A (EP): 7,8-Didehydro-4,5-epoxy-3,6-dimethoxy- 17-methylmorphinan (O-Methylcodeine) [Controlled Substance]

O OO

N(A) 100 mg

MM 0037.00 Imp. B (EP) as Hydrochloride Trihydrate: Morphine Hydrochloride Trihydrate [Controlled Substance]

O OHHO

N

x HClx 3 H2O

(A) 250 mg

MM 0280.00 Imp. B (EP) as Hemisulphate Pentahemihydrate: Morphine Hemisulphate Pentahemihydrate [Controlled Substance]

O OHHO

N

x H2SO4x 5 H2O

2

(A) 250 mg

MM 0037.02 Imp. C (EP): 7,7',8,8'-Tetradehydro-4,5:4',5'-diepoxy-3,3'-dimethoxy-17,17'-dimethyl-2,2'-bimorphinanyl-6,6'-diol (Codeine Dimer; Dimethyl Pseudomorphine)

O OHO

N

OHO O

N

(A) 100 mg

MM 0004.01 Codeine N-Oxide [Controlled Substance]

O OHO

NO (A) 250 mg

MM 0004.02 Codeinone

O OO

N(A) 100 mg

MM 0004.04 Codeimethine

O OHO

N(C) 50 mg

MM 0004.05 Norcodeine [Controlled Substance]

O OHO

HN (A) 100 mg

MM 0004.06 Acetylcodeine [Controlled Substance]

O OO

N

O

(A) 100 mg

MM 0004.08 Isocodeine [Controlled Substance]

O OHO

N(A) 100 mg




MM 0037.01 Pseudomorphine

O OHHO

N

OHO OH

N

(A) 100 mg

Colchicine MM 1083.00 Colchicine O

O

O

O

O

NH

O

(A) 100 mg

MM 1083.04 Imp. D (EP): N-[(7S,12aRa)-3-(β-D-Glucopyranosyl- oxy)-1,2,10-trimethoxy-9-oxo-5,6,7,9-tetrahydrobenzo[a]heptalen-7-yl]acetamide (Colchicoside)

O

O

NH

O

O

O

O

HO

HO

OH

OHO

(A) 100 mg

Cortisone MM 0214.00 Cortisone

O

O OH

O

OH(A) 500 mg

Cortisone Acetate MM 0186.00 Cortisone Acetate

O

O OH

O

O

O (A) 500 mg

MM 0187.00 Imp. A (EP): Hydrocortisone Acetate

O

HO OH

O

O

O (A) 500 mg

Cyclizine Hydrochloride New MM 1265.01 Imp. A (EP): 1-Methylpiperazine

HN

N (A) 100 mg

MM 0490.02 Imp. B (EP): Diphenylmethanol (Benzhydrol) OH

(B) 100 mg

Cyclobenzaprine Hydrochloride MM 0062.02 Cyclobenzaprine Hydrochloride

N x HCl

(A) 100 mg

Cyclopentolate Hydrochloride MM 0580.00 Cyclopentolate Hydrochloride O

ON

x HClHO

(A) 500 mg

MM 0580.01 Imp. A (EP): (2RS)-(1-Hydroxycyclopentyl)(phenyl)acetic Acid O

OHHO

(A) 100 mg

MM 0160.03 Imp. B (EP): Phenylacetic Acid [Drug Precursor] O

OH

(B) 100 mg




MM 0580.03 Imp. C (EP) as Hydrochloride: 2-(Dimethylamino)ethyl Phenylacetate Hydrochloride

O

ON

x HCl(A) 100 mg

Cynarine MM 0048.01 3,4-Dihydroxycinnamic Acid (Caffeic Acid)

OH

O

HO

HO

(B) 100 mg

Cyproheptadine Hydrochloride MM 0609.00 Cyproheptadine Hydrochloride Sesquihydrate N

x HCl x 11/2 H2O

(A) 500 mg

New MM 0609.01 Imp. A (EP): 5H-Dibenzo[a,d][7]annulene (Dibenzocycloheptene)

(A) 50 mg

MM 0062.01 Imp. B (EP): 10,11-Dihydro-5H-dibenzo[a,d][7]- annulen-5-one (Dibenzosuberone) O

(B) 100 mg

New MM 0609.07 Imp. C (EP) as Hydrochloride: 5-(1-Methyl- piperidin-4-yl)-5H-dibenzo[a,d][7]annulen-5- ol Hydrochloride

OHN

x HCl

(A) 50 mg

MM 0609.02 5H-Dibenzo[a,d]cyclohepten-5-one (Dibenzosuberenone) O

(C) 100 mg

MM 0609.04 Demethylcyproheptadine Hydrochloride NH

x HCl

(A) 100 mg

MM 0609.05 Cyproheptadine α-N-Oxide N

O (A) 100 mg

MM 0609.06 Cyproheptadine β-N-Oxide N

O (A) 100 mg

Cyproterone Acetate MM 0215.00 Cyproterone Acetate

O

O

O

Cl

O

(A) 250 mg

Dacarbazine New MM 1289.00 Dacarbazine

O

NH2

NHN

NN

N

(A) 50 mg

New MM 1289.02 Imp. B (EP): 5-Amino-1H-imidazole-4-carboxamide

O

NH2

NHN

H2N

(A) 100 mg

MM 0056.06 Imp. D (EP) as Hydrochloride: N-Methylmethanamine Hydrochloride

HN x HCl (C) 100 mg




DDT MM 2513.01 2,2-Bis(4-chlorophenyl)-1-chloroethane

Cl

Cl

Cl

(A) 100 mg

MM 2513.02 1-Chloro-3-[1-(4-chlorophenyl)ethyl]benzene

Cl

Cl(A) 100 mg

MM 2513.05 1,1-Bis(4-chlorophenyl)ethane

Cl Cl

(A) 100 mg

Dembrexine Hydrochloride Monohydrate New MM 1200.03 Imp. C (EP): 3,5-Dibromo-2-hydroxybenzaldehyde

Br Br

OH

O (A) 100 mg

MM 1200.04 Imp. D (EP): 2-Hydroxybenzaldehyde (Salicylaldehyde) OH

O (A) 100 mg

New MM 1200.05 Imp. E (EP): 2,4,6-Tribromophenol

Br Br

OH

Br (A) 100 mg

Demeclocycline Hydrochloride MM 0636.00 Demeclocycline Hydrochloride OH O OH O

NH2

O

OH

OH

N

HH x HCl

Cl OH

(A) 250 mg

Desipramine Hydrochloride MM 0589.00 Desipramine Hydrochloride

NH

x HClN

(A) 250 mg

MM 0077.00 Imipramine Hydrochloride

N x HClN

(A) 500 mg

MM 0076.06 Iminodibenzyl

NH

(B) 100 mg

Dexamethasone MM 0213.00 Dexamethasone

O

HO

F

OH

O

OH(A) 250 mg

MM 0200.00 Imp. B (EP): Betamethasone

O

HO

F

OH

O

OH(A) 250 mg

MM 0213.01 Imp. C (EP): 9--Fluoro-11,17,21- trihydroxy-16-methylpregn-4-ene-3,20-dione

O

HO

F

OH

O

OH(D) 50 mg




MM 0445.00 Imp. G (EP): Dexamethasone Acetate

O

HO

F

OH

O

O

O (A) 250 mg

Dexamethasone Acetate MM 0445.00 Dexamethasone Acetate

O

HO

F

OH

O

O

O (A) 250 mg

MM 0213.00 Imp. A (EP): 9-Fluoro-11,17,21-trihydroxy- 16-methylpregna-1,4-diene-3,20-dione (Dexamethasone)

O

HO

F

OH

O

OH(A) 250 mg

MM 0201.00 Imp. D (EP): 9-Fluoro-11,17-dihydroxy-16- methyl-3,20-dioxopregna-1,4-dien-21-yl Acetate (Betamethasone Acetate)

O

HO

F

OH

O

O

O (A) 250 mg

Dexamethasone Sodium Phosphate MM 0210.00 Dexamethasone Sodium Phosphate

O

HO

F

OH

O

O PONa

OONa (A) 250 mg

MM 0213.00 Imp. A (EP): Dexamethasone

O

HO

F

OH

O

OH

(A) 250 mg

MM 0303.00 Imp. B (EP): Betamethasone Sodium Phosphate

O

HO

F

OH

O

O PONa

OONa on request

Dexchlorpheniramine Maleate MM 1114.00 Dexchlorpheniramine Maleate

NN

Cl

OH

O

O

OHx

(A) 100 mg

MM 0059.00 Imp. A (EP) as Maleate: (3RS)-N,N-Dimethyl-3- phenyl-3-(pyridin-2-yl)propan-1-amine Maleate (Pheniramine Maleate) N

N

OH

O

O

OHx

(A) 100 mg

Dextromethorphan Hydrobromide MM 0033.00 Dextromethorphan Hydrobromide Monohydrate

O

N

x HBrx H2O

(A) 500 mg

MM 0033.10 Imp. A (EP) as Hydrochloride: ent-3-Methoxymorphinan Hydrochloride

O

HN

x HCl

(A) 100 mg




MM 0033.09 Imp. B (EP) as (L)-Tartrate: ent-17-Methylmorphinan-3-ol (L)-Tartrate

HO

N

HO

OH

OH

OH

O

O

x

(A) 100 mg

MM 0033.02 Imp. C (EP): ent-3-Methoxy-17-methylmorphinan-10-one

O

NO (D) 100 mg

MM 0033.11 Dextromethorphan N-Oxide Hydrochloride

O

N

x HCl

O (A) 100 mg

Dextropropoxyphene Hydrochloride MM 0098.01 Dextropropoxyphene Hydrochloride

[Controlled Substance] O

O

N

x HCl

(A) 50 mg

MM 0098.00 Dextropropoxyphene [Controlled Substance] O

O

N (A) 50 mg

MM 0098.06 Imp. A (EP): (2S,3R)-4-(Dimethylamino)-1,2-diphenyl-3-methylbutan-2-ol

OH

N (A) 100 mg

MM 0098.07 Imp. B (EP) as Hydrochloride: (1S,2R)-1-Benzyl- 3-(dimethylamino)-2-methyl-1-phenylpropyl Acetate Hydrochloride (Acetoxyphene Hydrochloride)

O

O

N

x HCl

(A) 100 mg

MM 0098.08 Imp. C: (EP) as Hydrochloride: (1S,2R)-1-Benzyl- 3-(dimethylamino)-2-methyl-1-phenyl-propyl Butanoate Hydrochloride (Butyroxyphene Hydrochloride)

O

O

N

x HCl

(A) 50 mg

MM 0291.04 Toluene (C) 100 mg

New MM 0098.11 Imp. F (EP) as Hydrochloride: (2RS)-3-(Dimethyl- amino)-2-methyl-1-phenylpropan-1-one Hydro- chloride

x HCl

O

N

(A) 50 mg

Diazepam MM 0023.00 Diazepam [Controlled Substance]

N

NO

Cl

(A) 100 mg

MM 0023.02 Imp. A (EP): 7-Chloro-5-phenyl-1,3-dihydro-2H- 1,4-benzodiazepin-2-one (Nordazepam) [Controlled Substance] N

HN

O

Cl

(A) 100 mg




MM 0023.04 Imp. B (EP): 2-Chloro-N-(4-chloro-2-benzoylphenyl)-N-methylacetamide

Cl

N

O

OCl (A) 100 mg

MM 0023.03 Imp. C (EP): 3-Amino-6-chloro-1-methyl-4-phenylquinolin-2(1H)-one

Cl

N

NH2

O(A) 100 mg

MM 0023.01 Imp. D (EP): [5-Chloro-2-(methylamino)phenyl]phenylmethanone (5-Chloro-2-(methylamino)benzophenone)

Cl

NH

O

(B) 100 mg

MM 0023.05 2'-Benzoyl-2,4'-dichloroacetanilide

Cl

NH

O

OCl (A) 100 mg

Dibutyl Sebacate MM 0925.00 Dibutyl Sebacate OO

O O

(A) 500 mg

Dichlorobenzyl Alcohol MM 0739.01 Bis-(2,4-dichlorobenzyl)Ether

ClCl

O

ClCl

(A) 100 mg

Diclofenac Sodium MM 0006.00 Diclofenac Sodium

NH

O ONa

ClCl

(A) 500 mg

MM 0006.01 Imp. A (EP): 1-(2,6-Dichlorophenyl)-1,3-dihydro-2H-indol-2-one

ClCl

NO

(A) 100 mg

MM 0006.03 Imp. B (EP): 2-[(2,6-Dichlorophenyl)amino]benzaldehyde NH

ClCl

O (A) 100 mg

MM 0006.04 Imp. C (EP): [2-[(2,6-Dichlorophenyl)amino]phenyl]methanol NH

ClCl

OH (A) 100 mg

MM 0006.09 Imp. D (EP): 2-[2-[(2-Bromo-6-chlorophenyl)amino]phenyl]acetic Acid

NH

ClBr

OH

O

(D) 100 mg

MM 0006.05 Imp. D (EP) as Sodium Salt: Sodium 2-[2-[(2-Bromo- 6-chlorophenyl)amino]phenyl]acetate

NH

ClBr

ONa

O

(D) 100 mg

MM 0006.02 Imp. E (EP): 1,3-Dihydro-2H-indol-2-one NH

O(B) 100 mg




MM 0006.06 1-(2-Bromo-6-chlorophenyl)indolin-2-one

ClBr

NO

(C) 10 mg

MM 0006.10 Methyl 2-[2-[(2,6-Dichlorophenyl)amino]phenyl]acetate (Methyl Ester of Diclofenac) NH

ClCl

O

O

(A) 100 mg

MM 0006.11 Ethyl [2-[(2,6-Dichlorophenyl)amino]phenyl]acetate (Ethyl Ester of Diclofenac) NH

ClCl

O

O

(A) 100 mg

MM 0181.06 Isopropyl 2-[2-[(2,6-Dichlorophenyl)amino]phenyl]acetate (Isopropyl Ester of Diclofenac) NH

ClCl

O

O

(A) 100 mg

MM 0006.12 2-(2,6-Dichlorophenylamino)benzoic Acid

NH

ClCl

OH

O (A) 100 mg

MM 0006.15 2,6-Dichlorodiphenylamine

NH

ClCl

(A) 100 mg

MM 0006.16 2-Bromo-6-chlorodiphenylamine

NH

ClBr

(A) 100 mg

MM 0006.17 1-(2,6-Dichlorophenyl)indolin-2,3-dione

ClCl

NO

O (A) 100 mg

MM 0006.18 Diclofenac Potassium

NH

ClCl

OK

O

(A) 100 mg

MM 0006.19 2-Chloro-N-(2,6-dichlorophenyl)-N-phenylacetamide

N

ClCl

O

Cl (A) 100 mg

MM 0006.20 2-[2-[(2,6-Dichlorophenyl)amino]phenyl]acetic Acid (Diclofenac)

NH

ClCl

OH

O

(A) 100 mg

MM 0006.21 2,6-Dichloroaniline NH2

ClCl(B) 100 mg

MM 0006.22 2-Bromo-6-chloroaniline NH2

ClBron request

MM 0006.27 N-Acetyl-N-phenyl-2,6-dichloroaniline N

ClCl

O (A) 100 mg

MM 0006.28 Diethyl Phthalate O

O

O

O

(C) 100 mg




Dicloxacillin Sodium MM 0229.00 Dicloxacillin Sodium Monohydrate

N

SH

O

OONa

x H2OHN

O

N

O

Cl

Cl on request

MM 0026.04 Imp. C (EP): (2S,5R,6R)-6-Amino-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]-heptane-2-carboxylic Acid (6-Aminopenicillanic Acid)

N

SH

O

H2N

OOH (B) 100 mg

Diflucortolone Valerate MM 0600.00 Diflucortolone Valerate

O

F

F

HO

OO

O (A) 100 mg

Digitoxin MM 0336.01 Digitoxigenin

HO

OH

O O (A) 50 mg

Digoxin MM 0212.00 Digoxin

O

OH

O O

HO

OH

OO

OOOH

HO

OH

OH

(A) 250 mg

Dihydrocodeine Hydrogen Tartrate New MM 0004.00 Imp. A (EP) as Monohydrate: Codeine

Monohydrate [Controlled Substance]

O OHO

N

x H2O

(A) 100 mg

New MM 0442.00 Imp. A (EP) as Phosphate Hemihydrate: Codeine Phosphate Hemihydrate [Controlled Substance]

O OHO

N

x H3PO4x 1/2 H2O

(A) 100 mg

New MM 0280.00 Imp. B (EP) as Hemisulphate Pentahemihydrate: Morphine Hemisulphate Pentahemihydrate [Controlled Substance]

O OHHO

N

2

x H2SO4x 5 H2O

(A) 250 mg

New MM 0037.00 Imp. B (EP) as Hydrochloride Trihydrate: Morphine Hydrochloride Trihydrate [Controlled Substance]

O OHHO

N

x HClx 3 H2O

(A) 250 mg




Diltiazem Hydrochloride MM 0068.00 Diltiazem Hydrochloride

N

S

OO

N

O

O

x HCl

(A) 500 mg

MM 0068.02 Imp. B (EP): (2S,3S)-2-(4-Methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl Acetate

NH

S

OO

O

O (A) 100 mg

MM 0068.03 Imp. D (EP) as Hydrochloride: (2S,3S)-2-(4-Methoxyphenyl)-5-[2-(methylamino)ethyl]-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl Acetate Hydrochloride (N-Desmethyldiltiazem Hydrochloride)

N

S

OO

HN

O

O

x HCl

(A) 100 mg

MM 0068.04 Imp. E (EP):(2S,3S)-3-Hydroxy-2-(4-methoxyphenyl)-2,3-dihydro-1,5-benzothiazepin-4(5H)-one

NH

S

OH

O

O (A) 100 mg

MM 0068.05 Imp. F (EP):(2S,3S)-5-[2-(Dimethylamino)ethyl]-3-hydroxy-2-(4-methoxyphenyl)-2,3-dihydro-1,5-benzothiazepin-4(5H)-one

N

S

OH

N

O

O (A) 100 mg

MM 0068.07 Diltiazem Sulphoxide

N

S

OO

N

O

O

O

(A) 100 mg

MM 0068.08 Diltiazem Maleate

N

S

OO

N

O

O

O

OH

O

OHx

(A) 100 mg

Dimenhydrinate MM 0599.00 Dimenhydrinate

ON N

N N

HN

Cl

O

O

x

(A) 500 mg

MM 0176.00 Imp. A (EP): Theophylline N

N N

HN

O

O (A) 500 mg

MM 0599.04 8-[(2-(Diphenylmethoxy)ethyl)(methyl)- amino]-1,3-dimethyl-3,7-dihydro-1H- purine-2,6-dione

N

N

O

O N

HN

N

O

(A) 100 mg

MM 0494.00 Imp. C (EP): Caffeine N

N N

N

O

O

(A) 500 mg




New MM 0599.08 Imp. E (EP): 8-Chloro-1,3,7-trimethyl-3,7- dihydro-1H-purine-2,6-dione (8-Chlorocaffeine)

N

N N

N

O

O

Cl

(A) 50 mg

MM 0490.03 Imp. F (EP) as Hydrochloride: 2-(Diphenylmethoxy)-N-methylethanamine Hydrochloride (Diphenhydramine Imp. A Hydrochloride; Nordiphenhydramine Hydrochloride) O

HN

x HCl

(A) 100 mg

MM 0490.04 Imp. G (EP) as Hydrochloride: N,N-Dimethyl-2-[(4-methylphenyl)- (phenyl)methoxy]ethanamine Hydrochloride (4-Methyldiphenhydramine Hydrochloride)

ON

x HCl

(A) 100 mg

MM 0640.00 Imp. H (EP) as Hydrochloride: 2-[(RS)-(4- Bromophenyl)(phenyl)methoxy]-N,N-dimethylethanamine Hydrochloride (4-Bromodiphen- hydramine Hydrochloride; Bromazine Hydro- chloride)

ON

x HCl

Br

(A) 100 mg

MM 0490.02 Imp. I (EP): Diphenylmethanol (Benzhydrol)

OH

(B) 100 mg

MM 0630.01 Imp. J (EP): Diphenylmethanone (Benzophenone)

O

(B) 100 mg

New MM 0599.14 Imp. K (EP): [Oxybis(methanetriyl)]tetrabenzene (Bis(diphenylmethyl) Ether)

O

(A) 50 mg

MM 0490.00 Diphenhydramine Hydrochloride

ON

x HCl

(A) 500 mg

MM 0155.02 8-Chlorotheophylline N

N N

HN

Cl

O

O

(B) 100 mg

MM 0599.03 8-[N-(2-Diphenylmethoxyethyl)-N,N- dimethylaminium]-1,3-dimethylxanthine inner salt

N

N

O

O N

N-

N+

O

(A) 100 mg

Dimetindene Maleate MM 0595.01 Imp. A (EP): 2-Ethylpyridine N (B) 100 mg

New MM 0595.02 Imp. B (EP) as Hydrochloride: 2-(1H-Inden- 2-yl)-N,N-dimethylethanamine Hydrochloride

Nx HCl

(A) 50 mg

New MM 0595.10 Imp. E (EP) as Hydrochloride: (2RS)-2-[2-(Dimethyl- amino)ethyl]indan-1-one Hydrochloride

N

O

x HCl

(A) 50 mg

New MM 0595.06 Imp. F (EP) as Hydrochloride: 2-(3-Butyl-1H- inden-2-yl)-N,N-dimethylethanamine Hydro- chloride

Nx HCl

(A) 50 mg




New MM 0595.07 Imp. G (EP) as Hydrochloride: N,N-Dimethyl- 2-(3-phenyl-1H-inden-2-yl)ethanamine Hydro- chloride N

x HCl

(A) 50 mg

Diphemanil Metilsulfate MM 1163.00 Diphemanil Metilsulfate N+

OS

O

O Ox

-

(D) 100 mg

Diphenhydramine Hydrochloride MM 0490.00 Diphenhydramine Hydrochloride

ON

x HCl

(A) 500 mg

MM 0490.03 Imp. A (EP) as Hydrochloride: 2-(Diphenylmethoxy)-N-methylethanamine Hydrochloride (Nordiphenhydramine Hydrochloride)

O

HN

x HCl

(A) 100 mg

MM 0490.04 Imp. B (EP) as Hydrochloride: 2-[(RS)- (4-Methylphenyl)phenylmethoxy]-N,N- dimethylethanamine Hydrochloride (4-Methyldiphenhydramine Hydrochloride) O

Nx HCl

(A) 100 mg

MM 0640.00 Imp. C (EP) as Hydrochloride: 2-[(RS)- (4-Bromophenyl)phenylmethoxy]-N,N- dimethylethanamine Hydrochloride (Bromazine Hydrochloride) O

Nx HCl

Br

(A) 100 mg

MM 0490.02 Imp. D (EP): Diphenylmethanol (Benzhydrol)

OH

(B) 100 mg

MM 0630.01 Imp. E (EP): Diphenylmethanone (Benzophenone)

O

(B) 100 mg

MM 0490.01 Diphenhydramine N-Oxide

ON

O

(A) 100 mg

Diphenylpyraline Hydrochloride MM 0557.00 Diphenylpyraline Hydrochloride

O

Nx HCl

(A) 500 mg

MM 0155.01 Diphenylpyraline O

N

(A) 100 mg

MM 0490.02 Diphenylmethanol (Benzhydrol) OH

(B) 100 mg

MM 0630.01 Diphenylmethanone (Benzophenone) O

(B) 100 mg




MM 0557.04 Diphenylpyraline N-Oxide O

N

O

(A) 100 mg

MM 0468.04 N-Desmethyldiphenylpyraline Hydrochloride (4-(Diphenylmethoxy)piperidine Hydrochloride)

O

NHx HCl

(A) 100 mg

Dipipanone Hydrochloride MM 0760.01 1,1-Diphenylbut-1-ene (A) 100 mg

MM 0760.02 1-(1-Methyl-3,3-diphenylpropyl)piperidine Hydrochloride

N

x HCl

(A) 100 mg

Dipotassium Clorazepate MM 0028.03 Imp. A (EP): (2-Amino-5-chlorophenyl)phenylmethanone

(Aminochlorobenzophenone) Cl

NH2

O

(B) 100 mg

MM 0023.02 Imp. B (EP): 7-Chloro-5-phenyl-1,3-dihydro-2H- 1,4-benzodiazepin-2-one (Nordazepam) [Controlled Substance] N

HN

O

Cl

(A) 100 mg

Diprafenon Hydrochloride MM 0428.01 2'-Hydroxy-3-phenylpropiophenone O

OH

(A) 100 mg

Diprophylline MM 0176.01 Imp. A (EP): N-Methyl-5-(methylamino)-1H-

imidazole-4-carboxamide (Theophyllidine) NH

HN N

HN

O (A) 100 mg

MM 0176.00 Imp. B (EP): 1,3-Dimethyl-3,7-dihydro-1H- purine-2,6-dione (Theophylline) N

N N

HN

O

O

(A) 500 mg

MM 0603.00 Imp. C (EP): 7-(2-Hydroxyethyl)-1,3-dimethyl- 3,7-dihydro-1H-purine-2,6-dione (Etofylline) N

N N

N

O

O

OH(A) 500 mg

Dipyridamole MM 0462.03 Imp. C (EP): 2,2'-[[6-Chloro-4,8-di(piperidin-1-

yl)pyrimido[5,4-d]pyrimidin-2-yl]nitrilo]diethanol

N

NN

N

N

Cl

N

N

OH

OH

(A) 100 mg




Disopyramide MM 0108.00 Disopyramide

O

NH2

N

N

(A) 500 mg

Dithranol MM 0137.00 Dithranol OHOOH (A) 500 mg

MM 0137.04 Imp. A (EP): Anthracen-9(10H)-one (Anthrone) O (A) 100 mg

MM 0137.01 Imp. B (EP): 1,8-Dihydroxyanthracene-9,10-dione (Danthron) OHOOH

O

(A) 100 mg

MM 0137.02 Imp. C (EP): 4,4',5,5'-Tetrahydroxy-9,9'-bianthracenyl-10,10'(9H,9'H)-dione (Dithranol Dimer)

OHOOH

OH O OH

(A) 100 mg

Dobutamine Hydrochloride MM 0384.00 Imp. A (EP) as Hydrochloride: Dopamine Hydrochloride HO

HO

NH2

x HCl(A) 500 mg

MM 0675.02 Imp. B (EP): 4-(4-Hydroxyphenyl)butan-2-one O

OH (C) 100 mg

Dodecylguanidinium Acetate MM 0451.03 Dodecylnitrile N (B) 100 mg

MM 0451.05 Dimethyldodecylamine N

(B) 100 mg

Domperidone MM 0107.00 Domperidone

N NHNNHN

O O

Cl

(D) 100 mg

MM 0107.06 Imp. A (EP): 5-Chloro-1-(piperidin-4-yl)- 1,3-dihydro-2H-benzimidazol-2-one HN NHN

O

Cl

(A) 100 mg

MM 0107.05 Imp. B (EP): 4-(5-Chloro-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)-1-formylpiperidine N NHN

O

Cl

O (A) 100 mg

MM 0107.03 Imp. F (EP): 1,3-Bis[3-[4-(5-chloro-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidin-1-yl]propyl]-1,3-dihydro-2H-benzimidazol-2-one

N NHNNN

O O

Cl

NHN N

O

Cl

(A) 50 mg

MM 0107.07 1,3-Dihydro-2H-benzimidazol-2-one HN

NH

O

(B) 100 mg




Donepezil Hydrochloride MM 0677.00 Donepezil Hydrochloride

O

O

O

N

x HCl

(D) 100 mg

MM 0677.01 Donepezil

O

O

O

N

(D) 100 mg

New MM 0677.16 1-Benzyl-4-[(5,6-dimethoxy-1H-inden-2-yl)methyl]piperidine

O

O

N

(A) 50 mg

Dopamine Hydrochloride MM 0384.00 Dopamine Hydrochloride HO

HO

NH2

x HCl(A) 500 mg

MM 0384.02 Imp. A (EP) as Hydrochloride: 5-(2-Aminoethyl)- 2-methoxyphenol Hydrochloride (4-O-Methyldopamine Hydrochloride)

HO

O

NH2

x HCl(A) 100 mg

MM 0384.04 Imp. C (EP): 2-(3,4-Dimethoxyphenyl)ethanamine O

O

NH2 (A) 100 mg

MM 0384.01 (R,S)-α-Methyldopamine Hydrobromide HO

HO

NH2

x HBr(A) 100 mg

Dorzolamide Hydrochloride New MM 0403.00 Dorzolamide Hydrochloride

SS

HN

S

H2N

OO

O O

x HCl

(A) 50 mg

Dosulepin Hydrochloride MM 0510.00 Dosulepin Hydrochloride

x HCl

N

S

(A) 100 mg

MM 0510.02 Imp. B (EP): Dibenzo[b,e]thiepin-11(6H)-one O

S

(A) 100 mg

MM 0510.08 Nordosulepin Hydrochloride

x HCl

NH

S

(A) 50 mg

Doxazosin Mesilate MM 0386.00 Doxazosin Mesilate

N

NO

O

NH2

N

N

O

O

O

SOH

OOx

(A) 100 mg

MM 0386.08 Doxazosin

N

NO

O

NH2

N

N

O

O

O(A) 100 mg




MM 0386.04 Imp. A (EP): (2RS)-2,3-Dihydro-1,4-benzodioxine-2-carboxylic Acid

O

OHO

O (A) 100 mg

MM 0386.05 Imp. B (EP) as Hydrochloride: 1-[(2RS)-2,3-Dihydro-1,4-benzodioxin-2-ylcarbonyl]piperazine Hydrochloride

O

ON

O

HNx HCl

(A) 100 mg

MM 0386.06 Imp. C (EP): 1,4-Bis(2,3-dihydro-1,4-benzodioxin- 2-ylcarbonyl)piperazine

O

ON

O

N

O

O

O

(A) 100 mg

MM 0085.07 Imp. D (EP): 6,7-Dimethoxyquinazoline-2,4(1H,3H)-dione

NH

HNO

O

O

O

(C) 100 mg

MM 0085.06 Imp. E (EP): 2,4-Dichloro-6,7-dimethoxyquinazoline N

NO

O

Cl

Cl

(A) 100 mg

MM 0386.01 Imp. F (EP): 2-Chloro-6,7-dimethoxyquinazolin-4-amine N

N

O

O

Cl

NH2

(A) 100 mg

MM 0386.12 Imp. F (EP) as Mesilate: 2-Chloro-6,7-dimethoxyquinazolin-4-amine Mesilate N

NO

O

NH2

Cl

SOH

OOx

(A) 100 mg

MM 0085.01 Imp. G (EP): 6,7-Dimethoxy-2-(piperazin-1-yl)quinazolin-4-amine

N

NO

O

N

NH2

NH (A) 100 mg

MM 0085.03 Imp. H (EP): 2,2'-(Piperazine-1,4-diyl)bis(6,7-dimethoxyquinazolin-4-amine)

N

NO

O

N

NH2

N N

NO

O

NH2 (D) 100 mg

Doxepin Hydrochloride MM 0032.00 Doxepin Hydrochloride

O

N

x HCl

(A) 500 mg

New MM 0032.03 Imp. A (EP): Dibenzo[b,e]oxepin-11(6H)-one (Doxepinone) O

O

(A) 100 mg

New MM 0032.04 Imp. B (EP): (11RS)-11-[3-(Dimethylamino)- propyl]-6,11-dihydrodibenzo[b,e]oxepin- 11-ol (Doxepinol)

O

OH

N (A) 50 mg

New MM 0032.08 Imp. C (EP) as E/Z-Mixture: (E,Z)-3-(Dibenzo[b,e]- oxepin-11(6H)-ylidene)-N-methylpropan-1-amine ((E,Z)-Desmethyldoxepin)

O

NH(A) 50 mg

Doxylamine Hydrogen Succinate MM 0101.00 Doxylamine Hydrogen Succinate

NO

NOH

O

OH

O

x

(A) 500 mg




New MM 0101.02 Imp. B (EP) as Hydrochloride: (1RS)-1-Phenyl- 1-(pyridin-2-yl)ethanol Hydrochloride

NOH

x HCl

(A) 50 mg

New MM 0101.03 Imp. C (EP) as Hydrogen Fumarate: N,N- Dimethyl-2-[(RS)-1-phenyl(pyridin-2-yl)- methoxy]ethanamine Hydrogen Fumarate N

ON

OH

O

HO

O

x

(A) 50 mg

MM 0101.04 Imp. D (EP): Phenyl(pyridin-2-yl)methanone (2-Benzoylpyridine)

NO

(A) 100 mg

MM 0101.05 Doxylamine N-Oxide Dihydrochloride

NO

NO x 2 HCl

(A) 100 mg

New MM 0101.08 N-Desmethyldoxylamine Hydrogen Succinate

NO

HN

xOH

O

O

OH

(A) 50 mg

Drofenine Hydrochloride MM 0768.00 Drofenine Hydrochloride

O

O

N

x HCl

(A) 500 mg

MM 0768.01 Drofenine N-Oxide Hydrochloride

O

O

N

x HCl

O

(A) 100 mg

Droperidol MM 0138.01 Imp. A (EP): 1-(1,2,3,6-Tetrahydropyridin-

4-yl)-1,3-dihydro-2H-benzimidazol-2-one HN

N

NHO

(A) 50 mg

MM 0138.04 Imp. D (EP) as Hydrochloride: (1RS)-1-[4-(4-Fluorophenyl)-4-oxobutyl]- 4-(2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)-1,2,3,6-tetrahydropyridine 1-Oxide Hydrochloride

N

NO

F

NHO

O

x HCl

(A) 100 mg

Dropropizine MM 1017.00 Dropropizine

N

N

OH

OH (A) 500 mg

Duloxetine Hydrochloride New MM 1122.00 Duloxetine Hydrochloride

x HCl

O NH

S

on request

New MM 0043.04 Imp. D (Pharmeuropa): Naphthalen-1-ol (1-Naphthol)

OH

(B) 100 mg

Ebastine MM 0468.00 Ebastine

O

NO

(A) 100 mg




MM 0490.02 Imp. A (EP): Diphenylmethanol (Benzhydrol)

OH

(B) 100 mg

MM 0468.03 Imp. B (EP): 1-[4-(1,1-Dimethylethyl)phenyl]ethanone

O

(A) 100 mg

MM 0468.04 Imp. C (EP) as Hydrochloride: 4-(Diphenyl- methoxy)piperidine Hydrochloride

O

NHx HCl

(A) 100 mg

MM 0468.05 Imp. D (EP): 1-[4-(1,1-Dimethylethyl)phenyl]- 4-(4-hydroxypiperidin-1-yl)butan-1-one

HO

N

O

(A) 100 mg

MM 0468.06 Imp. E (EP) as Hydrogen Fumarate: 1-[4-(1,1-Dimethylpropyl)phenyl]-4-[4-(diphenylmethoxy)piperidin- 1-yl]butan-1-one Hydrogen Fumarate

O

N

O

O

OHHO

O

x

(A) 100 mg

Econazole Nitrate MM 0524.00 Econazole Nitrate

O

Cl

x HNO3

N

N

Cl

Cl (A) 500 mg

MM 0281.01 Imp. A (EP): (1RS)-1-(2,4-Dichlorophenyl)-2-(1H-imidazol-1-yl)ethanol

HO

N

N

Cl

Cl (A) 100 mg

MM 0524.02 Imp. B (EP) as Nitrate: (2RS)-2-[(4-Chlorobenzyl)oxy]- 2-(2,4-dichlorophenyl)ethanamine Nitrate

O

Cl

x HNO3

NH2

Cl

Cl (D) 100 mg

MM 0524.03 Imp. C (EP) as Chloride: 1-(4-Chlorobenzyl)- 3-[(2RS)-2-[(4-chlorobenzyl)oxy]-2-(2,4- dichlorophenyl)ethyl]imidazolium Chloride

O

ClN+

N

Cl

Cl

Cl

Cl-

(A) 100 mg

Emedastine Difumarate New MM 1277.02 Imp. B (EP): 2-Chloro-1-(2-ethoxyethyl)-1H-

Benzimidazole

N

N Cl

O (A) 100 mg

Enalapril Maleate MM 0010.00 Enalapril Maleate

HN

O O

N

O

OH

OH

O

O

x

OOH (A) 100 mg




MM 0010.05 Imp. B (EP): (2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]propanoic Acid

HN

O O

OH

O (A) 100 mg

MM 0010.01 Imp. C (EP): (2S)-1-[(2S)-2-[[(1S)-1-Carboxy- 3-phenylpropyl]amino]propanoyl]pyrrolidine-2- carboxylic Acid (Enalaprilat)

HN

HO O

N

OO

OH (D) 100 mg

MM 0010.06 Imp. D (EP): Ethyl (2S)-2-[(3S,8aS)-3-Methyl-1,4-dioxo-octahydropyrrolo[1,2-]pyrazin-2-yl]-4-phenylbutanoate (Enalapril diketopiperazine) N

O O

O

NO

H (A) 100 mg

MM 0015.02 Imp. I (EP): 1H-Imidazole (Imidazole)

N

HN (B) 100 mg

MM 0010.15 (2S)-2[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]propanoic Acid Ethyl Ester Hydrochloride

HN

O O

O

O

x HCl

(A) 100 mg

Enilconazole MM 0281.01 Imp. E (EP): (1RS)-1-(2,4-Dichlorophenyl)-2-(1H-imidazol-1-yl)ethanol

N

HO

N

Cl

Cl (A) 100 mg

Enrofloxacin MM 0395.00 Enrofloxacin

NN

O

OH

O

N

F

(A) 100 mg

MM 0018.01 Imp. A (EP): 7-Chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline- 3-carboxylic Acid

NCl

O

OH

O

F

(A) 100 mg

MM 0018.06 Imp. B (EP) as Hydrochloride Monohydrate: Ciprofloxacin Hydrochloride Monohydrate NN

O

OH

O

HN

F

x HClx H2O

(A) 500 mg

MM 0395.01 Imp. C (EP) as Hydrochloride: 1-Cyclopropyl-7-(4-ethylpiperazin-1-yl)-4- oxo-1,4-dihydroquinoline-3-carboxylic Acid Hydrochloride (Desfluoroenrofloxacin Hydrochloride)

NN

O

OH

O

N

x HCl

(A) 100 mg

MM 0018.04 Imp. G (EP): 7-[(2-Aminoethyl)amino]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid NHN

O

OH

O

H2N

F

(D) 50 mg

MM 0395.07 Enrofloxacin N-Oxide Hydrochloride

NN

O

OH

O

N

F

O

x HCl

(A) 100 mg

Entacapone MM 1221.02 Imp. A (EP): (2Z)-2-Cyano-3-(3,4-dihydroxy-

5-nitrophenyl)-N,N-diethylprop-2-enamide

NO2

HO

HON

NO

(A) 50 mg




New MM 1221.04 Imp. B (EP): Ethyl (2E)-2-Cyano-3-(3,4- dihydroxy-5-nitrophenyl)prop-2-enoate O2N

HO

OHN

O

O (A) 50 mg

MM 1221.01 Imp. C (EP): 3,4-Dihydroxy-5-nitrobenzaldehyde O2N

HO

OH

O (A) 100 mg

New MM 1221.05 Imp. D (EP): (2E)-2-Cyano-3-(3-ethoxy-4- hydroxy-5-nitrophenyl)-N,N-diethylprop-2- enamide

O2N

HO

ON

N

O (A) 50 mg

New MM 1221.06 Imp. E (EP): 3,5-Dinitrobenzene-1,2-diol O2N

HO

OH

NO2 (A) 50 mg

New MM 1221.07 Imp. F (EP): (2E)-2-Cyano-3-(3,4-dihydroxy- 5-nitrophenyl)prop-2-enoic Acid O2N

HO

OHN

O

OH

(A) 50 mg

New MM 1221.03 Imp. H (EP): (2E)-3-(3,4-Dihydroxy-5-nitrophenyl)-2-(piperidin-1-ylcarbonyl)prop-2- ennitrile

O2N

HO

OHN

N

O (A) 50 mg

MM 1221.09 Imp. I (EP): Propyl (2E)-2-Cyano-3-(3,4- dihydroxy-5-nitrophenyl)prop-2-enoate O2N

HO

OHN

O

O (A) 50 mg

Ephedrine Hydrochloride MM 0652.00 Ephedrine Hydrochloride [Drug Precursor] H

N

OH

x HCl

(A) 500 mg

MM 2115.00 Imp. B (EP) as Hydrochloride: Pseudoephedrine Hydrochloride [Drug Precursor]

HN

OH

x HCl

(A) 500 mg

New MM 0652.03 (1S,2R)-(+)-Ephedrine Hydrochloride [Drug Precursor] HN

OH

x HCl

(A) 100 mg

Ephedrine Sulphate MM 1147.00 Ephedrine Sulphate [Drug Precursor]

HN

OH

2

x H2SO4

(A) 250 mg

Erdosteine MM 0544.00 Erdosteine

NH

SOH

OOS O (A) 100 mg

MM 0544.01 2-Chloro-N-(2-oxotetrahydrothiophen-3-yl)acetamide

NH

Cl

OS O (A) 100 mg

Erythromycin MM 0132.13 Imp. B (EP): N-Demethylerythromycin A O

O

HO

OH

O

HO

O

O

O

OH

OO

NH

OH

(D) 100 mg




MM 0132.10 Imp. E (EP): Erythromycin A Enol Ether

O

O

HO

OH

OO

O

O

OH

OO

N

OH

(A) 50 mg

Esomeprazole Magnesium Trihydrate MM 0095.03 Imp. A (EP): 5-Methoxy-1H-benzimidazole-2-thiol

SH

NH

N

O (A) 100 mg

MM 0095.04 Imp. B (EP): 2-[(RS)-[(3,5-Dimethylpyridin- 2-yl)methyl]sulphinyl]-5-methoxy-1H-benzimidazole

N

S

O

NH

N

O (A) 100 mg

MM 0095.06 Imp. C (EP): 5-Methoxy-2-[[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]- sulphanyl]-1H-benzimidazole (Ufiprazole)

N

OS

NH

N

O (A) 100 mg

MM 0095.05 Imp. D (EP): 5-Methoxy-2-[[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulphonyl]-1H-benzimidazole (Omeprazole Sulphone)

N

OS

NH

N

O

O O

(A) 100 mg

MM 0095.07 Imp. E (EP): 4-Methoxy-2-[[(RS)-(5-methoxy-1H-benzimidazol-2-yl)sulphinyl]methyl]-3,5-dimethylpyridine 1-Oxide (Omeprazole N-Oxide)

N

OS

O

NH

N

O

O

(A) 100 mg

Estradiol Benzoate MM 0301.00 Estradiol Benzoate OH

O

O

(A) 500 mg

MM 0300.00 Imp. A (EP) as Hemihydrate: Estradiol Hemihydrate

OH

HO

x 1/2 H2O

(A) 500 mg

MM 0301.02 Imp. C (EP): Estra-1,3,5(10)-triene-3,17-diyl Dibenzoate (Estradiol 3,17-Dibenzoate) O

O

O

O (A) 100 mg

MM 0301.07 Imp. D (EP): 3-Hydroxyestra-1,3,5(10)-trien-17- yl Benzoate (Estradiol 17-Benzoate) O

HO

O (A) 100 mg

MM 0301.03 Imp. E (EP): 17-Hydroxyestra-1,3,5(10)-trien-3-yl Benzoate (17-epi-Estradiol Benzoate)

OH

O

O

(C) 10 mg

MM 0301.08 Imp. G (EP): 17-Oxoestra-1,3,5(10)-trien-3-yl Benzoate (Estrone Benzoate)

O

O

O

(A) 100 mg

MM 0278.01 Benzoic Acid OH

O (B) 100 mg




Estradiol Enanthate MM 0473.00 Estradiol Enanthate

O

HO

O (A) 100 mg

Estradiol Hemihydrate MM 0300.00 Estradiol Hemihydrate OH

HO

x 1/2 H2O

(A) 500 mg

MM 0282.00 Imp. A (EP): 3-Hydroxyestra-1,3,5(10)-trien-17-one (Estrone) O

HO

(A) 500 mg

MM 0300.01 Imp. B (EP): Estra-1,3,5(10)-triene-3,17-diol (17-Estradiol; 17-epi-Estradiol)

OH

HO

(A) 100 mg

MM 0300.06 Imp. C (EP): 4-Methylestra-1,3,5(10)-triene-3,17-diol (4-Methylestradiol)

OH

HO

(A) 100 mg

MM 0300.02 Imp. D (EP): Estra-1,3,5(10),9(11)-tetraene-3,17β-diol (9,11-Didehydroestradiol)

OH

HO

(D) 100 mg

MM 0300.03 6-Hydroxyestradiol OH

HO

OH

(D) 50 mg

MM 0300.08 6-Ketoestradiol OH

HO

O

(A) 100 mg

Estradiol Valerate MM 0209.00 Estradiol Valerate

O

HO

O (A) 500 mg

MM 0300.00 Imp. A (EP) as Hemihydrate: Estradiol Hemihydrate OH

HO

x 1/2 H2O

(A) 500 mg

MM 0209.06 Imp. B (EP): 17-Hydroxyestra-1,3,5(10)-trien-3-yl Pentanoate (Estradiol 3-Valerate)

OH

O

O

(A) 100 mg

MM 0209.01 Imp. C (EP): 3-Hydroxyestra-1,3,5(10),9(11)-tetraen-17-yl Pentanoate (9,11-Didehydroestradiol Valerate) O

HO

O (D) 100 mg

MM 0209.07 Imp. D (EP): 3-Hydroxy-4-methylestra-1,3,5(10)-trien- 17-yl Pentanoate (4-Methylestradiol Valerate) O

HO

O (D) 100 mg




MM 0209.02 Imp. E (EP): Estra-1,3,5(10)-trien-3,17-diyl Dipentanoate (Estradiol 3,17-Divalerate) O

O

O

O

(A) 100 mg

MM 0209.04 Imp. F (EP): 3-Hydroxyestra-1,3,5(10)-trien-17-yl Butanoate (Estradiol Butyrate) O

HO

O (A) 100 mg

MM 0209.03 17-epi-Estradiol Valerate (17-Estradiol Valerate) O

HO

O (D) 100 mg

Estramustine Sodium Phosphate MM 0100.01 Estramustine OH

ON

O

Cl

Cl

(D) 100 mg

MM 0100.02 17-17'-Bis3-{bis(2-chloroethyl)carbamoyloxy}estra-1,3,5(10)- trienyl Pyrophosphate Disodium Salt

O

ON

O

Cl

Cl

PO

PO

NaO O O ONa

O N

O

Cl

Cl

(D) 50 mg

Estriol MM 0130.00 Estriol OH

HO

OH

(A) 100 mg

MM 0130.06 Imp. A (EP): Estra-1,3,5(10),9(11)-tetraene-3,16,17-triol (9,11-Didehydroestriol)

OH

HO

OH

(D) 100 mg

MM 0282.00 Imp. B (EP): 3-Hydroxyestra-1,3,5(10)-trien-17-one (Estrone) O

HO

(A) 500 mg

MM 0130.01 Imp. C (EP): 3-Methoxyestra-1,3,5(10)-triene-16,17-diol (Estriol 3-Methyl Ether)

OH

O

OH

(D) 100 mg

MM 0300.00 Imp. D (EP) as Hemihydrate: Estradiol Hemihydrate

OH

HO

x 1/2 H2O

(A) 500 mg

MM 0130.05 Imp. E (EP): Estra-1,3,5(10)-triene-3,16,17-triol (17-epi-Estriol)

OH

HO

OH

(D) 100 mg

MM 0130.04 Imp. F (EP): Estra-1,3,5(10)-triene-3,16,17-triol (16-epi-Estriol)

OH

HO

OH

(D) 100 mg

MM 0130.03 Imp. G (EP): Estra-1,3,5(10)-triene-3,16,17-triol (16,17-epi-Estriol)

OH

HO

OH

(D) 100 mg

MM 0130.22 Imp. I (EP): 3-Hydroxy-17-oxa-D-homoestra-1,3,5(10)-trien-17a-one

HO

O

O on request




MM 0130.02 6-Hydroxyestriol OH

HO

OH

OH

(D) 100 mg

MM 0130.14 Estriol 16,17-Diacetate O

HO

O

O

O

(D) 100 mg

MM 0130.15 Estriol Triacetate O

O

O

O

OO

(D) 100 mg

MM 0130.16 Estriol 3-Benzyl Ether OH

O

OH

(D) 100 mg

MM 0130.17 16-Oxoestradiol OH

HO

O

(D) 100 mg

MM 0130.18 6-Oxoestriol OH

HO

OH

O

(D) 100 mg

Estrogens conjugated New MM 0282.00 Imp. I (EP): 3-Hydroxyestra-1,3,5(10)-trien-

17-one (Estrone)

O

HO

(A) 500 mg

Estrone MM 0282.00 Estrone O

HO

(A) 500 mg

MM 0282.01 Estrone 3-Methyl Ether O

O

(A) 100 mg

Ethacridine Lactate Monohydrate MM 0798.00 Ethacridine Lactate Monohydrate

NH2N

NH2

O

OH

O

OHxx H2O

(A) 250 mg

Ethinylestradiol MM 0123.00 Ethinylestradiol OH

HO

(A) 500 mg

MM 0123.02 Imp. B (EP): 19-Nor-17-pregna-1,3,5(10),9(11)-tetraen-20-yne-3,17-diol (9,11-Didehydroethinylestradiol)

OH

HO

(D) 50 mg

MM 0282.00 Imp. C (EP): 3-Hydroxyestra-1,3,5(10)-trien-17-one (Estrone) O

HO

(A) 500 mg

MM 0300.00 Imp. D (EP) as Hemihydrate: Estradiol Hemihydrate

OH

HO

x 1/2 H2O

(A) 500 mg




MM 0123.07 Imp. E (EP): 19-Nor-17-pregna- 1,3,5(10)-trien-20-yne-3,6,17-triol (6-Hydroxyethinylestradiol)

OH

HO

OH

(D) 100 mg

MM 0123.06 Imp. F (EP): 19-Nor-17-pregna- 1,3,5(10)-trien-20-yne-3,6,17-triol (6-Hydroxyethinylestradiol)

OH

HO

OH

(D) 25 mg

MM 0123.05 Imp. G (EP): 3,17-Dihydroxy-19- nor-17-pregna-1,3,5(10)-trien-20-yn-6-one (6-Oxoethinylestradiol, 6-Ketoethinylestradiol)

OH

HO

O

(D) 100 mg

MM 0123.08 Imp. I (EP): 19-Nor-17-pregna- 1,3,5(10),6-tetraen-20-yne-3,17-diol (6,7-Didehydroethinylestradiol)

HO

OH (D) 50 mg

MM 0300.01 Imp. L (EP): Estra-1,3,5(10)-triene- 3,17-diol (17-Estradiol; 17-epi-Estradiol)

OH

HO

(A) 100 mg

Ethionamide MM 0845.00 Ethionamide

N

NH2

S (A) 250 mg

MM 0845.01 Ethionamide Sulphoxide

N

NH2

SO (D) 100 mg

Ethosuximide MM 0750.00 Ethosuximide H

N OO(A) 500 mg

Ethyl Parahydroxybenzoate MM 0498.00 Ethyl Parahydroxybenzoate

HO

O

O (A) 500 mg

MM 0498.05 Sodium Ethyl Parahydroxybenzoate

NaO

O

O (A) 500 mg


HO

OH

O (B) 100 mg


HO

O

O (A) 500 mg

MM 0432.00 Imp. C (EP): Propyl 4-Hydroxybenzoate (Propyl Parahydroxybenzoate)

HO

O

O (A) 500 mg

MM 0496.00 Imp. D (EP): Butyl 4-Hydroxybenzoate (Butyl Parahydroxybenzoate)

HO

O

O (A) 500 mg

Ethylmorphine Hydrochloride MM 0037.00 Imp. B (EP) as Hydrochloride Trihydrate:

Morphine Hydrochloride Trihydrate [Controlled Substance]

O OHHO

N

x HClx 3 H2O

(A) 250 mg




MM 0280.00 Imp. B (EP) as Hemisulphate Pentahemihydrate: Morphine Hemisulphate Pentahemihydrate [Controlled Substance]

O OHHO

N

2

x H2SO4x 5 H2O

(A) 250 mg

MM 0004.00 Imp. C (EP) as Monohydrate: Codeine Monohydrate [Controlled Substance]

O OHO

N

x H2O

(A) 100 mg

MM 0442.00 Imp. C (EP) as Phosphate Hemihydrate: Codeine Phosphate Hemihydrate [Controlled Substance]

O OHO

N

x H3PO4x 1/2 H2O

(A) 100 mg

Etilefrine Hydrochloride MM 0035.00 Etilefrine Hydrochloride

HO

OHHN x HCl

(A) 500 mg

MM 0081.00 Imp. B (EP) as Hydrochloride: (1RS)- 1-(3-Hydroxyphenyl)-2-(methylamino)ethanol Hydrochloride (Phenylephrine Hydrochloride)

HO

OHHN

x HCl

(A) 500 mg

MM 0973.00 Imp. C (EP) as Hydrochloride: (1RS)-2-Amino-1-(3-hydroxyphenyl)ethanol Hydrochloride (Norfenefrine Hydrochloride)

HO

OH

NH2 x HCl

(A) 500 mg

New MM 0035.08 Imp. D (EP) as Hydrochloride: 2-(Benzylethyl-amino)-1-(3-hydroxyphenyl)ethanone Hydrochloride (Benzyletilefrone Hydrochloride) HO

O

Nx HCl

(A) 100 mg

MM 0035.05 Imp. E (EP): 1-(3-Hydroxyphenyl)ethanone (3-Hydroxyacetophenone) HO

O (C) 100 mg

MM 0035.06 Imp. F (EP): N-Benzylethanamine (Benzylethylamine)

HN

(C) 100 mg

MM 0035.50 3-Benzoyloxyacetophenone O

O

O

(A) 100 mg

MM 0035.51 3-Benzoyloxy--bromoacetophenone O

O

O

Br

on request

Etodolac MM 0911.00 Etodolac

OHN

O

OH

(A) 250 mg

MM 0911.01 Imp. A (EP): 2-[(1RS)-1-Ethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl]acetic Acid (8-Desethyl Etodolac) O

HN

O

OH

(A) 100 mg

MM 0911.02 Imp. B (EP): 2-[(1RS)-1-Ethyl-8-methyl-1,3,4,9- tetrahydropyrano[3,4-b]indol-1-yl]acetic Acid (8-Methyl Etodolac) O

HN

O

OH

(A) 100 mg

MM 0911.03 Imp. C (EP): 2-[(1RS)-8-Ethyl-1-methyl-1,3,4,9- tetrahydropyrano[3,4-b]indol-1-yl]acetic Acid (1-Methyl Etodolac) O

HN

O

OH

(A) 100 mg




New MM 0911.04 Imp. D (EP): 2-[(1RS)-1-Ethyl-8-(1-methylethyl)- 1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl]acetic Acid (8-Isopropyl Etodolac) O

HN

O

OH

(A) 50 mg

MM 0911.06 Imp. F (EP): 2-[(1RS)-8-Ethyl-1-(1-methylethyl)- 1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl]acetic Acid (1-Isopropyl Etodolac) O

HN

O

OH

(A) 100 mg

MM 0911.07 Imp. G (EP): 2-[(1RS)-8-Ethyl-1-propyl-1,3,4,9- tetrahydropyrano[3,4-b]indol-1-yl]acetic Acid (1-Propyl Etodolac) O

HN

O

OH

(A) 100 mg

MM 0911.08 Imp. H (EP): 2-(7-Ethylindol-3-yl)ethanol OH

HN (A) 100 mg

MM 0911.10 Imp. J (EP): (1RS)-1,8-Diethyl-1-methyl-1,3,4,9- tetrahydropyrano[3,4-b]indole (Decarboxy Etodolac

OHN

(A) 100 mg

MM 0911.11 Imp. K (EP): Methyl 2-[(1RS)-1,8-Diethyl-1,3,4,9- tetrahydropyrano[3,4-b]indol-1-yl]acetate (Etodolac Methyl Ester) O

HN

O

O

(A) 100 mg

Etofenamate MM 0410.00 Imp. A (EP): 2-[[3-(Trifluoromethyl)phenyl]amino]benzoic Acid

(Flufenamic Acid)

O

OH

NH

F

F F

(A) 500 mg

MM 0105.02 Imp. B (EP): Butyl 2-[[3-(Trifluoromethyl)phenyl]amino]benzoate (Butyl Flufenamate)

O

O

NH

F

F F

(A) 100 mg

MM 0105.03 Imp. C (EP): N-Phenyl-3-(trifluoromethyl)aniline

NH

F

F F

(A) 100 mg

MM 0105.04 Imp. D (EP): 2,2'-Oxybis(ethylene) Bis[2-[[3-(trifluoromethyl)phenyl]amino]benzoate]

O

O

NH

F

O

O

HN

F

O

F F F F

(A) 100 mg

MM 0105.05 Imp. E (EP): 2-(2-Butoxyethoxy)ethyl 2-[[3- (Trifluoromethyl)phenyl]amino]benzoate

O

O

NH

F

OO

F F

(A) 100 mg

MM 0105.06 Imp. F (EP): 2,2'-Oxydiethanol HOO

OH (A) 100 mg




MM 0105.07 Imp. G (EP): 2-Hydroxyethyl 2-[[3-(Trifluoromethyl)phenyl]amino]benzoate

O

O

NH

F

OH

F F

(A) 100 mg

MM 0105.08 Etofenamate Myristate O

O

NH

F

OO

O

F F

(A) 100 mg

MM 0105.09 Etofenamate Palmitate O

O

NH

F

OO

O

FF

(A) 100 mg

MM 0105.10 Etofenamate Stearate O

O

NH

F

OO

O

F F

(A) 100 mg

MM 0105.11 Triethylene Glycol Flufenamate O

O

NH

F

OO

OH

F F

(A) 100 mg

Etofylline MM 0603.00 Etofylline

N

N N

N

O

OOH

(A) 500 mg

Etomidate New MM 1264.00 Etomidate

O

O

N

N

(A) 100 mg

New MM 1264.04 Imp. A (EP) as R-Enantiomer: 1-[(1R)-1- Phenylethyl]-1H-imidazole-5-carboxylic Acid (Etomidate Acid) O

OH

N

N

(A) 50 mg

Famciclovir New MM 0620.01 9-[4-Acetoxy-3-(acetoxymethyl)butyl]-2-amino-

6-chloropurine N

N N

N

H2NO

O

O

O

Cl (A) 100 mg

Famotidine MM 0029.00 Famotidine

S N

NH2

N

SN

H2N

NH2

SNH2

O O

(A) 250 mg




MM 0029.06 Imp. A (EP) as Hydrochloride: 3-[[[2- [(Diaminomethylene)amino]thiazol-4-yl]- methyl]sulphanyl]propanimidamide Hydrochloride

S NH2

NH

N

SN

H2NNH2

x HCl

(A) 100 mg

MM 0029.05 Imp. B (EP) as Dimaleate: 3,5-Bis[2-[[[2-[(diaminomethylene)amino]-thiazol-4-yl]methyl]sulphanyl]ethyl]-4H-1,2,4,6-thiatriazine 1,1-Dioxide Dimaleate

SN

SN

NH

NS

N

O O

S N

SN

H2NNH2

NH2

H2N

OH

OH

O

O

x 2

(D) 50 mg

MM 0029.01 Imp. C (EP) as Hydrochloride: 3-[[[2-[(Diaminomethylene)amino]thiazol-4-yl]methyl]sulphanyl]-N-sulphamoylpropanamide Hydrochloride

S NH

O

N

SN

H2N

NH2S

NH2

O O

x HCl

(A) 100 mg

MM 0029.02 Imp. D (EP): 3-[[[2-[(Diaminomethylene)amino]thiazol-4-yl]methyl]sulphanyl]propanamide S NH2

O

N

SN

H2N

NH2 (A) 100 mg

MM 0029.07 Imp. E (EP): 2,2'-[Disulphanediylbis-(methylenethiazole-4,2-diyl)]diguanidine SN

SN

H2NNH2

S

S

NN

NH2

H2N (A) 100 mg

MM 0029.03 Imp. F (EP): 3-[[[2-[(Diaminomethylene)amino]thiazol-4-yl]methyl]sulphanyl]propanoic Acid S OH

O

N

SN

H2N

NH2 (A) 100 mg

MM 0029.09 Imp. G (EP) as Maleate: N-Cyano-3-[[[2-(diaminomethylene)amino]thiazol-4-yl]methyl]sulphanyl]propanimidamide Maleate

S NH

NH

N

SN

H2NNH2 N

OH

OH

O

O

x

(A) 100 mg

MM 0029.10 Imp. I (Pharmeuropa): 3-[[[2-[(Diaminomethylene)amino]thiazol-4-yl]methyl]sulfinyl]-N-sulfamoylpropanamide

S NH

O

N

SN

H2N

NH2S

NH2

O O

O

(D) 50 mg

MM 0029.04 Famotidine Sulphoxide S N

NH2

N

SN

H2N

NH2

SNH2

O OO

(A) 100 mg

MM 0029.51 2-[(Diaminomethylene)amino]-4-(4-cyanobutyl)thiazole Hydrochloride

N

SN

H2NNH2

N

x HCl

on request

Felodipine MM 0139.00 Felodipine H

N

O

O

Cl

O

OCl

(A) 100 mg

MM 0139.01 Imp. A (EP): Ethyl Methyl 4-(2,3-Dichlorophenyl)-2,6-dimethylpyridine-3,5-dicarboxylate

N

O

O

Cl

O

OCl

(D) 50 mg

MM 0139.02 Imp. B (EP): Dimethyl 4-(2,3-Dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate

HN

O

O

Cl

O

OCl

(A) 100 mg

MM 0139.03 Imp. C (EP): Diethyl 4-(2,3-Dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate

HN

O

O

Cl

O

OCl

(A) 100 mg




Fenbendazole MM 2500.00 Imp. A (EP): Methyl (1H-Benzimidazol-2-yl)carbamate

(Carbendazim) N

HN

NH

O

O (A) 100 mg

MM 0518.01 Fenbendazole Sulphoxide (Oxfendazole)

S N

HN

NH

O

O

O

(A) 100 mg

MM 0518.02 Fenbendazole Sulphone

S N

HN

NH

O

O

OO

(A) 100 mg

Fenbufen MM 0918.00 Fenbufen O

OH

O

(A) 500 mg

MM 0918.03 Imp. C (EP): Biphenyl (A) 100 mg

MM 0918.05 4-(4-Chlorophenyl)-4-oxobutanoic Acid (3-(4-Chlorobenzoyl)propionic Acid)

Cl

O

OH

O

(A) 100 mg

Fenfluramine Hydrochloride MM 0608.00 Fenfluramine Hydrochloride H

N

x HCl

FF

F

(A) 500 mg

MM 0608.01 Norfenfluramine Hydrochloride NH2

x HCl

FF

F

(A) 100 mg

MM 0608.02 N-Nitrosofenfluramine N

FF

F

NO (A) 100 mg

Fenofibrate MM 0505.00 Fenofibrate

Cl

O

OO

O (A) 500 mg

MM 0505.01 Imp. A (EP): (4-Chlorophenyl)(4-hydroxyphenyl)methanone Cl

O

OH (C) 100 mg

MM 0505.03 Imp. C (EP): (3RS)-3-[4-(4-Chlorobenzoyl)- phenoxy]butan-2-one Cl

O

O

O (A) 100 mg

MM 0505.04 Imp. D (EP): Methyl 2-[4-(4-Chlorobenzoyl)- phenoxy]-2-methylpropanoate Cl

O

OO

O (A) 100 mg

MM 0505.05 Imp. E (EP): Ethyl 2-[4-(4-Chlorobenzoyl)- phenoxy]-2-methylpropanoate Cl

O

OO

O (A) 100 mg

MM 0505.06 Imp. F (EP): (4-Chlorophenyl)[4-(1-methylethoxy)phenyl]methanone

Cl

O

O (A) 100 mg




New MM 0505.07 Imp. G (EP): 1-Methylethyl 2-[[2-[4-(4-Chlorobenzoyl)phenoxy]-2- methylpropanoyl]oxy]-2-methylpropanoate

Cl

O

OO

O

O

O

(A) 50 mg

Fenoprofen Calcium MM 0790.00 Fenoprofen Calcium Dihydrate

Ca 2+

x 2 H2OO O-

O2

(A) 500 mg

Fentanyl MM 0528.00 Fentanyl [Controlled Substance]

N

N

O

(A) 100 mg

MM 0528.09 Imp. A (EP) as Hydrochloride: N-Phenyl-N- [cis,trans-1-oxido-1-(2-phenylethyl)piperidin- 4-yl]propanamide Hydrochloride (Fentanyl N-Oxide Hydrochloride)

N

N

O

O

x HCl

(A) 100 mg

MM 0528.08 Imp. B (EP): N-Phenyl-N-(piperidin-4-yl)propanamide NH

N

O (A) 100 mg

MM 0528.03 Imp. C (EP): N-phenyl-N-[1-(2-phenylethyl)- piperidin-4-yl]acetamide

N

N

O

(A) 100 mg

MM 0528.04 Imp. D (EP): N-phenyl-1-(2-phenylethyl)piperidin-4-amine

N

HN

(A) 100 mg

MM 0093.17 Imp. F (EP) as Hydrochloride: Aniline Hydrochloride (Phenylamine Hydrochloride)

NH2

x HCl(B) 100 mg

MM 0528.07 Imp. G (EP): N-Phenylpropanamide NH

O (A) 100 mg

Fexofenadine Hydrochloride MM 0507.01 Imp. A (EP): 2-[4-[4-[4-(Hydroxydiphenyl-

methyl)piperidin-1-yl]butanoyl]phenyl]-2-methylpropanoic Acid (Ketofexofenadine)

O

N

OH

O

OH

(A) 100 mg

MM 0507.03 Imp. C (EP): (1RS)-4-[4-(Hydroxydiphenyl- methyl)piperidin-1-yl]-1-[4-(1-methylethyl)- phenyl]butan-1-ol OH

N

OH

(A) 100 mg

MM 0055.02 Imp. E (EP): Diphenyl(piperidin-4-yl)methanol

NH

OH

(B) 100 mg




Finasteride MM 0415.00 Finasteride

NH

O

O HN (A) 100 mg

MM 0415.01 Imp. A (EP): N-(1,1-Dimethylethyl)-3-oxo- 4-aza-5α-androstane-17β-carboxamide (Dihydrofinasteride)

NH

O

O HN

H

(A) 100 mg

MM 0415.02 Imp. B (EP): Methyl 3-Oxo-4-aza-5-androst- 1-ene-17-carboxylate (-1-Aza Ester)

NH

O

OO

H

(A) 100 mg

New MM 0415.04 3-Oxo-4-aza-5alpha-androstane-17beta-carboxylic Acid

NH

O

OOH

H

(A) 100 mg

Flavoxate Hydrochloride MM 0156.00 Flavoxate Hydrochloride

O

OON

O

x HCl

(A) 100 mg

MM 0156.01 Imp. A (EP): 3-Methyl-4-oxo-2-phenyl-4H-1- benzopyran-8-carboxylic Acid (3-Methyl- flavone-8-carboxylic Acid)

O

OHO

O (A) 100 mg

MM 0156.02 Imp. B (EP): Ethyl 3-Methyl-4-oxo-2-phenyl- 4H-1-benzopyran-8-carboxylate (3-Methyl- flavone-8-carboxylic Acid Ethyl Ester)

O

OO

O (A) 100 mg

MM 0156.05 Imp. C (EP): 1-Methylethyl-3-Methyl-4-oxo- 2-phenyl-4H-1-benzopyran-8-carboxylate (3-Methylflavone-8-carboxylic Acid Isopropyl Ester)

O

OO

O (A) 50 mg

Flecainide Acetate MM 0488.02 Imp. B (EP): (RS)-(Piperidin-2-yl)methanamine H2N

HN

(A) 100 mg

MM 0488.04 Imp. D (EP): 2,5-Bis(2,2,2-trifluoroethoxy)benzoic Acid O

O

OH

O

F

F F

F

F F

(A) 100 mg

Fluanisone MM 1247.02 1-(2-Methoxyphenyl)piperazine Dihydrochloride

HN

N

O

x 2 HCl

(A) 100 mg

Flubendazole MM 0463.00 Flubendazole

O

N

HNF

NHO

O (A) 100 mg

MM 0463.02 Imp. B (EP): (2-Amino-1H-benzimidazol-5-yl)(4-fluorophenyl)methanone

O

N

HNF

NH2

(A) 100 mg




MM 0463.03 Imp. C (EP): (4-Fluorophenyl)(2-hydroxy-1H-benzimidazol-5-yl)methanone

O

N

HNF

OH

(C) 50 mg

MM 0463.04 Imp. D (EP): (1H-Benzimidazol-5-yl)(4-fluorophenyl)methanone

O

N

HNF on request

MM 0463.05 Imp. E (EP): Methyl [5-(2-Fluorobenzoyl)-1H-benzimidazol-2-yl]carbamate

O

N

HN

NHO

O

F

(C) 50 mg

MM 0463.06 Imp. F (EP): Methyl [5-(4-Fluorobenzoyl)-1-methyl-1H-benzimidazol-2-yl]carbamate

O

N

NF

NHO

O (C) 50 mg

MM 0463.07 Imp. G (EP): Methyl [5-[4-(1-Methylethoxy)benzoyl]-1H-benzimidazol-2-yl]carbamate

O

N

HNO

NHO

O (D) 100 mg

Flucloxacillin Sodium MM 0489.00 Flucloxacillin Sodium Hydrate

N

SH

O

OONa

HN

N

O

F

Cl

O

x H2O

(A) 500 mg

MM 0489.01 Imp. A (EP) as Disodium Salt: (4S)-2-[Carboxy[[[3-(2-chloro-6-fluorophenyl)-5-methylisoxazol-4-yl]carbonyl]amino]methyl]-5,5-dimethylthiazolidine-4-carboxylic Acid Disodium Salt (Penicilloic Acids of Flucloxacillin Disodium Salt)

HN

S

OONa

HN

N

O

F

Cl

OO ONa

(A) 100 mg

MM 0489.02 Imp. B (EP): (2RS,4S)-2-[[[[3-(2-Chloro-6-fluorophenyl)-5-methylisoxazol-4-yl]carbonyl]amino]methyl]-5,5-dimethyl-thiazolidine-4-carboxylic Acid (Penilloic Acids of Flucloxacillin)

HN

S

OOH

NHN

OF

Cl

O

(A) 50 mg


N

SH

O

H2N

OOH (B) 100 mg

MM 0489.03 Imp. D (EP): 3-(2-Chloro-6-fluorophenyl)-5-methylisoxazole-4-carboxylic Acid

OHN

OF

Cl

O

(C) 100 mg

Fluconazole MM 0235.00 Fluconazole

N

N

N

N

N

N

HO

F

F (A) 100 mg

MM 0235.11 Imp. A (EP): (2RS)-2-(2,4-Difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)-3-(4H-1,2,4-triazol-4-yl)propan-2-ol

N

N

N N

N

N

HO

F

F (A) 100 mg

MM 0235.12 Imp. B (EP): 2-[2-Fluoro-4-(1H-1,2,4-triazol-1- yl)phenyl]-1,3-bis(1H-1,2,4-triazol-1-yl)propan-2-ol

N

N

N

N

N

N

HO

F

N

NN (D) 100 mg




MM 0235.13 Imp. C (EP): 1,1'-(1,3-Phenylene)di-1H-1,2,4-triazole N

NN

N

NN (A) 50 mg

MM 0235.14 Imp. D (EP): 2-(4-Fluorophenyl)-1,3-bis(1H- 1,2,4-triazol-1-yl)propan-2-ol

N

N

N

N

N

N

HO

F (A) 100 mg

MM 0235.02 Imp. F (EP): (2RS)-2-(2,4-Difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)propane-1,2-diol

OH

N

N

N

HO

F

F (A) 50 mg

New MM 0235.07 Imp. H (EP): (2RS)-1-Bromo-2-(2,4-difluorophenyl)- 3-(1H-1,2,4-triazol-1-yl)propan-2-ol

Br

N

N

N

HO

F

F (A) 50 mg

MM 0235.01 2-(2,4-Difluorophenyl)propane-1,2,3-triol

OH

HO

HO

F

F (A) 100 mg

MM 0235.03 1H-1,2,4-Triazol HN

N

N(B) 100 mg

MM 0235.04 2-Chloro-2',4'-difluoroacetophenone

F

F

O

Cl

(C) 100 mg

MM 0235.06 1-(2,4-Difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanol

F

F

HO

NN

N

(A) 100 mg

MM 0235.09 4-Amino-1,2,4-triazole N

N

N

H2N

(C) 100 mg

Flucytosine MM 0593.00 Imp. A (EP): 5-Fluoropyrimidine-2,4(1H,3H)-dione (Fluorouracil)

NH

O

HN

O

F(A) 500 mg

Flufenamic Acid MM 0410.00 Flufenamic Acid O

OH

NH

F

F F

(A) 500 mg

Flumetasone Pivalate MM 0427.01 Imp. A (EP): 6,9-Difluoro-11,17,21-trihydroxy-16-

methylpregna-1,4-diene-3,20-dione (Flumetasone)

O

HO

F

F

OH

O

OH

(A) 100 mg




Flunarizine Dihydrochloride MM 0175.00 Flunarizine Dihydrochloride

N

N

F

F

x 2 HCl

(A) 500 mg

MM 0175.04 Imp. A (EP): 1-[Bis(4-fluorophenyl)methyl]piperazine N

F

FNH (A) 100 mg

MM 0175.03 Imp. C (EP) as Dihydrochloride: 1-[(RS)-(2-Fluorophenyl)(4-fluoro-phenyl)methyl]-4-[(2E)-3-phenylprop- 2-enyl]piperazine Dihydrochloride

N

NF

Fx 2 HCl

(A) 100 mg

MM 0175.02 Chlorobis-(4-fluorophenyl)methane Cl

FF

(B) 100 mg

MM 0175.05 1-Bis(4-fluorophenyl)methyl-4-(ethoxycarbonyl)piperazine

N

FF

N

O O on request

MM 0175.06 Flunarizine N-Oxide Dihydrochloride

N

N

F

F

x 2 HCl

O (A) 100 mg

Flunitrazepam MM 0069.00 Flunitrazepam [Controlled Substance]

N

NO

O2N

F

on request

MM 0069.02 Imp. B (EP): 5-(2-Fluorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one (Demethylflunitrazepam)

N

HN

O

O2N

F

(A) 100 mg

Flunixin Meglumine MM 0915.00 Flunixin Meglumine

N

OH

O

NH

F

HO

OH

HN

HO

OH

OHx

FF (A) 100 mg

MM 0915.01 Imp. A (EP): 2-Chloropyridine-3-carboxylic Acid N

OH

O

Cl (A) 100 mg

MM 0915.03 Imp. C (EP): Ethyl 2-Chloropyridine-3-carboxylate N

O

O

Cl (A) 100 mg

Fluorescein Sodium MM 0294.01 Imp. A (EP): Resorcinol

HO OH

(B) 100 mg




MM 0133.04 Imp. C (EP): 2-(2,4-Dihydroxybenzoyl)benzoic Acid

HO OH

O

OH

O

(A) 100 mg

Fluorouracil MM 0593.00 Fluorouracil

NH

O

HN

O

F(A) 500 mg

MM 0265.03 Imp. A (EP): Pyrimidine-2,4,6-(1H,3H,5H)- trione (Barbituric Acid)

NH

O

HN

O

O

(C) 100 mg

MM 0593.01 Imp. B (EP): Dihydropyrimidine-2,4,5(3H)- trione (Isobarbituric Acid or 5-Hydroxyuracil)

NH

O

HN

O

O(A) 100 mg

MM 0593.03 Imp. C (EP): Pyrimidine-2,4(1H,3H)-dione (Uracil)

NH

O

HN

O (C) 100 mg

MM 0593.05 Imp. E (EP): 5-Chloropyrimidine-2,4(1H,3H)dione (5-Chlorouracil)

NH

O

HN

O

Cl(A) 100 mg

MM 0593.06 Imp. F (EP): 2-Ethoxy-5-fluoropyrimidin- 4(1H)-one (2-Ethoxy-5-fluorouracil)

NH

O

N

O

F(A) 100 mg

Fluoxetine Hydrochloride MM 0256.00 Fluoxetine Hydrochloride O

HN

x HClF

F F

(A) 50 mg

MM 0256.01 Imp. A (EP): (1RS)-3-(Methylamino)-1-phenylpropan-1-ol HOHN (A) 100 mg

MM 0256.02 Imp. B (EP) as Hydrochloride: N-Methyl-3- phenylpropan-1-amine Hydrochloride (Methyl-3-phenylpropylamine Hydrochloride) [Controlled Substance]

x HCl

HN (A) 100 mg

MM 0256.03 Imp. C (EP) as Hydrochloride:(3RS)-N-Methyl-3-phenyl-3-[3-(trifluoromethyl]phenoxy]propan-1-amine Hydrochloride

OHN

x HCl

FF

F

(A) 100 mg

MM 0256.05 4-Hydroxybenzotrifluoride OH

F

F F

(B) 100 mg

MM 0256.06 4-Chlorobenzotrifluoride Cl

F

F F

(B) 100 mg

MM 0256.10 3-Dimethylamino-1-phenylpropan-1-ol OH

N

(A) 100 mg

MM 0256.16 N-Formylfluoxetine O N

F

O

F F

(A) 100 mg

New MM 256.17 (3RS)-N-Methyl-3-phenyl-3-[2-(trifluoromethyl)-phenoxy]propan-1-amine Hydrochloride (2-Trifluoromethylisomer of Fluoxetine Hydro-chloride)

OHN

x HCl

FF

F(A) 100 mg




Fluoxymesterone MM 0959.00 Fluoxymesterone

HOOH

F

O

(A) 100 mg

Flupentixol Decanoate MM 0182.00 Flupentixol Decanoate

S

CF3

NN

O

O

on request

MM 0182.08 Imp. B (BP): 2-Trifluoromethylthioxanthone

S

CF3

O (A) 100 mg

MM 0182.05 1-(2-Hydroxyethyl)piperazine HNN

OH (B) 100 mg

MM 0182.06 cis/trans-3-[2-(Trifluoromethyl)-9H-thioxanthen-9-ylidene]propene

S

CF3

on request

MM 0182.07 4-Chloro-3-nitrobenzotrifluoride CF3O2N

Cl

(B) 100 mg

MM 0182.09 4-Fluoro-3-nitrobenzotrifluoride

F

CF3O2N (B) 100 mg

Flupentixol Dihydrochloride MM 0182.08 Imp. G (EP): 2-(Trifluoromethyl)-9H-thioxanthen-9-one

(2-Trifluoromethylthioxanthone) S

CF3

O (A) 100 mg

MM 0182.05 1-(2-Hydroxyethyl)piperazine HNN

OH (B) 100 mg

MM 0182.06 cis/trans-3-[2-(Trifluoromethyl)-9H-thioxanthen-9-ylidene]propene

S

CF3

on request

MM 0182.07 4-Chloro-3-nitrobenzotrifluoride CF3O2N

Cl

(B) 100 mg

New MM 0223.06 Flupentixol Dihydrochloride N

NOH

S

F

F F

x 2 HCl

(A) 100 mg

Fluphenazine Dihydrochloride MM 0114.00 Fluphenazine Dihydrochloride

S

N N

NOH

F

F F

x 2 HCl

(A) 500 mg

MM 0114.01 Imp. A (EP): 2-[4-[3-[5-Oxo-2-(trifluoromethyl)- 10H-5λ4-phenothiazin-10-yl]propyl]piperazin-1- yl]ethanol (Fluphenazine S-Oxide) S

N N

NOH

F

F F

O

(A) 100 mg

MM 0114.07 Imp. D (EP): 10,10'-[Piperazine-1,4-diylbis(propane-3,1-diyl)]bis[2-(trifluoromethyl)-10H-phenothiazine]

N

NN

N

S

S

F

F F

F

F F (A) 100 mg




MM0826.00 Imp. E (EP): 2-[4-[3-[2-Chloro-10H-phenothiazin- 10-yl]propyl]piperazin-1-yl]ethanol (Perphenazine)

S

N N

NOH

Cl

(A) 100 mg

MM 0114.04 Fluphenazine N,N',S-Trioxide Dihydrochloride

S

N N

NOH

F

x 2 HCl

O

OO

F F

on request

Flurazepam Monohydrochloride MM 0070.01 Imp. A (EP): [5-Chloro-2-[[2-(diethylamino)ethyl]amino]phenyl]-

(2-fluorophenyl)methanone Cl

HN

O

F

Non request

MM 0070.02 Imp. B (EP): 7-Chloro-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4- benzodiazepin-2-one

N

HN

O

Cl

F

(A) 100 mg

MM 0070.03 2-Chloro-10-(2-diethylaminoethyl)-9,10-dihydroacridin-9-one

Cl

N

O

N (A) 100 mg

MM 0070.06 Flurazepam [Controlled Substance]

N

NO

Cl

F

N (A) 100 mg

Flurbiprofen MM 0727.01 Imp. A (EP): (2RS)-2-(Biphenyl-4-yl)propanoic

Acid OH

O

(A) 50 mg

New MM 0727.03 Imp. C (EP): (2RS)-2-(2-Fluorobiphenyl-4-yl)- 2-hydroxypropanoic Acid

F OH

O

HO (A) 50 mg

Flutamide MM 0161.00 Flutamide

NO2

HN

O

F

FF (A) 500 mg

MM 0161.03 Imp. A (EP): 4-Nitro-3-(trifluoromethyl)aniline

NO2

H2NF

F F (A) 100 mg

MM 0161.04 Imp. B (EP): N-[4-Nitro-3-(trifluoromethyl)phenyl]acetamide

NO2

HN

O

F

F F (A) 100 mg

MM 0161.05 Imp. C (EP): N-[4-Nitro-3-(trifluoromethyl)phenyl]propanamide

NO2

HN

O

F

F F (A) 100 mg

MM 0161.06 Imp. D (EP): 3-(Trifluoromethyl)aniline H2N

F

F F (B) 100 mg

MM 0161.07 Imp. E (EP): 2-Methyl-N-[3-(trifluoromethyl)phenyl]propanamide HN

O

F

F F (A) 100 mg




MM 0161.08 Imp. F (EP): 2-Methyl-N-[2-nitro-5-(trifluoromethyl)phenyl]propanamide

O2N

HN

O

F

F F (D) 100 mg

MM 0161.01 2-Hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)-phenyl]propanamide (2-Hydroxyflutamide)

NO2

HN

O

F

F FHO (A) 100 mg

MM 0161.09 Trifluoromethylbenzene F

F F (B) 100 mg

MM 0161.10 3-Nitrobenzotrifluoride O2N

F

F F (B) 100 mg

MM 0161.12 3-Trifluoromethyl-4-nitrophenol

NO2

HOF

F F (A) 100 mg

Fluticasone Propionate New MM 1244.10 6,9-Difluoro-11,17-dihydroxy-16-methyl-

3-oxoandrosta-1,4-diene-17-carboxylic Acid

O

HO

F

OH

OOH

F

(A) 100 mg

Fluvastatin Sodium MM 0676.00 Fluvastatin Sodium

N

F

OH

OH

O

ONa

(D) 100 mg

Folic Acid MM 0621.00 Folic Acid

NH

NH

O

OH

O

O OH

N

N

N

NH

O

H2N

(A) 500 mg

MM 0621.01 Imp. A (EP): (2S)-2-[(4-Aminobenzoyl)amino]pentanedioic Acid (N-(4-Aminobenzoyl)-L-glutamic Acid)

H2N

NH

O

OH

O

O OH (A) 100 mg

MM 0621.02 Imp. B (EP) as Sulphate: 2,5,6-Triaminopyrimidin-4(1H)-one Sulphate N

NH

H2N

O

NH2

NH2

x H2SO4

(A) 100 mg

MM 0621.04 Imp. D (EP): 4-[[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino]benzoic Acid (Pteroic Acid)

N

NH

H2N

O

N

N

NH

OH

O (D) 50 mg

MM 0094.03 4-Aminobenzoic Acid

H2N

OH

O (B) 100 mg

MM 0169.00 L-Glutamine OH

NH2

O

H2N

O

(A) 500 mg




Formoterol Fumarate Dihydrate MM 0447.00 Formoterol Fumarate Dihydrate

HO

HN

OHHN

O

O

O

HOOH

O

x x 2 H2O

and enantiomer2

(D) 50 mg

Furosemide MM 0014.00 Furosemide O OH

S

Cl

HN

O

H2N

O O

(A) 500 mg

MM 0014.02 Imp. A (EP): 2-Chloro-4-[(furan-2-ylmethyl)amino]-5-sulphamoylbenzoic Acid

O OH

S

Cl

HNO

H2N

O O

(A) 100 mg

MM 0014.03 Imp. B (EP): 2,4-Dichloro-5-sulphamoylbenzoic Acid O OH

S

Cl

Cl

H2N

O O

(B) 100 mg

MM 0014.01 Imp. C (EP): 2-Amino-4-chloro-5-sulphamoylbenzoic Acid O OH

S

Cl

NH2

H2N

O O

(A) 100 mg

MM 0014.04 Imp. D (EP): 2,4-Bis[(furan-2-ylmethyl)amino]- 5-sulphamoylbenzoic Acid

O OH

S

HN

O

OHN

H2N

O O

(D) 100 mg

MM 0014.05 Imp. E (EP): 2,4-Dichlorobenzoic Acid O OH

Cl

Cl

(B) 100 mg

MM 0014.50 Ethyl 2,4-Dichloro-5-sulphamoylbenzoate O O

S

Cl

Cl

H2N

O O

(A) 100 mg

Gabapentin MM 0684.01 Imp. A (EP): 2-Azaspiro[4.5]decan-3-one

(3,3-Pentamethylene-4-butyrolactam) HN

O (A) 100 mg

MM 0684.07 Imp. E (EP): 1-(Carboxymethyl)cyclohexanecarboxylic Acid

HO

O

OH

O (A) 100 mg

Ganciclovir New MM 0485.00 Ganciclovir

HN

N

O

H2N N

N

O

HO

OH

(A) 100 mg

MM 0061.02 Imp. F (EP): 2-Amino-1,9-dihydro-6H-purin-6-one (Guanine) HN

N

O

H2N NH

N

(B) 100 mg




MM 0485.09 Imp. I (EP): 2-[(2-Amino-6-oxo-1,6-dihydro- 9H-purin-9-yl)methoxy]propane-1,3-diyl Dipropanoate (Ganciclovir Dipropionate)

HN

N

O

H2N N

N

O

O

O

O

O

(A) 100 mg

MM 0485.10 Imp. J (EP): 2-[2-(Propanoylamino)-6-oxo- 1,6-dihydro-9H-purin-9-yl]methoxy] propane-1,3-diyl dipropanoate (Ganciclovir Tripropionate)

HN

N

O

NH

N

N

O

O

O

O

O

O

(A) 100 mg

Gemcitabine Hydrochloride New MM 1257.00 Gemcitabine Hydrochloride

ON

N

O

NH2

OH F

HO

F

x HCl

(A) 100 mg

MM 0749.05 Imp. A (EP): 4-Aminopyrimidin-2(1H)-one (Cytosine) N

NH

NH2

O

(A) 100 mg

Gemfibrozil MM 0641.00 Gemfibrozil

O OH

O

(A) 250 mg

MM 0641.08 Imp. A (EP): 2,5-Dimethylphenol (p-Xylenol) OH (A) 100 mg

MM 0641.07 Imp. E (EP): 5-[2,5-Dimethyl-4-(prop-1-enyl)- phenoxy]-2,2-dimethylpentanoic Acid

O OH

O

(D) 100 mg

MM 0641.02 Imp. H (EP): 1,3-Bis(2,5-dimethylphenoxy)propane OO (A) 100 mg

MM 0641.01 3-(2,5-Dimethylphenoxy)propyl Chloride (3-(2,5-Xylyloxy)propyl Chloride)

O Cl (A) 100 mg

MM 0641.03 Gemfibrozil Isobutyl Ester O O

O

(A) 100 mg

Gestodene MM 0124.06 Imp. L (EP): 13-Ethyl-17-hydroxy-18,19-

dinor-17-pregna-5,15-dien-20-yn-3-one (56)-Gestodene)

OH

O

(A) 100 mg

Glibenclamide MM 0008.00 Glibenclamide

SNH

NH

OO O

NH

O

O

Cl

(A) 500 mg

MM 0008.01 Imp. A (EP): 5-Chloro-2-methoxy-N-(2-(4-sulfamoylphenyl)ethyl)benzamide

SNH2

O O

NH

O

O

Cl

(A) 100 mg

MM 0008.02 Imp. B (EP): Methyl [[4-[2-[(5-Chloro-2-methoxybenzoyl)amino]ethyl]phenyl]-sulphonyl]carbamate

SNH

O

OO O

NH

O

O

Cl

(A) 100 mg




New MM 0942.09 Imp. C (Pharmeuropa): 1-[[4-[2-[(Cyclohexylcarbamoyl)amino]- ethyl]phenyl]sulfonyl]-3-cyclohexylurea (N-(Cyclohexylcarbamoyl)-4-[2-[(cyclohexylcarbamoyl)amino]ethyl] benzene-Sulphonamide)

NH

NH

OS

NH

O O

NH

O (A) 100 mg

New MM 0008.07 Imp. D (Pharmeuropa): 1-[[4-[2-[(5-Chloro-2-methoxybenzoyl)amino]ethyl]phenyl]-sulfonyl]-3-butylurea Cl

O

NH

OS

NH

O O

NH

O (A) 50 mg

MM 0008.03 5-Chloro-2-methoxybenzoic Acid OH

O

O

Cl(B) 100 mg

MM 0008.04 5-Chloro-N-(2-phenylethyl)-2-methoxybenzamide NH

O

O

Cl

(A) 100 mg

Gliclazide MM 0325.00 Gliclazide

NH

SO O

NH

O

N(A) 500 mg

MM 0325.01 Imp. A (EP): 4-Methylbenzenesulphonamide NH2

SO O (C) 100 mg

MM 0325.02 Imp. B (EP): 2-Nitroso-octahydrocyclopenta[c]pyrrole

NN

O

(A) 100 mg

MM 0325.03 Imp. C (EP): Ethyl [(4-Methylphenyl)sulphonyl]- Carbamate N

H

SO

OOO (A) 100 mg

MM 0325.06 Imp. F (EP): 1-(Hexahydrocyclopenta[c]pyrrol- 2(1H)-yl)-3-[(2-methylphenyl)sulphonyl]urea

NH

SNH

O

N

O O(A) 100 mg

MM 0325.09 Methyl N-Methyl-p-tolylsulphoncarbamate N

SO

OO O (A) 100 mg

Glimepiride MM 0647.00 Glimepiride

NO

NH

O

SNH

O O

NH

O (D) 100 mg

MM 0647.02 Imp. A (EP): 1-[[4-[2-[[(3-Ethyl-4-methyl-2-oxo-2,3-dihydro-1H-pyrrol-1-yl)carbonyl]-amino]ethyl]phenyl]sulphonyl]-3-(cis-4-methylcyclohexyl)urea (cis-Glimepiride) NO

NH

O

SNH

NH

OO O (D) 100 mg

MM 0647.01 Imp. B (EP): 3-Ethyl-4-methyl-2-oxo-N-[2-(4-sulphamoylphenyl)ethyl]-2,3-dihydro-1H-pyrrole-1-carboxamide (Glimepiride Sulphonamide)

SNH2

O O

NH

N

O

O

(A) 100 mg

MM 0647.03 Imp. C (EP): Methyl [[4-[2-[[(3-Ethyl-4-methyl-2-oxo-2,3-dihydro-1H-pyrrol-1-yl)carbonyl]amino]ethyl]phenyl]- sulphonyl]carbamate (Glimepiride Carbamate)

SNH

O O

NH

N

O

O

O

O (A) 100 mg

MM 0647.04 Imp. D (EP): 1-[[3-[2-[[(3-Ethyl-4-methyl-2-oxo- 2,3-dihydro-1H-pyrrol-1-yl)carbonyl]amino]ethyl]-phenyl]sulphonyl]-3-(trans-4-methylcyclohexyl)-urea

SNH

NH

OO O

HN

O

N

O

(D) 100 mg




MM 0647.08 cis-4-Methylcyclohexylamine Hydrochloride

H2N

x HCl(A) 100 mg

Glipizide MM 0942.01 Imp. A (EP): 5-Methyl-N-[2-(4-sulphamoyl-

phenyl)ethyl]pyrazine-2-carboxamide

N

NNH

OS

NH2

O O (A) 100 mg

MM 0678.03 Imp. B (EP): Cyclohexanamine

H2N

(C) 100 mg

MM 0942.04 Imp. D (EP): 6-Methyl-N-[2-(4-sulphamoylphenyl)ethyl]pyrazine-2-carboxamide

N

NNH

OS

NH2

O O (A) 100 mg

MM 0942.05 Imp. E (EP): 1-Cyclohexyl-3-[[4-[2-[[(6-methyl-pyrazin-2-yl)carbonyl]amino]ethyl]phenyl]- sulphonyl]urea

N

NNH

OS

NH

O O

NH

O (A) 100 mg

MM 0942.06 Imp. F (EP): Ethyl [2-(4-Sulphamoylphenyl)- ethyl]carbamate

O NH

OS

NH2

O O (A) 100 mg

MM 0942.07 Imp. G (EP): Methyl [[4-[2-[[(5-Methylpyrazin- 2-yl)carbonyl]amino]ethyl]phenyl]- sulphonyl]carbamate

N

NNH

OS

NH

O O

O

O (A) 100 mg

MM 0942.08 Imp. H (EP): 4-[2-[(Cyclohexylcarbamoyl)amino]- ethyl]benzenesulphonamide

NH

NH

OS

NH2

O O (A) 100 mg

MM 0942.09 Imp. I (EP): N-(Cyclohexylcarbamoyl)- 4-[2-[(cyclohexylcarbamoyl)amino]- ethyl]benzenesulphonamide

NH

NH

OS

NH

O O

NH

O (A) 100 mg

Glutamine MM 0169.00 L-Glutamine

OH

NH2

O

H2N

O

(A) 500 mg

MM 0169.01 N-Phenylacetyl-L-glutamine (Phenylacetylglutamine)

OH

HN

O

O

H2N

O

(A) 100 mg

MM 0169.02 Phenylacetamide NH2

O

(A) 100 mg

MM 0169.03 D-Glutamine OH

NH2

O

H2N

O

(A) 100 mg

Glycopyrronium Bromide MM 0834.00 Glycopyrronium Bromide

O

O

Br-

OH

N+

and enantiomer

(A) 100 mg

MM 0834.05 Imp. B (EP): Oxophenylacetic Acid (Benzoylformic Acid)

O

O

OH

(A) 100 mg

MM 0792.03 Imp. C (EP): (2RS)-2-Hydroxy-2-phenylacetic Acid (Mandelic Acid)

OH

O

OH

(A) 100 mg

MM 0278.01 Imp. D (EP): Benzoic Acid

O

OH

(B) 100 mg




MM 0834.07 Imp. H (EP): Methyl 2-oxo-2-Phenylacetate (Methyl Benzoylformate)

O

O

O

(A) 100 mg

MM 0834.01 Imp. J (EP): 2-(RS)-Cyclopentyl-2-hydroxy- 2-phenylacetic Acid α-Cyclopentylmandelic Acid)

OH

O

OH

(A) 100 mg

MM 0834.08 Imp. K (EP): (2RS)-2-Cyclopentyl-2-phenylacetic Acid OH

O (A) 100 mg

MM 0834.06 Imp. M (EP): Cyclopentylphenylmethanone O

(A) 100 mg

Granisetron Hydrochloride MM 0398.00 Granisetron Hydrochloride

NHN

H

H

x HCl

O

NN

on request

New MM 0398.04 Imp. D (EP): 1-Methyl-1H-indazole-3-carboxylic Acid

OH

O

NN(A) 100 mg

New MM 0398.07 Imp. G (EP): 2-Methyl-2H-indazole-3-carboxylic Acid OH

O

NN (A) 100 mg

New MM 0398.08 Imp. H (EP): 1H-Indazole-3-carboxylic Acid OH

O

NHN (A) 100 mg

Griseofulvin MM 0582.00 Griseofulvin

OO

O

O

Cl

O

O

(A) 500 mg

Guaiacol MM 0354.04 Guaiacol OH

O

(A) 500 mg

MM 0814.04 Imp. A (EP): Benzene-1,2-diol (Pyrocatechol) OH

OH

(C) 100 mg

MM 0045.11 Imp. B (EP): Phenol OH (B) 100 mg

MM 0814.06 Imp. C (EP): 1,2-Dimethoxybenzene (Veratrole) O

O

(C) 100 mg

MM 0814.08 Imp. E (EP): Methyl Benzoate O

O (C) 100 mg

MM 1131.00 Imp. G (EP): 4-Methoxyphenol (Mequinol) OH

O

(A) 500 mg

MM 0007.09 Imp. H (EP): 3-Methoxyphenol OH

O

(B) 100 mg

Guaifenesin MM 0354.00 Guaifenesin

O

O

OH

OH(A) 500 mg




MM 0354.04 Imp. A (EP): 2-Methoxyphenol (Guaiacol)

O

OH (A) 500 mg

MM 0354.01 Imp. B (EP): 2-(2-Methoxyphenoxy)propane-1,3-diol (B-Isomer)

O

O

OHHO (A) 100 mg

MM 0354.02 Imp. C (EP): 1,1'-Oxybis[3-(2-methoxyphenoxy) propan-2-ol] (Bisether)

O

O

OH

O

OH

O

O

(A) 100 mg

MM 0354.03 Imp. D (EP): 1,3-Bis(2-methoxyphenoxy)propan-2-ol

O

O

OH

O

O

(A) 100 mg

Guanidine Thiocyanate New MM 1315.00 Guanidine Thiocyanate NH

NH2H2NHS Nx (A) 100 mg

Halofantrine Hydrochloride MM 0433.00 Halofantrine Hydrochloride

x HCl

FF

F

Cl

Cl

NHO

(A) 100 mg

Haloperidol MM 1165.00 Haloperidol F

O

N

OH

Cl(A) 250 mg

Haloperidol Decanoate MM 1276.12 Imp. L (EP): 1-(4-Fluorophenyl)ethanone F

O

(A) 100 mg

Harpagoside MM 0370.01 Methyl trans-Cinnamate

O

O (B) 100 mg

Heptaminol Hydrochloride MM 0653.00 Heptaminol Hydrochloride NH2

HOx HCl on request

Hexetidine MM 0337.03 Imp. C (EP): 2,6-Bis(2-ethylhexyl)-7a-

methylhexahydro-1H-imidazo[1,5-c]imidazole (Hexedine)

N

NN

(A) 100 mg

Hexylresorcinol MM 0111.00 Hexylresorcinol HO OH (A) 500 mg

MM 0045.11 Imp. A (EP): Phenol OH (B) 100 mg

MM 0294.01 Imp. B (EP): Resorcinol HO OH (B) 100 mg

Homatropine Methylbromide MM 0792.00 Homatropine Methylbromide

O

OH

O

N+

H

H

HBr-

and enantiomer

(A) 250 mg




MM 0792.03 Imp. C (EP): (2RS)-2-Hydroxy-2-phenylacetic Acid (Mandelic Acid) OH

OH

O (A) 100 mg

MM 0792.04 Imp. D (EP) as Bromide: (1R,2R,4S,5S,7s)-7-[[(2S)-3-Hydroxy-2-phenylpropanoyl]oxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane Bromide (Methylhyoscine Bromide)

O

O

OH

N+ O

H

H

H

H

H

Br-

(A) 100 mg

MM 0792.06 Imp. F (EP): Methyl (2RS)-2-Hydroxy-2-phenylacetate (Methyl Mandelate) O

OH

O (A) 100 mg

Hydrochlorothiazide MM 0011.00 Hydrochlorothiazide

NH

NHS

O OS

Cl

H2N

O O (A) 500 mg

MM 0011.03 Imp. A (EP): Chlorothiazide

N

NHS

O OS

Cl

H2N

O O (A) 500 mg

MM 0011.01 Imp. B (EP): 4-Amino-6-chlorobenzene-1,3-disulphonamide (Salamide)

NH2

NH2S

O OS

Cl

H2N

O O (B) 100 mg

Hydrocodone Hydrogen Tartrate 2.5-Hydrate MM 0037.00 Imp. A (EP) as Hydrochloride Trihydrate: Morphine

Hydrochloride Trihydrate [Controlled Substance]

O OHHO

N

x HClx 3 H2O

(A) 250 mg

MM 0280.00 Imp. A (EP) as Hemisulphate Pentahemihydrate: Morphine Hemisulphate Pentahemihydrate [Controlled Substance]

O OHHO

N

2

x H2SO4x 5 H2O

(A) 250 mg

MM 0004.00 Imp. C (EP) as Monohydrate: Codeine Monohydrate [Controlled Substance]

O OHO

N

x H2O

(A) 100 mg

MM 0442.00 Imp. C (EP) as Phosphate Hemihydrate: Codeine Phosphate Hemihydrate [Controlled Substance]

O OHO

N

x H3PO4x 1/2 H2O

(A) 100 mg

MM 0672.00 Imp. D (EP) as Hydrochloride: 4,5-Epoxy-14- hydroxy-3-methoxy-17-methylmorphinan-6- one Hydrochloride (Oxycodone Hydrochloride) [Controlled Substance]

O OO

N

HO x HCl

(A) 100 mg

MM 0004.02 Imp. E (EP): 7,8-Didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-one (Codeinone)

O OO

N (A) 100 mg

MM 0004.03 Imp. F (EP): 7,8-Didehydro-4,5-epoxy-3,6-dimethoxy-17-methylmorphinan (Methylcodeine; O-Methylcodeine) [Controlled Substance]

O OO

N (A) 100 mg

MM 0630.01 Imp. H (EP): Diphenylmethanone (Benzophenone) O (B) 100 mg

Hydrocortisone MM 0185.00 Hydrocortisone

O

HO OH

O

OH(A) 500 mg




MM 0193.00 Imp. A (EP): Prednisolone

O

HO OH

O

OH(A) 500 mg

MM 0214.00 Imp. B (EP): 17,21-Dihydroxypregn-4-ene- 3,11,20-trione (Cortisone)

O

O OH

O

OH(A) 500 mg

MM 0187.00 Imp. C (EP): Hydrocortisone Acetate (Hydrocortisone 21-Acetate)

O

HO OH

O

O

O (A) 500 mg

MM 0185.06 Imp. D (EP): 6,11,17,21-Tetrahydroxypregn-4-ene-3,20-dione (6-Hydroxyhydrocortisone)

O

HO OH

OOH

OH

(A) 100 mg

MM 0185.07 Imp. E (EP): 11,17,21-Trihydroxypregna-4,6-diene-3,20-dione (-Hydrocortisone)

O

HO OH

OOH

(D) 100 mg

MM 0185.08 Imp. F (EP): 17,21-Dihydroxypregn-4-ene-3,20-dione (Reichstein's Substance S)

O

OH

O

OH(A) 100 mg

MM 0185.13 6α-Hydroxyhydrocortisone

O

HO OH

OOH

OH

(D) 50 mg

Hydrocortisone Acetate MM 0187.00 Hydrocortisone Acetate

O

HO OH

O

O

O (A) 500 mg

MM 0185.00 Imp. A (Pharmeuropa): 11,17,21-Trihydroxy- pregn-4-ene-3,20-dione (Hydrocortisone)

O

HO

O

OHOH

(A) 500 mg

MM 0187.06 Hydrocortisone 11,17,21-Triacetate

O

O

OO

O

O

OO

(B) 10 mg

MM 0187.09 11,17,21-Trihydroxypregna-4,6-diene-3,20-dione 21-Acetate

O

HO

OO

OH

O (D) 100 mg

MM 0194.00 Imp. C (Pharmeuropa): 11,17-Dihydroxy-3,20- dioxopregna-1,4-dien-21-yl Acetate (Prednisolone Acetate)

O

HO

O

O

O

OH

(A) 500 mg

MM 0186.00 Imp. D (Pharmeuropa): 17-Hydroxy-3,11,20-Trioxopregn-4-en-21-yl Acetate (Cortisone Acetate)

O

O

O

O

O

OH

(A) 500 mg




Hydrocortisone 17-Butyrate MM 0188.00 Hydrocortisone 17-Butyrate

O

HO

OOH

O

O

(A) 500 mg

MM 0188.01 Hydrocortisone 21-Butyrate

O

HO

OO

OH

O (A) 100 mg

Hydrocortisone Hydrogen Succinate MM 0185.00 Imp. A (EP): Hydrocortisone

O

HO OH

O

OH(A) 500 mg

MM 0187.00 Imp. B (EP): Hydrocortisone Acetate

O

HO OH

O

O

O (A) 500 mg

Hydromorphone Hydrochloride MM 0037.00 Imp. C (EP) as Hydrochloride Trihydrate:


O OHHO

N

x HClx 3 H2O

(A) 250 mg

MM 0280.00 Imp. C (EP) as Hemisulphate Pentahemi- hydrate: Morphine Hemisulphate Pentahemi- hydrate [Controlled Substance]

O OHHO

N

2

x H2SO4x 5 H2O

(A) 250 mg

Hydroxychloroquine Sulphate MM 0764.00 Hydroxychloroquine Sulphate NCl

HNN

OH

x H2SO4

(A) 500 mg

MM 0764.02 Desethylhydroxychloroquine Dihydrochloride NCl

HNNH

OH

x 2 HCl(D) 100 mg

MM 0764.04 O-Acetylhydroxychloroquine NCl

HNN

O

O

(A) 100 mg

MM 0764.05 Hydroxychloroquine N-Oxide Dihydrochloride NCl

HNN

OH

O

x 2 HCl

(B) 10 mg

Hydroxyethyl Salicylate MM 0112.00 Hydroxyethyl Salicylate

OH

O

O

OH(A) 500 mg

MM 0045.00 Imp. A (EP): Salicylic Acid

OH

OH

O (A) 500 mg




Hydroxyzine Hydrochloride MM 0852.00 Hydroxyzine Hydrochloride Cl

N

NO

OH

x 2 HCl

(A) 250 mg

MM 0380.01 Imp. A (EP): (RS)-1-[(4-Chlorophenyl)phenylmethyl]piperazine Cl

N

NH (A) 100 mg

MM 0852.02 Imp. B (EP) as Dihydrochloride: 2-[2-[4-(Diphenylmethyl)piperazin-1-yl]ethoxy]-ethanol Dihydrochloride (Decloxizine Dihydrochloride)

N

NO

OH

x 2 HCl

(A) 50 mg

Hymechromone MM 0294.00 Hymecromone HO O O (A) 500 mg

MM 0294.01 Imp. A (EP): 1,3-Dihydroxybenzene (Resorcinol) HO OH (B) 100 mg

MM 0294.02 Imp. B (EP): 7-Hydroxy-2-methyl-4H-1-benzopyran-4-one HO O

O

(A) 100 mg

MM 0294.03 2,4-Dihydroxyacetophenone HO

O

OH (B) 100 mg

MM 0294.04 Hymecromone Acetate O O O

O

(A) 100 mg

MM 0294.50 7-Acetoxy-3-acetyl-2-4H-1-benzopyran-4-one O O

O O

O

(A) 100 mg

Hyoscine Butylbromide MM 0683.00 Hyoscine Butylbromide

O

O

OH

N O

H

H

HBr

+

(A) 500 mg

MM 0546.00 Imp. A (EP) as Hydrobromide Trihydrate: Hyoscine Hydrobromide Trihydrate

ON

OH

HO

H

H

x HBrx 3 H2O

O

H

H

(A) 500 mg

MM 0601.03 Imp. B (EP): (2RS)-3-Hydroxy-2-phenylpropanoic Acid (DL-Tropic Acid; Tropic Acid) OH

O

OH

(A) 100 mg

Hyoscine Hydrobromide MM 0546.00 Hyoscine Hydrobromide Trihydrate

ON

OH

HO

H

H

x HBrx 3 H2O

O

H

H

(A) 500 mg

MM 0546.06 Imp. C (EP): (1R,2R,4S,5S,7s)-9-Methyl-3-oxa- 9-azatricyclo[3.3.1.02,4]non-7-yl 2-Phenylprop- 2-enoate (Apohyoscine) O

NH

O

H

H

O

H

H

(A) 100 mg

MM 0601.03 Imp. D (EP): (2RS)-3-Hydroxy-2-phenylpropanoic Acid (DL-Tropic Acid; Tropic Acid) OH

OH

O (A) 100 mg




MM 0546.07 Hyoscine N-Oxide Hydrobromide

ON

OH

HO

H

H

O

H

H

Ox HBr

(A) 100 mg

Hyoscyamine Sulphate MM 0601.03 Imp. A (EP): (2RS)-3-Hydroxy-2-phenylpropanoic Acid

(DL-Tropic Acid; Tropic Acid) OH

O

OH

(A) 100 mg

MM 0546.00 Imp. D (EP) as Hydrobromide Trihydrate: Hyoscine Hydrobromide Trihydrate

ON

OH

HO

H

H

x HBrx 3 H2O

O

H

H

(A) 500 mg

MM 0289.01 Imp. G (EP) as Hydrochloride: (1R,3r,5S)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 2-Phenylprop-2-enoate Hydrochloride (Apoatropine Hydrochloride) O

O

NH

x HCl

H

H (D) 100 mg

Ibandronate Sodium Monohydrate New MM 1326.00 Ibandronate Sodium Monohydrate

N P

O

PO

HOOH

OH

OH

ONa

x H2O

(A) 100 mg

Ibuprofen MM 0002.00 Ibuprofen

OH

O

(A) 500 mg

MM 0002.13 Imp. A (EP): (2RS)-2-[3-(2-Methylpropyl)phenyl]propanoic Acid OH

O

(A) 100 mg

MM 0002.01 Imp. B (EP):(2RS)-2-(4-Butylphenyl)propanoic Acid OH

O

(A) 100 mg

MM 0002.10 Imp. C (EP): (2RS)-2-[4-(Methylpropyl)phenyl]propanamide NH2

O

(A) 100 mg

MM 0002.11 Imp. D (EP): (2RS)-2-(4-Methylphenyl)propanoic Acid OH

O

(A) 100 mg

MM 0002.04 Imp. E (EP): 1-[4-(2-Methylpropyl)phenyl]ethanone O (A) 100 mg

MM 0002.28 Imp. F (EP): 3-[4-(2-Methylpropyl)phenyl]propanoic Acid OH

O (A) 100 mg

MM 0002.38 Imp. G (EP): (1RS,4RS)-7-(2-Methylpropyl)-1- [4-(2-methylpropyl)phenyl]-1,2,3,4-tetrahydronaphthalene-1,4-dicarboxylic Acid

O OH

O

OH

and enantiomer

(D) 50 mg

MM 0002.30 Imp. H (EP):(3RS)-1,3-Bis[4-(2-methylpropyl)phenyl]butan-1-one

O (D) 100 mg

MM 0002.31 Imp. I (EP): 1-(2-Methylpropyl)-4-[(3RS)-3- [4-(2-methylpropyl)phenyl]butyl]benzene

(A) 50 mg

MM 0002.02 Imp. J (EP): (2RS)-2-[4-(2-Methylpropanoyl)phenyl]propanoic Acid OH

O

O

(A) 100 mg

MM 0002.26 Imp. K (EP): (2RS)-2-(4-Formylphenyl)propanoic Acid

O

OH

O

(A) 100 mg




MM 0002.24 Imp. L (EP): 2-[4-(1-Hydroxy-2-methylpropyl)phenyl]propanoic Acid (1-Hydroxyibuprofen)

OH

OH

O

(A) 100 mg

MM 0002.34 Imp. M (EP): (2RS)-2-Hydroxy-2-[4-(2-methylpropyl)phenyl]propanoic Acid

OH

O

OH (A) 100 mg

MM 0002.35 Imp. N (EP): (2RS)-2-(4-Ethylphenyl)propanoic Acid OH

O

(A) 100 mg

MM 0002.33 Imp. O (EP): 2-[4-(1-Methylpropyl)phenyl]propanoic Acid OH

O

(A) 100 mg

MM 0002.19 Imp. P (EP):(2RS)-2-[4-(2-Methylpropyl)phenyl]propan-1-ol OH

(A) 100 mg

MM 0002.36 Imp. Q (EP): 2-[4-(2-Methylpropyl)phenyl]ethanol OH (A) 100 mg

MM 0002.37 Imp. R (EP): 1,1'-(Ethane-1,1-diyl)-4,4'-(2- methylpropyl)dibenzene

(A) 100 mg

MM 0002.03 4-Isobutylbenzoic Acid OH

O (A) 100 mg

MM 0002.07 2-(4-Isobutyrylphenyl)propanamide NH2

O

O

(A) 100 mg

MM 0002.08 4-Acetylbenzoic Acid OH

O

O

(A) 100 mg

MM 0002.09 4-Isobutyrylacetophenone O

O

(A) 100 mg

MM 0002.14 2-(4-Isobutyrylphenyl)propane

O

(A) 100 mg

MM 0002.15 2-Hydroxypropyl 2-(4-Isobutylphenyl)propanoate O

O

OH (A) 100 mg

MM 0002.16 1-Hydroxyprop-2-yl 2-(4-Isobutylphenyl)propanoate O

O

OH

on request

MM 0002.17 2,3-Dihydroxypropyl 2-(4-Isobutylphenyl)propanoate O

O

OH

OH (D) 50 mg

MM 0002.18 1,3-Dihydroxyprop-2-yl 2-(4-Isobutylphenyl)propanonate O

O

OH

OH

on request

MM 0002.20 2-(4-n-Propylphenyl)propanoic Acid OH

O

(A) 100 mg

MM 0002.21 2-(4-Isobutylphenyl)propionitrile N

(A) 100 mg

MM 0002.23 Isopropyl 2-(4-Isobutylphenyl)propanonate O

O

(A) 100 mg

MM 0002.25 1-Ethyl-4-isobutylbenzene (A) 100 mg




MM 0002.29 (1RS,4SR)-7-(2-Methylpropyl)-1-[4-(2-methylpropyl)phenyl]-1,2,3,4-tetrahydronaphthalene- 1,4-dicarboxylic Acid

O OH

O

OH

and enantiomer

(D) 100 mg

MM 0002.32 2-[4-(2-Hydroxy-2-methylpropyl)phenyl]propanoic Acid (2-Hydroxyibuprofen)

HO

OH

O

(A) 100 mg

MM 0002.45 (2SR)-2-(4-Isobutylphenyl)-N-((SR)-1-phenylethyl)propanamide

HN

O

and enantiomer

(A) 100 mg

MM 0002.46 (2SR)-2-(4-Isobutylphenyl)-N-((RS)-1-phenylethyl)propanamide

HN

O

and enantiomer

(A) 100 mg

MM 0002.48 4-Isobutylstyrene (B) 10 mg

MM 0002.50 1-(4-Isobutylphenyl)ethanol OH

(A) 100 mg

MM 0002.51 4-(1-Hydroxy-2-methylpropyl)acetophenone O

OH

(A) 100 mg

MM 0002.53 Ibuprofen Methyl Ester O

O

(A) 100 mg

MM 0002.57 1-(4-Isopropylphenyl)ethanone (4-Isopropylacetophenone)

O (A) 100 mg

MM 0002.59 2-(4-Isopropylphenyl)acrylic Acid OH

O

(C) 50 mg

Idoxuridine MM 0791.00 Idoxuridine

O

HON

HN

O

O

I

OH

(A) 500 mg

Imidocarb Dipropionate MM 0742.00 Imidocarb Dipropionate O

NH

NH

N

HN

HN

N

x 2

O

OH

(A) 100 mg

Imipramine Hydrochloride MM 0077.00 Imipramine Hydrochloride

N x HClN

(A) 500 mg

MM 0589.00 Imp. A (EP) as Hydrochloride: 3-(10,11-Dihydro- 5H-dibenzo[b,f]azepin-5-yl)-N-methylpropan-1- amine Hydrochloride (Desipramine Hydrochloride)

NH

x HClN

(A) 250 mg

MM 0077.05 Imp. B (EP): 3-(5H-Dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine (Depramine; 10,11-Dehydroimipramine)

NN

(A) 100 mg




MM 0077.08 Imp. C (EP) as Hydrochloride: 10-[3-(Dimethylamino)propyl]acridin-9(10H)-one Hydrochloride

NN

O

x HCl

(A) 100 mg

MM 0077.03 N-[3-(10,11-Dihydro-5H-dibenzo-[b,f]azepin-5-yl)propyl]-N,N',N'-trimethylpropane-1,3-diamine Dihydrochloride

N

x 2 HCl

N N

(B) 10 mg

MM 0077.04 10-Hydroxyimipramine BH3-

Aduct

NN

HO

x BH3

(A) 100 mg

MM 0076.06 Iminodibenzyl

NH

(B) 100 mg

MM 0077.12 Imipramine N-Oxide

NNO

(A) 100 mg

Indanazoline Hydrochloride MM 0588.02 4-Aminoindan Hydrochloride

NH2

x HCl

(A) 100 mg

Indapamide MM 0477.00 Indapamide

SH2N

O O

Cl

NH

O

N

(A) 250 mg

MM 0477.01 Imp. A (EP): (2RS)-2-Methyl-1-nitroso- 2,3-dihydro-1H-indole

ONN

(A) 100 mg

MM 0477.02 Imp. B (EP): 4-Chloro-N-(2-methyl-1H- indol-1-yl)-3-sulphamoylbenzamide S

H2N

O O

Cl

NH

O

N

(A) 100 mg

MM 0477.04 4-Chloro-3-sulfamoylbenzoic Acid S

H2N

O O

Cl

OH

O (C) 100 mg

MM 0477.05 N-(4-Chloro-3-sulfamoylbenzoyl)-2-methylindoline S

H2N

O O

Cl

O

N

(D) 100 mg

MM 0477.07 Triethylamine N

(C) 100 mg

MM 0477.08 2-Methylindoline HN

(A) 100 mg

MM 0477.09 1-Amino-2-methylindoline Hydrochloride

H2NN

x HCl(D) 100 mg

Indometacin MM 0584.00 Indometacin

N

O

O

Cl

OH

O

(A) 500 mg

MM 0063.03 Imp. A (EP): 4-Chlorobenzoic Acid OH

O

Cl

(B) 100 mg




New MM 0584.02 3,4-Dichloroindometacin ([1-(3,4-Dichlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetic Acid) N

O

O

Cl

OH

O

Cl(A) 50 mg

Indoramin Hydrochloride MM 0802.02 Imp. A (BP): 3-(2-Bromoethyl)indole H

N

Br

(A) 100 mg

Ipecacuanha MM 0131.02 Emetine Dihydrochloride N

HNO

OO

H

O

x 2 HCl(A) 100 mg

Ipratropium Bromide New MM 0601.03 Imp. C (EP): (2RS)-3-Hydroxy-2-phenylpropanoic

Acid (dl-Tropic Acid) OH

O

OH

(A) 100 mg

New MM 0289.03 Imp. D (EP): 2-Phenylpropenoic Acid (Atropic Acid)

OH

O (A) 100 mg

Iprindole Hydrochloride MM 0478.00 Iprindole Hydrochloride

NN

x HCl

(A) 100 mg

Irbesartan MM 0862.01 Imp. A (EP): 1-(Pentanoylamino)-N-[[2'-(1H-

tetrazol-5-yl)biphenyl-4-yl]methyl]cyclopentanecarboxamide

NH

N

NN

HN

O

NHO

(A) 50 mg

Isoamyl Benzoate MM 1086.00 Isoamyl Benzoate

O

O (A) 500 mg

Isoconazol Nitrate MM 0541.00 Isoconazole Nitrate

O

x HNO3

N

N

Cl

Cl

Cl

Cl

(A) 100 mg


HO

Cl Cl

N N (A) 100 mg

MM 0541.02 Imp. B (EP) as Nitrate: (2RS)-2-[(2,6-Dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethanamine Nitrate

O

x HNO3

NH2

Cl

Cl

Cl

Cl

(D) 100 mg




MM 0281.00 Imp. C (EP) as Nitrate: 1-[(2RS)-2-[(2,4-Dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole Nitrate (Miconazole Nitrate)

O

x HNO3

N

N

Cl

Cl

ClCl

(A) 500 mg

Isoflurane MM 0500.02 Imp. B (EP): 2-(Difluoromethoxy)-1,1,1-trifluoroethane

FO

F

F

F F

(A) 100 mg

MM 0500.03 Imp. C (EP): (2RS)-2-Chloro-2-(chlorodifluoromethoxy)- 1,1,1-trifluoroethane O

Cl

Cl

FF

F

F F

(A) 100 mg

MM 0500.04 Imp. D (EP): 1,1-Dichloro-1-(difluoromethoxy)-2,2,2-trifluoroethane FO

FClCl

F

F F

(A) 100 mg

MM 0500.05 Imp. E (EP): 1,1-Dichloro-1-(chlorodifluoromethoxy)-2,2,2- trifluoroethane O

ClCl

Cl

F F

F

F F

(A) 100 mg

MM 0500.06 Imp. F (EP): Acetone O (C) 100 mg

Isoproturon MM 2503.02 3-(2-Isopropylphenyl)-1,1-dimethylurea

HN N

O

(A) 100 mg

MM 2503.03 3-(3-Isopropylphenyl)-1,1-dimethylurea HN N

O

(A) 100 mg

Isosorbide Dinitrate MM 0126.05 Imp. B (EP): Isosorbide 2-Nitrate

O

O

HO

O

H

HNO2 (A) 100 mg

MM 0502.00 Imp. C (EP): Isosorbide Mononitrate (Isosorbide 5-Nitrate)

O

O

O

OH

H

H

O2N

(A) 500 mg

MM 0126.01 2-Monomethyl Isosorbide

O

O

HO

O

H

H on request

MM 0126.02 Dimethyl Isosorbide

O

O

O

O

H

H (B) 100 mg

MM 0126.03 Isosorbide

O

O

HO

OH

H

H (A) 500 mg

MM 0126.04 Isomannit Dinitrate

O

O

O

O

H

HNO2

O2N

on request

Isosorbide Mononitrate MM 0502.00 Isosorbide Mononitrate

O

O

O

OH

H

H

O2N

(A) 500 mg

MM 0126.05 Imp. C (EP): Isosorbide 2-Nitrate

O

O

HO

O

H

HNO2 (A) 100 mg




MM 0126.03 Isosorbide

O

O

HO

OH

H

H (A) 500 mg

Isoxsuprine Hydrochloride MM 0576.00 Isoxsuprine Hydrochloride

HO

OH HN

O x HCl

and enantiomere

(A) 500 mg

Itraconazole MM 0258.00 Itraconazole

O O

O

N

N

N

Cl Cl

N

N

N

NN

O

and enantiomer

(A) 100 mg

MM 0258.02 Imp. A (EP): 4-[4-[4-(4-Methoxyphenyl)piperazin- 1-yl]phenyl]-2-[(1RS)-1-methylpropyl]-2,4-dihydro- 3H-1,2,4-triazol-3-one

O

N

N

N

NN

O

(A) 100 mg

MM 0258.04 Imp. C (EP): 4-[4-[4-[4-[[cis-2-(2,4-Dichlorophenyl)- 2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]- methoxy]phenyl]piperazin-1-yl]phenyl]-2-propyl- 2,4-dihydro-3H-1,2,4-triazol-3-one

O O

O

N

N

N

Cl Cl

N

N

N

NN

O

and enantiomer

(A) 100 mg

MM 0258.05 Imp. D (EP): 4-[4-[4-[4-[[cis-2-(2,4-Dichlorophenyl)- 2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]- methoxy]phenyl]piperazin-1-yl]phenyl]-2-(1- methylethyl)-2,4-dihydro-3H-1,2,4-triazol-3-one

O O

O

N

N

N

Cl Cl

N

N

N

NN

O

and enantiomer

(A) 100 mg




MM 0258.07 Imp. F (EP): 2-Butyl-4-[4-[4-[4-[[cis-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan- 4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-2,4- dihydro-3H-1,2,4-triazol-3-one

O O

O

N

N

N

Cl Cl

N

N

N

NN

O

and enantiomer

(A) 100 mg

MM 0258.10 2,4-Dihydro-4-[4-[4-(4-methoxyphenyl)-1-piperazinyl]phenyl]-3H-1,2,4-triazol-3-one

O

N

N

N

NHN

O

(A) 100 mg

MM 0258.11 cis-2-(2,4-Dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolane-4-methanol Mesilate

O O

O

N

N

N

Cl Cl

and enantiomer

S

O O

(A) 100 mg

Ketamine Hydrochloride MM 0144.00 Ketamine Hydrochloride O

Cl

NH

x HCl

(A) 500 mg

MM 0144.01 Imp. A (EP): 1-[(2-Chlorophenyl)- (methylimino)methyl]cyclopentanol

ClNHO

(A) 100 mg

MM 0144.02 Imp. B (EP): (2RS)-2-(2-Chloro- phenyl)-2-hydroxycyclohexanone

OClOH (A) 100 mg

Ketoconazole MM 0145.00 Ketoconazole

O

O

N

N

O

N

NO and enantiomer

Cl (A) 500 mg

MM 0145.04 Imp. D (EP): 1-[4-[[(2RS,4SR)-2-(2,4-Dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine

O

O

N

N

O

N

HN and enantiomer

Cl (A) 100 mg

New MM 0145.05 1-Acetyl-4-(4-hydroxyphenyl)piperazine NN OH

O (A) 100 mg

Ketoprofen MM 0001.00 Ketoprofen

OH

O

O

(A) 500 mg




MM 0001.01 Imp. A (EP):1-(3-Benzoylphenyl)ethanone (3-Acetylbenzophenone)

O O (A) 100 mg

MM 0001.03 Imp. B (EP): (3-Benzoylphenyl)acetic Acid OH

O

O

(A) 100 mg

MM 0001.07 Imp. C (EP):3-[(1RS)-1-Carboxylethyl]benzoic Acid HO

OH

O

O

(A) 100 mg

MM 0001.12 Imp. D (EP): (2RS)-2-[3-(4-Methylbenzoyl)phenyl]propanoic AcidOH

O

O

(D) 100 mg

MM 0001.05 Imp. E (EP):(2RS)-2-(3-Benzoylphenyl)propanamide NH2

O

O

(A) 100 mg

MM 0001.04 Imp. F (EP): (2RS)-2-(3-Benzoylphenyl)propanenitrile O

N

(A) 100 mg

MM 0001.20 Imp. G (EP): 3-[(1RS)-1-Cyanoethyl]benzoic Acid HO

O

N

(A) 100 mg

MM 0001.22 Imp. H (EP): 3-(Cyanomethyl)benzoic Acid HO

O

N

(A) 100 mg

MM 0001.14 Imp. I (EP): (3-Benzoylphenyl)ethanenitrile O

N

(A) 100 mg

MM 0001.23 Imp. J (EP): (2RS)-2-[3-(2,4-Dimethylbenzoyl)- phenyl]propanoic Acid OH

O

O

(D) 50 mg

MM 0001.02 3-Ethylbenzophenone O (A) 100 mg

MM 0001.11 3-(1-Hydroxyethyl)benzophenone O OH (A) 100 mg

MM 0001.13 3-Methylbenzophenone O (B) 100 mg

MM 0001.17 3-(1-Methoxyethyl)benzophenone O O (A) 100 mg

MM 0001.18 2-[3-(-Hydroxybenzyl)phenyl]propanoic Acid OH

OH

O

(A) 100 mg

MM 0001.19 Ethyl 2-(3-Benzoylphenyl)propionate(Ketoprofen Ethyl Ester) O

O

O

(A) 100 mg

MM 0001.21 Isopropyl 2-(3-Benzoylphenyl)propionate O

O

O

(A) 100 mg

MM 0001.50 3-(1-Acetoxyethyl)benzophenone O

O

O (A) 100 mg

MM 0001.32 Methyl 2-(3-Benzoylphenyl)propionate (Ketoprofen Methyl Ester)

O

O

O

(A) 100 mg

MM 0001.33 2-Ethylhexyl 2-(3-Benzoylphenyl)propionate (Ketoprofen 2-Ethylhexyl Ester) O

O

O

(A) 100 mg

Ketorolac Trometamol MM 0851.00 Ketorolac Trometamol

O

N OH

O

HONH2

OH

OH

x

(A) 250 mg




MM 0851.03 Imp. I (EP): Phenyl(2,3-dihydro-1H-pyrrolizin- 5-yl)methanone

O

N

(A) 100 mg

Ketotifen Hydrogen Fumarate MM 0180.00 Ketotifen Hydrogen Fumarate

OHHO

O

OS

O

N

x

(A) 250 mg

MM 0180.04 Ketotifen S

O

N (A) 100 mg

MM 0180.08 Imp. B (EP): (4RS)-10-Methoxy-4-(1-methylpiperidin-4-yl)-4H-benzo[4,5]cyclohepta[1,2- b]thiophen-4-ol

S

O

N

OH

(A) 100 mg

MM 0180.07 Imp. D (EP): 4-[(aRaS)-1-Methylpiperidin-4- ylidene]-4,9-dihydro-10H-benzo[4,5]- cyclohepta[1,2-b]thiophen-10-one N-Oxide (Ketotifen N-Oxide)

S

O

N

O (A) 100 mg

MM 0180.11 10-Methoxy-4H-benzo[4,5]cyclohepta[1,2-b]thiophen-4-one S

O

O

(A) 100 mg

Labetalol Hydrochloride MM 0438.00 Labetalol Hydrochloride

HO

OHHN

O NH2

x HCl

(A) 500 mg

Lacidipine MM 0407.00 Lacidipine H

N

O

O

O

O

O

O

(A) 100 mg

MM 0407.01 Imp. A (BP): Ethyl Methyl (E)-4-{2-[2-(tert- Butoxycarbonyl)vinyl]phenyl}-1,4-dihydro-2,6- dimethyl-pyridine-3,5-dicarboxylate

HN

O

O

O

O

O

O

(A) 100 mg

MM 0407.02 Imp. B (BP): Diethyl (E)-4-{2-[2-(tert-Butoxy- carbonyl)vinyl]phenyl}-2,6-dimethylpyridine- 3,5-dicarboxylate

N

O

O

O

O

O

O

(A) 100 mg




Lamivudine New MM 0749.00 Lamivudine

N

N

NH2

O

O

SHO

(A) 100 mg


O

OH

(A) 500 mg

MM 0749.05 Imp. E (EP): 4-Aminopyrimidin-2(1H)-one(Cytosine) N

NH

NH2

O

(A) 100 mg

MM 0593.03 Imp. F (EP): Pyrimidine-2,4(1H,3H)-dione (Uracil) HN

NH

O

O

(C) 100 mg

Lamotrigine MM 0922.00 Lamotrigine N

N

N

Cl

Cl

NH2

NH2

(A) 100 mg

MM 0922.01 Imp. A (EP): 3-Amino-6-(2,3-dichlorophenyl)-1,2,4-triazin-5(4H)-one NN

NH

Cl

Cl

NH2

O

(A) 100 mg

MM 0922.03 Imp. C (EP): (2Z)-[2-(Diaminomethylidene)- diazanylidene](2,3-dichlorophenyl)acetonitrile

NN

NH2

Cl

Cl

NH2

N

(A) 100 mg

New MM 0922.04 Imp. D (EP): 6-(2,3-Dichlorophenyl)-1,2,4- triazine-3,5(2H,4H)-dione N

HN

NH

Cl

Cl

O

O

(A) 50 mg

MM 0922.05 Imp. E (EP): 2,3-Dichlorobenzoic Acid O

OH

Cl

Cl

(A) 100 mg

New MM 0922.07 Imp. G (EP): 6-(2,4-Dichlorophenyl)-1,2,4- triazine-3,5-diamine

NN

N

NH2

NH2Cl

Cl (A) 50 mg

Lansoprazole MM 0474.00 Lansoprazole

N

SO

F

F F

O

NH

N

(A) 100 mg

MM 0474.07 Imp. A (EP): 2-[(RS)-[[3-Methyl-1-oxido- 4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methyl]- sulphinyl]-1H-benzimidazole (Lansoprazole N-Oxide) N

SO

F

F F

O

NH

N

O

(D) 100 mg

MM 0474.01 Imp. B (EP): 2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methyl]sulphonyl]-1H- benzimidazole (Lansoprazole Sulphone)

N

SO

F

F FNH

N

O O

(A) 100 mg

MM 0474.06 Imp. C (EP): 2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methyl]sulphanyl]-1H- benzimidazole

N

SO

F

F FNH

N

(A) 100 mg




MM 0474.03 Imp. D (EP): 1H-Benzimidazol-2-ol

OH

NH

N

(B) 100 mg

MM 0474.05 Imp. E (EP): 1H-Benzimidazole-2-thiol

SH

NH

N

(A) 100 mg

MM 0474.02 Imp. F (EP): 2-[(RS)-[(4-Chloro-3-methylpyridin- 2-yl)methyl]sulphinyl]-1H-benzimidazole

N

SCl

O

NH

N

(A) 100 mg

MM 0474.04 4-Ethoxyacetophenone O

O

(C) 100 mg

MM 0474.08 Lansoprazole Sulphone N-Oxide

N

SO

F

F FNH

N

O OO

(A) 100 mg

MM 0474.09 2-Chloromethyl-3-methyl-4-(2,2,2-trifluoroethoxy)pyridine Hydrochloride

N

ClO

F

F F

x HCl

(A) 100 mg

MM 0474.13 1-Methyl-12-thioxopyrido[1',2':3,4]imidazo[1,2-a]benzimidazol-2(12H)-one

NN

N

SO

(D) 100 mg

Leflunomide MM 0859.00 Leflunomide

O F

HN

FF

N

O(D) 100 mg

MM 0859.01 Imp. A (EP) as Hydrochloride: 4-(Trifluoro- methyl)aniline Hydrochloride F

H2N

FF

x HCl

(A) 100 mg

MM 0859.02 Imp. B (EP): (2Z)-2-Cyano-3-hydroxy-N-[4- (trifluoromethyl)phenyl]but-2-enamide (Teriflunomide)

O F

HN

FF

N

OH

(A) 100 mg

MM 0859.03 Imp. C (EP): 5-Methyl-N-[3-(trifluoromethyl)- phenyl]isoxazole-4-carboxamide

O

HN

F

F FN

O(A) 100 mg

MM 0859.04 Imp. D (EP): 5-Methylisoxazole-4-carboxylic Acid

O

OH

N

O(A) 100 mg

MM 0859.05 Imp. E (EP): 3-Methyl-N-[4-(trifluoromethyl)phenyl]isoxazole-4-carboxamide

O

HN

N

O

F

F F

(A) 50 mg

MM 0859.06 Imp. F (EP): 5-Methyl-N-[2-(trifluoromethyl)- phenyl]isoxazole-4-carboxamide

O

HN

N

O

FF

F(A) 100 mg

MM 0859.07 Imp. G (EP): 5-Methyl-N-(4-methylphenyl)- isoxazole-4-carboxamide

O

HN

N

O(A) 100 mg

New MM 0859.08 Imp. H (EP): 2-Cyano-N-[4-(trifluoromethyl)- phenyl]acetamide

O

HN

F

F F

N (A) 50 mg

Levamisole Hydrochloride New MM 0706.00 Levamisole Hydrochloride

N

SNx HCl (A) 100 mg

MM 0706.04 Imp. D (EP): 6-Phenyl-2,3-dihydro-imidazo[2,1-b]thiazole N

SN (A) 100 mg




Levocetirizine Dihydrochloride MM 1035.00 Levocetirizine Dihydrochloride

N

NO

OH

O

Cl

x 2 HCl

(D) 100 mg

Levodopa MM 0262.00 Levodopa

OH

O

HO

HONH2

(A) 500 mg

MM 0634.00 Imp. B (EP): (2S)-2-Amino-3-(4-hydroxyphenyl)propanoic Acid (Tyrosine) OH

O

HONH2

(A) 100 mg

MM 0262.05 Imp. C (EP): (2RS)-2-Amino-3-(4-hydroxy-3-methoxyphenyl)propanoic Acid (3-Methoxy-DL-tyrosine; (DL)-3-O-Methyldopa)

HONH2

O

OH

O

(A) 100 mg

MM 0262.06 4-Hydroxy-3-methoxymandelic Acid

HO

OH

OH

O

O

(A) 100 mg

Levodropropizine MM 1246.02 Imp. B (EP) as Hydrochloride: 1-Phenyl-

piperazine Hydrochloride N

NH

x HCl

(A) 100 mg

Levofloxacin MM 0846.00 Levofloxacin

N

O

N

O

F

N

OH

O

(A) 100 mg

Levomenthol MM 0388.00 Levomenthol OH (A) 500 mg

Levomepromazine Hydrochloride MM 0266.00 Levomepromazine Hydrochloride

x HClN

S

O

N

(A) 500 mg

Levomepromazine Maleate MM 0019.00 Levomepromazine Maleate O

OH

O

OHx

N

S

O

N

(A) 100 mg

MM 0019.02 Imp. A (EP): 2-Methoxyphenothiazine

NH

S

O

(A) 100 mg

MM 0019.01 Imp. B (EP): 10-[(2R)-3-(Dimethylamino)-2- methylpropyl]-2-methoxy-10H-phenothiazine 5-Oxide (Levomepromazine S-Oxide)

N

S

O

N

O

(A) 100 mg




MM 0019.07 N-Demethyllevomepromazine Hydrochloride

x HClN

S

O

NH

(D) 100 mg

MM 0019.09 Levomepromazine Sulphone Hydrochloride

N

S

O

N

O

Ox HCl

(A) 100 mg

Levonorgestrel MM 0121.00 Levonorgestrel OH

O

(A) 250 mg

MM 0121.08 Imp. G (Pharmeuropa): 13-Ethyl-617- dihydroxy-18,19-dinor-17-pregn-4-en- 20-yn-3-one (6-Hydroxylevonorgestrel)

OH

O

OH

(D) 50 mg

MM 0121.01 Imp. H (Pharmeuropa): 13-Ethyl-617- dihydroxy-18,19-dinor-17-pregn-4-en- 20-yn-3-one (6-Hydroxylevonorgestrel)

OH

O

OH

(D) 100 mg

MM 0121.02 Imp. J (Pharmeuropa): 13-Ethyl-17-hydroxy- 18,19-dinor-17-pregn-4-en-20-yn-3,6-dione (6-Oxolevonorgestrel, 6-Ketolevonorgestrel)

OH

O

O

(D) 100 mg

MM 0121.12 Imp. L (Pharmeuropa): 13-Ethylgon-4-ene-3,17- dione (Levodione, 18-Methyl-19-norandrost-4- ene-3,17-dione)

O

O

(D) 100 mg

MM 0121.11 Imp. M (Pharmeuropa): 13-Ethyl-17-hydroxy- 18,19-dinor-17-pregna-4,6-dien-20-yn-3-one (6-Levonorgestrel, 6,7-Didehydrolevonorgestrel)

OH

O

(D) 100 mg

Lidocaine Hydrochloride MM 0102.04 Lidocaine Hydrochloride Monohydrate

O

HN

Nx HClx H2O

(A) 500 mg

MM 0102.00 Lidocaine

O

HN

N

(A) 500 mg

MM 0102.02 Imp. A (EP): 2,6-Dimethylaniline NH2

(B) 100 mg

MM 0102.01 Imp. B (EP): 2-(Diethylazinoyl)-N-(2,6- dimethylphenyl)acetamide (Lidocaine N2- Oxide)

O

HN

N

O (A) 100 mg

MM 0102.08 Imp. C (EP): N-(2,6-Dimethylphenyl)acetamide

O

HN

(A) 100 mg

MM 0102.05 Imp. D (EP) as Hydrochloride: N-(2,6- Dimethylphenyl)-2-(ethylamino)acetamide Hydrochloride (Monoethylglycinexylidide Hydrochloride)

O

HN

NH

x HCl

(A) 100 mg

MM 0102.09 Imp. E (EP) as Hydrochloride: 2,2'- (Azanediyl)bis[N-(2,6-dimethylphenyl)- acetamide] Hydrochloride O

HN

NH

HN

O

x HCl(A) 100 mg

MM 0102.10 Imp. F (EP) as Hydrochloride: 2-(Diethyl- amino)-N-(2,3-dimethylphenyl)acetamide Hydrochloride O

HN

N x HCl(A) 100 mg




MM 0102.11 Imp. G (EP) as Hydrochloride: N-(2,6- Dimethylphenyl)-2-[(1-methylethyl)amino]- acetamide Hydrochloride O

HN

NH

x HCl(A) 100 mg

MM 0102.03 Imp. H (EP): 2-Chloro-N-(2,6-dimethylphenyl)acetamide HN

O

Cl

(B) 100 mg

New MM 0102.12 Imp. I (EP) as Hydrochloride: 2-(Diethylamino)- N-(2,4-dimethylphenyl)acetamide Hydrochloride

O

HN

N x HCl

(A) 100 mg

New MM 0102.13 Imp. J (EP) as Hydrochloride: 2-(Diethylamino)- N-(2,5-dimethylphenyl)acetamide Hydrochloride

O

HN

N x HCl

(A) 50 mg

MM 0102.14 Imp. K (EP) as Hydrochloride: N-(2,6-Dimethyl- phenyl)-2-(ethylmethylamino)acetamide Hydro- chloride O

HN

N x HCl(A) 100 mg

Liothyronine Sodium MM 0626.00 Liothyronine Sodium

O

I

HO I

I

ONa

O

NH2

(A) 50 mg

MM 0626.01 Liothyronine O

I

HO I

I

OH

O

NH2

(A) 100 mg

Lisinopril Dihydrate MM 0598.00 Lisinopril Dihydrate

HN

OHO

N

OO

OH

x 2 H2O

H2N

(A) 100 mg

MM 0598.01 Imp. A (EP): (2RS)-2-Amino-4-phenylbutanoic Acid NH2

OHO

(A) 100 mg

MM 0598.02 Imp. B (EP) as Hydrate: 4-Methylbenzenesulphonic Acid HydrateS

OH

O O

x H2O

(C) 100 mg

Lomustine MM 0923.02 Imp. B (EP): 1-(2-Chloroethyl)-3-cyclohexylurea

NH

NH

O

Cl

(A) 100 mg

MM 0923.03 Imp. C (EP): 1,3-Dicyclohexylurea

NH

NH

O (A) 100 mg

Loperamide Hydrochloride MM 0025.00 Loperamide Hydrochloride Cl

x HClN

OH

O

N

(A) 500 mg

New MM 0025.14 Imp. A (EP): 4-[4-(4'-Chlorobiphenyl-4-yl)-4- hydroxypiperidin-1-yl]-N,N-dimethyl-2,2- diphenylbutanamide

N

OH

O

N

Cl (A) 50 mg




MM 0025.15 Imp. B (EP) as Bromide: 4-(4-Chlorophenyl)- 1,1-bis[4-(dimethylamino)-4-oxo- 3,3-diphenylbutyl]-4-hydroxypiperidinium Bromide

N+

O

N

ON

OH

ClBr-

(A) 100 mg

MM 0025.04 Imp. C (EP): 4-(4-Chlorophenyl)piperidin-4-ol Cl

NH

OH

(B) 100 mg

MM 0025.05 Imp. D (EP): 4-(4-Hydroxy-4-phenylpiperidin-1-yl)-N,N-dimethyl-2,2-diphenylbutanamide

N

OH

O

N

(A) 100 mg

MM 0025.09 Imp. F (EP): Loperamide Oxide

N

O

N

OH

Cl

O

(A) 100 mg

MM 0025.11 Imp. H (EP): 4-[4-(4-Chlorophenyl)-3,6- dihydropyridin-1(2H)-yl]-N,N-dimethyl-2,2- diphenylbutanamide

N

O

N

Cl (A) 100 mg

MM 0025.07 Ethyl Diphenylacetate

O

O

(A) 100 mg

MM 0025.08 ,-Diphenyl--butyrolactone O

O

(A) 100 mg

MM 0025.10 Dimethyl-(tetrahydro-3,3-diphenyl-2-furilidine)ammonium Bromide

Br-

O

N+

(A) 100 mg

Loratadine MM 0257.00 Loratadine

N O

O

N

Cl (A) 100 mg

MM 0257.03 Imp. A (EP): Ethyl 4-[(11RS)-8-Chloro-11- hydroxy-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl]piperidine-1- carboxylate

N O

O

N

Cl

OH

(A) 100 mg




MM 0257.02 Imp. B (EP): 8-Chloro-5,6-dihydro-11H- benzo[5.6]cyclohepta[1,2-b]pyridin-11-one

O

N

Cl (A) 100 mg

MM 0257.08 Imp. C (EP): Ethyl 4-(4,8-Dichloro-5,6-dihydro- 11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11- ylidene)piperidine-1-carboxylate

N O

O

N

Cl

Cl

(D) 100 mg

MM 0257.01 Imp. D (EP): 8-Chloro-11-(piperidin-4-ylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine (Descarboethoxyloratadine; Desloratadine)

NH

N

Cl (A) 50 mg

MM 0257.05 Imp. G (EP): 8-Chloro-11-(1-methylpiperidin-4- ylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta- [1,2-b]pyridine

N

N

Cl (A) 100 mg

MM 0257.07 Imp. H (EP): Ethyl 4-Oxopiperidine-1-carboxylate N O

O

O

(A) 100 mg

MM 0257.06 (11RS)-8-Chloro-11-hydroxy-11-(1-methylpiperidin-4-yl)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine N

N

Cl

OH

(A) 100 mg

Lorazepam MM 0071.00 Lorazepam [Controlled Substance]

N

HN

O

Cl

Cl

OH

(A) 100 mg

MM 0071.01 Imp. A (EP): (2-Amino-5-chlorophenyl)(2-chlorophenyl)methanone (2-Amino-2',5-dichlorobenzophenone) Cl

NH2

O

Cl

(B) 100 mg

MM 0071.07 Imp. B (EP): (3RS)-7-Chloro-5-(2-chlorophenyl)- 2-oxo-2,3-dihydro-1H-1,4-benzodiazepin-3-yl Acetate (Lorazepam Acetate) [Controlled Substance]

N

HN

O

Cl

Cl

O

O

(A) 100 mg

MM 0071.06 Imp. C (EP): 7-Chloro-5-(2-chlorophenyl)- 1,3-dihydro-2H-1,4-benzodiazepin-2-one 4-Oxide N

HN

O

Cl

ClO

(A) 100 mg

MM 0071.03 Imp. D (EP): (5RS)-7-Chloro-5-(2-chlorophenyl)- 4,5-dihydro-1H-1,4-benzodiazepine-2,3-dione

NH

HN

O

Cl

Cl

O

(A) 100 mg

MM 0071.02 Imp. E (EP): 6-Chloro-4-(2-chlorophenyl)- quinazoline-2-carbaldehyde

Cl

N

N

Cl

O (A) 100 mg




MM 0071.04 6-Chloro-4-(2-chlorophenyl)-2-quinazolinecarboxylic Acid

Cl

N

N

Cl

O

OH

(A) 100 mg

MM 0071.08 6-Chloro-4-(2-chlorophenyl)-2-quinazolinemethanol

Cl

N

N

Cl

OH (A) 100 mg

MM 0071.09 6-Chloro-4-(2-chlorophenyl)-2(1H)-quinazolinone

N

HN

Cl

O

Cl

(A) 100 mg

Losartan Potassium MM 0168.00 Losartan

N

N

OH

Cl

NHNN

N

on request

MM 0168.14 Imp. B (Pharmeuropa) : [2'-(1H-Tetrazol-5-yl)biphenyl-4-yl]methanol N

NN

HNHO

(A) 50 mg

MM 0168.04 Imp. C (Pharmeuropa) : [2-Butyl-5-chloro-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-imidazol-4-yl]methanol

N

N

ClN

NN

HN

HO

(D) 50 mg

MM 0168.08 Imp. D (EP) : 2-Butyl-4-chloro-1H-imidazole-5-carbaldehyde

NH

N

O

Cl

(A) 100 mg

MM 0168.05 Imp. E (EP): 5-(4'-Methylbiphenyl-2-yl)-1H-tetrazole N

NN

HN(A) 50 mg

MM 0168.15 Imp. F (EP) : 5-[4'[[2-Butyl-4-chloro-5-[[(1- methylethyl)oxy]methyl]-1H-imidazol-1-yl]- methyl]biphenyl-2-yl]-1H-tetrazole (Losartan Isopropyl Ether)

N

N

O

Cl

N

NN

HN

(A) 100 mg

MM 0173.04 Imp. G (EP) : Triphenylmethanol OH

(A) 100 mg

MM 0168.16 Imp. H (EP) : [2-Butyl-4-chloro-1-[[2'-[2- (triphenylmethyl)-2H-tetrazol-5-yl]biphenyl- 4-yl]methyl]-1H-imidazol-5-yl]methanol

N

N

OH

Cl

N

NN

N

(A) 100 mg




MM 0168.18 Imp. J (EP) : [2-Butyl-4-chloro-1-[[2'-(1H- tetrazol-5-yl)biphenyl-4-yl]methyl]-1H- imidazol-5-yl]methyl Acetate

N

N

O

Cl

N

NN

HN

O (A) 100 mg

MM 0168.12 Losartan Methyl Ether

N

N

O

Cl

N

NN

HN

(A) 100 mg

Lovastatin MM 0050.00 Lovastatin

HO O

O

O

OH

(A) 100 mg

MM 0377.00 Imp. A (EP): (1S,7S,8S,8aR)-8-[2-[(2R,4R)-4-Hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl]-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-Methylbutanoate (Mevastatin)

O

O

OH

O O

(A) 100 mg

MM 0050.01 Imp. B (EP) as Sodium Salt: (3R,5R)-7-[(1S,2S,6R,8S,8aR)-2,6-Dimethyl-8-[[(2S)-2-methylbutanoyl]oxy]-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic Acid Sodium Salt (Lovastatin Hydroxy Acid Sodium Salt)

HO O

OH

OH

O

ONa

(A) 100 mg

MM 0050.03 Imp. C (EP): (1S,3R,7S,8S,8aR)-3,7-Dimethyl-8-[2-[(2R)-6-oxo-3,6-dihydro-2H-pyran-2-yl]ethyl]-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-Methylbutanoate (Dehydrolovastatin) H

O O

O

O (A) 100 mg

Malic Acid New MM 1332.01 Imp. A (EP): (E)-Butenedioic Acid (Fumaric Acid)

OH

O

HO

O

(B) 100 mg

Maprotiline Hydrochloride MM 0820.00 Maprotiline Hydrochloride

NH x HCl

(A) 250 mg

MM 0820.01 Imp. A (EP): 3-(9,10-Ethanoanthracen-9(10H)-yl)prop-2-enal

O

(A) 50 mg

MM 0820.02 Imp. B (EP) as Hydrochloride: 3-(9,10-Ethanoanthracen-9(10H)-yl)-N-[3-(9,10-ethanoanthracen-9(10H)-yl)propyl]-N-methylpropan-1-amine Hydrochloride

Nx HCl

(C) 10 mg

MM 0820.03 Imp. C (EP) as Hydrochloride: 3-(9,10-Ethanoanthracen-9(10H)-yl)propan-1-amine Hydrochloride NH2 x HCl

(C) 10 mg

MM 0820.04 Imp. D (EP) as Hydrochloride: 3-(9,10-Ethanoanthracen-9(10H)-yl)-N-methylprop-2-en-1-amine Hydrochloride (Dehydromaprotiline Hydrochloride)

NH x HCl

(A) 50 mg




MM 0820.05 Imp. E (EP) as Hydrochloride: 3-(9,10-Ethanoanthracen-9(10H)-yl)-N,N-dimethylpropan-1-amine Hydrochloride N

x HCl

(A) 100 mg

Mebendazole MM 0882.02 Imp. B (EP): (2-Hydroxy-1H-benzimidazol-5-

yl)phenylmethanone

O

N

HN

OH

(A) 50 mg

MM 0882.04 Imp. D (EP): Methyl (5-Benzoyl-1-methyl-1H- benzimidazol-2-yl)carbamate

O

N

NNH

O

O (A) 50 mg

MM 0882.05 Imp. E (EP): Ethyl (5-Benzoyl-1H-benzimidazol-2-yl)carbamate

O

N

HN

NH

O

O (A) 50 mg

MM 0882.06 Imp. F (EP): Methyl [5-(4-Methylbenzoyl)-1H- benzimidazol-2-yl]carbamate

O

N

HN

NH

O

O (A) 50 mg

Mebeverine Hydrochloride MM 0319.00 Mebeverine Hydrochloride

O

NO

O

O

O

x HCl

(A) 100 mg

MM 0319.02 Imp. A (Pharmeuropa): 4-Methoxyphenylacetone

O

O (B) 100 mg

MM 0319.03 Imp. B (Pharmeuropa) as Hydrochloride: N-[(1RS)- 1-[(4-Methoxyphenyl)methyl]ethyl]ethanamine Hydrochloride

O

NHx HCl

(A) 100 mg

MM 0319.01 Imp. D (Pharmeuropa): 3,4-Dimethoxybenzoic Acid (Veratric Acid)

O

HO

O

O

(B) 100 mg

Mechlorethamine Hydrochloride MM 0823.00 Mechlorethamine Hydrochloride

NCl Cl

x HCl (A) 500 mg

Meclofenoxate Hydrochloride MM 0044.00 Meclofenoxate Hydrochloride

Cl

OO

O

Nx HCl

(A) 500 mg

MM 0044.02 (4-Chlorophenoxy)acetic Acid

Cl

OOH

O (B) 100 mg

Meclozine Hydrochloride MM 0586.00 Meclozine Dihydrochloride

N

ClN

x 2 HCl

(A) 500 mg

New MM 0586.06 3-Methylbenzaldehyde

O

(A) 100 mg

MM 0380.09 Imp. B (EP): (RS)-(4-Chlorophenyl)phenylmethanol (4-Chlorobenzhydrol)

OH

Cl

(B) 100 mg




MM 0380.10 Imp. C (EP): (4-Chlorophenyl)phenylmethanone (4-Chlorobenzophenone)

O

Cl

(B) 100 mg

New MM 0586.08 Imp. D (EP): 1,1'-(1,3-Phenylenebismethylene)- bis[4-[(4-chlorophenyl)phenylmethyl]piperazine]

Cl

N

N

N

N

Cl

(A) 50 mg

New MM 0586.09 Imp. E (EP): 1-(Diphenylmethyl)-4-[(3-methylphenyl)methyl]piperazine

N

N

(A) 50 mg

MM 0380.04 Imp. F (EP): 1,4-Bis[(4-chlorophenyl)phenylmethyl]-piperazine

N

NCl

Cl

(A) 100 mg

MM 0380.01 Imp. H (EP): 1-[(RS)-(4-Chlorophenyl)phenylmethyl]piperazine ((RS)-1-[(4-Chlorophenyl)- phenylmethyl]piperazine)

N

NHCl

(A) 100 mg

MM 0586.05 Meclozine N-Oxide

N

ClN

O

(B) 10 mg

MM 0586.07 N-(3-Methylbenzyl)piperazine Dihydrochloride

N

HNx 2 HCl

(A) 100 mg

Medroxyprogesterone MM 0635.00 Medroxyprogesterone

O

O

OH(A) 100 mg

Medroxyprogesterone Acetate MM 0532.00 Medroxyprogesterone Acetate

O

O

O

O

(A) 100 mg

MM 0532.01 Imp. A (EP): 6-Hydroxy-6-methyl-3,20-dioxopregn-4-en-17-yl Acetate (6-Hydroxymedroxyprogesterone Acetate)

O

O

O

O

OH

(D) 100 mg

MM 0635.00 Imp. B (EP):17-Hydroxy-6-methylpregn-4-ene-3,20-dione (Medroxyprogesterone)

O

O

OH(A) 100 mg

MM 0532.05 Imp. E (EP): 6-Methylidene-3,20-dioxopregn-4-en-17-yl Acetate (6-Methylenehydroxyprogesterone Acetate)

O

O

O

O

(A) 100 mg




MM 0532.06 Imp. F (EP): 6-Methyl-3,20-dioxo-5-pregnan-17-yl Acetate (4,5-Dihydromedroxyprogesterone Acetate)

O

O

O

O

H

(D) 50 mg

MM 0532.07 Imp. G (EP): 6-Methyl-3,20-dioxopregna-4,6-dien-17-yl Acetate (Megestrol Acetate)

O

O

O

O

(A) 250 mg

MM 0532.09 Imp. H (EP): 3,20-Dioxopregn-4-en-17-yl Acetate (Hydroxyprogesterone Acetate)

O

O

O

O

(A) 100 mg

Mefenamic Acid MM 0327.00 Mefenamic Acid

OH

O

NH

(A) 500 mg

MM 0327.01 Imp. A (EP): 2,3-Dimethylaniline NH2 (B) 100 mg

MM 0327.02 Imp. B (EP): N-(2,3-Dimethylphenyl)-2-[(2,3-dimethylphenyl)amino]benzamide

NH

O

NH

(A) 100 mg

MM 0217.14 Imp. C (EP): 2-Chlorobenzoic Acid OH

O

Cl

(A) 100 mg

MM 0278.01 Imp. D (EP): Benzoic Acid OH

O (B) 100 mg

Mefloquine Hydrochloride MM 1198.01 2,8-Bis-(trifluoromethyl)-4-quinolinol

NF

F F

OH

FF

F(A) 100 mg

Megestrol Acetate MM 0532.07 Megestrol Acetate

O

O

O

O

(A) 250 mg

MM 0532.00 Imp. A (EP): 6-Methyl-3,20-dioxopregn-4-en-17-yl Acetate (Medroxyprogesterone Acetate)

O

O

O

O

(A) 100 mg

New MM 0532.09 Imp. K (Pharmeuropa): 3,20-Dioxopregn-4-en-17-yl Acetate

O

O

O

O

(A) 100 mg




Meloxicam MM 0246.00 Meloxicam

NS

O O

OH O

HN

S

N

(A) 500 mg

MM 0084.03 Imp. A (EP): Ethyl 4-Hydroxy-2-methyl- 2H-1,2-benzothiazine-3-carboxylate 1,1-Dioxide N

SO O

OH O

O

(A) 100 mg

MM 0246.01 Imp. B (EP): 5-Methylthiazol-2-amine S

NH2N (A) 100 mg

MM 0246.16 Imp. C (EP): N-[(2Z)-3,5-Dimethylthiazol-2(3H)- ylidene]-4-hydroxy-2-methyl-2H-1,2-benzothiazine- 3-carboxamide 1,1-Dioxide

NS

OH O

N

S

N

O O (A) 50 mg

MM 0246.17 Imp. D (EP): N-[(2Z)-3-Ethyl-5-methylthiazol-2(3H)-ylidene]-4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxamide 1,1-Dioxide

NS

OH O

N

S

N

O O (A) 50 mg

MM 0084.02 Imp. E (EP): Methyl 4-Hydroxy-2-methyl- 2H-1,2-benzothiazine-3-carboxylate 1,1-Dioxide N

SO O

OH O

O

(A) 100 mg

MM 0084.12 Imp. F (EP): Isopropyl 4-Hydroxy-2-methyl-2H- 1,2-benzothiazine-3-carboxylate 1,1-Dioxide (1-Methylethyl 4-Hydroxy-2-methyl-2H-1,2- benzothiazine-3-carboxylate 1,1-Dioxide)

NS

OH O

O

O O (A) 100 mg

Melperone MM 0321.00 Melperone

F

O

N

(A) 100 mg

Memantine Hydrochloride MM 1045.01 1-Hydroxy-3,5-dimethyladamantane OH (A) 100 mg

MM 1045.04 1-Chloro-3,5-dimethyladamantane Cl (A) 100 mg

Mephenesin MM 0810.00 Mephenesin

O

OH

OH(A) 500 mg

Mephentermine Hemisulphate MM 0740.00 Mephentermine Hemisulfate H

Nx ½ H2SO4

(A) 500 mg

Mepivacaine Hydrochloride MM 0368.00 Mepivacaine Hydrochloride

HN

O

Nx HCl

(A) 500 mg

MM 0102.02 Imp. A (EP): 2,6-Dimethylaniline NH2

(B) 100 mg

MM 0368.02 Imp. B (EP) as Hydrochloride: (RS)-N-(2,6- Dimethylphenyl)piperidine-2-carboxamide Hydrochloride

HN

O

NH

x HCl

(A) 50 mg




MM 0368.03 Imp. C (EP): N-(2,6-Dimethylphenyl)pyridine-2-carboxamide HN

O

N

(A) 100 mg

New MM 0368.07 Imp. E (EP): (RS)-N-(4-Chloro-2,6-dimethylphenyl)-1-methylpiperidine-2-carboxamide

HN

O

N

Cl

(A) 50 mg

MM 0368.06 Mepivacaine N-Oxide HN

O

NO

(A) 100 mg

Mepyramine Maleate MM 0559.00 Mepyramine Maleate

O

OH

O

OHx

NN

O N

(A) 500 mg

MM 0559.02 Imp. A (EP): N-(4-Methoxybenzyl)pyridin-2-amine NH

O N

(A) 100 mg

MM 0164.03 Imp. B (EP): 4-Methoxybenzaldehyde (Anisaldehyde)

O

O (C) 100 mg

MM 0084.01 Imp. C (EP): Pyridin-2-amine N

NH2 (B) 100 mg

MM 0559.05 Mepyramine N-Oxide Dihydrochloride N

N

O N

O

x 2 HCl

(A) 100 mg

Mequinol MM 1131.00 Mequinol

HO

O (A) 500 mg

Mesalazine MM 0217.00 Mesalazine

OH

OHH2N

O (A) 500 mg

MM 0042.01 Imp. A (EP): 4-Aminophenol H2N

OH

(B) 100 mg

MM 0042.07 Imp. B (EP): 3-Aminophenol

OHH2N

(B) 100 mg

MM 0217.06 Imp. C (EP): 2-Aminophenol

OH

NH2

(A) 100 mg

MM 0217.07 Imp. D (EP): 3-Aminobenzoic Acid OH

O

NH2

(A) 100 mg

MM 0217.09 Imp. F (EP): 3-Amino-2-hydroxybenzoic Acid (3-Aminosalicylic Acid) OH

O

OH

NH2

(A) 100 mg

MM 0217.10 Imp. G (EP): 2,5-Dihydroxybenzoic Acid OH

O

OH

HO(A) 100 mg

MM 0045.00 Imp. H (EP): 2-Hydroxybenzoic Acid (Salicylic Acid) OH

O

OH

(A) 500 mg

MM 0217.12 Imp. I (EP): 2-Hydroxy-5-(phenyldiazenyl)benzoic Acid (Phenylazosalicylic Acid) OH

O

OH

NN

(A) 50 mg




MM 0093.17 Imp. K (EP) as Hydrochloride: Aniline Hydrochloride H2Nx HCl

(B) 100 mg

MM 0217.14 Imp. L (EP): 2-Chlorobenzoic Acid OH

O

Cl

(A) 100 mg

MM 0217.15 Imp. M (EP): 2-Chloro-5-nitrobenzoic Acid OH

O

Cl

O2N(A) 100 mg

MM 0217.16 Imp. N (EP): 2-Hydroxy-5-nitrobenzoic Acid (5-Nitrosalicylic Acid) OH

O

OH

O2N(A) 100 mg

MM 0227.04 Imp. O (Pharmeuropa): 4-Aminobenzene- sulfonic Acid (Sulfanilic Acid)

H2N

SOH

O O

(A) 100 mg

MM 0217.02 5-Acetaminosalicylic Acid OH

O OH

NH

O

(A) 100 mg

Metamizole Sodium MM 0052.00 Metamizole Sodium Monohydrate

NN

ON S

OO

ONa x H2O

(A) 500 mg

MM 0052.02 Imp. A (EP): 4-Formylamino-1,5-dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one (4-Formylaminophenazone) N

N

O HN O (A) 100 mg

MM 0052.04 Imp. B (EP): 4-Amino-1,5-dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one (Ampyrone) N

N

ONH2

(A) 100 mg

MM 0052.10 Imp. C (EP) as Hydrochloride: 4-Methylamino-1,5-dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one Hydrochloride (4-Methylaminophenazone Hydrochloride)

NN

O HN

x HCl

(A) 100 mg

MM 0052.05 Imp. D (EP): 4-Dimethylamino-1,5-dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one (4,4-Dimethylaminophenazone) N

N

ON

(A) 100 mg

MM 0052.01 4-Acetylaminophenazone N

N

O HN O

(A) 100 mg

MM 0052.50 4-Benzylideneaminoantipyrine

NN

ON

(A) 100 mg

Metformin Hydrochloride MM 0056.00 Metformin Hydrochloride NH

H2N NH

N

NH

x HCl(A) 500 mg

MM 0056.01 Imp. A (EP): Cyanoguanidine NH

H2N NH

N (B) 100 mg

MM 0056.07 Imp. B (EP) as Nitrate: (4,6-Diamino-1,3,5- triazin-2-yl)guanidine Nitrate N N

NH2N NH

NH2

NH

NH2

x HNO3

(A) 100 mg

MM 0056.03 Imp. C (EP): N,N-Dimethyl-1,3,5-triazine-2,4,6-triamine

N N

NH2N N

NH2

(A) 100 mg

MM 0056.04 Imp. D (EP): 1,3,5-Triazine-2,4,6-triamine (Melamine) N N

NH2N NH2

NH2

(B) 100 mg

MM 0056.05 Imp. E (EP) as Hydrochloride:1-Methylbiguanide Hydrochloride NH

H2N NH

NH

NH

x HCl(A) 100 mg




MM 0056.06 Imp. F (EP) as Hydrochloride: N-Methylmethanamine Hydrochloride HN x HCl (C) 100 mg

Methadone Hydrochloride New MM 0531.04 Imp. C (EP) as Hydrochloride: (3RS)-4-(Dimethyl-

amino)-3-methyl-2,2-diphenylbutanenitrile Hydro- chloride (Isodidiavalo Hydrochloride)

N

N

x HCl

(A) 50 mg

MM 0531.06 Imp. E (EP): Diphenylacetonitrile N

(A) 100 mg

Methamphetamine Hydrochloride MM 0964.00 Methamphetamine Hydrochloride

[Controlled Substance] HN

x HCl(A) 100 mg

Methotrexate MM 0040.00 Methotrexate

N

NN

N

NH2

H2N

N

NH

OO OH

O

OH

(A) 500 mg

MM 0040.08 Imp. A (EP) as Hydrochloride: (2,4-Diaminopteridin-6-yl)methanol Hydrochloride

N

NN

N

NH2

H2N

OH x HCl

(A) 100 mg

Methoxsalen MM 0555.00 Methoxsalen

O OO

O (A) 500 mg

MM 0555.01 5-Methoxypsoralen (Bergapten) O OO

O

(A) 100 mg

Methoxyphenamine Hydrochloride MM 0655.00 Methoxyphenamine Hydrochloride

O

HN

x HCl

(A) 500 mg

Methyl Nicotinate MM 0549.00 Methyl Nicotinate

N O

O (A) 500 mg

MM 0553.00 Imp. A (EP): Nicotinic Acid N OH

O (A) 500 mg

Methyl Parahydroxybenzoate MM 0431.00 Methyl Parahydroxybenzoate

HO

O

O (A) 500 mg


HO

OH

O (B) 100 mg

MM 0498.00 Imp. B (EP): Ethyl 4-Hydroxybenzoate (Ethyl Parahydroxybenzoate)

HO

O

O (A) 500 mg

MM 0432.00 Imp. C (EP): Propyl 4-Hydroxybenzoate (Propyl Parahydroxybenzoate)

HO

O

O (A) 500 mg





HO

O

O (A) 500 mg

MM 0431.01 Sodium Methyl Parahydroxybenzoate

NaO

O

O (A) 500 mg

Methylphenidate Hydrochloride MM 1031.04 Ritalinic Acid

HN

OHO (A) 100 mg

Methylprednisolone MM 0190.00 Methylprednisolone

O

HO

OOH

OH(A) 100 mg

MM 0190.01 Imp. A (EP): 17,21-Dihydroxy-6-methylpregna-1,4-diene-3,11,20-trione

O

O

OOH

OH(D) 50 mg

Methylprednisolone Acetate MM 0191.00 Methylprednisolone Acetate

O

HO

OO

OH

O (D) 100 mg

MM 0190.00 Imp. B (EP): Methylprednisolone

O

HO

OOH

OH(A) 100 mg

MM 0194.00 Imp. E (EP): Prednisolone Acetate

O

HO

OO

OH

O (A) 500 mg

Methylprednisolone Hydrogen Succinate MM 0192.00 Methylprednisolone Hydrogen Succinate Sodium Salt

O

HO

OO

OH

OONa

O

on request

MM 0190.00 Imp. A (EP): Methylprednisolone

O

HO

OOH

OH(A) 100 mg

MM 0191.00 Imp. C (EP): Methylprednisolone Acetate

O

HO

OO

OH

O (D) 100 mg

Methyltestosterone MM 0558.00 Methyltestosterone

O

OH (A) 250 mg




MM 0323.00 Testosterone

O

OH (A) 500 mg

Metixene Hydrochloride MM 0125.01 Imp. A (EP): 9H-Thioxanthene

S

(A) 100 mg

MM 0125.02 Imp. B (EP): 9H-Thioxanthen-9-one (Thioxanthone)

S

O

(B) 100 mg

MM 0125.03 3-Chloromethyl-1-methylpiperidine Cl

N

on request

Metoclopramide MM 0073.00 Metoclopramide Hydrochloride Monohydrate

OH2N

ClNH

O

Nx HClx H2O

(A) 500 mg

MM 0073.03 Imp. A (EP): 4-(Acetylamino)-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxybenzamide

ONH

ClNH

O

NO

(A) 100 mg

MM 0073.04 Imp. B (EP): Methyl 4-(Acetylamino)-5-chloro-2-methoxybenzoate

ONH

Cl

O

O O

(A) 100 mg

MM 0073.02 Imp. C (EP): 4-Amino-5-chloro-2-methoxybenzoic Acid

OH2N

Cl

O

OH

(B) 100 mg

MM 0073.05 Imp. D (EP): Methyl 4-(Acetylamino)-2-methoxybenzoate

ONH

O

O O

(A) 100 mg

MM 0073.01 Imp. E (EP): N,N-Diethylethane-1,2-diamine H2N

N

(B) 100 mg

MM 0073.06 Imp. F (EP): 4-Amino-5-chloro-N-[2-(diethylamino)ethyl]-2-hydroxybenzamide

OHH2N

ClNH

O

N

(A) 100 mg

MM 0073.07 Imp. G (EP): N'-(4-Amino-5-chloro-2-methoxybenzoyl)-N,N-diethylethane-1,2-diamine N-Oxide (Metoclopramide N-Oxide)

OH2N

ClNH

O

N

O

(A) 100 mg

MM 0073.08 Imp. H (EP): 4-(Acetylamino)-2-hydroxybenzoic Acid

OHNH

O

O OH

(A) 100 mg

MM 0073.09 Methyl 4-Amino-2-hydroxybenzoate

OHH2N

O

O (A) 100 mg

MM 0073.10 Methyl 4-(Acetylamino)-2-hydroxybenzoate

OHNH

O

O O

(A) 100 mg

Metoprolol Succinate MM 0279.00 Metoprolol Succinate

O

O

OHHN

2

O

HOOH

O

x

(A) 100 mg




MM 0027.04 Imp. A (EP): (2RS)-1-(Ethylamino)-3-[4-(2-methoxyethyl)-phenoxy]propan-2-ol

O

O

OHHN

(A) 100 mg

MM 0027.01 Imp. B (EP): 4-(2-Methoxyethyl)phenol O

OH (A) 100 mg

MM 0027.24 Imp. C (EP) as Hydrochloride: 4-[(2RS)-2- Hydroxy-3-[(1-methylethyl)amino]propoxy]- benzaldehyde Hydrochloride

O

OH HN

Ox HCl

(A) 100 mg

MM 0027.06 Imp. D (EP): (2RS)-3-[4-(2-Methoxyethyl)phenoxy]propane-1,2-diol

O

O

OH

OH(A) 100 mg

MM 0027.07 Imp. E (EP): (2RS)-1-[2-(2-Methoxyethyl)phenoxy]-3-[(1-methylethyl)amino]propan-2-ol

O

OHHN

O

(A) 100 mg

MM 0027.08 Imp. F (EP): (2RS)-1-[(1-Methylethyl)amino]-3-phenoxy- propan2-ol

O

OHHN

(A) 100 mg

MM 0027.09 Imp. G (EP): 2-(4-Hydroxyphenyl)ethanol HO

OH (A) 100 mg

MM 0027.10 Imp. H (EP): (2RS)-1-[4-(2-Hydroxyethyl)phenoxy]-3-[(1-methylethyl)amino]propan-2-ol

HO

O

OHHN

(A) 100 mg

MM 0027.11 (2RS)-1-(4-Ethenylphenoxy)-3-[(1-methylethyl)amino]- propan-2-ol

O

OHHN

(A) 100 mg

MM 0027.12 Imp. J (EP): 1-[2-Hydroxy-3-[(1-methylethyl)amino]propoxy]-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol

O

O

OH

O

OHHN

(A) 50 mg

MM 0027.13 (2RS)-1-[4-[(EZ)-2-Methoxyethenyl]phenoxy]-3-[(1methylethyl)amino]propan-2-ol

O

OHHN

O

(A) 100 mg

MM 0027.28 Imp. M (EP) as Dihydrochloride: 1,3-Bis[(1-methylethyl)amino]propan-2-ol Dihydrochloride

HN

OHHN x 2 HCl

(A) 100 mg

MM 0027.16 Imp. N (EP): (2RS)-3-[(1-Methylethyl)amino]propane-1,2-diol HO

OHHN

(A) 100 mg

MM 0027.03 Imp. O (EP): 1,1'-[(1-Methylethyl)imino]bis- [3-[4-(2-methoxyethyl)phenoxy]propan-2-ol]

O

O

OH

N

O

O

OH (A) 100 mg

Metoprolol Tartrate MM 0027.00 Metoprolol Tartrate

O

O

OHHN

2

O

HOOH

O

x

OH

OH

(A) 500 mg

MM 0027.04 Imp. A (EP): (2RS)-1-(Ethylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol

O

O

OHHN

(A) 100 mg

MM 0027.01 Imp. B (EP): 4-(2-Methoxyethyl)phenol O

OH (A) 100 mg

MM 0027.24 Imp. C (EP) as Hydrochloride: 4-[(2RS)-2- Hydroxy-3-[(1-methylethyl)amino]propoxy]- benzaldehyde Hydrochloride

O

OH HN

Ox HCl

(A) 100 mg

MM 0027.06 Imp. D (EP): (2RS)-3-[4-(2-Methoxyethyl)phenoxy]propane-1,2-diol

O

O

OH

OH(A) 100 mg

MM 0027.07 Imp. E (EP): (2RS)-1-[2-(2-Methoxyethyl)- phenoxy]-3-[(1-methylethyl)amino]propan-2-ol

O

OHHN

O

(A) 100 mg




MM 0027.08 Imp. F (EP): (2RS)-1-[(1-Methylethyl)amino]- 3-phenoxypropan-2-ol

O

OHHN

(A) 100 mg

MM 0027.09 Imp. G (EP): 2-(4-Hydroxyphenyl)ethanol HO

OH (A) 100 mg

MM 0027.10 Imp. H (EP): (2RS)-1-[4-(2-Hydroxyethyl)- phenoxy]-3-[(1-methylethyl)amino]propan-2-ol

HO

O

OHHN

(A) 100 mg

MM 0027.11 (2RS)-1-(4-Ethenylphenoxy)-3-[(1-methylethyl)amino]propan-2-ol

O

OHHN

(A) 100 mg

MM 0027.12 Imp. J (EP): 1-[2-Hydroxy-3-[(1-methylethyl)amino]propoxy]-3-[4- (2-methoxyethyl)phenoxy]propan-2-ol

O

O

OH

O

OHHN

(A) 50 mg

MM 0027.13 (2RS)-1-[4-[(EZ)-2-Methoxyethenyl]phenoxy]-3-[(1methylethyl)amino]propan-2-ol

O

OHHN

O

(A) 100 mg

MM 0027.28 Imp. M (EP) as Dihydrochloride: 1,3-Bis[(1-methylethyl)amino]propan-2-ol Dihydrochloride

HN

OHHN x 2 HCl

(A) 100 mg

MM 0027.16 Imp. N (EP): (2RS)-3-[(1-Methylethyl)amino]propane-1,2-diol HO

OHHN

(A) 100 mg

MM 0027.03 Imp. O (EP): 1,1'- [(1-Methylethyl)imino]bis- [3-[4-(2-methoxyethyl)phenoxy]propan- 2-ol]

O

O

OH

N

O

O

OH (A) 100 mg

MM 0027.02 1-[4-(2-Methoxyethyl)phenoxy]-2,3-epoxypropane

O

OO (A) 100 mg

MM 0027.17 1-Chloro-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol

O

O Cl

OH (A) 100 mg

MM 0027.18 4,4'-(2-Hydroxy-1,3-propandiyldioxy)- bis[(2-methoxyethyl)benzene)]

O

O O

OH

O

(A) 100 mg

MM 0027.22 3-Chloropropane-1,2-diol OH

OH

Cl(B) 100 mg

MM 0027.26 1-[2-(2-Methoxyethyl)phenyoxy]-2,3-epoxypropane O

O O (C) 50 mg

Metronidazole MM 0012.00 Metronidazole

N

N

O2NOH

(A) 500 mg

MM 0012.02 Imp. A (EP): 2-Methyl-4-nitroimidazole NH

NO2N (B) 100 mg

MM 0012.05 Imp. B (EP): 4-Nitroimidazole NH

NO2N (C) 100 mg

MM 0012.06 Imp. C (EP): 2-(4-Nitro-1H-imidazol-1-yl)ethanol N

N

OH

O2N(A) 100 mg

MM 0012.07 Imp. D (EP): 2-(5-Nitro-1H-imidazol-1-yl)ethanol N

N

OHO2N (A) 100 mg

MM 0012.01 Imp. E (EP): 2-(2-Methyl-4-nitro-1H-imidazol-1-yl)ethanol N

N

OH

O2N(A) 100 mg

MM 0012.09 Imp. G (EP): 2-(2-Methyl-5-nitro-1H- imidazol-1-yl)acetic Acid N

N

OHO2N

O

(A) 100 mg

MM 0012.04 1-(2-Hydroxyethyl)-2-hydroxymethyl-5-nitroimidazole (Hydroxymetronidazole) N

N

O2NOH

OH

(A) 100 mg




Metronidazole Benzoate MM 0278.00 Metronidazole Benzoate

N

N

O2NO

O

(A) 100 mg

MM 0012.00 Imp. A (EP): Metronidazole N

N

O2NOH

(A) 500 mg

MM 0012.02 Imp. B (EP): 2-Methyl-5-nitroimidazole (2-Methyl-4-nitroimidazole) NH

N

O2N (B) 100 mg

MM 0278.01 Imp. C (EP): Benzoic Acid OH

O (B) 100 mg

MM 0278.04 2-(2-Methyl-4-nitro-1H-imidazol-1-yl)ethyl Benzoate

N

N

O

OO2N

(A) 100 mg

Mevastatin MM 0377.00 Mevastatin

O

O

OH

O O

(A) 100 mg

Mexiletine Hydrochloride MM 0146.00 Mexiletine Hydrochloride

O

NH2

x HCl

(A) 500 mg

MM 0146.01 Imp. A (EP): 2,6-Dimethylphenol OH

(A) 100 mg

MM 0146.02 Imp. B (EP): 1-(2,6-Dimethylphenoxy)propan-2-one O

O (A) 100 mg

New MM 0146.06 Imp. D (EP) as Hydrochloride: (2RS)-2-(2,6-Di- methylphenoxy)propan-1-amine Hydrochloride

ONH2 x HCl

(A) 50 mg

Mianserin Hydrochloride MM 0147.00 Mianserin Hydrochloride

N

N

x HCl

(A) 100 mg

MM 0147.01 Imp. A (EP): [2-[(2RS)-4-Methyl-2-phenylpiperazin-1-yl]phenyl]methanol

N

N

OH

(A) 100 mg

MM 0147.04 Imp. C (EP): (2-Aminophenyl)methanol H2N

OH

(B) 100 mg

MM 0147.06 Mianserin N-Oxide

N

N

O (D) 100 mg

Miconazole Nitrate MM 0281.00 Miconazole Nitrate

O

x HNO3

N

N

Cl

Cl

ClCl

(A) 500 mg




MM 0074.00 Miconazole

O

N

N

Cl

Cl

ClCl

(A) 250 mg


HO

N

N

Cl

Cl (A) 100 mg

MM 0524.00 Imp. B (EP) as Nitrate: 1-[(2RS)-2-[(4-Chlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole Nitrate (Econazole Nitrate)

O

x HNO3

N

N

Cl

Cl

Cl

(A) 500 mg

MM 0281.03 Imp. C (EP) as Nitrate: (2RS)-2-[(2,4-Dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethanamine Nitrate

O

x HNO3

NH2

Cl

Cl

ClCl

(D) 100 mg

MM 0541.00 Imp. D (EP) as Nitrate: 1-[(2RS)-2-[(2,6-Dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole Nitrate (Isoconazole Nitrate)

O

x HNO3

N

N

Cl

Cl

Cl

Cl

(A) 100 mg

MM 0281.06 Imp. F (EP) as Nitrate: 1-[(2RS)-2-[(3,4-Dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole Nitrate

O

x HNO3

N

N

Cl

Cl

Cl

Cl

(A) 100 mg

MM 0281.07 Imp. G (EP) as Nitrate: 1-[(2RS)-2-[(2,5-Dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole Nitrate

O

x HNO3

N

N

Cl

Cl

Cl

Cl

(A) 100 mg

MM 0281.08 Imp. H (EP) as Nitrate: 1-[(2RS)-2-Benzyloxy-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole Nitrate

O

x HNO3

N

N

Cl

Cl (A) 100 mg

MM 0281.09 Imp. I (EP) as Nitrate: 1-[(2RS)-2-[(2-Chlorobenzyl)- oxy]-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole Nitrate

O

x HNO3

N

N

Cl

Cl

Cl

(A) 100 mg

MM 0281.10 1-(2,4-Dichlorobenzoylmethyl)imidazole

O

N

N

Cl

Cl (A) 100 mg




Midazolam MM 0070.02 Imp. F (EP): 7-Chloro-5-(2-fluorophenyl)-1,3-

dihydro-2H-1,4-benzodiazepin-2-one (1-Des[(diethylamino)ethyl]flurazepam) N

HN

O

Cl

F

(A) 100 mg

Minoxidil MM 0521.00 Minoxidil

N

NN NH2

NH2

O

(A) 500 mg

MM 0521.01 Imp. A (EP): 6-Chloropyrimidine-2,4-diamine 3-Oxide N

NCl NH2

NH2

O

(A) 100 mg

MM 0521.02 Imp. B (EP): 6-Chloropyrimidine-2,4-diamine N

NCl NH2

NH2

(C) 100 mg

MM 0521.05 Imp. E (EP): 6-(Piperidin-1-yl)pyrimidine-2,4-diamine (Desoxyminoxidil)

N

NN NH2

NH2

(A) 100 mg

Mirtazapine New MM 1005.00 Mirtazapine

N

N

N

(A) 100 mg

MM 1005.02 Imp. A (EP): (14bRS)-2-Methyl-1,2,3,4,10- 14b-hexahydropyrazino[2,1-a]pyrido[2,3- c][2]benzazepine 2-Oxide

N

N

N

O(A) 100 mg

MM 1005.03 Imp. B (EP): [2-[(2RS)-4-Methyl-2-phenylpiperazin-1-yl]pyridin-3-yl]methanol

N

N

NHO

(A) 100 mg

New MM 1005.09 Imp. D (EP) as Maleate: (14bRS)-1,2,3,4,10,14b- Hexahydropyrazino[2,1-a]pyrido[2,3-c][2]benzazepine Maleate

N

N

NHx

O

OH

O

OH

(A) 50 mg

MM 1005.01 Imp. E (EP): (2RS)-4-Methyl-1-(3-methylpyridin-2-yl)-2-phenylpiperazine

N

N

N

(A) 100 mg

MM 1005.07 1-Methyl-3-phenylpiperazine

HN

N

(A) 100 mg

Moclobemide MM 0250.00 Moclobemide O

NH

Cl

N

O (A) 100 mg

Modafinil New MM 540.01 Imp. A (EP): [(RS)-(Diphenylmethyl)sulfinyl]acetic

Acid SOH

OO (A) 50 mg




New MM 0540.02 Imp. B (EP): 2-[(Diphenylmethyl)sulfonyl]acetamide S

NH2

OO O (A) 50 mg

New MM 0540.03 Imp. C (EP): Methyl [(RS)-(Diphenylmethyl)sulfinyl]- acetate S

O

OO (A) 50 mg

New MM 0599.14 Bis(diphenylmethyl) Ether

O

(A) 50 mg

New MM 0540.04 2-[(Diphenylmethyl)sulfenyl]acetamide S

NH2

O (A) 50 mg

New MM 540.06 Bis(diphenylmethyl)disulfide

SS

(A) 50 mg

Molsidomine MM 0267.00 Molsidomine

O

NN

ON

N

O

O

+

-(A) 250 mg

MM 0267.02 Imp. A (EP) as Hydrochloride: 3-(Morpholin-4-yl)sydnonimine Hydrochloride (Linsidomine Hydrochloride)

O

NN

ON

HN+

-

x HCl

(A) 100 mg

MM 0267.03 Imp. B (EP): 4-Nitrosomorpholine N

O

N

O (A) 100 mg

MM 0267.01 Imp. C (EP): (2E)-(Morpholin-4-ylimino)acetonitrile N

O

NN (A) 100 mg

MM 0267.06 Imp. E (EP): Morpholine O

HN (A) 100 mg

Montelukast Sodium MM 0698.00 Montelukast Sodium

NCl SONa

O

HO

on request

Morphine Hydrochloride MM 0037.00 Morphine Hydrochloride Trihydrate


O OHHO

N

x HClx 3 H2O

(A) 250 mg

MM 0442.00 Imp. A (EP) as Phosphate Hemihydrate: Codeine Phosphate Hemihydrate [Controlled Substance]

O OHO

N

x ½ H2O

x H3PO4

(A) 100 mg




MM 0037.01 Imp. B (EP): 7,7',8,8'-Tetradehydro-4,5:4',5'-diepoxy-17,17'-dimethyl-2,2'-bimorphinanyl-3,3',6,6'-tetrol (Pseudomorphine; 2,2'-Bimorphine)

O OHHO

NOHO OH

N

(A) 100 mg

MM 0037.03 Imp. F (EP): (17S)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan- 3,6-diol17-Oxide (Morphine N-Oxide) [Controlled Substance]

O OHHO

NO (A) 100 mg

MM 0037.02 7,7',8,8'-Tetradehydro-4,5a:4',5'a-diepoxy-3,3'-dimethoxy-17,17'-dimethyl-2,2'-bimorphinanyl-6a,6'a-diol (Codeine Dimer; Dimethyl Pseudomorphine)

O OHO

NOHO O

N

(A) 100 mg

Morphine Sulphate MM 0280.00 Morphine Hemisulphate Pentahemihydrate


O OHHO

N

x H2SO4

2

x 5 H2O

(A) 250 mg

MM 0442.00 Imp. A (EP) as Phosphate Hemihydrate: Codeine Phosphate Hemihydrate [Controlled Substance]

O OHO

N

x ½ H2O

x H3PO4

(A) 100 mg

MM 0037.01 Imp. B (EP): 7,7',8,8'-Tetradehydro-4,5:4',5'-diepoxy-17,17'-dimethyl-2,2'-bimorphinanyl-3,3',6,6'-tetrol (Pseudomorphine;2,2'-Bimorphine)

O OHHO

NOHO OH

N

(A) 100 mg

MM 0037.03 Imp. F (EP): (17S)-7,8-Didehydro-4,5-epoxy- 17-methylmorphinan-3,6-diol 17-Oxide (Morphine N-Oxide) [Controlled Substance]

O OHHO

NO (A) 100 mg

Moxifloxacin Hydrochloride MM 0885.00 Moxifloxacine Hydrochloride

NN

O

OH

O

F

OHN

H

H

x HCl

(D) 100 mg

Moxonidine MM 1278.02 Imp. B (EP): N-(Imidazolidin-2-ylidene)-4,6-

dimethoxy-2-methylpyrimidin-5-amine (4-Methoxymoxonidine) N

N O

O

N NH

HN

(A) 100 mg

Mycophenolate Mofetil MM 1001.00 Mycophenolate Mofetil

O

O OH

O

O

O

N

O

(D) 100 mg

MM 1001.05 Imp. E (EP): Methyl (4E)-6-(4-Hydroxy-6- methoxy-7-methyl-3-oxo-1,3-dihydroisobenzofuran-5-yl)-4-methylhex-4-enoate

O

O OH

O

O

O

(A) 100 mg

MM 1001.06 Imp. F (EP): (4E)-6-(4-Hydroxy-6-methoxy-7- methyl-3-oxo-1,3-dihydroisobenzofuran-5-yl)- 4-methylhex-4-enoic Acid (Mycophenolic Acid)

O

O OH

O

OH

O

(A) 100 mg

MM 1001.07 Imp. G (EP): 2-(Morpholin-4-yl)ethyl (4E)-6-(4-Hydroxy-6-methoxy-7-methyl- 3-oxo-1,3-dihydroisobenzofuran-5-yl)- 4-methylhex-4-enoate N-Oxide

O

O OH

O

O

O

N

O

O (A) 100 mg




MM 1001.08 Imp. H (EP): 7-Hydroxy-5-methoxy-4-methyl- 6-[2-[(2RS)-2-methyl-5-oxotetrahydrofuran-2- yl]ethyl]isobenzofuran-1(3H)-one

O

O OH

O

OO

(A) 100 mg

Nabumetone MM 0153.00 Nabumetone

O

O (A) 500 mg

MM 0153.02 Imp. A (EP): 3-(6-Methoxynaphthalen-2-yl)-5-methylcyclohexanone

O

O (A) 100 mg

MM 0153.03 Imp. B (EP): (5RS)-5-(6-Methoxynaphthalen-2-yl)-3-methylcyclohex-2-enone

O

O (A) 100 mg

MM 0153.04 Imp. C (EP): (2RS)-4-(6-Methoxynaphthalen-2-yl)-butan-2-ol

O

OH (A) 100 mg

MM 0153.05 Imp. D (EP): (E)-4-(6-Methoxynaphthalen-2-yl)-but-3-en-2-one

O

O (A) 100 mg

New MM 0153.06 Imp. E (EP): 1,5-Bis(6-methoxynaphthalen- 2-yl)pentan-3-one

O

O

O

(A) 50 mg

MM 0153.07 Imp. F (EP): 6,6'-Dimethoxy-2,2'-binaphthalenyl

O

O (A) 100 mg

MM 0152.01 (6-Methoxy-2-naphthyl)acetic Acid ((6-Methoxynaphthalen- 2-yl)acetic Acid, -Demethylnaproxen)

O

OH

O

(A) 100 mg

Nadolol MM 0439.00 Nadolol

HO

OH

O

OHHN

and enantiomers

on request

MM 0439.06 Imp. F (EP) as Hydrochloride: (2RS)-1-[(1,1- Dimethylethyl)amino]-3-(naphthalen-1-yloxy)- propan-2-ol Hydrochloride

O

OHHN x HCl

(A) 50 mg

MM 0439.07 Imp. G (EP) as Hydrochloride: (2RS)-1-[(1,1- Dimethylethyl)amino]-3-[(5,6,7,8-tetrahydro- naphtalen-1-yl)oxy]-propan-2-ol Hydrochloride

O

OHHN x HCl

(A) 50 mg

Nafcillin Sodium MM 0392.00 Nafcillin Sodium

N

S

ONaO

H

O

NH

O

O

on request

MM 0392.02 Penilloic Acids of Nafcillin

HN

O

S

HN

OHO

O

(D) 100 mg

MM 0026.04 6-Aminopenicillanic Acid

N

SH

O

H2N

OOH (B) 100 mg

MM 0392.04 2-Ethoxynaphthoic Acid OHO

O

(B) 100 mg




Naftidrofuryl Hydrogen Oxalate MM 0373.00 Naftidrofuryl Hydrogen Oxalate

O

O

O

N O OH

OHO

x

(A) 500 mg

Naloxone Hydrochloride Dihydrate MM 0272.00 Naloxone Hydrochloride Dihydrate

O OHO

NOH x HCl

x 2 H2O

(A) 250 mg

Naltrexone MM 0233.00 Naltrexone Hydrochloride

O OHO

N

x HClHO

(A) 100 mg

Nandrolone MM 0660.00 Nandrolone

H

O

OH (A) 250 mg

MM 0660.01 19-Norandrost-4-ene-3,17-dione (Estr-4-ene-3,17-dione)

H

O

O (A) 100 mg

Nandrolone Decanoate MM 0982.00 Nandrolone Decanoate

H

O

O

O (A) 100 mg

MM 0660.00 Imp. D (EP): 17β-Hydroxyestr-4-en-3-one (Nandrolone)

H

O

OH (A) 250 mg

Naphazoline Hydrochloride MM 0075.00 Naphazoline Hydrochloride

N

HN

x HCl

(A) 500 mg

MM 0075.06 Imp. A (EP) as Hydrochloride: N-(2-Aminoethyl)-2-(naphthalen-1-yl)acetamide Hydrochloride (Naphthylacetylethylenediamine Hydrochloride)

O

NH

NH2

x HCl

(A) 100 mg

MM 0075.02 Imp. B (EP): (Naphthalen-1-yl)acetic Acid (1-Naphthylacetic Acid)

O

OH

(B) 100 mg

MM 0075.04 Imp. C (EP): (Naphthalen-1-yl)acetonitrile (1-Naphthylacetonitrile)

N (B) 100 mg

MM 0075.05 Ethyl (1-Naphthyl)acetate O

O

(A) 100 mg




MM 0075.07 (Naphthalen-1-y)lacetamide (1-Naphthylacetamide) O

NH2

(A) 100 mg

Naphazoline Nitrate MM 0286.00 Naphazoline Nitrate

N

HN

x HNO3

(A) 500 mg

MM 0075.06 Imp. A (EP) as Hydrochloride: N-(2-Aminoethyl)-2-(naphthalen-1-yl)acetamide Hydrochloride (Naphthylacetylethylenediamine Hydrochloride)

O

NH

NH2

x HCl

(A) 100 mg

MM 0075.02 Imp. B (EP): (Naphthalen-1-yl)acetic Acid (1-Naphthylacetic Acid)

O

OH

(B) 100 mg

MM 0075.04 Imp. C (EP): (Naphthalen-1-yl)acetonitrile (1-Naphthylacetonitrile) N (B) 100 mg

MM 0075.05 Ethyl (1-Naphthyl)acetate O

O

(A) 100 mg

MM 0075.07 (Naphthalen-1-yl)acetamide (1-Naphthylacetamide)

O

NH2

(A) 100 mg

Naproxen MM 0152.00 Naproxen

O

OH

O

(A) 500 mg

MM 0152.06 Imp. A (EP): (2S)-2-(6-Hydroxynaphthalen-2-yl)- propanoic Acid (O-Demethylnaproxen)

HO

OH

O

(A) 100 mg

MM 0152.09 Imp. B (EP): (2S)-2-(5-Chloro-6-methoxynaphthalen-2-yl)propanoic Acid (5-Chloronaproxen) O

OH

O

Cl

(A) 100 mg

MM 0152.10 Imp. C (EP): (2S)-2-(5-Bromo-6-methoxynaphthalen-2-yl)propanoic Acid (5-Bromonaproxen) O

OH

O

Br

(A) 100 mg

MM 0152.11 Imp. D (EP): (2S)-2-(5-Iodo-6-methoxynaphthalen-2-yl)propanoic Acid (5-Iodonaproxen) O

OH

O

I

(A) 100 mg

MM 0152.02 Imp. E (EP): Methyl (2S)-2-(6-Methoxy- naphthalen-2-yl)propanoate (Naproxen Methyl Ester) O

O

O

(A) 100 mg

MM 0152.12 Imp. F (EP): Ethyl (2S)-2-(6-Methoxy- naphthalen-2-yl)propanoate (Naproxen Ethyl Ester) O

O

O

(A) 100 mg

MM 0152.14 Imp. H (EP): 6-Methoxynaphthalen-2-ol (Hydroxynerolin) O

OH (A) 100 mg

MM 0152.01 Imp. I (EP):(6-Methoxynaphthalen-2-yl)acetic Acid (-Demethylnaproxen) O

OH

O

(A) 100 mg

MM 0152.18 Imp. J (EP): 2-Ethyl-6-methoxynaphthalene (Ethylnerolin) O

(A) 100 mg




MM 0152.16 Imp. K (EP): (1RS)-1-(6-Methoxynaphthalen-2-yl)ethanol

O

OH (A) 100 mg

MM 0152.07 Imp. L (EP): 1-(6-Methoxynaphthalen-2-yl)ethanone (Acetylnerolin)

O

O (B) 100 mg

MM 0152.08 Imp. M (EP): 2-Methoxynaphthalene (Nerolin)

O

(B) 100 mg

MM 0152.17 Imp. N (EP): 2-Bromo-6-methoxynaphthalene O

Br (C) 100 mg

MM 0152.04 Naproxen Sodium

O

ONa

O

(A) 500 mg

MM 0152.15 2-Carboxy-6-methoxynaphthalene

O

OH

O (A) 100 mg

Nateglinide MM 0847.00 Nateglinide

HN

O

OH

O

on request

New MM 0847.03 Imp. B (Pharmeuropa): N-[[trans-4-(Propan- 2-yl)cyclohexyl]carbonyl]-L-phenylalanine H

NOH

O

O

(A) 50 mg

New MM 0314.03 Imp. C (EP): Phenylalanine H2N

OH

O (B) 100 mg

MM 0847.04 Imp. E (Pharmeuropa): N-[(trans-4-Ethyl- cyclohexyl)carbonyl]-D-phenylalanine (Nateglinide Ethyl Analog)

HN

OH

O

O

(A) 50 mg

MM 0847.06 Imp. G (Pharmeuropa): Ethyl N-[[trans-4-(Propan- 2-yl)cyclohexyl]carbonyl]-D-phenylalaninate (Nateglinide Ethyl Ester)

HN

O

O

O

(A) 50 mg

Nevirapine Anhydrous MM 1146.01 Imp. A (EP): 11-Ethyl-4-methyl-5,11-dihydro-

6H-dipyrido [3,2-b:2',3'-e][1,4]diazepin-6-one

NH

NN N

O

(A) 100 mg

MM 1146.02 Imp. B (EP): 4-Methyl-5,11-dihydro-6H- dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one

NH

HNN N

O

(A) 100 mg

MM 1146.03 Imp. C (EP): 4-Methyl-11-propyl-5,11-dihydro- 6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one

NH

NN N

O

(D) 100 mg

MM 1146.04 3-Amino-2-chloro-4-methylpyridine NCl

H2N

(A) 100 mg




Nicardipine Hydrochloride MM 0465.00 Nicardipine Hydrochloride H

N

O

O

O

O

N

NO2

x HCl

(A) 250 mg

MM 0465.01 3-Methyl 5-[Methyl(phenylmethyl)amino]- ethyl 2,6-Dimethyl-4-(3-nitrophenyl)pyridine- 3,5-dicarboxylate Dihydrochloride

N

O

O

O

O

N

NO2

x 2 HCl

(A) 100 mg

Nicergoline MM 0115.00 Nicergoline

N

O

O

NN

O

HBr (A) 100 mg

MM 0115.02 Imp. A (EP): [(6aR,9R,10aS)-10a-Methoxy- 4,7-dimethyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinolin-9-yl]methyl 5-Chloro- pyridine-3-carboxylate (Chloronicergoline)

N

O

O

NN

O

HCl (D) 50 mg

MM 0115.04 Imp. C (EP): [(6aR,9R,10aS)-10a-Methoxy-4,7-dimethyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinolin-9-yl]methanol (Methylmethoxylumilysergol)

N

OHN

O

H (D) 100 mg

MM 0115.06 Imp. D (EP): 5-Bromopyridine-3-carboxylic Acid

HO

O

N

Br (B) 100 mg

MM 0115.03 5-Debromonicergoline N

O

O

NN

O

H on request

Nicorandil MM 0924.00 Nicorandil

N

NH

O

ONO2

(A) 100 mg

Nicotinamide MM 0552.00 Nicotinamide

N NH2

O (A) 500 mg

MM 0552.01 Isonicotinamide

N

NH2

O (A) 100 mg

Nicotine MM 0517.00 Nicotine

N N

(A) 500 mg

MM 0517.03 Imp. C (EP): (5S)-1-Methyl-5-(pyridin-3-yl)pyrrolidin-2-one (Cotinine) N N O

(A) 100 mg

MM 0517.01 Imp. G (EP): 3-[(2S)-Piperidin-2-yl]pyridine (Anabasine) N N

H

(A) 100 mg

Nicotinic Acid MM 0553.00 Nicotinic Acid

N OH

O (A) 500 mg




New MM 0553.06 Imp. B (EP): 2,2'-Bipyridine-5,5'-dicarboxylic Acid (6,6'-Dinicotinic Acid) N OH

O

NHO

O

(A) 100 mg

MM 0553.03 Imp. E (EP): Pyridine-4-carboxylic Acid (Isonicotinic Acid)

N

OH

O (A) 100 mg

MM 0549.00 Methyl Nicotinate N O

O (A) 500 mg

MM 0104.00 Benzyl Nicotinate N O

O (A) 500 mg

Nifedipine MM 0003.00 Nifedipine

O

O

O

O

HN

NO2

(A) 500 mg

MM 0003.02 Imp. A (EP): Dimethyl 2,6-Dimethyl-4-(2-nitrophenylpyridine-3,5-dicarboxylate (Nitrophenylpyridine Analogue of Nifedipine)

O

O

O

O

N

NO2

(A) 100 mg

MM 0003.01 Imp. B (EP): Dimethyl 2,6-Dimethyl-4-(2-nitrosophenylpyridine-3,5-dicarboxylate (Nitrosophenylpyridine Analogue of Nifedipine)

O

O

O

O

N

NO

(A) 100 mg

MM 0003.07 Imp. C (EP) as E/Z-Mixture: Methyl (E/Z)-2-(2-Nitrobenzylidene)-3-oxobutanoate

NO2

O

O

O

(A) 100 mg

MM 0003.08 Imp. D (EP): Methyl 3-Aminobut-2-enoate O

O

H2N (C) 100 mg

MM 0003.03 2-Nitrobenzaldehyde O

NO2

(B) 100 mg

Niflumic Acid MM 0850.00 Niflumic Acid

N

OH

O

NH

F

F F

(A) 250 mg

MM 0915.01 Imp. A (EP): 2-Chloropyridine-3-carboxylic Acid (2-Chloronicotinic Acid)

N

OH

O

Cl (A) 100 mg

MM 0850.05 Imp. B (EP): 2-Hydroxy-N-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide H

NF

F F

O

N OH (A) 100 mg

MM 0161.06 Imp. C (EP): 3-(Trifluoromethyl)aniline

NH2

F

FF (B) 100 mg




MM 0850.01 Imp. F (EP): Methyl 2-[[3-(Trifluoromethyl)- phenyl]amino]pyridine-3-carboxylate (Niflumic Acid Methyl Ester)

N

O

O

NH

F

FF (A) 100 mg

Nifuroxazide MM 0574.00 Nifuroxazide

ON

HN

OH

O

O2N

(A) 500 mg

MM 0574.01 Imp. A (EP): 4-Hydroxybenzohydrazide (p-Hydroxybenzohydrazide) H2N

HN

OH

O

(C) 100 mg

MM 0431.00 Imp. B (EP): Methyl 4-Hydroxybenzoate (Methyl Parahydroxybenzoate) O

OH

O

(A) 500 mg

MM 0943.02 Imp. C (EP): (5-Nitrofuran-2-yl)methylidene Diacetate ((5-Nitrofuran-2-yl)methylene Diacetate)

OOO2N

O

O

O

(A) 100 mg

Nifursol MM 0444.00 Nifursol OH

O2N

NO2

NH

O

N ONO2

(A) 100 mg

MM 0444.01 5-Nitro-2-furfural O NO2

O (C) 100 mg

MM 0444.02 5-Nitrofurfural Hydrazone O NO2

NH2N(A) 100 mg

MM 0444.03 3,5-Dinitrosalicylic Acid Hydrazide OH

O2N

NO2

NH

O

NH2

(A) 100 mg

Nikethamide MM 0627.00 Nikethamide

N N

O (A) 500 mg

Nimesulide MM 0378.00 Nimesulide

OO2N

HN

S

O O

(A) 250 mg

MM 0378.01 Imp. A (EP): N-(2,4-Dinitro-6-phenoxyphenyl)methanesulphonamide

OO2N

HN

SOO

NO2 (A) 100 mg

MM 0378.02 Imp. B (EP): N-(2-Phenoxyphenyl)methanesulphonamide

O

HN

SOO

(A) 100 mg

MM 0378.03 Imp. C (EP): 2-Phenoxyaniline

O

NH2 (A) 100 mg




MM 0378.04 Imp. D (EP): 4-Nitro-2-phenoxyaniline

O

NH2

O2N

(A) 100 mg

MM 0378.05 Imp. E (EP): N,N-Bis(methylsulphonyl)-2- phenoxyaniline

O

NS

S

O

O

O O

(A) 100 mg

MM 0378.06 Imp. F (EP): N,N-Bis(methylsulphonyl)-4- nitro-2-phenoxyaniline

O

NS

S

O2NO O

O

O (A) 100 mg

MM 0378.07 Imp. G (EP): 4-Nitro-2-phenoxyphenol

O

OH

O2N

(A) 50 mg

Nimodipine MM 0416.00 Nimodipine H

N

O

O

OO

O

NO2

(A) 100 mg

MM 0416.01 Imp. A (EP): 2-Methoxyethyl 1-Methylethyl 2,6-Dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate

N

O

OO

O

O

NO2

(A) 100 mg

MM 0416.02 Imp. B (EP): Bis(1-methylethyl) 2,6-Dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate

HN

O

O

O

O

NO2

(A) 100 mg

MM 0416.03 Imp. C (EP): Bis(2-methoxyethyl) 2,6-Dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate

HN

O

O

OO

O

NO2

O

(A) 100 mg

Nitrazepam MM 0078.00 Nitrazepam [Controlled Substance]

N

HN

O

O2N

(A) 100 mg

MM 0078.02 Imp. A (EP): 3-Amino-6-nitro-4-phenylquinolin-2(1H)-one

O2N

HN

NH2

O (A) 100 mg

MM 0078.01 Imp. B (EP): (2-Amino-5-nitrophenyl)phenylmethanone (2-Amino-5-nitrobenzophenone) O2N

NH2

O

(B) 100 mg

MM 0078.03 Imp. C (EP): 2-Bromo-N-[4-nitro-2-(phenylcarbonyl)phenyl]acetamide NH

O

OBr

O2N

(A) 50 mg




MM 0078.05 Imp. D (EP): 2-(1,3-Dioxo-1,3-dihydro-2H- isoindol-2-yl)-N-[4-nitro-2-(phenylcarbonyl)- phenyl]acetamide NH

O

ON

O

O

O2N

(A) 50 mg

MM 0078.07 7-Aminonitrazepam

N

HN

O

H2N

(A) 100 mg

Nitrendipine MM 0092.00 Nitrendipine H

N

NO2

O

O

O

O

(A) 500 mg

MM 0092.03 Imp. A (EP): Ethyl Methyl 2,6-Dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate (Photolysis Product)

N

NO2

O

O

O

O

(A) 100 mg

MM 0092.01 Imp. B (EP): Dimethyl 2,6-Dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate

HN

NO2

O

O

O

O

(A) 100 mg

MM 0092.02 Imp. C (EP): Diethyl 2,6-Dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate

HN

NO2

O

O

O

O

(A) 100 mg

MM 0092.04 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylic Acid Methyl Ester

HN

NO2

OH

O

O

O

(A) 50 mg

MM 0092.05 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylic Acid Ethyl Ester

HN

NO2

OH

O

O

O

(A) 50 mg

Nitrofural MM 0943.00 Nitrofural OO2N

N

HN NH2

O

(A) 500 mg

MM 0943.02 Imp. B (EP): (5-Nitrofuran-2-yl)methylene Diacetate

OO2NO

O

O

O

(A) 100 mg

Nitrofurantoin MM 0506.00 Nitrofurantoin

OO2N NN

HNO

O

(A) 500 mg

Nizatidine MM 0220.00 Nizatidine

NO2

NH

NH

S

NS

N (A) 500 mg

MM 0220.01 Imp. A (EP): N,N‘-Dimethyl-2-nitroethene-1,1-diamine NO2

NH

NH

(A) 100 mg




MM 0220.09 Imp. B (EP): (EZ)-N-Methyl-1-methylsulphanyl)-2-nitroethen-1-amine NO2

S NH

(A) 100 mg

MM 0220.02 Imp. C (EP): (EZ)-N-[2-[[[2-[(Dimethylamino)methyl]thiazol-4-yl]methyl]sulphinyl]ethyl]-N‘-methyl-2-nitroethene-1,1-diamine

NO2

NH

NH

S

NS

N

O

(C) 50 mg

MM 0220.04 Imp. D (EP) as Dioxalate: 2-[[[2-[(Dimethyl- amino)methyl]thiazol-4-yl]methyl]sulphanyl]- ethanamine Dioxalate

NH2

S

NS

N HO O

OHO

x 2

(A) 50 mg

MM 0220.10 Imp. G (EP): N,N'-Bis[2-[[[2-[(dimethylamino)- methyl]thiazol-4-yl]methyl]sulphanyl]ethyl]-2- nitroethene-1,1-diamine

NH

NH

S

NS

N

NO2

S SN

N(A) 50 mg

MM 0220.11 Imp. H (EP) as Hydrochloride: 2-(Dimethylamino)thioacetamide Hydrochloride

S

NH2

N x HCl(A) 100 mg

MM 0086.07 Imp. K (EP): 3-(Methylamino)-5,6-dihydro-2H-1,4-thiazin-2-one Oxime

N

S

NH

NOH (A) 100 mg

Nonivamide MM 1033.00 Nonivamide

HO

ONH

O (A) 500 mg

MM 1033.01 4-(Aminomethyl)-2-methoxyphenol Hydrochloride (Vanillylamine Hydrochloride)

HO

ONH2 x HCl

(A) 100 mg

MM 1033.02 N-[(4-Hydroxy-3-methoxyphenyl)methyl]octanamide (N-Vanillyloctanamide)

HO

ONH

O (A) 100 mg

MM 1033.03 N-[(4-Hydroxy-3-methoxyphenyl)methyl]-decanamide (N-Vanillyldecanamide)

HO

ONH

O (A) 100 mg

MM 1033.04 N,O-Dinonanoylvanillylamine

O

ONH

O

O

(A) 100 mg

Noradrenaline Tartrate MM 0614.02 Imp. A (EP): Adrenaline (L-Adrenaline)

HO

HO

HN

OH (A) 500 mg

MM 0384.00 Imp. C (EP) as Hydrochloride: Dopamine Hydrochloride HO

HO

NH2

x HCl(A) 500 mg

Norethisterone MM 0218.00 Norethisterone

O

OH (A) 250 mg

MM 0218.04 Imp. A (EP): 17-Hydroxy-19-nor-17-pregna-4,6-dien-20-yn-3-one (6,7-Didehydronorethisterone)

O

OH (D) 100 mg

MM 0660.01 Imp. B (EP): Estr-4-ene-3,17-dione (Norandrostenedione)

O

O (A) 100 mg

MM 0218.01 Imp. H (EP): 6,17-Dihydroxy-19-nor-17-pregn-4-en-20-yn-3-one (6β-Hydroxynorethisterone)

O

OH

OH

(D) 100 mg




MM 0218.02 6-Hydroxynorethisterone

O

OH

OH

(D) 50 mg

MM 0218.03 6-Ketonorethisterone

O

OH

O

(D) 100 mg

Norethisterone Acetate MM 0219.00 Norethisterone Acetate

O

O

O (A) 100 mg

MM 0218.00 Imp. A (EP): Norethisterone

O

OH (A) 250 mg

MM 0219.10 Imp. B (EP): 3-Oxo-19-nor-17-pregn-5(10)-en-20-yn-17-yl Acetate

O

O

O on request

MM 0219.01 Imp. F (EP): 6-Hydroxy-3-oxo-19-nor-17-pregn-4-en-20-yn-17-yl Acetate (6-Hydroxynorethisterone Acetate)

O

O

O

OH

(D) 100 mg

MM 0219.03 Imp. G (EP): 3,6-Dioxo-19-nor-17-pregn-4-en-20-yn-17-yl Acetate (6-Ketonorethisterone Acetate)

O

O

O

O

(D) 100 mg

MM 0219.02 6-Hydroxynorethisterone Acetate

O

O

O

OH

(D) 50 mg

MM 0219.04 6,7-Didehydronorethisterone Acetate

O

O

O (D) 100 mg

Norfenefrine Hydrochloride MM 0973.00 Norfenefrine Hydrochloride

HO

OH

NH2 x HCl

(A) 500 mg

Norfloxacin MM 0350.00 Norfloxacin

N N

O

FOH

O

HN (A) 250 mg

MM 0350.01 Imp. A (EP): 7-Chloro-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid NCl

O

OH

O

F

(A) 100 mg

MM 0350.03 Imp. D (EP): 1-Ethyl-6-fluoro-7-(piperazin-1-yl)quinolin-4(1H)-one NN

O

HN

F

(D) 100 mg




MM 0350.04 Imp. G (EP): 1-Ethyl-6-fluoro-7-(4-formyl-piperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid NN

O

OH

O

N

F

O (D) 100 mg

Nortriptyline Hydrochloride MM 0079.00 Nortriptyline Hydrochloride

x HCl

NH

(A) 500 mg

MM 0062.01 Imp. A (EP): 10,11-Dihydro-5H-dibenzo[a,d][7]annulen-5-one (Dibenzosuberone)

O

(B) 100 mg

MM 0079.01 Imp. B (EP) as Hydrochloride: 3-(5H-Dibenzo- [a,d][7]annulen-5-ylidene)-N-methylpropan-1- amine Hydrochloride (Norcyclobenzaprine Hydrochloride)

NH x HCl

(A) 50 mg

MM 0062.03 Imp. D (EP): 5-[3-(Dimethyl-amino)propyl]- 10,11-dihydro-5H-dibenzo-[a,d][7]annulen-5-ol

OH

N (A) 100 mg

MM 0062.02 Imp. E (EP) as Hydrochloride: 3-(5H- Dibenzo[a,d][7]annulen-5-ylidene)-N,N-dimethylpropan-1-amine Hydrochloride (Cyclobenzaprine Hydrochloride)

N x HCl

(A) 100 mg

MM 0062.00 Imp. F (EP) as Hydrochloride: Amitriptyline Hydrochloride

N x HCl

(A) 500 mg

MM 0062.12 Imp. J (EP) as Hydrochloride: [3-(10,11- Dihydro-5H-dibenzo[a,d][7]annulen- 5-ylidene)propyl]-dimethylamine Oxide Hydrochloride (Amitriptyline N-Oxide Hydrochloride)

N x HCl

O(B) 10 mg

Nucleosides New MM 1316.01 Cytidine

O

OH

HO N

N

O

NH2

OH

(A) 100 mg

New MM 1316.02 2'-Deoxycytidine

O

OH

HO N

N

O

NH2 (A) 100 mg

Ofloxacin MM 0228.00 Ofloxacin

N

O

N

O

F

N

OH

O

(A) 500 mg

MM 0228.04 Imp. A (EP): (RS)-9,10-Difluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid (FPA) N

O

F

O

FOH

O

(A) 100 mg

MM 0228.05 Imp. B (EP): (RS)-9-Fluoro-3-methyl-10-(4- methylpiperazin-1-yl)-2,3-dihydro-7H-pyrido- [1,2,3-de]-1,4-benzoxazin-7-one

N

O

N

O

F

N (A) 100 mg




MM 0228.08 Imp. E (EP): (RS)-9-Fluoro-3-methyl-7-oxo-10-(piperazin-1-yl)-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid

N

O

N

O

F

HN

OH

O

(A) 100 mg

MM 0228.10 Imp. F (EP) as Hydrochloride: 4-[(RS)-6-Carboxy-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-10-yl]-1-methylpiperazine 1-Oxide Hydrochloride (Ofloxacin N-Oxide Hydrochloride)

N

O

N

O

F

N

OH

O

O

x HCl

(A) 100 mg

Olanzapine New MM 0329.00 Olanzapine

N

N

N

HN

S

on request

MM 0329.08 Imp. A (EP): 5-Methyl-2-[(2-nitrophenyl)- amino]thiophene-3-carbonitrile

HN

S

N

O2N

(A) 50 mg

MM 0329.02 Imp. B (EP): 2-Methyl-5,10-dihydro-4H- thieno[2,3-b][1,5]benzodiazepin-4-one (Olanzapine Lactame)

OHN

HN

S

(A) 50 mg

MM 0329.07 Imp. C (EP): 1-(Chloromethyl)-1-methyl-4-(2- methyl-10H-thieno[2,3-b][1,5]benzodiazepin- 4-yl)piperazin-1-ium Chloride (Olanzapine-N- Chloromethyl Chloride)

N

N+

N

HN

S

Cl

Cl-

(A) 100 mg

New MM 0329.03 Imp. D (EP): 1-Methyl-4-(2-methyl-10H-thieno- [2,3-b][1,5]benzodiazepin-4-yl)piperazin-1-oxide (Olanzapine N-Oxide)

N

N

N

HN

S

O (A) 50 mg

Omeprazole MM 0095.00 Omeprazole

N

O

SO

HN

NO

(A) 500 mg

MM 0095.03 Imp. A (EP): 5-Methoxy-1H-benzimidazole-2-thiol SH

HN

NO

(A) 100 mg

MM 0095.04 Imp. B (EP): 2-[(RS)-[(3,5-Dimethylpyridin -2-yl)methyl]sulphinyl]-5-methoxy-1H- benzimidazole NS

O

HN

NO

(A) 100 mg

MM 0095.06 Imp. C (EP): 5-Methoxy-2-[[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulphanyl]-1H-benzimidazole (Ufiprazole)

N

O

S

HN

NO

(A) 100 mg

MM 0095.05 Imp. D (EP): 5-Methoxy-2-[[(4-methoxy-3,5-dimethylpyridin-2-yl) methyl]sulphonyl]-1H-benzimidazole (Omeprazole Sulphone) N

O

S

HN

NOO

O

(A) 100 mg

MM 0095.07 Imp. E (EP): 4-Methoxy-2-[[(RS)-(5-methoxy-1H-benzimidazol-2-yl)sulphinyl]methyl]-3,5-dimethylpyridine 1-Oxide (Omeprazole N-Oxide)

N

OS

O

NH

N

O

O

(A) 100 mg

MM 0095.01 Imp. F (EP): 8-Methoxy-1,3-dimethyl-12-thioxopyrido[1',2':3,4]imidazo[1,2-a]-benzimidazol-2(12H)-one N

N

N

S

OO

(D) 50 mg

MM 0095.02 Imp. G (EP): 9-Methoxy-1,3-dimethyl-12-thioxopyrido[1',2':3,4]imidazo[1,2-a]-benzimidazol-2(12H)-one N

N

N

S

O

O (D) 50 mg




MM 0095.15 Imp. H (EP): 2-[(RS)-[(4-Chloro-3,5-dimethylpyridin-2-yl)methyl]sulfinyl]-5-methoxy-1H-benzimidazole

N

S

O

NH

N

O

Cl

(D) 100 mg

MM 0095.16 Imp. I (EP): 4-Methoxy-2-[[(5-methoxy-1H-benzimidazol-2-yl)sulphonyl]methyl]-3,5-dimethylpyridine 1-Oxide (Omeprazole Sulphone N-Oxide)

N

OS

NH

N

O

OO O

(A) 100 mg

MM 0095.08 5-Methoxy-2-[[(3,5-dimethylpyridin-2-yl)methyl]sulphanyl]-1H-benzimidazole

N

S

NH

N

O (A) 100 mg

MM 0095.19 5-Methoxy-2-[[(4-chloro-3,5-dimethylpyridin-2-yl) methyl]sulphanyl]-1H-benzimidazole

N

ClS

NH

N

O (D) 100 mg

MM 0095.20 5-Methoxy-1,3-dihydrobenzimidazol-2-one

O

NH

NH

O (A) 100 mg

MM 0095.23 2-[[(4-Methoxy-3,5-dimethylpyridin-2-yl)methyl]sulphinyl]-1H-benzimidazole

N

OS

O

NH

N

(A) 100 mg

MM 0095.24 5-Methoxy-2-(4-methoxy-3,5-dimethylpyridin-2-yl)-1H-benzimidazole

NH

N

O

N

O

(A) 100 mg

Ondansetron Hydrochloride Dihydrate MM 0252.00 Ondansetron Hydrochloride Dihydrate

N

O

N

N x HClx 2 H2O

(A) 100 mg

MM 0252.09 Ondansetron N

O

N

N(A) 100 mg

MM 0252.03 Imp. A (EP): (3RS)-3-(Dimethylamino)methyl-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one

N

O

N

(A) 100 mg

MM 0252.02 Imp. B (EP): 6,6'-Methylene bis[(3RS)-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-1,2,3,9-tetrahydro-4H-carbazol-4-one]

N N

N NN N

OO

(D) 50 mg

MM 0252.01 Imp. C (EP): 9-Methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one N

O

(A) 100 mg

MM 0252.04 Imp. D (EP): 9-Methyl-3-methylene-1,2,3,9-tetrahydro-4H-carbazol-4-one

N

O

(A) 100 mg

MM 0015.02 Imp. E (EP): 1H-Imidazole (Imidazole) N

NH

(B) 100 mg

MM 0252.06 Imp. F (EP): 2-Methyl-1H-imidazole N

NH

(B) 100 mg

MM 0252.07 Imp. G (EP): (3RS)-3-[(1H-Imidazol-1-yl)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one (C-Demethylondansetron)

N

O

N

N(A) 100 mg

MM 0252.08 Imp. H (EP): (3RS)-3-[(2-Methyl-1H-imidazol-1-yl)methyl]-1,2,3,9-tetrahydro-4H-carbazol-4-one (N-Demethylondansetron)

HN

O

N

N(A) 100 mg




Opipramol Dihydrochloride MM 0422.01 5-(3-Piperazin-1-yl-propyl)-5H-dibenzo[b,f]azepine

Dihydrochloride N

N

NH

x 2 HCl

(A) 100 mg

Ornidazole MM 0948.00 Ornidazole

N

N

O2N

Cl

OH

(A) 500 mg

MM 0012.02 2-Methyl-4-nitroimidazole NH

N

O2N (B) 100 mg

MM 0948.02 3-(2-Methyl-5-nitro-1H-imidazol-1-yl)propane-1,2-diol N

N

O2N

OH

OH

(A) 100 mg

MM 0948.03 3-(2-Methyl-5-nitro-1H-imidazol-1-yl)-1,2-epoxypropane N

N

O2N

O

(A) 100 mg

MM 0948.04 1-(3-Chloro-2-hydroxypropyl)-2-methyl-4-nitroimidazole N

N

Cl

OHO2N

(A) 100 mg

Orphenadrine Hydrochloride MM 0801.00 Orphenadrine Hydrochloride

ON

x HCl

(A) 500 mg

MM 0801.01 Imp. A (EP): (RS)-(2-Methylphenyl)phenylmethanol (2-Methylbenzhydrol)

OH

(A) 100 mg

MM 0801.02 Imp. B (EP): (2-Methylphenyl)phenylmethanone (2-Methylbenzophenone)

O

(A) 100 mg

MM 0801.03 Imp. C (EP) as Hydrochloride: (RS)-2-[(2-Methyl- phenyl)phenylmethoxy]ethanamine Hydrochloride

ONH2

x HCl

(A) 50 mg

MM 0490.00 Imp. D (EP) as Hydrochloride: Diphenhydramine Hydrochloride

ON

x HCl

(A) 500 mg

MM 0801.05 Imp. E (EP) as Hydrochloride: (RS)-N,N-Dimethyl-2-[(3-methylphenyl)phenylmethoxy]ethanamine Hydrochloride(meta-Methylbenzyl Isomer Hydrochloride)

ON x HCl

(A) 100 mg

MM 0490.04 Imp. F (EP) as Hydrochloride: (RS)-N,N-Dimethyl- 2-[(4-methylphenyl)phenylmethoxy]ethanamine Hydrochloride (para-Methylbenzyl Isomer Hydro- chloride; 4-Methyldiphenhydramine Hydrochloride) O

Nx HCl

(A) 100 mg

MM 0801.07 N-Desmethylorphenadrine Hydrochloride

O

HN

x HCl

(A) 100 mg




Oxacillin Sodium MM 0686.00 Oxacillin Sodium Monohydrate

O

N NH

O N

S

O

OONa

H

x H2O

(A) 250 mg

MM 0026.04 Imp. A (EP): (2S,5R,6R)-6-Amino-3,3-dimethyl- 7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2- carboxylic Acid (6-Aminopenicillanic Acid)

N

S

O

OOH

HH2N

(B) 100 mg

MM 0682.00 Imp. E (EP) as Sodium Salt Monohydrate: Cloxacillin Sodium Monohydrate

N

S

O

OONa

H

x H2OHN

O

N

O

Cl (A) 500 mg

Oxalic Acid Dihydrate MM 0928.00 Oxalic Acid Dihydrate

OHO

O OH

x 2 H2O(A) 500 mg

MM 0928.01 Oxalic Acid

OHO

O OH (A) 500 mg

Oxaliplatin MM 0928.00 Imp. A (EP) as Dihydrate: Ethanedioic Acid

Dihydrate (Oxalic Acid Dihydrate) OHO

O OH

x 2 H2O(A) 500 mg

Oxazepam MM 0080.00 Oxazepam [Controlled Substance]

N

HN

O

Cl

OH

(D) 100 mg

MM 0028.03 Imp. D (EP): (2-Amino-5-chlorophenyl)phenylmethanone (2-Amino-5-chlorobenzophenone) Cl

NH2

O

(B) 100 mg

MM 0028.02 Imp. E (EP): 7-Chloro-5-phenyl-1,3-dihydro- 2H-1,4-benzodiazepin-2-one 4-Oxide (Demoxepam) N

HN

O

ClO

(A) 100 mg

MM 0080.03 6-Chloro-4-phenyl-3,4-dihydroquinazoline-2-carboxylic Acid

Cl

N

NH

O

OH

(A) 100 mg

Oxcarbazepine MM 0076.17 Oxcarbazepine

N

O NH2

O (A) 100 mg

MM 0076.10 10-Hydroxy-10,11-dihydrocarbamazepine

N

O NH2

HO (A) 100 mg

Oxeladin Hydrogen Citrate MM 0547.00 Oxeladin Hydrogen Citrate

OO

N

O

x

OH

O

OH

O

OHOH

O

(A) 500 mg




MM 0547.02 Imp. A (EP): 2-[2-(Diethylamino)ethoxy]ethanol HOO

N (A) 100 mg

MM 0547.01 Oxeladin N-Oxide

OO

N

O

O

(B) 10 mg

Oxfendazole MM 0518.02 Imp. B (EP): Methyl [5-(Phenylsulphonyl)-

1H-benzimidazol-2-yl]carbamate (Fenbendazole Sulphone) S N

HN

NH

O

O

O O

(A) 100 mg

Oxolinic Acid MM 0898.00 Oxolinic Acid

O

O

N

OH

OO

(A) 250 mg

Oxomemazine MM 0957.00 Oxomemazine

S

N

N

O O

(A) 100 mg

MM 0958.00 Trimeprazine Tartrate

HO

OH

OH

OH

O

O

N

S

N

x

2

(A) 500 mg

MM 0958.02 Trimeprazine Sulphoxide Hydrochloride

S

N

N

O

x HCl

(A) 100 mg

MM 0958.04 Oxomemazine N-Oxide Hydrochloride (Trimeprazine Sulphone N-Oxide Hydrochloride)

S

N

NO

OO

x HCl

(A) 100 mg

Oxprenolol Hydrochloride MM 0129.00 Oxprenolol Hydrochloride

O

O

OH HN

x HCl

(A) 500 mg

New MM 0129.01 1-(2-Hydroxyphenoxy)-3-(isopropylamino)-2-propanol Hydrochloride

OH

O

OHHN

x HCl

(A) 50 mg

Oxybuprocaine Hydrochloride MM 0543.00 Oxybuprocaine Hydrochloride

O

O

H2N

O

N

x HCl

(A) 500 mg

MM 0094.03 Imp. A (EP): 4-Aminobenzoic Acid OH

O

H2N

(B) 100 mg

MM 0543.02 Imp. B (EP): 4-Amino-3-butoxybenzoic Acid OH

O

H2N

O

(A) 100 mg

MM 0543.03 Imp. C (EP): 4-Amino-3-hydroxybenzoic Acid OH

O

H2N

OH

(A) 100 mg




MM 0543.05 Oxybuprocaine N-Oxide Dihydrochloride

O

O

H2N

O

N

x 2 HClO

(A) 100 mg

Oxybutynin Hydrochloride MM 0047.00 Oxybutynin Hydrochloride (A) 250 mg

MM 0047.06 Imp. B (EP): 4-(Diethylamino)but-2-ynyl 2-Hydroxy-2,2-diphenylacetate (Diphenyl analogue of Oxybutynin) O

N

O

HO

(A) 100 mg

MM 0047.04 Imp. C (EP) as Hydrochloride: 4-(Ethylmethylamino)but-2-ynyl (RS)-2-Cyclohexyl-2-hydroxy-2-phenylacetate Hydrochloride (Methylethyl analogue of Oxybutynin Hydrochloride)

ON

O

x HClHO

(D) 100 mg

MM 0047.01 Imp. D (EP): (RS)-2-Cyclohexyl-2-hydroxy-2-phenylacetic Acid (Phenylcyclohexylglycolic Acid)

OH

O

HO

(A) 100 mg

MM 0047.07 Imp. E (EP): 4-(Ethylpropylamino)but-2-ynyl (RS)-2-Cyclohexyl-2-hydroxy-2-phenylacetate (Ethylpropyl analogue of Oxybutynin) O

N

O

HO

(A) 100 mg

MM 0047.02 Methyl (RS)-2-Cyclohexyl-2-hydroxy-2- phenylacetate (Phenylcyclohexylglycolic Acid Methyl Ester)

O

O

OH

(A) 100 mg

MM 0047.03 4-Diethylaminobut-2-yn-1-ol NHO

(A) 100 mg

MM 0047.11 Desethyloxybutynin Hydrochloride

ONH

O

HOx HCl

(D) 100 mg

MM 0047.50 Propargyl (RS)-2-Cyclohexyl-2-hydroxy-2-phenylacetate (Phenylcyclohexylglycolic Acid Propargyl Ester)

O

O

HO

(B) 10 mg

Oxycodone Hydrochloride MM 0672.00 Oxycodone Hydrochloride


O OO

N

HO x HCl

(A) 100 mg

MM 0672.03 Imp. C (EP) as Hydrochloride: 4,5-Epoxy-14-hydroxy-3-methoxymorphinan-6-one Hydrochloride (Noroxycodone Hydrochloride)

O OO

HN

HO x HCl

(D) 50 mg

MM 0672.05 4,5-Epoxy-3-methoxy-17-methylmorphinan-6,14-diol Hydrochloride (6-Oxycodol Hydrochloride) [Controlled Substance]

O OHO

N

HO x HCl

on request

MM 0672.06 Oxycodone N-Oxide

O OO

N

HO

O (D) 50 mg

Oxymetazoline Hydrochloride MM 0177.00 Oxymetazoline Hydrochloride

HN

NHOx HCl

(A) 250 mg




MM 0177.01 Imp. A (EP) as Hydrochloride: N-(2-Aminoethyl)-2-[4-(1,1-dimethylethyl)-3-hydroxy-2,6-dimethylphenyl)]acetamide Hydrochloride

HOHN

O

NH2 x HCl

(A) 100 mg

MM 0089.00 Imp. B (EP) as Hydrochloride: Xylometazoline Hydrochloride x HCl

NH

N(A) 500 mg

MM 0177.07 Imp. C (EP): 2-[4-(1,1-Dimethylethyl)-3- hydroxy-2,6-dimethylphenyl]acetamide

OH

NH2

O

(A) 100 mg

MM 0177.04 Imp. D (EP): [4-(1,1-Dimethylethyl)-3-hydroxy- 2,6-dimethylphenyl]acetic Acid

OH

OH

O

(A) 100 mg

MM 0177.05 Imp. E (EP): [4-(1,1-Dimethylethyl)-3-hydroxy- 2,6-dimethylphenyl]acetonitrile

OH

N

(D) 100 mg

Oxyphenbutazone MM 0933.00 Oxyphenbutazone Monohydrate

N

N

O

O

OH

x H2O

(A) 250 mg

Oxytetracycline Hydrochloride MM 0554.00 Oxytetracycline Hydrochloride OH O OH O

NH2

O

OH

OH

NOHHO

HH x HCl

(A) 500 mg

MM 0452.00 Imp. B (EP) as Hydrochloride: Tetracycline Hydrochloride OH O OH O

NH2

O

OH

OH

N

HH x HCl

HO

(A) 500 mg

Pantoprazole Sodium Sesquihydrate MM 0099.00 Pantoprazole Sodium

N

O

OS

O

NNa

N

O

F

F

(D) 100 mg

MM 0099.01 Pantoprazole

N

O

OS

O

NH

N

O

F

F

(D) 100 mg

MM 0099.02 Imp. A (EP): 5-(Difluoromethoxy)-2-[[(3,4- dimethoxypyridin-2-yl)methyl]sulphonyl]- 1H-benzimidazole (Pantoprazole Sulphone) S

NH

N

O

F

F O

O

N

O

O

(A) 100 mg

MM 0099.03 Imp. B (EP): 5-(Difluoromethoxy)-2-[[(3,4- dimethoxypyridin-2-yl)methyl]sulphanyl]- 1H-benzimidazole

N

O

OS

NH

N

O

F

F

(A) 100 mg

MM 0099.04 Imp. C (EP): 5-(Difluoromethoxy)-1H-benzimidazole-2-thiol

SH

NH

N

O

F

F

(A) 100 mg

MM 0099.11 Mixture of Imp. D and F (EP): 5- and 6-(Di- fluoromethoxy)-2-[(RS)-[(3,4-dimethoxypyridin- 2-yl)methyl]sulphinyl]-1-methyl-1H-benzimidazole

N

O

OS

O

N

N

O

F

F

N

O

OS

O

N

N

O

F

F +

(D) 100 mg




MM 0099.05 2-Chloromethyl-3,4-dimethoxypyridine Hydrochloride Cl

N

OO

x HCl

(A) 100 mg

MM 0099.06 Pantoprazole N-Oxide

N

O

OS

O

NH

N

O

F

F

O

(D) 100 mg

MM 0099.07 Pantoprazole Sulphone N-Oxide

N

O

OS

NH

N

O

F

F

OO O

(A) 100 mg

Paracetamol MM 0042.00 Paracetamol H

N

OHO

(A) 500 mg

MM 0042.08 Imp. A (EP): N-(2-Hydroxyphenyl)acetamide (2-Acetamidophenol)

OH

O

HN

(B) 100 mg

MM 0042.05 Imp. B (EP): N-(4-Hydroxyphenyl)propanamide (N-Propionyl-4-aminophenol)

HN

OHO

(A) 100 mg

MM 0042.09 Imp. C (EP): N-(3-Chloro-4-hydroxyphenyl)acetamide (3-Chloro-4-hydroxyacetanilide)

HO

HN

O

Cl(A) 100 mg

MM 0042.10 Imp. D (EP): N-Phenylacetamide (Acetanilide) HN

O

(B) 100 mg

MM 0042.11 Imp. E (EP): 1-(4-Hydroxyphenyl)ethanone (4-Hydroxyacetophenone)

HO

O (B) 100 mg

MM 0042.03 Imp. F (EP): 4-Nitrophenol NO2

HO

(B) 100 mg

MM 0042.12 Imp. G (EP): 1-(4-Hydroxyphenyl)ethanone Oxime (4-Hydroxyacetophenone Oxime)

NHO

HO

(A) 100 mg

MM 0042.04 Imp. H (EP): 4-(Acetylamino)phenyl Acetate (N,O-Diacetyl-4-aminophenol)

HN

OO

O(A) 100 mg

MM 0042.13 Imp. I (EP): 1-(2-Hydroxyphenyl)ethanone (2-Hydroxyacetophenone)

O

OH

(B) 100 mg

MM 0042.02 Imp. J (EP): N-(4-Chlorophenyl)acetamide (4-Chloroacetanilide)

HN

OCl

(B) 100 mg

MM 0042.01 Imp. K (EP): 4-Aminophenol NH2

HO

(B) 100 mg

MM 0042.07 3-Aminophenol NH2HO (B) 100 mg

Paroxetine Hydrochloride Anhydrous MM 1032.02 Imp. B (EP): 1,3-Benzodioxol-5-ol (Sesamol) O

O

OH (A) 100 mg

MM 1032.07 Imp. G (EP) as Hydrochloride: 4-(4-Fluorophenyl)- 1-methyl-1,2,3,6-tetrahydropyridine Hydrochloride x HCl

N

F (A) 100 mg

MM 1032.12 [(3S,4R)-4-(4-Fluorophenyl)-1-methylpiperidin-3-yl]methanol

HO N

F (A) 100 mg

Pentetrazol MM 0692.00 Pentetrazol N

NN

N(A) 500 mg




Pentoxifylline MM 0761.00 Pentoxifylline

N

N N

N

O

OO (A) 500 mg

MM 0577.00 Imp. A (EP): Theobromine HN

N N

N

O

O (A) 500 mg

MM 0176.03 Imp. B (EP): 3-Methyl-3,7-dihydro-1H-purine- 2,6-dione (3-Methylxanthine) HN

N N

HN

O

O (A) 100 mg

MM 0176.00 Imp. C (EP): Theophylline N

N N

HN

O

O (A) 500 mg

MM 0494.00 Imp. F (EP): Caffeine N

N N

N

O

O (A) 500 mg

Pentoxyverine Hydrogen Citrate MM 1268.01 Imp. A (EP): 1-Phenylcyclopentanecarboxylic Acid

OH

O (A) 100 mg

Peppermint Oil MM 0388.00 (-)-Menthol (Levomenthol)

OH

(A) 500 mg

MM 0163.12 (+)-(R)-Pulegone

O

(A) 100 mg

Perazine Dimaleate MM 0815.00 Perazine Dimaleate

S

N

N

N O

HO

HO

O

x 2

(A) 100 mg

Perazine Dimalonate MM 0157.00 Perazine Dimalonate

S

N

N

N

O

OH

O

HO

x 2

on request

MM 0157.01 Perazine Sulphoxide

S

N

N

N

O

(A) 100 mg

MM 0157.02 Phenothiazine

S

HN (B) 100 mg

MM 0157.03 1-(3-Chloropropyl)-4-methylpiperazine N

N

Cl

on request

Perphenazine MM 0826.00 Perphenazine

S

N

Cl

N

NOH

(A) 100 mg




MM 0826.01 Imp. A (EP): 2-[4-[3-(2-Chloro-5-oxido-10H- phenothiazin-10-yl)propyl]piperazin-1-yl]- ethanol (Perphenazine Sulphoxide) S

N

Cl

N

NOHO

(A) 100 mg

New MM 0826.02 Imp. B (EP): 2-[4-[3-(10H-Phenothiazin-10- yl)propyl]piperazin-1-yl]ethanol

S

N N

NOH

(A) 50 mg

Phenacetin MM 0551.00 Phenacetin

O

HN

O

(A) 100 mg

MM 0042.00 Paracetamol HN

OHO

(A) 500 mg

MM 0042.01 4-Aminophenol NH2

HO

(B) 100 mg

Phenethyl Alcohol MM 0953.00 Phenylethyl Alcohol OH (A) 500 mg

Pheniramine Maleate MM 0059.00 Pheniramine Maleate O

OH

O

OHx

N

N

(A) 100 mg

MM 0059.02 Imp. A (EP): 2-Benzylpyridine N (C) 100 mg

MM 0059.03 Imp. B (EP): 4-Benzylpyridine N (C) 100 mg

MM 0059.09 Imp. C (EP) as Sesquifumarate: (3RS)-N,N- Dimethyl-3-phenyl-3-(pyridin-4-yl)propan- 1-amine Sesquifumarate

N

N

xOH

O

HO

O

1,5

(A) 100 mg

MM 0059.08 Imp. D (EP) as Dihydrochloride: N,N,N',N'-Tetramethyl-3-phenyl-3-(pyridin-2-yl)pentane-1,5-diamine Dihydrochloride

N N

Nx 2 HCl

(D) 100 mg

MM 0059.01 Pheniramine N

N (A) 100 mg

MM 0059.05 Pheniramine N-Oxide Dihydrochloride N

NO

x 2 HCl

(A) 100 mg

MM 0059.06 Norpheniramine Maleate HN

N

OH

O

OH

O

x

(A) 100 mg




Phentolamine Mesilate MM 0171.04 Imp. B (EP) as Hydrochloride: 2-(Chloromethyl)-

4,5-dihydro-1H-imidazole Hydrochloride Cl

NH

N

x HCl100 mg

Phenobarbital MM 0265.07 Imp. B (EP): (5RS)-5-Ethyl-6-imino-5-

phenyldihydropyrimidine-2,4(1H,3H)- dione

NH

HN O

NH

O (A) 50 mg

MM 0265.08 Imp. C (EP): 5-Methyl-5-phenylpyrimidine- 2,4,6(1H,3H,5H)-trione

NH

HN O

O

O (A) 50 mg

MM 0265.01 Phenylethylacetylurea (2-Phenylbutyrylurea) N

H

O

NH2

O (A) 100 mg

MM 0265.02 N-Benzoyl-N'-(2-phenyl)butanoylurea NH

O

NH

O O (A) 100 mg

MM 0265.03 Barbituric Acid

NH

HN O

O

O (C) 100 mg

Phenoxyethanol MM 0952.00 Phenoxyethanol O

OH (A) 500 mg

Phenoxymethylpenicillin Potassium MM 0026.00 Phenoxymethylpenicillin Potassium

N

SH

O

OOK

HN

O

O

(A) 250 mg

MM 0160.00 Imp. A (EP) as Potassium Salt: Benzylpenicillin Potassium

N

SH

O

OOK

HN

O

(A) 250 mg

MM 0026.03 Imp. B (EP): Phenoxyacetic Acid

OOH

O

(B) 100 mg


N

SH

O

H2N

OOH (B) 100 mg

MM 0026.02 Imp. D (EP): (2S,5R,6R)-3,3-Dimethyl-7-oxo-6-[[2-(4-hydroxyphenoxy)acetyl]amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid (4-Hydroxyphenoxymethylpenicillin)

N

SH

O

OOH

HN

O

O

HO

(A) 100 mg

MM 0026.01 Imp. E (EP): (4S)-2-[Carboxy[(phenoxyacetyl) amino]methyl]-5,5-dimethylthiazolidine-4- carboxylic Acid (Penicilloic Acids of Phenoxymethylpenicillin)

HN

S

OOH

HN

O

O OHO

(A) 100 mg

MM 0026.05 Imp. F (EP): (2RS,4S)-5,5-Dimethyl-2- [[(phenoxyacetyl)amino]methyl]thiazolidine- 4-carboxylic Acid (Penilloic Acids of Phenoxymethylpenicillin)

HN

S

OOH

NH

O

O

(A) 100 mg




Phenylbutazone MM 0548.00 Phenylbutazone

N

N

O

O(A) 500 mg

MM 0548.01 Imp. A (EP): (2RS)-2-[(1,2-Diphenyldiazanyl)- carbonyl]hexanoic Acid

N

NH

O

OHO

(D) 100 mg

MM 0548.02 Imp. B (EP): 4-Butyl-4-hydroxy-1,2-diphenylpyrazolidine-3,5-dione

N

N

O

O

OH

(A) 50 mg

MM 0548.03 Imp. C (EP): 1,2-Diphenyldiazane (1,2-Diphenylhydrazine)

HN

NH

(A) 100 mg

MM 0548.04 Imp. D (EP): 1,2-Diphenyldiazene N

N

(C) 100 mg

MM 0548.05 Imp. E (EP) as Dihydrochloride: Biphenyl-4,4'-diamine Dihydrochloride (Benzidine Dihydrochloride)

H2N NH2x 2 HCl (A) 100 mg

Phenylephrine Hydrochloride MM 0081.00 Phenylephrine Hydrochloride

HOHN

OH

x HCl

(A) 500 mg

MM 0081.03 Imp. C (EP) as Hydrochloride: 1-(3-Hydroxyphenyl)-2-(methylamino)ethanone Hydrochloride (Phenylephrone Hydrochloride)

HOHN

O

x HCl

(D) 100 mg

MM 0081.08 Imp. E (EP) as Hydrochloride: 2-(Benzyl-methylamino)-1-(3-hydroxyphenyl)ethanone Hydrochloride (Benzylphenylephrone Hydrochloride)

HO N

O

x HCl

(D) 100 mg

MM 0081.05 1,2,3,4-Tetrahydro-4,6-dihydroxy-2-methylisoquinoline Hydrochloride

HO

OH

N

x HCl

(A) 100 mg

MM 0081.06 1,2,3,4-Tetrahydro-4,8-dihydroxy-2-methylisoquinoline Hydrochloride

OH

N

OH

x HCl

(A) 50 mg

Phenylpropanolamine Hydrochloride MM 0656.00 Phenylpropanolamine Hydrochloride [Drug Precursor]

NH2

OH

and enatiomere

x HCl

(A) 500 mg

Phenyltoloxamine Citrate MM 0770.00 Phenyltoloxamine Citrate

xO

NOH

O

OH

O

OHO

OH

(A) 500 mg

Phenytoin MM 0630.00 Phenytoin

NH

HN O

O

(A) 500 mg

MM 0630.01 Imp. A (EP): Diphenylmethanone (Benzophenone)

O

(B) 100 mg




MM 0630.02 Imp. B (EP): Diphenylethanedione (Benzil)

O

O (B) 100 mg

MM 0630.04 Imp. C (EP): Amino(diphenyl)acetic Acid (2,2-Diphenylglycine)

O

OH

NH2

(A) 100 mg

MM 0630.06 Imp. E (EP): (Carbamoylamino)(diphenyl)acetic Acid HN

O

NH2

O

OH

(A) 50 mg

MM 0630.08 Imp. F (EP): 5-(4-Methylphenyl)-5-phenylimidazolidine-2,4-dione

NH

HN O

O

(A) 100 mg

MM 0630.07 1-Methyl-5,5-diphenylimidazolidine-2,4-dione

NH

N O

O

(D) 100 mg

MM 0630.03 5-(4-Methylphenyl)hydantoin

NH

HN O

O

(A) 100 mg

Phenytoin Sodium MM 0622.00 Phenytoin Sodium

N

HN ONa

O

(A) 500 mg

MM 0630.01 Imp. A (EP): Diphenylmethanone (Benzophenone)

O

(B) 100 mg

MM 0630.02 Imp. B (EP): Diphenylethanedione (Benzil) O

O

(B) 100 mg

MM 0630.04 Imp. C (EP): Amino(diphenyl)acetic Acid (2,2-Diphenylglycine)

O

OH

NH2

(A) 100 mg

MM 0630.08 Imp. F (EP): 5-(4-Methylphenyl)-5- phenylimidazolidine-2,4-dione

NH

HN O

O

(A) 100 mg

MM 0630.07 1-Methyl-5,5-diphenylimidazolidine-2,4-dione

NH

N O

O

(D) 100 mg

MM 0630.03 5-(4-Methylphenyl)hydantoin

NH

HN O

O

(A) 100 mg

Pholcodine MM 0037.00 Imp. A (EP) as Hydrochloride Trihydrate:


O OHHO

N

x HClx 3 H2O

(A) 250 mg

MM 0280.00 Imp. A (EP) as Hemisulphate Pentahemihydrate: Morphine Hemisulphate Pentahemihydrate [Controlled Substance]

O OHHO

N

2

x H2SO4x 5 H2O

(A) 250 mg




MM 0442.00 Imp. B (EP) as Phosphate Hemihydrate: Codeine Phosphate Hemihydrate [Controlled Substance]

O OHO

N

x H3PO4x 1/2 H2O

(A) 100 mg

MM 0004.00 Imp. B (EP) as Monohydrate: Codeine Monohydrate [Controlled Substance]

O OHO

N

x H2O

(A) 100 mg

Pilocarpine Hydrochloride MM 0338.00 Pilocarpine Hydrochloride

x HCl

O ON

N

(A) 500 mg

MM 0338.01 Imp. A (EP) as Hydrochloride: (3R,4R)-3-Ethyl-4- [(1-methyl-1H-imidazol-5-yl)methyl]dihydrofuran- 2(3H)-one Hydrochloride (Isopilocarpine Hydrochloride)

x HCl

O ON

N

(A) 100 mg

MM 0338.02 Imp. B (EP) as Sodium Salt: (2S,3R)-2-Ethyl-3- (hydroxymethyl)-4-(1-methyl-1H-imidazol-5- yl)butanoic Acid Sodium Salt (Pilocarpic Acid Sodium Salt)

N

N ONa

OOH (A) 100 mg

MM 0338.03 Imp. C (EP) as Sodium Salt: (2R,3R)-2-Ethyl-3- (hydroxymethyl)-4-(1-methyl-1H-imidazol-5- yl)butanoic Acid Sodium Salt (Isopilocarpic Acid Sodium Salt)

N

N ONa

OOH (A) 100 mg

Pindolol MM 0082.00 Pindolol

NH

O NH

OH

(A) 250 mg

MM 0082.08 Imp. B (EP): 1-[4-[2-Hydroxy-3-[(1-methylethyl)amino]propoxy]-1H-indol-1-yl]-3-[(1- methylethyl)amino]propan-2-ol

OHN

OHN

OHHN

(D) 100 mg

MM 0082.06 Imp. C (EP): 1,1'-[(1-Methylethyl)imino]bis[3- (1H-indol-4-yloxy)propan-2-ol] O N

OH

HN

OH

O NH(A) 100 mg

MM 0082.02 Imp. D (EP): (2RS)-3-(1H-Indol-4-yloxy)propane- 1,2-diol O OH

OH

HN(A) 100 mg

MM 0082.01 Imp. E (EP): 1H-Indol-4-ol

NH

OH (A) 100 mg

Pioglitazone Hydrochloride New MM 0616.06 Imp. C (Pharmeuropa): (5RS)-5-[4-[2-

(5-Ethylpyridin-2-yl)ethoxy]benzyl]-3- [2-(5-ethylpyridin-2-yl)ethyl]-1,3- thiazolidine-2,4-dione

N O

NS

O

O

N (A) 50 mg

New MM 0616.08 Imp. E (Pharmeuropa): Ethyl 3-[4-[2-(5- Ethylpyridin-2-yl)ethoxy]phenyl]propanoate

N O

O

O

(A) 50 mg

New MM 0616.04 5-[4-[2-(5-Ethylpyridin-2-yl)ethoxy]benzyl]-2-iminothiazolidin-4-one

N O

NHS

NH

O

(A) 100 mg

Pipazetate Hydrochloride MM 0486.06 Bis-(2-piperidinoethyl)ether Dihydrochloride (BPEE

Dihydrochloride) O

NNx 2 HCl

(A) 100 mg




MM 0486.02 1,2-Dipiperidinoethane (DPE) N

N

(A) 100 mg

MM 0486.05 2-(2-Piperidinoethoxy)ethanol Hydrochloride HO

ON

x HCl (A) 100 mg

Pipemidic Acid Trihydrate MM 0401.00 Pipemidic Acid Trihydrate

N

N N

O

OH

O

N

HN

x 3 H2O

(A) 250 mg

Pipenzolate Bromide MM 0783.00 Pipenzolate Bromide

O

OOH

N+

Br-

(A) 500 mg

MM 0630.01 Diphenylmethanone (Benzophenone) O

(B) 100 mg

MM 0783.09 Benzilic Acid O

HOOH

(B) 100 mg

Piperacillin MM 0295.00 Piperacillin

N

S

OHO

H

O

HN

NH

O

ON

N

O

O

(A) 100 mg

Piperacillin Sodium MM 0296.00 Piperacillin Sodium

N

S

ONaO

H

O

HN

NH

O

ON

N

O

O

(A) 100 mg

MM 0253.00 Imp. A (EP) as Sodium Salt: Ampicillin Sodium

N

S

ONaO

H

O

HN

NH2

O

(A) 500 mg

MM 0296.05 Imp. E (EP): 1-Ethylpiperazine-2,3-dione NH

O

O

N (A) 100 mg

MM 0296.07 Imp. G (EP): (2R)-2-[[(4-Ethyl-2,3-dioxopiperazin-1-yl)- carbonyl]amino]-2-phenylacetic Acid

OH

NH

O

ON

N

O

O

(A) 100 mg

MM 0026.04 Imp. H (EP): (2S,5R,6R)-6-Amino-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]-heptane-2-carboxylic Acid (6-Aminopenicillanic Acid)

N

SH

O

H2N

OOH (B) 100 mg

Piprinhydrinate MM 0155.00 Piprinhydrinate

O

N

N

N N

HN

Cl

O

O

on request




MM 0155.01 Diphenylpyraline O

N

(A) 100 mg

MM 0155.02 8-Chlorotheophylline N

N N

HN

Cl

O

O

(B) 100 mg

MM 0490.02 Diphenylmethanol (Benzhydrol) OH

(B) 100 mg

Piracetam MM 0083.00 Piracetam

NH2

O

N

O

(A) 500 mg

MM 0083.05 Imp. A (EP): Pyrrolidin-2-one (2-Pyrrolidone) NH

O

(B) 100 mg

MM 0083.04 Imp. B (EP): Methyl (2-Oxopyrrolidin-1-yl)acetate O

O

N

O

(A) 100 mg

MM 0083.02 Imp. C (EP): Ethyl (2-Oxopyrrolidin-1-yl)acetate O

O

N

O

(A) 100 mg

MM 0083.01 Imp. D (EP): (2-Oxopyrrolidin-1-yl)acetic Acid OH

O

N

O

(A) 100 mg

MM 0083.03 N-Vinyl-2-pyrrolidone N

O

(A) 100 mg

MM 0083.06 2-Chloroacetamide O

NH2Cl

(C) 100 mg

Piroxicam MM 0084.00 Piroxicam

NS

O O

OH O

HN N

(A) 500 mg

MM 0084.01 Imp. A (EP): Pyridin-2-amine (2-Pyridylamine) NH2N (B) 100 mg

MM 0084.08 Imp. B (EP): 4-Hydroxy-N-(pyridin-2-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-Dioxide NH

SO O

OH O

HN N

(A) 100 mg

MM 0084.09 Imp. C (EP): 4-Hydroxy-2-methyl-2H-1,2-benzothiazine- 3-carboxamide1,1-Dioxide N

SO O

OH O

NH2

(A) 100 mg

MM 0084.07 Imp. D (EP): Methyl (1,1-Dioxido-3-oxo-1,2-benzisothiazol-2(3H)-yl)acetate N

SOO

OO

O

(A) 100 mg

MM 0084.05 Imp. E (EP): Ethyl (1,1-Dioxido-3-oxo-1,2-benzisothiazol-2(3H)-yl)acetate N

SOO

OO

O

(A) 100 mg

MM 0084.10 Imp. F (EP): 1-Methylethyl (1,1-Dioxido-3-oxo-1,2-benzisothiazol-2(3H)-yl)acetate N

SO

O

OO

O

(A) 100 mg

MM 0084.04 Imp. G (EP): Methyl 4-Hydroxy- 2H-1,2-benzothiazine-3-carboxylate 1,1-Dioxide NH

SO O

OH O

O

(A) 100 mg

MM 0084.06 Imp. H (EP): Ethyl 4-Hydroxy- 2H-1,2-benzothiazine-3-carboxylate 1,1-Dioxide NH

SO O

OH O

O

(A) 100 mg




MM 0084.11 Imp. I (EP): 1-Methylethyl 4-Hydroxy-2H-1,2-benzothiazine-3-carboxylate 1,1-Dioxide NH

SO O

OH O

O

(A) 100 mg

MM 0084.02 Imp. J (EP): Methyl 4-Hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-Dioxide N

SO O

OH O

O

(A) 100 mg

MM 0084.03 Imp. K (EP): Ethyl 4-Hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-Dioxide N

SO O

OH O

O

(A) 100 mg

MM 0084.12 Imp. L (EP): 1-Methylethyl 4-Hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-Dioxide N

SO O

OH O

O

(A) 100 mg

MM 0084.13 N-Methylsaccharin N

SOO

O

(A) 100 mg

MM 0084.15 4-Isopropoxy-2-methyl-N-(2-pyridinyl)-2H- 1,2-benzothiazine-3-carboxamide 1,1-Dioxide N

SO O

O O

HN N

(A) 100 mg

MM 0084.16 N,N'-Di-(2-pyridinyl)oxamide HNN

O

NH

O

N

(C) 50 mg

MM 0084.17 N-(2-Pyridinyl)oxamic Acid Hydrochloride HNN

O

OH

O

x HCl

on request

MM 0084.20 2-(1,1-Dioxido-3-oxo-1,2-benzisothiazol-2(3H)-yl)acetamide N

SOO

ONH2

O

(A) 100 mg

MM 0084.21 N-(6-Methyl-2-pyridyl)-4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxamide-1,1-Dioxide N

SO O

OH O

HN N

(B) 10 mg

MM 0084.22 4-Methoxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazine-3-carboxamide-1,1-Dioxide N

SO O

O O

HN N

(C) 10 mg

MM 0084.23 2-Methyl-N-2-(1-methylpyridinium)-2H-1,2-benzothiazine-3-carboxamide-4-olate 1,1-Dioxide N

SO O

O O

HN N

(B) 10 mg

MM 0084.24 4-Hydroxy-2H-1,2-benzothiazine-3-carboxamide 1,1-Dioxide NH

SO O

OH O

NH2

(B) 10 mg

Potassium Sorbate MM 0955.00 Potassium Sorbate O

OK

(A) 500 mg

Povidone MM 0083.03 Imp. A (EP): 1-Ethenylpyrrolidin-2-one

(1-Vinylpyrrolidin-2-one, N-Vinyl-2-pyrrolidone) N O

(A) 100 mg

MM 0083.05 Imp. B (EP): Pyrrolidin-2-one (2-Pyrrolidone) HN O

(B) 100 mg

MM 0537.01 Vinyl Acetate O

O

(B) 100 mg

Pralidoxime Methyl Sulphate MM 0689.00 Pralidoxime Methyl Sulphate

NN

OH

OS

O

OO(A) 100 mg

MM 0689.01 2-Carboxy-N-methylpyridinium Iodide N

OH

O

I-

(A) 100 mg




MM 0689.02 2-Carbamoyl-N-methylpyridinium Methanesulfonate N

NH2O

S

OOO (A) 100 mg

Prasterone MM 0651.00 Prasterone O

HO

(A) 500 mg

MM 0651.02 16-Dehydropregnenolone Acetate Oxime

O

NOH

O

(A) 100 mg

Pravastatin Sodium MM 0503.00 Pravastatin Sodium

OH

O OH

O

ONa

OH

OH

(A) 100 mg

MM 0503.04 Imp. D (EP): (1S,3S,7S,8S,8aR)-3-Hydroxy-8-[2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl]-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-Methylbutanoate (Pravastatin Lactone)

OH

O OH

OH

O

O (D) 100 mg

Prazepam MM 0023.02 Imp. A (EP): 7-Chloro-5-phenyl-1,3-dihydro-

2H-1,4-benzodiazepin-2-one (Nordazepam) [Controlled Substance] N

HN

O

Cl

(A) 100 mg

MM 0028.03 Imp. C (EP): (2-Amino-5-chlorophenyl)phenylmethanone

Cl

NH2

O

(B) 100 mg

Praziquantel MM 0615.00 Praziquantel O

N

N

O

H

(A) 250 mg

MM 0615.02 Imp. B (EP): 2-(Cyclohexylcarbonyl)- 2,3,6,7-tetrahydro-4H-pyrazino[2,1-a]- isoquinolin-4-one

O

N

N

Oon request

Prazosin Hydrochloride MM 0085.00 Prazosin Hydrochloride

N

N

N

N

O

O

NH2

O

O

x HCl

(A) 100 mg

MM 0085.04 Imp. A (EP): 2-Chloro-6,7-dimethoxyquinazoline-4-amine N

N

O

O

NH2

Cl (A) 100 mg




MM 0085.05 Imp. B (EP): 1,4-Bis(furan-2-ylcarbonyl)piperazine

N

N

O

O

O

O

(A) 100 mg

MM 0085.01 Imp. C (EP): 6,7-Dimethoxy-2-(piperazin-1-yl)quinazolin-4-amine N

NH

N

N

O

O

NH2

(A) 100 mg

MM 0085.02 Imp. D (EP): 1-(Furan-2-ylcarbonyl)piperazine

HN

N

O

O

(A) 100 mg

MM 0085.03 Imp. E (EP): 2,2'-(Piperazin-1,4-diyl)bis-(6,7-dimethoxyquinazolin-4-amine)

NN

N

O

O

NH2

N

N

O

O

NH2

N

(D) 100 mg

MM 0085.06 2,4-Dichloro-6,7-dimethoxyquinazoline N

N

O

O

Cl

Cl (A) 100 mg

MM 0085.07 6,7-Dimethoxyquinazoline-2,4(1H,3H)-dione

NH

HNO

O

O

O

(C) 100 mg

Prednisolone MM 0193.00 Prednisolone

O

HO OH

O

OH(A) 500 mg

MM 0185.00 Imp. A (EP): Hydrocortisone

O

HO OH

O

OH(A) 500 mg

MM 0482.00 Imp. B (EP): 17,21-Dihydroxypregna-1,4- diene-3,11,20-trione (Prednisone)

O

O OH

O

OH(A) 250 mg

MM 0194.00 Imp. C (EP): 11�,17-Dihydroxy-3,20-dioxopregna-1,4-dien-21-yl Acetate (Prednisolone Acetate)

O

HO OH

O

O

O (A) 500 mg

MM 0193.01 (20R)-Hydroxyprednisolone

O

HO OH

HO

OH(C) 10 mg

MM 0193.02 (20S)-Hydroxyprednisolone

O

HO OH

HO

OH(D) 50 mg

Prednisolone Acetate MM 0194.00 Prednisolone Acetate

O

HO

OO

OH

O (A) 500 mg

MM 0187.00 Imp. A (EP): Hydrocortisone Acetate

O

HO

OO

OH

O (A) 500 mg




MM 0193.00 Imp. B (EP): Prednisolone

O

HO OH

OOH

(A) 500 mg

MM 0194.04 Prednisolone 17-Acetate

O

HO O

O

OH

O

(C) 50 mg

MM 0194.07 Prednienic Acid

O

HO OH

OHO (A) 100 mg

Prednisolone Pivalate MM 0304.00 Prednisolone Pivalate

O

HO OH

OO

O (D) 250 mg

Prednisolone Sodium Phosphate MM 0305.00 Prednisolone Sodium Phosphate

O

HO OH

O

OP

ONa

O ONa (A) 100 mg

Prednisolone Sodium Sulfobenzoate MM 0484.01 Sodium 3-Sulfobenzoate

HO

O

SONa

O O (C) 100 mg

Prednisone MM 0482.00 Prednisone

O

OOH

OHO(A) 250 mg

Prednisone Acetate MM 0196.00 Prednisone Acetate

O

OO

OH

O

O

(A) 250 mg

Prilocaine Hydrochloride MM 0563.00 Prilocaine Hydrochloride H

N

O

NH

x HCl

(A) 500 mg

New MM 0563.01 Imp. A (EP): (RS)-2-Chloro-N-(2-methylphenyl)- Propanamide

HN

O

Cl

(A) 100 mg

MM 0563.02 Imp. B (EP): 2-Methylbenzenamine (o-Toluidine)

NH2 (A) 100 mg

New MM 0563.03 Imp. C (EP) as Hydrochloride: (RS)-2-Ethylamino- N-(2-methylphenyl)propanamide Hydrochloride

HN

O

NH

x HCl(A) 50 mg

New MM 0563.04 Imp. D (EP) as Hydrochloride: (RS)-N-(3-Methyl- phenyl)-2-(propylamino)propanamide Hydrochloride

HN

O

NH x HCl

(A) 50 mg

New MM 0563.05 Imp. E (EP) as Hydrochloride: (RS)-N-(4-Methylphenyl)-2-(propylamino)propanamide Hydrochloride

HN

O

NH

x HCl(A) 50 mg




Primidone MM 1030.01 Imp. A (EP) as Hydrate: 2-Ethyl-2-phenylpropane-

diamide Hydrate (Ethylphenylmalonamide Hydrate) NH2

NH2O

O

x H2O

(A) 100 mg

MM 1030.03 Imp. C (EP): (2RS)-2-Phenylbutanamide NH2

O

(A) 100 mg

MM 1030.04 Imp. D (EP): (2RS)-2-Cyano-2-phenylbutanamide

NH2

O

N (A) 50 mg

MM 1030.05 Imp. E (EP): (2RS)-2-Phenylbutanoic Acid OH

O

(A) 100 mg

Probenecid MM 0657.00 Probenecid

OH

O

SN

OO

(A) 500 mg

Procainamide Hydrochloride MM 0550.00 Procainamide Hydrochloride

H2N

NH

O

Nx HCl

(A) 500 mg

MM 0550.02 Procainamide N-Oxide Dihydrochloride

H2N

NH

O

Nx 2 HCl

O(A) 100 mg

Procaine Hydrochloride MM 0596.00 Procaine Hydrochloride

ON

O

H2N

x HCl

(A) 500 mg

MM 0094.03 4-Aminobenzoic Acid OH

O

H2N

(B) 100 mg

Progesterone MM 0222.00 Progesterone

O

O (A) 500 mg

MM 0222.03 Imp. C (EP): (20R)-20-Hydroxypregn-4-en-3-one

O

HO (A) 100 mg

MM 0222.01 Imp. E (EP): (20R)-3-Oxopregn-4-en-20-yl Acetate

O

O

O (D) 100 mg

MM 0222.08 11α-Hydroxyprogesterone

O

O

HO

(A) 100 mg

MM 0222.12 11-Ketoprogesterone

O

O

O

(A) 100 mg




MM 0222.14 Pregnanediol (5β-Pregnane-3α,20(S)-diol)

HO

HO

H

(A) 100 mg

MM 0222.15 Pregnanetriol (5β-Pregnane-3α,17,20(S)-triol)

HO

HO

H

OH

on request

Proguanil Hydrochloride MM 0162.05 Imp. B (EP): 4-Chloroaniline Cl

NH2

(B) 100 mg

Prolintane Hydrochloride MM 0663.00 Prolintane Hydrochloride

N x HCl

(A) 100 mg

Promazine Hydrochloride MM 0290.00 Promazine Hydrochloride

S

N

N

x HCl

(A) 500 mg

MM 0290.01 Imp. A (EP): 3-(10H-Phenothiazin-10-yl)-N,N-dimethylpropan-1-amine S-Oxide (Promazine Sulphoxide)

S

N

N

O

(A) 100 mg

MM 0290.02 N,N-Dimethyl-3-chloropropylamine Hydrochloride NCl x HCl (B) 100 mg

MM 0157.02 Phenothiazine

S

HN (B) 100 mg

Promethazine Hydrochloride MM 0412.00 Promethazine Hydrochloride

S

NN

x HCl

(A) 500 mg

MM 0157.02 Imp. A (EP): Phenothiazine

S

NH

(B) 100 mg

MM 0412.02 Imp. B (EP) as Hydrochloride: (2RS)-N,N- Dimethyl-2-(10H-phenothiazin-10-yl)propan- 1-amine Hydrochloride (Isopromethazine Hydrochloride)

S

NN

x HCl

(A) 100 mg

New MM 0412.03 Imp. C (EP) as Hydrochloride: (2RS)-N-Methyl- 1-(10H-phenothiazin-10-yl)propan-2-amine Hydrochloride (Norpromethazine Hydrochloride) S

N

HN

x HCl

(A) 50 mg

MM 0412.04 Imp. D (EP): (2RS)-N,N-Dimethyl-1-(10H-phenothiazin-10-yl)propan-2-amine S-Oxide (Promethazine Sulphoxide)

S

N

O

N

(A) 100 mg

MM 0412.05 Promethazine Sulphoxide N-Oxide Hydrochloride

S

NN

x HCl

O

O(A) 100 mg




MM 0412.06 (2RS)-N-Methyl-2-(10H-phenothiazin-10-yl)propan-1-amine Hydrochloride (Norisopromethazine Hydrochloride)

S

N

HN

x HCl

(A) 100 mg

Propafenone Hydrochloride MM 0405.00 Propafenone Hydrochloride OO

OH

NH

x HCl

(A) 500 mg

MM 0405.02 Imp. A (EP): 1-(2-Hydroxyphenyl)-3-phenylpropan-1-one OHO (A) 100 mg

MM 0405.03 Imp. B (EP) as Hydrochloride: (2E)-1-[2-[(2RS)-2-Hydroxy-3-(propylamino)propoxy]phenyl]-3-phenylprop-2-en-1-one Hydrochloride

O

OH

NH

O

x HCl

(A) 50 mg

MM 0405.04 Imp. C (EP): 1-[2-[[(2RS)-Oxiranyl]methoxy]phenyl]-3-phenylpropan-1-one

OO

O (A) 50 mg

New MM 0405.05 Imp. D (EP): 1-[2-[(2RS)-2,3-Dihydroxy-propoxy]phenyl]-3-phenylpropan-1-one

O

OH

OHO (A) 50 mg

MM 0405.06 Imp. E (EP): 1-[2-[(2RS)-3-Chloro-2-hydroxypropoxy]phenyl]-3-phenylpropan-1-one

O

OH

ClO (A) 50 mg

MM 0405.07 Imp. F (EP): 1,1'-[2-Hydroxypropane- 1,3-diylbis(oxy-2,1-phenylene)]bis(3- phenylpropan-1-one)

OO

OH

O O (A) 50 mg

MM 0405.09 Imp. H (EP): (2RS)-2-Phenyl-2,3-dihydro-4H-1-benzopyran-4-one

O

O

(A) 100 mg

MM 0405.01 5-Hydroxypropafenone Hydrochloride

OH

OO

OH

NH

x HCl

(A) 100 mg

Propentofylline MM 0875.01 3-Methyl-7-propylxanthine

HN

N N

N

O

O

(A) 100 mg

MM 0875.02 1-(3-Hydroxypropyl)-3-methyl-7-propylxanthine

N

N N

N

O

O

HO

(A) 100 mg

MM 0875.03 1,7-Bis-(5-oxohexyl)-3-methylxanthine

N

N N

N

O

O

O

O (A) 100 mg

Propofol MM 0461.00 Propofol OH (A) 250 mg

MM 0461.03 Imp. A (EP): 2,4-Bis(1-methylethyl)phenol OH (A) 100 mg




MM 0461.04 Imp. C (EP): 2-(1-Methylethyl)phenol OH (C) 100 mg

MM 0461.02 Imp. E (EP): 3,3',5,5'-Tetrakis(1- Methylethyl)bisphenyl-4,4'-diol

OHHO

(A) 100 mg

MM 0461.05 Imp. F (EP): 3-(1-Methylethyl)phenol HO

(C) 100 mg

MM 0461.08 Imp. G (EP): 2-(1-Methylethoxy)-1,3-bis(1-methylethyl)benzene O

(A) 100 mg

MM 0461.06 Imp. H (EP): 4-(1-Methylethyl)phenol HO (C) 100 mg

MM 0461.07 Imp. I (EP): Oxydibenzene O (B) 100 mg

MM 0461.13 Imp. J (EP): 2,6-Bis(1-methylethyl)benzene-1,4-dione O

O

(A) 50 mg

MM 0461.11 Imp. K (EP): 1-(1-Methylethoxy)-2-(1-methylethyl)benzene O

(A) 100 mg

MM 0461.15 Imp. M (Pharmeuropa): 2,6-Diisopropylbenzoic Acid O OH (A) 50 mg

Propranolol Hydrochloride MM 0043.00 Propranolol Hydrochloride

O

OH HN x HCl

(A) 500 mg

MM 0043.01 Imp. A (EP): (2RS)-3-(Naphthalen-1- yloxy)propane-1,2-diol (Diol Derivative) O

OH

OH

(A) 100 mg

MM 0043.03 Imp. B (EP) as Hydrochloride: 1,1'-[(1- Methylethyl)imino]bis[3-(naphthalen-1- yloxy)propan-2-ol] Hydrochloride (Tertiary Amine Derivative Hydrochloride)

O

OH

O

OH

N

x HCl

(A) 100 mg

New MM 0043.02 Imp. C (EP): 1,3-Bis(naphthalen-1-yloxy)- propan-2-ol (Bis-ether Derivative) O

OH

O

(A) 50 mg

MM 0043.04 1-Naphthol

OH

(B) 100 mg

MM 0043.05 1-(1-Naphtyloxy)-2,3-epoxypropane OO

(A) 100 mg

Propyl Gallate MM 1037.00 Propyl Gallate

HO

HO

OH

O

O (A) 500 mg

Propyl Parahydroxybenzoate MM 0432.00 Propyl Parahydroxybenzoate

HO

O

O (A) 500 mg





HO

OH

O (B) 100 mg


HO

O

O (A) 500 mg

MM 0498.00 Imp. C (EP): Ethyl 4-Hydroxybenzoate (Ethyl Parahydroxybenzoate)

HO

O

O (A) 500 mg


HO

O

O (A) 500 mg

MM 0432.01 Sodium Propyl Parahydroxybenzoate

NaO

O

O (B) 100 mg

Propylhexidrine Hydrochloride MM 0664.00 Propylhexidrine Hydrochloride

NHx HCl (A) 100 mg

Propyphenazone MM 0036.00 Propyphenazone

N

N

O (A) 500 mg

MM 0036.05 Imp. A (EP): Phenazone

N

N

O (A) 100 mg

MM 0036.04 Imp. C (EP): 4-[(1RS)-1,3-Dimethylbutyl]- 1,5-dimethyl-2-phenyl-1,2-dihydro-3H- pyrazol-3-one

N

N

O (A) 50 mg

Protionamide New MM 0844.01 Protionamide Sulphoxide

N

NH2

SO (A) 50 mg

Proxymetacaine Hydrochloride MM 0404.00 Proxymetacaine Hydrochloride

H2N

O

O

O

N x HCl

(A) 500 mg

MM 0404.01 3-Amino-4-propoxybenzoic Acid Hydrochloride H2N

O

OH

O

x HCl

(A) 100 mg

MM 0404.02 Proxymetacaine N-Oxide Dihydrochloride H2N

O

O

O

N x 2 HClO

(C) 50 mg

Proxyphylline MM 1284.00 Proxyphylline

N

N N

N

O

O

OH (A) 250 mg

Pseudoephedrine Hydrochloride MM 2115.01 Methcathinone Hydrochloride

(2-Methylamino-1-phenylpropan-1-one Hydrochloride) [Controlled Substance]

NH

O

x HCl

(A) 100 mg

MM 2115.04 (1S,2S)-N-Acetylpseudoephedrine N

OH

O

(A) 100 mg




MM 2115.05 (1S,2S)-N,O-Diacetylpseudoephedrine

N

O

O

O

(A) 100 mg

New MM 0652.00 Imp. A (EP) as Hydrochloride: Ephedrine Hydrochloride [Drug Precursor]

HN

OH

x HCl

(A) 500 mg

New MM 1147.00 Imp. A (EP) as Sulphate: Ephedrine Sulphate [Drug Precursor]

HN

OH

2

x H2SO4

(A) 250 mg

New MM 2115.03 (1S,2S)-O-Acetylpseudoephedrine Hydrochloride

NH

O

O

x HCl

(A) 50 mg

Pyrazinamide MM 0385.00 Pyrazinamide

N

NNH2

O on request

MM 0385.01 Imp. A (EP): Pyrazine-2-carboxylic Acid

N

NOH

O (A) 100 mg

Pyridostigmine Bromide New MM 0429.00 Pyridostigmine Bromide

Br-N+

ON

O (A) 100 mg

MM 0429.02 Imp. B (EP) as Iodide: 3-Hydroxy-1-methylpyridinium Iodide

I-N+

HO

(A) 100 mg

Pyridoxine Hydrochloride MM 0021.00 Pyridoxine Hydrochloride N

HO

OH

OH x HCl

(A) 500 mg

MM 0021.01 Imp. A (EP) as Hydrochloride: 6-Methyl- 1,3-dihydrofuro[3,4-c]pyridin-7-ol Hydrochloride

N

HO

O

x HCl

(D) 100 mg

MM 0021.02 Imp. B (EP) as Hydrochloride: 5-(Hydroxymethyl)-2,4-dimethylpyridin-3-ol Hydrochloride

N

HOOH x HCl

(A) 100 mg

MM 0021.03 Pyridoxine Diacetate N

HO

O

O

O

O

(A) 100 mg

MM 0021.05 Pyridoxal Hydrochloride N

HO

O

OH x HCl

(A) 100 mg

MM 0021.06 Pyridoxamine Dihydrochloride N

HO

NH2

OH x 2 HCl

(A) 100 mg

MM 0021.07 4-Pyridoxic Acid N

HO

OH

OH

O

(D) 50 mg

Quetiapine Fumarate MM 1130.01 Imp. B (Pharmeuropa) as Dihydrochloride:

11-(Piperazin-1-yl)dibenzo[b,f][1,4]thiazepine Dihydrochloride

N

NH

N

S

x 2 HCl

(A) 100 mg




MM 1130.09 Imp. G (Pharmeuropa): Dibenzo[b,f][1,4]thiazepin- 11(10H)-one

OHN

S

(A) 100 mg

New MM 1130.10 Imp. H (Pharmeuropa): 2-[2-[4-(Dibenzo[b,f][1,4]- thiazepin-11-yl)-1-oxidopiperazin-1-yl]ethoxy]- ethanol (Quetiapine N-Oxide)

N

NO

OH

N

S

O (A) 50 mg

Quinapril Hydrochloride MM 0011.01 4-Amino-6-chlorobenzene-1,3-disulphonamide (Salamide)

S

Cl NH2

H2NS

NH2

O O O O (B) 100 mg

MM 0010.05 Imp. B (Pharmeuropa): (2S)-2-[[(1S)-1- (Ethoxycarbonyl)-3-phenylpropyl]amino]- propanoic Acid

HN

O O

OH

O (A) 100 mg

Quinine Dihydrochloride MM 0458.00 Quinine Dihydrochloride

N

O

HO N

H

H

x 2 HCl

(A) 500 mg

Quinuclidinyl Benzilate MM 0783.09 Benzilic Acid

HO

O

OH(B) 100 mg

MM 0825.02 3-Quinuclidinol N

OH

(A) 100 mg

Rabeprazole Sodium MM 0618.01 Rabeprazole Sodium

N

O

S

O

NaN

N

O on request

MM 0618.00 Rabeprazole

N

O

S

O

HN

N

O on request

MM 0618.02 2-[[[4-(3-Methoxypropoxy)-3-methyl-2-pyridinyl]methyl]thio]-1H-benzimidazole

N

O

S

HN

N

O (A) 100 mg

MM 0618.03 Rabeprazole Sulphone

N

O

S

HN

N

O

OO

(A) 100 mg

MM 0618.04 Rabeprazole N-Oxide

N

O

S

OHN

N

O

O

(D) 100 mg

MM 0618.05 Rabeprazole Sulphone N-Oxide

N

O

S

HN

N

O

OO

O

(A) 100 mg




MM 0618.07 2-Chloromethyl-3-methyl-4-(3-methoxypropoxy)pyridine Hydrochloride

N

O

Cl

O

x HCl

(A) 100 mg

Raloxifene Hydrochloride MM 0738.00 Raloxifene Hydrochloride SHO

OH

O

ON

x HCl

(A) 100 mg

New MM 0738.01 Imp. C (EP): [6-Hydroxy-2-(4-hydroxyphenyl)-1- benzothiophen-3-yl][4-[2-(piperidin-1-yl)ethoxy]- phenyl]methanone N-Oxide (Raloxifene N-Oxide)

ON

O

S

HO

OH

O (A) 50 mg

Ramipril MM 0448.05 Imp. D (EP): Ethyl (2S)-2-[(3S,5aS,8aS,9aS)-3-

Methyl-1,4-dioxodecahydro-2H-cyclopenta[4,5]- pyrrolo[1,2-a]pyrazin-2-yl]-4-phenylbutanoate (Ramipril Diketopiperazine) N

OO

O

O

N H

H

H

(A) 100 mg

MM 0010.05 Imp. F (EP): (2S)-2-[[(1S)-1-(Ethoxycarbonyl)- 3-phenylpropyl]amino]propanoic Acid

HN

OH

O

OO

(A) 100 mg

MM 0291.04 Imp. G (EP): Methylbenzene (Toluene) (C) 100 mg

MM 0448.04 Imp. M (EP): (2R,3R)-2,3-Bis(benzoyloxy)- butanedioic Acid (Dibenzoyltartric Acid)

O

OO OH

O

OHOO

(A) 100 mg

New MM 0448.11 (2S,3aS,6aS)-Octahydro-cyclopenta[b]pyrrole-2-carboxylic Acid Phenylmethyl Ester Hydrochloride

HN

H H

O O

x HCl

(A) 100 mg

Ranitidine Hydrochloride MM 0086.00 Ranitidine Hydrochloride O

SN

HN

HN

x HCl

NO2

(A) 500 mg

MM 0086.02 Imp. A (EP): N,N'-Bis[2-[[[5-[(dimethylamino)methyl]furan-2-yl]-methyl]sulphanyl]ethyl]-2-nitroethene-1,1-diamine

OSN

HN

NO2

HN O

S N(A) 100 mg

MM 0086.01 Imp. B (EP): 2-[[[5-[(Dimethylamino)methyl]- furan-2-yl]methyl]sulphanyl]ethanamine

OSN

NH2 (A) 100 mg

MM 0086.03 Imp. C (EP): N-[2-[[[5-[(Dimethylamino)- methyl]furan-2-yl]methyl]sulphinyl]ethyl]-N'- methyl-2-nitroethene-1,1-diamine (Ranitidine Sulphoxide)

OSN

HN

HN

O

NO2

(A) 100 mg

MM 0086.06 Imp. D (EP) as Sodium Salt: N-[2-[[[5- [(Dimethylamino)methyl]furan-2-yl]- methyl]sulphanyl]ethyl]-2-nitroacetamide Sodium Salt

OSN

HN ONa

NO2

(A) 100 mg

MM 0086.05 Imp. E (EP): N-[2-[[[5-[(Dimethyloxidoamino)- methyl]furan-2-yl]methyl]sulphanyl]ethyl]- N'-methyl-2-nitroethene-1,1-diamine (Ranitidine N-Oxide)

OSN

HN

HN

O

NO2

(D) 100 mg




MM 0086.17 Imp. F (EP) as Hydrochloride: [5-[(Dimethyl- amino)methyl]furan-2-yl]methanol Hydrochloride

OOHN x HCl (A) 100 mg

MM 0086.07 Imp. G (EP): 3-(Methylamino)-5,6-dihydro-2H-1,4-thiazin-2-one Oxime

N

S

NH

NOH (A) 100 mg

MM 0086.08 Imp. H (EP): N-Methyl-2-nitroacetamide

NH

O

NO2 (A) 100 mg

MM 0086.10 Imp. I (EP): 2,2'-Methylenebis[N-[2-[[[5-[(dimethylamino)methyl]furan-2-yl]methyl]sulphanyl]ethyl]-N'- methyl-2-nitroethene-1,1-diamine]

OSN

NH

NH

OSN

HN

HN

NO2

NO2

(A) 100 mg

MM 0220.09 Imp. K (EP): N-Methyl-1-methylthio-2- nitroethenamine ((EZ)-N-Methyl-1-(methylsulphanyl)-2-nitroethen-1-amine) N

HS

NO2 (A) 100 mg

Ranolazine Dihydrochloride New MM 1320.01 2-[(2-Methoxyphenoxy)methyl]oxirane

O

O

O (A) 100 mg

Reagents MM 0334.01 Diethylhexylphthalate (Bis-(2-ethylhexyl) Phthalate)

O

O

O

O

(C) 500 mg

MM 0334.02 3-(N-Morpholino)propane Sulfonic Acid (MOPS) O

N SOH

O O

(C) 500 mg

MM 0334.03 3-(N-Morpholino)ethane Sulfonic Acid (MES)

O

NS

OH

O O (C) 500 mg

MM 0334.08 Salicylaldehyde Azine

N N

HO

OH

(A) 100 mg

Repaglinide New MM 0944.00 Repaglinide

NH

N O OH

O

O

(A) 100 mg

New MM 0944.02 Imp. B (EP): [3-Ethoxy-4-(ethoxycarbonyl)- phenyl]acetic Acid

HO

O O

O

O

(A) 100 mg

New MM 0944.01 Imp. C (EP) as N-Acetyl-L-glutamate: (1S)- 3-Methyl-1-[2-(piperidin-1-yl)phenyl]butan- 1-amine N-Acetyl-L-glutamate

NH2

N

O

HO OH

O

HN

O

x

(A) 100 mg

Ribavirin MM 0542.00 Ribavirin

O

OHOH

HON

N

N

H2N

O (A) 250 mg

MM 0542.01 Imp. A (EP): 1--D-Ribofuranosyl-1H-1,2,4- triazole-3-carboxylic Acid

O

OHOH

HON

N

N

HO

O (D) 100 mg

MM 0542.03 Imp. C (EP): 1H-1,2,4-Triazole-3-carboxylic Acid

NNH

NHO

O (D) 100 mg




MM 0542.04 Imp. D (EP): 1H-1,2,4-Triazole-3-carboxamide

NNH

NH2N

O (D) 100 mg

MM 0542.05 1-(5-O-Benzoyl-�-D-ribofuranosyl)-1H-1,2,4- triazole-3-carboxamide (5'-O-Benzoylribavirin)

O

OHOH

ON

N

N

O

H2N

O (D) 100 mg

MM 0542.06 Imp. F (EP): 1-(5-O-Acetyl--D-ribofuranosyl)-1H-1,2,4-triazole-3-carboxamide (5'-O-Acetylribavirin)

O

OHOH

ON

N

N

O

H2N

O (D) 100 mg

Riboflavin MM 0030.00 Riboflavin

N

N

NH

N

O

O

HO OH

OH

OH

(A) 500 mg

Rifampicin MM 0514.02 3-Formylrifamycin Isonicotinylhydrazone

O

OH

OH

OO

HN

O

O

OH

O

O

N

HN

OH

OH

O

Non request

Risedronate Sodium 2.5 Hydrate New MM 0777.00 Risedronate Sodium 2.5 Hydrate

NP

O

PO

HOOH

x 2,5 H2O

OH

OH

ONa

(A) 100 mg

Risperidone MM 0491.00 Risperidone

N

N

O

N

N O

F

(A) 100 mg

MM 0491.01 Imp. A (EP): 3-[2-[4-[(E)-(2,4-Difluorophenyl)- (hydroxyimino)methyl]piperidin-1-yl]ethyl]-2- methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]- pyrimidin-4-one

N

N

O

N

N

F

FHO

(D) 100 mg

MM 0491.02 Imp. B (EP): 3-[2-[4-[(Z)-(2,4-Difluorophenyl)- (hydroxyimino)methyl]piperidin-1-yl]ethyl]-2- methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]- pyrimidin-4-one

N

N

O

N

N

F

FOH

(A) 100 mg

MM 0491.03 Imp. C (EP): (9RS)-3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl]-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one (9-Hydroxyrisperidone)

N

N

O

N

N O

F

OH (D) 100 mg

MM 0491.04 Imp. D (EP): 3-[2-[4-(5-Fluoro-1,2-benzisoxazol- 3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9- tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one

N

N

O

N

N O

F (D) 100 mg

MM 0491.05 Imp. E (EP): (6RS)-3-[2-[4-(6-Fluoro-1,2- benzisoxazol-3-yl)piperidin-1-yl]ethyl]-2,6- dimethyl-6,7,8,9-tetrahydro-4H-pyrido- [1,2-a]pyrimidin-4-one

N

N

O

N

N O

F

(D) 50 mg




MM 0491.08 Imp. F (EP): 2-[2-Methyl-4-oxo-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-3-yl]ethyl 4-(6-Fluoro- 1,2-benzisoxazol-3-yl)piperidin-1-carboxylate

O N

N O

FO

N

N

O

(A) 100 mg

MM 0491.10 Imp. H (EP): 3-[2-[4-(2,4-Difluorobenzoyl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydro-4H-pyrido-[1,2-a]pyrimidin-4-one

N

N

O

N

O

F

F

(A) 100 mg

MM 0491.09 3-[2-[4-(4-Fluoro-2-hydroxybenzoyl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydro-4H-pyrido-[1,2-a]pyrimidin-4-one

N

N

O

N

O

F

OH

(A) 100 mg

MM 0491.13 Imp. L (EP) as Hydrochloride: 3-(2-Chloroethyl)- 2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]- pyrimidin-4-one Hydrochloride (Risperidone Piperidopyrimidinone Intermediate Hydrochloride)

N

N

O

Clx HCl

(A) 100 mg

New MM 0491.18 3-[2-[4-[2-Fluoro-4-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl]benzoyl]piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydro-4H-pyrido-[1,2-a]-pyrimidin-4-one

N

N

O

N

O

N

F

NO

F (D) 50 mg

Ritodrine Hydrochloride MM 0063.06 Imp. A (BP): Tyramine

HO

NH2 (B) 100 mg

Ritonavir New MM 1034.00 Ritonavir

O

N NH

N

S

HN

O

NH

O

O

N

S

OH

on request

Ronidazole MM 1026.01 (1-Methyl-5-nitroimidazol-2-yl)methanol

N

NO2N OH

(A) 100 mg

Rosiglitazone Maleate MM 0522.01 Rosiglitazone Maleate N

NO

NHS

O

O O

OH

OH

O

x

(D) 100 mg

Rosuvastatin Calcium New MM 0936.01 4-(4-Fluorophenyl)-6-isopropyl-

2-[methyl(methylsulfonyl)amino]pyrimidine-5-carbaldehyde

N N

NS

O O

FO

(A) 100 mg

New MM 0936.02 4-(4-Fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidine-5-methanol

N N

NS

O O

FHO

(A) 100 mg




Roxatidine Acetate Hydrochloride New MM 0597.03 N-[3-[3-[(Piperidin-1-yl)methyl]phenoxy]propan-

1-yl]phthalimide Hydrochloride O N

N

O

O

x HCl

(A) 50 mg

Rutoside Trihydrate MM 0109.03 Imp. C (EP) as Dihydrate: 2-(3,4-Dihydroxyphenyl)-

3,5,7-trihydroxy-4H-1-benzopyran-4-one Dihydrate (Quercetin Dihydrate)

O

HO OH

O

OH

OH

HO x 2 H2O

(A) 100 mg

Saccharin Sodium MM 0818.00 Saccharin Sodium

NNaS

OO

O

(A) 500 mg

Salbutamol Sulphate MM 0381.00 Salbutamol Sulphate

x H2SO4

HO

OH

OHHN

2

(A) 500 mg

MM 0381.02 Imp. B (EP): (1RS)-2-[(1,1-Dimethylethyl)- amino]-1-(4-hydroxyphenyl)ethanol

HO

OHHN

(A) 50 mg

MM 0381.03 Imp. C (EP): (1RS)-2-[(1,1-Dimethylethyl)amino]-1-(4-hydroxy-3-methylphenyl)ethanol

HO

OH HN

(A) 50 mg

MM 0381.05 Imp. E (EP): (1RS)-2-[Benzyl(1,1-dimethylethyl)amino]-1-[4-hydroxy-3-(hydroxymethyl)- phenyl]ethanol

HO

OH

OH

N

(A) 100 mg

MM 0381.07 Imp. G (EP) as Hydrochloride: 2-[Benzyl(1,1-dimethylethyl)amino]-1-[4-hydroxy-3-(hydroxymethyl)phenyl]ethanone Hydrochloride

HO

OH

O

N x HCl

(D) 50 mg

MM 0381.08 4-[2-[(1,1-Dimethylethyl)amino]ethyl]-2- methylphenol

HO

HN (A) 100 mg

MM 0381.10 Imp. J (EP) as Hydrochloride: 2-[(1,1-Dimethyl-ethyl)amino]-1-[4-hydroxy-3-(hydroxymethyl)-phenyl]ethanone Hydrochloride (Salbutamone Hydrochloride)

HO

OH

OHN

x HCl

(D) 50 mg

MM 0381.17 4-[(1RS)-2-(tert-Butylamino)-1-hydroxyethyl]-2- ethylphenol Hydrobromide

HO

OHHN

x HBr

(A) 50 mg

Salicylic Acid MM 0045.00 Salicylic Acid

OH

OH

O (A) 500 mg

MM 0045.01 Imp. A (EP): 4-Hydroxybenzoic Acid HO

O

OH

(B) 100 mg




MM 0045.02 Imp. B (EP): 4-Hydroxyisophthalic Acid HO

OH

O

OH

O (A) 100 mg

MM 0045.11 Imp. C (EP): Phenol

OH

(B) 100 mg

MM 0045.12 Imidazole Salicylate

OH

O

O

NH

HN

(A) 100 mg

MM 0045.13 Choline Salicylate

OH

O

O

NOH

on request

MM 0045.14 N,N-Diethylsalicylamide

OH

N

O (A) 100 mg

Salmeterol Xinafoate New MM 0536.03 Imp. B (EP): (1RS)-1-[4-Hydroxy-3-(hydroxy-

methyl)phenyl]-2-[[6-(2-phenylethoxy)hexyl]- amino]ethanol

HO

OH

OHHN

O

(A) 100 mg

New MM 0536.07 Imp. F (EP): (1RS)-1-(4-Hydroxy-3-methylphenyl)-2-[[6-(4-phenylbutoxy)hexyl]amino]ethanol

HO

OHHN

O

(A) 50 mg

Secnidazole MM 0119.00 Secnidazole

N

NO2N

OH (A) 100 mg

MM 0012.02 2-Methyl-4-nitroimidazole NH

NO2N (B) 100 mg

Selegiline Hydrochloride MM 0656.00 Imp. C (EP) as Hydrochloride: (1RS, 2SR)-2-

Amino-1-phenylpropan-1-ol Hydrochloride (Phenylpropanolamine Hydrochloride)

NH2

OH

and enatiomer

x HCl

(A) 500 mg

Sertraline Hydrochloride MM 0317.01 Sertraline Hydrochloride HN

Cl

Cl

x HCl

(A) 100 mg

MM 0317.00 Sertraline HN

Cl

Cl

(A) 100 mg

MM 0317.05 Imp. B (EP) as Hydrochloride: (1RS,4RS)-N- Methyl-4-phenyl-1,2,3,4-tetrahydronaphthalen- 1-amine Hydrochloride

HN

and enantiomer

x HCl

(A) 100 mg




MM 0317.06 Imp. C (EP) as Hydrochloride: (1RS,4RS)-4- 4-Chlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine Hydrochloride

HN

Cland enantiomer

x HCl

(D) 100 mg

MM 0317.10 Imp. E (EP): (2R)-Hydroxyphenylacetic Acid ((R)-Mandelic Acid)

OH

OH

O (A) 100 mg

MM 0792.03 Imp. E (EP) as Racemate: Hydroxyphenylacetic Acid (Mandelic Acid)

OH

OH

O (A) 100 mg

MM 0317.09 Imp. F (EP) as Racemate: 4-(3,4-Dichlorophenyl)- 3,4-dihydronaphthalen-1(2H)-one (Sertraline Tetralone Derivative)

Cl

Cl

O (A) 100 mg

Sibutramine Hydrochloride New MM 0991.04 Imp. A (Pharmeuropa) as Hydrochloride: (1RS)-

1-[1-(2-Chlorophenyl)cyclobutyl]-N,N,3-trimethyl- butan-1-amine Hydrochloride N

Cl

x HCl

(A) 50 mg

New MM 0991.05 Imp. B (Pharmeuropa) as Hydrochloride: (1RS)- 1-[1-(3-Chlorophenyl)cyclobutyl]-N,N,3-trimethyl- butan-1-amine Hydrochloride N

Cl x HCl

(A) 50 mg

New MM 0991.06 Imp. C (Pharmeuropa) as Hydrochloride: (1RS)- 1-[1-(4-Chlorophenyl)cyclobutyl]-N,N-dimethyl- pentan-1-amine Hydrochloride

ClN

x HCl

(A) 50 mg

MM 0991.02 Imp. D (Pharmeuropa) as Hydrochloride: (1RS)-1-[1-(4-Chlorophenyl)cyclobutyl]- N,3-dimethylbutan-1-amine Hydrochloride (N-Monodesmethylsibutramine Hydrochloride)

ClHN

x HCl

(A) 100 mg

New MM 0991.07 Imp. E (Pharmeuropa): (4-Chlorophenyl)acetonitrile

Cl

N(A) 50 mg

MM 0991.03 Imp. G (Pharmeuropa) as Hydrochloride: (1RS)-1-[1-(4-Chlorophenyl)cyclobutyl]-3-methylbutan- 1-amine Hydrochloride (N,N-Didesmethyl- sibutramine Hydrochloride)

ClNH2

x HCl

(A) 100 mg

MM 0991.09 Imp. H (Pharmeuropa): 2-(4-Chlorophenyl)-2-(prop- 2-en-1-yl)pent-4-enenitrile

Cl

N

(A) 50 mg

MM 0991.10 Imp. I (Pharmeuropa): (1RS)-1-[1-(4-Chlorophenyl)- cyclobutyl]-3-methylbutan-1-ol

ClOH

(A) 50 mg

New MM 0991.11 Imp. J (Pharmeuropa): 1-[1-(4-Chlorophenyl)cyclobutyl]-3-methylbutan-1-one

ClO

(A) 50 mg

Sibutramine Hydrochloride Monohydrate New MM 0991.00 Sibutramine Hydrochloride Monohydrate

ClN

x HClx H2O

(A) 100 mg

Sildenafil Citrate MM 0254.00 Sildenafil Citrate

O

SN

OO

N

N

HNN

N

O

HO

O

OH

O

HO

O

HO

x

(D) 100 mg




MM 0254.09 Sildenafil

O

SN

OO

N

N

HNN

N

O (D) 100 mg

MM 0254.04 Imp. B (Pharmeuropa): 5-[2-Ethoxy-5-[(4- methyl-4-oxidopiperazin-1-yl)sulfonyl]phenyl]- 1-methyl-3-propyl-6,7-dihydro-1Hpyrazolo- [4,3-d]pyrimidin-7-one (Sildenafil N-Oxide)

O

SN

OO

N

N

HNN

N

O

O

(A) 100 mg

MM 0254.22 Imp. C (Pharmeuropa): 5-[2-Hydroxy-5-[(4- methylpiperazin-1-yl)sulfonyl]phenyl]-1- methyl-3-propyl-6,7-dihydro-1H-pyrazolo- [4,3-d]pyrimidin-7-one (Desethylsildenafil)

OH

SN

OO

N

N

HNN

N

O (D) 100 mg

MM 0254.06 Imp. D (Pharmeuropa): 4-Ethoxy-3-(1-methyl- 7-oxo-3-propyl-6,7-dihydro-1Hpyrazolo[4,3-d]- pyrimidin-5-yl)benzenesulfonic Acid (3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H- pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxy- benzenesulfonic Acid)

O

SHO

OO

N

HNN

N

O on request

MM 0254.01 4-[[2-Ethoxy-5-[(4-methyl-1-piperazinyl)-sulfonyl]benzoyl]amino]-1-methyl-3-propyl-1H-pyrazole-5-carboxamide

O

SN

OO

N

NH

H2NN

N

O

O

(A) 100 mg

MM 0254.02 2-Ethoxy-5-[(4-methyl-1-piperazinyl)sulfonyl]benzoic Acid

O

SN

OO

N

OH

O (A) 100 mg

MM 0254.05 4-Amino-1-methyl-3-propyl-1H-pyrazole-5-carboxamide

H2N

H2NN

N

O (A) 100 mg

MM 0254.08 1-[[3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl]piperazine (Desmethylsildenafil)

O

SN

OO

HN

N

HNN

N

O (D) 100 mg

MM 0254.11 3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxy-N-[2-(methylamino)ethyl]- benzenesulfonamide

SNH

O O

NHO

N

HNN

N

O on request

MM 0254.21 2-Ethoxy-5-(4-methylpiperazine-1-sulfonyl)benzaldehyde (1-[(4-Ethoxy-3-formylphenyl)sulfonyl]-4-methylpiperazine)

O

SN

OO

N

O (A) 100 mg

New MM 0254.29 5-(2-Ethoxyphenyl)-1-methyl-3n-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one

O

N

HNN

N

O (A) 100 mg

Silybin MM 0472.00 Silybin

OHO

OH O

OH

O

O

OH

O

OH on request

Simvastatin MM 0158.00 Simvastatin

HO O

O

O

OH

(A) 100 mg




MM 0158.01 Imp. A (EP) as Sodium Salt: (3R,5R)-7- [(1S,2S,6R,8S,8aR)-8-[(2,2-Dimethylbutanoyl)oxy]- 2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphthalen- 1-yl]-3,5-dihydroxyheptanoic Acid Sodium Salt (Tenivastatin Sodium Salt; Simvastatin Hydroxy Acid Sodium Salt)

HO O

OH

OH

O

ONa

(A) 100 mg

MM 0158.02 Imp. B (EP): (1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-(Acetyloxy)-6-oxotetrahydro-2H-pyran-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-Dimethylbutanoate (Simvastatin Acetate Ester)

HO O

O

O

O

O

(A) 100 mg

MM 0158.03 Imp. C (EP): (1S,3R,7S,8S,8aR)-3,7-Dimethyl-8-[2-[(2R)-6-oxo-3,6-dihydro-2H-pyran-2-yl]ethyl]-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-Dimethylbutanoate (Anhydrosimvastatin)

HO O

O

O (A) 100 mg

MM 0050.00 Imp. E (EP): Lovastatin

HO O

O

O

OH

(A) 100 mg

Sodium Benzoate MM 0730.00 Sodium Benzoate

ONa

O (A) 500 mg

Sodium Cromoglicate MM 0039.00 Sodium Cromoglicate

O O

OH

O O

OO

NaO

O

ONa

O (A) 500 mg

MM 0039.03 Imp. A (EP): 1-(2,6-Dihydroxyphenyl)ethanone (2',6'-Dihydroxyacetophenone)

OH

OH

O

(B) 100 mg

MM 0039.04 Imp. B (EP): Diethyl 5,5'-[(2-hydroxypropane- 1,3-diyl)dioxy]bis(4-oxo-4H-1-benzopyran-2- carboxylate) (Ethyl Cromoglicate)

O O

OH

O O

OO

O

O

O

O (A) 100 mg

MM 0039.01 Succinophenone; Diphenacyl O

O

(A) 100 mg

MM 0039.02 1,3-Bis(2-acetyl-3-hydroxyphenoxy)-2-propanol

O O

OH

HO OH

OO

(A) 100 mg

Sodium Cyclamate MM 0678.05 Cyclamic Acid H

NS

OH

O O

(A) 100 mg

MM 0093.17 Imp. B (EP) as Hydrochloride: Aniline Hydrochloride (Phenylamine Hydrochloride)

NH2

x HCl(B) 100 mg

MM 0678.03 Imp. C (EP): Cyclohexanamine NH2 (C) 100 mg

MM 0678.04 Imp. D (EP): N-Cyclohexylcyclohexanamine HN (C) 100 mg

Sodium Fluoride MM 0734.00 Sodium Fluoride NaF (A) 500 mg




Sodium Picosulfate MM 0054.00 Sodium Picosulfate

N

O OSS

NaO ONa

O O O O

(A) 500 mg

MM 0054.01 Imp. A (EP): 4-[(RS)-(4-Hydroxyphenyl)- (pyridin-2-yl)methyl]phenyl Sodium Sulphate (4-[(Pyridin-2-yl)(4-hydroxyphenyl)methyl]- phenyl Sodium Sulphate) N

HO OS

ONa

O O

(A) 100 mg

MM 0031.01 Imp. B (EP): 4,4'-[(Pyridin-2-yl)methylene]- diphenol (4,4'-(Pyridin-2-ylmethylene)diphenol)

N

HO OH (A) 100 mg

MM 0054.02 Imp. C (EP): 2-[(RS)-(Pyridin-2-yl)[4-(sulphonatooxy)phenyl]methyl]phenyl Disodium Sulphate (2,4'-[(Pyridin-2-yl)-methylene]bisphenyl Bis- (Sodium Sulphate)) N

O

OS

SONa

NaO

O O

O O

(D) 50 mg

MM 0031.04 2,4'-[(Pyridin-2-yl)methylene]bisphenol (2-[(RS)-(4-Hydroxyphenyl)(pyridin-2-yl)methyl]phenol)

N

HO

OH

(A) 50 mg

Sodium Thiophene-2-carboxylate MM 1081.00 Sodium Thiophene-2-carboxylate

SONa

O (A) 250 mg

Sorbic Acid MM 0954.00 Sorbic Acid O

OH

(A) 500 mg

Sotalol Hydrochloride MM 0046.00 Sotalol Hydrochloride

NH

HN

SO O

OH

x HCl

(A) 100 mg

MM 0046.01 Imp. A (EP) as Hydrochloride: N-[4-[2- [(1-Methylethyl)amino]ethyl]phenyl]- methanesulphonamide Hydrochloride N

H

HN

SO O x HCl

(A) 100 mg

MM 0046.02 Imp. B (EP) as Hydrochloride: N-[4-[[(1- Methylethyl)amino]acetyl]phenyl]- methanesulphonamide Hydrochloride

NH

HN

SO O

O

x HCl

(A) 100 mg

MM 0046.03 Imp. C (EP):N-(4-Formylphenyl)methanesulphonamide

NH

SO O

O (A) 100 mg

Spironolactone MM 0197.00 Spironolactone

O S

O

O

O (A) 500 mg

New MM 0197.01 Imp. F (EP): (2'R)-3',4'-Dihydro-5'H-spiro[androst- 4,6-diene-17,2'-furan]-3,5'-dione (Canrenone)

O

O

O (A) 100 mg




Stavudine New MM 0534.00 Stavudine

O

HON

HN

O

O (A) 100 mg

MM 0534.01 Imp. A (EP): 5-Methylpyrimidine-2,4(1H,3H)-dione (Thymine)

NH

HN

O

O (A) 100 mg

MM 0534.03 Imp. C (EP): 1-(2-Deoxy--D-erythro-pentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione (Thymidine)

O

HON

HN

O

O

OH

(A) 100 mg

Strychnine Nitrate MM 0658.00 Strychnine Nitrate

N

N

O O

H

H

H

x HNO3

(A) 500 mg

MM 0658.02 Strychnine N-Oxide Hydrochloride

N

N

O O

H

H

H

x HCl

O on request

Sulfacetamide MM 0579.00 Sulfacetamide

H2N

SNH

OO O (A) 500 mg

Sulfacetamide Sodium MM 1087.00 Sulfacetamide Sodium Monohydrate

H2N

SN

OO

x H2O

O

Na

(A) 500 mg

MM 0227.05 Imp. A (EP): Sulfanilamide S

NH2

O O

H2N

(A) 100 mg

Sulfadiazine MM 0623.00 Sulfadiazine

S

H2N

NH

OO

N

N (A) 500 mg

MM 0623.03 Imp. A (Pharmeuropa): Pyrimidin-2-amine

H2N N

N (A) 100 mg

MM 0227.04 Imp. B (Pharmeuropa): 4-Aminobenzenesulfonic Acid (Sulphanilic Acid)

S

H2N

OH

OO (A) 100 mg

MM 0227.05 Imp. D (Pharmeuropa): 4-Aminobenzenesulfonamide (Sulfanilamide)

S

H2N

NH2

OO (A) 100 mg

MM 0623.02 Imp. E (Pharmeuropa): N-[4-(Pyrimidin-2-ylsulfamoyl)- phenyl]acetamide (Acetylsulfadiazine) S

NH

OO

N

N

NH

O

(A) 50 mg

New MM 0623.07 N-[(4-Aminophenyl)sulfonyl]-N-(pyrimidin-2-yl)acetamide (Acetylsulfadiazine) S

H2N

N

OO

N

N

O

(A) 50 mg




Sulfadimidine MM 0581.00 Imp. A (Pharmeuropa): 4-Amino-N-(4-methyl-2-

pyrimidyl)benzenesulphonamide (Sulfamerazine)

H2N

SNH

O O

N

N

(A) 500 mg

MM 623.00 Imp. B (Pharmeuropa): 4-Amino-N-pyrimidin-2- ylbenzenesulphonamide (Sulfadiazine)

H2N

SNH

O O

N

N (A) 500 mg

MM 0883.00 Imp. C (Pharmeuropa): (4-Aminophenylsulphonyl)- guanidine (Sulfaguanidine)

H2N

SNH

O O

NH2

NH (A) 100 mg

MM 0227.05 Imp. D (Pharmeuropa): 4-Aminobenzenesulphonamide (Sulfanilamide)

H2N

SNH2

O O (A) 100 mg

MM 0579.00 Imp. E (Pharmeuropa): N-[(4-Aminophenyl)sulfonyl]- acetamide (Sulfacetamide)

H2N

SNH

O O O (A) 500 mg

MM 0227.04 Imp. F (Pharmeuropa): 4-Aminobenzenesulphonic Acid (Sulphanilic Acid)

H2N

SOH

O O (A) 100 mg

Sulfadimethoxine Sodium MM 1020.00 Sulfadimethoxine Sodium

S

H2N

NNa

OO NN

O

O

(A) 500 mg

Sulfafurazole MM 0583.00 Sulfafurazole

H2N

SNH

OO O N (A) 500 mg

Sulfaguanidine MM 0883.00 Sulfaguanidine

H2N

SNH

O O

NH2

NH (A) 100 mg

MM 0227.05 Imp. A (EP): 4-Aminobenzenesulphonamide (Sulphanilamide)

H2N

SNH2

O O (A) 100 mg

MM 0883.02 Imp. B (EP): N-[(4-Aminophenyl)sulphonyl]urea (Sulphacarbamide)

H2N

SNH

O O

NH2

O (A) 50 mg

Sulfamerazine MM 0581.00 Sulfamerazine

N

NNH

S

H2N

OO

(A) 500 mg

MM 0227.05 Sulphanilamide NH2

S

H2N

OO (A) 100 mg

Sulfamethoxazole MM 0227.00 Sulfamethoxazole

NH

S

H2N

O O

NO

(A) 500 mg




MM 0227.01 Imp. A (EP): N-[4-[(5-Methylisoxazol-3-yl)-sulphamoyl]phenyl]acetamide

NH

SO O

NO

NH

O

(A) 100 mg

MM 0227.03 Imp. B (EP): 4-[[(4-Aminophenyl)sulphonyl]amino]-N-(5-methylisoxazol-3-yl)benzenesulphonamide

NH

SN

O

NH

S

H2N

O O

O O

(A) 100 mg

MM 0227.02 Imp. C (EP): 5-Methylisoxazol-3-amine

H2N NO

(B) 100 mg

MM 0227.04 Imp. D (EP): 4-Aminobenzenesulphonic Acid (Sulphanilic Acid) OH

S

H2N

O O (A) 100 mg

MM 0227.05 Imp. E (EP): 4-Aminobenzenesulphonamide (Sulphanilamide) NH2

S

H2N

O O (A) 100 mg

Sulfamethylphenazole MM 1108.00 Sulfamethylphenazole

NH

S

H2N

NN

O O(A) 100 mg

Sulfaquinoxaline Sodium MM 0702.00 Sulfaquinoxaline Sodium

N

NNaN

SO O

NH2 on request

Sulfasalazine MM 0045.00 Imp. H (EP): Salicylic Acid

HO

O OH

(A) 500 mg

Sulfathiazole MM 0578.00 Sulfathiazole N

SNH

SOO

H2N

(A) 500 mg

Sulindac MM 0624.00 Sulindac

OH

F

S

O

O

(A) 500 mg

Sulpiride MM 0051.00 Sulpiride

NNH

O

SO

O

H2N

O

(A) 500 mg

MM 0051.01 Imp. A (EP): [(2RS)-1-Ethylpyrrolidin-2-yl]methanamine N

H2N

(A) 100 mg

MM 0051.02 Imp. B (EP): Methyl 2-Methoxy-5-sulphamoylbenzoate O

O

S

O

O

H2N

O

(A) 100 mg

MM 0051.03 Imp. C (EP): Ethyl 2-Methoxy-5-sulphamoylbenzoate O

O

S

O

O

H2N

O

(A) 100 mg

MM 0051.04 Imp. D (EP): 2-Methoxy-5-sulphamoylbenzoic Acid OH

O

S

O

O

H2N

O

(A) 100 mg




MM 0051.05 Imp. E (EP): 2-Methoxy-5-sulphamoylbenzamide NH2

O

S

O

O

H2N

O

(A) 100 mg

MM 0051.06 Imp. F (EP): 1-Ethyl-2-[[(2-methoxy-5- sulphamoylbenzoyl)amino]methyl]pyrrolidine 1-Oxide (Sulpiride N-Oxide)

NNH

O

S

O

ONH2

O

O(A) 100 mg

MM 0051.07 Imp. G (EP): (RS)-N-[(1-Ethylpyrrolidin-2-yl)methyl]-2-hydroxy-5-sulphamoylbenzamide N

NH

O

SO

O

H2N

OH

(A) 100 mg

MM 0051.08 5-Sulphamoylsalicylic Acid OH

O

S

O

O

H2N

OH

(A) 100 mg

MM 0051.09 5-Sulphosalicylic Acid Dihydrate OH

O

S

O

O

HO

OH

x 2 H2O

(C) 100 mg

Sumatriptan Succinate New MM 0310.04 Imp. D (EP) as Maleate: N,N-Dimethyl-

2-[5-[(methylsulfamoyl)methyl]-1H-indol- 3-yl]ethanamine N-Oxide Maleate

HN

SNH

N

O

O OO

OH

O

OHx

(A) 100 mg

New MM 0310.05 Imp. E (EP): [3-(2-Aminoethyl)-1H-indol-5-yl]- N-methylmethanesulfonamide

HN

SNH

NH2

O O(A) 100 mg

Suplatast Tosilate MM 0722.01 Methyl Toluene-4-sulphonate

SO

OO (B) 100 mg

Tamoxifen Citrate MM 0053.00 Tamoxifen Citrate

ON

O

HO

O

HO O

OH

HOx

(A) 100 mg

MM 0053.02 Imp. B (EP): 1-[4-(2-Dimethylaminoethoxy)phenyl]-1,2-diphenylbutan-1-ol O

N

OH

(A) 100 mg

MM 0053.14 Imp. C (EP) Z-Isomer: 2-[4-[(Z)-1,2-Diphenyl-ethenyl]phenoxy]-N,N-dimethylethanamine O

N

on request

MM 0053.15 Imp. C (EP) E-Isomer: 2-[4-[(E)-1,2-Diphenylethenyl]phenoxy]-N,N-dimethylethanamine

ON (A) 50 mg

MM 0053.16 Imp. D (EP) Z-Isomer: 2-[4-[(Z)-1,2-Diphenylprop-1-enyl]phenoxy]-N,N-dimethylethanamine O

N

(A) 50 mg




MM 0053.17 Imp. D (EP) E-Isomer: 2-[4-[(E)-1,2-Diphenylprop-1-enyl]phenoxy]-N,N-dimethylethanamine

ON on request

MM 0053.05 Imp. E (EP):2-[2-[(EZ)-1,2-Diphenylbut-1-enyl)phenoxy]-N,N-dimethylethanamine

ON

(A) 100 mg

MM 0053.12 Imp. F (EP) as Hydrochloride: 2-[4-[(Z)-1,2-Diphenylbut-1-enyl]phenoxy]-N-methylethanamine Hydrochloride O

NH

x HCl

(A) 100 mg

MM 0053.07 Imp. G (EP): (2RS)-1-[4-[2-(Dimethylamino)ethoxy]phenyl]-2-phenylbutan-1-one O

N

O

(A) 100 mg

MM 0053.08 1,2-Diphenylbutan-1-one

O

(A) 100 mg

MM 0053.09 1-(4-Methoxyphenyl)-1,2-diphenylbutan-1-ol O

OH

(A) 100 mg

MM 0053.10 (EZ)-1-(4-Hydroxyphenyl)-1,2-diphenylbut-1-ene OH

(C) 50 mg

MM 0053.18 Tamoxifen N-Oxide O

NO

(A) 100 mg

Tamsulosin Hydrochloride MM 0938.00 Tamsulosin Hydrochloride

O

O

HN

O

SNH2

OO

x HCl

(D) 100 mg

MM 0938.02 Imp. A (EP) as Hydrochloride: 5-[(2R)-2- [Bis[2-(2-ethoxyphenoxy)ethyl]amino]- propyl]-2-methoxybenzenesulfonamide Hydrochloride

O

ON

O

SNH2

OOx HCl

O

O (A) 100 mg

MM 0938.03 Imp. B (EP): 5-[(2R)-2-Aminopropyl]-2-methoxybenzenesulfonamide

H2N

O

SNH2

OO (A) 100 mg

MM 0938.04 Imp. C (EP) as Hydrochloride: 2-Methoxy-5-[(2R)-2-[(2-phenoxyethyl)amino]propyl]benzenesulfonamide Hydrochloride

O

HN

O

SNH2

OO

x HCl

(A) 100 mg

MM 0938.05 Imp. D (EP) as Hydrochloride: 2-Methoxy- 5-[(2R)-2-[[2-(2-methoxyphenoxy)ethyl]- amino]propyl]benzenesulfonamide Hydrochloride

O

O

HN

O

SNH2

OO

x HCl

(A) 100 mg

MM 0938.06 Imp. E (EP): 5-Formyl-2-methoxybenzene- Sulfonamide O

O

SNH2

OO (A) 50 mg




MM 0938.07 Imp. F (EP) as Hydrochloride: 2-(2-Ethoxy- phenoxy)ethanamine Hydrochloride

O

ONH2 x HCl

(A) 100 mg

New MM 0938.10 Imp. G (EP) as Racemate Hydrochloride: 5-[(2RS)-2-[[2-(2-Ethoxyphenoxy)ethyl]- amino]propyl]-2-methoxybenzenesulfonamide Hydrochloride (Tamsulosin Racemate Hydrochloride)

O

O

HN

O

SNH2

OO

x HCl

(A) 50 mg

MM 0938.01 Imp. H (EP) as Racemate Hydrochloride: (2RS)-N-[2-(2-Ethoxyphenoxy)ethyl]-1-(4-methoxyphenyl)propan- 2-amine Hydrochloride

O

O

HN

O

x HCl

(A) 100 mg

MM 0938.09 Imp. I (EP): 1-(2-Bromoethoxy)-2-ethoxybenzene

O

OBr

(A) 100 mg

Telmisartan New MM 0939.01 Imp. A (EP): 4-Methyl-6-(1-methyl-1H-benz-

imidazol-2-yl)-2-propyl-1H-benzimidazole

NH

N

NN

(A) 100 mg

New MM 0939.10 Methyl 4'-(Bromomethyl)biphenyl-2-carboxylate BrO O (A) 100 mg

Temazepam MM 0087.00 Temazepam [Controlled Substance]

N

NO

Cl

OH

on request

MM 0023.01 Imp. A (EP): [5-Chloro-2-(methylamino)- phenyl]phenylmethanone (5-Chloro-2-(methylamino)benzophenone) Cl

NH

O

(B) 100 mg

MM 0080.00 Imp. B (EP): Oxazepam [Controlled Substance]

N

HN

O

Cl

OH

(D) 100 mg

Tenofovir Disoproxil Fumarate New MM 1329.00 Tenofovir Disoproxil Fumarate

N

N N

N

NH2

OP

OO

O

O

OO

O

OO

OH

HO

O

O

x

on request

Tenoxicam MM 0084.01 Imp. A (EP): Pyridin-2-amine H2N

N

(B) 100 mg

MM 0247.01 Imp. B (EP): Methyl 4-Hydroxy-2-methyl-2H-thieno[2,3-e]1,2-thiazine-3-carboxylate 1,1-Dioxide N

S

OH O

OS

O O (A) 100 mg




MM 0247.04 Imp. C (EP): N-Methylthiophene-2-carboxamide HNS

O

(A) 100 mg

MM 0247.06 Imp. E (EP): 2-Methylthieno[2,3-d]isothiazol-3(2H)-one 1,1-Dioxide

SN

S

O O

O

(A) 100 mg

New MM 0247.10 2-(Methoxycarbonyl)-3-thiophenesulfonyl Chloride

O

ClS

O

S

O O (A) 100 mg

Terazosin Hydrochloride Dihydrate MM 0843.00 Terazosin Hydrochloride Dihydrate

N

NO

O

NH2

N

N

O

O x HClx 2 H2O

(A) 100 mg

MM 0085.04 Imp. A (EP): 2-Chloro-6,7- dimethoxyquinazolin-4-amine N

NO

O

NH2

Cl (A) 100 mg

MM 0843.02 Imp. B (EP): 1-(4-Hydroxy- 6,7-dimethoxyquinazolin-2-yl)-4-[[(2RS)- tetrahydrofuran-2-yl]carbonyl]piperazine

N

NO

O

OH

N

N

O

O

(A) 100 mg

MM 0085.01 Imp. C (EP): 6,7-Dimethoxy- 2-(piperazin-1-yl)quinazolin-4-amine

N

NO

O

NH2

N

NH (A) 100 mg

MM 0843.04 Imp. D (EP) as Hydrochloride: 1-(4-Amino-6,7- dimethoxyquinazolin-2-yl)-4-formylpiperazine Hydrochloride

N

NO

O

NH2

N

N

O

x HCl

(A) 100 mg

MM 0085.03 Imp. E (EP): 2,2'-(Piperazine-1,4-diyl)bis(6,7- dimethoxyquinazolin-4-amine)

N

NO

O

NH2

N

N N

N

NH2

O

O

(D) 100 mg

MM 0085.00 Imp. K (EP) as Hydrochloride: Prazosin Hydrochloride

N

NO

O

NH2

N

N

O

O x HCl

(A) 100 mg

MM 0085.02 Imp. L (EP): 1-(Furan-2-ylcarbonyl)piperazine

HN

N

O

O

(A) 100 mg

MM 0085.05 Imp. M (EP): 1,4-Bis(furan-2- ylcarbonyl)piperazine

N

N

O

O

O

O

(A) 100 mg

MM 0843.15 Imp. N (EP): 1-[[(2RS)-Tetrahydrofuran-2-yl]carbonyl]piperazine

HN

N

O

O

(A) 100 mg

MM 0843.16 Imp. O (EP): 1,4-Bis[(tetrahydrofuran-2-yl)carbonyl]piperazine

N

N

O

O

O

O

(A) 100 mg




Terbinafine Hydrochloride MM 0696.00 Terbinafine Hydrochloride

x HClN

(A) 100 mg

MM 0696.02 Imp. A (EP) as Hydrochloride: N-Methyl-C-(naphthalen-1-yl)methanamine Hydrochloride (Secundary Amine Hydrochloride)

x HClNH

(A) 100 mg

MM 0696.03 Imp. B (EP) as Hydrochloride: (2Z)-N,6,6-Trimethyl-N-(naphthalen-1-ylmethyl)hept-2-en-4-yn-1-amine Hydrochloride (cis-Terbinafine Hydrochloride)

x HClN

(D) 100 mg

MM 0696.04 Imp. C (EP) as Hydrochloride: (2E)-N,6,6-Trimethyl-N-(naphthalen-2-ylmethyl)hept-2-en-4-yn-1-amine Hydrochloride (trans-iso-Terbinafine Hydrochloride)

Nx HCl

(D) 100 mg

MM 0696.05 Imp. D (EP) as Hydrochloride: (2E)-N,6,6-Trimethyl-N-[(4-methylnaphthalen-1-yl)methyl]hept-2-en-4-yn-1-amine Hydrochloride (4-Methylterbinafine Hydrochloride

x HClN

(D) 100 mg

MM 0696.07 N-Demethylterbinafine Hydrochloride x HClN

H

(D) 50 mg

New MM 0696.10 Imp. F (EP) as Hydrochloride: (2Z)-N,6,6-Trimethyl-N-(naphthalen-2-ylmethyl)hept-2-en-4-yn-1-amine Hydrochloride (cis-Iso-terbinafine Hydrochloride)

x HClN

(D) 50 mg

Terbutaline Sulphate MM 0708.01 Imp. A (EP): 3,5-Dihydroxybenzoic Acid (-Resorcylic Acid)

HO

OH

OH

O (B) 100 mg

MM 0708.03 Imp. B (EP) as Hemisulphate: (4RS)-2-(1,1-Dimethylethyl)-1,2,3,4-tetrahydroisoquinoline-4,6,8-triol Hemisulphate

HO

OH

OH

x 1/2 H2SO4N

(D) 100 mg

Terfenadine MM 0055.00 Terfenadine

OH

N

OH

(A) 500 mg

MM 0055.04 Imp. A (EP): 1-[4-(1,1-Dimethylethyl)phenyl]-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]butan-1-one (Terfenadone)

OH

N

O

(A) 100 mg

MM 0055.07 Imp. B (EP): (1RS)-1-[4-(1,1-Dimethylethyl)phenyl]-4-[4-(diphenylmethyl)piperidin-1-yl]butan-1-ol

N

OH

(A) 100 mg

MM 0055.12 Imp. E (EP) as Hydrochloride: 1-[(4RS)-4-[4-(1,1-Dimethylethyl)phenyl]-4-hydroxybutyl]piperidine-4-carboxylic Acid Hydrochloride HO

N

OH

O x HCl

(A) 100 mg




MM 0055.09 Imp. G (EP): [1-[4-[4-(1,1-Dimethylethyl)- phenyl]but-3-enyl]piperidin-4- yl]diphenylmethanol

OH

N

(A) 100 mg

MM 0055.10 Imp. H (EP): [1-[4-[4-(1,1-Dimethylethyl)phenyl]butyl]piperidin-4-yl]diphenylmethanol

OH

N

(A) 100 mg

MM 0055.02 Imp. I (EP): Diphenyl(piperidin-4-yl)methanol (Azacyclonol)

OH

NH (B) 100 mg

MM 0055.03 Imp. J (EP): Ethyl 1-[(4RS)-4-[4-(1,1-Dimethylethyl)phenyl]-4-hydroxybutyl]-piperidine-4-carboxylate

O

N

OH

O

(A) 100 mg

Testosterone MM 0323.00 Testosterone

O

OH (A) 500 mg

MM 0323.01 Imp. A (EP): Androst-4-ene-3,17-dione (Androstenedione)

O

O (A) 100 mg

MM 0323.02 Imp. B (EP): 3-Ethoxyandrosta-3,5-dien-17-one (Androstenedione Ethylenolether)

O

O (A) 100 mg

MM 0323.03 Imp. C (EP): 17-Hydroxyandrost-4-en-3-one (Epitestosterone)

O

OH (A) 100 mg

MM 0323.04 Imp. D (EP): Androst-4-ene-3,17-diol (4-Androstenediol)

HO

OH (A) 100 mg

MM 0323.05 Imp. E (EP): 3-Oxoandrost-4-en-17-yl Acetate (Testosterone Acetate)

O

O

O (A) 100 mg

MM 0565.00 Imp. F (EP): 17-Hydroxy-5-androstan-3-one (Androstanolone, Stanolone)

O

OH

H

(A) 250 mg

MM 0323.07 Imp. G (EP): Androsta-1,4-diene-3,17-dione (Androstadienedione)

O

O (A) 100 mg

MM 0864.00 Imp. H (EP): 17-Hydroxyandrosta-1,4-dien-3-one (Boldenone)

O

OH (A) 100 mg




MM 0323.12 Imp. I (EP): 17-Hydroxyandrosta-4,6-dien-3-one (6-testosterone)

O

OH (A) 100 mg

MM 0323.13 Imp. J (EP): 3-Methoxyandrosta-3,5-dien- 17-one (Androstenedione Methylenolether)

O

O (A) 100 mg

Testosterone Benzoate MM 0493.00 Testosterone Benzoate

O

O

O (D) 250 mg

MM 0323.00 Testosterone

O

OH (A) 500 mg

MM 0278.01 Benzoic Acid OH

O (B) 100 mg

Testosterone Enantate MM 1119.00 Testosterone Enantate

O

O

O (A) 100 mg

MM 0863.08 Imp. B (EP): 3-Oxoandrost-4-en-17-yl Hexanoate (Testosterone Caproate)

O

O

O (A) 100 mg

MM 0323.00 Imp. D (EP): 17-Hydroxyandrost-4-en-3-one (Testosterone)

O

OH (A) 500 mg

Testosterone Isocaproate MM 0863.00 Testosterone Isocaproate

O

O

O (A) 100 mg

MM 0323.00 Imp. A (EP): Testosterone

O

OH (A) 500 mg

MM 0323.05 Imp. B (EP): 3-Oxoandrost-4-en-17-yl Acetate (Testosterone Acetate)

O

O

O (A) 100 mg

MM 0897.00 Imp. C (EP): Testosterone Propionate

O

O

O (A) 100 mg




MM 0863.07 Imp. D (EP): 3-Oxoandrost-4-en-17-yl 2-Methylpropanoate(Testosterone Isobutyrate)

O

O

O (A) 100 mg

MM 0863.08 Imp. E (EP): 3-Oxoandrost-4-en-17-yl Hexanoate (Testosterone Caproate)

O

O

O (A) 100 mg

MM 1119.00 Imp. F (EP): Testosterone Enantate

O

O

O (A) 100 mg

MM 0863.09 Imp. G (EP): 3-Oxoandrost-4-en-17-yl 4-Methylpentanoate (Epitestosterone Isocaproate)

O

O

O (A) 100 mg

Testosterone Propionate MM 0897.00 Testosterone Propionate

O

O

O (A) 100 mg

MM 0323.05 Imp. A (EP): 3-Oxoandrost-4-en-17-yl Acetate (Testosterone Acetate) O

O

O (A) 100 mg

MM 0863.07 Imp. B (EP): 3-Oxoandrost-4-en-17-yl 2-Methyl- propanoate (Testosterone Isobutyrate) O

O

O (A) 100 mg

MM 0323.00 Imp. C (EP): Testosterone OH

O

(A) 500 mg

MM 0897.04 Imp. D (EP): 3-Oxoandrosta-1,4-dien-17-yl Propanoate O

O

O (C) 50 mg

MM 0897.05 Imp. E (EP): 3-Oxoandrosta-4,6-dien-17-yl Propanoate O

O

O (A) 100 mg

Tetracaine Hydrochloride MM 0504.00 Tetracaine Hydrochloride

x HClO

O

NH

N(A) 500 mg

MM 0094.03 Imp. A (EP): 4-Aminobenzoic Acid OH

O

H2N

(B) 100 mg




MM 0504.01 Imp. B (EP): 4-(Butylamino)benzoic Acid OH

O

NH

(A) 100 mg

MM 0504.04 Imp. C (EP): Methyl 4-(Butylamino)benzoate O

O

NH

(A) 100 mg

MM 0504.02 Tetracaine N-Oxide O

O

NH

NO (A) 100 mg

Tetracycline Hydrochloride MM 0452.00 Tetracycline Hydrochloride OH O OH O

NH2

O

OH

OH

N

HH x HCl

HO

(A) 500 mg

Tetramisole Hydrochloride MM 0703.00 Tetramisole Hydrochloride

N

N Sx HCl

(A) 500 mg

Tetrazepam MM 0091.00 Tetrazepam [Controlled Substance]

N

NO

Cl

(A) 100 mg

MM 0091.06 Imp. B (EP): 7-Chloro-5-cyclohexyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one

N

HN

O

Cl

(A) 100 mg

MM 0091.07 Imp. C (EP): 7-Chloro-5-cyclohexyl-1-methyl- 1,3-dihydro-2H-1,4-benzodiazepin-2-one

N

NO

Cl

(A) 100 mg

MM 0091.03 Imp. E (EP): 7-Chloro-5-(cyclohex-1-enyl)-1,3- dihydro-2H-1,4-benzodiazepin-2-one (Nortetrazepam) N

HN

O

Cl

(A) 100 mg

MM 0091.04 6-Chloro-2-methyl-4-oxo-4H-3,1-benzoxazine

Cl

N

O

O

(A) 100 mg

MM 0091.52 2-Bromo-4'-chloro-2'-(cyclohexylcarbonyl)acetanilide

Cl

NH

O

OBr on request

Tetryzoline Hydrochloride MM 0088.00 Tetryzoline Hydrochloride

NHN

x HCl

(A) 100 mg

MM 0088.03 Imp. A (EP): (1RS)-1,2,3,4-Tetrahydronaphthalene-1-carbonitrile (-Cyanotetraline)

N (A) 100 mg

MM 0088.02 1,2,3,4-Tetrahydro-1-naphthalenecarboxylic Acid O OH (A) 100 mg




MM 0088.04 Methyl 1,2,3,4-Tetrahydro-1-naphthalenecarboxylate O O (A) 100 mg

MM 0088.05 N-(2-Aminoethyl)-1,2,3,4-tetrahydronaphthalene-1-yl-carboxamide Hydrochloride ((1,2,3,4-Tetrahydro-1-naphthyl)formyl- ethylenediamine Hydrochloride)

OHN

NH2

x HCl

(A) 100 mg

MM 0088.06 2-(1,2,3,4-Tetrahydro-1-naphthalenyl)-1H-imidazole Hydrochloride NHN

x HCl

(A) 100 mg

Thalidomide MM 0940.00 Thalidomide

N

O

O

NH

O

O

(A) 100 mg

Theobromine MM 0577.00 Theobromine

HN

N N

N

O

O (A) 500 mg

Theophylline MM 0176.00 Theophylline

N

N N

HN

O

O (A) 500 mg

MM 0494.00 Imp. A (EP): Caffeine N

N N

N

O

O

(A) 500 mg

MM 0176.03 Imp. B (EP): 3-Methyl-3,7-dihydro-1H-purine-2,6-dione (3-Methylxanthine) HN

N N

HN

O

O (A) 100 mg

MM 0176.02 Imp. C (EP): N-(6-Amino-1,3-dimethyl-2,4- dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)formamide N

NO

O

NH2

HN

O

(A) 100 mg

MM 0176.01 Imp. D (EP): N-Methyl-5-(methylamino)-1H-imidazole- 4-carboxamide (Theophyllidine) N

H

HN NH

N

O (A) 100 mg

MM 0603.00 Imp. F (EP): Etofylline

N

N N

N

O

OOH (A) 500 mg

MM 0176.04 1-Methylxanthine N

NH

NH

N

O

O on request

MM 0176.05 7-Methylxanthine HN

NH

N

N

O

O (A) 100 mg

Theophylline-Ethylenediamine MM 0494.00 Imp. A (EP): Caffeine

N

N N

N

O

O

(A) 500 mg

MM 0176.03 Imp. B (EP): 3-Methyl-3,7-dihydro-1H-purine-2,6-dione (3-Methylxanthine) HN

N N

HN

O

O (A) 100 mg




MM 0176.02 Imp. C (EP): N-(6-Amino-1,3-dimethyl-2,4- dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)formamide

N

NO

O

NH2

HN

O

(A) 100 mg

MM 0176.01 Imp. D (EP): N-Methyl-5-(methylamino)-1H- imidazole-4-carboxamide (Theophyllidine) N

H

HN NH

N

O (A) 100 mg

MM 0603.00 Imp. F (EP): Etofylline

N

N N

N

O

OOH (A) 500 mg

MM 0577.00 Imp. G (EP): Theobromine HN

N N

N

O

O (A) 500 mg

Thiamazole MM 0889.00 Thiamazole

N

NH

S (A) 500 mg

MM 0889.02 Imp. B (EP): 1-Methyl-1H-imidazole N

N

(B) 100 mg

MM 0889.03 Imp. C (EP): 1-Methyl-2-(methylsulphanyl)-1H-imidazole N

N

S (A) 100 mg

MM 0889.04 Imp. C (EP) as Hydrochloride: 1-Methyl-2-(methylsulphanyl)-1H-imidazole Hydrochloride

N

N

S

x HCl(A) 100 mg

Thiamine Hydrochloride MM 0049.00 Thiamine Hydrochloride (Vitamin B1)

N+ N

N

NH2

S

HO

Cl-

x HCl

(A) 500 mg

MM 0049.05 Imp. E (EP): 3-[(4-Amino-2-methylpyrimidin-5-yl)methyl]-5-(2-hydroxyethyl)-4-methylthiazol-2(3H)-thione (Thioxothiamine)

N N

N

NH2

S

HO

S (A) 100 mg

MM 0049.02 5-(2-Hydroxyethyl)-4-methylthiazole N

S OH

(A) 100 mg

MM 0049.04 4-Amino-5-hydroxymethyl-2-methylpyrimidine Hydrochloride N

N NH2

OHx HCl

(A) 100 mg

Thiamphenicol MM 0737.00 Thiamphenicol

ClNH

O

Cl OH

SOH

OO (A) 500 mg

Thioctic Acid MM 0127.00 Thioctic Acid

S S

OH

O (A) 500 mg

Thioridazine Hydrochloride MM 0116.05 2-Methylthiophenothiazine

NH

S

S

(A) 100 mg

Tiabendazole MM 0602.00 Tiabendazole

N

HN

N

S(A) 500 mg

MM 0602.01 Imp. A (EP): Benzene-1,2-diamine NH2

NH2 (C) 100 mg




Tiamulin Hydrogen Fumarate MM 0394.00 Tiamulin Hydrogen Fumarate

O

H

HO

O

O

SN

OH

O

O

HOx

(A) 100 mg

MM 0460.10 Fumaric Acid OH

HO

O

O (B) 100 mg

MM 0394.04 Imp. A (EP): (3aS,4R,5S,6S,8R,9R,9aR,10R)- 6-Ethenyl-5,8-dihydroxy-4,6,9,10-tetramethyl- octahydro-3a,9-propano-3aH-cyclopentacyclo- octen-1(4H)-one (Mutilin)

O

H

HO

HO(A) 100 mg

New MM 0394.06 Imp. C (EP) as Dihydrochloride: 2,2'-(Disulfane- 1,2-diyl)bis(N,N-diethylethanamine) Dihydrochloride

SS

NN

x 2 HCl

(A) 50 mg

New MM 0394.13 Imp. J (EP): (3aS,4R,5S,6S,8R,9R,9aR,10R)-6-Ethenyl- 5-hydroxy-4,6,9,10-tetramethyl-1-oxo-decahydro-3a,9-propano-3aH-cyclopentacyclo-octen-8-yl Acetate (Mutilin 14-Acetate)

O

H

HO

O

O

(A) 50 mg

MM 0394.18 Imp. P (EP): (3aS,4R,5S,6S,8R,9R,9aR,10R)-6- Ethenyl-5-hydroxy-4,6,9,10-tetramethyl-1-oxodecahydro-3a,9-propano-3aH-cyclopentacyclo- octen-8-yl [(Phenylsulphonyl)oxy]acetate

O

H

HO

O

O

OS

O O (A) 50 mg

Tiapride Hydrochloride New MM 0073.01 Imp. C (EP): N,N-Diethylethane-1,2-diamine

H2NN

(B) 100 mg

New MM 1331.04 N-[2-(Diethylamino)ethyl]-2-hydroxy-5-(methylsulfonyl)benzamide S

O O

OH

NH

O

N

(A) 100 mg

Ticlopidine Hydrochloride MM 0150.00 Ticlopidine Hydrochloride

N

S

x HCl

Cl

(A) 500 mg

MM 0150.12 Imp. A (EP): Thieno[3,2-c]pyridine N

S (A) 100 mg

MM 0150.06 Imp. B (EP): 6,7-Dihydrothieno[3,2-c]pyridin-4(5H)-one HN

S

O

(A) 100 mg

MM 0150.01 Imp. C (EP) as Hydrochloride: (2-Chloro- phenyl)methanamine Hydrochloride NH2 x HCl

Cl

(A) 100 mg

MM 0150.07 Imp. D (EP) as Hydrochloride: 5-Benzyl-4,5,6,7-tetrahydrothieno[3,2-c]pyridine Hydrochloride N

Sx HCl

(A) 100 mg

MM 0150.13 Imp. E (EP) as Chloride: 5-(2-Chlorobenzyl)-thieno[3,2-c]pyridinium Chloride N+

S

Cl-

Cl

(A) 50 mg

New MM 0150.14 Imp. F (EP) as Hydrochloride: 6-(2-Chloro- benzyl)-4,5,6,7-tetrahydrothieno[2,3-c]- pyridine Hydrochloride

N S

Cl

x HCl

(A) 50 mg

MM 0150.08 Imp. G (EP) as Hydrochloride: 5-(3-Chlorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine Hydrochloride N

S

Clx HCl

(A) 100 mg

MM 0150.09 Imp. H (EP) as Hydrochloride: 5-(4-Chlorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine Hydrochloride N

SClx HCl

(C) 50 mg

MM 0150.11 Imp. I (EP) as Hydrochloride: N-(2-Chlorobenzyl)-2-(thiophen-2-yl)ethanamine Hydrochloride NH

S

x HCl

Cl

(A) 100 mg




MM 0150.10 Imp. J (EP) as Dihydrochloride: N,N'-Bis(2-chlorobenzyl)ethane-1,2-diamine Dihydrochloride NH

NH

Clx 2 HCl

Cl

(A) 100 mg

MM 0150.15 Imp. L (EP): 5-(2-Chlorobenzyl)-6,7-dihydrothieno[3,2-c]pyridin-4(5H)-one N

S

OCl

(A) 50 mg

MM 0150.04 5-(2-Chlorobenzoyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine N

S

OCl

(A) 100 mg

Tilidine Hydrochloride Hemihydrate MM 0134.00 Tilidine Hydrochloride Hemihydrate

[Controlled Substance] x HClx 1/2 H2O

OO

N

and enantiomer

(A) 100 mg

MM 0134.01 Imp. A (EP): Ethyl (1RS,2RS)-2-(Dimethylamino)-1-phenylcyclohex-3-enecarboxylate (cis-Tilidine) [Controlled Substance]

OO

N

and enantiomer

(D) 100 mg

MM 0134.03 Imp. D (EP) as Hydrochloride: Ethyl (2RS)-3-Dimethylamino-2-phenylpropanoate Hydrochloride

x HCl

N

O

O

(A) 100 mg

MM 0134.05 Tilidine [Controlled Substance]

OO

N

and enantiomer

(A) 100 mg

Timolol Maleate MM 0440.00 Timolol Maleate O

OH

O

OHx

NS

N N

O

OHHN

O

(A) 250 mg

MM 0440.04 Imp. D (EP): 4-(Morpholin-4-yl)-1,2,5-thiadiazol- 3-ol

NS

N N

OH

O

(A) 100 mg

MM 0440.03 N-Benzyl-tert-butylamine

HN

(B) 100 mg

MM 0440.05 3-Hydroxy-4-morpholino-1,2,5-thiadiazole 1-Oxide NS

N N

OH

O

O(A) 100 mg

MM 0440.02 (S)-Isotimolol

NS

N N

O

O

HO NH

(A) 100 mg

Tinidazole MM 0012.02 Imp. A (EP): 2-Methyl-5-nitro-1H-imidazole

(2-Methyl-4-nitroimidazole) NH

N

O2N (B) 100 mg

Tioconazole New MM 0281.01 Imp. D (EP): (1RS)-1-(2,4-Dichlorophenyl)-2-

(1H-imidazol-1-yl)ethanol

N

N

HO

Cl

Cl (A) 100 mg




Tiotropium Bromide Monohydrate New MM 1293.05 Imp. E (EP): Methyl 2-Hydroxy-2,2-dithiophen-2-ylacetate

O

O

OH

S

S

(A) 100 mg

MM 1293.06 Imp. F (EP): Dithiophen-2-ylmethanone S

S

O

(A) 100 mg

Tizanidine Hydrochloride New MM 0887.04 N-Acetyltizanidine

NS

N

Cl

NH

N

N

O

(A) 50 mg

New MM 0887.05 1-Acetylimidazolidine-2-thione

NH

N

S

O (A) 50 mg

Tolazoline Hydrochloride MM 0585.00 Tolazoline Hydrochloride

HN

Nx HCl

(A) 500 mg

Tolbutamide MM 0325.01 Imp. A (EP): (4-Methylphenyl)sulfonamide

(Toluenesulfonamide; 4-Methylbenzene- sulfonamide)

SNH2

O O (C) 100 mg

Tolnaftate MM 0731.01 Imp. A (EP): Naphthalen-2-ol (-Naphthol)

HO

(A) 100 mg

MM 0731.04 Imp. D (EP): N,3-Dimethylaniline (N-Methyl-m-toluidine)

NH

(A) 100 mg

New MM 0731.03 O-Naphthalen-2-yl Chlorothioformate

Cl O

S (A) 100 mg

Tolmetin Sodium Dihydrate MM 0571.00 Tolmetin Sodium Dihydrate

N ONa

O

O

x 2 H2O

on request

Tolterodine Tartrate New MM 0900.00 Tolterodine Tartrate

N

OH

OH

OH

OH

O

HO

O

x

(A) 100 mg

Topiramate New MM 1348.00 Topiramate

OO

O

OO

OS

NH2

O O (A) 100 mg

Torasemide, Anhydrous New MM 1283.02 Imp. B (EP): 4-[(3-Methylphenyl)amino]-

pyridine-3-Sulfonamide N

NH

SNH2

O O (A) 100 mg




New MM 1283.03 Imp. C (EP): 1-Ethyl-3-[[4-[(3-methylphenyl)amino]- pyridin-3-yl]sulfonyl]urea N

NH

SNH

O O

NH

O (A) 50 mg

New MM 1283.04 Imp. D (EP): 1-Butyl-3-[[4-[(3-methylphenyl)amino]- pyridin-3-yl]sulfonyl]urea N

NH

SNH

O O

NH

O (A) 50 mg

Tramadol Hydrochloride MM 0007.00 Tramadol Hydrochloride

OHO

Nx HCl

and enantiomer

(A) 500 mg

MM 0007.01 Imp. A (EP) as Hydrochloride: (1RS,2SR)- 2-[(Dimethylamino)methyl]-1-(3-methoxyphenyl)- cyclohexanol Hydrochloride

OHO

Nx HCl

and enantiomer

(A) 100 mg

MM 0007.03 Imp. B (EP) as Hydrochloride: [2-(3-Methoxyphenyl)cyclohex-1-enyl]-N,N- dimethylmethanamine Hydrochloride

Nx HCl

O (A) 100 mg

MM 0007.04 Imp. C (EP) as Hydrochloride: (1RS)-[2-(3-Methoxy- phenyl)cyclohex-2-enyl]-N,N-dimethylmethanamine Hydrochloride

Nx HCl

O (A) 100 mg

MM 0007.06 Imp. D (EP) as Hydrochloride: (1RS,2RS)-2- [(Dimethylamino)methyl]-1-(3-hydroxyphenyl)- cyclohexanol Hydrochloride

OHHO

Nx HCl

and enantiomer

(A) 100 mg

MM 0007.02 Imp. E (EP) as Hydrochloride: (2RS)- 2-[(Dimethylamino)methyl]- cyclohexanone Hydrochloride

N x HCl

O (A) 100 mg

MM 0007.05 3-Bromoanisole O Br (B) 100 mg

MM 0007.07 N-Desmethyltramadol Hydrochloride OH

O

NH

and enantiomer

x HCl

(A) 100 mg

MM 0007.08 N,O-Didesmethyltramadol Hydrochloride OH

HO

NH

x HCl

and enantiomer

(A) 100 mg

MM 0007.09 3-Methoxyphenol O OH (B) 100 mg

MM 0007.11 Tramadol N-Oxide OH

O

N

and enantiomer

O

(A) 100 mg

MM 0007.50 [2-(3-Hydroxyphenyl)cyclohex-1-enyl]-N,N-dimethylmethanamine Hydrochloride

Nx HCl

HO (A) 100 mg

Tranexamic Acid MM 0330.00 Tranexamic Acid

OH

O

H2N

(A) 500 mg




MM 0330.04 Imp. D (EP): 4-Aminomethylbenzoic Acid OH

O

H2N

(B) 100 mg

Trazodone Hydrochloride MM 0421.00 Trazodone Hydrochloride

ClN

NN

NN

O

x HCl

(A) 100 mg

MM 0421.13 Imp. A (BP) as Hydrochloride: 4-(3-Chloro-phenyl)-1-[3-(3-oxo-2,3- dihydro-1,2,4-triazolo[4,3-a]pyridin-2- yl)propyl]piperazine N1-oxide Hydrochloride (Trazodone N-Oxide Hydrochloride)

ClN

NN

NN

O

x HCl

O

(A) 50 mg

New MM 0421.02 Imp. B (BP): 2-[3-(4-Phenylpiperazin-1-yl)- propyl]-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one N

NN

NN

O

(A) 50 mg

MM 0421.03 Imp. C (BP) as Dihydrochloride: 2-[3-[4-(4-Chlorophenyl)piperazin-1-yl]propyl]-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one Dihydrochloride

N

NN

NN

O

Cl

x 2 HCl

on request

New MM 0421.04 Imp. D (BP) as Hydrochloride: 2-3- [4-(3-Bromo-phenyl)piperazin-1-yl]- propyl-1,2,4-triazolo[4,3-a]-pyridin- 3(2H)-one Hydrochloride

N

NN

NN

O

Br x HCl

(A) 50 mg

MM 0421.06 Imp. F (BP) as Hydrochloride: 1-(3-Chlorophenyl)-4-(3-chloropropyl)piperazine Hydrochloride N

NCl

Cl x HCl

(A) 100 mg

New MM 0421.07 Imp. G (BP) as Hydrochloride: 3-[4-(3- Chlorophenyl)piperazin-1-yl]propyl Isobutyl Ether Hydrochloride

N

NO

Clx HCl

(D) 50 mg

MM 0421.08 Imp. H (BP) as Dihydrochloride: 1,3-Bis-[4-(3-chloro-phenyl)piperazin-1-yl]propane Dihydrochloride N

NN

ClNCl

x 2 HCl

(A) 100 mg

MM 0421.10 3-[4-(3-Chlorophenyl)piperazin-1-yl]propanol

ClN

NHO

(A) 100 mg

MM 0421.11 1,2,4-Triazolo-[4,3-a]pyridine-3(2H)-one N NH

N

O

(A) 100 mg

MM 0421.12 1,4-Bis-3-chlorophenylpiperazine ClN

NCl

on request

Triacetin MM 0966.00 Triacetin

O

O

O

O

O

O (A) 500 mg

Triamcinolone MM 0198.01 Triamcinolone

O

F

OH

OH

OH

O

HO

(A) 250 mg




MM 0198.02 Imp. A (EP): 9-Fluoro-11,17-dihydroxy-3,20- dioxopregna-1,4-diene-16,21-diyl Diacetate (Triamcinolone 16,21-Diacetate)

O

F

O

O

OH

O

HO

O

O

(A) 100 mg

MM 0508.03 Imp. C (EP): 9-Fluoro-11,16,17,21-tetrahydroxypregn-4-ene-3,20-dione (Pretriamcinolone)

O

F

OH

OH

OH

O

HO

on request

Triamcinolone Acetonide MM 0198.00 Triamcinolone Acetonide

O

HO

F

OO

OOH (A) 250 mg

MM 0198.01 Imp. A (EP): Triamcinolone

O

HO

F

OHOH

OOH (A) 250 mg

MM 0198.05 Imp. C (Pharmeuropa): 9-Fluoro-11�,21,21- trihydroxy-16�,17-(1-methylethylidenedioxy)- pregna-1,4-diene-3,20-dione (Triamcinolone Acetonide 21-Aldehyde Hydrate)

O

HO

F

OO

OOH

OH

(A) 100 mg

MM 0198.02 Triamcinolone 16,21-Diacetate

O

HO

F

OHO

OO

O

O (A) 100 mg

Triamcinolone Hexacetonide MM 0306.00 Triamcinolone Hexacetonide

O

HO

F

OO

OO

O (A) 100 mg

MM 0198.00 Imp. A (EP): Triamcinolone Acetonide

O

HO

F

OO

OOH (A) 250 mg

MM 0198.01 Triamcinolone

O

HO

F

OHOH

OOH (A) 250 mg

Triamterene MM 0269.00 Triamterene

N

NN

N

NH2

NH2

H2N (A) 500 mg

MM 0269.02 Imp. A (EP): 5-Nitrosopyrimidine-2,4,6-triamine (Nitrosotriaminopyrimidine) N

N

NO

NH2

NH2H2N

(B) 100 mg




MM 0269.01 Sodium Hydroxytriamterene Sulphate N

NN

N

NH2

NH2

H2N

OS

NaO

OO

(B) 10 mg

Tributyl Acetylcitrate MM 0499.00 Tributyl Acetylcitrate O O

OO

O

O

O

O

on request

MM 0499.01 Imp. A (EP): Tributyl 2-Hydroxypropane-1,2,3-tricarboxylate (Tributyl Citrate)

O O

OO

O

O

HO(C) 100 mg

MM 0499.02 Imp. B (EP) (E-Isomer): Tributyl (E)-Propene-1,2,3-tricarboxylate (Tributyl (E)-Aconitate)

O OO

O

OO

(A) 100 mg

Triclabendazole MM 0313.00 Triclabendazole

O

N

HN

Cl

Cl

Cl

S

(D) 100 mg

Triclosan MM 0610.00 Triclosan

O

Cl

Cl OH

Cl

(A) 500 mg

Trihexyphenidyl Hydrochloride MM 0237.00 Trihexyphenidyl Hydrochloride

N

OHx HCl

(A) 500 mg

MM 0237.03 Imp. A (EP) as Hydrochloride: 1-Phenyl-3- (piperidin-1-yl)propan-1-one Hydrochloride

O

N x HCl

(A) 100 mg

MM 0237.01 Acetophenone O (B) 100 mg

MM 0237.04 Trihexyphenidyl N-Oxide

N

OH O

(C) 50 mg

Trimebutine MM 0417.00 Trimebutine

O

O

O

O

O

N

(A) 500 mg

MM 0417.05 Trimebutine Maleate O

O

O

O

O

NOH

O

x

O

OH

(A) 500 mg

MM 0417.01 Imp. A (EP) as Hydrochloride: (2RS)-2- (Dimethylamino)-2-phenylbutanol Hydro- chloride

OHN x HCl

(A) 100 mg

MM 0093.13 Imp. B (EP): 3,4,5-Trimethoxybenzoic Acid

O

O

OOH

O

(B) 100 mg

MM 0093.11 Imp. C (EP): Methyl 3,4,5-Trimethoxybenzoate O

O

O

O

O

(A) 100 mg




MM 0417.11 Imp. D (EP): (1RS)-1-[(Dimethylamino)-methyl]- 1-phenylpropyl 3,4,5-Trimethoxybenzoate

O

O

O

O

O

N (A) 50 mg

MM 0417.07 Imp. E (EP) as Hydrochloride: (2RS)-2-(Methyl- amino)-2-phenylbutyl 3,4,5-Trimethoxy-benzoate Hydrochloride (N-Desmethyltrimebutine Hydro- chloride)

x HClO

O

O

O

O

HN

(A) 50 mg

MM 0417.10 1-Dimethylaminomethyl-1-phenyl-1-propanol Hydrochloride (alpha-[(Dimethylamino)methyl]-alpha-ethyl-benzenemethanol Hydrochloride)

x HCl

HON (A) 100 mg

Trimeprazine Tartrate MM 0958.00 Trimeprazine Tartrate

HO

OH

OH

OH

O

O

N

S

N

x

2

(A) 500 mg

MM 0957.00 Trimeprazine Sulphone (Oxomemazine)

S

N

N

O O

(A) 100 mg

MM 0958.02 Trimeprazine Sulphoxide Hydrochloride

S

N

N

O

x HCl

(A) 100 mg

MM 0958.04 Trimeprazine Sulphone N-Oxide Hydrochloride (Oxomemazine N-Oxide Hydrochloride)

S

N

NO

OO

x HCl

(A) 100 mg

Trimetazidine Dihydrochloride MM 0539.00 Trimetazidine Dihydrochloride

N

HN

O

O

O

x 2 HCl

(A) 100 mg

MM 0539.01 Imp. A (EP) as Dihydrochloride: 1-(3,4,5- Trimethoxybenzyl)piperazine Dihydrochloride N

HN

O

O

O

x 2 HCl

(A) 100 mg

MM 0539.02 Imp. B (EP): 1,4-Bis(2,3,4-trimethoxy-benzyl)piperazine N

N

O

O

O

O

O

O

(A) 100 mg

MM 0539.03 Imp. C (EP): 2,3,4-Trimethoxybenzaldehyde

OO

O

O

(B) 100 mg

MM 0539.04 Imp. D (EP): (2,3,4-Trimethoxyphenyl)methanol HO

O

O

O

(A) 100 mg

MM 0539.05 Imp. E (EP) as Dihydrochloride: 1-(2,4,5- Trimethoxybenzyl)piperazine Dihydrochloride N

HNO

O

O

x 2 HCl

(A) 100 mg

MM 0539.06 Imp. F (EP) as Dihydrochloride: 1-(2,4,6-Tri- methoxybenzyl)piperazine Dihydrochloride N

HNO

O

O

x 2 HCl

(A) 100 mg

MM 0539.07 Imp. G (EP) as Hexahydrate: Piperazine Hexahydrate NH

HNx 6 H2O (B) 100 mg




MM 0539.09 Imp. H (EP): Ethyl 4-(2,3,4-Trimethoxybenzyl)- piperazine-1-carboxylate N

N

O

O

OO

O

(A) 100 mg

MM 0539.10 Imp. I (EP) as Dihydrochloride: 1-Methyl-4- (2,3,4-trimethoxybenzyl)piperazine Dihydrochloride (N-Methyltrimetazidine Dihydrochloride)

N

N

O

O

O

x 2 HCl

(A) 100 mg

MM 0539.08 1-Formyl-4-(2,3,4-trimethoxybenzyl)piperazine Hydrochloride

N

N

O

O

O

x HCl

O

(A) 100 mg

Trimethoprim MM 0093.00 Trimethoprim O

O

ON

N NH2

NH2

(A) 500 mg

MM 0093.06 Imp. A (EP): N 2-Methyl-5-(3,4,5-trimethoxybenzyl)pyrimidine-2,4-diamine

O

O

ON

N NH

NH2

(A) 100 mg

MM 0093.01 Imp. B (EP): (2,4-Diaminopyrimidin-5-yl)-(3,4,5-trimethoxy-phenyl)methanone

O

O

ON

N NH2

NH2O

(A) 100 mg

MM 0093.08 Imp. C (EP): (RS)-(2,4-Diaminopyrimidin-5-yl)(3,4,5-trimethoxy-phenyl)methanol

O

O

ON

N NH2

NH2OH

(A) 100 mg

MM 0093.04 Imp. D (EP): 2-Amino-5-(3,4,5-trimethoxybenzyl)pyrimidin-4-ol O

O

ON

N NH2

OH

(A) 100 mg

MM 0093.03 Imp. E (EP): 4-Amino-5-(3,4,5-trimethoxybenzyl)pyrimidin-2-ol O

O

ON

N OH

NH2

(A) 100 mg

MM 0093.09 Imp. F (EP): 5-(3-Bromo-4,5-dimethoxybenzyl)pyrimidine-2,4-diamine

O

O

BrN

N NH2

NH2

(A) 100 mg

MM 0093.10 Imp. G (EP): 5-(4-Ethoxy-3,5-dimethoxybenzyl)pyrimidine-2,4-diamine

O

O

ON

N NH2

NH2

(A) 100 mg

MM 0093.11 Imp. H (EP): Methyl 3,4,5-Trimethoxybenzoate O

O

OO

O

(A) 100 mg

MM 0093.12 Imp. I (EP): 3-(Phenylamino)-2-(3,4,5-trimethoxybenzyl)prop-2-enenitrile (E/Z-mixture)

O

O

O

HN

N

(A) 100 mg

MM 0093.13 Imp. J (EP): 3,4,5-Trimethoxybenzoic Acid O

O

OOH

O

(B) 100 mg

MM 0093.17 Imp. K (EP) as Hydrochloride: Aniline Hydrochloride

NH2

x HCl(B) 100 mg

MM 0093.02 5-(3,4,5-Trimethoxybenzyl)pyrimidin-2,4-diol O

O

ON

N OH

OH

(B) 10 mg




MM 0093.05 2-Amino-5-(4-hydroxy-3,5-dimethoxybenzyl)pyrimidin-4-ol O

HO

ON

N NH2

OH

(A) 100 mg

MM 0093.07 N4-Methyl-5-(3,4,5-trimethoxybenzyl)pyrimidine-2,4-diamine O

O

ON

N NH2

NH

(C) 50 mg

Trimipramine Maleate MM 0240.00 Trimipramine Maleate

O

OH

O

OHNN x

(A) 500 mg

MM 0240.01 Trimipramine

NN

(A) 100 mg

MM 0240.04 Imp. A (EP): (2RS)-3-(10,11-Dihydro-5H-dibenzo- [b,f]azepin-5-yl)-N,N,2-trimethylpropan-1-amine N-oxide (Trimipramine N-Oxide)

NNO

(A) 100 mg

MM 0240.02 Imp. B (EP) as Hydrochloride: (2RS)-3-(10,11- Dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,2-dimethylpropan-1-amine Hydrochloride (Desmethyltrimipramine Hydrochloride)

NH

N x HCl

(A) 100 mg

MM 0240.05 Imp. C (EP) as Hydrochloride: (2RS)-3-(5H- Dibenzo[b,f]azepin-5-yl)-N,N,2-trimethylpropan- 1-amine Hydrochloride

NN x HCl

(A) 50 mg

MM 0077.00 Imp. D (EP) as Hydrochloride: Imipramine Hydrochloride

N x HClN

(A) 500 mg

MM 0076.06 Imp. F (EP): 10,11-Dihydro-5H-dibenzo[b,f]azepine (Iminodibenzyl)

NH

(B) 100 mg

Tropicamide MM 0601.00 Tropicamide

N

N

O

OH

(A) 250 mg

MM 0601.01 Imp. A (EP): N-(Pyridin-4-ylmethyl)ethanamine N

HN (A) 100 mg

MM 0601.03 Imp. C (EP): (2RS)-3-Hydroxy-2- phenylpropanoic Acid (Tropic Acid) OH

O

OH

(A) 100 mg

MM 0160.03 Imp. D (Pharmeuropa): Phenylacetic Acid [Drug Precursor] OH

O (B) 100 mg

Tropisetron Hydrochloride MM 0763.01 Imp. A (EP): (1R,3r,5S)-8-Methyl-8-

azabicyclo[3.2.1]oct-3-ol (Tropine) HO

NH

H

H (A) 100 mg

MM 0763.02 Imp. B (EP): 1H-Indole-3-carboxylic Acid OH

HN

O (A) 100 mg




Trospium Chloride MM 0783.09 Imp. A (EP): Hydroxydiphenylacetic Acid

(Benzilic Acid) OH

O

OH

(B) 100 mg

Tryptophan MM 0172.00 L-Tryptophan H

N

O

OH

NH2(A) 500 mg

MM 0172.09 Imp. A (EP): 3,3'-[Ethylidenebis(1H-indole-1,3-diyl)]bis[(2S)-2-aminopropanoic] Acid (1,1'-Ethylidenebistryptophan)

N

O

OH

NH2

N

NH2

O

HO

(D) 100 mg

MM 0172.03 Imp. D (EP): (S)-2-Amino-3-(5-hydroxy-1H-indol-3-yl)propanoic Acid (5-Hydroxytryptophan)

HN

O

OH

NH2

HO

(A) 100 mg

MM 0172.13 N-Acetyltryptophan HN

O

OH

HN

O (A) 100 mg

Tyrosine MM 0634.00 Tyrosine HO

OH

O

NH2(A) 100 mg

Valaciclovir Hydrochloride, Anhydrous MM 0061.02 Imp. A (EP): 2-Amino-1,9-dihydro-6H-

purin-6-one (Guanine) HN

N NH

N

O

H2N

(B) 100 mg

MM 0061.00 Imp. B (EP): 2-Amino-9-[(2-hydroxyethoxy)methyl]-1,9-dihydro-6H-purin-6- one (Aciclovir)

HN

N N

N

O

H2N

O

OH

(A) 500 mg

MM 0619.07 Imp. G (EP): N,N-Dimethylpyridin-4-amine

N

N (A) 100 mg

MM 0061.01 Imp. I (EP): 2-[(2-Amino-6-oxo-1,6-dihydro- 9H-purin-9-yl)methoxy]ethyl Acetate HN

N N

N

O

H2N

O

O

O

(A) 100 mg

Valproic Acid MM 0751.00 Valproic Acid O

OH

(A) 500 mg

MM 0751.11 Sodium Valproate O

ONa

(A) 500 mg

MM 0751.01 Imp. A (EP): Pentanoic Acid (Valeric Acid) OH

O (C) 100 mg

MM 0751.02 Imp. B (EP): (2RS)-2-Ethylpentanoic Acid OH

O (A) 100 mg

MM 0751.03 Imp. C (EP): (2RS)-2-(1-Methylethyl)pentanoic Acid OH

O (A) 100 mg




MM 0751.04 Imp. D (EP): 2,2-Dipropylpentanoic Acid OH

O (A) 100 mg

MM 0751.05 Imp. E (EP): Pentanamide (Valeramide) NH2

O (A) 100 mg

MM 0751.06 Imp. F (EP): 2-Propylpentanamide NH2

O (A) 100 mg

MM 0751.07 Imp. G (EP): 2,2-Dipropylpentanamide NH2

O (A) 100 mg

MM 0751.08 Imp. H (EP): Pentanenitrile (Valeronitrile) N (C) 100 mg

MM 0751.09 Imp. I (EP): 2-Propylpentanenitrile N (A) 100 mg

MM 0751.10 Imp. J (EP): 2,2-Dipropylpentanenitrile N (A) 100 mg

Vancomycin Hydrochloride MM 0239.00 Vancomycin Hydrochloride

O

HONH2

OOH

HO

HO

O

O

Cl

HO

NH

O

NH

OH

OH

HN O

NH

O

HN

NH2O

O

HN

O

NHOH

Cl

O

O

OH

x HCl

O

O OH

(A) 100 mg

Venlafaxine Hydrochloride MM 0393.00 Venlafaxine Hydrochloride

O

N

OH

x HCl

(D) 100 mg

MM 0393.02 Imp. A (EP) as Hydrochloride: 2-(4- Methoxyphenyl)-N,N-dimethylethanamine Hydrochloride O

Nx HCl

(A) 100 mg

MM 0393.07 Imp. B (EP) as Hydrochloride: Ethyl (2RS)-3- (Dimethylamino)-2-(4-methoxyphenyl)propanoate Hydrochloride

O

N

O O

x HCl

(A) 100 mg

MM 0393.08 Imp. C (EP) as Hydrochloride: 1-[(1RS)-2-Amino-1-(4-methoxyphenyl)ethyl]cyclohexanol Hydrochloride

O

NH2

OH

x HCl

(A) 100 mg

MM 0393.04 Imp. D (EP) as Hydrochloride: 1-[(1RS)-1-(4- Methoxyphenyl)-2-(methylamino)ethyl]cyclohexanol Hydrochloride

O

HN

OH

x HCl

(A) 100 mg

MM 0393.09 Imp. E (EP) as Hydrochloride: (5RS)-5-(4- Methoxyphenyl)-3-methyl-1-oxa-3-azaspiro- [5.5]undecane Hydrochloride

O

N

O

x HCl

(A) 100 mg




MM 0393.10 Imp. F (EP) as Hydrochloride: (2RS)-2- (Cyclohex-1-enyl)-2-(4-methoxyphenyl)- N,N-dimethylethanamine Hydrochloride

O

Nx HCl

(A) 100 mg

MM 0393.03 Imp. G (EP) as Hydrochloride: (2RS)-2- Cyclohexyl-2-(4-methoxyphenyl)-N,N- dimethylethanamine Hydrochloride

O

Nx HCl

(A) 100 mg

MM 0393.11 Imp. H (EP): 1-[(1RS)-1-(4-Methoxyphenyl)- 2-[[2-(4-methoxyphenyl)ethyl]amino]ethyl]- Cyclohexanol

O

HN

OH

O

(A) 50 mg

MM 0393.01 O-Desmethylvenlafaxine

HO

N

OH(A) 100 mg

Verapamil Hydrochloride MM 0022.00 Verapamil Hydrochloride

O

O N

O

x HCl

O

N

(A) 500 mg

MM 0022.07 Imp. A (EP) as Dihydrochloride: N,N'- Bis[2-(3,4-dimethoxyphenyl)ethyl]- N,N'-dimethylpropane-1,3-diamine Dihydrochloride

O

O N N O

Ox 2 HCl (A) 100 mg

MM 0022.08 Imp. B (EP) as Hydrochloride: 2-(3,4-Dimethoxyphenyl)-N-methylethanamine Hydrochloride

O

O NHx HCl

(A) 100 mg

MM 0022.09 Imp. C (EP) as Hydrochloride: 2-(3,4- Dimethoxyphenyl)-N,N-dimethylethanamine Hydrochloride

O

O Nx HCl

(A) 100 mg

MM 0022.02 Imp. D (EP): 3-Chloro-N-[2-(3,4-dimethoxyphenyl)ethyl]-N-methylpropan-1-amine

O

O N Cl

(A) 100 mg

MM 0022.05 Imp. E (EP): (3,4-Dimethoxyphenyl)methanol O

OOH

(B) 100 mg

MM 0022.10 Imp. F (EP) as Hydrochloride: (2RS)- 2-(3,4-Dimethoxyphenyl)-5-(methylamino)- 2-(1-methylethyl)pentanenitrile Hydrochloride HN

O

x HCl

O

N

(A) 100 mg

MM 0022.04 Imp. G (EP): 3,4-Dimethoxybenzaldehyde O

O

O (B) 100 mg

MM 0022.11 Imp. H (EP) as Hydrochloride: (2RS)-2-(3,4-Dimethoxyphenyl)-5-[[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino]-2-ethylpentanenitrile Hydrochloride

O

O N

Ox HClO

N

(A) 100 mg

MM 0022.12 Imp. I (EP) as Hydrochloride: (2RS)-2-(3,4-Dimethoxyphenyl)-2-[2-[[2-(3,4-dimethoxy-phenyl)ethyl](methyl)amino]ethyl]-3-methyl-butanenitrile Hydrochloride

NO

O

O

O

x HCl

N (A) 50 mg




MM 0022.21 Imp. J (EP) as Maleate: (2RS)- 2-(3,4-Dimethoxyphenyl)- 5-[[2-(3,4-dimethoxyphenyl)ethyl]amino]- 2-(1-methylethyl)pentanenitrile Maleate (N-Norverapamil Maleate) O

O NH

O

O

N

OH

O

O

OHx

(A) 100 mg

MM 0022.03 Imp. K (EP): (2RS)-2-(3,4-Dimethoxyphenyl)-3-methylbutylnitrile O

N

O (A) 100 mg

MM 0022.13 Imp. L (EP): 1-(3,4-Dimethoxyphenyl)-2- methylpropan-1-one O

O

O (A) 100 mg

MM 0022.15 Imp. N (EP) as Hydrochloride: 5,5'- (Methylimino)bis[2-(3,4-dimethoxyphenyl)-2-(1-methylethyl)pentanenitrile] Hydrochloride N

O

O

O x HClO

NN

(A) 50 mg

MM 0022.16 Imp. O (EP) as Hydrochloride: (2RS)- 2-(3,4-Dimethoxyphenyl)- 5-[2-[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino]- 2-propylpentanenitrile Hydrochloride

O

O N

Ox HClO

N

(A) 100 mg

MM 0022.06 Diisopropylhomoveratylcyanide O

N

O (D) 100 mg

MM 0022.18 3,4-Dimethoxyphenylacetonitrile O

O

N

(A) 100 mg

MM 0022.19 Verapamil N-Oxide Hydrochloride O

O N

O

x HCl

O

N

O

(C) 50 mg

Vincamine MM 0519.00 Vincamine

NN

H

OO

HO

(A) 100 mg

Vinpocetine MM 0406.00 Vinpocetine

NN

O

O

H

(D) 100 mg

MM 0406.02 Imp. A (EP): Ethyl (12RS,13aSR,13bSR)-13a- Ethyl-12-hydroxy-2,3,5,6,12,13,13a,13b-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]- naphthyridine-12-carboxylate (Ethyl Vincaminate)

NN

H

O

O

HO

and enantiomer

(D) 100 mg

MM 0406.01 Imp. B (EP): Methyl (13aS,13bS)-13a-Ethyl- 2,3,5,6,13a,13b-hexahydro-1H-indolo[3,2,1- de]pyrido[3,2,1-ij][1,5]naphthyridine-12- carboxylate (Apovincamine)

NN

O

O

H

(D) 100 mg




Voriconazole New MM 1094.04 Imp. A (EP): 1-(2,4-Difluorophenyl)-2-

(1H-1,2,4-triazol-1-yl)ethanone

N

NN

O

F

F (A) 100 mg

Warfarin Sodium MM 0732.01 Imp. A (EP): (5RS)-3-(2-Hydroxyphenyl)-5-phenylcyclohex-

2-enone

OH

O

(A) 100 mg

MM 0732.02 Imp. B (EP): 4-Hydroxy-2H-1-benzopyran- 2-one (4-Hydroxycoumarin)

O O

OH

(A) 100 mg

MM 0732.03 Imp. C (EP): (3E)-4-Phenylbut-3-en-2-one (Benzalacetone)

O

(A) 100 mg

Xylazine Hydrochloride MM 0515.00 Xylazine Hydrochloride H

NS

Nx HCl

(A) 500 mg

MM 0102.02 Imp. A (EP): 2,6-Dimethylaniline (2,6-Xylidine) H2N

(B) 100 mg

Xylometazoline Hydrochloride MM 0089.00 Xylometazoline Hydrochloride

N

NH

x HCl

(A) 500 mg

MM 0089.07 Imp. A (EP) as Hydrochloride: N-(2-Aminoethyl)-2- [4-(1,1-dimethylethyl)-2,6-dimethylphenyl]acetamide Hydrochloride

O

NH

NH2

x HCl

(A) 100 mg

MM 0089.04 Imp. B (EP): 2-(Chloromethyl)-5-(1,1-dimethylethyl)-1,3-dimethylbenzene

Cl

(A) 100 mg

MM 0089.03 Imp. C (EP): [4-(1,1-Dimethylethyl)-2,6-dimethylphenyl]acetonitrile N

(A) 100 mg

MM 0089.05 Imp. D (EP): 1-(1,1-Dimethylethyl)-3,5-dimethylbenzene (C) 100 mg

MM 0089.02 Imp. F (EP): [4-(1,1-Dimethylethyl)-2,6-dimethylphenyl]acetic Acid O

OH

(A) 100 mg

Zaleplon New MM 1322.02 N-[3-[3-(Dimethylamino)-1-oxo-2-propenyl]phenyl]-N-ethylacetamide

O

N

O

N

(A) 100 mg




Zidovudine MM 0534.00 Imp. A (EP): 1-[(2R,5S)-5-(Hydroxymethyl)-2,5-dihydrofuran-2-yl)-

5-methylpyrimidine-2,4(1H,3H)-dione (Stavudine)

O

HON

HN

O

O (A) 100 mg

MM 0173.02 Imp. B (EP): 1-(3-Chloro-2,3-dideoxy--D- erythro-pentofuranosyl)-5-methylpyrimidine- 2,4(1H,3H)-dione

O

HON

HN

O

O

Cl

(A) 100 mg

MM 0534.01 Imp. C (EP): 5-Methylpyrimidine-2,4(1H,3H)dione (Thymine)

NH

HN

O

O (A) 100 mg

MM 0173.04 Imp. D (EP): Triphenylmethanol OH

(A) 100 mg

New MM 0534.03 Imp. E (Pharmeuropa): 1-(2-Deoxy-�-D-erythro- pentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)- dione (Thymidine)

O

HON

HN

O

O

OH

(A) 100 mg

Zileuton MM 1297.03 1-Benzo-[b]thien-2-ylethanone

S

O (A) 100 mg

New MM 1297.02 2-(Benzo[b]thien-2-oyl)benzo[b]thiophene O

S S

(A) 50 mg

Ziprasidone Hydrochloride Monohydrate New MM 1273.00 Ziprasidone Hydrochloride Monohydrate

N

N

N S

HN

Cl

O

x HCl x H2Oon request

Zolpidem Tartrate MM 0333.01 Imp. A (EP): N,N-Dimethyl-2-[7-methyl-

2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]acetamide

N

N

N

O

(D) 100 mg

MM 0333.02 2-[6-Methyl-2-(4-methylphenyl)imidazo-[1,2-a]pyridin-3-yl]acetamide

N

N

NH2

O

(A) 100 mg

MM 0333.03 2-[6-Methyl-2-(4-methylphenyl)imidazo-[1,2-a]pyridin-3-yl]acetic Acid

N

N

OH

O

(A) 100 mg

MM 0333.04 Methyl 2-[6-Methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]acetate

N

N

O

O

(D) 50 mg

MM 0333.05 6-Methyl-2-(4-methylphenyl)imidazo-[1,2-a]pyridine-3-acetonitrile

N

N

N

(A) 100 mg




MM 0333.06 Oxozolpidem (N,N,6-Trimethyl-2-(4-methylphenyl)--oxo- imidazo [1,2-a]pyridine-3-acetamide)

N

N

N

O

O

(D) 100 mg

MM 0333.07 Zolpaldehyde (6-Methyl-2-(4-methylphenyl)-imidazo[1,2-a]pyridine-3-carboxaldehyde)

N

N

O

(A) 100 mg

MM 0333.08 Zolpyridine (4-Methyl-N-(5-methyl-2-pyridinyl)-benzamide) HN

ON

(A) 100 mg

MM 0333.09 6-Methyl-2-(4-methylphenyl)--oxo-imidazo[1,2- a]pyridine-3-acetamide

N

N

NH2

O

O

(A) 100 mg

MM 0333.10 Methyl -Hydroxy-6-methyl-2-(4-methylphenyl)- imidazo[1,2-a]pyridine-3-acetate

N

N

O

O

HO

(A) 100 mg

Zopiclone MM 0149.00 Zopiclone

N

Cl

NN

NO

O

O

N

N

(D) 100 mg

MM 0149.01 Imp. A (EP): (5RS)-6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-Methylpiperazine-1-carboxylate 4-Oxide (Zopiclone Oxide) N

Cl

NN

NO

O

O

N

NO

(D) 100 mg

MM 0149.02 Imp. B (EP): (7RS)-6-(5-Chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one

N

Cl

NN

NO

HO (D) 100 mg

New MM 0149.03 Imp. C (EP): 6-(5-Chloropyridin-2-yl)-6,7- dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one

N

Cl

NN

NO

(A) 50 mg

MM 0149.04 2-Amino-5-chloropyridine

N

Cl

H2N

(A) 250 mg

MM 0149.05 3-(5-Chloropyridine-2-carbamoyl)-2-pyrazinecarboxylic Acid

N

Cl

NH

O

N

NOH

O

(A) 100 mg

MM 0149.06 6-(5-Chloropyridin-2-yl)- 6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5,7-dione

N

Cl

NN

NO

O (A) 100 mg

MM 0149.07 5-(Chloropyridine-2-yl-carbamoyl)pyrazine

N

NNH

O

N

Cl (A) 100 mg

MM 0149.50 2-Acetylamino-5-chloropyridine

NH

O

N

Cl (A) 100 mg

European Pharmacopoeia

Certified liquidsfor viscosity measurements

International commission on pharmaceutical enzymes

European pharmacopoeia reagents

WHO International Standards for Antibiotics

From Atorvastatin to Zopiclone:Over 2,700 pharmaceutical impuritiesLGC Standards offers over 2,700 reference standards for impurities to support the pharmaceutical industry worldwide.

• Acknowledged by regulation authorities worldwide• Impurities linked to the European Pharmacopoeia (EP) whereever possible • Customised pharmaceutical impurities created on request • Detailed certificates of analysis provided • Additional documentation on request• Assistance in finding the right material to suit your analyses

• Atorvastatin• Bupropion

• Clopidogrel• Esomeprazol• Ibuprofen• Naproxen• Omeprazole• Risperidone

• Sildenafil• Steroid hormones

• Venlafaxine• Zopiclone

Over 20 new products per month: Check out our new impurities on www.lgcstandards.com/newimpurities

© LGC Limited, 2011. All rights reserved. 2297/NLh/0811


Edition 2011/2012 Looking for impurity reference standards with CofAs? See our LGC impurity chapter from page 7 on. 223

European Pharmacopoeia Background The European Pharmacopoeia (EP) Commission includes in its membership delegates from nations who

have adopted the European Pharmacopoeia. The EP Commission is in charge of judging the suitability of monographs. Prior to release, a new monograph must be adopted by the EP Commission, and then published in the annual ‘Fascicule’. Member States then officially adopt the new monograph on 1st January of the following year. To support the monographs of the European Pharmacopoeia, a collection of reference substances has been made available which includes: 1. Current, official, European Pharmacopoeia Chemical Reference Substances (EP CRS) and Biological Reference Preparations (BRP) 2. Reference Spectra 3. Other reference preparations, including Enzymes and Substrates from the International Commission on Pharmaceutical Enzymes and Certified Viscosity Standards from Van Swinden Laboratories. 4. With supplement 4.3, the revised EP general method 2.2.6 replaces CRS reference liquids with certified reference materials available from suppliers of chemical reagents or materials certified for metrology. Ten liquid CRMs, certified by the Physical Chemistry Division of the Central Office of Measures (GUM), Warsaw in Poland, cover the wide range of refractive index from 1,333 (water) to 1,657 (1-bromonaphthalene). More detailed information is given in the chapter "Dyes and refractive index CRMs" of this catalogue. 5. European Pharmacopoeia Reagents. The European Pharmacopoeia have discontinued the publication of lot lists in printed formate. Therefore LGC Standards will collect available information of the European Pharmacopoeia and provide you with a non-official lot list, which includes all new official batches and changes of the European Pharmacopoeia. Of course you can continue to send us queries about actual lot numbers anytime, as usual. Please contact your local offices. We are happy to help then.

Relationship with other pharmacopoeias in Europe Any reference substance, spectra or preparation required for a new EP monograph, is made available as

soon as the monograph comes into force. Many of the member countries of the European Pharmacopoeia Commission have adopted the EP in full, and their monographs require only EP CRS/BRP. When an EP monograph is adopted by the pharmacopoeia of a member state of the Council of Europe then any reference material that may have been available from a national pharmacopoeia, e.g. BP or PF, will usually be discontinued in favour of the EP reference substance. However, a number of member countries of the EP Commission maintain national pharmacopoeial monographs, especially for finished dosage forms, which require the use of separate reference substances. A separate chapter in this catalogue includes lists of the reference substances produced for the British, French, Swiss and International pharmacopoeia monographs. The International Pharmacopoeia (IP) reference substances are described in the section referring to the WHO (World Health Organization).

Production and certification European Pharmacopoeia reference substances and preparations are selected and verified by the EP

laboratories as being suitable for the use as prescribed in the relevant monograph of the European Pharmacopoeia. Since CRS and BRP are officially certified by the European Pharmacopoeia Commission, it should be noted that neither certificates of analysis nor data not relevant to the use of the products as defined by the EP monograph are provided with the reference product or substance.


224 Looking for impurity reference standards with CofAs? See our LGC impurity chapter from page 7 on. Edition 2011/2012

Storage, shelf life and expiry dates European Pharmacopoeia CRS/BRP are subject to regular inspection and repeated analysis by EP scientific

staff. Each EP CRS/BRP is, on receipt by the customer, fit for the intended use. No expiry date is indicated on the reference materials because the products or substances comply with the requirements of the corresponding monograph and are monitored regularly. When batches are to be changed, LGC Standards can provide you with the date on which the previous lot will no longer be official. In specific cases for reasons related to filling or labeling, sub-batches are obtained from the same batch of bulk material. However, all the necessary precautions are taken in order to guarantee that the quality and specifications of the sub-batches do not differ from one to another. The EP changed the labeling structure of the sub-batches recently. Sub-batches are now labeled for example as 2.1, 2.2, 2.3 instead of 2a, 2b, 2c. The EP is also currently over-labelling all its reference standards vials with a secondary label. This new secondary label is useful for customs purposes as it can be peeled off. It can also be stuck onto your laboratory book to prove the use of the reference standard. All the required information to perform the tests described in the European Pharmacopoeia monographs are stated on the primary label. EP recommends only sufficient material should be purchased for immediate use and that unopened vials should be stored in the dark unless otherwise stated. Whilst most EP CRS/BRP can be shipped at ambient temperature, certain items have to be maintained at controlled temperatures at all times and are subject to special shipping charges and storage conditions (details are available on request). Where no drying conditions are stated, the substance is to be used as received. Once opened, EP can no longer guarantee the stability of the material and any of the CRS/BRP not used should be disposed of and not kept for future use.

Validation of secondary standards All secondary in-house working standards have to be validated against the corresponding EP CRS/BRP.

Please make sure that the secondary material is used only for the same official purposes for which the primary pharmacopoeial material was designed.

Proper use EP discontinued their use code number system as of January 2006.

For information on the use of the substances please refer to the monograph or contact your local LGC Standards office.

Opening For reference substances and preparations supplied in sealed glass ampoules the following technique is

suitable for opening the ampoule: tap gently to collect the material at the lower end, score the ampoule with a file, heat a glass rod to white heat and apply firmly to the file mark. If the glass does not crack, deepen and extend the file mark, and repeat the process. Eye and hand protection MUST be used. Many reference substances are supplied as lyophilised material in a septum vial. No attempt should be made to open the vial and weigh out the powder. It is important to strictly follow the monograph instructions, reconstitute the material in a buffer solvent and handle the resultant solution volumetrically.

Toxicity The potential toxicity of certain reference substances is such that special precautions should be taken to

avoid contact. Such substances should be manipulated in a glove box. If this is not possible, gloves, eye protection and a mask should be worn. Following the guidelines suggested by the EP does not replace the need to carry out a full hazard assessment. Biological and blood products should be regarded as potentially hazardous to health and therefore used and disposed of according to established laboratory safety procedures.

Controlled Substances The EP’s product range contains substances subject to Controlled Substance regulations schedules.

Special ordering procedures apply, so please contact LGC Standards for details and costs.

Code Product Unit

EPY0000055 Acamprosate calcium - Reference Spectrum unit

EPY0000116 Acamprosate impurity A 3-aminopropane-1-sulphonic acid

50 mg

EPY0000500 Acarbose 94.7 mg

EPY0000354 Acarbose for identification 10 mg



Code Product Unit

EPY0000427 Acarbose for peak identification 40 mg

EPA0040000 Acebutolol hydrochloride 50 mg

EPY0000359 Acebutolol impurity B N-[3-acetyl-4-[(2RS)-2-hydroxy-3-[(1-methylethyl) amino]propoxy]phenyl]acetamide (diacetolol)

10 mg

EPY0000127 Acebutolol impurity C N-(3-acetyl-4-hydroxyphenyl)butanamide

20 mg

EPY0000128 Acebutolol impurity I N-[3-acetyl-4-[(2RS)-3-(ethylamino)-2-hydroxypropoxy]phenyl) butanamide

0.004 mg

EPY0000056 Aceclofenac - Reference Spectrum unit

EPY0001094 Aceclofenac for peak identification 10 mg

EPY0000085 Aceclofenac impurity F benzyl[[[2-[(2,6-dichlorophenyl)amino]phenyl]acetyl]oxy]acetate

20 mg

EPY0000086 Aceclofenac impurity H [[[[[[[2-[(2,6-dichlorophenyl)amino]phenyl]acetyl]oxy]acetyl]oxy]acetyl]oxy]acetic acid

10 mg

EPY0000810 Acemetacin 100 mg

EPY0000811 Acemetacin impurity A 4-chlorobenzoic acid

10 mg

EPY0000842 Acemetacine impurity mixture 0.06 mg

EPA0070000 Acesulfame potassium 50 mg

EPA0070020 Acesulfame potassium impurity B 5-chloro-6-methyl-1,2,3-oxathiazin-4(3H)-one 2,2-dioxide

50 mg

EPA0100000 Acetazolamide 100 mg

EPY0001084 Acetazolamide for system suitability 0.0068 mg

EPY0000002 Acetylcholine chloride 50 mg

EPA0150000 Acetylcysteine 50 mg

EPA0152000 Acetylcysteine impurity C N,N'-diacetyl-L-cystine

10 mg

EPA0153000 Acetylcysteine impurity D N,S-diacetyl-L-cysteine

10 mg

EPY0000565 ß-Acetyldigoxin 50 mg

EPY0000642 β-Acetyldigoxin for peak identification 10 mg

EPA0200000 Acetylsalicylic acid 100 mg

EPA0208000 N-Acetyltryptophan 125 mg

EPA0202000 N-Acetyltyrosine 200 mg

EPY0000693 Acholeplasma laidlawii BRP 1 mL

EPA0220000 Aciclovir 75 mg

EPY0001264 Aciclovir for system suitability 10 mg

EPY0001271 Aciclovir for peak identification 1 0.3 mg

EPY0001269 Aciclovir for peak identification 2 0.003 mg

EPA0225000 Acitretin 100 mg

EPY0001121 Adapalene 100 mg

EPY0001120 Adapalene impurity C 1-[2-(methyloxy)phenyl]tricyclo[3.3.1.1]decane

6 mg

EPY0001119 Adapalene for peak identification 2.022 mg

EPA0230000 Adenine 50 mg

EPA0230200 Adenosine 50 mg

EPY0000110 Adipic acid 50 mg

EPY0000882 Adrenaline 5 mg

EPY0000883 Adrenaline with impurity F 10 mg

EPA0300000 Adrenaline tartrate 100 mg

EPY0000740 Adrenaline impurity mixture 0.005 mg

EPY0000707 Adrenaline tartrate with impurity A 15 mg

EPY0000728 Agnus castus fruit standardised dry extract 200 mg



Code Product Unit

EPA0325000 Alanine 60 mg

EPA0325100 Albendazole 50 mg

EPA0325200 Alcuronium chloride 50 mg

EPA0325450 Alfacalcidol 5 mg

EPA0325451 Alfacalcidol - Reference Spectrum unit

EPA1225000 Alfadex 150 mg

EPA0325500 Alfentanil hydrochloride - Reference Spectrum unit

EPA0325800 Alfuzosin hydrochloride 10 mg

EPY0000832 Alfuzosin for system suitability 10 mg

EPA0349000 Allantoin 60 mg

EPA0350000 Allopurinol 50 mg

EPA0350010 Allopurinol impurity A 5-amino-1H-pyrazole-4-carboxamide

10 mg

EPA0350020 Allopurinol impurity B 5-formylamino-1H-pyrazole-4-carboxamide

10 mg

EPA0350030 Allopurinol impurity C N-(4H-1,2,4-triazol-4-yl)1H-pyrazole-4-carboxamide

10 mg

EPA0350040 Allopurinol impurity D ethyl 5-amino-1H-pyrazole-4-carboxylate

10 mg

EPA0350050 Allopurinol impurity E ethyl 5-(formylamino)-1H-pyrazole-4-carboxylate

20 mg

EPA0351000 Allylstrychnine bromide 10 mg

EPY0000235 Almagate 25 mg

EPY0000255 Almagate - Reference Spectrum unit

EPA0357000 Alprazolam Controlled Substance 100 mg

EPA0360000 Alprenolol hydrochloride 100 mg

EPY0000054 Alprostadil 50 mg

EPY0000606 Altizide 150 mg

EPY0000843 Altizide impurity B 3-[(2,2-dimethoxyethyl)sulphanyl]prop-1-ene

15 mg

EPY0000687 Alverine citrate 5 mg

EPY0000595 Alverine for peak identification 0.125 mg

EPY0000607 Alverine impurity D N-(3-cyclohexylpropyl)-N-ethyl-3-phenylpropan-1-amine

10 mg

EPA0363000 Amantadine hydrochloride 100 mg

EPA0363700 Ambroxol hydrochloride 125 mg

EPA0900000 Amfetamine sulphate - Reference Spectrum unit

EPA0365000 Amidotrizoic acid dihydrate 100 mg

EPA0368000 Amikacin 200 mg

EPA0365900 Amikacin sulphate 200 mg

EPY0001117 Amikacin for system suitability 20 mg

EPA0370000 Amiloride hydrochloride 100 mg

EPY0000020 Amiloride impurity A methyl-3,5-diamino-6-chloropyrazine-2-carboxylate

10 mg

EPY0000173 4-Aminobenzoic acid 60 mg

EPA0420000 Aminocaproic acid 50 mg

EPA0460000 7-Aminodesacetoxycephalosporanic acid 20 mg

EPA0496000 Aminoglutethimide 125 mg

EPA0496005 Aminoglutethimide impurity A (3RS)-3-(3-aminophenyl)-3-ethylpiperidine-2,6-dione; (3-aminoglutethimide)

20 mg

EPA0496020 Aminoglutethimide impurity D 3,3'-[diazenediyldi(4,1-phenylene)]bis(3-ethylpiperidine-2,6-dione) (azoglutethimide)

10 mg

EPA0575000 Amiodarone hydrochloride 100 mg



Code Product Unit

EPY0000129 Amiodarone impurity D (2-butyl-benzofuran-3-yl)-(4-hydroxy-3,5-diiodophenyl)methanone

20 mg

EPY0000130 Amiodarone impurity E (2-butylbenzofuran-3-yl)(4-hydroxyphenyl)methanone

20 mg

EPA0590000 Amisulpride 50 mg

EPA0590004 Amisulpride impurity B 4-amino-N-[[(2RS )-1-ethylpyrrolidin-2-yl] methyl]-5-(ethylsulphonyl)-2-hydroxybenzamine

10 mg

EPY0000563 Amitriptyline hydrochloride 10 mg

EPY0000049 Amlodipine besilate 150 mg

EPY0001067 Amlodipine for peak identification 10 mg

EPY0001068 Amlodipine impurity A 3-ethyl 5-methyl (4RS)-4-(2-chlorophenyl)-2-[[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethoxy]methyl]-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate

10 mg

EPY0001069 Amlodipine impurity B 3-ethyl 5-methyl (4RS)-4-(2-chlorophenyl)-6-methyl-2-[[2-[[2-(methylcarbamoyl)benzoyl]amino]ethoxy]methyl]-1,4-dihydropyridine-3,5-dicarboxylate

10 mg

EPY0001070 Amlodipine impurity G dimethyl 4-(2-chlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate

10 mg

EPY0000302 Ammonio methacrylate copolymer (type A) - Reference Spectrum unit

EPY0000303 Ammonio methacrylate copolymer (type B) - Reference Spectrum unit

EPA0650000 Amobarbital Controlled Substance 500 mg

EPA0700000 Amobarbital sodium Controlled Substance 500 mg

EPA0800000 Amoxicillin trihydrate 100 mg

EPY0000005 Amphotericin B 100 mg

New EPY0001361 Amphotericin B for microbiological assay 100 mg

EPY0001014 Amphotericin B for peak identification 10 mg

EPA1000000 Ampicillin (anhydrous) 250 mg

EPA1100000 Ampicillin trihydrate 150 mg

New EPY0001244 Amylmetacresol 285 mg

New EPY0001245 Amylmetacresol for peak identification 10 mg

New EPY0001386 Angelica dahuria root 160 mg

EPA1200000 Anhydrotetracycline hydrochloride 15 mg

EPA1210000 Antazoline hydrochloride 50 mg

EPY0000172 Apomorphine hydrochloride - Reference Spectrum unit

EPA1220000 Alpha-apo-oxytetracycline 20 mg

EPA1230000 Beta-apo-oxytetracycline 20 mg

EPA1250000 Aprotinin solution BRP 0.5 mL

EPY0001154 Aprotinin for system suitability 2.7 mg

EPA1269000 L-Arabinitol 10 mg

EPY0000806 Arbutin 100 mg

EPA1270000 Arginine 50 mg

EPY0000304 Arginine aspartate 20 mg

EPA1271000 Arginine hydrochloride 50 mg

EPY0001185 Aristolochic acid I 11 mg

EPY0001175 Aristolochic acid for system suitability 1 mg

EPY0000079 Articaine hydrochloride 100 mg

EPY0000080 Articaine impurity A methyl3-[[2-(propylamino)acetyl]amino]-4-methylthiophene-2-carboxylate

15 mg

EPY0000081 Articaine impurity E methyl 4-methyl-3-[[(2RS)-2-[(1-methylethyl)amino]propanoyl] amino]thiophene-2-carboxylate

10 mg

EPA1300000 Ascorbic acid (Vitamin C) 100 mg

EPY0001024 Ascorbic acid impurity C D-sorbosonic acid

20 mg

EPY0001170 Ascorbic acid impurity D Methyl D-sorbosonate

10 mg



Code Product Unit

EPY0000800 Ascorbyl palmitate 10 mg

EPY0000305 Asparagine monohydrate 60 mg

EPA1320000 Aspartame 40 mg

EPA1321000 Aspartame impurity A 2-(5-benzyl-3,6-dioxopiperazin-2-yl)acetic acid (diketopiperazine)

10 mg

EPA1330000 Aspartic acid 50 mg

EPY0001171 Astragaloside IV 40 mg

EPA1340000 Atenolol 100 mg

EPY0001089 Atenolol for system suitability 5 mg

New EPY0001327 Atorvastatine calcium trihydrate 150 mg

New EPY0001328 Atorvastatin impurity A desfluoroatorvastatin

10 mg

New EPY0001329 Atorvastatin impurity B 3-epi-atorvastatin

10 mg

New EPY0001330 Atorvastatin impurity C fluoroatorvastatin

10 mg

New EPY0001331 Atorvastatin impurity D 3-[(4-fluorophenyl)carbonyl]-2-(2-methylpropanoyl)-N,3-diphenyloxirane-2-carboxamide

10 mg

New EPY0001332 Atorvastatin impurity E ent-atorvastatin

10 mg

EPY0000424 Atracurium besilate 120 mg

EPY0000503 Atracurium for impurity F identification 5 mg

EPY0000504 Atracurium for peak identification 5 mg

EPY0000878 Atropine 30 mg

EPY0000845 Atropine for peak identification 0.25 mg

EPY0000816 Atropine impurity B (1R,3r,5S)-8-azabicyclo[3.2.1]oct-3-yl (2RS)-3-hydroxy-2-phenylpropanoate (noratropine)

10 mg

EPA1400000 Atropine sulphate 50 mg

EPY0000029 Azaperone 50 mg

EPA1500000 Azathioprine 100 mg

EPY0001240 Azathioprine impurity A 1-methyl-4-nitro-1H-imidazol-5-amine

10 mg

EPY0001246 Azathioprine impurity G 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)sulfanyl]-7H-purin-2-amine (thiamiprine)

5 mg

EPY0000326 Azelastine hydrochloride 25 mg

EPY0000327 Azelastine impurity B 1-benzoyl-2-[(4RS)-1-methylhexahydro-1H-azepin-4-yl]diazane

5 mg

EPY0000328 Azelastine impurity D 4-(4-chlorobenzyl)phthalazin-1(2H)-one

5 mg

EPY0000329 Azelastine impurity E 3-(4-chlorobenzilidene)isobenzofuran-1(3H)-one

5 mg

EPY0000306 Azithromycin 200 mg

EPY0000637 Azithromycin for peak identification 15 mg

EPY0000641 Azithromycin for system suitability 0.05 mg

EPY0000307 Azithromycin impurity A 6-demethylazithromycin

10 mg

EPY0000285 B19 virus DNA for NAT testing BRP 150 mg

EPB0070000 Bacampicillin hydrochloride 120 mg

EPB0100000 Bacitracin zinc 150 mg

EPB0200000 Baclofen 50 mg

EPB0200050 Baclofen impurity A (RS)-4-amino-3-(4-chlorophenyl)butyric acid lactam

50 mg

EPY0001273 Baicalin 10 mg

EPB0250000 Bambuterol hydrochloride 100 mg

EPB0300000 Barbital Controlled Substance 500 mg

EPY0000295 Basic butylated methacrylate copolymer - Reference Spectrum unit



Code Product Unit

EPB0305000 Beclometasone dipropionate anhydrous 150 mg

EPY0000351 Beclometasone dipropionate monohydrate 10 mg

EPY0000352 Beclometasone dipropionate for system suitability 10 mg

EPY0000469 Beclometasone dipropionate for peak identification 10 mg

EPY0001073 Beclometasone dipropionate impurities F and N 0.052 mg

EPY0001025 Benazepril hydrochloride 160 mg

EPY0001038 Benazepril for system suitability 0.016 mg

EPY0001026 Benazepril impurity A [(3R)-3-[[(1R)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetic acid

10 mg

EPB0400000 Bendroflumethiazide 100 mg

EPY0000564 Bendroflumethiazide impurity A 4-amino-6-(trifluoromethyl)benzene-1,3-disulphonamide

5 mg

EPY0000044 Benfluorex hydrochloride 50 mg

EPY0000043 Benfluorex hydrochloride for system suitability 360 mg

EPB0470000 Benperidol 100 mg

EPB0477000 Benserazide hydrochloride 50 mg

EPB0477010 Benserazide impurity A (RS)-2-amino-3-hydroxypropanohydrazide

20 mg

EPY0001071 Benserazide impurity C (2RS)-2-amino-3-hydroxy-2'-[(1EZ)-(2,3,4-trihydroxybenzylidene)]propanohydrazide

10 mg

EPY0001079 Benserazide for peak identification 10 mg

EPY0001064 Benzaldehyde 150 mg

EPY0001060 Benzalkonium chloride for system suitability 20 mg

EPB0500000 Benzathine benzylpenicillin 125 mg

EPY0000775 Benzbromarone 10 mg

EPB0550000 Benzethonium chloride 100 mg

EPB0600000 Benzocaine 50 mg

EPY0000647 Benzophenone 40 mg

EPY0000167 Benzyl alcohol 50 mg

EPB0670000 Benzyl benzoate - Reference Spectrum unit

EPB0680000 S-Benzylmercaptoacetyltriglycin 10 mg

EPB0700000 Benzylpenicillin potassium 50 mg

EPB0900000 Benzylpenicillin sodium 200 mg

EPY0001149 Berberine chloride 20 mg

EPB0950000 Betadex 200 mg

EPY0000391 Betahistine dihydrochloride 50 mg

EPB0990000 Betahistine mesilate 100 mg

EPB1000000 Betamethasone 75 mg

EPB1030000 Betamethasone acetate 100 mg

EPB1040000 Betamethasone diproprionate 100 mg

EPB1045000 Betamethasone sodium phosphate 100 mg

EPB1054000 Betamethasone-17-valerate 100 mg

EPB1055000 Betamethasone-21-valerate 15 mg

EPY0001027 Betamethasone valerate for system suitability 25 mg

EPY0001065 Betamethasone valerate impurity mixture 0.018 mg

New EPY0001360 Betaxolol for peak identification 15 mg

EPB1103000 Betaxolol hydrochloride 60 mg

EPB1103100 Betaxolol impurity A (RS)-3-(4-ethylphenoxy)-1-[(1-methylethyl)-amido]propan-2-ol

10 mg

New EPY0001354 Betaxolol impurity C 2-[[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]methyl]oxirane

5 mg

EPB1115000 Bezafibrate 100 mg

EPY0001078 Bicisate labelling kit 1024 mg



Code Product Unit

EPB1110000 Bifonazole 100 mg

EPB1110004 Bifonazole impurity B 4-[(RS)-(biphenyl-4-yl)phenylmethyl]-1H-imidazole trifluoroacetate

10 mg

EPY0001059 Bilberry dry extract 250 mg

EPB1116000 Biotin (Vitamin H) 20 mg

EPB1120000 Biperiden hydrochloride 60 mg

EPB1121000 Biperiden impurity A (1RS)-1-[(1SR,2SR,4SR)-bicyclo[2.2.1]hept-5-en-2-yl]-1-phenyl-3-(piperidin-1-yl)propan-1-ol (endo form)

20 mg

EPB1130000 1,3-bis(2-acetyl-3-hydroxyphenoxy)-2-propanol 50 mg

EPB1140000 Bisacodyl 50 mg

EPY0000608 Bisacodyl for peak identification 10 mg

EPY0000694 Bisacodyl for system suitability 5 mg

EPY0000812 Bisoprolol fumarate 50 mg

EPY0000877 Bisoprolol for system suitability method A 1 mg

EPY0000813 Bisoprolol for system suitability method B 1 mg

EPB1141000 Bleomycin sulphate 7 mg

EPY0000434 Boldine 30 mg

EPB1142000 Bordetella pertussis mouse antiserum BRP 0.5 mg

EPB1143000 Bromazepam Controlled Substance 60 mg

EPY0000645 Bromazepam for system suitability Controlled Substance 10 mg

EPB1145000 Bromhexine hydrochloride 100 mg

EPY0000200 Bromhexine impurity C N-(2-aminobenzyl)-N-methylcyclohexanamine

10 mg

EPB1150000 Bromocriptine mesilate 30 mg

EPY0000677 Bromocriptine mesilate for system suitability 5 mg

EPB1152000 Bromperidol 100 mg

EPB1152050 Bromperidol decanoate 60 mg

EPB1153000 Brompheniramine maleate 100 mg

EPY0000468 Brotizolam Controlled Substance 10 mg

EPY0000470 Brotizolam impurity B 2-bromo-4-(2-chlorophenyl)-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine (demethylbrotizolam)

10 mg

EPB1155000 Brucella melitensis Rev. 1 strain BRP 1 mL

EPB1157300 Budesonide 110 mg

EPY0001148 Budesonide for system suitability 10 mg

EPB1156000 Bufexamac 100 mg

EPB1157400 Buflomedil hydrochloride 100 mg

EPB1157410 Buflomedil impurity B 4-(pyrrolidin-1-yl)-1-(4-hydroxy-2,6-dimethoxyphenyl)butan-1-one

20 mg

EPB1158000 Bumetanide 150 mg

EPY0000309 Bumetanide impurity A 3-nitro-4-phenoxy-5-sulphamoylbenzoic acid

5 mg

EPY0000310 Bumetanide impurity B 3-amino-4-phenoxy-5-sulphamoylbenzoic acid

5 mg

EPB1160000 Bupivacaine hydrochloride 100 mg

EPY0000088 Bupivacaine impurity B (2RS)-N-(2,6-dimethylphenyl)piperidine-2-carboxamide

20 mg

EPY0000089 Bupivacaine impurity E 6-(butylamino)-N-(2,6-dimethylphenyl)hexanamide

20 mg

EPY0001108 Buprenorphine Controlled Substance 10 mg

EPY0001109 Buprenorphine hydrochloride Controlled Substance 10 mg

EPY0001122 Buprenorphine for system suitability Controlled Substance 10 mg

EPB1168000 Buserelin 2 mg

EPB1168020 D-His-Buserelin 0.5 mg



Code Product Unit

EPY0000131 Buspirone hydrochloride 5 mg

EPY0000471 Buspirone for system suitability 2 mg

EPB1170000 Busulfan 50 mg

EPB1217000 Butyl parahydroxybenzoate 100 mg

EPB1212000 Butylhydroxyanisole 50 mg

EPB1215000 Butylhydroxytoluene Plastic additive 07

50 mg

New EPY0001304 Butyl methanesulfonate 30 µl

New EPY0001357 Butyl parahydroxybenzoate impurity E 2-methylpropyl 4-hydroxybenzoate (iso-butyl parahydroxybenzoate)

15 mg

EPY0000472 Cabergoline 100 mg

EPC0100000 Caffeine 70 mg

EPY0000787 Caffeine for system suitability 20 mg

EPC0166000 Calcifediol 5 mg

EPC0166001 Calcifediol - Reference Spectrum unit

EPY0000499 Calcipotriol (anhydrous) - Reference Spectrum unit

EPY0000473 Calcipotriol monohydrate 5 mg

EPY0000474 Calcipotriol monohydrate - Reference Spectrum unit

EPC0200000 Calcitonin (salmon) 2x0.98 mg

EPY0000632 Calcitonin-Gly 0.4 mL

EPC0200010 N-acetyl-cys1-calcitonin 20 mg

EPC0225000 Calcitriol 10 mg

EPC0226000 Calcitriol - Reference Spectrum unit

EPC0250000 Calcium folinate 100 mg

EPC0299000 Calcium glucoheptonate 60 mg

EPC0300000 Calcium gluconate 100 mg

EPC0340000 Calcium levulinate dihydrate 250 mg

EPC0350000 Calcium oxalate monohydrate 500 mg

EPC0400000 Calcium pantothenate 60 mg

EPC0405000 Camphor (racemic) 50 mg

New EPY0001388 Candesartan cilexetil 60 mg

New EPY0001389 Candesartan for system suitability 10 mg

EPC0410000 Canrenone 50 mg

EPC0426000 Caprylic acid 200 mg

EPY0000671 Capsaicin 50 mg

EPC0430000 Captopril 10 mg

EPY0001182 Captopril for system suitability 20 mg

New EPY0001219 Captopril impurity B (2S) 1-[(2S)-3-bromo-2-methylpropanoyl]pyrrolidine-2-carboxylic acid

250 mg

EPY0001220 Captopril impurity C (2RS)-2-methyl-3-sulphanylpropanoic acid

10 mg

EPY0001221 Captopril impurity D (2RS)-3-bromo-2-methylpropanoic acid

10 mg

EPY0000435 Captopril impurity E (2S)-1-isobutyryl-pyrrolidine-2-carboxylic acid

10 mg

EPY0000113 Carbachol 50 mg

EPC0450000 Carbamazepine 200 mg

EPY0000033 Carbamazepine impurity A 10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide(10,11-dihydrocarbamazepine)

10 mg

EPC0451000 Carbasalate calcium - Reference Spectrum unit

EPY0001161 Carbasalate impurity B 2-[[2-(acetyloxy)benzoyl]oxy]benzoic acid (acetylsalicylsalicylic acid)

5 mg

EPC0455000 Carbenicillin sodium 50 mg

EPC0460000 Carbidopa 50 mg



Code Product Unit

EPC0465000 Carbimazole 100 mg

EPC0470000 Carbocisteine 60 mg

EPC0499900 Carbon dioxide - Reference Spectrum unit

EPC0550000 Carboplatin - Reference Spectrum unit

EPY0000475 Carboprost trometamol 40 mg

EPY0000536 Carboprost trometamol - Reference Spectrum unit

EPY0000035 Carisoprodol 50 mg

EPY0000036 Carisoprodol impurity A (2RS)-2-(hydroxymethyl)-2-methylpentyl(1-methylethyl)carbamate

10 mg

EPY0001214 Carmellose 10 mg

EPC0580004 Carmustine - Reference Spectrum unit

EPC0580010 Carmustine impurity A 1,3-bis(2-chloroethyl)urea

20 mg

EPY0000846 Carprofen for veterinary use 30 mg

EPY0000884 Carprofen for system suitability 5 mg

EPY0000192 Carteolol hydrochloride - Reference Spectrum unit

EPY0000193 Carteolol for system suitability 30 mg

EPY0000075 Carvedilol - Reference Spectrum unit

EPY0000103 Carvedilol impurity C (2RS)-1-[benzyl[2-(2-methoxyphenoxy)ethyl]amino]-3-(9H-carbazol-4-yloxy) propan-2-ol

10 mg

EPC0600000 Casein BRP 100 g

EPC0630000 Cefaclor 450 mg

EPC0640000 Delta-3-Cefaclor 20 mg

EPC0650000 Cefadroxil 250 mg

EPC0675000 Cefalexin monohydrate 150 mg

EPC0682000 Cefalotin sodium 100 mg

EPY0000505 Cefalotin for impurity B identification 10 mg

EPC0682300 Cefamandole nafate 125 mg

EPY0000240 Cefapirin sodium 100 mg

EPC0682400 Cefatrizine propylene glycol 150 mg

EPC0682410 Cefatrizine impurity A 7-amino-(6R,7R)-3-[(2H-1,2,3-triazol-4-yl)sulfanyl]-methyl-8-oxo-5-thia-1-azabicyclo[4.2.O]oct-2-ene-2-carboxylic acid(7-ACA triazole)

60 mg

EPC0682800 Cefazolin 150 mg

EPY0000633 Cefepime dihydrochloride monohydrate 150 mg

EPY0000634 Cefepime dihydrochloride monohydrate for system suitability 15 mg

New EPY0001336 Cefepime impurity E (6R,7R)-7-amino-3-[(1-methylpyrrolidinio)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

10 mg

EPC0684000 Cefixime 200 mg

EPC0684750 Cefoperazone dihydrate 100 mg

EPC0684800 Cefoperazone sodium - Reference Spectrum unit

EPY0000420 Cefotaxime acid 80 mg

EPC0685000 Cefotaxime sodium 30 mg

EPY0000506 Cefotaxime sodium for peak identification 10 mg

EPC0688000 Cefoxitin sodium 100 mg

New EPY0001305 Cefpodoxime proxetil 70 mg

New EPY0001306 Cefpodoxime proxetil for peak identification 10 mg

New EPY0001318 Cefpodoxime proxetil for impurity H identification 10 mg

EPC0690000 Cefradine 300 mg

EPY0001111 Ceftazidime for peak identification 10 mg

EPY0000568 Cefradine for peak identification 6 mg

EPY0001174 Cefradine impurity mixture 0.04 mg

EPC0690500 Ceftazidime 200 mg



Code Product Unit

EPC0690510 Ceftazidime impurity A (6R,7R)-7-[[(Z)-2-(2-aminothiazol-4-yl)-2-[(1-carboxy-1-methylethoxy) imino]acetyl]amino]-8-oxo-3-[(1-pyridinio)-methyl]-5-thia-1-azabicyclo [4.2.O]oct-3-ene-2-carboxylate (delta-2-ceftazidime)

15 mg

EPC0691000 Ceftriaxone sodium 80 mg

EPC0692000 Ceftriaxone impurity A E-isomer

10 mg

EPC0694990 Cefuroxime axetil 60 mg

EPC0695000 Cefuroxime sodium 150 mg

EPY0000311 Celiprolol hydrochloirde 10 mg

EPY0000312 Celiprolol impurity I 1-acetyl-1-(4-ethoxyphenyl)-3,3-diethylurea

0.02 mg

EPY0000239 Celiprolol for peak identification 20 mg

EPY0000784 Cellulose acetate 40 mg

EPC0698005 Cellulose acetate butyrate - Reference Spectrum unit

EPY0001054 Cellulose acetate phthalate 10 mg

EPC0700000 Cephaeline hydrochloride 15 mg

EPC0980650 Cetirizine dihydrochloride 100 mg

EPY0001197 Cetirizine for peak identification 1.01 mg

EPC0980651 Cetirizine impurity A (RS)-1-[(4-chlorophenyl)phenylmethyl]piperazine

10 mg

EPC0984100 Cetostearyl isononanoate - Reference Spectrum unit

EPC0990000 Cetyl alcohol 250 mg

EPY0000073 Cetyl palmitate 15 60 mg

EPY0000074 Cetyl palmitate 95 50 mg

EPC1000000 Cetylpyridinium chloride 50 mg

EPC1050000 Chenodeoxycholic acid 125 mg

EPY0000104 Chitosan hydrochloride 30 mg

EPC1100000 Chlorambucil 100 mg

New EPY0001298 Chlorambucil for system suitability 10 mg

New EPY0001299 Chlorambucil with impurity G 10 mg

EPC1200000 Chloramphenicol 500 mg

EPC1300000 Chloramphenicol dipalmitate 100 mg

EPC1350000 Chloramphenicol disodium disuccinate 25 mg

EPC1400000 Chloramphenicol palmitate isomer 100 mg

EPC1425000 Chloramphenicol sodium succinate 1500 mg

EPC1435000 Chlorcyclizine hydrochloride 100 mg

EPC1450000 Chlordiazepoxide Controlled Substance 2x50 mg

EPC1500000 Chlordiazepoxide hydrochloride Controlled Substance 100 mg

EPY0000476 Chlordiazepoxide impurity A 7-chloro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one 4-oxide

10 mg

EPC1510000 Chlorhexidine 50 mg

EPC1520000 Chlorhexidine diacetate 10 mg

EPC1540000 Chlorhexidine dihydrochloride 50 mg

EPC1530000 Chlorhexidine for performance test 50 mg

EPY0000569 Chlorogenic acid 20 mg

EPC2223030 1-(4-Chlorophenyl)-1-phenylethanol Clemastine fumarate impurity C

20 mg

EPC1650000 Chloroquine sulphate 200 mg

EPC1700000 Chlorothiazide 100 mg

EPC1800000 Chlorphenamine maleate 100 mg

EPY0000436 Chlorphenamine impurity A 2-(4-chlorophenyl)-4-(dimethylamino)-2-[2-(dimethylamino)ethyl]butanenitrile

0.01 mg

EPY0000437 Chlorphenamine impurity C (3RS)-3-(4-chlorophenyl)-N-methyl-3-(pyridin-2-yl)propan-1-amine

10 mg



Code Product Unit

EPC1900000 Chlorpromazine hydrochloride 200 mg

EPY0000507 Chlorpromazine impurity A 3-(2-chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1- amine S-oxide (chlorpromazine sulphoxide)

10 mg

EPY0000479 Chlorpromazine impurity D 3-(2-chloro-10H-phenothiazin-10-yl)-N-methypropan-1-amine (demethylchlorpromazine)

10 mg

EPY0000508 Chlorpromazine impurity E 2-chloro-10H-phenothiazine

10 mg

EPC1905000 Chlorpropamide 100 mg

EPC1905020 Chlorpropamide impurity B 1,3-Dipropylurea

50 mg

EPC1915000 Chlorprothixene hydrochloride 50 mg

EPC1950000 Chlortalidone 150 mg

EPY0000779 Chlortalidone for peak identification 1.017 mg

EPC2000000 Chlortetracycline hydrochloride 100 mg

EPC2100000 Cholecalciferol 500 mg

EPC2150000 Cholecalciferol for system suitability 1 mL

EPC2155000 Cholesterol 60 mg

EPC2158000 Cholic acid 60 mg

EPY0000280 Chondroitin sulphate sodium 250 mg

EPY0000593 Chondroitin sulphate sodium (marine) 100 mg

EPC2160000 Chymotrypsin BRP 100 mg

EPY0000040 Ciclopirox 100 mg

EPC2162701 Ciclopirox impurity A (RS)-2-(3-cyclohexyl-5-methyl-4,5-dihydroisoxazol-5-yl)acetic acid

20 mg

EPC2162702 Ciclopirox impurity B 6-cyclohexyl-4-methyl-2H-pyran-2-one

20 mg

EPC2162700 Ciclopirox olamine 150 mg

EPC2163000 Ciclosporin 120 mg

EPY0000361 Ciclosporin for system suitability 5 mg

EPC2170000 Cilastatin sodium 10 mg

EPC2174000 Cilazapril 50 mg

EPC2174002 Cilazapril impurity A 1,1-dimethylethyl(1S,9S)-9-[[(S)-1-ethoxycarbonyl-3-phenylpropyl]amino]- 10-oxo-octahydro-6H-pyridazino[1,2a][1,2]diazepine-1-caboxylate

25 mg

EPC2174005 Cilazapril impurity D (1S,9S)-9-[[(R)-1-ethoxycarbonyl-3-phenylpropyl]amino]-10-oxo-octahydro-6H-pyridazino[1,2a][1,2]diazepine-1-carboxylic acid

10 mg

EPC2175000 Cimetidine 50 mg

EPC2175500 Cimetidine hydrochloride 100 mg

EPY0001130 Cimetidine for peak identification 10 mg

EPY0001146 Cimetidine for system suitability 0.5085 mg

EPC2177000 Cinchocaine hydrochloride 60 mg

EPY0000176 Cineole 180 mg

EPC2180000 Cinnarizine 100 mg

EPY0000362 Ciprofibrate 5 mg

EPY0000363 Ciprofibrate for system suitability 5 mg

EPY0000198 Ciprofloxacin 20 mg

EPC2190000 Ciprofloxacin hydrochloride 100 mg

EPY0000199 Ciprofloxacin hydrochloride for peak identification 10 mg

EPC2190050 Ciprofloxacin impurity A 7-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid (fluoroquinolonic acid)

10 mg

EPC2210000 Cisplatin 100 mg

EPY0001018 Cisplatin impurity A trans-diamminedichloroplatinium (II)

10 mg



Code Product Unit

EPY0001019 Cisplatin impurity B amminetrichloroplatinate (-)

10 mg

EPY0001007 Citalopram hydrochloride 5 mg

EPY0001008 Citalopram hydrobromide 5 mg

EPY0000855 Citalopram for system suitability 0.06 mg

EPA1202000 Citric acid (anhydrous) 50 mg

EPC2219000 Citric acid monohydrate 50 mg

EPY0000639 Cladribine 50 mg

EPY0000609 Cladribine for peak identification 10 mg

EPY0000610 Cladribine impurity C 2-chloro-7H-purin-6-amine

5 mg

EPY0000320 Clarithromycin 160 mg

EPY0000321 Clarithromycin for peak identification 30 mg

EPY0000269 Clazuril for system suitability 10 mg

EPC2221000 Clebopride malate 100 mg

EPC2223000 Clemastine fumarate 100 mg

EPC2248000 Clenbuterol hydrochloride 30 mg

EPC2248010 Clenbuterol impurity B 1-(4-amino-3,5-dichlorophenyl)-2-[(1,1-dimethylethyl)amino]ethanone (clenbuterol ketone)

10 mg

EPC2250000 Clindamycin hydrochloride 200 mg

EPC2269000 Clindamycin phosphate 250 mg

EPY0000364 Clioquinol 5 mg

EPY0000205 Clobazam - Reference Spectrum unit

EPY0000241 Clobazam impurity A 7-chloro-5-phenyl-1,5-dihydro-1,5-dihydro-3H-1,5-benzodiazepine-2,4-dione

10 mg

EPY0000559 Clobetasol propionate 40 mg

EPY0000570 Clobetasol for peak identification 2 mg

EPY0000571 Clobetasol impurity J (17R)-4'-chloro-5'-ethyl-9-fluoro-11ß-hydroxy-16ß-methylspiro[androsta-1,4-diene-17,2'(3'H)-furan]-3,3'-dione (17 alpha-spiro compound)

0.4 mg

EPC2285000 Clobetasone butyrate 50 mg

EPY0001137 Clobetasone butyrate for system suitability 30 mg

EPY0000888 Clodronate disodium tetrahydrate 5 mg

EPY0000885 Clodronate impurity D (chloromethylene)bis(phosphonic acid)

5 mg

EPY0000313 Clofazimine 150 mg

EPY0000358 Clofazimine for system suitability 10 mg

EPC2300000 Clofibrate 0.5 mL

EPC2320000 Clomifene citrate 50 mg

EPC2332000 Clomifene citrate for performance test 50 mg

EPC2360000 Clomipramine hydrochloride 100 mg

EPY0000132 Clomipramine impurity C 3-(3-chloro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine

10 mg

EPY0000133 Clomipramine impurity D 3-(3,7-dichloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl) N,N-dimethylpropan-1-amine

10 mg

EPY0000134 Clomipramine impurity F 3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine

5 mg

EPC2385000 Clonazepam Controlled Substance 50 mg

EPC2385015 Clonazepam impurity B 3-Amino-4-(2-chlorophenyl)-6-nitro-1H-quinolin-2-one

25 mg

EPY0000286 Clonazepam - Reference Spectrum unit

EPC2400000 Clonidine hydrochloride 100 mg

EPY0000801 Clonidine impurity B 1-acetyl-2-[(2,6-dichlorophenyl)amino]-4,5-dihydro-1H-imidazole

20 mg

EPY0000833 Clopamide 40 mg



Code Product Unit

EPY0000848 Clopamide for system suitability 10 mg

New EPY0001333 Clopidogrel hydrogen sulfate 60 mg

New EPY0001334 Clopidogrel for system suitability 100 mg

New EPY0001335 Clopidogrel impurity A (2S)-(2-chlorophenyl)[6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]acetic acid

10 mg

EPY0000392 Closantel sodium dihydrate 20 mg

EPY0000393 Closantel for system suitability 20 mg

EPC2424400 Clostridia (multi-component) rabbit antiserum (for vaccines-vet.use) BRP

1 mg

EPC2424550 Clostridium tetani guinea pig antiserum (for vaccines-human use) BRP

3x1 mL

EPC2424500 Clostridium tetani guinea pig antiserum (for vaccines - vet.use) BRP

1 mg

EPC2425600 Clostridium tetani rabbit antiserum (for vaccines - vet.use) BRP

1 mg

EPC2430000 Clotrimazole 100 mg

EPY0000818 Clotrimazole impurity E (2-chlorophenyl)phenylmethanone (2-chlorobenzophenone)

15 mg

EPY0000849 Clotrimazole for peak identification 1 mg

EPC2450000 Cloxacillin sodium 200 mg

EPC2460000 Clozapine 60 mg

EPY0000758 Clozapine for peak identification 0.41 mg

EPY0000162 Cocaine hydrochloride - Reference Spectrum unit

EPC2480000 Cocoyl caprylocaprate 40 mg

EPY0000722 Codeine Controlled Substance 20 mg

EPC2500000 Codeine - Reference Spectrum unit

EPY0000334 Codeine impurity A 7,8-didehydro-4,5α-epoxy-3,6α-dimethoxy-17-methylmorphinan (o-methylcodeine) Controlled Substance

10 mg

EPC2500100 Codeine hydrochloride dihydrate - Reference Spectrum unit

EPC2510000 Codergocrine mesilate 60 mg

EPC2580000 Colchicine 50 mg

EPY0000209 Colchicine for system suitability 10 mg

EPY0000374 Colestyramine 10 mg

EPC2600000 Colistimethate sodium 20 mg

EPY0000277 Colistin sulphate 25 mg

EPC2700000 Colistin sulphate for microbiological assay 25 mg

EPC2725000 Copovidone - Reference Spectrum unit

EPC2800000 Cortisone acetate 250 mg

EPY0000438 Coumarin 80 mg

EPC2900000 Cotton wool standard for neps 1000 mg

EPY0001053 Crospovidone 5 mg

EPC2970000 Crotamiton 100 mg

EPC2970005 Crotamiton impurity A N-ethyl-N-(2-methylphenyl)but-3-enamide

30 mg

EPY0001061 Cyanidin chloride 20 mg

EPC3000000 Cyanocobalamin 20 mg

EPC3090000 Cyclizine hydrochloride 50 mg

EPY0000886 Cyclizine impurity A 1-methylpiperazine

15 mg

EPY0000887 Cyclizine impurity B diphenylmethanol (benzhydrol)

10 mg

EPC3200000 Cyclobenzaprine hydrochloride 100 mg

EPC3230000 Cyclohexa-1,4-dienylglycine 20 mg

EPC3245000 Cyclopentolate hydrochloride 2x50 mg



Code Product Unit

EPY0001088 Cyclopentolate for system suitability 60 mg

EPC3250000 Cyclophosphamide 50 mg

EPC3280000 Cyproheptadine hydrochloride 30 mg

EPY0001095 Cyproheptadine impurity C 5-(1-methylpiperidin-4-yl)-5H-dibenzo[a,d][7]annulen-5-ol

5 mg

EPC3283000 Cyproterone acetate 30 mg

New EPY0001390 Cyproterone acetate for peak identification 5 mg

EPY0001223 Cyproterone impurity mixture 0.01 mg

EPC3290000 Cysteine hydrochloride monohydrate 50 mg

EPC3300000 Cystine 100 mg

EPC3350000 Cytarabine 150 mg

EPY0000733 Dacarbazine 20 mg

EPY0000734 Dacarbazine impurity A 3,7-dihydro-4H-imidazo[4,5-d]-1,2,3-triazin-4-one (2-azahypoxanthine)

10 mg

EPY0000735 Dacarbazine impurity B 5-amino-1H-imidazole-carboxamide

10 mg

EPD0070000 Dalteparin sodium 250 mg

EPY0000600 Danaparoid sodium 10 mg

EPD0100000 Dapsone 100 mg

EPD0125000 Daunorubicin hydrochloride 100 mg

EPD0120000 Daunorubicinone Daunorubicin aglycone

10 mg

EPD0160000 Deferoxamine mesilate 30 mg

EPD0201000 Dehydrohexetidine 50 mg

EPY0000611 Dembrexine hydrochloride monohydrate 10 mg

EPD0300000 Demeclocycline hydrochloride 100 mg

EPD0350000 N-Demethylerythromycin A 10 mg

EPY0000228 Demethylflumazenil - Reference Spectrum unit

EPD0406000 Deoxyminoxidil 0.25 mg

EPD0406200 Deptropine citrate 60 mg

EPD0430000 Dequalinium chloride 50 mg

EPD0431000 Dequalinium chloride for performance test 50 mg

EPY0001321 Dermatan sulfate and oversulfated chondroitin sulfate 1 mL

EPD0480000 Desacetylvinblastine 2x1 mg

EPY0000879 Desflurance - Reference Spectrum unit

EPY0000807 Desflurane impurity A 1,1'-oxybis(1,2,2,2-tetrafluoroethane)

1 mL

EPD0500000 Desipramine hydrochloride 100 mg

EPD0600000 Deslanoside 150 mg

EPD0630000 Desmethylmetrifonate 30 mg

EPD0650000 Desmopressin 0.98 mg

EPY0000509 Desogestrel 50 mg

EPY0000510 Desogestrel for system suitability 10 mg

EPD0400000 Desoxycortone acetate 100 mg

EPY0000001 Detomidine hydrochloride 100 mg

EPD0660020 Detomidine impurity B (RS)-(1-benzyl-1H-imidazol-5-yl)(2,3-dimethylphenyl)methanol

20 mg

EPD0700000 Dexamethasone 60 mg

EPY0001177 Dexamethasone for system suitability 10 mg

EPD0710000 Dexamethasone acetate 100 mg

EPY0001169 Dexamethasone acetate impurity E 9-fluoro-11beta,17-dihydroxy-16alpha-methyl-3,20-dioxopregn-4-en-21-yl acetate

0.013 mg

EPY0000538 Dexamethasone isonicotinate 10 mg

EPY0000511 Dexamethasone isonicotinate for impurity C identification 10 mg



Code Product Unit

EPD0718000 Dexamethasone pivalate 50 mg

EPD0720000 Dexamethasone sodium phosphate 100 mg

EPD0720800 Dexchlorpheniramine maleate 60 mg

EPD0730000 Dexpanthenol 5 mg

EPD0731000 Dextran 25 mg

EPD0731005 Dextran 1 50 mg

EPD0732000 Dextran Vo 10 mg

EPD0733000 Dextran 4 for calibration 50 mg





EPD0738000 Dextran 40 for performance test 50 mg

EPD0739000 Dextran 60/70 for performance test 50 mg

EPY0000744 Dextranomer 50 mg

EPD0740000 Dextromethorphan hydrobromide 100 mg

EPY0000261 Dextromethorphan impurity A ent-3-methoxymorphinan

5 mg

EPY0001058 Dextropropoxyphene hydrochloride Controlled Substance 10 mg

EPY0001150 Dextropropoxyphene for system suitability Controlled Substance 5 mg

EPD0940000 Diazepam Controlled Substance 30 mg

EPY0000596 Diazepam for system suitability Controlled Substance 0.5 mg

EPD0950000 Diazoxide 50 mg

EPD0970000 Dibenzocycloheptene 20 mg

EPD1000000 Dibenzosuberone 100 mg

EPY0000480 Dibrompropamidine diisetionate 10 mg

EPY0000481 Dibrompropamidine for system suitability 20 mg

EPD1010000 Dibutyl phthalate 1 mL

EPY0000275 Dichlorodiaminocyclohexaneplatinum 10 mg

EPY0000259 Diclazuril for system suitability 20 mg

EPY0000264 Diclazuril for veterinary use - Reference Spectrum unit

EPD1039990 Diclofenac potassium 100 mg

EPD1040000 Diclofenac impurity A 1-(2,6-dichlorophenyl)-indolin-2-one

0.005 mg

EPD1050000 Dicloxacillin sodium 250 mg

EPD1060000 Dicycloverine hydrochloride 100 mg

EPY0000439 Didanosine 10 mg

EPY0000440 Didanosine for system suitability 10 mg

EPY0000441 Didanosine impurity A 1,7-dihydro-6H-purin-6-one (hypoxanthine)

10 mg

EPY0000442 Didanosine impurity G 9-(2,3-dideoxy-β-D-glycero-pentofuranosyl)-9H-purin-6-amine (2',3'-dideoxyadenosine)

10 mg

EPD1200000 Dienestrol 150 mg

EPD1250000 Diethanolamine fusidate 50 mg

EPD1300000 Diethylcarbamazine citrate 250 mg

EPY0000217 Diethylene glycol (monoethyl ether) - Reference Spectrum unit

EPD1410000 Diethyl phthalate 1 mL

EPD1500000 Diethylstilbestrol 100 mg

EPD1600000 Diethylstilbestrol dimethyl ether 10 mg

EPD1700000 Diethylstilbestrol monomethyl ether 10 mg

EPD1750000 Diflunisal 30 mg

EPD1800000 Digitoxin 250 mg



Code Product Unit

EPY0000640 Digoxigenin 5 mg

EPD1900000 Digoxin 30 mg

EPY0000554 Digoxin for peak identification 10 mg

EPD1940001 Dihydralazine sulphate (hydrated) - Reference Spectrum unit

EPY0000232 Dihydralazine for system suitability 10 mg

EPY0000216 Dihydrocodeine hydrogen tartrate - Reference Spectrum unit

EPY0000053 17 alpha-dihydroequilin 10 mg

EPD1945000 Dihydroergocristine mesilate 250 mg

EPD1950000 Dihydroergotamine mesilate 100 mg

EPY0000831 Dihydroergotamine for peak identification 10 mg

EPD1952000 Dihydroergotamine tartrate 150 mg

EPD1954000 Dihydrostreptomycin sulphate (for LC assay) 25 mg

EPY0000544 Dihydrotachysterol 30 mg

EPY0000482 Dihydrotachysterol for system suitability 5 mg

EPD1980000 Diltiazem hydrochloride 300 mg

EPY0001141 Diltiazem for system suitability 10 mg

EPD2000000 Dimenhydrinate 100 mg

EPY0000234 N,N-Dimethylacetamide - Reference Spectrum unit

EPY0001103 Dimenhydrinate for peak identification 1 mg

EPD2050000 Dimethyl sulfoxide 1 mL

EPD2200000 Dimeticone 200 mg

EPD2205000 Dimetindene maleate 50 mg

EPD2255000 Dinoprost trometamol 60 mg

EPD2250000 Dinoprostone 100 mg

EPD2250015 Dinoprostone impurity C (E)-7-[(1S,2R,3R)-3-hydroxy-2-[(E)-(3S)-3-hydroxyoct-1-enyl]- 5-oxocyclopentyl]-hept-5-enoic acid (5-trans-PGE2;(5E)-PGE2)

10 mg

EPY0000094 Diosmin 50 mg

EPY0000095 Diosmin for system suitability 5 mg

EPD2600000 Diphenhydramine hydrochloride 100 mg

EPY0000135 Diphenhydramine impurity A 2-(diphenylmethoxy)-N-methylethanamine

10 mg

EPD2630000 Diphenoxylate hydrochloride - Reference Spectrum unit

EPY0000258 Diphtheria toxin BRP 1 mL

EPD2700000 Diphtheria vaccine (absorbed) BRP 32 mg

EPY0000376 Dipivefrine hydrochloride 100 mg

EPY0000394 Dipivefrine for system suitability 10 mg

EPD2750100 Dipotassium clorazepate - Reference Spectrum unit

EPD2800000 Diprophylline 100 mg

EPD2850000 Dipyridamole 50 mg

EPY0000802 Dipyridamole for peak identification 2 mg

EPD2880000 Dirithromycin 100 mg

EPD2900000 Disodium edetate 100 mg

EPD2920000 Disopyramide 100 mg

EPD2922000 Disopyramide phosphate 100 mg

EPD2950000 Disulfiram 100 mg

EPD2953000 Dithranol 125 mg

EPD2953025 Dithranol impurity C Dithranol-dimer 4,4',5,5'-tetrahydroxy-9,9'-bianthracenyl-10,10'(9H,9'H)-dione

20 mg

EPD2953050 Dithranol impurity D 1-hydroxyanthracen-9(10H)-one

20 mg

EPD2954000 Dobutamine hydrochloride 100 mg

EPY0001239 Dobutamine impurity mixture 0.1 mg



Code Product Unit

EPY0001133 Docetaxel trihydrate 160 mg

EPY0001155 Docetaxel for system suitability 10 mg

EPD2954600 Docosahexaenoic acid ethyl ester 150 mg

EPD2954500 Docusate sodium - Reference Spectrum unit

EPY0000365 Dodecyl gallate 30 mg

EPD2955000 Domperidone 150 mg

EPD2957000 Domperidone maleate 150 mg

EPD2960000 Dopamine hydrochloride 50 mg

EPY0000612 Dopexamine dihydrochloride 10 mg

EPY0000613 Dopexamine impurity B 2-methoxy-4-[2-[[6-[(2-phenylethyl)hexyl]amino]ethyl]phenol

10 mg

EPY0000614 Dopexamine impurity F 4-Chloro-5-[2-[[6-[(2-phenylethyl)amino]hexyl]amino]ethyl]benzene-1,2-diol

10 mg

EPY0000726 Dorzolamide hydrochloride 50 mg

EPY0000727 Dorzolamide impurity A (4R,6R)-4-(ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b] thiopyran-2-sulphonamide 7,7-dioxide

5 mg

EPY0000750 Dorzolamide for system suitability 5 mg

EPD2962000 Dosulepin hydrochloride 100 mg

EPD2962005 Dosulepin impurity A (E)-3-(6,11-dihydrodibenzo[b,e]thiepin-11-ylidene)- N,N'-dimethylpropan-1-amine S-oxide

50 mg

New EPY0001385 Doubleteeth pubescent angelica root 500 mg

EPD2963000 Doxapram hydrochloride 50 mg

EPY0000208 Doxapram impurity B (4RS)-1-ethyl-4-[2-[(2-hydroxyethyl)amino]ethyl]-3,3-diphenylpyrolidin-2-one

10 mg

EPY0000553 Doxazosin mesilate 60 mg

EPY0000551 Doxazosin impurity D 6,7-dimethoxyquinazoline-2,4(1H,3H)-dione

10 mg

EPY0000552 Doxazosin impurity F 2-chloro-6,7-dimethoxyquinazolin-4-amine

10 mg

EPY0000838 Doxepin hydrochloride 5 mg

EPY0000851 Doxepin for system suitability 1 mg

EPD2975000 Doxorubicin hydrochloride 150 mg

EPD3000000 Doxycycline hyclate 50 mg

EPY0000163 Doxylamine hydrogen succinate - Reference Spectrum unit

EPY0000160 Doxylamine impurity A N,N-dimethyl-2-[1(RS)-1-phenyl-1-(pyridin-4-yl)ethoxy]ethanamine

50 mg

EPD3100000 Droperidol 150 mg

EPY0001105 Drospirenone 60 mg

EPY0001115 Drospirenone impurity E 3-oxo-6alpha,7alpha,15alpha,16alpha-tetrahydro-3'H,3''H-dicyclopropa [6,7:15,16]pregn-4-ene-21,17-carbolactone (17-epidrospirenone)

0.06 mg

EPY0001004 Dydrogesterone 50 mg

EPY0001005 Dydrogesterone impurity A 9β,10-pregna-4,6,8(14)-triene-3,20-dione

6 mg

EPY0001006 Dydrogesterone impurity B pregna-4,6-diene-3,20-dione

5 mg

EPY0000249 Ebastine - Reference Spectrum unit

EPY0000247 Ebastine impurity C 4-(diphenylmethoxy)piperidine

10 mg

EPY0000248 Ebastine impurity D 1-[4-(1,1-dimethylethyl)phenyl]-4-(4-hydroxypiperidin-1-yl)butan-1-one

10 mg

EPY0001236 Econazole 10 mg

EPY0000254 Econazole for system suitability 20 mg

EPE0050000 Econazole nitrate 100 mg



Code Product Unit

EPE0085000 Eicosapentaenoic acid ethyl ester 200 mg

EPY0000537 Emedastine difumarate 10 mg

EPY0000512 Emedastine impurity E 1-(2-ethoxyethyl)-2-(hexahydro-1H-1,4-diazepin-1yl)benzimidazole

10 mg

EPE0100000 Emetine hydrochloride 100 mg

EPE0110000 Enalapril for system suitability 20 mg

EPE0109000 Enalapril maleate 50 mg

EPY0001211 Enalapril impurity mixture 0.06 mg

EPY0000615 Enalaprilat dihydrate 100 mg

EPY0000629 Enalaprilat for system suitability 10 mg

EPY0000678 Enalaprilat impurity G (2SR)-2-[(3SR,8aRS)-3-methyl-1,4-dioxohexahydropyrrolo [1,2-a]pyrazin-2(1H)-4-phenylbutanoic acid

0.005 mg

EPY0000136 Enilconazole 60 mg

EPY0000137 Enilconazole impurity E (1RS)-1-(2,4-dichlorophenyl)-2-(-1H-imidazol-1-yl)ethanol

20 mg

EPE0150000 Endotoxin standard BRP 11 mg

EPE0180000 Enoxaparin sodium 200 mg

EPE0180500 Enoxolone 100 mg

EPY0001259 Enrofloxacin 5 mg

EPY0001160 Enrofloxacin for system suitability 10 mg

New EPY0001249 Entacapone 160 mg

New EPY0001250 Entacapone impurity A Z isomer of entacapone

10 mg

EPE0200000 Enterokinase BRP 500 mg

EPE0305000 Ephedrine hydrochloride (racemic) Drug Precursor 50 mg

EPE0300000 Ephedrine hydrochloride Drug Precursor 150 mg

EPE0400000 4-Epianhydrotetracycline hydrochloride 15 mg

EPE0430000 4-Epichlortetracycline hydrochloride 20 mg

EPE0440000 4-Epidemeclocycline hydrochloride 20 mg

EPE0500000 6-Epidoxycycline hydrochloride 50 mg

EPY0001139 Epinastine hydrochloride 20 mg

EPY0001128 Epinastine hydrochloride for system suitability 10 mg

EPE0530000 4-Epioxytetracycline 40 mg

EPE0550000 Epirubicin hydrochloride 100 mg

EPE0600000 4-Epitetracycline hydrochloride 30 mg

EPY0000052 Equilin 15 mg

EPE0850010 Eq influenza Subtype 1 Strain A/eq/Newmarket/77 Horse Antiserum BRP 3x1 mg

EPE0850021 Eq influenza Subtype 2 American-like/Newmarket Horse Antiserum BRP 3x1 mg

EPE0850022 Eq Influenza Subtype 2 European-like/Newmarket Horse Antiserum BRP 3x1 mg

EPY0000712 Eq Influenza Subtype 2 American-like/South Africa Horse Antiserum BRP 3x1 mg

EPE0900000 Ergocalciferol 500 mg

EPE1000000 Ergometrine maleate Drug Precursor 50 mg

EPE1100000 Ergosterol 20 mg

EPE1200000 Ergotamine tartrate Drug Precursor 100 mg

EPY0000051 Erysipelas ELISA coating antigen BRP 0.4 mg

EPY0000177 Erythritol 1000 mg

EPE1300000 Erythromycin for microbiological assay 250 mg

EPE1305000 Erythromycin A 250 mg

EPE1310000 Erythromycin B 50 mg

EPE1320000 Erythromycin C 50 mg

EPE1400000 Erythromycin estolate 100 mg

EPE1500000 Erythromycin ethylsuccinate 10 mg



Code Product Unit

EPE1500800 Erythromycin stearate 50 mg

EPE1515000 Erythropoietin BRP 37.5 mg

EPY0000324 Esketamine hydrochloride - Reference Spectrum unit

EPY0000338 Esketamine impurity D (2R)-2-(2-chlorophenyl)-2-(methylamino)cyclohexanone ((R)-ketamine)

10 mg

EPY0001028 Esomeprazole magnesium trihydrate 10 mg

EPY0000749 Essential oil 1000 mg

EPE1600000 Estradiol benzoate 250 mg

EPY0000852 Estradiol benzoate for system suitability 10 mg

EPY0000045 Estradiol butyrate 10 mg

EPE1620000 Estradiol hemihydrate 100 mg

EPY0000314 Estradiol for peak identification 10 mg

EPY0000046 Estradiol valerate 50 mg

EPE1680000 Estriol 50 mg

EPE1680005 Estriol impurity A 9,11-didehydroestriol

20 mg

EPE1700000 Estrone 15 mg

EPE1800000 Etacrynic acid 100 mg

EPY0001263 Etacrynic acid for system suitability 10 mg

EPE1830000 Etamsylate 30 mg

EPE1840000 Ethacridine lactate monohydrate 50 mg

EPE1850000 Ethambutol hydrochloride 250 mg

EPY0000803 Ethambutol for system suitability 10 mg

EPA1202800 Ethanol (anhydrous) - Reference Spectrum unit

EPE1860100 Ethanol 96% - Reference Spectrum unit

EPE1900000 Ethinylestradiol 100 mg

EPY0001124 Ethinylestradiol for system suitability 25.3 mg

EPE2000000 Ethionamide 100 mg

EPE2150000 Ethosuximide 30 mg

EPE2250000 Ethosuximide impurity A 2-Ethyl-2-methylsuccinic acid

15 mg

EPE2195000 Ethyl acetate - Reference Spectrum unit

EPE2195900 Ethylcellulose - Reference Spectrum unit

EPE2202000 1-N-Ethylgaramin sulphate 50 mg

EPE2205500 1,1'-Ethylidenebistryptophan 2x0.00167 mg

EPY0000617 Ethyl indole-3-carboxylate 10 mg

EPE2300000 Ethylmorphine hydrochloride - Reference Spectrum unit

EPE2400000 Ethylnicotinamide 150 mg

EPE2425000 Ethyl parahydroxybenzoate 150 mg

EPE2450000 Etifenin 25 mg

EPE2451000 Etilefrine hydrochloride 75 mg

EPE2451010 Etilefrine impurity A 2-ethylamino-1-(3-hydroxyphenyl)ethanone

20 mg

EPY0000572 Etidronate disodium 10 mg

EPE2470000 Etodolac 60 mg

EPE2470050 Etodolac impurity H 2-(7-ethylindol-3-yl)ethanol

10 mg

EPY0000768 Etodolac for peak identification 10 mg

EPE2499900 Etofenamate 40 mg

EPE2499901 Etofenamate for peak identification 15 mg

EPE2499914 Etofenamate impurity G 2-hydroxyethyl 2-[[3-(trifluoromethyl)phenyl]amino]-benzoate

20 mg

EPE2500000 Etofylline 100 mg



Code Product Unit

EPE2503000 Etomidate 50 mg

EPE2503004 Etomidate impurity B methyl-1-[(1RS)-1-phenylethyl]-1H-imidazole-5-carboxylate

25 mg

EPE2600000 Etoposide 150 mg

New EPY0001365 Etoposide for system suitability 10 mg

EPE5000000 Eugenol 500 µL

EPF0005000 Famotidine 100 mg

EPY0000382 Famotidine for system suitability 10 mg

EPF0007000 Famotidine impurity B 3,5-bis[2-[[[2-[(diaminomethylene)amino] thiazol-4-yl]methyl]thio]-ethyl]- 4H-1,2,4,6-thiatriazine1,1-dioxide

10 mg

EPY0000409 Famotidine impurity D 3-[[[2-[(diaminomethylene)amino]thiazol-4-yl]methyl]sulphanyl]propanamide

10 mg

EPY0000556 Febantel 110 mg

EPY0000660 Febantel for system suitability 10 mg

EPY0000731 Felbinac 10 mg

EPY0000732 Felbinac impurity A 4-acetyl biphenyl

20 mg

EPF0030000 Felodipine 120 mg

EPY0000415 Felypressin 0.994 mg

EPF0040000 Fenbendazole 150 mg

EPF0040010 Fenbendazole impurity A methyl(1H-benzimidazol-2-yl)carbamate

20 mg

EPF0040020 Fenbendazole impurity B methyl[5(6)-chlorobenzimidazol-2-yl]carbamate

20 mg

EPF0041000 Fenbufen 100 mg

EPF0048000 Fenofibrate 100 mg

EPF0048005 Fenofibrate impurity A (4-chlorophenyl)(4-hydroxyphenyl)methanone

20 mg

EPF0048010 Fenofibrate impurity B 2[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoic acid (fenofibric acid)

10 mg

EPF0048035 Fenofibrate impurity G 1-methylethyl 2-[[2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoyl] oxy]-2-methylpropanoate

25 mg

EPY0000756 Fenoterol for peak identification 1.2 mg

EPF0050000 Fenoterol hydrobromide 100 mg

EPF0054990 Fentanyl - Reference Spectrum unit

EPF0055000 Fentanyl citrate - Reference Spectrum unit

EPF0060000 Fenticonazole nitrate 50 mg

EPF0060040 Fenticonazole impurity D (RS)-1-[2-(2,4-dichlorophenyl)-2-hydroxyethyl]-3- [4-(phenylsuphanyl)benzyl]imidazolium nitrate

20 mg

EPF0100000 Ferrous gluconate 100 mg

EPY0001013 Ferulic acid 20 mg

EPY0000789 Fexofenadine hydrochloride 60 mg

EPY0000751 Fexofenadine impurity A 2-[4-[4-[4-(hydroxydiphenylmethyl)piperidin-1-yl] butanoyl]phenyl]-2-methylpropanoic acid

5 mg

EPY0000752 Fexofenadine impurity B 2-[3-[(1RS)-1-hydroxy-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]butyl]phenyl]-2-methylpropanoic acid

0.01 mg

EPY0000753 Fexofenadine impurity C (1RS)-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]-1-[4-(1-methylethyl)phenyl]butan-1-ol

5 mg

EPY0001173 Filgrastim 0.2 mL

EPY0000090 Finasteride 60 mg

EPY0000091 Finasteride for system suitability 100 mg

EPY0000736 Flavoxate hydrochloride 10 mg



Code Product Unit

EPY0000737 Flavoxate impurity A 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylic acid

10 mg

EPY0000738 Flavoxate impurity B ethyl 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate

10 mg

EPF0120000 Flecainide acetate 200 mg

EPF0120005 Flecainide impurity A 3-[2,5-bis(2,2,2-trifluoroethoxy)phenyl]-1,5,6,7,8,8a- hexahydroimidazo[1,5-a]pyridine

50 mg

EPY0001274 Flecainide for system suitability 10 mg

EPF0120010 Flecainide impurity B (piperidin-2-yl)methanamine

25 mg

EPY0000138 Flubendazole 25 mg

EPY0000139 Flubendazole for system suitability 20 mg

EPY0000892 Flucloxacillin magnesium octahydrate 5 mg

EPY0000889 Flucloxacillin impurity C 6-aminopenicillanic acid

5 mg

EPY0000890 Flucloxacillin impurity D 3-(2-chloro-6-fluorophenyl)-5-methylisoxazole-4-carboxylic acid

5 mg

EPY0000891 Flucloxacillin impurity E 6-aminopenicillanic acid flucloxacillin amide

5 mg

EPF0150000 Flucloxacillin sodium 250 mg

EPY0000557 Fluconazole 50 mg

EPY0000558 Fluconazole for peak identification 10 mg

EPY0000573 Fluconazole impurity B 2-[2-fluro-4-(1H-1,2,4-triazol-1-yl)phenyl]-1,3-bis(1H-1,2,4-triazol-1-yl)propan-2-ol

10 mg

EPY0000574 Fluconazole impurity C 1,1´-(1,3-phenylene)di-1H-1,2,4-triazole

5 mg

EPF0175000 Flucytosine 100 mg

EPY0001262 Flucytosine for system suitability 0.3 mg

EPY0000419 Fludarabine phosphate 100 mg

EPF0180000 Fludrocortisone acetate 100 mg

EPF0188000 Flumazenil - Reference Spectrum unit

EPY0000335 Flumazenil impurity B ethyl 8-hydroxy-5-methyl-6-oxo-5,6-dihydro-4H-imidazo [1,5-a][1,4]benzodiazepine-3-carboxylate

5 mg

EPF0189000 Flumequine 60 mg

EPF0189020 Flumequine impurity B ethyl(RS)-9-fluoro-5-methyl-1-oxo-6,7-dihydro-1H,5H-benzo[i,j] quinolizine-2-carboxylate (flumequine ethyl ester)

0.1 mg

EPF0188500 Flumetasone pivalate 100 mg

EPF0189900 Flunarizine dihydrochloride 100 mg

EPY0000265 Flunarizine dihydrochloride - Reference Spectrum unit

EPY0000266 Flunarizine dihydrochloride for system suitability 20 mg

EPF0190000 Flunitrazepam Controlled Substance 100 mg

EPY0000169 Flunitrazepam - Reference Spectrum unit

EPY0000443 Flunixin meglumine 10 mg

EPY0000444 Flunixin impurity B 2-methyl-3-(trifluoromethyl)aniline

10 mg

EPY0000445 Flunixin impurity C ethyl 2-chloropyridine-3-carboxylate

50 mg

EPF0200000 Fluocinolone acetonide 100 mg

EPF0230000 Fluocortolone pivalate 100 mg

EPY0000796 Fluorescein 120 mg

EPY0000804 Fluorescein impurity C 2-(2,4-dihydroxybenzoyl)benzoic acid

0.01 mg

EPY0000454 Diacetylfluorescein 100 mg

EPF0245000 Fluoresceine sodium - Reference Spectrum unit



Code Product Unit

EPF0250000 Fluorouracil 40 mg

EPY0000762 Fluorouracil impurity A pyrimidine-2,4,6(1H,3H,5H)-trione (barbituric acid)

10 mg

EPY0000763 Fluorouracil impurity B dihydropyrimidine-2,4,5(3H)-trione (isobarbituric acid or 5-hydroxyuracil)

10 mg

EPY0000764 Fluorouracil impurity C pyrimidine-2,4(1H,3H)-dione (uracil)

10 mg

EPY0000765 Fluorouracil impurity F 2-ethoxy-5-fluoropyrimidin-4(1H)-one (2-ethoxy-5-fluorouracil)

10 mg

EPY0000791 Fluorouracil impurity mixture 0.0002 mg

EPF0253000 Fluoxetine hydrochloride 250 mg

EPF0253020 Fluoxetine impurity B methyl(3-phenylpropyl)amine Controlled Substance

10 mg

EPF0253030 Fluoxetine impurity C (RS)-methyl-[3-phenyl-3-(3-trifluoromethylphenoxy)-propyl]amine

5 mg

EPY0000064 Flupentixol dihydrochloride 100 mg

EPY0000067 Flupentixol impurity D 2-[2-[4-[3-[(EZ)-2-(trifluoromethyl)-9H-thioxanthen-9-ylidene]propyl] piperazin-1-yl]ethoxy]ethanol

15 mg

EPY0000078 Flupentixol impurity F 2-[4-[(EZ)-3-[(9RS)-2-(trifluoromethyl)-9H-thioxanthen-9-yl)prop-2-enyl]- piperazin-1-yl]ethanol

25 mg

EPF0260000 Fluphenazine decanoate 60 mg

EPY0000009 Fluphenazine enantate 100 mg

EPF0280000 Fluphenazine dihydrochloride 50 mg

EPY0000708 Fluphenazine impurity mixture 0.07 mg

EPY0000298 Fluphenazine octanoate 10 mg

EPY0000299 Fluphenazine sulphoxide 10 mg

EPY0000211 Flurazepam monohydrochloride - Reference Spectrum unit

EPF0285200 Flurbiprofen 50 mg

EPF0285202 Flurbiprofen impurity A (2RS)-2-(biphenyl-4-yl)propanoic acid

20 mg

EPY0000236 Fluspirilene 20 mg

EPY0000375 Fluspirilene impurity C 8-[4,4-bis((4-fluorophenyl)butyl]-3-(hydroxymethyl)-1- phenyl-1,3,8-triazaspiro[4.5]decan-4-one

10 mg

EPF0285600 Flutamide 50 mg

EPF0285603 Flutamide impurity C N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide

20 mg

EPY0000284 Fluticasone propionate 100 mg

EPY0000221 Fluticasone impurity D S-methyl 6a,9a-difluoro-11b-hydroxy-16a-methyl-3-oxo-17a-propionyloxy-androsta-1,4-diene-17β-carbothioate (S-methyl derivative)

10 mg

EPF0290000 Flutrimazole 100 mg

EPF0290010 Flutrimazole impurity B (RS)-(2-fluorophenyl)(4-fluorophenyl)phenylmethanol

60 mg

EPY0001090 Fluvastatin sodium 110 mg

EPY0001082 Fluvastatin for system suitability 0.5 mg

EPY0000854 Fluvoxamine maleate 5 mg

EPY0000853 Fluvoxamine for system suitability 1.004 mg

EPY0000916 Fluvoxamine impurity D 5-methoxy-1-[4-(trifluoromethyl)phenyl]pentan-1-one

10 mg

EPY0000386 Foeniculin for peak identification Star anise oil

100 mg

EPF0300000 Folic acid 150 mg

EPY0001242 Folic acid impurity A (2S)-2-[(4-aminobenzoyl)amino]pentanedioic acid (N-(4-aminobenzoyl)-l-glutamic acid)

15 mg



Code Product Unit

EPY0001243 Folic acid impurity D 4-[[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino]benzoic acid (pteroic acid)

70 mg

EPF0372000 Formoterol fumarate dihydrate 10 mg

EPY0000339 Formoterol for impurity I identification 10 mg

EPY0000340 Formoterol fumarate for system suitability 10 mg

EPF0380000 Formylfolic acid 10-Formylfolic acid

30 mg

EPF0389000 Foscarnet sodium hexahydrate 50 mg

EPF0389004 Foscarnet impurity B disodium(ethoxyoxydophosphanyl)formate

10 mg

EPY0001222 Foscarnet impurity D Ethyl (diethoxyphosphinyl)formate

50 mg

EPY0001213 Foscarnet impurity mixture 0.012 mg

EPY0000782 Fosfomycin calcium 10 mg

EPF0399900 Fosfomycin calcium - Reference Spectrum unit

EPF0399950 Fosfomycin sodium - Reference Spectrum unit

EPF0400000 Fosfomycin trometamol 1500 mg

EPY0001227 Fosinopril sodium 60 mg

EPY0001228 Fosinopril impurity A (2S,4S)-4-cyclohexyl-1-[[(R)-hydroxy(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid

5 mg

EPY0001229 Fosinopril impurity B (2RS,4RS)-4-cyclohexyl-1-[[(RS)-[(1SR)-2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid

5 mg

EPY0001230 Fosinopril impurity C mixture of (2S,4S)-4-cyclohexyl-1-[[(S)-[(1S)-2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid and (2S,4S)-4-cyclohexyl-1-[[(R)-[(1R)-2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid

10 mg

EPY0001231 Fosinopril impurity D (2S,4R)-4-cyclohexyl-1-[[(R)-[(1S)-2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid

10 mg

EPY0001232 Fosinopril impurity I [(RS)-[(1SR)-2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphoryl]acetic acid

5 mg

EPY0001233 Fosinopril impurity K (2S,4S)-4-cyclohexyl-1-(2,2-dimethyl-1-oxopropyl)pyrrolidine-2-carboxylic acid

5 mg

EPY0001212 Fosinopril impurity mixture 0.02 mg

EPF0450000 Framycetin sulphate 2x25 mg

EPF0550000 Fructose 100 mg

EPF0600000 Fumaric acid 100 mg

EPF0700000 Furosemide 100 mg

EPF0702000 Furosemide impurity A 2-chloro-4-(furfurylamino)-5-sulphamoylbenzoic acid

5 mg

EPF1000000 Fusidic acid - Reference Spectrum unit

New EPY0001280 Gabapentin 300 mg

New EPY0001281 Gabapentin impurity A 2-azaspiro[4.5]decan-3-one

20 mg

New EPY0001348 Gabapentin impurity B (1-cyanocyclohexyl)acetic acid

20 mg

New EPY0001349 Gabapentin impurity D [1-[(3-oxo-2-azaspiro[4.5]dec-2-yl)methyl]cyclohexyl]acetic acid

10 mg

EPG0049000 Galactitol 50 mg

EPG0050000 Galactose 60 mg

EPY0001279 Galantamine hydrobromide 10 mg

EPY0001190 Galantamine natural for system suitability 10 mg

EPY0001201 Galantamine racemic mixture 10 mg

EPY0001191 Galantamine synthetic for system suitability 5 mg

EPG0100000 Gallamine triethiodide 100 mg



Code Product Unit

EPG0150000 Gammacyclodextrin 50 mg

EPY0001129 Ganciclovir 220 mg

EPY0001144 Ganciclovir impurity mixture 0.005 mg

EPY0000675 Gemcitabine hydrochloride 50 mg

EPY0000676 Gemcitabine impurity A 4-aminopyrimidin-2(1H)-one (Cytosine)

20 mg

EPY0000513 Gemfibrozil 5 mg

EPY0000514 Gemfibrozil for system suitability 0.196 mg

EPG0200000 Gentamicin sulphate 2x25 mg

New EPY0001363 Gentamicin for peak identification 10 mg

EPY0001112 Gestodene 100 mg

EPY0001110 Gestodene for system suitability 10 mg

EPY0001116 Gestodene impurity I 13-ethyl-17-hydroxy-5-methoxy-18,19-dinor-5alpha,17alpha-pregn-15-en-20-yn-3-one

0.01 mg

EPY0001012 Ginkgo dry extract for peak identification 150 mg

EPY0001010 Ginkgolic Acid 20 mg

EPG0300000 Gitoxin 30 mg

EPG0325000 Glibenclamide 100 mg

EPG0325010 Glibenclamide impurity A 4-[2-(5-Chloro-2-methoxybenzamido)ethyl]benzenesulphonamide

10 mg

EPY0000242 Glibenclamide impurity B methyl [[4-[2-[(5-chloro-2-methoxybenzoyl)amino]ethyl]phenyl] sulphonyl]carbamate

10 mg

EPG0326000 Gliclazide 20 mg

EPG0326004 Gliclazide impurity B 2-nitroso-octahydrocyclopenta[c]pyrrole

25 mg

EPG0326012 Gliclazide impurity F 1-(hexahydrocyclopenta[c]pyrrol-2-(1H)-yl-3-[(2-methylphenyl)sulphonyl]urea

30 mg

EPY0000515 Glimepiride 60 mg

EPY0000516 Glimepiride for system suitability 0.012 mg

EPG0340000 Glipizide 50 mg

EPG0342000 Glipizide impurity A 4-[2-(5-methylpyrazine-2-carboxamido)ethyl]benzene sulphonamide

10 mg

EPY0000523 Glipizide impurity C ethyl 2-[4-[(cyclohexylcarbamoyl)sulphamoyl]phenyl]ethyl]carbamate

10 mg

EPY0000643 Glipizide impurity D 6-methyl-N-[2-(4-sulphamoylphenyl)ethyl]pyrazine-2-carboxamide

10 mg

EPY0001140 Glipizide impurity mixture 0.002 mg

EPY0000191 Human glucagon 2x0.952 mg

EPG0350500 Glucose 100 mg

EPG0355000 Glutamic acid 50 mg

EPY0000517 Glutathione 10 mg

EPG0360000 Glutethimide Controlled Substance 50 mg

EPG0400000 Glycerol (85 per cent) - Reference Spectrum unit

EPG0400002 Glycerol dibehenate 2000 mg

EPG0400004 Glycerol distearate 2000 mg

EPY0000794 Glycerol monocaprylate 400 mg

EPY0000795 Glycerol monocaprylocaprate 500 mg

EPG0400006 Glycerol monolinoleate 2000 mg

EPG0400007 Glycerol mono-oleate 2000 mg

EPG0400008 Glycerol monostearate 40-55 2000 mg

EPG0400101 Glyceryl trinitrate - Reference Spectrum unit

EPG0400100 Glyceryl trinitrate solution 0.5 mL

EPG0450000 Glycine 50 mg

New EPY0001308 Glycopyrronium bromide 10 mg



Code Product Unit

EPY0001309 Glycopyrronium for peak identification 10 mg

New EPY0001358 Glycopyrronium impurity N N(3RS)-3-[(2RS)-(2-cyclopentyl-2-hydroxy-2-phenylacetyl)oxy]-1,1-dimethylpyrrolidinium

10 mg

EPY0000433 Ammonium glycyrrhizate 70 mg

EPG0460000 Glycyrrhizate (monoammonium) 300 mg

EPG0525000 Gonadorelin 5 mg

EPY0000125 Goserelin 2 mg

EPY0000126 Gosereline - Reference Spectrum unit

EPY0000019 4-D-Ser-goserelin 0.1 mg

EPY0000194 Goserelin validation mixture 1 mg

EPG0550000 Gramicidin 250 mg

EPY0000396 Granisetron hydrochloride 120 mg

EPY0000477 Granisetron impurity A 2-methyl-N-[(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-2H-indazole-3-carboxamide

1 mg

EPY0000478 Granisetron impurity B N-[(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3-carboxamide

1 mg

EPY0000395 Granisetron impurity E (1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]nonan-3-amine

2x10 mg

EPG0600000 Griseofulvin 50 mg

EPY0000619 Guaiacol 2200 mg

EPG0700000 Guaifenesin 100 mg

EPY0000117 Halofantrine hydrochloride 125 mg

EPY0000118 Halofantrine impurity C [1,3-dichloro-6-(trifluoromethyl)phenantren-9-yl]methanol

10 mg

EPH0100000 Haloperidol 50 mg

EPH0100100 Haloperidol decanoate 60 mg

EPH0150000 Halothane - Reference Spectrum unit

EPY0000673 Harpagoside 1.03 mg

EPY0001287 Heparin calcium for NMR identification 30 mg

EPY0001282 Heparin for Physio-Chemical Analysis 300 mg

EPH0185000 Heparin Low-Molecular-Mass for assay BRP 5x10 mg

EPH0190000 Heparin Low-Molecular-Mass for calibration CRS 25 mg

EPH0200000 Heparin sodium BRP 2 mL

EPY0001283 Heparin sodium for NMR identification 30 mg

EPH0205010 Hepatitis A vaccine (inactivated,absorbed) Type B BRP 3x0.5 mL

EPY0001192 Hepatitis A Vaccine (Inactivated, Non-Adsorbed) 0.8 ml

EPY0000389 Hepatitis B vaccine (rDNA) BRP method A (thiomersal free) 2x0.5 mL

EPH0210010 Hepatitis B vaccine (rDNA) BRP method B 2x1 mL

EPH0215000 Hepatitis C Virus RNA for NAT testing BRP 5x40 mg

EPH0220000 Heptadecanol 2x600 mg

EPY0000063 Heptaminol hydrochloride 150 mg

EPY0000057 Heptaminol impurity A (2RS)-6-methylhept-5-en-2-amine

20 mg

EPH0250000 alpha-Hexachlorocyclohexane 10 mg

EPH0330000 Hexamidine diisetionate 50 mg

EPH0325000 Hexetidine 100 mg

EPH0400000 Hexobarbital 500 mg

EPH0420000 Hexylresorcinol 100 mg

EPH0500000 Hide Powder 500 mg

EPH0600000 Histamine dihydrochloride 250 mg

EPH0700000 Histamine phosphate 250 mg

EPH0750000 Histidine 100 mg

EPH0755000 Histidine hydrochloride monohydrate 100 mg



Code Product Unit

EPH0800000 Homatropine hydrobromide 100 mg

EPH0830000 Homatropine methylbromide 25 mg

EPH0837000 L-Homocycsteine thiolactone hydrochloride - Reference Spectrum unit

EPH0900000 Human albumin for electrophoresis BRP 1 mL

EPY0000219 Human anti-D immunoglobulin BPR unit

EPY0000667 Human coagulation factor VII concentrate BRP 2x26 mg

EPH0920000 Human coagulation factor VIII concentrate BRP 5x34 mg

EPH0920500 Human coagulation factor IX concentrate BRP 5x30 mg

EPH0950000 Human hepatisis A immunoglobulin BRP 3x10 mg

EPH0990000 Human immunoglobulin BRP 15800 mg

EPH1000000 Human immunoglobulin for electrophoresis BRP 96 mg

EPY0000488 Human immunoglobulin (molecular size) BRP 3x700 mg

EPH1005000 Human Plasma Pools for NAT Validation 3502 mg

EPH1100000 Human rabies immunoglobulin BRP 3x170 mg

EPH1110000 Human tetanus immunoglobulin BRP 87 mg

EPY0000502 Human vaccinia immunoglobulin 3x1 mL

EPH1115000 Hyaluronidase BRP 50 mg

EPH1120000 Hydralazine hydrochloride 20 mg

EPY0001151 Hydrastine hyrochloride 20 mg

EPH1200000 Hydrochlorothiazide 150 mg

EPY0000646 Hydrocodone hydrogen tartrate 2.5-hydrate Controlled Substance 10 mg

EPY0000710 Hydrocodone for peak identification Controlled Substance 10 mg

EPH1300000 Hydrocortisone 100 mg

EPY0001092 Hydrocortisone for peak identification 5 mg

EPH1400000 Hydrocortisone acetate 125 mg

EPH1425000 Hydrocortisone hydrogen succinate 100 mg

EPH1426000 Hydrogenated wool fat 250 mg

EPY0000446 Hydromorphone hydrochloride Controlled Substance 10 mg

EPB0650000 Hydrous benzoyl peroxide - Reference Spectrum unit

EPH1428000 Hydroxocobalamin 10 mg

EPY0000119 Hydroxycarbamide 175 mg

EPH1429400 Hydroxyethyl salicylate 125 mg

New EPY0001322 Hydroxyethyl starch (high Mw) 800 mg

EPY0001277 Hydroxyethyl starch (medium MW) 1200 mg

EPH1429700 4-Hydroxyphenoxymethylpenicillin potassium 20 mg

EPH1430000 D-alpha-(4-Hydroxy-phenyl)glycine 50 mg

EPY0000186 Hydroxypropylbetadex 10 mg

EPH1435000 Hydroxyzine hydrochloride 600 mg

EPY0000011 Hymecromone 100 mg

EPY0000012 Hymecromone impurity A Resorcinol

25 mg

EPY0000013 Hymecromone impurity B 7-hydroxy-2-methyl-4H-1-benzopyran-4-one

25 mg

EPY0000483 Hyoscine 10 mg

EPY0000484 Hyoscine impurity A (1R,2R,4S,5S,7s)-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl (2S)-3-hydroxy-2-phenylpropanoate (norhyoscine)

10 mg

EPH1450000 Hyoscine butylbromide 20 mg

EPY0000447 Hyoscine butylbromide impurity E (1R,2R,4S,5S,7S)-9-butyl-7-[[(2S)-3-hydroxy-2-phenylpropanoyl]oxy]-3-oxa-9-azoni atricyclo[3.3.1.02,4]nonane

10 mg

EPH1500000 Hyoscine hydrobromide 50 mg



Code Product Unit

EPY0000448 Hyoscine hydrobromide impurity B (1R,2R,4S,5S,7s)-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl(2S)- 3-hydroxy-2-phenylpropanoate

10 mg

EPH1600000 Hyoscyamine sulphate 100 mg

EPY0000449 Hyoscyamine impurity E (1R,3s,5S)-8-azabicyclo[3.2.1] oct-3-yl(2S)-3-hydroxy-2-phenylpropanoate

10 mg

EPY0000915 Hypromellose phthalate 10 mg

EPI0020000 Ibuprofen 160 mg

EPB1220000 Ibuprofen impurity B (2RS)-2-(4-Butylphenyl)propionic acid (0,06% solution in Acetonitrile)

1.15 mL

EPY0000140 Ibuprofen impurity F 3-[4-(2-methylpropyl)phenyl]propanoic acid

5 mg

EPY0000881 Ibuprofen for peak identification 0.09 mg

EPI0050000 Idoxuridine 50 mg

EPI0060000 Ifosfamide 50 mg

EPI0060100 Ifosfamide - Reference Spectrum unit

EPI0060002 Ifosfamide impurity A 3-[(2-chloroethyl)amino]propyl dihydrogen phosphate

30 mg

EPI0060004 Ifosfamide impurity B bis[3-[(2-chloroethyl)amino]propyl]dihydrogen diphosphate

20 mg

EPI0060010 Ifosfamide impurity E 3-chloro-N-(2-chloroethyl)propan-1-amine

10 mg

EPI0060012 Ifosfamide impurity F (RS)-2-chloro-3-(2-chloroethyl)-1,3,2-oxazaphosphinane 2-oxide

10 mg

EPI0086000 Imidazole 100 mg

New EPY0001205 Imperatorin 20 mg

EPI0090000 Imipenem 100 mg

EPI0100000 Imipramine hydrochloride 50 mg

EPY0000893 Imipramine for system suitability 10 mg

EPY0001153 Immunoglobulin for anti-A, anti-B antibodies limit test 45 mg

EPY0000540 Immunoglobulin panel for anti-D antibodies test BRP 2000 mg

EPI0150000 Indapamide 150 mg

EPI0150020 Indapamide impurity B 4-chloro-3-sulphamoyl-N-(2-methyl-1H-indol-1-yl)benzamide

5 mg

EPY0000788 Indinavir 100 mg

EPY0000880 Indinavir sulphate - Reference Spectrum unit

EPY0000746 Indinavir for system suitability 20 mg

EPI0200000 Indometacin 50 mg

EPY0000349 Insulin aspart 3.89 mg

EPI0305000 Insulin (bovine) 7.99 mg

EPI0310000 Insulin (human) 7.03 mg

EPY0000348 Insulin lispro 5.93 mg

EPI0320000 Insulin (porcine) 8.61mg

EPI0320300 Interferon alfa-2a 1 mg

EPI0320301 Interferon alfa-2b 0.2 mL

EPY0001101 Interferon beta-1a 0.5 mL

EPI0320330 Interferon gamma 1b 2x0.6 mL

EPI0320331 Interferon gamma-1b validation solution 0.2 mL

EPI0328000 Iobenguane sulphate 25 mg

EPY0000839 Iobenguane sulphate - Reference Spectrum unit

EPY0001294 Iodixanol 60 mg

EPY0001292 Iodixanol impurity C 5-[acetyl[3-[[3,5-bis[(2,3-dihydroxypropyl)carbamoyl]-2,4,6-triiodophenyl]amino]-2-hydroxypropyl]amino]-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide

10 mg



Code Product Unit

EPY0001291 Iodixanol impurity E 5-[acetyl[3-[acetyl[3-carbamoyl-5-[(2,3-dihydroxypropyl)carbamoyl]-2,4,6-triiodophenyl]amino]-2-hydroxypropyl]amino]-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide

10 mg

EPY0001293 Iodixanol impurity H 5-[acetyl[3-[acetyl[3-[[3-[3-[acetyl[3,5-bis[(2,3-dihydroxypropyl)carbamoyl]-2,4,6-triiodophenyl]amino]-2-hydroxypropoxy]-2-hydroxypropyl]carbamoyl]-5-[(2,3-dihydroxypropyl)carbamoyl]-2,4,6-triiodophenyl]amino]-2-hydroxypropyl]amino]-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide

10 mg

EPI0320800 Iohexol 150 mg

EPI0320810 Iohexol impurity A 5-acetamido-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-tri-iodobenzene-1,3- dicarboxamide

50 mg

EPI0320820 Iohexol impurity J 5-amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-tri-iodobenzene-1,3-dicarboxamide

125 mg

EPY0000672 Iohexol for peak identification 10 mg

EPI0329000 Iopamidol 50 mg

EPI0329010 Iopamidol impurity A N,N'-bis[2-hydroxy-1-(hydroxymethyl)ethy]- 5-amino-2,4,6-tri-iodoisophthalamide

10 mg

EPY0000406 Iopamidol impurity H 4-chloro-N,N'-bis(2-hydroxy-1-(hydroxymethyl)ethyl)-5-(2-hydroxypropanoyl)amino)2,6-diiodobenzenz-1,3-dicarboxamide

10 mg

EPI0330000 Iopanoic acid 100 mg

EPY0001297 Iopentol 10 mg

EPY0001020 Iopromide 100 mg

EPY0001077 Iopromide impurity A 5-amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-N-methylbenzene-1,3- dicarboxamide

0.125 mg

EPY0001021 Iopromide for system suitability 1 5 mg

EPY0001022 Iopromide for system suitability 2 5 mg

EPI0340000 Iotalamic acid 100 mg

EPA0560000 Iotalamic acid impurity A 5-Amino-2,4,6-tri-iodo-N-methylisophthalamic acid

20 mg

EPY0000555 Iotrolan 100 mg

EPY0000658 Iotrolan for system suitability 5 mg

EPY0000141 Ioxaglic acid 125 mg

EPY0000142 Ioxaglic acid impurity A 3-amino-5[[(2-hydroxyethyl)amino]carbonyl]-2,4,6-trioiodobenzoic acid

20 mg

EPI0360000 Ipratropium bromide 120 mg

EPY0000276 Ipratropium bromide impurity A (1R,3r,5S,8r)-3-hydroxy-8-methyl-8-(1-methylethyl)-8-azoniabicyclo[3.2.1]octane

10 mg

EPI0361000 Ipratropium bromide impurity B (1R,3r,5S,8s)-3-[[(2RS)-3-hydroxy-2-phenylpropanoyl]oxy]-8-methyl-8-(1-methylethyl)-8-azoniabicyclo[3.2.1]octane

10 mg

EPY0001166 Irbesartan 60 mg

EPY0001156 Irbesartan impurity A 1-(pentylamino)-N-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]cyclopentanecarboxamide

10 mg

EPI0375000 Isoconazole 200 mg

EPI0380000 Isoconazole nitrate 200 mg

EPI0400000 Isoemetine hydrobromide 25 mg

EPY0000858 Isoflurane 1.5 mL

EPY0000037 Isoflurane - Reference Spectrum unit

EPI0460000 Isoleucine 50 mg

EPI0465000 Isomalt 3000 mg

EPY0000070 Isomaltooligosaccharide 0.9 mg

EPI0500000 Isoniazid 100 mg

EPI0599990 Isoprenaline hydrochloride 50 mg

EPI0600000 Isoprenaline sulphate 500 mg

EPI0725000 Isopropyl hexadecanoate 100 mg



Code Product Unit

EPI0750000 Isopropyl tetradecanoate 2 mL

EPI0775000 Isosorbide dinitrate 300 mg

EPI0775010 Isosorbide mononitrate 100 mg

EPI0775020 Isosorbide-2-nitrate 50 mg

EPI0800000 Isotretinoin 60 mg

EPI0900000 Isoxsuprine hydrochloride 50 mg

EPY0000366 Isradipine 125 mg

EPY0000367 Isradipine impurity D methyl 1-methylethyl 4-(2,1,3-benzoxadiazol-4-yl)-2,6-dimethylpyridine-3,5-dicarboxylate

5 mg

EPI7000000 Itraconazole 150 mg

EPY0001100 Itraconazole for system suitability 15 mg

EPI8000010 Ivermectin 150 mg

EPY0000575 Ivy leaf standardised tincture 2 mL

EPY0000041 Josamycin 150 mg

EPY0000042 Josamycin propionate 150 mg

EPY0001315 Josamycin for peak identification 25 mg

EPK0100000 Kanamycin B sulphate 20 mg

EPK0200000 Kanamycin monosulphate 150 mg

EPY0000450 Ketamine hydrochloride Controlled Substance 10 mg

EPK0551000 Ketamine impurity A 1-[(2-chlorophenyl)(methylimino)methyl]cyclopentanol

50 mg

EPY0000246 Ketobemidone hydrochloride - Reference Spectrum unit

EPY0000244 Ketobemidone impurity B 1-(4-(3-hydroxyphenyl)-1-methyl-4-piperidyl)ethanone

5 mg

EPY0000245 Ketobemidone impurity C 1-(4-(3-hydroxyphenyl)-4-piperidyl)propan-1-one

5 mg

EPK0600000 Ketoconazole 150 mg

EPK1000000 3-Ketofusidic acid 10 mg

EPK2000000 Ketoprofen 50 mg

EPK2000010 Ketoprofen impurity A 1-(3-benzoylphenyl)ethanone

10 mg

EPK2000015 Ketoprofen impurity C 3-[(1RS)-1-carboxyethyl]benzoic acid

5 mg

EPY0000486 Ketorolac trometamol 10 mg

EPY0000626 Ketorolac trometamol for peak identification 5 mg

EPY0000164 Ketotifen hydrogen fumarate - Reference Spectrum unit

EPY0000161 Ketotifen impurity G 4-(1-methylpiperidin-4-ylidene)-4H-benzo(4,5)cyclohepta(1,2-b)thiophen-9,10-dione

0.0225 mg

EPL0050000 Labetalol hydrochloride 80 mg

EPL0129000 Lactitol monohydrate 60 mg

EPY0000257 Lactobionic acid 100 mg

EPA1206000 Lactose (anhydrous) 100 mg

EPL0100000 Lactose 100 mg

EPL0130000 Lactulose 3000 mg

EPY0000188 Lactulose for system suitability 12 mg

EPY0000425 Lamivudine 150 mg

EPY0000518 Lamivudine for system suitability 1 10 mg

EPY0000426 Lamivudine for system suitability 2 10.3 mg

EPY0001030 Lamotrigine 10 mg

EPY0001031 Lamotrigine for peak identification 20 mg

EPY0001085 Lamotrigine for system suitability 10 mg

EPY0001032 Lamotrigine impurity E 2,3-dichlorobenzoic acid

10 mg

EPY0000773 Lansoprazole 60 mg



Code Product Unit

EPY0000774 Lansoprazole for peak identification 1 mg

EPY0000654 Leflunomide 100 mg

EPY0000487 Leflunomide impurity A 4-(trifluoromethyl)aniline

25 mg

EPY0000674 Leflunomide for peak identification 1 mg

EPY0000685 Letrozole 70 mg

EPL0375000 Leucine 50 mg

EPL0376000 Leuprorelin 0.925 mg

EPL0376001 Leuprorelin - Reference Spectrum unit

EPY0000047 Levamisole for system suitability 60 mg

EPL0380000 Levamisole hydrochloride 50 mg

EPY0000048 Levamisole - Reference Spectrum unit

New EPY0001253 Levetiracetam 110 mg

EPY0001254 Levetiracetam impurity A (2RS)-2-(2-oxopyrrolidin-1-yl)butanoic acid 10 mg

EPY0001255 Levetiracetam impurity B (2Z)-2-(2-oxopyrrolidin-1-yl)but-2-enamide 10 mg

EPY0001256 Levetiracetam impurity C pyridin-2-ol

10 mg

EPY0001257 Levetiracetam impurity D (2R)-2-(2-oxopyrrolidin-1-yl)butanamide ((R)-etiracetam)

10 mg

EPL0390000 Levocabastine hydrochloride 125 mg

EPL0390008 Levocabastine impurity D 1-[cis-4-cyano-4-(4-fluorophenyl)cyclohexyl]-4-phenylpiperidine-4-carboxylic acid

20 mg

EPL0399900 Levocarnitine 125 mg

EPL0399905 Levocarnitine impurity A (E)-or(Z)-4-(trimethylammonio)but-2-enoate

50 mg

EPL0400000 Levodopa 100 mg

EPL0420000 Levodropropizine 60 mg

EPL0420002 Levodropropizine impurity A (2R)-3-(4-phenylpiperazin-1-yl)propane-1,2-diol(dextrodropropizine)

20 mg

EPY0001033 Levodropropizine impurity B 1-phenylpiperazine

50 mg

EPY0001048 Levodropropizine impurity C 2,3-epoxypropan-1-ol

300 mg

EPL0500000 Levomepromazine hydrochloride 100 mg

EPL0505000 Levomepromazine maleate 50 mg

EPL0551000 Levonorgestrel 30 mg

EPL0570000 Levothyroxine sodium 100 mg

EPL0595000 Lidocaine 50 mg

EPL0600000 Lidocaine hydrochloride 100 mg

EPL0650000 Lincomycin hydrochloride 250 mg

EPL0700000 Liothyronine sodium 50 mg

EPY0000860 Liothyronine for peak identification 0.0046 mg

EPY0001235 Lisinopril for system suitability 2 mg

EPL0702000 Lisinopril dihydrate 50 mg

EPL0702100 Lisinopril dihydrate for performance test 2x2 mg

EPY0001234 Lisinopril impurity F (2S)-1-[(2S)-6-amino-2-[[(1S)-1-carboxy-3-cyclohexylpropyl]amino]hexanoyl]pyrrolidine-2-carboxylic acid (cyclohexyl analogue)

0.01 mg

EPL0720000 Lithium clavulanate 125 mg

EPL0720800 Lithocholic acid 60 mg

EPY0000112 Lobeline hydrochloride 50 mg

EPL0745000 Lomustine 50 mg

EPL0750000 Loperamide hydrochloride 50 mg

EPY0000322 Loperamide hydrochloride for system suitability 15 mg

EPY0000341 Loperamide oxide monohydrate 20 mg



Code Product Unit

EPY0000688 Loratadine 60 mg

EPY0000603 Loratadine for system suitability 20 mg

EPY0000604 Loratadine impurity F ethyl 4-[(11RS)-8-chloro-11-fluoro-6,11-dihydro-5H-benzo[5,6]cyclohepta [1,2-b]pyridin-11-yl]piperidine-1-carboxylate

10 mg

EPY0000605 Loratadine impurity H ethyl 4-oxopiperidine-1-carboxylate

50 mg

EPL0750500 Lorazepam Controlled Substance 100 mg

EPY0000576 Lorazepam for system suitability Controlled Substance 0.8 mg

EPY0000718 Lorazepam impurity D (5RS)-7-chloro-5-(2-chlorophenyl)-4,5-dihydro-1H-1,4-benzodiazepine-2,3-dione

10 mg

EPY0001062 Losartan potassium 50 mg

EPY0001072 Losartan impurity D 2-butyl-4-chloro-1H-imidazole-5-carbaldehyde

6 mg

EPY0001076 Losartan for system suitability 0.0015 mg

EPL0790000 Lovastatin 40 mg

EPY0001136 Lovastatine for peak identification 20 mg

EPL0800000 Lynestrenol 50 mg

EPY0001034 Lynestrenol for peak identification 20 mg

EPY0000397 Lysine acetate 60 mg

EPL0900000 Lysine hydrochloride 50 mg

New EPY0001284 Lufenuron 140 mg

EPY0001261 Lufenuron for peak identification 0.4028 mg

EPY0001265 Lufenuron impurity G 2,5-dichloro-4-[[[(2,6-difluorophenyl)carbonyl]carbamoyl]amino]phenyl phenyl carbonate

15 mg

New EPY0001369 Macrogol 30 dipolyhydroxystearate 100 mg

EPY0000745 Macrogol 40 sorbitol heptaoleate 20 mg

EPY0001157 Macrogol polyvinyl alcohol grafted polymer 400 mg

EPM0088000 Magnesium aspartate dihydrate 60 mg

EPM0120000 Malathion 250 mg

EPM0120005 Malathion impurity A diethyl(2RS)-2-[(methoxy)(methylsulfanyl)-S-phosphinothioyl] butane dioate (isomalathion)

10 mg

EPM0120010 Malathion impurity B diethyl(2RS)-2-(dimethoxy-S-phosphinothioyl)-butanedioate (maloxon)

10 mg

EPM0100000 Maleic acid 100 mg

EPY0000143 Malic acid - Reference Spectrum unit

EPM0160000 Maltitol 1200 mg

EPM0200000 Mannitol 1200 mg

EPM0206000 Maprotiline hydrochloride 100 mg

EPM0206040 Maprotiline impurity D 3-(9,10-dihydro-9,10-ethanoanthracen-9-yl)-N-methylprop-2-en-1-amine; (dehydromaprotiline)

25 mg

EPY0000819 Marbofloxacin 10 mg

EPY0000820 Marbofloxacin for peak identification 20 mg

EPM0210000 Measles vaccine (live) BRP 5x80 mg

EPM0215000 Mebendazole 20 mg

EPY0000144 Mebendazole for system suitability 20 mg

EPY0000168 Mebendazole - Reference Spectrum unit

EPY0001086 Mebrofenin 120 mg

EPM0220000 Meclozine hydrochloride 150 mg

EPY0001310 Meclozine impurity B 4-chlorobenzhydrol

15 mg

EPY0001311 Meclozine impurity H 1-(4-chlorobenzhydryl)piperazine

15 mg

EPM0240000 Medronic acid 20 mg



Code Product Unit

EPY0001107 Medronic acid impurity A Tris(1-methylethoxy)phosphane

60 µl

EPY0001106 Medronic acid impurity B Tetrakis(1-methylethyl)methhylenediphosphonate

40 µl

EPM0250000 Medroxyprogesterone acetate 100 mg

EPM0250010 Medroxyprogesterone acetate for performance test 50 mg

EPY0000598 Medroxyprogesterone acetate for system suitability 10 mg

EPM0252600 Mefenamic acid 50 mg

EPY0001081 Mefenamic acid impurity A 2,3-dimethylaniline

100 mg

EPM0253000 Mefloquine hydrochloride 100 mg

EPM0260100 Megestrol acetate - Reference Spectrum unit

EPY0001209 Meglumine 10 mg

EPY0001080 Meloxicam 50 mg

EPY0001035 Meloxicam impurity A ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide

5 mg

EPY0001036 Meloxicam impurity B 5-methylthiazol-2-amine

5 mg

EPY0001037 Meloxicam impurity C N-[(2Z)-3,5-dimethylthiazol-2(3H)-ylidene]-4-hydroxy-2-methyl-2H-1,2- benzothiazine-3-carboxamide 1,1-dioxide

5 mg

EPY0001039 Meloxicam impurity D N-[(2Z)-3-ethyl-5-methylthiazol-2(3H)-ylidene]-4-hydroxy-2-methyl-2H-1,2- benzothiazine-3-carboxamide 1,1-dioxide

5 mg

EPM0300000 Menadione 100 mg

EPM0350000 Menthol 150 mg

EPM0370000 Mepivacaine hydrochloride 100 mg

EPM0370020 Mepivacaine impurity B (RS)-N-(2,6-dimethylphenyl)piperidine-2-carboxamide

60 mg

EPM0400000 Meprobamate Controlled Substance 100 mg

EPM0500000 Mepyramine maleate 1000 mg

EPY0000679 Mepyramine impurity A N-(4-methoxybenzyl)pyridin-2-amine

10 mg

EPY0000680 Mepyramine impurity C pyridin-2-amine

10 mg

New EPY0001252 Meropenem trihydrate 110 mg

EPY0000297 Mesalazine 125 mg

EPY0001040 Mesityl oxid 100 mg

EPY0000337 Mesna - Reference Spectrum unit

EPY0000316 Mesna impurity C 2-(acetylsulphanyl)ethanesulphonic acid

10 mg

EPY0000317 Mesna impurity D 2,2'-(disulphanediyl)bis(ethanesulphonic acid)

10 mg

EPY0000227 Meso-rich exametazime 0.5 mg

EPY0000097 Mesterolone 60 mg

EPY0000096 Mesterolone impurity A 17β-hydroxy-1alpha-methylandrost-4-en-3-one

30 mg

EPM0600000 Mestranol 100 mg

EPY0000301 Metacresol - Reference Spectrum unit

EPM0600500 Metacycline hydrochloride 50 mg

EPM0600900 Metamizole sodium 100 mg

EPM0600905 Metamizole impurity A 4-formylamino-1,5-dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one

15 mg

EPM0605000 Metformin hydrochloride 50 mg

EPY0000770 Methacrylic acid-ethylacrylate copolymer (1:1) type A 200 mg

EPY0000323 Methacrylic acid-ethyl acrylate copolymer (1:1) - type B 200 mg



Code Product Unit

EPM0610000 Methacrylic acid-ethylacrylate copolymer (1:1) - Reference Spectrum unit

EPM0610030 Methacrylic acid-ethyl acrylate copolymer (1:1), dispersion 30% - Reference Spectrum unit

EPM0620000 Methacrylic acid-methylmethacrylate copolymer (1:1) - Reference Spectrum unit

EPM0630000 Methacrylic acid-methylmethacrylate copolymer (1:2) - Reference Spectrum unit

EPM0800000 Methadone hydrochloride - Reference Spectrum unit

EPY0000428 Methanol - Reference Spectrum unit

EPM0900000 Methaqualone - Reference Spectrum unit

EPY0000754 Methenamine 10 mg

EPM0950000 DL-Methionine 50 mg

EPM0960000 Methionine 50 mg

EPM1000000 Methotrexate 100 mg

EPY0000602 Methotrexate for peak identification 20 mg

EPY0000663 Methotrexate impurity C (2S)-2-[[4-[[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]methylamino]benzoyl]amino]pentanedioic acid (N-methylfolic acid, methopteridine)

10 mg

EPM1000008 Methotrexate impurity D 4-[[(2-amino-4hydroxypteridin-6-yl)methyl]methyl-amino]benzoic acid

10 mg

EPY0000664 Methotrexate impurity E 4-[[(2,4-diaminopteridin-6-yl)methyl]methylamino]benzoic acid (4-amino-N10-methylpteroic acid, APA)

10 mg

EPM1100000 3-Methoxymethyldopa 20 mg

EPM1300000 Methylatropine bromide 100 mg

EPM1400000 Methylatropine nitrate 100 mg

EPM1450000 Methylcarbidopa 1 mg

EPM1470000 Methyl 2-(4-chlorophenoxy)-2-methylpropionate 0.5 mL

EPM1500000 Methyldopa 50 mg

EPY0001083 Methyldopa for system suitability 0.024 mg

EPM1550000 Methylene chloride 2 mL

EPM1551000 2-(1-Methylethyl)pentanoic acid 25 mg

EPM1556000 Methyl 12-hydroxystearate 100 mg

EPY0000398 Methyl nicotinate 25 mg

EPY0000776 Methylergometrine maleate 10 mg

EPY0000777 Methylergometrine for system suitability 0.53 mg

EPM1625000 Methylnitrosoindoline 100 mg

EPM1650000 Methyl parahydroxybenzoate 150 mg

EPY0001017 Methylphenidate hydrochloride Controlled Substance 40 mg

EPY0000910 Methylphenidate impurity mixture 0.04 mg

EPM1700000 Methylphenobarbital Controlled Substance 500 mg

EPM1750000 Methylprednisolone 150 mg

EPM1755000 Methylprednisolone acetate 100 mg

EPM1755200 Methylprednisolone hydrogen succinate 125 mg

EPM1755220 Methylprednisolone hydrogen succinate for performance test 50 mg

EPY0000190 N-Methylpyrrolidone - Reference Spectrum unit

EPM1770180 Methyl ricinoleate 125 mg

EPY0000418 Methylrosanilinium chloride 40 mg

EPY0000407 Methylrosanilinium chloride for system suitability 10 mg

EPM1770200 Methyl stearate 100 mg

EPM1800000 Methyltestosterone 100 mg

EPY0000861 Methyltestosterone for system suitability 10 mg

EPM1800900 Methylthioninium chloride 50 mg

EPM1800902 Methylthioninium impurity A 3-(dimethylamino)-7-(methylamino)phenothiazin-5-ylium

20 mg

EPM1808000 Metixene hydrochloride 75 mg



Code Product Unit

EPM1824990 Metoclopramide 100 mg

EPM1825000 Metoclopramide hydrochloride 50 mg

EPM1824995 Metoclopramide impurity A 4-(acetylamino)-5-chloro-N-(2-diethylaminoethyl)-2-methoxybenzamide

25 mg

EPM1825010 Metoclopramide impurity E N,N-diethylethane-1,2-diamine

20 mg

EPY0000701 Metolazone 80 mg

EPY0000702 Metolazone for system suitability 10 mg

EPY0000171 Metoprolol succinate - Reference Spectrum unit

EPM1830000 Metoprolol tartrate 60 mg

EPY0000145 Metoprolol impurity A (2RS)-1-(ethylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol

10 mg

EPM1845000 Metrifonate 100 mg

EPM1850000 Metronidazole 50 mg

EPM1851000 Metronidazole benzoate 50 mg

EPY0000069 Metronidazole benzoate - Reference Spectrum unit

EPY0000087 Metronidazole impurity A 2-methyl-4-nitroimidazole

10 mg

EPM1860000 Mexiletine hydrochloride 100 mg

EPY0000202 Mexiletine impurity C 1,1'-[(3,3',5,5'-tetramethylbiphenyl-4,4'-diyl)bisoxy]dipropan-2-amine

2 mg

EPY0000203 Mexiletine impurity D (2RS)-2-(2,6-dimethylphenoxy)propan-1-amine

2 mg

EPM1875000 Mianserin hydrochloride 50 mg

EPY0001041 Mianserin impurity B (14bRS)-2-methyl-1,2,3,4,10,14b-hexahydrodibenzo[c,f] pyrazino[1,2-a]azepine-8-sulfonic acid

10 mg

EPY0000862 Mianserin hydrochloride for system suitability 1.01 mg

EPM1880000 Miconazole 70 mg

EPM1900000 Miconazole nitrate 100 mg

EPM2200000 Midazolam Controlled Substance 50 mg

EPY0000562 Midazolam impurity C acide 8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo [1,5-a][1,4]benzodiazepine-3-carboxylique

0.08 mg

EPY0000599 Midazolam for system suitability Controlled Substance 1 mg

EPY0000539 Milk thistle standardised dry extract 120 mg

EPM2280000 Minocycline hydrochloride 125 mg

EPM2300000 Minoxidil 50 mg

EPY0000705 Mirtazapine 10 mg

EPY0000721 Mirtazapine for system suitability 10 mg

EPY0000490 Misoprostol 30 mg

EPY0001162 Misoprostol for system suitability 5 mg

EPY0000378 Mitomycin 120 mg

EPM2305000 Mitoxantrone hydrochloride 60 mg

EPM2305005 Mitoxantrone impurity A 1-amino-5,8-dihydroxy-4-[[2-[(2-hydroxyethyl)amino]ethyl]amino]anthracene-9,10-dione

5 mg

EPY0000635 Modafinil 110 mg

EPY0000636 Modafinil for system suitability 0.1 mg

EPY0000251 Molgramostim 0.3 mL

EPY0000821 Molsidomine 5 mg

EPY0000822 Molsidomine impurity B N-Nitrosomorpholine

10 mg

EPY0000823 Molsidomine impurity D morpholine-4-carbaldehyde

10 mg

EPM2900000 Mometasone furoate 100 mg

EPY0000028 Morantel hydrogen tartrate 50 mg



Code Product Unit

EPY0000451 Morphine hydrochloride Controlled Substance 25 mg

EPY0000452 Morphine sulphate Controlled Substance 40 mg

EPY0000830 Morphine for system suitability Controlled Substance 10 mg

EPY0000772 Moxidectin 70 mg

EPY0000747 Moxidectin for system suitability 10 mg

EPY0000703 Moxifloxacin hydrochloride 110 mg

EPY0000717 Moxifloxacin for peak identification 10 mg

EPY0000226 Moxonidine 50 mg

EPY0000222 Moxonidine impurity A 4,6-dichloro-N-(imidazolidin-2-ylidene)-2-methylpyrimidin-5-amine

10 mg

EPM3600000 Mumps vaccine (live) BRP 5x33 mg

EPM3805000 Mupirocin - Reference Spectrum unit

EPM3805500 Mupirocin calcium - Reference Spectrum unit

EPM3806000 Mupirocin lithium 100 mg

EPY0000489 Mycophenolate mofetil 30 mg

EPY0000519 Mycophenolate mofetil for peak identification 10 mg

EPY0000692 Mycoplasma fermentans BRP 1 mL

EPY0000690 Mycoplasma hyorhinis BRP 1 mL

EPY0000691 Mycoplasma orale BRP 1 mL

EPY0000689 Mycoplasma synoviae BRP 1 mL

EPY0000485 Myo-inositol 1020 mg

EPN0020000 Nabumetone 60 mg

EPN0020020 Nabumetone impurity D (E)-4-(6-methoxynaphthalen-2-yl)but-3-en-2-one

10 mg

EPN0020030 Nabumetone impurity F 6,6'-dimethoxy-2,2'-binaphthalenyl

10 mg

EPY0000146 Nadolol 100 mg

New EPY0001215 Nadolol impurity mixture 0.01 mg

EPN0025000 Nadroparin calcium 250 mg

EPY0000077 Naftidrofuryl - Reference Spectrum unit

EPY0000120 Naftidrofuryl impurity A 2-[(naphtalen-1-yl)methyl]-3-(tetrahydrofuran-2-yl)propanoic acid

10 mg

EPY0000121 Naftidrofuryl impurity B ethyl 2-[(naphtalen-1-yl)methyl]-3-(tetrahydrofuran-2-yl)propanoate

25 mg

EPY0000331 Naftidrofuryl impurity F 2-[(diethylamino)ethyl 2-[(naphthalen-2-yl)methyl]-3-(tetrahydrofuran-2-yl)propanoate

10 mg

EPN0050000 Nalidixic acid 100 mg

EPN0075000 Naloxone hydrochloride dihydrate 100 mg

EPY0000695 Naloxone for peak identification 10 mg

EPY0000400 Naltrexone hydrochloride 50 mg

EPY0000410 Naltrexone impurity C N-(3-butenyl)-noroxymorphone

15 mg

EPY0000542 Nandrolone decanoate 5 mg

EPY0000547 Nandrolone decanoate for peak identification 10 mg

EPY0000548 Nandrolone decanoate for system suitability 10 mg

EPN0080000 Naphazoline hydrochloride 50 mg

EPN0100000 Naphazoline nitrate 10 mg

EPN0200000 Naphazoline impurity A N-(2-aminoethyl)-2-(naphthalen-1-yl)acetamide (Naphthylacetylethylenediamine)

10 mg

EPN0250000 Naproxen 100 mg

EPY0000399 Naproxen (racemic) 10 mg

EPY0000631 Naproxen impurity L 1-(6-Methoxynaphthalen-2-yl)ethanone (Acetylnerolin)

10 mg

EPN0300000 Neamine 0.5 mg



Code Product Unit

EPN0399000 Neohesperidin dihydrochalcone 125 mg

EPN0399004 Neohesperidin dihydrochalcone impurity B 7-[[2-O-(6-deoxy-α-L-mannopyranosyl)-ß-D-glucopyranosyl]oxy]-5-hydroxy-2- (3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one (neodiosmin)

10 mg

EPN0400000 Neomycin sulphate 50 mg

EPN0401000 Neomycin sulphate for microbiological assay 25 mg

EPN0500000 Neostigmine bromide 50 mg

EPN0550000 Neostigmine metilsulfate 50 mg

EPN0559000 Netilmicin sulphate 2x25 mg

EPY0000520 Nevirapine (anhydrous) 30 mg

EPY0000521 Nevirapine for peak identification 0.058 mg

EPY0000388 Newcastle Disease Vaccine (inacativated) BRP 4 uc

EPY0000287 Nicergoline - Reference Spectrum unit

New EPY0001373 Nicergoline 50 mg

New EPY0001362 Nicergoline for peak identification 1 mg

EPY0001352 Nicergoline for system suitability 10 mg

EPY0000283 Nicergoline impurity A [(6aR,9R,10aS)-10a-methoxy-4,7-dimethyl-4,6,6a,7,8,9,10,10a-octahydroindol [4,3-fg]quinolin-9-yl]methyl 5-chloropyridine-3-carboxylate

10 mg

New EPY0001356 Nicergoline imprity D 5-bromopyridine-3-carboxylic acid

20 mg

EPN0560000 Niclosamide (anhydrous) 50 mg

EPN0600000 Nicotinamide 50 mg

EPN0590000 Nicotine - Reference Spectrum unit

EPN0590200 Nicotine ditartrate 120 mg

EPY0001023 Nicotine for system suitability 1.25 mg

EPN0700000 Nicotinic acid 100 mg

EPY0001268 Nicotinic acid impurity mixture 0.12 mg

EPN0750000 Nifedipine 50 mg

EPN0750010 Nifedipine impurity A Dimethyl 2,6-dimethyl-4-(2-nitrophenyl) pyridine-3,5-dicarboxylate

20 mg

EPN0750015 Nifedipine impurity B Dimethyl 2,6-dimethyl-4-(2-nitrosophenyl) pyridine-3,5-dicarboxylate

20 mg

EPY0000824 Niflumic acid 10 mg

EPY0000825 Niflumic acid impurity A 2-chloropyridine-3-carboxylic acid

10 mg

EPY0000826 Niflumic acid impurity B 2-hydroxy-N-(3-(trifluoromethyl)phenyl)pyridine-3-carboxamide

10 mg

EPY0000827 Niflumic acid impurity E 6-((3-(trifluoromethyl)phenyl)amino)pyridine-3-carboxylic acid

15 mg

EPY0000836 Nifuroxazide 10 mg

EPN0800000 Nikethamide 1 mL

EPY0000829 Nilutamide 110 mg

EPY0000894 Nilutamide impurity B 4-nitro-3-(trifluoromethyl)aniline

5 mg

EPN0845000 Nimesulide 100 mg

EPN0845008 Nimesulide impurity D 4-nitro-2-phenoxyaniline

0.004 mg

EPY0001237 Nimesulide for peak identification 10 mg

EPN0850000 Nimodipine 50 mg

EPN0850010 Nimodipine impurity A 2-methoxyethyl 1-methylethyl 2,6-dimethyl-4-(3-nitrophenyl) pyridine-3,5-dicarboxylate

1 mL

EPN0900000 Nitrazepam Controlled Substance 100 mg

EPN0900010 Nitrazepam impurity A 3-amino-6-nitro-4-phenylquinol-2-one

25 mg



Code Product Unit

EPN0905000 Nitrendipine 60 mg

EPN0905005 Nitrendipine impurity A ethyl methyl-2,6-dimethyl-4-(3-nitrophenyl) pyridine-3,5-dicarboxylate; (nitrophenylpyridine analogue)

30 mg

EPN0930000 Nitric oxide - Reference Spectrum unit

EPN0950000 Nitrofural 100 mg

New EPY0001377 Nitrofural for peak identification 0.11 mg

EPN1000000 Nitrosotriaminopyrimidine 50 mg

EPN1090000 Nizatidine 250 mg

EPN1090060 Nizatidine impurity F (EZ)N1,N1-[thiazole-2,4-diylbis(methylenesulphanediylethylene)] bis(N’-methyl-2-nitroethene-1,1-diamine)

10 mg

EPN1080000 Nomegestrol acetate 100 mg

EPN1080005 Nomegestrol acetate impurity A 6-alpha-methyl-3,20-dioxo-19-norpregn-4-en-17-yl acetate

50 mg

New EPY0001314 1-nonadecanol 400 mg

EPY0000670 Nonivamide 10 mg

EPY0000755 Nonoxinol 9 10 mg

EPN1100000 Noradrenaline tartrate 200 mg

EPY0000681 Noradrenaline impurity D 4[(1R)-2-amino-1-methoxyethyl]benzene-1,2-diol (Noradrenaline methyl ether)

15 mg

EPY0000682 Noradrenaline impurity E 2-chloro-1-(3,4-dihydroxyphenyl)ethanone

10 mg

EPY0000686 Noradrenaline impurity F N-benzyl-1-phenylmethanamine

10 mg

EPN1130000 Norcyclobenzaprine 25 mg

EPN1140000 Nordazepam Controlled Substance Dipotassium clorazepate impurity B

50 mg

EPN1200000 Norethisterone 100 mg

EPN1225000 Norethisterone acetate 100 mg

EPY0000522 Norethistherone for system suitability 10 mg

EPN1230000 Norfloxacin 50 mg

New EPY0001301 Norfloxacin for peak identification 10 mg

EPN1230010 Norfloxacin impurity A 7-chloro-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

20 mg

EPY0001015 Norfloxacin for system suitability 8 mg

EPY0000724 Norgestimate 10 mg

EPY0000725 Norgestimate for system suitability 5 mg

EPN1250000 Norgestrel 30 mg

EPN1279000 Norpseudoephedrine hydrochloride Controlled Substance 50 mg

EPY0001296 Nortriptyline for system suitability 20 mg

EPN1280000 Nortriptyline hydrochloride 10 mg

EPN1300000 Noscapine 100 mg

EPN1400000 Nystatin 100 mg

EPO0100900 Octoxinol 10 300 mg

EPY0000368 Octyl gallate 30 mg

EPO0101000 Octyldodecanol 400 mg

EPO0120000 Ofloxacin 50 mg

EPO0120010 Ofloxacin impurity A (RS)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido [1,2,3-de][1,4]benzoxazine-6-carboxylic acid (FPA)

20 mg

EPO0120050 Ofloxacin impurity E (RS)-9-fluoro-3-methyl-10-(piperazin-1-yl)-7-oxo-2,3-dihydro-7H-pyrido [1,2,3-de] [1,4]benzoxazine-6-carboxylic acid

20 mg

EPY0000805 Oleuropein 20 mg



Code Product Unit

EPO0146000 Olsalazine sodium 60 mg

EPO0146010 Olsalazine sodium for performance test 60 mg

EPO0150000 Omeprazole 50 mg

EPY0001043 Omeprazole magnesium 10 mg

EPY0001042 Omeprazole for peak identification 10 mg

EPO0151000 Omeprazole impurity D Omeprazole sulphone

5 mg

EPY0000218 Ondansetron hydrochloride dihydrate 200 mg

EPY0000197 Ondansetron for LC system suitability 10 mg

EPY0000196 Ondansetron for TLC system suitability 30 mg

New EPY0001345 Ondansetron impurity A (3RS)-3-[(dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one

10 mg

EPY0000195 Ondansetron impurity D 9-methyl-3-methylene-1,2,3,9-tetrahydro-4H-carbazol-4-one

10 mg

New EPY0001326 Ondansetron impurity E Imidazole

10 mg

New EPY0001320 Ondansetron impurity F 10 mg

New EPY0001346 Ondansetron impurity G (3RS)-3-[(1H-imidazol-1-yl)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one (C-demethylondansetron)

10 mg

EPY0001125 Orbifloxacin 200 mg

EPY0001147 Orbifloxacin impurity mixture 0.0008 mg

EPO0180000 Orciprenaline sulphate 100 mg

EPY0000895 Orciprenaline for system suitability 5 mg

EPY0000101 Orphenadrine citrate 100 mg

EPY0000100 Orphenadrine hydrochloride 100 mg

EPY0001181 Orphenadrine for peak identification 0.42 mg

EPY0000102 Orphenadrine impurity E (RS)-N,N-dimethyl-2-[(3-methylphenyl)phenylmethoxy]ethanamine (meta-methylbenzyl isomer)

30 mg

New EPY0001337 Oseltamivir phosphate impurity B free

300 mg

New EPY0001338 Oseltamivir impurity A (3R,4R,5S)-5-acetamido-4-amino-3-(1-ethylpropoxy)cyclohex-1-ene-1-carboxylic acid

10 mg

New EPY0001339 Oseltamivir impurity B ethyl (1R,2R,3S,4R,5S)-4-acetamido-5-amino-2-azido-3-(1-ethylpropoxy)cyclohexanecarboxylate

10 mg

New EPY0001340 Oseltamivir impurity C (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)cyclohex-1-ene-1-carboxylic acid

10 mg

New EPY0001341 Oseltamivir impurity H tributylphosphane oxide

30 mg

New EPY0001207 Osthole 20 mg

EPO0200000 Ouabain 150 mg

EPY0000638 Oxacillin sodium monohydrate 110 mg

EPY0000560 Oxacillin for peak identification 10 mg

EPY0000271 Oxaliplatin 250 mg

EPY0000272 Oxaliplatin impurity B (SP-4-2)-diaqua[(1R,2R)-cyclohexane-1,2-diamine-kN,kN']platinum (diaquodiaminocyclohexaneplatinum)

15 mg

EPY0000273 Oxaliplatin impurity C (OC-6-33)-[(1R,2R)-cyclohexane-1,2-diamine-kN,kN'][ethanedioato(2-)-kO¹,kO²]dihydroxyplatinum

15 mg

EPY0000274 Oxaliplatin impurity D (SP-4-2)-[(1S,2S)-cyclohexane-1,2-diamine-kN,kN'][ethanedioato(2-)- kO¹,kO² ]platinum (S,S-enantiomer of oxaliplatin)

10 mg

EPO0225000 Oxazepam Controlled Substance 50 mg

EPY0000543 Oxazepam for peak identification 0.008 mg

EPY0000350 Oxeladin hydrogen citrate 50 mg



Code Product Unit

EPY0000404 Oxeladin impurity C 2-(diethylamino)ethyl 2-ethyl-2-phenylbutanoate

10 mg

EPY0000390 Oxeladin impurity D 2-(2-diethylaminoethoxy)ethyl 2-phenyl-butyrate dihydrogen citrate

20 mg

EPO0225800 Oxfendazole for veterinary use 50 mg

EPY0000224 Oxfendazole impurity B methyl[5-(phenylsulphonyl)-1H-benzimidazole-2-yl]carbamate

10 mg

EPY0000709 Oxitropium bromide 50 mg

EPY0000715 Oxitropium bromide impurity B (1R,2R,4S,5S,7s)-7-[[(2S)-3-hydroxy-2-phenylpropanoyl)oxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane (methylhyoscine)

15 mg

EPY0000713 Oxitropium bromide impurity D (1R,2R,4S,5S,7s,9r)-9-ethyl-9-methyl-7-[(2-phenylprop-2-enoyl)oxy]-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane (apo-N-ethylhyoscine)

10 mg

EPO0240000 Oxolinic acid 50 mg

EPO0240005 Oxolinic acid impurity A 8-hydroxy-1,3-dioxolo[4,5-g]quinoline-7-carboxylic acid

20 mg

EPO0240010 Oxolinic acid impurity B ethyl 5-ethyl-8-oxo-5,8-dihydro-1,3-dioxolo[4,5-g]quinoline-7-carboxylate

20 mg

EPO0250000 Oxprenolol hydrochloride 50 mg

EPO0260000 Oxibendazole 100 mg

EPO0270000 Oxybuprocaine hydrochloride 150 mg

EPO0288000 Oxybutynin hydrochloride 150 mg

EPO0288005 Oxybutynin impurity A 4-(diethylamino)but-2-ynyl(RS)-2-(cyclohex-3-enyl)-2-cyclohexyl-2-hydroxyacetate

10 mg

EPY0000492 Oxycodone hydrochloride Controlled Substance 100 mg

EPY0000453 Oxycodone impurity D 7,8-didehydro-4,5 alpha-epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one (14-hydroxycodeinone)

50 mg

EPO0290000 Oxymetazoline hydrochloride 80 mg

EPY0001044 Oxymetazoline impurity A N-(2-aminoethyl)-2-[4-(1,1-dimethylethyl)-3-hydroxy-2,6-dimethylphenyl]acetamide

10 mg

EPO0400000 Oxytetracycline 100 mg

EPO0500000 Oxytetracycline hydrochloride 20 mg

EPO0700000 Oxytocin 1 mg

EPO0770000 Oxytocin/Desmopressin validation mixture about 0.1 mg oxytocin + 0.1 mg desmopressin per vial

0.2 mg

EPY0000698 Paclitaxel 40 mg

EPY0000699 Paclitaxel impurity C N-debenzoyl-N-hexanoylpaclitaxel

5 mg

EPY0000700 Paclitaxel natural for peak identification 10 mg

EPY0000719 Paclitaxel semi-synthetic for peak identification 10 mg

EPY0000739 Paclitaxel semi-synthetic for system suitability 1 mg

EPP0090000 Palmitic acid 100 mg

EPY0000524 Pamidronate disodium pentahydrate 10 mg

EPP0100000 Pancrease powder (amylse and lipase) BRP 2000 mg

EPP0200000 Pancreas powder (protease) BRP 2000 mg

EPP0250000 Pancuronium bromide Vecuronium impurity B

20 mg

EPY0000577 Pancuronium bromide for system suitability 20 mg

EPY0000835 Pantoprazole sodium sesquihydrate 20 mg

EPY0001001 Pantoprazole for system suitability 0.5055 mg

EPP0270000 Papaverine hydrochloride 25 mg

EPP0300000 Paracetamol 50 mg

EPY0000780 Paraffin (hard) 10 mg

EPY0000058 Paraffin (liquid) - Reference Spectrum unit

EPY0000913 Paraffin (White soft) 10 mg



Code Product Unit

EPY0000912 Paraffin (Yellow soft) 10 mg

EPP0305000 Parnaparin sodium 250 mg

EPY0000578 Paroxetine hydrochloride (anhydrous) 100 mg

EPY0000281 Paroxetine hydrochloride hemihydrate 200 mg

EPY0000233 Paroxetine impurity A (3S,4R)-3-[[1,3-benzodioxol-5-yloxy]methyl]-4-phenylpiperidine (desfluoroparoxetine)

15 mg

EPY0000579 Paroxetine hydrochloride (anhydrous) impurity C (3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-1-benzyl-4-(4-fluorophenyl)piperidine (N-benzylparoxetine)

10 mg

EPY0000256 Paroxetine impurity D (3R,4S)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine ((+)-trans-paroxetine)

5 mg

EPY0000580 Paroxetine impurity E (3RS,4RS)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4fluorophenyl)piperidine (cis-paroxetine)

5 mg

EPY0000581 Paroxetine hydrochloride (anhydrous) impurity H [(3S,4R)-1-benzyl-4-(4-fluorophenyl)piperidin-3-yl]methanol

10 mg

EPY0000630 Paroxetine for system suitability 5 mg

EPP0309000 Pefloxacin mesilate dihydrate 200 mg

EPP0309020 Pefloxacin impurity B 1-ethyl-6-chloro-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (chlorinated homologue of pefloxacin)

10 mg

EPP0309030 Pefloxacin impurity C 1-ethyl-6-fluoro-5-(4-methylpiperazin-1yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (isopefloxacin)

0.01 mg

EPP0307000 Penbutolol sulphate 100 mg

EPP0307005 Penbutolol impurity A (2S)-1-[2-(cyclopent-1-enyl)phenoxy]-3-[(1,1-dimethylethyl)amino]propan-2-ol

20 mg

EPP0310000 Penicillamine 100 mg

EPP0320000 Penicillamine disulphide 3,3-(disulphanediyl)bis[(2)-2-amino-3-methylbutanoic]acid

100 mg

EPP0400100 Pentaerythrityl tetranitrate diluted 600 mg

EPP0405000 Pentamidine diisetionate 30 mg

EPP0405500 Pentazocine - Reference Spectrum unit

EPP0405510 Pentazocine hydrochloride - Reference Spectrum unit

EPY0000417 Pentazocine lactate - Reference Spectrum unit

EPY0001051 Pentetate sodium calcium 100 mg

EPP0500000 Pentobarbital Controlled Substance 500 mg

EPP0510000 Pentoxifylline 100 mg

EPY0000076 Pentoxyverine hydrogen citrate - Reference Spectrum unit

EPY0000098 Pentoxyverine impurity A 1-phenylcyclopentanecarboxylic acid

10 mg

EPY0000099 Pentoxyverine impurity B 2-(diethylamino)ethyl-1-phenylcyclopentanecarboxylate (caramiphen)

10 mg

EPP0525000 Pepsin powder 2000 mg

EPY0000010 Pergolide mesilate 150 mg

EPY0000237 Perindopril impurity A (2S,3aS,7aS)-octahydro-1Hindole-2-carboxylic acid

10 mg

EPY0000207 Perindopril for stereochemical purity 40 mg

EPY0000238 Perindopril tert-butylamine 40 mg

EPY0000771 Perindopril for peak identification 5 mg

EPP0550000 Perphenazine 100 mg

EPY0001045 Perphenazine for system suitability 5 mg

EPY0000021 Pertussis toxin BRP 2x0.05 mg

EPP0600000 Pethidine hydrochloride - Reference Spectrum unit

EPP0600002 Pethidine impurity A 1-methyl-4-phenylpiperidine (MPP)

20 mg

EPP0800000 Phenazone 20 mg



Code Product Unit

EPY0001138 Phenazone impurity A 5-methyl-2-phenyl-2,4-dihydro-3-pyrazol-3-one

20 mg

EPP0850000 Pheniramine maleate 250 mg

EPP0900000 Phenobarbital Controlled Substance 200 mg

New EPY0001350 Phenobarbital impurity A (5RS)-5-ethyl-2,6-diimino-5-phenyltetrahydropyrimidin-4(1H)-one

15 mg

New EPY0001351 Phenobarbital impurity B (5RS)-5-ethyl-6-imino-5-phenyldihydropyrimidine-2,4(1H,3H)-dione

15 mg

EPP0950000 Phenoxyethanol 2 mL

EPP1000000 Phenoxymethylpenicillin 250 mg

EPP1100000 Phenoxymethylpenicillin potassium 250 mg

EPP1109000 Phentolamine mesilate - Reference Spectrum unit

EPY0001127 Phentolamine mesilate 10 mg

EPY0001251 Phentolamine mesilate for system suitability 10 mg

EPP1150000 Phenylalanine 60 mg

EPP1200000 Phenylbutazone 100 mg

EPY0000147 Phenylbutazone impurity B (4-butyl-4-hydroxy-1,2-diphenyl-3,5)pyrazolidinedione

20 mg

EPP1240000 Phenylephrine 60 mg

EPP1250000 Phenylephrine hydrochloride 50 mg

EPY0000683 Phenylephrine hydrochloride for peak identification 2 mg

EPY0000229 Phenylmercuric acetate - Reference Spectrum unit

EPP1255100 Phenylmercuric borate - Reference Spectrum unit

EPP1260000 Phenylpropanolamine hydrochloride Drug Precursor 50 mg

EPP1290000 Phenytoin 100 mg

EPY0001167 Phenytoin for system suitability 20 mg

EPP1300000 Phenytoin sodium 250 mg

EPY0000493 Phloroglucinol (anhydrous) 210 mg

EPY0000761 Pholcodine Controlled Substance 10 mg

EPY0000798 Pholcodine for peak identification Controlled Substance 10 mg

EPY0000766 Phthalic acid benzene-1,2-dicarboxylic acid

20 mg

EPP1500000 Phthalylsulfathiazole 100 mg

EPP1600000 Physostigmine salicylate 100 mg

EPP1605000 Physostigmine sulphate 100 mg

EPP1609000 Phytomenadione 150 mg

EPP1609010 trans-Epoxyphytomenadione 10 mg

EPY0001104 Picosulfate for system suitability 0.5 mg

EPP1645000 Picotamide monohydrate 125 mg

EPP1645005 Picotamide impurity A 4-methoxybenzene-1,3-dicarboxylic acid

25 mg

EPY0000124 Pidolate impurity B (2S)-2-[[[(2S)-5-oxopyrrolidin-2-yl]carbonyl]amino]pentanedioic acid

60 mg

EPY0000123 Pidolic acid 125 mg

EPP1650000 Pilocarpine hydrochloride 50 mg

EPP1700000 Pilocarpine nitrate 50 mg

EPY0000106 Pilocarpine nitrate for system suitability 20 mg

EPY0000525 Pimobendan 10 mg

EPY0000401 Pimobendan for system suitability 0.1 mg

EPP1750000 Pimozide 150 mg

EPP1800000 Pindolol 100 mg

EPY0000061 Pipemidic acid trihydrate - Reference Spectrum unit

EPP1890000 Piperacillin 100 mg

EPP1900000 Piperazine adipate 250 mg



Code Product Unit

EPP2000000 Piperazine citrate 250 mg

EPP2100000 Piperazine hydrate 250 mg

EPY0000288 Piracetam 120 mg

EPY0000038 Pirenzepine dihydrochloride monohydrate 250 mg

EPP2120000 Piretanide 100 mg

EPP2120002 Piretanide impurity A 4-phenoxy-3(1H-pyrrol-1-yl)-5-sulphamoylbenzoic acid

20 mg

EPP2130000 Piroxicam 100 mg

EPP2130100 Piroxicam for system suitability 10 mg

EPP2150000 Pivampicillin 50 mg

EPP2152000 Pivmecillinam hydrochloride 100 mg

EPP2152015 Pivmecillinam impurity C methylene 2,2-dimethylpropanoate (2RS,4S)-2-[[[(hexahydo-1H-azepin-1-yl) methylene]amino]methyl]-5,5-dimethylthiazolidin-4-carboxylate

10 mg

EPP2155001 Plastic additive 01 (2RS)-2-ethylhexyl)benzene-1,2-dicarboxylate

2 mL

EPP2155003 Plastic additive 03 N,N'-ethylenedialcanamide

100 mg

EPE0800000 Plastic additive 04 Epoxidised soya oil

500 mg

EPP2155005 Plastic additive 05 Epoxidised linseed oil

500 mg

EPP2155008 Plastic additive 08 Ethylene bis [3,3-bis[3-(1,1-dimethylethyl)-4-hydroxyphenyl]butanoate]

500 mg

EPP2155009 Plastic additive 09 pentaerythrityl tetrakis[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate] 250 mg

EPP2155010 Plastic additive 10 4,4',4''-(2,4,6-trimethylbenzene-1,3,5-triyltrismethylene)-trio[2,6-bis(1,1-dimethylethyl)phenol]

250 mg

EPP2155011 Plastic additive 11 Octadecyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)-propionate

500 mg

EPP2155012 Plastic additive 12 Tris(2,4-di-1,1-dimethylethylphenyl)phosphite R

250 mg

EPP2155013 Plastic additive 13 1,3,5-tris(3,5-di-1,1-dimethylethyl-4-hydroxybenzyl)-1H,3H,5H-1,3,5-triazine-2,4,6-trione

250 mg

EPP2155014 Plastic additive 14 2,2'-Di(octadecycloxy)5,5'-spirobi(1,3,2,-dioxaphosphorinane) R

250 mg

EPP2155015 Plastic additive 15 Dioctadecyl disulphide

500 mg

EPP2155016 Plastic additive 16 Didodecyl 3,3'-thiodipropionate R

250 mg

EPP2155017 Plastic additive 17 Dioctadecyl 3,3'-thiodipropionate R

250 mg

EPP2155018 Plastic additive 18 100 mg

EPO0140000 Plastic additive 20 Oleamide R

100 mg

EPE1260000 Plastic additive 21 Erucamide R

100 mg

EPP2155022 Plastic additive 22 Copolymer of dimethyl butanedioate and 1-(2-hydroxyethyl)-2,2,6,6-tetramethylpiperidin-4-ol Synonyms: copolymer of dimethyl succinate and (4-hydroxy-2,2,6,6-tetramethylpiperidin-1-yl)ethanol

100 mg

EPP2155023 Plastic additive 23 di(isooctyl)2,2'-[(dioctylstannylene)bis(thio)]diacetate containing about 27% of (tri(isooctyl)2,2',2''-[monooctylstannylidyne)tris(thio)]triacetate Tin-content of 15.4%

200 mg

EPP2160000 Poliomyelitis vaccine (inactivated) BRP 5x0.5 mL

EPP2161000 Poliomyelitis vaccine (oral) BRP 5x1 mL

EPP2163920 Poloxamer 124 30 mg





Code Product Unit



EPP2170000 Polyacrylate - Reference Spectrum unit

EPP2400000 Polymyxin B sulphate 25 mg

EPY0000355 Polymyxin B sulphate for microbiological assay 25 mg

EPY0000289 Polysorbate 20 - Reference Spectrum unit




EPY0000792 Poly(vinyl acetate) dispersion 30% 1500 mg

EPP2600000 Poly(vinyl chloride) 100 mg

EPP2649610 Potassium clavulanate - Reference Spectrum unit

EPY0001168 Potassium clavulanate impurity G 5 mg

EPY0000315 Potassium hydrogen aspartate hemihydrate 50 mg

EPP2650000 Potassium sorbate 100 mg

New EPY0001275 Potassium sucrose octasulfate 100 mg

EPP2660000 Povidone 50 mg

EPY0000466 Povidone (iodinated) 10 mg

EPY0001266 Pramipexole dihydrochloride monohydrate 5 mg

EPY0001267 Pramipexole impurity D (6R)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine

5 mg

EPY0001187 Pramipexole for system suitability 15 mg

EPY0000215 Pravastatin sodium - Reference Spectrum unit

EPY0000223 Pravastatin impurity A (3R,5R)-3,5-dihydroxy-7-[(1S,2S,6R,8S,8aR)-6-hydroxy-2-methyl-8-[[(2S)- 2-methylbutanoyl]oxy]-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid (6'-epipravastatin)

0.1 mg

EPY0000204 Pravastatin 1,1,3,3-tetramethylbutylamine 30 mg

EPP2669000 Prazepam Controlled Substance 50 mg

EPP2670000 Praziquantel 150 mg

EPP2675000 Praziquantel impurity A (11bRS)-2-benzoyl-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isoquinolin-4-one

10 mg

EPP2680000 Prazosin hydrochloride 50 mg

EPP2698000 Prednicarbate 100 mg

EPP2698060 Prednicarbate impurity F 1,2-dihydroprednicarbate

10 mg

EPP2700000 Prednisolone 150 mg

New EPY0001355 Prednisolone for system suitability 10 mg

New EPY0001359 Prednisolone for peak identification 10 mg

EPP2800000 Prednisolone acetate 120 mg

EPY0000582 Prednisolone acetate for peak identification 10 mg

EPP2804000 Prednisolone hexanoate 10 mg

EPP2805000 Prednisolone pivalate 100 mg

EPP2810000 Prednisolone sodium phosphate 100 mg

EPP2900000 Prednisone 100 mg

EPP2920000 Pregnenolone isobutyrate 150 mg

EPY0000263 Prekallikrein activator in albumin BRP 3x1 mL

EPP2939000 Prilocaine 150 mg

EPP2939060 Prilocaine hydrochloride 100 mg

EPP2939025 Prilocaine impurity E (RS)-N-(methylphenyl)-2-(propylamino)propanamide

25 mg

EPP2940000 Primaquine diphosphate 500 mg

EPP2950000 Primidone 150 mg

EPY0000369 Primidone for peak identification 5 mg



Code Product Unit

EPP3000000 Probenecid 100 mg

EPP3050000 Procainamide hydrochloride 100 mg

EPP3090000 Procaine benzylpenicillin 250 mg

EPP3100000 Procaine hydrochloride 100 mg

EPP3200000 Prochlorperazine maleate 100 mg

EPP3300000 Progesterone 50 mg

EPY0000148 Progesterone impurity C (20R)-20-hydroxypregn-4-en-3-one

10 mg

EPY0000179 Proguanil hydrochloride - Reference Spectrum unit

EPY0000181 Proguanil impurity C 1,5-bis(4-chlorophenyl)biguanide

10 mg

EPY0000182 Proguanil impurity D 1,5-bis(1-methylethyl)biguanide

10 mg

EPP3350000 Proline 60 mg

EPP3390000 Promazine hydrochloride 100 mg

EPP3400000 Promethazine hydrochloride 50 mg

EPY0000769 Promethazine impurity D (2RS)-N,N-dimethyl-1-(10H-phenothiazin-10-yl)propan-2-amine S-oxide

10 mg

EPY0000797 Promethazine for peak identification 10 mg

EPP3490000 Propacetamol hydrochloride - Reference Spectrum unit

EPY0000455 Propafenone hydrochloride 10 mg

EPY0000456 Propafenone impurity B 2E)-1-[2-[(2RS)-2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenylprop-2-en-1-one

10 mg

EPY0000278 Propanol - Reference Spectrum unit

EPY0000016 Propofol 290 mg

EPY0000017 Propofol for peak identification 0.1 mL

EPY0000018 Propofol impurity J 2,6-bis (1-methylethyl)-1,4-benzoquinone

20 mg

EPP3500000 Propranolol hydrochloride 30 mg

EPP3600000 Propranolol hydrochloride for performance test 20 mg

EPY0000318 Propylene glycol dilaurate 100 mg

EPY0000319 Propylene glycol monolaurate 100 mg

EPP3640000 Propyl gallate 50 mg

EPP3650000 Propyl parahydroxybenzoate 100 mg

EPP3700000 Propylthiouracil 100 mg

EPP3750000 Propyphenazone 200 mg

EPP3760000 Protirelin 2x5.03 mg

EPP3760020 D-His Protirelin 0.1 mg

EPP3800000 Proxyphylline 100 mg

EPP3850000 Pseudoephedrine hydrochloride Drug Precursor 100 mg

EPY0000387 Pseudoisoeugenyl 2-methylbutyrate for peak identification 100 mg

EPP3900000 Purpureaglycoside A 25 mg

EPP4000000 Purpureaglycoside B 25 mg

EPY0000402 Pyrantel embonate 10 mg

EPY0000403 Pyrantel impurity A 1-methyl-2-[(Z)-2-(thiophen-2-yl)ethenyl]-1,4,5,6-tetrahydropyrimidine

20 mg

EPP4050000 Pyrazinamide 30 mg

EPP4099900 Pyridostigmine bromide 50 mg

EPP4099910 Pyridostigmine impurity A pyridin-3-yl-dimethylcarbamate

20 mg

EPP4100000 Pyridoxine hydrochloride 100 mg

EPY0001226 Pyridoxine impurity A 6-methyl-1,3-dihydrofuro[3,4-c]pyridin-7-ol

5 mg

EPP4200000 Pyrimethamine 250 mg



Code Product Unit

EPY0000659 Pyrrolidone 20 mg

EPY0001009 Quercetin dihydrate 20 mg

EPQ0100000 Quinidine sulphate 300 mg

EPQ0200000 Quinine sulphate 300 mg

EPR0100000 Rabies vaccine (inactivated) for veterinary use BRP 3x86 mg

EPY0000896 Racecadotril 110 mg

EPY0000897 Racecadotril impurity A Ethanethioic acid

1 mL

EPY0000898 Racecadotril impurity G benzyl[[(2RS)-2-benzyl-3-sulfanylpropanoyl]amino]acetate

10 mg

EPY0000902 Racecadotril for peak identification 5 mg

EPY0001134 Raloxifene hydrochloride 110 mg

EPY0001135 Raloxifene hydrochloride for peak identification 10 mg

EPR0145000 Ramipril 20 mg

EPR0145005 Ramipril impurity A (2S,3aS,6aS)-1-[(S)-2-[[(S)-1-(methoxycarbonyl)-3-phenylpropyl]amino] propanoly]octahydrocyclopenta[b]pyrrole-2-carboxylic acid (ramipril methylester)

10 mg

EPR0145010 Ramipril impurity B (2S,3aS,6aS)-1-[(S)-2-[[(S)-1-[(methylethoxy)carbonyl]-3-phenylpropyl] amino] propanoyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid (ramipril isopropyl ester)

10 mg

EPR0145015 Ramipril impurity C (2S,3aS,6aS)-1-[(S)-2-[[(S)-1-(ethoxycarbonyl)-3-cyclohexylpropyl]amino] propanoyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid (hexahydroramipril)

10 mg

EPR0145020 Ramipril impurity D ethyl(2S)-2-[(3S,5aS,8aS,9aS)-3-methyl-1,4-dioxodecahydro -1H-cyclopenta[e]pyrrolo[1,2a]pyrazin-2-yl]-4-phenylbutanoate (ramipril diketopiperazine)

10 mg

EPR0150000 Ranitidine hydrochloride 100 mg

EPY0000416 Ranitidine impurity J 1,1'-N-[methylenebis(sulphanediylethylene)]bis (N'-methyl-2-nitroethene-1,1-diamine)

0.00025 mg

EPY0000411 Ranitidine for system suitability 20 mg

EPY0000457 Repaglinide 20 mg

EPY0000458 Repaglinide for system suitability 6 mg

EPY0000459 Repaglinide impurity E 2-ethoxy-4-[2-[[(1R)-3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl] amino]-2-oxoethyl]benzoic acid

10 mg

EPR0200000 Reserpine 100 mg

EPR0250000 Residual solvents solution class I 1500 mg

EPY0000767 Resorcinol 20 mg

EPR0300000 Retinol acetate 1000 mg

EPR0290000 Retinol ester 100 mg

EPR0500500 Reviparin sodium 250 mg

EPY0000377 Ribavirin 2x100 mg

EPY0000353 Ribavirin for system suitability 1 mg

EPR0600000 Riboflavin (Vitamine B2) 100 mg

EPY0000757 Riboflavin for peak identification 0.1 mg

EPR0630000 Riboflavine sodium phosphate 250 mg

EPY0000662 Ribonucleic acid 100 mg

EPY0000149 Rifabutin 150 mg

EPY0000184 Rifabutin impurity A 1-(2-methylpropyl)piperidin-4-one

20 mg

EPR0700000 Rifampicin 500 mg

EPR0800000 Rifampicin quinone 100 mg

EPR0900000 Rifamycin B 50 mg



Code Product Unit

EPR0950000 Rifamycin S 50 mg

EPR1000000 Rifamycin sodium 300mg

EPY0001074 Rifaximin 160 mg

EPY0001075 Rifaximin for system suitability 10 mg

EPY0000250 Rilmenidine dihydrogenophosphate - Reference Spectrum unit

EPY0000187 Rilmenidine for system suitability 30 mg

EPR1000600 Risperidone 50 mg

EPY0000370 Risperidone for system suitability 20 mg

New EPY0001276 Risperidone impurity K 3-[2-[4-(1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydro-4Hpyrido[1,2-a]pyrimidin-4-one (desfluoro risperidone)

0.015 mg

EPR1300000 RK 13 cells cell lines (kidney,rabbit) titration of live measles, mumps and rubella vaccines

2x1 mL

EPY0000714 Ritonavir 80 mg

EPY0000706 Ritonavir for peak identification 10 mg

EPY0000594 Rocuronium bromide - Reference Spectrum unit

EPY0000527 Rocuronium for peak identification 10 mg

EPY0000742 Ropivacaine hydrochloride monohydrate 10 mg

EPY0000743 Ropivacaine impurity G (+)-(2R)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide ((R)-ropivacaine)

5 mg

EPY0000786 Rosmarinic acid 40 mg

EPR1500000 Roxithromycin 125 mg

EPY0000220 Roxithromycin for system suitability 5 mg

EPR2000000 Rubella vaccine (live) BRP 5x18 mg

EPY0000494 Ruscogenins 10 mg

EPY0000105 Rutoside trihydrate 100 mg

EPS0040000 Saccharin 30 mg

EPS0050000 Saccharin Sodium 50 mg

EPS0100000 Salbutamol 50 mg

EPY0000030 Salbutamol impurity B (1RS)-2-[(1,1-dimethylethyl)amino]-1-(4-hydroxyphenyl)ethanol

5 mg

EPY0000071 Salbutamol impurity D 5-[(1RS)-2-[(1,1-dimethylethyl)amino]-1-hydroxyethyl]-2- hydroxybenzaldehyde

5 mg

EPY0000031 Salbutamol impurity F 1,1'[oxybis[methylene(4-hydroxy-1,3-phenylene)]]bis [2-[(1,1-dimethylethyl)amino]ethanol]

5 mg

EPY0000034 Salbutamol impurity G 2-[benzyl(1,1-dimethylethyl)amino]-1-[4-hydroxy-3-hydroxymethyl) phenyl]ethanone

5 mg

EPY0000032 Salbutamol impurity I (1RS)-2-[(1,1-dimethylethyl)amino]-1-[3-(hydroxymethyl)-4-benzyloxyphenyl] ethanol

0.006 mg

EPY0001186 Salbutamol impurity J 2-[(1,1-dimethylethyl)amino]-1-[4-hydroxy-3-(hydroxymethyl)phenyl]ethanone (salbutamone)

0.00045 mg

EPS0150000 Salbutamol sulphate 50 mg

EPY0001288 Salbutamol sulfate for system suitability 10 mg

EPY0000669 Salicin 50 mg

EPS0200000 Salicylic acid 100 mg

EPY0000405 Salicylic acid impurity B 4-hydroxyisophthalic acid

10 mg

EPY0000422 Salmeterol xinafoate 40 mg

EPY0000423 Salmeterol xinafoate for system suitability 25 mg

EPY0001052 Santonin 20 mg

EPY0001049 Saquinavir mesilate 70 mg

EPY0001056 Saquinavir for system suitability 0.3033 mg



Code Product Unit

EPY0000814 Selamectin 100 mg

EPY0000815 Selamectin for system suitability 5 mg

EPS0360000 Selegiline hydrochloride 50 mg

EPS0360090 (RS)-Selegiline hydrochloride 25 mg

EPS0400000 Senna extract 50 mg

EPS0450000 Serine 50 mg

EPS0460000 Sertaconazole nitrate 125 mg

EPY0000828 Sertraline hydrochloride 200 mg

EPY0000866 Sertraline for peak identification 2.8 mg

EPY0000867 Sertraline for system suitability 3.2 mg

EPY0001285 Sertraline impurity E 15 mg

EPY0000371 Sestamibi labelling kit 22 mg

EPY0001046 Sevoflurane 1 mL

EPS0500000 Silicone elastomer 2000 mg

EPS0600000 Silicone oil 1 mL

EPS0650000 Simvastatin 100 mg

EPY0001066 Simvastatin for peak identification 10 mg

EPS0660000 Sisomicin sulphate 50 mg

EPY0000014 Sodium alendronate 150 mg

EPS0695000 Sodium amidotrizoate 125 mg

EPY0000300 Sodium aminosalicylate dihydrate - Reference Spectrum unit

EPY0000039 Sodium ascorbate 50 mg

EPS0700000 Sodium calcium edetate 100 mg

EPS0710000 Sodium cetostearyl sulphate 100 mg

EPS0750000 Sodium cromoglicate 10 mg

New EPY0001300 Sodium cromoglicate for system suitability 20 mg

EPS0760000 Sodium cyclamate 100 mg

EPS0765000 Diclofenac sodium 100 mg

EPS0781000 Sodium hyaluronate - Reference Spectrum unit

EPS0780000 Sodium hyaluronate BRP 300 mg

EPY0000620 Sodium laurilsulfate 40 mg

EPY0000808 Sodium phenylbutyrate 5 mg

EPY0000809 Sodium phenylbutyrate impurity C 4-cyclohexylbutanoic acid

10 mg

EPS0785000 Sodium picosulphate 100 mg

EPY0000210 Sodium polystyrene sulphonate - Reference Spectrum unit

EPY0000268 Sodium propionate - Reference Spectrum unit

EPS0800000 Sodium salicylate 100 mg

EPS0808000 Sodium stearyl fumarate 50 mg

EPS0808060 Sodium stearyl maleate 10 mg

EPS0900000 Sodium taurocholate BRP 10000 mg

EPS0930000 Sodium valproate 150 mg

EPS0945000 Somatostatin 2.45 mg

EPS0947000 Somatropin 35 mg

EPY0000711 Somatropin/desamidosomatropin resolution mixture 33 mg

EPS0950000 Sorbic acid 10 mg

EPY0000385 1,4-Sorbitan 50 mg

EPS1000000 Sorbitol 1200 mg

EPY0000114 Sotalol hydrochloride 25 mg

EPY0000115 Sotalol impurity B N-[4-[[(1-methylethyl)amino]acetyl]phenyl]methanesulphonamide

20 mg

EPY0001011 Spanish sage oil for peak identification 250 mg



Code Product Unit

EPY0000597 Spectinomycin hydrochloride 100 mg

EPY0000549 Spectinomycin for system suitability 20 mg

EPY0000655 Spectinomycin sulphate tetrahydrate 10 mg

EPY0001126 Spike lavender oil 400 µl

EPS1100000 Spiramycin 200 mg

EPY0000381 Spirapril hydrochloride monohydrate 60 mg

EPY0000332 Spirapril for system suitability 15 mg

EPS1200000 Spironolactone 100 mg

New EPY0001295 Spironolactone for system suitability 2.055 mg

EPY0000185 Squalane 0.25 mL

EPY0001050 St.John's wort standardised dry extract 500 mg

EPY0001091 Standardised artichoke leaf dry extract 60 mg

EPS1250000 Stanozolol 125 mg

EPS1250010 Stanozolol impurity A (5α,17β)-17-hydroxy-17-methylandrostan-3-one

10 mg

EPS1300000 Starch BRP 50000 mg

EPY0000408 Stavudine 100 mg

EPY0000421 Stavudine for system suitability 10 mg

EPS1340000 Stearic acid Plastic additive 19

100 mg

EPS1350000 Stearyl alcohol 250 mg

EPY0000868 Streptokinase for system suitability 30 µl

EPS1400000 Streptomycin sulphate 100 mg

EPS1500000 Succinylsulfathiazole 100 mg

New EPY0001324 Sucralfate 10 mg

New EPY0001344 Sucralose 550 mg

New EPY0001342 Sucralose impurity B 1,6-dichloro-1,6-dideoxy-β-D-fructofuranosyl 6-chloro-6-deoxy-α-D-glucopyranoside (1‘,6,6‘-trichloro-1‘,6,6‘-trideoxysucrose)

0.5 mg

EPS1600000 Sucrose 100 mg

EPS1608100 Sufentanil - Reference Spectrum unit

EPS1609000 Sufentanil citrate - Reference Spectrum unit

EPY0000529 Sulbactam sodium 10 mg

EPY0000528 Sulbactam 150 mg

EPY0000550 Sulbactam for peak identification 20 mg

EPS1700000 Sulfacetamide sodium 50 mg

EPS1800000 Sulfadiazine 100 mg

EPS1900000 Sulfadimidine 100 mg

EPS1950000 Sulfadoxine 50 mg

EPS1975000 Sulfafurazole 100 mg

EPS1975600 Sulfaguanidine 60 mg

EPS2000000 Sulfamerazine 100 mg

EPS2050000 Sulfamethizole 100 mg

EPS2100000 Sulfamethoxazole 50 mg

EPY0000412 Sulfamethoxazole impurity A N-(4-(5-methyl)-isoxazol-3-ylsulphamoyl)phenylacetamide

5 mg

EPY0000413 Sulfamethoxazole impurity F 4-amino-N-(3-methylisoxazol-5-yl)benznesulphonamide

5 mg

EPS2150000 Sulfamethoxypyridazine 50 mg

EPS2151000 Sulfanilamide 100 mg

EPS2159100 Sulfapyridine 20 mg

EPS2155000 Sulfasalazine 2x250 mg

EPS2155010 Sulfasalazine derivative for resolution 2-hydroxy-5-[[4-[[(6-methylpyridin-2-yl)amino]-sulfonyl]phenyl]azo]benzoic acid

20 mg



Code Product Unit

EPS2158000 Sulfathiazole 100 mg

EPS2159000 Sulfinpyrazone 30 mg

EPY0001238 Sulfinpyrazone for system suitability 0.5 mg

EPS2159010 Sulfinpyrazone impurity A 1,2-diphenyl-4-(2-phenylsulphonylethyl)pyrazolidine-3,5-dione

20 mg

EPS2159015 Sulfinpyrazone impurity B 1,2-diphenyl-4-(2-phenylthioethyl)pyrazolidine-3,5-dione

20 mg

EPS2160000 Sulfisomidine 50 mg

EPS2180000 Sulindac 50 mg

EPS2190000 Sulpiride 100 mg

EPS2191000 Sulpiride impurity A [(2RS)-1-ethylpyrrolidin-2-yl]methanamine

20 mg

EPS2192000 Sulpiride impurity B methyl 2-methoxy-5-sulphamoylbenzoate

20 mg

EPY0000530 Sultamicillin 10 mg

EPY0000531 Sultamicillin tosilate 200 mg

EPY0000532 Sultamicillin for peak identification 10 mg

EPY0000022 Sumatriptan succinate 50 mg

EPY0000026 Sumatriptan impurity mixture 3 mg

EPY0000027 Sumatriptan for system suitability 2 mg

EPS2200000 Suxamethonium chloride 1000 mg

EPS2400000 Suxibuzone 50 mg

EPS2400004 Suxibuzone impurity B (4-butyl-3,5-dioxo-1,2-diphenylpyrazolidin-4-yl)methyl ethyl butanedioate

10 mg

EPS2400006 Suxibuzone impurity C 4-butyl-4-(hydroxymethyl)-1,2-diphenyl-1,2-dihydro-4H-pyrazole-3,5-dione

10 mg

EPS5000001 Swine erysipelas bacteria, serotyp 1 (for vaccines-vet.use) BRP 1 mg

EPS5000002 Swine erysipelas bacteria, serotyp 2 (for vaccines-vet.use) BRP 1 mg

EPT0010000 Talampicillin hydrochloride 50 mg

EPT0014000 Tamoxifen citrate 80 mg

EPT0015000 Tamoxifen citrate for performance test 30 mg

EPY0000650 Tamsulosin hydrochloride 10 mg

EPY0000653 Tamsulosin racemate 10 mg

EPY0000651 Tamsulosin impurity D 2-methoxy-5[(2R)-2-[[2-(2-methyoxyphenoxy)ethyl]amino]propyl]benzenesulfonamide

10 mg

EPY0000652 Tamsulosin impurity H (2R)-N-[2-(2-ethoxyphenoxy)ethyl]-1-(4-methoxyphenyl)propan-2-amine

10 mg

EPY0001102 Teicoplanin 52 mg

EPY0001047 Teicoplanin for identification 40 mg

EPY0000648 Telmisartan 30 mg

EPY0000649 Telmisartan for peak identification 10 mg

EPY0001003 Telmisartan for system suitability 0.26 mg

EPT0040000 Temazepam Controlled Substance 50 mg

EPY0000344 Temazepam impurity C (3RS)-7-chloro-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl acetate Controlled Substance

5 mg

EPY0000345 Temazepam impurity D (3RS)-7-chloro-3-methoxy-1-methyl-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one Controlled Substance

5 mg

EPY0000346 Temazepam impurity F (5RS)-7-chloro-1-methyl-5-phenyl-4,5-dihydro-1H-1,4-benzodiazepine-2,3-dione

5 mg

EPY0000347 Temazepam impurity G (5RS)-7-chloro-1,4-methyl-5-phenyl-4,5-dihydro-1H-1,4-benzodiazepine-2,3-dione

5 mg

EPT0040800 Tenoxicam 100 mg

EPY0001114 Tenoxicam impurity mixture 0.0042 mg

EPY0000621 Terazosin hydrochloride dihydrate 40 mg



Code Product Unit

EPY0000666 Terazosin for system suitability 0.5 mg

EPY0000622 Terazosin impurity A 2-chloro-6,7-dimethoxyquinazolin-4-amine

10 mg

EPY0000665 Terazosin impurity E 2,2`-(piperazine-1,4-diyl)bis(6,7-dimethoxyquinazolin-4-amine)

10 mg

EPY0000623 Terazosin impurity L 1-(furan-2-ylcarbonyl)piperazine

10 mg

EPY0000624 Terazosin impurity N 1-[[(2RS)-tetrahydrofuran-2-yl]carbonyl]piperazine

10 mg

EPY0000535 Terbinafine hydrochloride 10 mg

EPY0001143 Terbinafine for system suitability 10 mg

EPT0050000 Terbutaline sulphate 100 mg

EPT0050015 Terbutaline impurity C 1-(3,5-dihydroxyphenyl)-2-[(1,1- dimethylethyl)amino]-ethanone

15 mg

EPT0060000 Terconazole 250 mg

EPT0071000 Terfenadine 100 mg

EPT0080000 Terfenadine impurity A 1-[4-(1,1-dimethylethyl)phenyl]-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl] butan-1-one (ketone)

20 mg

EPT0100000 Testosterone 30 mg

EPT0200000 Testosterone acetate 10 mg

EPT0210000 Testosterone caproate 50 mg

EPT0240000 Testosterone decanoate 50 mg

EPY0000696 Testosterone decanoate for system suitability 0.4 mg

EPT0250000 Testosterone enantate 100 mg

New EPY0001312 Testosterone enantate for peak identification 10 mg

New EPY0001317 Testosterone enantate for system suitability 20 mg

New EPY0001313 Testosterone enantate impurity H delta-5-testosterone-3,17-dienantate

10 mg

EPY0000342 Testosterone for impurity D identification 20 mg

EPY0000343 Testosterone for system suitability 20 mg

EPT0260000 Testosterone isocaproate 50 mg

EPY0000716 Testosterone isocaproate for system suitability 5 mg

EPT0300000 Testosterone propionate 50 mg

EPY0000170 Testosterone propionate - Reference Spectrum unit

EPT0400000 Tetanus vaccine (adsorbed) BRP 30 mg

EPY0001087 Tetra-O-acetyl-mannose triflate 60 mg

EPT0500000 Tetracaine hydrochloride 100 mg

EPY0001002 Tetracaine for system suitability 2 mg

EPT0550000 Tetracosactide 2x0.366mg

EPT0600000 Tetracycline hydrochloride 100 mg

EPY0001165 Tetrandrine 20 mg

EPY0000015 Tetrazepam - Reference Spectrum unit

EPY0000008 Tetrazepam impurity C 7-chloro-5-cyclohexyl-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one

20 mg

EPY0000460 Tetryzoline hydrochloride 10 mg

EPY0000723 Thebaine Controlled Substance 10 mg

EPT0700000 Theobromine 100 mg

EPT0800000 Theophylline 100 mg

EPY0000294 Theophylline - Reference Spectrum unit

EPY0000336 Thiamazole 125 mg

EPY0000372 Thiamazol impurity A 2,2-dimethoxy-N-methylethanamine

15 mg

EPY0000373 Thiamazol impurity C 1-methyl-2-(methylsulphanyl)-1H-imidazole

20 mg



Code Product Unit

EPY0000467 Thiamine hydrochloride 10 mg

EPY0000059 Thiamine impurity E 3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-5-(2-hydroxyethyl) 4-methyl-4-thiazolidine-2-thione

10 mg

EPY0000060 Thiamine nitrate - Reference Spectrum unit

EPT1100000 Thiamphenicol 125 mg

EPY0000546 Thioctic acid 110 mg

EPY0000592 Thioctic acid for system suitability 10 mg

EPY0000545 Thioctic acid containing impurity B 30 mg

EPY0000109 Thiomersal 30 mg

EPT1200000 Thiopental 500 mg

EPY0000704 Thioridazine 10 mg

EPT1300000 Thioridazine hydrochloride 100 mg

EPY0000541 Thioridazine for system suitability 0.21 mg

EPT1305100 Thioxanthene 20 mg

EPT1305000 Thioxanthone 10 mg

EPT1340000 Threonine 50 mg

EPT1350000 Thymol 50 mg

EPT1410000 Tiabendazole 50 mg

EPY0000414 Tiamulin for peak identification 10 mg

EPY0000333 Tiamulin hydrogen fumarate 500 mg

EPY0000379 Tiamulin - Reference Spectrum unit

EPY0000151 Tianeptine sodium - Reference Spectrum unit

EPY0000152 Tianeptine for system suitability 30 mg

EPY0000153 Tianeptine impurity A ethyl 7-bromoheptanoate

20 mg

EPT1405000 Tiapride hydrochloride 60 mg

EPT1405050 Tiapride N-oxide 20 mg

EPT1410900 Tiaprofenic acid 50 mg

EPT1410910 Tiaprofenic acid impurity C (2RS)-2-(5-benzoylthiophen-3-yl)propanoic acid

20 mg

EPY0000748 Tibolone - Reference Spectrum unit

EPY0000668 Tibolone for system suitability 10 mg

EPY0000465 Ticarcillin monosodium 250 mg

EPT1420010 Ticarcillin impurity A (2S,5R,6R)-3,3-dimethyl-7-oxo-6-[[(thiophen-3-yl)acetyl]-amino]-4-thia-1- azabicyclo[3.2.0]heptane-2-carboxylic acid (decarboxyticarcillin)

50 mg

EPT1423000 Ticlopidine hydrochloride 50 mg

EPT1423025 Ticlopidine impurity F 6-(2-chlorobenzyl)4,5,6,7-tetrahydrothieno [3,2-c]pyridine

10 mg

EPY0000325 Tilidine hydrochloride hemihydrate - Reference Spectrum unit

EPY0001270 Timolol for system suitability 5.045 mg

EPT1450000 Timolol maleate 100 mg

EPY0000644 (R)-timolol 20 mg

EPT1470000 Tinidazole 100 mg

EPY0000899 Tinidazole impurity A 2-methyl-5-nitro-1H-imidazole

10 mg

EPT1471000 Tinidazole impurity B 1-(2-ethylsulphonylethyl)-2-methyl-4-nitroimidazole

20 mg

EPT1490000 Tinzaparin sodium 250 mg

EPY0000292 Tioconazole - Reference Spectrum unit

EPY0000282 Tioconazole for system suitability 50 mg

EPY0001188 Tiotropium bromide monohydrate 10 mg

EPY0001216 Tiotropium impurity F dithiophen-2-ylmethanone

10 mg



Code Product Unit

EPY0001179 Tiotropium impurity mixture 0.08 mg

EPY0001189 Tiotropium for system suitability 10 mg

EPT1500000 Tobramycin 51 mg

EPY0001210 Tobramycin for identification 250 mg

EPY0000383 All-rac-alpha-tocopherol for peak identification 15 mg

EPY0000384 All-rac-alpha-tocopheryl acetate for peak identification 15 mg

EPT1550000 alpha-Tocopherol 500 mg

EPT1600000 alpha-Tocopheryl acetate 500 mg

EPT1610000 RRR-alpha-Tocopheryl hydrogen succinate 125 mg

EPT1700000 Tolbutamide 100 mg

EPY0000154 Tolfenamic acid 100 mg

EPT1707000 Tolnaftate 60 mg

EPY0001123 Tolnaftate for system suitability 10 mg

EPY0000461 Torasemide anhydrous 10 mg

EPY0000462 Torasemide for system suitability 0.4 mg

New EPY0001366 Torasemide impurity E ethyl[[4-[(3-methylphenyl)amino]pyridin-3-yl]sulfonyl]carbamate

0.0006 mg

EPY0000155 Tramadol hydrochloride 75 mg

EPY0000156 Tramadol impurity A (1RS,2SR)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol

15 mg

EPY0000157 Tramadol impurity E (2RS)-2-[(dimethylamino)methyl]cyclohexanone

15 mg

EPY0000072 Tramazoline hydrochloride monohydrate 20 mg

EPY0000065 Tramazoline impurity A N-(naphthalen-1-yl)-4,5-dihydro-1H-imidazol-2-amine

10 mg

EPY0000066 Tramazoline impurity B mixture of: 1-acetyl-2-[(5,6,7,8-tetrahydronaphthalen-1-yl)amino]-4,5-dihydro-1H-imidazole and N-(4,5-dihydro-1H-imidazol-2-yl)-N-(5,6,7,8-tetrahydronaphthalen-1-yl)acetamide

10 mg

EPY0000501 Trandolapril 10 mg

EPY0000495 Trandolapril impurity C (2S,3aR,7aS)-1-[(2S)-2-[[(1S)-3-cyclohexyl-1-(ethoxycarbonyl)propyl]amino]propanoyl]octahydro-1H-indole-2-carboxylic acid (hexahydrotrandolapril)

10 mg

EPY0000496 Trandolapril impurity D ethyl (2S)-2-[(3S,5aS,9aR,10aS)-3-methyl-1,4-dioxodecahydropyrazino[1,2-a]indol-2(1H)-yl]-4-phenylbutanoate (trandolapril diketopiperazine)

10 mg

EPT1810000 Tranexamic acid 50 mg

EPT1820000 Trapidil 50 mg

EPT1820002 Trapidil impurity A 5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-ol

20 mg

EPT1820004 Trapidil impurity B 1,2,4-triazol-3-amine

20 mg

EPY0001172 Trehalose dihydrate 250 mg

EPT1850000 Tretinoin 50 mg

EPT1899000 3,4,6-Tri-O-acetyl-D-glucal - Reference Spectrum unit

EPG0400010 Triacetin - Reference Spectrum unit

EPT1899990 Triamcinolone 150 mg

EPT1900000 Triamcinolone acetonide 100 mg

EPT1950000 Triamcinolone hexacetonide 100 mg

EPY0000050 Triamcinolone impurity C 9-fluoro-11ß-16alpha,17,21-tetrahydroxypregn-4-ene-3,20-dione

10 mg

EPY0000837 Triamterene 10 mg

EPY0000870 Triamterene impurity B 2,7-diamino-6-phenylpteridin-4-ol

0.5 mg

EPT1975000 Triazolam Controlled Substance 10 mg

EPY0000165 Tribenoside 150 mg



Code Product Unit

EPY0000166 Tribenoside impurity A 3,5,6-tri-O-benzyl-1,2-O-(1-methylethylidene)-α-D-glucofuranose

30 mg

EPY0001055 Tributyl acetylcitrate 1 mL

EPY0000279 Tri-n-butyl phosphate 300 µL

EPY0000799 Tributyl acetylcitrate for peak identification 25 mg

EPT1977990 Tricaprin 150 mg

EPT1977995 Tricaproin 40 mg

EPT1978000 Tricaprylin 225 mg

EPY0000111 Trichloroacetic acid - Reference Spectrum unit

EPT1985000 Trichlorotrifluoroethane 2.5 mL

EPT1986000 Triethyl citrate - Reference Spectrum unit

EPT2000000 Trifluoperazine hydrochloride 100 mg

EPT2005000 Triflusal 50 mg

EPT2005010 Triflusal impurity B 2-hydroxy-4-(trifluoromethyl)benzoic acid

25 mg

EPY0000720 Triglycerol diisostearate 200 mg

EPY0000108 Trihexyphenidyl hydrochloride 100 mg

EPY0000068 Trihexyphenidyl impurity A 1-phenyl-3-(piperidin-1-yl)propan-1-one

20 mg

EPT2009000 Trilaurin 1250 mg

New EPY0001260 Trimebutine for system suitability 1.017 mg

New EPY0001319 Trimebutine maleate 10 mg

EPY0000092 Trimetazidine dihydrochloride - Reference Spectrum unit

EPY0000093 Trimetazidine for system suitability 50 mg

EPT2100000 Trimethadione 250 mg

EPT2200000 Trimethoprim 50 mg

EPY0000684 Trimethoprim for system suitability 0.00075 mg

EPT2200010 Trimethoprim impurity B (2,4-diaminopyrimidin-5-yl)(3,4,5- trimethoxyphenyl)methanone

10 mg

EPT2450000 Trimethyltetradecylammonium bromide 200 mg

EPT2500000 Trimipramine maleate 100 mg

EPY0000759 Trimipramine for peak identification 0.51 mg

EPT2500100 Trimyristin 500 mg

EPT2501200 Tristearin 100 mg

EPT2545000 Trolamine 2250 mg

EPY0001184 Trolamine impurity A Ethanolamine

250 mg

EPY0001183 Trolamine impurity B Diethanolamine

1 mL

EPT2550000 Trometamol 100 mg

EPT2580000 Tropicamide 50 mg

EPY0001316 Tropicamide for peak identification 10 mg

EPY0001247 Tropicamide impurity C (2RS)-3-hydroxy-2-phenylpropanoic acid (tropic acid)

10 mg

EPY0001248 Tropicamide impurity D Phenylacetic acid Drug Precursor

10 mg

EPY0000616 Tropisetron hydrochloride 40 mg

EPY0000618 Tropisetron impurity B 1H-indole-3-carboxylic acid

10 mg

EPT2580300 Tropine 50 mg

EPY0000429 Trospium chloride 10 mg

EPY0000432 Trospium impurity A Hydroxydiphenylacetic acid (benzilic acid)

20 mg

EPY0000431 Trospium impurity B (1R,3r,5S)-8-azabicyclo[3.2.1]oct-3-yl hydroxydiphenylacetate

15 mg



Code Product Unit

EPY0000430 Trospium impurity C (1R,3r,5S)-3-hydroxyspiro[8-azoniabicyclo[3.2.1]octane-8,1'-pyrrolidinium]

5 mg

EPY0000497 Troxerutin 30 mg

EPT2600000 Trypsin BRP 100 mg

EPT2610000 Tryptophan 100 mg

EPT2800000 Tubocurarine chloride 100 mg

EPT2880000 Tylosin 150 mg

EPT2880100 Tylosin D 5 mg

EPY0000498 Tylosin phosphate for peak identification 10 mg

EPT2880200 Tylosin tartrate - Reference Spectrum unit

EPT2900000 Tyrosine 50 mg

EPT3000000 Tyrothricin 20 mg

EPU0020000 Ubidecarenone 50 mg

EPU0020001 Ubidecarenone for system suitability 1 mg

EPU0020008 Ubidecarenone impurity D 5,6-dimethoxy-3-methyl-2-[(all-E)-3,7,11,15,19,23,27,31,35- nonamethylhexatriaconta-2,6,10,14,18,22,26,30,34-nonaenyl] benzene-1,4-dione

5 mg

EPU0100000 Uracil arabinoside 60 mg

EPU0600000 Urea 100 mg

EPU0800000 Ursodeoxycholic acid 100 mg

EPY0001163 Ursodeoxycholic acid for system suitability 1.26 mg

EPY0001225 Valaciclovir for system suitability 10 mg

EPY0000834 Valaciclovir hydrochloride (anhydrous) 100 mg

EPY0001096 Valaciclovir impurity D 2-[(2-amino-6-oxo-1,6dihydro-9H-purin-9-yl)methoxy]ethyl N-ethyl-L-valinate

10 mg

EPY0001097 Valaciclovir impurity E 2-[(2-amino-6-oxo-1,6dihydro-9H-purin-9-yl)methoxy]ethyl N-[(benzyloxy)carbonyl]-L-valinate

10 mg

EPY0001098 Valaciclovir impurity F para-toluenesulfonate 2-hydroxyethyl L-valinate

12 mg

EPY0001099 Valaciclovir impurity G N,N-dimethylpyridin-4-amine

10 mg

EPY0000583 Valerian standardised dry extract 400 mg

EPV0030000 Valine 50 mg

EPY0000584 Valnemulin hydrochloride 10 mg

EPY0000533 Valnemulin hydrogen tartrate 120 mg

EPY0000585 Valnemulin for peak identification 20 mg

EPY0000586 Valnemulin impurity E (3aS,4R,5S,6S,8R,9R,9aR,10R)-6-ethenyl-5-hydroxy-4,6,9,10-tetramethyl-1-oxodecahydro-3a,9-propano-3aH-cyclopenta[8]annulen-8-yl 2-hydroxyacetate (pleuromulin)

10 mg

EPV0033000 Valproic acid 100 mg

EPY0001132 Valsartan 10 mg

EPY0001131 Valsartan for peak identification 10 mg

EPY0001145 Valsartan for system suitability 0.202 mg

EPV0045000 Vancomycin hydrochloride 100 mg

EPV0050000 Vanillin 100 mg

EPY0001198 Varicella vaccine (live) 420 mg

EPY0000561 Vecuronium bromide 10 mg

EPY0000625 Vecuronium for peak identification 10 mg

EPY0001093 Vedaprofen 5 mg

EPY0001118 Vedaprofen impurity mixture 0.006 mg

EPY0000587 Venlafaxine hydrochloride 50 mg

EPY0000588 Venlafaxine for system suitability 1 mg

EPV0100000 Verapamil hydrochloride 100 mg



Code Product Unit

EPV0100018 Verapamil impurity I (2RS)-2-(3,4-dimethoxyphenyl)-2-[2-[[2-(3,4)dimethoxyphenyl)- ethyl](methyl)amino]ethyl]3-methylbutanenitrile

5 mg

EPV0100026 Verapamil impurity M 5,5'-[[2-(3,4)dimethoxyphenyl)ethyl]imino]bis[2-(3,4-dimethoxyphenyl)- 2-(1-methylethyl)pentanenitrile

10 mg

EPY0000661 Verbenalin 11 mg

EPV0180000 VERO cells 2x1 mL

EPV0200000 Viscosimeter calibration liquids 250 mL

EPV0300000 Vinblastine sulphate 5 mg

EPV0305000 Vinblastine sulphate - Reference Spectrum unit

EPV0400000 Vincristine sulphate 4.98 mg

EPV0405000 Vincristine sulphate - Reference Spectrum unit

EPV0500000 Vindesine sulphate 5.11 mg

EPV0500010 Vindesine sulphate - Reference Spectrum unit

EPY0000463 Vinorelbine tartrate 50 mg

EPY0000464 Vinorelbine impurity B 4-O-deacetylvinorelbine

7 mg

EPY0000589 Vinpocetine 10 mg

EPY0000590 Vinpocetine impurity A (12RS,13aSR,13bSR)-13a-ethyl-12-hydroxy-2,3,5,6, 12,13,13a,13b-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate (ethyl vincaminate)

10 mg

EPY0000591 Vinpocetine impurity B (13aS,13bS)-13a-ethyl-2,3,5,6,13a,13b-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate (apovincamine)

10 mg

EPY0000790 Vinpocetine impurity C ethyl(13aS,13bS)-13a-ethyl-9-methoxy-2,3,5,6,13a,13b-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate (methoxyvinpocetine)

10 mg

EPY0000760 Vinpocetine impurity D (12RS,13aRS,13bRS)-13a-ethyl-2,3,5,6,12,13,13a,13b-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate (dihydrovinpocetine)

10 mg

EPY0000793 Vinyl acetate 200 mg

EPW0100000 Warfarin sodium 10 mg

EPY0000778 Warfarin sodium clathrate 10 mg

EPX0075000 Xylazine hydrochloride 125 mg

EPY0000158 Xylazine impurity C 2,6-dimethylphenyl isothiocyanate

50 mg

EPY0000159 Xylazine impurity E N-(2,6-dimethylphenyl)-S-methyldithiourea

50 mg

EPY0001224 Xylazine impurity mixture 0.02 mg

EPX0080000 Xylitol 500 mg

EPX0100000 Xylometazoline Hydrochloride 100 mg

EPX0101000 Xylometazoline impurity A N-(2-aminoethyl)-2-(4-1,1-dimethylethyl-2,6-dimethylphenyl)acetamide

10 mg

EPX0200000 Xylose 100 mg

EPY0000656 Yohimbine hydrochloride 20 mg

EPZ1900000 Zidovudine 60 mg

EPZ1902000 Zidovudine impurity A 1-[(2R,5S)-5-hydroxymethyl-2,5-dihydro-2-furyl]-5-methylpyrimidine-2,4(1H,3H)-dione

10 mg

EPZ1904000 Zidovudine impurity B 1-(3-chloro-2,3-dideoxy-ß-D-ribofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione

10 mg

EPZ2000000 Zinc acexamate 50 mg

EPZ2000010 Zinc acexamate impurity A 6-[[6-(acetylamino)hexanoyl]amino] hexanoic acid

50 mg

New EPY0001272 Ziprasidone for system suitability 1 10 mg

New EPY0001241 Ziprasidone for system suitability 2 0.465 mg

New EPY0001286 Ziprasidone hydrochloride monohydrate 100 mg



Code Product Unit

EPZ2500000 Zolpidem tartrate Controlled Substance 200 mg

EPZ2500010 Zolpidem impurity A N,N'-dimethyl-2-[7-methyl-2-(4-methylphenyl)imidazol [1,2-a]pyridin-3-yl] acetamide

10 mg

EPZ3000000 Zopiclone Controlled Substance 60 mg

EPZ3001000 Zopiclone oxide 20 mg

EPY0000062 Zuclopenthixol decanoate - Reference Spectrum unit

EPY0000534 Zuclopenthixol for system suitability 0.1 mg

EPY0000083 Zuclopenthixol impurity B 2-chloro-9H-thioxanthen-9-one

10 mg

ATCC microbiology products


ATCC microbiology products As a scientist you know the importance of using the best materials to support your quality control

programme. As Europe’s only officially authorized distributor of ATCC® cultures, LGC Standards can supply all ATCC organisms specified in the pharmacopoeia. ATCC maintains the highest standards for its biological materials, employing stringent quality control procedures to produce cultures which are well characterized and have low passage numbers. Long-term subculturing of biological materials can have adverse effects on the culture population, including genetic drift, unwanted selection, contamination, and varied cell responses. ATCC quality control cultures sold by LGC Standards are never subcultured or transferred in any way from ATCC’s strains and our European stock-holding means orders are usually filled within 3 - 5 working days. So whether it is quality control strains, genomic DNA, media or growth supplements, antibiotics for selection, or a huge selection of organisms, take the time and guesswork out of ordering your microbiology supplies with authentic, high-quality ATCC materials - exclusively from LGC Standards.

European Pharmacopoeia, 7th Edition (2011-2013), general chapters Code Product Unit

2.6.1. - Sterility ATCC-16404 Aspergillus brasiliensis (formerly Aspergillus niger) amp.

ATCC-6633 Bacillus subtilis subsp. spizizenii amp.

ATCC-10231 Candida albicans amp.

ATCC-11437 Clostridium sporogenes amp.


ATCC-9027 Pseudomonas aeruginosa amp.

ATCC-6538 Staphylococcus aureus subsp. aureus amp.

2.6.2. - Mycobacteria ATCC-25177 Mycobacterium tuberculosis amp.

2.6.7. - Mycoplasmas ATCC-23206 Acholeplasma laidlawii (Sabin) Edward and Freundt deposited as Mycoplasma laidlawii amp.

ATCC-19989 Mycoplasma fermentans amp.

ATCC-19610 Mycoplasma gallisepticum amp.

ATCC-17981 Mycoplasma hyorhinis Switzer amp.

ATCC-29052 Mycoplasma hyorhinis amp.

ATCC-23714 Mycoplasma orale amp.

ATCC-15531 Mycoplasma pneumoniae amp.

ATCC-25204 Mycoplasma synoviae amp.

2.6.12. - Microbiological examination of non-sterile products ATCC-16404 Aspergillus brasiliensis (formerly Aspergillus niger) amp.

ATCC-6633 Bacillus subtilis amp.




2.6.13. - Microbiological examination of non-sterile products ATCC-10231 Candida albicans amp.



ATCC-8739 Escherichia coli amp.

ATCC-14028 Salmonella enterica subsp. enterica serovar Typhimurium amp.


European Pharmacopoeia, 7th Edition (2011-2013), general chapters


Code Product Unit

2.6.27. - Microbiological control of cellular products ATCC-16404 Aspergillus brasiliensis (formerly Aspergillus niger) amp.


ATCC-25285 Bacteroides fragilis amp.




ATCC-11827 Propionibacterium acnes amp.



ATCC-19615 Streptococcus pyogenes amp.

ATCC-9610 Yersinia enterocolitica amp.

2.7.2. - Microbiological assay of antibiotics ATCC-14884 Bacillus pumilus amp.


ATCC-6633 Bacillus subtilis subsp. spizizenii amp.

ATCC-4617 Bordetella bronchiseptica amp.

ATCC-10541 Enterococcus hirae amp.



ATCC-10031 Klebsiella pneumoniae subsp. pneumoniae amp.

ATCC-9341 Kocuria rhizophila (formerly Micrococcus luteus) amp.

ATCC-10240 Micrococcus luteus amp.

ATCC-607 Mycobacterium smegmatis amp.

ATCC-9763 Saccharomyces cerevisiae amp.


ATCC-6538P Staphylococcus aureus subsp. aureus amp.

ATCC-12228 Staphylococcus epidermidis amp.

5.1.2. - Biological indicators of sterilisation ATCC-9372 Bacillus atrophaeus (formerly Bacillus subtilis var. niger) amp.

ATCC-27142 Bacillus pumilus (strain recommended by ATCC®) amp.

ATCC-7953 Geobacillus stearothermoplus (formerly Bacillus stearothermophilus) amp.

5.1.3. - Efficacy of antimicrobial preservation ATCC-16404 Aspergillus niger amp.





All care has been taken in compiling catalogue numbers, however users should consult the Pharmacopoeia directly to confirm the testing requirements and recommended organisms before ordering or undertaking the testing procedures as described in the Pharmacopoeia.

Certified Liquids for Viscosity Measurements in the European Pharmacopoeia


Certified Liquids for Viscosity Measurements in the European Pharmacopoeia

Newtonian liquids with a certified viscosity are supplied by Van Swinden Laboratorium BV and are distributed by LGC Standards. Liquids are available with kinematic viscosities up to 48000 mm2·s-1 and certified at temperatures between 15°C and 140°C. Viscosities are certified in mm2·s-1 (kinematic viscosity, v) or in mPa.s (dynamic viscosity,η) 1 mPa.s = 1 cps (centipoise) 1 mm2.s-1= 1 cst (centistoke) Standard liquids are available from stock, in 250 ml packs and certified at 20°C to following viscosities: v = 0,6 ; 1,0 ; 2,2; 4,9 ; 1; 20 ; 31 ; 56 ; 67 ; 85 ; 100 ; 132 ; 167 ; 217 ; 262; 340 ; 423 ; 537 ; 644 ; 783 ; 1000 ; 1260 ; 1800 ; 3650 ; 5075 ; 10175 ; 18400 ; 46500 η = 0,4 ; 1,0 ; 1,8; 4,0 ; 8,9 ; 17,0 ; 26,0 ; 48,0 ; 58,0 ; 74,0 ; 87,0 ; 116,0 ; 146,0 ; 191,0 ; 230,0 ; 300,0 ; 375,0 ; 474,0 ; 572,0 ; 700,0 ; 862,0 ; 1085 ; 1560 ; 3175 ; 4430 ; 8935 ; 16300 ; 41300 All viscosities are calibrated relative to the viscosity of pure water. Stated values are nominal values, certified values will not deviate more than 10% from the nominal value. The uncertainty of the certified viscosities is at least 0.3% at the lowest viscosity, increasing up to 0.5% at 48000 mm2.s-1.

Shelf life Standards up to 500 mPa.s are mineral oil based, and have a shelf life of 12 months from date of certification. Above 500 mPa.s Polyisobutylene is used, these materials have a shorter shelf life, and should be ordered as needed. Liquids can be prepared and certified to any viscosity between 0.6 mm2.s-1 and 80,000 mm2.s-1. The price depends on the viscosity required, the degree of precision between nominal viscosity required and certified viscosity achieved, and temperature of certification. Additional charges are applied for extra certification temperatures and for certification of dynamic viscosity. Please ask for a quotation. Liquids supplied by customers may be certified for viscosity, charges vary: please ask for a quotation.

International Commission on Pharmaceutical Enzymes


International Commission on Pharmaceutical Enzymes The Commission on Pharmaceutical Enzymes was formed in 1960, with a remit to establish quantitative

methods and an exact definition of enzyme activity for pharmacologically significant enzymes. One consequence of the work of FIP “Federation International Pharmaceutique” has been the production and certification of reference substances for both enzymes and substrates. More recently the work of the Commission has been reflected in those monographs of the European Pharmacopoeia which call for enzyme standards. The FIP products marked (EP) in this list are those which are required in certain EP monographs.

Enzymes Code Product Unit

FIP1 Fungal Amylase 2 g

FIP2(EP) Amylase (pancreatic) 2 g

FIP3 Fungal Protease 2 g

FIP4 Bromelain 250 mg

FIP5 Endocellulase 1 g

FIP6(EP) Chymotrypsin 100 mg

FIP7 Fungal Lipase 500 mg

FIP8(EP) Lipase (pancreatic) 2 g

FIP9 Lysozyme hydrochloride 250 mg

FIP10 Papain 2 g

FIP11(EP) Pepsin 2 g

FIP12(EP) Protease (pancreatic) 2 g

FIP13(EP) Trypsin 100 mg

FIP14(EP) Hyaluronidase 50 mg

Substrates FIP15(EP) Enterokinase 500 mg

FIP16 Micrococcus Luteus sp. 1 g

FIP17 Starch (EP) 50 g

FIP18(EP) Casein 100 g

FIP19 Haemoglobin 10 g

FIP20 Hydroxyethylcellulose 100 g

FIP21 Sodium Taurocholate 10 g

FIP22(EP) Sodium hyaluronate 300 mg

European Pharmacopoeia Reagents


European Pharmacopoeia Reagents Chapters 2 and 4 of the European Pharmacopoeia describe the preparation of several hundred reagents and

standards used for the testing of pharmaceutical raw materials. LGC Standards offers a large number of these ready-to-use reagents and standard solutions within the spectrum of this new catalogue. The primary solutions for coloration are produced by LGC Standards, the other reagents are manufactured by Reagecon. All are manufactured and tested in compliance with the prescriptions of EP. The products are supplied with certificates of analysis. Lot numbers and expiry dates are stated on all product labels as well. The reagents are always supplied as per the most recently issued EP supplement. Reagents from other pharmacopoeias are also available on request. Please contact your local LGC Standards office for further details.

Reagents as outlined in Chapter 2 Code Product Unit

REAEPPOSO1 Primary opalescence suspension 100 mL

Coloration: primary solutions WESEPYS01 Coloration-primary solution yellow 100 mL

WESEPRS01 Coloration-primary solution red 100 mL

WESEPBS01 Coloration-primary solution blue 100 mL

Coloration: standard solutions REAEP703 Standard solution B (brown) 125 mL

REAEP704 Standard solution BY (brownish yellow) 125 mL

REAEP706 Standard solution Y (yellow) 125 mL

REAEP705 Standard solution GY (greenish yellow) 125 mL

REAEP707 Standard solution R (red) 125 mL

REAHADM1 HCL dilution matrix (10 g/l HCl) 1 L

Reference buffer solutions - all @ 25°C REAEP168 ph Buffer solution 1.68 500 mL

REAEP401 ph Buffer solution 4.01 500 mL




Conductivity & resistivity solutions - @ 20°C REAEP1330 Conductivity standard

Electrolytic conductivity ............ 1330 µS/cm at 20°C

Resistivity .................................................. 752 cm

500 mL

REAEP133 Conductivity standard Electrolytic conductivity .............. 133 µS/cm at 20°C

Resistivity ................................................ 7519 cm

500 mL

REAEP266 Conductivity standard Electrolytic conductivity ............. 26.6 µS/cm at 20°C

Resistivity .............................................. 37594 cm

500 mL

Reagents as outlined in Chapter 4 (4.1.1) of Ph.Eur. REA1000401 Acetic acid (30%) 1 L

REA1000402 Acetic acid, dilute (12%) 1 L

REA1000501 Acetic anhydride solution R1 1 L

REA1002501 Alcohol, aldehyde free 1 L

REA1004702 Ammonia, dilute R1 1 L

REA1004703 Ammonia, dilute R2 1 L

REA1005201 Ammonium carbonate solution 1 L

REA1007301 Anisaldehyde, solution 100 mL

REA1007302 Anisaldehyde, solution R1 100 mL

REA1009301 Barium chloride, solution R1 1 L



Code Product Unit

REA1009401 Barium hydroxide, solution 1 L

REA1011601 Biuret reagent 1 L

REA1012601 Bromocresol green solution 100 mL

REA1012602 Bromocresol green-methyl red solution 100 mL

REA1012701 Bromocresol purple solution 100 mL

REA1012801 Bromophenol blue solution 100 mL

REA1012803 Bromophenol blue solution R2 100 mL

REA1012901 Bromothymol blue solution R1 100 mL

REA1015201 Calcium sulphate solution 1 L

REA1022901 Crystal violet solution 100 mL

REA1023100 Cupri-citric solution 1 L

REA1023300 Cupri-tartaric (Solution I 500 mL & Solution II 500 mL) 1 L

REA1031101 Dimidium bromide - sulphan blue mixed solution 1 L

REA1032101 Diphenylamine solution 1 L

REA1032102 Diphenylamine solution R1 1 L

REA1037702 Ferric ammonium sulphate solution R2 100 mL

REA1038100 Ferroin 100 mL

REA1039101 Formaldehyde solution 100 mL

REA1039401 Fuchsin solution, decolorised 100 mL

REA1039402 Fuchsin solution, decolorised R1 100 mL

REA1043101 Holmium perchlorate solution 1 L

REA1043501 Hydrochloric acid R1 1 L

REA1043503 Hydrochloric acid, dilute 1 L

REA1043504 Hydrochloric acid, dilute R1 1 L

REA1045901 Iodine bromide solution 1 L

REA1046300 Iodoplatinate reagent 200 mL

REA1048001 Lanthanum nitrate solution 1 L

REA1048101 Lead acetate cotton 10 g

REA1048102 Lead acetate paper Pack of 50

REA1052101 Mercuric bromide paper Pack of 50

REA1053601 Methoxyphenylacetic reagent 100 mL

REA1054801 Methyl orange mixed solution 100 mL

REA1054802 Methyl orange solution 100 mL

REA1055101 Methyl red mixed solution 100 mL

REA1055102 Methyl red solution 100 mL

REA1056700 Molybdovanadic reagent 100 mL

REA1056801 Mordant black 11 triturate 100 mL

REA1057601 Naphtobenzein solution 100 mL

REA1058303 Ninhydrin, solution 100 mL

REA1058304 Ninhydrin solution R1 100 mL

REA1058305 Ninhydrin solution R2 100 mL

REA1058402 Acide nitrique dilué 100 mL

REA1062901 Perchloric acid solution 100 mL

REA1063601 Phenol red solution 100 mL

REA1063603 Phenol red solution R2 500 mL

REA1063702 Phenolphthalein solution 100 mL

REA1063703 Phenolphthalein solution R1 100 mL

REA1065000 Phosphomolybdotungstic reagent 100 mL

REA1065200 Phosphomolybdotungstic solution 100 mL

REA1065801 Picric acid solution 100 mL

REA1065802 Picric acid solution R1 100 mL

REA1069101 Potassium chloride, 0.1 M 1 L



Code Product Unit

REA1069201 Potassium chromate, solution 1 L

REA1069501 Potassium dichromate, solution 1 L

REA1069801 Potassium ferrocyanide, solution 100 mL

REA1070001 Potassium hydrogen phthalate, 0.2 M 1 L

REA1070302 Potassium hydroxide in alcohol (10% v/v) 1 L

REA1070303 Potassium hydroxide solution alcoholic 100 mL

REA1070501 Potassium iodide and starch solution 125 mL

REA1070502 Potassium iodide solution 1 L

REA1070600 Potassium iodobismuthate, solution 100 mL

REA1070602 Potassium iodobismuthate, solution R2 (short shelf life) 100 mL

REA1070902 Potassium permanganate, solution 1 L

REA1071301 Potassium pyroantimonate, solution 125 mL

REA1071600 Potassium tetraiodomercurate, solution alkaline (100 ml of both solutions) 200 mL

REA1075201 Ruthenium red solution 100 mL

REA1078301 Silver nitrate solution R1 1 L

REA1078302 Silver nitrate solution R2 1 L

REA1079301 Sodium carbonate solution

1 L

REA1081401 Sodium hydroxide solution 1 L

REA1081402 Sodium hydroxide solution dilute 1 L

REA1081404 Sodium hydroxide solution strong 1 L

REA10816005 Sodium hypochlorite solution strong 500 mL

REA1083901 Sodium sulfure solution 100 mL

REA1085103 Starch, solution 100 mL

REA1086804 Sulphuric acid, dilute 1 L

REA1089602 Thiocetamide solution 1 L

REA1090701 Thymolphthalein solution 100 mL

REA1094201 Tris(hydroymethyl) aminomethane solution 100 mL

REA1102301 Zinc acetate solution 1 L

REA1096601 Zinc chloride formic acid solution 1 L

REA1096602 Zinc chloride solution, iodinated 1 L

Standard solutions for limit tests as outlined in Chapter 4 (4.1.2) of Ph.Eur. REA5000200 Aluminium standard solution (200 ppm Al) 100 mL

REA5000300C Ammonium standard solution (100 ppm NH4) 100 mL

REA5000500C Arsenic standard solution (10 ppm As) 100 mL

REA5000700C Cadmium standard solution (0.1% Cd) 100 mL

REA5000800C Calcium standard solution (400 ppm Ca) 100 mL

REA5000802C Calcium standard solution alcoholic (400 ppm Ca) 1 L

REA5000900C Chloride standard solution (8 ppm CI) 100 mL

REA5001000 Chromium standard solution (100 ppm Cr) 1 L

REA5001100 Copper standard solution (0.1% Cu) 100 mL

REA5001200C Ferrocyanide standard solution (100 ppm Fe) 100 mL

REA5001400C Fluoride standard solution (10 ppm F) 100 mL

REA5001600C Iron standard solution (20 ppm Fe) 100 mL

REA5001602C Iron standard solution (8 ppm Fe) 100 mL

REA5001701C Lead standard solution (100 ppm Pb) 100 mL

REA5001800C Lagnesium standard solution (100 ppm Mg) 100 mL

REA5002000C Nickel standard solution (10 ppm Ni) 100 mL

REA5002100C Nitrate standard solution (100 ppm NO3) 100 mL

REA5002200C Phosphate standard solution (5 ppm PO4) 100 mL

REA5002400C Potassium standard solution (100 ppm K) 100 mL

REA5002700C Sodium standard solution (200 ppm Na) 100 mL



Code Product Unit

REA5002800C Sulphate standard solution (10 ppm SO4) 100 mL

REA5003100C Tin standard solution (5 ppm Sn) 1 L

REA5003401C Zinc standard solution (100 ppm Zn) 100 mL

Buffer solutions as outlined in Chapter 4 (4.1.3) of Ph.Eur. REA4000100 Buffered acetone solution 1 L

REA4000600 Buffer solution pH 3.5 1 L

REA4001400 Acetate buffer solution pH 4.6 1 L

REA4004800 Phosphate buffer solution pH 7.4 1 L

REA4008300 Buffer (phosphate) solution pH 9.0 1 L

REA4007200 Ammonium chloride buffer solution pH 9.5 1 L

REA4007300 Ammonium chloride buffer solution pH 10.0 1 L

Volumetric solutions as outlined in Chapter 4 (4.2.2) of Ph.Eur. REA3000100 0.1M Ammonium and cerium nitrate 1 L

REA3000200 0.01M Ammonium and cerium nitrate 1 L

REA3000300 0.1M Ammonium and cerium sulphate 1 L

REA3000500 0.1M Ammonium thiocyanate 1 L

REA3000600 0.1M Barium chloride 1 L

REA3000900 0.004M Benzethonium chloride 1 L

REA3001100 0.1M Cerium sulphate 1 L

REA3008700 1M Cupriethylenediamine hydroxide solution 1 L

REA3001300 0.1M Ferric ammonium sulphate 1 L

REA3001500 6M Hydrochloric acid 1 L



REA3002100 0.1M Hydrochloric acid 1 L

REA3008800 0.1M Hydrochloric acid, alcoholic 1 L

REA3002700 0.05M Iodine 1 L

REA3003100 0.1M Lead nitrate 1 L

REA3003300 0.1M Lithium methoxide 1 L

REA3003500 0.02M Mercuric nitrate 1 L

REA3003900 0.1M Perchloric acid 1 L

REA3004200 0.033M Potassium bromate 1 L

REA3002900 0.01M Iodine 1 L

REA3009100 11M Potassium hydroxide 1 L

REA3004800 0.1M Potassium hydroxide 1 L

REA3004900 0.5M Potassium hydroxide 1 L

REA3005000 0.5M Potassium hydroxide, alcoholic 1 L

REA3005100 0.1M Potassium hydroxide, alcoholic 1 L

REA3005300 0.02M Potassium permanganate 1 L

REA3005600 0.1M Silver nitrate 1 L

REA3009300 0.001M Sodium nitrate 1 L

REA3005800 0.1M Sodium arsenite 1 L

REA3005900 0.1M Sodium edetate 1 L

REA3006300 1M Sodium hydroxide 1 L

REA3006600 0.1M Sodium hydroxide 1 L

REA3007000 0.1M Sodium hydroxide, ethanolic 1 L

REA3007100 0.1M Sodium methoxide 1 L

REA3007200 0.1M Sodium nitrate 1 L

REA3007300 0.1M Sodium thiosulphate 1 L

REA3007800 0.5M Sulphuric acid 1 L

REA3008000 0.05M Sulphuric acid 1 L



Code Product Unit

REA3008300 0.1M Tetrabutylammonium hydroxide 1 L

REA3008400 0.1M Tetrabutylammonium hydroxide in 2-propanol 1 L

REA3008600 0.1M Zinc sulphate 1 L



WHO International Standards for Antibiotics In 2006, the EDQM has been designated a WHO Collaborative Centre for the International

Standards for Antibiotics (ISA). These standards are essential in the standardisation and quality control of antibiotic material and pharmaceutical products. They are supplied for assays described in the specifications for quality control of antibiotic material. The EDQM is for example responsible for the establishment and storage of the WHO ISA materials. All biological preparations listed in this catalogue are supplied exclusively as WHO ISA materials for use as primary standards in the establishment of National/Regional secondary working standards and for no other purpose. You can order the ISA materials directly with your supplies for other reference materials available from LGC Standards. For further information please contact your local LGC Standards office.

Code Product Unit

EPISA_29078 Second International Standard for Amphotericin B 100 mg

EPISA_29384 Third International Standard for Nystatin 100 mg

EPISA_62_003 Bacitracin 100 mg

EPISA_62_008 Spiramycin 50 mg

EPISA_62_013 Dihydrostreptomycin 200 mg

EPISA_65_062 Colistin 75 mg

EPISA_66_231 Rifamycin SV 100 mg

EPISA_66_254 Colistin Methane Sulfonate 75 mg

EPISA_67_301 Polymoyxin B 75 mg

EPISA_68_041 Neomycin B 25 mg

EPISA_72_406 Neomycin 50 mg

EPISA_76_538 Erythromycin 75 mg

EPISA_76_539 Streptomycin 100 mg

EPISA_78_547 Bleomycin Complex A2/B2 7 mg

EPISA_80_543 Sisomicin 63 mg

EPISA_82_510 Tobramycin 11.2 mg

EPISA_83_521 Kanamycin 13 mg

EPISA_83_577 Netilmicin 7.5 mg

EPISA_90_704 Teicoplanin 54 mg

EPISA_92_670 Gentamicin 50 mg

EPISA_TYN Tylosin 40 mg



We constantly add new products to our range, so please contact us to find out about our products and services and to make sure you are automatically kept up to date by subscribing to our free newsletter. Please send an e-mail to [email protected]

BritishPharmacopoeia

PharmacopéeFrançaise

PharmacopoeiaHelvetica

InternationalPharmacopeia

Ultra-pure solvents fromLGC StandardsUltra HPLC (UHPLC) requires solvents of superiorquality in order to achieve the optimum performance of the instrument and columns.

UHPLC can provide very significant increases in resolution, speed, and sensitivity, compared to conventional HPLC. To ensure these benefits are realised, and so gain the full benefits of invest-ment in such sophisticated technology, solvents of the highest purity are required.

The range of Optigrade® solvents from LGC Stan-dards has been designed to support high resolution and sensitivity for UHPLC and MS by tightly controlling the trace metal impurities, organic impurities and particle levels. Also available are selectedbuffers for mobile phase preparation, and several blends of water and acetonitrile with formic acid, acetic acid and trifluoroacetic acid.

LGC Standards Optigrade® solvents combine:• The highest specification for UV• Low gradient shift• Minimal peak impurities• Lowest ionic background for MS detection

Our Optigrade® solvents for UHPLC and MS:• Are micro filtered at 0.1 μm• Have a residue of max 1ppm following evaporation• Are packed under inert gas for improved shelf life• Provided with MSDS and certificate of analysis


© LGC Limited, 2011. All rights reserved. 2297/NLh/0811

British Pharmacopoeia


British Pharmacopoeia Background British Pharmacopoeia chemical reference substances (BPCRS) available from BP are issued under the

authority of the British Pharmacopoeia Commission and are solely for use in tests and assays of the British Pharmacopoeia or the British Pharmacopoeia (Veterinary). The list in this catalogue is current as of June 2011, and includes all available BPCRS needed to follow the current official monographs. Most BP monographs for active substances conform with the monographs issued by the European Pharmacopoeia, and so require the use of European Pharmacopoeia chemical reference substances. Details of these are to be found under the ‘European Pharmacopoeia’ section of this catalogue.

Production and certification British Pharmacopoeia reference substances and preparations are selected and verified by the BP

Laboratories as being suitable for the use as prescribed in the relevant monographs of the British Pharmacopoeia.

Documentation BPCRS are of two types – normal CRS for identification purposes and Assay Standards. Assay Standards

are provided with a documented assay value, determined by the BP Laboratories. The BP laboratories do not make available any other BPCRS certificates of analysis or other information, in connection with the prescribed use of the BPCRS.

Controlled substances Controlled drugs are subject to import and export control restrictions. Please contact LGC Standards for

details.

Shelf life and expiry dates British Pharmacopoeia chemical reference substances are subjected to regular inspection and repeat

analysis by BP scientific staff. Each BPCRS is, on receipt by the customer, fit for the intended use. BP supplies only current lots. Formally, all BPCRS are supplied with three months shelf life. For this reason users are advised to order only as many units as required immediately.

Code Product Unit

BP 001 Acepromazine maleate 50 mg

New BP 904 Acetazolamide Assay Standard 600 mg

BP 681 4-Acetyl 2-fluorobiphenyl 25 mg

New BP 907 Acetylcysteine Assay Standard 200 mg

BP 438 Aciclovir Assay Standard 100 mg

BP 003 Adrenaline (epinephrine) acid tartrate Assay Standard 100 mg

BP 763 Albendazole Assay Standard 100 mg

BP 436 Alexandrian senna fruit powder Assay Standard 1 g

BP 006 Alfadolone acetate Assay Standard 100 mg

BP 007 Alfaxalone Assay Standard 100 mg

New BP 825 Alfuzosin hydrochloride Assay Standard 100 mg

BP 415 Alimemazine tartrate Assay Standard 100 mg

BP 831 Allopurinol Impurity A 20 mg

BP 832 Allopurinol Impurity B 10 mg

BP 843 Allopurinol Impurity C 10 mg

BP 844 Allopurinol Impurity D 10 mg

BP 845 Allopurinol Impurity E 20 mg

BP 560 9-Allyl-2-chlorothioxanthen-9-ol 25 mg

BP 725 Alverine citrate Assay Standard 100 mg

BP 724 Alverine citrate impurity standard solution 1 mL

BP 530 Amantadine hydrochloride Assay Standard 200 mg



Code Product Unit

BP 853 Amikacin Sulphate Assay Standard 200 mg

BP 008 Amiloride hydrochloride Assay Standard 100 mg

BP 010 4-Amino-6-chlorobenzene-1-3-disulphonamide 50 mg

BP 374 3-Amino-6-chloro-1-methyl-4-phenylquinolin-2-ol 50 mg

BP 839 3-amino-4-(2-chlorophenyl)-6-nitroquinolin-2(1H)-one 25 mg

BP 813 2-Amino-5-chloropyridine 25 mg

BP 012 2-Amino-4,6-Dichlorophenol hydrochloride 50 mg

BP 011 7-Aminodesacetoxycephalosporanic acid 20 mg

BP 602 (E)-4-Amino-2-ethylidenebutyric acid hydrochloride 25 mg

BP 684 Aminoglutethimide Assay Standard 100 mg

New BP 881 Aminoglutethimide impurity A 20 mg

BP 417 2-Amino-1-(4-nitrophenyl)propane-1,3-diol 50 mg

BP 601 3-Aminopent-4-ene-1,1-dicarboxylic acid 25 mg

BP 536 3-Amino-4-phenoxy-5-sulphamoylbenzoic acid 25 mg

BP 014 3-Amino-4-propoxybenzoic acid 50 mg

BP 532 Amiodarone hydrochloride Assay Standard 100 mg

BP 785 Anhydrous Ampicillin Assay Standard 250 mg

BP 021 Ampicillin trihydrate 500 mg

BP 015 Amitraz Assay Standard 200 mg

BP 016 Amitriptyline hydrochloride Assay Standard 150 mg

BP 019 Amoxicillin Trihydrate Assay Standard 500 mg

BP 748 Amoxicillin impurity standard 25 mg

BP 546 Apramycin 250 mg

BP 694 Arginine hydrochloride Assay Standard 100 mg

BP 461 Ascorbic acid 100 mg

BP 617 Aspirin Assay Standard 100 mg

BP 492 Atenolol Assay Standard 100 mg

BP 370 Atenolol impurity standard 50 mg

BP 023 Atropine sulphate Assay Standard 200 mg

BP 366 1-(3-Azabicyclo[3.3.0]oct-3-yl)-3-o-tolylsulphonylurea 30 mg

BP 024 2-Azahypoxanthine 50 mg

BP 025 Azaperone Assay Standard 100 mg

BP 534 Azapropazone Assay Standard 100 mg

BP 515 Azapropazone impurity A 10 mg

BP 516 Azapropazone impurity B 10 mg

BP 517 Azapropazone impurity C 10 mg

BP 527 Azapropazone impurity standard 50 mg

BP 028 Baclofen Assay Standard 150 mg

BP 535 Baclofen lactam 25 mg

BP 030 Beclometasone dipropionate Assay Standard 100 mg

BP 760 Beclometasone 17-propionate 25 mg

BP 761 Beclometasone 21-propionate 25 mg

BP 685 Benserazide hydrochloride Assay Standard 100 mg

BP 036 Benzatropine mesilate Assay Standard 100 mg

BP 610 Benzydamine hydrochloride Assay Standard 100 mg

BP 426 Benzyl benzoate Assay Standard 0.1 mL

BP 611 1-Benzyl-3-(3-diethylamino-propoxy)-1H-indazole 50 mg

BP 037 (1S,2R)-1-benzyl-3-dimethylamino-2-methyl-1-phenylpropyl acetate 25 mg

BP 609 1-Benzyl-1-H-indazol-3-ol 50 mg

BP 824 Betahistine dihydrochloride Assay Standard 100 mg

BP 575 Betamethasone Assay Standard 100 mg

BP 041 Betamethasone sodium phosphate 100 mg



Code Product Unit

BP 042 Betamethasone valerate Assay Standard 100 mg

BP 043 Betamethasone 21-valerate 50 mg

BP 686 Betaxolol hydrochloride Assay Standard 100 mg

BP 755 Bezafibrate Assay Standard 100 mg

BP 046 2-(Biphenyl-4-yl)propionic acid 25 mg

BP 047 Bisacodyl Assay Standard 100 mg

BP 612 Bretylium tosilate Assay Standard 200 mg

BP 613 2-Bromobenzyldimethylamine hydrochloride 0.1 mL

BP 050 Bromocriptine Mesilate Assay Standard 100 mg

BP 440 Buclizine hydrochloride impurity standard 50 mg

BP 793 Budesonide Assay Standard 110 mg

BP 537 Bumetanide Assay Standard 100 mg

BP 479 Bupivacaine hydrochloride Assay Standard 100 mg

BP 403 Busulfan Assay Standard 25 mg

BP 192 2-tert-Butylamino-1-(4-hydroxy-3-methylphenyl)ethanol sulphate 25 mg

BP 531 2-Butyl-3-(4-hydroxy-3,5-di-iodobenzoyl)benzofuran 25 mg

BP 766 Caffeine Assay Standard 100 mg

BP 355 Calcitonin (salmon) Assay Standard 10 µg

BP 059 Capreomycin sulphate 50 mg

BP 538 Captopril Assay Standard 100 mg

BP 500 Captopril disulphide 25 mg

BP 477 2-Carbamoyl-1-methyl-3-[2-(5-methylimidazol-4-yl-methylthio)ethyl]guanidine dihydrochloride 25 mg

BP 523 Carbaryl Assay Standard 100 mg

BP 060 Carbidopa Assay Standard 100 mg

BP 749 Carbimazole Assay Standard 100 mg

BP 711 Carboplatin Assay Standard 100 mg

BP 767 Carmellose sodium Assay Standard 100 mg

BP 567 Carteolol hydrochloride Assay Standard 100 mg

BP 792 Cefaclor Assay Standard 450 mg

BP 784 Cefadroxil Assay Standard 100 mg

BP 061 Cefalexin Assay Standard 150 mg

BP 562 Cefalonium Assay Standard 100 mg

New BP 819 Cefazolin Sodium 150 mg

New BP 820 Cefoxitin Sodium Assay Standard 200 mg

BP 063 Cefradine Assay Standard 300 mg

New BP 976 Ceftriaxone sodium Assay Standard 100 mg

New BP 977 Ceftriaxone sodium E-isomer 10 mg

BP 502 Cefuroxime axetil Assay Standard 100 mg

New BP 925 Cefuroxime sodium Assay Standard 150 mg

BP 757 Celiprolol hydrochloride Assay Standard 100 mg

New BP 926 Chenodeoxycholic acid 25 mg

BP 064 Chlorambucil Assay Standard 100 mg

BP 854 Chloramphenicol Assay Standard 500 mg

BP 067 Chlorcyclizine hydrochloride 100 mg

BP 068 Chlorhexidine acetate Assay Standard 100 mg

BP 441 1,4-bis(4-Chlorobenzhydryl)piperazine 25 mg

BP 756 N-p-chlorobenzoyltyramine 25 mg

BP 604 4-Chlorobenzylphthalazinone 25 mg

BP 376 6-Chloro-4-(2-chlorophenyl)quinazoline-2-carboxaldehyde 50 mg

BP 442 6-Chloro-1,4-dihydro-1-methyl-4-phenylquinazolin-4-ol 25 mg

BP 470 7-Chloro-1-5-dihydro-5-phenyl-1,5-benzodiazepine-2,4(3H)-dione 25 mg



Code Product Unit

BP 049 17β,17'β-bis(3-[bis-(2-chloroethyl)carbamoyloxy] estra-1,3,5,(10)-trienyl)pyrophosphate

25 mg

BP 446 5-(2-Chloroethyl)-4-methyl-3-[2-(4-methylthiazol-5-yl)ethyl]thiazolium chloride 25 mg

BP 071 4-[2-(5-Chloro-2-methoxybenzamido)ethyl]benzenesulphonamide 25 mg

New BP 965 5-Chloro-1-methyl-4-nitroimidazole 100 mg

BP 378 5-Chloro-2-methylaminobenzophenone 50 mg

BP 443 6-(2-Chlorophenyl)-2,4-dihydro-2-[(dimethylamino)methylene] 8-nitroimidazo[1,2-a][1,4]benzodiazepin-1-one

25 mg

BP 074 4-Chloro-5-sulphamoylanthranilic acid 25 mg

BP 075 2-(4-Chloro-3-sulphamoylbenzoyl)benzoic acid 25 mg

BP 076 Chlorothiazide 100 mg

BP 559 2-Chlorothioxanthone 25 mg

BP 077 2-(6-Chlorothymoxy)ethyldimethylamine hydrochloride 25 mg

BP 079 2-Chlorotritanol 25 mg

BP 080 Chloroxylenol Assay Standard 500 mg

BP 081 Chlorphenamine maleate Assay Standard 100 mg

BP 856 Chlorpromazine hydrochloride 50 mg

BP 467 Chlorpromazine sulphoxide 50 mg

BP 491 Chlortalidone Assay Standard 100 mg

BP 783 Chlortetracycline hydrochloride Assay Standard 100 mg

BP 618 Cholic acid Assay Standard 100 mg

BP 475 Cimetidine Assay Standard 100 mg

BP 809 Cisplatin Assay Standard 100 mg

BP 833 Clarithromycin Assay Standard 100 mg

BP 834 Clarithromycin impurity E 20 mg

BP 525 Clemastine fumarate Assay Standard 200 mg

BP 084 Clioquinol Assay Standard 200 mg

BP 507 Clobazam Assay Standard Controlled Substance 100 mg

BP 522 Clobetasol impurity A 25 mg

BP 521 Clobetasol propionate Assay Standard 100 mg

BP 482 Clobetasone butyrate Assay Standard 100 mg

BP 406 Clocortolone hexanoate 100 mg

BP 663 Clofazimine Assay Standard 100 mg

BP 543 Clomethiazole edisilate Assay Standard 100 mg

New BP 980 Clomipramine hydrochloride 100 mg

New BP 983 Clomipramine Impurity F 10 mg

New BP 981 Clomipramine impurity C 10 mg

BP 484 Clonazepam Assay Standard Controlled Substance 100 mg

BP 085 Clonidine hydrochloride Assay Standard 100 mg

BP 565 trans-Clopenthixol acetate dihydrochloride 50 mg

BP 566 trans-Clopenthixol decanoate dihydrochloride 25 mg

BP 561 trans-Clopenthixol hydrochloride 25 mg

BP 628 Cloprostenol sodium Assay Standard 50 mg

BP 379 Clotrimazole Assay Standard 50 mg

BP 088 Cloxacillin benzathine Assay Standard 250 mg

New BP 905 Clozapine Assay Standard 100 mg

BP 091 Co-dergocrine mesilate Assay Standard 50 mg

BP 715 Cocaine hydrochloride Assay Standard Controlled Substance 100 mg

BP 514 Codeine hydrochloride Assay Standard Controlled Substance 100 mg

BP 090 Codeine Phosphate Assay Standard Controlled Substance 200 mg

BP 787 Colecalciferol Assay Standard 500 mg

BP 614 Colestipol hydrochloride 50 mg



Code Product Unit

BP 551 Colestyramine Assay Standard 500 mg

BP 585 Cortisone acetate Assay Standard 100 mg

BP 094 Crotamiton Assay Standard 100 mg

BP 466 Cyanocobalamin Assay Standard 100 mg

BP 478 2-Cyano-1-methyl-3-[2-(5-methylimidazol-4-yl-methylsulphinyl)ethyl]guanidine 25 mg

BP 096 Cyclizine hydrochloride Assay Standard 100 mg

BP 886 Cyclobenzaprine hydrochloride 25 mg

BP 098 Cyclopenthiazide 100 mg

BP 380 Cyclopentolate hydrochloride Assay Standard 100 mg

BP 688 Cyproterone acetate Assay Standard 100 mg

BP 383 Cytarabine Assay Standard 100 mg

BP 100 Dacarbazine 25 mg

BP 771 Dantrolene Assay Standard 100 mg

BP 428 Dantron 50 mg

BP 429 Dantron impurity standard 100 mg

BP 102 Dapsone Assay Standard 100 mg

BP 103 Debrisoquine sulphate 100 mg

BP 104 Decoquinate 50 mg

BP 791 Delta-3-Cefaclor 20 mg

BP 572 Deltamedrane 25 mg

BP 631 Deltamethrin Assay Standard 100 mg

BP 632 Deltamethrin impurity standard 40 mg

BP 789 Demeclocycline hydrochloride Assay Standard 100 mg

New BP 889 N-Demethylerythromycin A 10 mg

BP 504 Desacetylmetipranolol 25 mg

BP 730 N-Desalkylflurazepam 25 mg

New BP 987 Desferrioxamine mesilate 30 mg

New BP 931 Desipramine hydrochloride 100 mg

BP 689 Desmethyl benzatropine hydrochloride 50 mg

BP 568 Desogestrel Assay Standard 100 mg

BP 816 Desogestrel impurity D 25 mg

BP 817 Desogestrel impurity E 25 mg

BP 594 Desogestrel Δ3-isomer 25 mg

BP 578 Dexamethasone Assay Standard 100 mg

BP 108 Dexamethasone sodium phosphate 50 mg

BP 646 Dexamethasone phosphate Assay Standard 100 mg

BP 811 Dexamethasone impurity standard 25 mg

BP 465 Dextropropoxyphene HCl Assay Standard Controlled Substance 100 mg

BP 549 Diacetylfluorescein Assay Standard 200 mg

New BP 887 Diamorphine Hydrochloride Assay Standard Controlled Substance 150 mg

BP 111 Diazepam Controlled Substance 100 mg

BP 114 Dibenzo[b,e]thiepin-11(6H)-one 25 mg

BP 124 3-(Dibenzo[b,e]thiepin-11(6H)-ylidene)-N,N-dimethylaminopropan-1-amine-S-oxide hydrochloride

25 mg

BP 858 Dibenzosuberone 100 mg

BP 608 3-(1,5-Dibenzyl-1H-indazole-3-yl)oxypropyl dimethylamine hydrochloride 25 mg

BP 116 Dichlorophen Assay Standard 100 mg

BP 420 Dichlorophen impurity standard Assay Standard 100 mg

BP 721 1-(2,5-Dichlorophenyl)-5-isopropylbiguanide hydrochloride 25 mg

BP 619 Diclofenac sodium Assay Standard 100 mg

BP 598 Diclofenac diethylamine 100 mg

BP 828 Diclofenac impurity A 25 mg



Code Product Unit

BP 810 Dicloxacillin sodium 250 mg

BP 118 Diethanolamine fusidate Assay Standard 100 mg

BP 361 2-Diethylaminoethyl-3-(1-naphthyl)-2-(1-naphthylmethyl)propionate oxalate 25 mg

BP 737 Diethylcarbamazine citrate 100 mg

BP 119 Diethyl-4-decyloxy-3-ethoxyanilinomethylenemalonate 50 mg

New BP 859 Diethylstilbestrol Assay Standard 100 mg

BP 677 Diethyl stilbestrolmonophosphate 25 mg

BP 401 Diflucortolone valerate Assay Standard 100 mg

BP 397 Diflucortolone valerate impurity standard 25 mg

BP 855 Digitoxin Assay Standard 250 mg

BP 431 Dihydrocodeine Tartrate Assay Standard Controlled Substance 100 mg

BP 120 Dihydroergocristine mesilate 25 mg

BP 122 2,3-Dihydro-6-phenylimidazo [2,1-b] thiazole 50 mg

BP 815 bis-(1,7-dihydro-6H-purine)-6,6-disulphide 25 mg

BP 726 Diltiazem HCl 100 mg

New BP 899 Diltiazem Impurity Standard 25 mg

BP 582 6,6-Dimethoxy-2,2'-binaphthyl 25 mg

BP 195 4-Dimethylamino-3-methyl-1,2-diphenylbutan-2-ol hydrochloride 25 mg

BP 607 3-Dimethylaminopropyl 2-benzylaminobenzoate hydrochloride 25 mg

BP 456 1,5-Dimethylhexyl(methyl)amine 50 mg

BP 865 Dimethyl-2,6-dimethyl-4-(2-nitrophenyl)pyridine-3,5-dicarboxylate 25 mg

BP 866 Dimethyl-2,6-dimethyl-4-(2-nitrosophenyl)pyridine-3,5-dicarboxylate 25 mg

BP 511 Dimethyl{5-[2-(1-methylamino-2-nitrovinylamino) ethylsulphinylmethyl]furfuryl}amine 25 mg

BP 364 2,2-Dimethyl-5(2,4-xylyloxy)valeric acid 25 mg

BP 690 Dimpylate Assay Standard 0.1 mL

BP 691 Dimpylate for chromatography 0.1 mL

New BP 902 Dinoprostone Assay Standard 100 mg

New BP 896 Diphenhydramine hydrochloride 100 mg

BP 128 Dipipanone hydrochloride Assay Standard Controlled Substance 100 mg

BP 673 Dipivefrine hydrochloride Assay Standard 100 mg

BP 659 Dipivefrine impurity standard 100 mg

BP 589 Diprenorphine Assay Standard 100 mg

BP 131 Dipyridamole Assay Standard 100 mg

BP 384 N1,N2-Diquinoxalin-2-ylsulphanilamide 25 mg

BP 615 Disodium pamidronate Assay Standard 100 mg

BP 132 Disulfiram Assay Standard 50 mg

BP 385 Dithranol Assay Standard 100 mg

BP 674 Dobutamine hydrochloride Assay Standard 100 mg

BP 133 Docusate sodium Assay Standard 200 mg

BP 669 Domperidone maleate Assay Standard 100 mg

BP 468 Dopamine hydrochloride Assay Standard 100 mg

BP 134 Dosulepin hydrochloride Assay Standard 100 mg

BP 135 Doxapram hydrochloride Assay Standard 100 mg

BP 136 Doxepin hydrochloride Assay Standard 100 mg

New BP 823 Doxepin Impurity Standard 1 mg

New BP 990 Doxorubicin hydrochloride Assay Standard 100 mg

BP 780 Doxycycline hyclate Assay Standard 100 mg

BP 675 Droperidol Assay Standard 100 mg

BP 138 Dydrogesterone 50 mg

BP 139 Econazole nitrate Assay Standard 100 mg

BP 741 Enalapril maleate 100 mg

BP 742 Enalaprilat 20 mg



Code Product Unit

BP 743 Enalapril diketopiperazine 20 mg

BP 387 Ephedrine hydrochloride Assay Standard Drug Precursor 100 mg

New BP 992 Epirubicin hydrochloride 100 mg

BP 788 Ergocalciferol Assay Standard 500 mg

BP 405 Ergometrine maleate Assay Standard Drug Precursor 100 mg

BP 141 Ergotamine tartrate Assay Standard Drug Precursor 50 mg

BP 781 Erythromycin 50 mg

BP 794 Erythromycin A Assay Standard 250 mg

BP 795 Erythromycin B Assay Standard 50 mg

BP 796 Erythromycin C Assay Standard 50 mg

BP 790 Erythromycin estolate 100 mg

BP 798 Erythromycin ethyl succinate 50 mg

BP 488 Erythromycin stearate Assay Standard 100 mg

BP 396 Estradiol benzoate Assay Standard 50 mg

BP 729 Estradiol hemihydrate Assay Standard 100 mg

BP 142 Estramustine 25 mg

BP 752 Estriol Assay Standard 100 mg

BP 753 Estriol impurity standard 25 mg

BP 860 Estrone 25 mg

BP 616 Estropipate Assay Standard 100 mg

BP 143 Etacrynic acid Assay Standard 100 mg

BP 421 Ethinylestradiol Assay Standard 100 mg

BP 145 Ethopabate Assay Standard 100 mg

BP 146 Ethosuximide Assay Standard 200 mg

BP 150 Ethyldimethyl [2-(2-methylbenzhydryloxy)ethyl]ammonium chloride 25 mg

BP 437 N-Ethylglucamine hydrochloride 500 mg

BP 149 Ethyl meclofenamate 25 mg

BP 529 Etodolac Assay Standard 150 mg

BP 533 Etodolac acid dimer 10 mg

BP 541 Etodolac 1-methyl analogue 25 mg

BP 542 Etodolac 8-methyl analogue 10 mg

New BP 885 Etoposide Assay Standard 150 mg

BP 653 Famotidine Assay Standard 100 mg

BP 655 Famotidine degradation impurity 1 25 mg

BP 656 Famotidine degradation impurity 2 25 mg

BP 654 Famotidine impurity C 25 mg

BP 620 Felbinac Assay Standard 100 mg

BP 777 Felodipine Assay Standard 100 mg

BP 758 Felodipine impurity standard 20 mg

BP 692 Fenbendazole 100 mg

BP 693 Fenbendazole impurity C {5-(phenylthio)-2-aminobenzimidazole}

25 mg

BP 354 Fenbufen Assay Standard 100 mg

BP 661 Fenoterol degradation impurity A 25 mg

BP 660 Fenoterol hydrobromide Assay Standard 100 mg

BP 665 Fentanyl citrate Assay Standard Controlled Substance 100 mg

BP 666 Fentanyl impurity A 25 mg

BP 156 Fenthion Assay Standard 0.25 mL

BP 740 Finasteride Assay Standard 100 mg

BP 571 Flavoxate hydrochloride Assay Standard 100 mg

BP 676 Flecainide acetate Assay Standard 100 mg

BP 159 Fludrocortisone acetate Assay Standard 50 mg



Code Product Unit

BP 840 Flunitrazepam Controlled Substance 25 mg

BP 160 Fluocinolone acetonide Assay Standard 50 mg

BP 489 Fluocinonide Assay Standard 100 mg

BP 161 Fluocortolone hexanoate Assay Standard 50 mg

BP 162 Fluocortolone pivalate Assay Standard 50 mg

BP 163 4'-Fluoro-4-chlorobutyrophenone 0.5 mL

BP 573 Fluorometholone Assay Standard 100 mg

BP 797 Fluoxetine hydrochloride Assay Standard 250 mg

BP 164 Fluoxymesterone 50 mg

BP 738 cis-Flupentixol 25 mg

BP 554 Flupentixol decanoate dihydrochloride Assay Standard 100 mg

BP 556 trans-Flupentixol decanoate dihydrochloride 25 mg

BP 597 cis-Flupenthixol propionate dihydrochloride 100 mg

BP 167 Fluphenazine hydrochloride Assay Standard 100 mg

BP 574 Flurbiprofen sodium Assay Standard 100 mg

BP 587 Fluticasone propionate Assay Standard 100 mg

BP 588 Fluticasone S-methyl impurity 25 mg

BP 600 Fluvoxamine maleate Assay Standard 100 mg

BP 671 Fluvoxamine maleate impurity standard 100 mg

BP 627 3-Formylrifamycin SV 25 mg

BP 639 Form-2',4'-xylidide 25 mg

BP 623 Foscarnet sodium Assay Standard 100 mg

BP 678 Fosfestrol sodium 50 mg

BP 547 Furosemide Assay Standard 100 mg

BP 643 Gallamine impurity standard 100 mg

BP 363 Gemfibrozil Assay Standard 100 mg

BP 303 Gemfibrozil impurity A 2,2-dimethyl-5-(4-propen-1-yl)-2,5-xylyloxy)valeric acid

10 mg

BP 365 Gemfibrozil methyl ester 0.1 mL

BP 174 Gentamicin sulphate 25 mg

BP 175 Glibenclamide Assay Standard 100 mg

BP 368 Gliclazide Assay Standard 200 mg

BP 580 Gliquidone Assay Standard 150 mg

BP 581 Gliquidone sulphonamide 25 mg

BP 652 Glyceryl trinitrate solution Assay Standard 50 mL

BP 814 Goserelin Hexapeptide 10 mg

BP 180 Griseofulvin Assay Standard 100 mg

BP 181 Guanethidine monosulphate Assay Standard 100 mg

BP 879 Guanine 25 mg

BP 407 Haloperidol Assay Standard 150 mg

BP 185 Homatropine hydrobromide Assay Standard 100 mg

BP 186 Hydrochlorothiazide Assay Standard 200 mg

BP 576 Hydrocortisone Assay Standard 100 mg

BP 584 Hydrocortisone acetate Assay Standard 100 mg

BP 187 Hydrocortisone Hydrogen Succinate 100 mg

BP 188 Hydrocortisone sodium phosphate 100 mg

BP 190 Hydroflumethiazide 100 mg

BP 770 4'Hydroxyacetophenone 25 mg

BP 197 Hydroxycarbamide Assay Standard 200 mg

BP 526 2-(2-Hydroxyethyl)-1-methylpyrrolidine 0.1 mL

BP 196 5-[1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl]salicylic acid hydrochloride 50 mg

BP 829 D-alpha-(4-hydroxyphenyl)glycine 50 mg



Code Product Unit

BP 888 (5RS)-3-(2-hydroxyphenyl)-5-phenylcyclohex-2-enone 25 mg

BP 194 2-(6-Hydroxythymoxy)ethyldimethylamine hydrochloride 25 mg

BP 198 Hyoscine butylbromide Assay Standard 100 mg

BP 199 Hyoscine Hydrobromide Assay Standard 200 mg

BP 774 Hypromellose Assay Standard 100 mg

BP 539 Ibuprofen Assay Standard 200 mg

BP 202 Idoxuridine Assay Standard 100 mg

BP 759 Ifosfamide Assay Standard 100 mg

BP 664 Iminophenazine 25 mg

New BP 932 Imipramine hydrochloride 50 mg

New BP 999 Indapamide Assay Standard 150 mg

New BP 1000 Indapamide impurity B 10 mg

BP 625 Ipratropium bromide Assay Standard 100 mg

BP 557 4'-Isobutylacetophenone 100 mg

BP 550 Isoconazole nitrate Assay Standard 100 mg

BP 205 Isoprenaline hydrochloride Assay Standard 100 mg

BP 778 Isopromethazine hydrochloride 25 mg

BP 206 Isosorbide dinitrate 300 mg

BP 799 Isosorbide 2-nitrate 50 mg

BP 800 Isosorbide mononitrate Assay Standard 100 mg

BP 499 4'-(2-Isopropylaminoethyl)methanesulphonanilide hydrochloride 25 mg

BP 626 8s-Isopropyl-3β-hydroxytropanium bromide 25 mg

BP 621 Isradipine Assay Standard 100 mg

BP 622 Isradipine impurity B 25 mg

BP 624 Isradipine impurity D 25 mg

BP 864 Ivermectin Assay Standard 250 mg

BP 861 Kanamycin monosulpate 50 mg

BP 736 Ketamine Hydrochloride Controlled Substance 100 mg

BP 668 Ketoprofen Assay Standard 100 mg

BP 667 Ketoprofen ethyl ester 100 mg

BP 707 Lacidipine Assay Standard 100 mg

BP 647 Lacidipine impurity Standard 25 mg

BP 802 Lamivudine Assay Standard 200 mg

BP 872 Lansoprazole Assay Standard 100 mg

BP 873 Lansoprazole impurity standard 25 mg

BP 212 Levamisole hydrochloride 100 mg

BP 356 Levobunolol hydrochloride Assay Standard 100 mg

BP 213 Levodopa Assay Standard 100 mg

BP 772 Levomenthol Assay Standard 100 mg

BP 723 Levomepromazine maleate Assay Standard 100 mg

BP 634 Levomepromazine sulphoxide 25 mg

BP 501 Levonorgestrel Assay Standard 100 mg

BP 215 Lincomycin hydrochloride Assay Standard 250 mg

BP 727 Lidocaine Assay Standard 100 mg

BP 214 Lidocaine (Lignocaine) hydrochloride 50 mg

BP 733 Linseed oil 0.5 mL

BP 695 Lisinopril dihydrate Assay Standard 100 mg

BP 696 Lisinopril diketopiperazine 25 mg

BP 433 Lithium lactate Assay Standard 100 mg

New BP 927 Lithocholic acid 25 mg

BP 697 Lofepramine hydrochloride Assay Standard 100 mg

BP 635 Loperamide hydrochloride Assay Standard 100 mg



Code Product Unit

BP 636 Loperamide N-oxide 25 mg

BP 874 Loratadine Assay Standard 100 mg

New BP 875 Loratadine Impurity Standard 25 mg

BP 447 Loprazolam mesilate Controlled Substance 50 mg

BP 434 Lorazepam Assay Standard Controlled Substance 50 mg

BP 528 Lormetazepam Assay Standard Controlled Substance 100 mg

New BP 867 Losartan Potassium Assay Standard 150 mg

BP 218 Lymecycline 100 mg

BP 776 Lynestrenol 25 mg

New BP 1008 Mebendazole 10 mg

New BP 220 Meclozine hydrochloride 100 mg

BP 221 Medroxyprogesterone acetate Assay Standard 100 mg

BP 222 Megestrol 25 mg

BP 223 Megestrol acetate Assay Standard 100 mg

BP 629 Meloxicam Assay Standard 100 mg

BP 630 Meloxicam impurity standard 50 mg

BP 391 Melphalan Assay Standard 100 mg

BP 699 Mepivacaine hydrochloride Assay Standard 100 mg

BP 583 Meptazinol hydrochloride Assay Standard 100 mg

BP 773 Mercaptopurine Assay Standard 100 mg

BP 762 Mercaptopurine impurity standard 25 mg

BP 496 Mesoridazine besilate 50 mg

BP 226 Metaraminol tartrate 100 mg

New BP 227 Metformin hydrochloride Assay Standard 100 mg

BP 552 Methadone hydrochloride Assay Standard Controlled Substance 100 mg

BP 232 1-(2-Methoxyphenyl)piperazine 25 mg

BP 644 Methyl 4-acetamido-2-hydroxybenzoate 25 mg

BP 606 1-Methylazepan-4-one hydrochloride 25 mg

BP 605 1-Methyl-4-(2-benzoylhydrazino)azepan hydrochloride 25 mg

BP 239 3-Methyl-2,2-diphenyl-4-piperidinobutyronitrile 50 mg

BP 240 Methyldopa Assay Standard 100 mg

BP 241 Methyldopate hydrochloride Assay Standard 100 mg

BP 569 3-Methylflavone-8-carboxylic acid 25 mg

BP 570 3-Methylflavone-8-carboxylic acid ethyl ester 25 mg

BP 444 4-methyl-5-(2-hydroxyethyl)thiazole 25 mg

BP 457 2-Methyl-6-methylaminoheptan-2-ol 50 mg

BP 476 1-methyl-3-[2-(5-methylimidazol-4-yl-methylthio)ethyl]guanidine dihydrochloride 25 mg

BP 237 Methyl N-4[2-(5-chloro- 2-methoxybenzamido)ethyl]benzenesulphonyl carbamate

25 mg

BP 244 2-Methyl-5-Nitroimidazole 50 mg

BP 245 (1-Methyl-5-nitroimidazol-2-yl)methanol 25 mg

BP 641 N-Methyl-N'-(2,4-xylyl)formamidine hydrochloride 25 mg

BP 662 Methylphenobarbital Assay Standard Controlled Substance 100 mg

BP 248 Methylprednisolone Assay Standard 100 mg

BP 249 Methylprednisolone acetate Assay Standard 200 mg

BP 846 N-methyl-bis[beta-(2-pyridyl)ethyl]amine trihydrochloride 25 mg

BP 445 4-Methyl-5-vinylthiazole edisilate 25 mg

BP 409 Methysergide maleate Assay Standard 50 mg

BP 642 Metipranolol Assay Standard 100 mg

BP 357 Metoclopramide hydrochloride Assay Standard 100 mg

BP 540 Metoprolol tartrate Assay Standard 100 mg

BP 603 Metronidazole Assay Standard 150 mg



Code Product Unit

BP 735 Metronidazole benzoate 100 mg

BP 251 Mexenone 100 mg

BP 252 Mianserin hydrochloride Assay Standard 100 mg

BP 253 Miconazole nitrate Assay Standard 100 mg

BP 884 Miconazole impurity A 25 mg

BP 722 Midazolam Assay Standard Controlled Substance 100 mg

BP 394 Minocycline hydrochloride Assay Standard 125 mg

BP 637 Minoxidil Assay Standard 100 mg

BP 842 Mirtazapine Assay Standard 100 mg

BP 768 Mometasone furoate Assay Standard 100 mg

BP 254 Monosulfiram 100 mg

BP 648 Morphine sulphate Assay Standard Controlled Substance 100 mg

BP 358 Nabumetone Assay Standard 200 mg

New BP 851 Nabumetone impurity D 100 mg

BP 362 Naftidrofuryl oxalate Assay Standard 100 mg

BP 548 Naloxone hydrochloride Assay Standard 100 mg

BP 257 Nandrolone Assay Standard Controlled Substance 100 mg

BP 425 Nandrolone decanoate Controlled Substance 50 mg

BP 259 Nandrolone laurate Controlled Substance 50 mg

BP 260 Nandrolone Phenylpropionate Assay Standard Controlled Substance 100 mg

BP 360 3-(1-Naphthyl)-2-tetrahydrofurfurylpropionic acid 25 mg

BP 435 Naproxen Assay Standard 100 mg

BP 460 Nicotinamide Assay Standard 100 mg

BP 395 Nicotinyl alcohol tartrate 50 mg

BP 462 Nifedipine Assay Standard 100 mg

BP 651 Nimodipine Assay Standard 100 mg

BP 262 Nitrazepam Assay Standard Controlled Substance 100 mg

BP 263 Nitrofurfural diacetate 50 mg

BP 367 3-Nitroso-3-azabicyclo[3.3.O]octane 0.1 mL

BP 512 Noradrenaline (norepinephrine) acid tartrate 100 mg

BP 266 Norethisterone Assay Standard 50 mg

BP 267 Norethisterone acetate Assay Standard 100 mg

BP 670 Norfloxacin Assay Standard 100 mg

BP 714 Norgestrel 100 mg

BP 269 Nortriptyline hydrochloride Assay Standard 200 mg

BP 765 Omeprazole Assay Standard 100 mg

BP 808 Ondansetron hydrochloride dihydrate Assay Standard 100 mg

BP 806 Ondansetron impurity standard 25 mg

BP 805 Ondansetron for TLC system suitability 25 mg

BP 272 Orciprenaline sulphate 100 mg

BP 764 Oxibendazole 25 mg

BP 700 Oxybuprocaine hydrochloride Assay Standard 100 mg

BP 701 Oxybutynin hydrochloride Assay Standard 100 mg

BP 273 Oxyclozanide 200 mg

BP 782 Oxytetracycline Assay Standard 100 mg

BP 276 Pancuronium bromide Assay Standard 25 mg

BP 769 Paeoniflorin Assay Standard 20 mg

BP 277 Papaverine hydrochloride Assay Standard 100 mg

BP 371 Paracetamol Assay Standard 100 mg

BP 746 Paroxetine impurity standard 25 mg

BP 278 Pentagastrin 0.1 mg

BP 422 Perphenazine Assay Standard 100 mg



Code Product Unit

BP 683 Pethidine hydrochloride Assay Standard Controlled Substance 100 mg

New BP 901 Phenobarbital Assay Standard Controlled Substance 100 mg

BP 282 Phenoxymethylpenicillin potassium Assay Standard 500 mg

BP 520 Phentolamine mesilate 50 mg

BP 703 Phenylcyclohexylglycolic acid 25 mg

BP 284 Phenylephrine Hydrochloride Assay Standard 100 mg

BP 035 1-Phenyl-3-pyrrolidinopropan-1-one hydrochloride 50 mg

BP 423 Phytomenadione Assay Standard 0.25 mL

BP 503 Pilocarpine nitrate Assay Standard 200 mg

BP 682 Pimozide Assay Standard 100 mg

BP 450 3-Piperidylpropiophenone hydrochloride 50 mg

BP 463 Piroxicam Assay Standard 100 mg

BP 411 Pizotifen malate Assay Standard 50 mg

BP 288 Poldine metisulfate Assay Standard 100 mg

BP 289 Polythiazide Assay Standard 100 mg

BP 510 Potassium trichloroammineplatinate 25 mg

BP 399 Prazosin hydrochloride Assay Standard 100 mg

BP 464 Prednisolone Assay Standard 100 mg

BP 292 Prednisolone sodium phosphate Assay Standard 100 mg

BP 553 Prednisone Assay Standard 250 mg

BP 497 Prilocaine hydrochloride Assay Standard 100 mg

BP 293 Primidone Assay Standard 100 mg

BP 295 Procaine benzylpenicillin Assay Standard 100 mg

BP 638 Prochlorperazine maleate Assay Standard 100 mg

BP 493 Prochlorperazine mesilate Assay Standard 100 mg

BP 494 Prochlorperazine sulphoxide 25 mg

BP 296 Procyclidine hydrochloride Assay Standard 100 mg

BP 449 Progesterone Assay Standard 50 mg

BP 297 Proguanil hydrochloride Assay Standard 100 mg

BP 412 Promethazine hydrochloride Assay Standard 100 mg

BP 505 Promethazine sulphoxide 25 mg

BP 698 Propofol dimer 25 mg

BP 868 Propylene glycol Assay Standard 100 mg

BP 413 Pseudoephedrine hydrochloride Assay Standard Drug Precursor 100 mg

BP 717 Pseudomorphine trihydrate 25 mg

New BP 906 Pyrazinamide Assay Standard 100 mg

BP 458 Pyridoxine hydrochloride Assay Standard 100 mg

BP 863 Quinidine sulphate 300 mg

BP 862 Quinine sulphate 300 mg

BP 751 Ramipril Assay Standard 100 mg

BP 754 Ramipril impurity K Ramipril diketopiperazine acid

25 mg

BP 471 Ranitidine hydrochloride Assay Standard 100 mg

BP 593 Ribavirin Assay Standard 100 mg

BP 592 Ribavirin impurity standard 50 mg

BP 459 Riboflavin sodium phosphate 50 mg

BP 400 Rifampicin N-oxide 25 mg

BP 586 Ritodrine hydrochloride Assay Standard 200 mg

BP 451 Salbutamol Assay Standard 100 mg

BP 712 Salbutamol aldehyde impurity 25 mg

New BP 852 Salbutamol impurity B 10 mg

BP 704 Salbutamol ketone impurity 25 mg



Code Product Unit

BP 302 Salbutamol sulphate Assay Standard 100 mg

BP 705 Selegiline hydrochloride Assay Standard 100 mg

BP 739 Simvastatin Assay Standard 100 mg

BP 750 Sodium alginate 200 mg

BP 453 Sodium nitroprusside Assay Standard 200 mg

BP 490 Sodium picosulfate Assay Standard 100 mg

BP 452 Sodium valproate Assay Standard 500 mg

BP 498 Sotalol hydrochloride 100 mg

BP 818 Sucrose Assay Standard 1000 mg

BP 312 Sulfadiazine Assay Standard 100 mg

BP 310 Sulfadoxine Assay Standard 100 mg

BP 314 Sulfamethoxazole Assay Standard 100 mg

BP 779 Sulfasalazine Assay Standard 250 mg

BP 679 Sulpiride Assay Standard 100 mg

BP 745 Sumatriptan impurity standard 25 mg

BP 876 Tamsulosin hydrochloride Assay Standard 100 mg

BP 877 Tamsulosin hydrochloride impurity standard 25 mg

BP 455 Temazepam Assay Standard Controlled Substance 100 mg

BP 708 Tenoxicam Assay Standard 100 mg

BP 709 Tenoxicam degradation impurity standard 25 mg

BP 318 Terbutaline sulphate Assay Standard 100 mg

BP 650 Terfenadine Assay Standard 100 mg

BP 319 Testosterone decanoate Controlled Substance 100 mg

BP 321 Testosterone isocaproate Controlled Substance 100 mg

BP 322 Testosterone phenylpropionate Assay Standard Controlled Substance 100 mg

BP 702 Testosterone propionate Assay Standard Controlled Substance 100 mg

BP 480 Tetracycline hydrochloride Assay Standard 100 mg

BP 327 Theophylline Assay Standard 100 mg

BP 414 Thiamine mononitrate Assay Standard 100 mg

BP 495 Thioridazine Assay Standard 100 mg

BP 331 Thiotepa Assay Standard 100 mg

BP 332 2-Thymoxyethyldimethylamine hydrochloride 25 mg

BP 848 Tibolone Assay Standard 100 mg

BP 849 Tibolone Impurity Standard 10 mg

BP 645 Tioconazole Assay Standard 100 mg

BP 687 Tioconazole impurity standard 100 mg

BP 878 Tioguanine Assay Standard 100 mg

New BP 333 Tobramycin 100 mg

New BP 882 alpha-Tocopherol Assay Standard 200 mg

BP 744 Tramadol hydrochloride 100 mg

BP 734 Tranexamic acid impurity standard 25 mg

BP 544 Transplatin 25 mg

BP 590 Trazodone hydrochloride Assay Standard 100 mg

BP 591 Trazodone hydrochloride impurity standard 50 mg

BP 338 Triamcinolone Assay Standard 100 mg

BP 339 Triamcinolone acetonide Assay Standard 50 mg

BP 680 Triamcinolone hexacetonide Assay Standard 100 mg

BP 340 Triamterene Assay Standard 100 mg

BP 341 3,5,6-Trichloro-2-hydroxybenzoic acid 50 mg

BP 555 2-Trifluoromethylthioxanthone 25 mg

BP 034 Trihexyphenidyl hydrochloride Assay Standard 100 mg

BP 344 Trimethoprim Assay Standard 100 mg



Code Product Unit

BP 346 z-Triprolidine hydrochloride 50 mg

BP 347 Triprolidine hydrochloride 100 mg

BP 349 Tylosin 50 mg

BP 350 Urea Assay Standard 1 g

BP 706 Ursodeoxycholic acid Assay Standard 150 mg

BP 563 Vigabatrin Assay Standard 150 mg

BP 564 5-Vinyl-2-pyrrolidone 25 mg

BP 672 Warfarin Assay Standard 100 mg

BP 353 Xylometazoline hydrochloride Assay Standard 100 mg

BP 640 N,N'-bis(2,4-Xylyl)formamidine 25 mg

BP 803 Zidovudine Assay Standard 150 mg

BP 895 Zidovudine Impurity Standard 25 mg

BP 850 Zidovudine and Lamivudine Impurity Standard 50 mg

BP 812 Zopiclone Assay Standard 100 mg

BP 599 Zuclopenthixol acetate dihydrochloride Assay Standard 100 mg

BP 596 Zuclopenthixol decanoate dihydrochloride 100 mg

BP 558 Zuclopenthixol hydrochloride Assay Standard 100 mg




programme. As Europe’s only officially authorized distributor of ATCC cultures, LGC Standards can supply all ATCC organisms specified in the pharmacopoeia. ATCC maintains the highest standards for its biological materials, employing stringent quality control procedures to produce cultures which are well characterized and have low passage numbers. Long-term subculturing of biological materials can have adverse effects on the culture population, including genetic drift, unwanted selection, contamination, and varied cell responses. ATCC quality control cultures sold by LGC Standards are never subcultured or transferred in any way from ATCC’s strains and our European stock-holding means orders are usually filled within 3 - 5 working days. So whether it is quality control strains, genomic DNA, media or growth supplements, antibiotics for selection, or a huge selection of organisms, take the time and guesswork out of ordering your microbiology supplies with authentic, high-quality ATCC materials - exclusively from LGC Standards.

British Pharmacopoeia 2011, volume IV and Addenda Code Product Unit

Appendix XIV A - Biological assay of antibiotics ATCC-6633 Bacillus subtilis amp.




ATCC-10031 Klebsiella pneumoniae ss. pneumoniae amp.




ATCC-9144 Staphylococcus aureus ss. aureus amp.




Appendix XVI - Test for absence of Mycoplasma ATCC-23206 Acholeplasma laidlawii (Sabin) Edward and Freundt deposited as Mycoplasma laidlawii amp.

ATCC-19989 Mycoplasma fermentans deposited as Mycoplasma fermentans Edward amp.


ATCC-17981 Mycoplasma hyorhinis deposited as Mycoplasma hyorhinis Switzer amp.


ATCC-15531 Mycoplasma pneumoniae amp.


ATCC-CCL-81 Vero cells amp.

Appendix XVI A - Test for sterility ATCC-16404 Aspergillus brasiliensis Varga et al. deposited as Aspergillus niger van Tieghem amp.

ATCC-6633 Bacillus subtilies amp.





Appendix XVI B - Tests for microbial contamination ATCC-6633 Bacillus subtilis amp.



ATCC-13124 Clostridium perfringens amp.

ATCC-11437 Clostridium sporogenes (Metchnikoff) Bergey et al. amp.



British Pharmacopoeia 2011, volume IV and Addenda


Code Product Unit




Appendix XVI C - Efficacy of antimicrobial preservation ATCC-16404 Aspergillus niger amp.





Appendix XVIII - Methods of sterilization ATCC-27142** Bacillus pumilus amp.

ATCC-7953** Bacillus stearothermophilus amp.

ATCC-9372** Bacillus subtilis amp.

ATCC-19146 Brevendimonas diminuta (as Pseudomonas diminuta) amp.

Appendix XVI (Vet) 3 - Test for absence of mycoplasmas ATCC-23206 Acholeplasma laidlawii (Sabin) Edward and Freundt deposited as Mycoplasma laidlawii amp.


ATCC-17981 Mycoplasma hyorhinis Switzer amp.


ATCC-15531 Mycoplasma pneumoniae deposited as Mycoplasma pneumoniae Somerson et al. amp.


ATCC-CCL-81 Vero cells amp.

**=Alternative strain All care has been taken in compiling catalogue numbers, however users should consult the Pharmacopoeia directly to confirm the testing requirements and recommended organisms before ordering or undertaking the testing procedures as described in the Pharmacopoeia.

Pharmacopée Française


Pharmacopée Française The list of reference substances and reference spectra available from the Pharmacopée Française (PF) are issued under the authority of the PF and are solely for use in tests and assays of the Pharmacopoeia Française and Pharmacopoeia Française (Vétérinaire). The list in this catalogue is based on the information provided by the FP in July 2011. All PF CRS are available in restricted quantity and orders for multiple units will be reduced to a single unit

Proper use Reference substances from the PF are designed for specific applications, which are identified by a code

number included in each product description. Uses other than those shown below are possible, but the user is responsible for checking the suitability of the PF CRS for any non-monograph use. 1 Identification by infrared spectrophotometry 2 Identification by thin layer chromatography 3 Test for related substances by thin layer chromatography 4 Test for related substances by liquid chromatography 5 Test for related substances by gas chromatography 6 Assay by UV spectrophotometry by gas chromatography 7 Assay by fluorimetry 8 Assay by liquid chromatography 9 Assay by gas chromatography 10 Microbiological assay 11 Assay by volumetric titration

Shelf life and expiry dates French Pharmacopoeia chemical reference substances are subject to regular inspection and repeated

analysis by PF scientific staff. Each PF CRS is, on receipt by the customer, fit for the intended use. The shelf life and the expiry date are not given, and PF advises that unopened vials should not be stored for a long period of time.

Code Product Unit

FPC0050 Alimémazine tartrate 25 mg

FPC0071 Amodiaquine chlorhydrate 25 mg

FPC0072 Amprolium chlorhydrate (usage vétérinaire) 25 mg

FPC0141 Benzododecinium bromure 1000 mg

FPC0190 Bleu patente V 1000 mg

FPC0200 Boldine 100 mg

FPC0210 Butoformé 150 mg

FPC0271 Chlormadinone acetate 100 mg

FPC0423 Dichlorvos (usage vétérinaire) 1000 mg

FPC0600 Eosine disodique 200 mg

FPC0610 Epivincamine 50 mg

FPC0510 Erythromycine propionate unit

FPC0722 Furaltadone (usage vétérinaire) 250 mg

FPC0730 Furazolidone Reference Spectrum unit

FPC0892 Histamine 50 mg

FPC0898 Hydroquinidine chlorhydrate 100 mg

FPC1020 Ioxitalamique acide 250 mg

FPC1222 Linalyle acétate 2 mL

FPC2900 Lysine acétylsalicylate Reference Spectrum unit

FPC1350 Methylanthranilate de methyle 2 mL

FPC1560 Nifurtimox 250 mg

FPC1572 Nitro-5 furaldazine (usage vétérinaire) 50 mg

FPC1574 Nitro-5-furfurylidène diacétate (usage vétérinaire) 50 mg

FPC1576 Nitroxinil (usage vétérinaire) unit

FPC1600 Oxyquinol Reference Spectrum unit

FPC3300 Polytétrafluoroéthylène Reference Spectrum unit

FPC1780 Potassium gluconate 50 mg

Pharmacopée Française


Code Product Unit

FPC1785 Prasterone 300 mg

FPC2032 Strychnine sulfate (usage vétérinaire) 225 mg

FPC2034 Suc de papayer 500 mg

FPC2036 Sulconazole nitrate 200 mg

FPC2044 Sulfadiméthoxine 100 mg

FPC2120 Sulfogaiacol 100 mg

FPC2122 Sulfogaiacol (exempt de gaiacol) 1000 mg

FPC2210 Terpine 1000 mg

FPC2212 Tétramizole chlorhydrate (usage vétérinaire) 50 mg

FPC2230 Thiocolchicoside 300 mg

FPC2242 Thiotépa Reference Spectrum unit

FPC2520 Vincamine 250 mg

FPC2530 Venin d'Abeille PBR

Pharmacopoeia Helvetica


Pharmacopoeia Helvetica Background The range of reference substances available from the Pharmacopoeia Helvetica is issued under the authority

of the Pharmacopoeia Helvetica, and is solely for use in tests and assays of the Pharmacopoeia Helvetica. The Pharmacopoeia Helvetica contains, in addition to harmonised European Pharmacopoeia monographs, a number of national monographs. Some of the national monographs require CRS described in the list below. The list in this catalogue is based on the current Pharmacopoeia Helvetica.

Code Product Unit

SPC 015 α-(2-Piperidyl)phenylessigsäure 50 mg

SPC 160 Dexamfetaminsulfat Reference Spectrum unit

SPC 170 Diamorphinhydrochlorid wasserfrei Reference Spectrum unit

SPC 190 Drofeninhydrochlorid 1 g

SPC 204 Ethanol 70% Reference Spectrum unit

SPC 210 Ethanol with 2 % Ketone Reference Spectrum unit

SPC 300 Methacholinchlorid Reference Spectrum unit

SPC 335 Methylphenidathydrochlorid Reference Spectrum unit

SPC 320 Moclobemid Reference Spectrum unit

SPC 340 2-Naphthol Reference Spectrum unit

SPC 380 Oxychinolinsulfat Reference Spectrum unit

SPC 455 Saponin 500 mg

SPC 505 Terpinhydrat Reference Spectrum unit

SPC 515 Thiethylperazinhydrogenmaleat 200 mg

International Pharmacopeia


International Pharmacopeia Background The World Health Organization (WHO) as a specialised agency of the United Nations with a primary

responsibility for international health matters and public health, is the issuing body of the substances described in the International Pharmacopoeia. Progress towards better health requires international cooperation in the establishment of international standards for biological substances and pharmaceuticals. The WHO has therefore authorised the establishment and maintenance of a number of reference collections. Two are of particular interest to analysts involved in pharmaceutical and clinical measurement sciences: the collections of international biological reference substances and international chemical reference substances.

International biological reference substances The range of biological reference substances was established to provide a means of ensuring International

uniformity in the designation of the potency, activity or specificity of preparations that are used in the prevention, treatment or diagnosis of human or animal diseases, and for which chemical and physical assay terms are inappropriate. WHO biological reference substances are needed for certain antibiotic and hormone assays described in a number of pharmacopoeia. The majority of the preparations of interest to the analyst working in the fields of pharmaceutical analysis are held by the NIBSC in England.

International chemical reference substances International chemical reference substances are established upon the advice of the WHO expert committee

on specifications for pharmaceutical preparations. They are intended for use in physical and chemical tests and assays described in the specifications for quality control published in the International Pharmacopoeia (IP CRS), or as proposed in draft monographs. The list in this catalogue is based on the current WHO information.

Proper use Whilst the primary application of IP CRS is in physical and chemical tests and assays as described in the

International Pharmacopoeia, IP CRS do have applications in other aspects of pharmaceutical analysis where a certificate of purity is required.

Documentation Directions for use and analytical data are provided in certificates distributed with the IP CRS. The certificates

show how the identity and purity of the material was confirmed, and in many cases demonstrate traceability to another PRM. This information fulfills most of the requirements of a Certification Report as defined by the ISO Guides on the preparation and use of Certified Reference Materials.

Shelf life and expiry dates International Pharmacopoeia chemical reference substances are subject to regular inspection and repeated

analysis by the WHO Collaborating Centre. Each IP CRS is, on receipt by the customer, suitable for the intended use. Shelf life and expiry dates are not given, and IP advises that once opened, vials should not be stored for long periods of time. Only current lots are supplied by IP. For this reason users are advised to order only as required. Once opened IP can no longer guarantee the stability of the material and any of the CRS not used should be disposed of.

Controlled substances For information on ordering please contact LGC Standards.

Code Product Unit

ICRS1422 Abacavir sulfate 100 mg

ICRS1552 Abacavir sulfate for system suitability 10 mg

ICRS0201 Acetanilide (116°C) Melting Point Standard 1 g

ICRS0202 Acetazolamide 100 mg

ICRS0204 Allopurinol 100 mg

ICRS0206 Amidotrizoic acid 100 mg

ICRS0191 2-Amino-5-nitrothiazole 25 mg

ICRS0194 3-Aminopyrazole-4-carboxamide hemisulfate 100 mg



Code Product Unit

ICRS0193 3-Amino-2,4,6-triiodobenzoic acid 100 mg

ICRS0208 Amitriptyline hydrochloride 100 mg

ICRS0209 Amodiaquine hydrochloride 200 mg

ICRS1426 Amoxicillin trihydrate 100 mg

ICRS0210 Amphotericin B 400 mg

ICRS0211 Ampicillin (anhydrous) 200 mg

ICRS0212 Ampicillin sodium 200 mg

ICRS0213 Ampicillin trihydrate 200 mg

ICRS0214 Anhydrotetracycline hydrochloride 25 mg

ICRS1408 Artemether 100 mg

ICRS1407 Artemotil 100 mg

ICRS1410 Artenimol 100 mg

ICRS1409 Artesunate 100 mg

ICRS0215 Atropine sulfate 100 mg

ICRS0216 Azathioprine 100 mg

ICRS0218 Bacitracin zinc 200 mg

ICRS0221 Benzanilide (165°C) Melting Point Standard 1 g

ICRS0222 Benzil (96°C) Melting Point Standard 1 g

ICRS0225 Benzylpenicillin potassium 200 mg

ICRS0226 Benzylpenicillin sodium 200 mg

ICRS0227 Bephenium hydroxynaphthoate 100 mg

ICRS0228 Betamethasone 100 mg

ICRS0229 Betamethasone sodium phosphate 100 mg

ICRS0230 Betamethasone valerate 100 mg

ICRS0233 Bupivacaine hydrochloride 100 mg

ICRS0234 Caffeine 100 mg

ICRS0235 Caffeine (237°C) Melting Point Standard 1 g

ICRS0236 Calcium folinate (Leucovorin calcium) 100 mg

ICRS0237 Captopril 100 mg

ICRS0238 Captopril disulfide 25 mg

ICRS0239 Carbamazepine 100 mg

ICRS0240 Carbenicillin monosodium 200 mg

ICRS2132 Carbidopa 100 mg

ICRS0241 Chloramphenicol 200 mg

ICRS0242 Chloramphenicol palmitate 1 g

ICRS0243 Chloramphenicol palmitate (Polymorph A) 200 mg

ICRS0199 5-Chloro-2-methylaminobenzophenone 100 mg

ICRS0245 Chloroquine sulfate 200 mg

ICRS0190 2-(4-Chloro-3-sulfamoylbenzoyl)benzoic acid 50 mg

ICRS0246 Chlorphenamine hydrogen maleate 100 mg

ICRS0247 Chlorpromazine hydrochloride 100 mg

ICRS0248 Chlortalidone 100 mg

ICRS0249 Chlortetracycline hydrochloride 200 mg

ICRS0250 Cimetidine 100 mg

ICRS0252 Ciprofloxacin by compound A 20 mg

ICRS0253 Ciprofloxacin desfluoro-compound 20 mg

ICRS0255 Ciprofloxacin fluoroquinolonic acid 20 mg

ICRS0256 Ciprofloxacin hydrochloride 400 mg

ICRS0258 Cisplatin 100 mg

ICRS0259 Clomifene citrate 100 mg

ICRS0260 Zuclomifene (Clomifene citrate Z-isomer) 50 mg

ICRS0261 Cloxacillin sodium 200 mg



Code Product Unit

ICRS2130 Colchicine 100 mg

ICRS0263 Cortisone acetate 100 mg

ICRS0265 Dapsone 100 mg

ICRS0266 Desoxycortone acetate 100 mg

ICRS0267 Dexamethasone 100 mg

ICRS0268 Dexamethasone acetate 100 mg

ICRS0270 Dexamethasone sodium phosphate 100 mg

ICRS0282 Diazoxide 100 mg

ICRS0283 Dicloxacillin sodium 200 mg

ICRS0285 Dicoumarol 100 mg

ICRS1413 Didanosine 10 mg

ICRS1414 Didanosine for system suitability 10 mg

ICRS0286 Dicyanodiamide (210°C) Melting Point Standard 1 g

ICRS0287 Diethylcarbamazine dihydrogen citrate 100 mg

ICRS0288 Digitoxin 100 mg

ICRS0289 Digoxin 100 mg

ICRS0290 Dopamine hydrochloride 100 mg

ICRS0292 Doxorubicin hydrochloride 100 mg

ICRS1411 Efavirenz 100 mg

ICRS0294 Emetine hydrochloride 100 mg

ICRS0197 4-Epianhydrotetracycline hydrochloride 25 mg

ICRS0198 4-Epitetracycline hydrochloride 25 mg

ICRS0295 Ergocalciferol (Vitamin D2) 500 mg

ICRS0296 Ergometrine hydrogen maleate [Drug Precursor] 50 mg

ICRS0297 Ergotamine tartrate [Drug Precursor] 50 mg

ICRS0298 Erythromycin 250 mg

ICRS0299 Erythromycin B 25 mg

ICRS0300 Erythromycin C 25 mg

ICRS0301 Estradiol benzoate 100 mg

ICRS0302 Estrone 100 mg

ICRS0304 Ethambutol hydrochloride 100 mg

ICRS0305 Ethinylestradiol 100 mg

ICRS0306 Ethisterone 100 mg

ICRS0307 Ethosuximide 100 mg

ICRS0309 Flucloxacillin sodium 200 mg

ICRS0310 Flucytosine 100 mg

ICRS0311 Fludrocortisone acetate 200 mg

ICRS0312 Fluorouracil 100 mg

ICRS0315 Fluphenazine hydrochloride 100 mg

ICRS0316 Folic acid 100 mg

ICRS0195 3-Formylrifamycin 200 mg

ICRS0355 Framycetin sulfate (Neomycin B sulfate) 200 mg

ICRS0318 Furosemide 100 mg

ICRS0319 Gentamicin sulfate 100 mg

ICRS0322 Griseofulvin 200 mg

ICRS0323 Haloperidol 100 mg

ICRS0324 Hydrochlorothiazide 100 mg

ICRS0325 Hydrocortisone 100 mg

ICRS0326 Hydrocortisone acetate 100 mg

ICRS0327 Hydrocortisone sodium succinate 200 mg

ICRS0188 (-)-3-(4-Hydroxy-3-methoxyphenyl)-2-hydrazino-2-methylalanine (3-o-Methylcarbidopa) 25 mg

ICRS0189 (-)-3-(4-Hydroxy-3-methoxyphenyl)-2-methylalanine (3-o-Methylmethyldopa) 25 mg



Code Product Unit

ICRS0328 Ibuprofen 100 mg

ICRS0329 Imipramine hydrochloride 100 mg

ICRS1415 Indinavir 100 mg

ICRS0330 Indometacin 100 mg

ICRS0331 Isoniazid 100 mg

ICRS1416 Lamivudine 100 mg

ICRS1553 Lamivudine for system suitability 100 mg

ICRS0333 Lanatoside C 100 mg

ICRS0334 Levodopa 100 mg

ICRS0335 Levonorgestrel 200 mg

ICRS0336 Levothyroxine sodium 50 mg

ICRS0337 Lidocaine 100 mg

ICRS0338 Lidocaine hydrochloride 100 mg

ICRS0339 Liothyronine sodium 50 mg

ICRS0340 Loperamide hydrochloride 100 mg

ICRS2125 Lumefantrine 100 mg

New ICRS39627 Lumefantrine for system suitability 10 mg

ICRS0341 Mebendazole 200 mg

ICRS0454 Medroxyprogesterone acetate 100 mg

ICRS1549 DL-Methionine 100 mg

ICRS0345 Methotrexate 100 mg

ICRS0346 Methyldopa 100 mg

ICRS0347 Methyltestosterone 100 mg

ICRS0348 Meticillin sodium 200 mg

ICRS0350 Metronidazole 100 mg

ICRS0351 Nafcillin sodium 200 mg

ICRS2128 Naloxone hydrochloride 100 mg

ICRS1417 Nelfinavir mesilate 100 mg

ICRS0356 Neostigmine metilsulfate 100 mg

ICRS1412 Nevirapine anhydrous 100 mg

ICRS1423 Nevirapine impurity B 10 mg

ICRS0357 Nicotinamide 100 mg

ICRS0358 Nicotinic acid 100 mg

ICRS0366 Norethisterone 100 mg

ICRS0367 Norethisterone acetate 100 mg

ICRS2123 Norethisterone enantate 50 mg

ICRS0369 Nystatin 200 mg

ICRS0371 Oubain 100 mg

ICRS0372 Oxacillin sodium 200 mg

ICRS0373 Oxytetracycline dihydrate 200 mg

ICRS0374 Oxytetracycline hydrochloride 200 mg

ICRS0376 Papaverine hydrochloride 100 mg

ICRS0377 Paracetamol 100 mg

ICRS0378 Paromomycin sulfate 75 mg

ICRS0380 Phenacetin (136°C) Melting Point Standard 1 g

ICRS0382 Phenolphthalein (263°C) Melting Point Standard 1 g

ICRS0383 Phenoxymethylpenicillin 200 mg

ICRS0384 Phenoxymethylpenicillin calcium 200 mg

ICRS0385 Phenoxymethylpenicillin potassium 200 mg

ICRS0387 Phenytoin 100 mg

ICRS0388 Piperazine adipate 100 mg

ICRS0389 Piperazine citrate 100 mg



Code Product Unit

ICRS0390 Praziquantel 100 mg

ICRS0391 Prednisolone 100 mg

ICRS0392 Prednisolone acetate 100 mg

ICRS0393 Prednisolone hemisuccinate 200 mg

ICRS0394 Prednisolone sodium phosphate 200 mg

ICRS0395 Prednisone 100 mg

ICRS0396 Prednisone acetate 100 mg

ICRS0397 Probenecid 100 mg

ICRS0398 Procaine hydrochloride 100 mg

ICRS0399 Procarbazine hydrochloride 100 mg

ICRS0400 Progesterone 100 mg

ICRS0402 Propanolol hydrochlorid 100 mg

ICRS0403 Propylthiouracil 100 mg

ICRS0404 Pyrantel embonate (Pyrantel pamoate) 500 mg

ICRS1424 Pyrazinamide 100 mg

ICRS0405 Pyridostigmine bromide 100 mg

ICRS0406 Reserpine 100 mg

ICRS0408 Riboflavin 250 mg

ICRS0409 Rifampicin 300 mg

ICRS0410 Rifampicin quinone 200 mg

ICRS1421 Ritonavir 100 mg

ICRS1418 Saquinavir mesilate 100 mg

ICRS0411 Saccharin (229°C) Melting Point Standard 1 g

ICRS0412 Sodium amidotrizoate 100 mg

ICRS0413 Sodium cromoglicate 100 mg

ICRS0415 Spectinomycin hydrochloride 200 mg

ICRS1419 Stavudine 100 mg

ICRS0416 Streptomycin sulfate 100 mg

ICRS0417 Sulfacetamide 100 mg

ICRS0419 Sulfamethoxazole 100 mg

ICRS0420 Sulfamethoxypyridazine 100 mg

ICRS0421 Sulfanilamide 100 mg

ICRS0422 Sulfanilamide (166°C) Melting Point Standard 1 g

ICRS0423 Sulfapyridine (193°C) Melting Point Standard 4 g

ICRS0424 Sulfasalazine 100 mg

ICRS0425 Tamoxifen citrate 100 mg

ICRS0426 Tamoxifen E-isomer 10 mg

ICRS0427 Testosterone enantate 200 mg

ICRS0428 Testosterone propionate 100 mg

ICRS0429 Tetracycline hydrochloride 200 mg

ICRS0430 Thioacetazone 100 mg

ICRS0196 4,4'-Thiodianiline 50 mg

ICRS0431 Tolbutamide 100 mg

ICRS0432 Tolnaftate 100 mg

ICRS0433 Toluene-2-sulfonamide 100 mg

ICRS0434 Trimethadione 200 mg

ICRS0435 Trimethoprim 100 mg

ICRS0438 Vanillin (83°C) Melting Point Standard 1 g

ICRS0439 Warfarin 100 mg

ICRS1420 Zidovudine 100 mg

ICRS1554 Zidovudine impurity B 10 mg

Unites States Pharmacopeia and NationalFormulary

Phytochemical reference standards from ChromaDex

More than 2500 reference substances for phytochemical analysis

• Certified Reference Materials (CRM)

• Botanical Reference Materials (BRM)

• Extract Reference Materials (XRM)

• Standards with various documentation grades

• Reference standard kits

• Analytical methods.

Reference standards for/from:

• Artichoke

• Belladonna

• Bilbery

• Black Cohosh

• Carotenoids

• Cat’s Claw

• Devil’s Claw • Echinacea

• Ephedra

• Ginseng

• Kava Kava

• Reishi Mushroom

• Rosemary

• Soysaponins

• St. John’s Wort

• Tribulus Terrestris

• Valerian

• ... and many more.


United States Pharmacopeia and National Formulary


United States Pharmacopeia and National Formulary Background USP reference standards are highly purified substances that are provided specifically for use in the official

test methods of the United States Pharmacopeia and National Formulary. When used as a part of the relevant official monograph they provide the means to verify the compliance of a material with USP-NF standards for identity, concentration, quality and purity. Official USP and NF Reference Standards are made available as required for use in assays and tests appearing in the current edition of the USP-NF. They are collaboratively tested and approved for such use by the USP Reference Standards Committee and released only under the authority of the USP Board of Trustees. The range of USP reference standards includes: 1. Official USP and NF Reference Standards. 2. Former USP and NF Reference Standards, not required in the current USP or NF, but for which sufficient demand remains. 3. Food Chemicals Codex (FCC) reference standards, specified in the current edition of the Food Chemicals Codex. 4. Authentic Substances (AS), which are highly purified samples of chemicals, that are collaboratively tested and made available as a service to analysts. The list in this catalogue includes all amendments and new products made official by USP to July 2011.

Production and certification The development of USP reference standards is a multi-step process that makes much use of voluntary

cooperation from the pharmaceutical industry, government agencies including the United States Food and Drug Administration (FDA), and both USP in-house scientific staff and the members of the Committee of Revision. The following steps are adhered to, and the process takes from one to two years. 1. Preparation and purification of candidate material. 2. Testing and characterisation through a collaborative study (ring test). 3. Initial scientific and statistical review. Further analytical work is often required, and at this stage it is possible that the candidate material is rejected and the procedure restarted. 4. Preparation of a USP Reference Standards Committee letter, containing the data from the collaborative study for use by the Reference Standards Committee. This document is USP’s internal equivalent of a certification report. Approval of the document must be unanimous or further analytical work will be requested, or the whole cycle restarted. 5. Packaging and final quality control testing for homogeneity, integrity of the package, etc. USP generally does not provide certificates of analysis for USP reference standards (as outlined in their Document Disclosure Policy). USP reference standards are solely for use in the official tests and methods of the current official compendia. When handled in accordance with labelled instructions and monographs, they are considered as a value of 100.0% for compendial purposes, unless otherwise stated. In response to requests from LGC Standards, USP began listing the labelled purity values for reference standards and authentic substances. Each value is followed by a code to indicate the basis of the assignment. For example, a reference standard with a labelled purity of 0.998 mg/mg calculated on the "as is" basis, will be listed as "0.998 mg/mg (ai)". From now on, the values will be included for new lots released since January 1, 2004 and they will be included for all lots as they are released in the future. Below is a list of the basis codes and their meaning: (ai) as is (dr) dried (an) anhydrous (fb) free base. It must be noted that any other use of a USP reference standard in non-official procedures becomes the responsibility of the user.

Proper use A full description of the background to, proper use of and lot control procedures for USP-NF reference

standards is given in General Chapter <11> of the current USP-NF publication. Analysts are strongly advised to review this section on a regular basis. More information on USP publications and subscriptions is given in the ‘Publications and subscriptions’ section of this catalogue.



Shelf life and expiry dates USP reference standards are not labeled with an expiry date. The official lot number system provides greater

flexibility than a simple expiry date system. USP reference standards stocks are regularly and rigorously checked. Under normal circumstances a new lot is made official and held for future use, before the old lot is sold out. The old lot remains official for a period of time so that in-house reference substances can be recertified against the out-going and incoming lots and also to prevent unnecessary waste. It is the responsibility of each analyst to ensure that his particular supply of USP reference substance is current. As your supplier of choice, LGC Standards can provide lists of current lot numbers of USP reference standards, so call us to receive these today. Please take this opportunity to subscribe to this free service by contacting your local LGC Standards office.

Validation of secondary standards against USP reference substances All secondary in-house working standards have to be compared against the corresponding USP reference

standard. Please make sure that the secondary material is used only for the same official purposes for which the primary pharmacopoeial material also was designed.

Replacement lots and back orders Because of the rigorous nature of the approval process and the time taken, it is not always possible for USP

to have a new lot available before an existing lot is depleted. USP provides LGC Standards with regular information about the projected availability of back-ordered USP RS. Please contact LGC Standards for any enquiry.

Storage conditions The USP-NF states that “generally, reference standards should be stored in their original sealed containers

away from heat and protected from light. Avoid humid storage areas in particular”. In addition, the USP-NF recommends in its General Notices, that “where no specific storage directions or limitations are provided in the individual monograph, it is to be understood that conditions of storage include protection from moisture, freezing and excessive heat”.

Controlled Substances The USP list contains substances subject to Controlled Substance Regulations Schedules I, II, III, IV and

V. Special ordering procedures apply, please contact LGC Standards for details and costs.

Restricted Reference Standards The United States Government restricts the export of chemicals appearing on the US Munition list, the

Commerce Control list or in the Chemical Weapons Convention Annex on chemicals. Listed below are USP reference standards that are now currently restricted and may not be exported to any country outside the U.S.A. USP1106001 Chlorambucil USP1157002 Cyclophosphamide USP1376505 Mechlorethamine Hydrochloride USP1379300 Melphalan Hydrochloride USP1706009 Uracil Mustard

Code Product Unit

USP1000408 Abacavir Sulfate 200 mg

USP1000419 Abacavir Sulfate Racemic 4-[2-amino-6-(cyclopropylamino)9H-purin-9yl]-2-cyclopentene-1-methanol sulfate (2:1)

20 mg

USP1000420 Abacavir Related Compound A [4-(2,6-diamino-9H-purin-9-yl)cyclopent-2-enyl]methanol

20 mg

USP1000441 Abacavir Related Compound B [4-(2,5-diamino-6-chloropyrimidin-4-ylamino)cyclopent-2-enyl]methanol

20 mg

USP1000452 Abacavir Related Compound C [(1S,4R)-4-(2-amino-6-chloro-9H-purin-9-yl)cyclopent-2-enyl]methanol HCl

20 mg

USP1000485 Abacavir Related Compounds Mixture 15 mg

USP1000496 Abacavir Stereoisomers Mixture 15 mg

USP1000500 Abacavir System Suitability Mixture 15 mg

USP1000601 Acebutolol HCl 125 mg



Code Product Unit

USP1000612 Acebutolol Related Compound A N-(3-acetyl-4-hydroxyphenyl)butanamide (AS)

20 mg

USP1001003 Acenocoumarol 200 mg

USP1001502 Acepromazine Maleate 250 mg

USP1002505 Acesulfame Potassium 200 mg

USP1003009 Acetaminophen 400 mg

New USP1003010 Acetaminophen Related Compound A 4-(acetylamino)phenyl acetate

15 mg

USP1004001 Acetanilide Melting Point Standard (Approximately 114°C) 500 mg

USP1005004 Acetazolamide 2 g

USP1005706 Glacial Acetic Acid (AS) 3x1.5 mL

USP1006007 Acetohexamide 250 mg

USP1006506 Acetohydroxamic Acid 200 mg

USP1006801 Acetone 3x1.5 mL

USP1007000 Acetophenazine Maleate 200 mg

USP1008501 Acetylcholine Chloride 200 mg

USP1009005 Acetylcysteine 200 mg

USP1612619 N-Acetylneuraminic Acid 200 mg

USP1009901 Acetyltributyl Citrate 500 mg

USP1009923 Acetyltriethyl Citrate 500 mg

USP1010106 N-Acetyl-L-Tyrosine 100 mg

USP1011007 Acitretin 200 mg

USP1011018 Acitretin Related Compound A (2Z,4E,6E,8E)-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoic acid

20 mg

USP1011029 Acitretin Related Compound B ethyl(all-E)-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoate

20 mg

USP1012032 Actein 20 mg

USP1012065 Acyclovir 300 mg

USP1012076 Acyclovir Related Compound A 2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl acetate

50 mg

USP1012134 Ademetionine Disulfate Tosylate 500 mg

USP1012101 Adenine 200 mg

USP1012123 Adenosine 200 mg

USP1012112 S-Adenosyl-L-Homocysteine 50 mg

USP1012178 5'-Adenylic Acid 500 mg

USP1012190 Adipic Acid 100 mg

New USP1012214 Agar 500 mg

USP1012145 Agigenin 25 mg

USP1012203 Agnuside 25 mg

USP1012495 Beta Alanine 100 mg

USP1012509 L-Alanine 200 mg

USP1012553 Albendazole 200 mg

USP1012600 Albuterol 200 mg

USP1012633 Albuterol Sulfate 200 mg

USP1012644 Albuterol Related Compound A 4-[2-[(1,1-dimethylethyl)amino]-1-hydroxyethyl]-2-methylphenol sulfate

25 mg

USP1012757 Alclometasone Dipropionate 300 mg

New USP1012746 Alclometasone Dipropionate Related Compound A 11beta,17,21-trihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione 17,21-dipropionate

20 mg

USP1012768 Alcohol 5x1.2 mL

USP1012772 Dehydrated Alcohol 5x1.2 mL

USP1012699 Alcohol Determination-Acetonitrile 5x5 mL

USP1012688 Alcohol Determination-Alcohol 5x5 mL

USP1012780 Alendronate Sodium 200 mg



Code Product Unit

USP1012906 Alfentanil HCl Controlled Substance CII 500 mg

USP1012917 Alfuzosin HCl 150 mg

USP1012928 Alfuzosin System Suitability Mixture 15 mg

New USP1012848 Alitame 250 mg

USP1012939 Allantoin 200 mg

USP1012950 Alliin 25 mg

USP1013002 Allopurinol 250 mg

USP1013024 Allopurinol Related Compound A 3-Amino-4-carboxamidopyrazole Hemisulfate

50 mg

USP1013013 Allopurinol Related Compound B 5-(formylamino)-1H-pyrazole-4-carboxamide

25 mg

USP1013035 Allopurinol Related Compound C 5-(4H-1,2,4-triazol-4-yl)-1H-pyrazole-4-carboxamide

25 mg

USP1013046 Allopurinol Related Compound D ethyl 5-amino-1H-pyrazole-4-carboxylate

35 mg

USP1013068 Allopurinol Related Compound E ethyl 5-(formylamino)-1H-pyrazole-4-carboxylate

25 mg

USP1013079 Allopurinol Related Compound F ethyl-(E/Z)-3-(2-carbethoxy-2-cyanoethenyl)amino-1H-pyrazole-4-carboxylate

25 mg

USP1013057 S-Allyl-L-Cysteine 25 mg

USP1013512 Almotriptan Malate 200 mg

USP1013523 Almotriptan Related Compound A {3-[2-(Dimethylamino)ethyl]-5-[)pyrrolidine-1-yl)sulfonylmethyl]-1H-indol-1-yl}methanol

20 mg

New USP1013534 Almotriptan System Suitability Mixture of Almotriptan Malate and Almotriptan Monomethyl Analog

20 mg

USP1014005 Alphaprodine HCl Controlled Substance CII 250 mg

USP1015008 Alprazolam Controlled Substance CIV 200 mg

USP1015019 Alprazolam Related Compound A 2-(2-acetylhydrazino)-7-chloro-5-phenyl-3H-1,4-benzodiazepine

30 mg

USP1016000 Alprostadil 25 mg

USP1017105 Altretamine 500 mg

USP1017364 Aluminum Sulfate (AS) 2 g

USP1017502 Dried Aluminum Hydroxide Gel 200 mg

USP1018505 Amantadine HCl 200 mg

USP1019202 Amcinonide 200 mg

USP1019406 Amifostine 150 mg

USP1019417 Amifostine Disulfide 100 mg

New USP1019428 Amifostine Thiol 2-[(3-aminopropyl)amino]ethanethiol, dihydrochloride

50 mg

USP1019508 Amikacin 300 mg

USP1019701 Amiloride HCl 500 mg

USP1019712 Amiloride Related Compound A Methyl 3,5-diamino-6-chloropyrazine-2-carboxylate (AS)

30 mg

USP1019756 Aminobenzoate Potassium 200 mg

USP1019767 Aminobenzoate Sodium 200 mg

USP1019803 Aminobenzoic Acid p-aminobenzoic acid

200 mg

USP1020008 Aminobutanol 500 mg

USP1021000 Aminocaproic Acid 200 mg

USP1021204 4-Aminophenol 100 mg

USP1022808 2-Amino-5-chlorobenzophenone 25 mg

USP1025205 Aminoglutethimide 200 mg

USP1025307 m-Aminoglutethimide 100 mg

USP1025351 Aminohippuric Acid 200 mg

USP1025602 Amino Methacrylate Copolymer 1.5 g



Code Product Unit

USP1025806 2-[3-Amino-5-(n-methylacetamido)-2,4,6-triiodobenzamido]-2-deoxy-d-glucose 25 mg

USP1025908 Aminopentamide Sulfate 200 mg

USP1026004 m-Aminophenol 300 mg

USP1026401 Aminosalicylic Acid 125 mg

USP1026605 3-Amino-2,4,6-triiodobenzoic Acid 50 mg

USP1027007 5-Amino-2,4,6-triiodo-N-methylisophthalamic Acid 50 mg

USP1027302 Amiodarone HCl 200 mg

USP1027346 Amiodarone Related Compound D (2-butylbenzofuran-3-yl)(4-hydroxy-3,5-diiodophenyl)methanone

20 mg

USP1027357 Amiodarone Related Compound E (2-butylbenzofuran-3-yl)(4-hydroxyphenyl)methanone

25 mg

USP1027380 Amiodarone Related Compound H 2-chloro-N,N-diethylethanamine HCl

20 mg

USP1028000 Amitraz 200 mg

USP1029002 Amitriptyline HCl 200 mg

USP1029013 Amitriptyline Related Compound A Dibenzosuberone

30 mg

USP1029024 Amitriptyline Related Compound B 5-[3-(dimethylamino)propyl]-10,11-dihydro-5H-dibenzo[a,d]-cyclohepten-5-ol

25 mg

USP1029501 Amlodipine Besylate 350 mg

USP1029512 Amlodipine Related Compound A 3-Ethyl,5-methyl [2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-3,5-pyridinedicarboxylate]fumarate

25 mg

USP1029909 Ammonio Methacrylate Copolymer Type A 500 mg

USP1029910 Ammonio Methacrylate Copolymer Type B 500 mg

USP1029942 Ammonium Carbonate (AS) 2 g

USP1029953 Ammonium Chloride 200 mg

USP1029986 Ammonium Phosphate Dibasic (AS) 1 g

USP1030001 Amobarbital Controlled Substance CII 200 mg

USP1031004 Amodiaquine HCl 500 mg

USP1031401 Amoxapine 200 mg

USP1031503 Amoxicillin 200 mg

USP1031514 Amoxicillin Related Compound A (2S,5R,6R)-6-Amino-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid

15 mg

USP1031525 Amoxicillin Related Compound B L-amoxicillin

15 mg

USP1031536 Amoxicillin Related Compound C (4S)-2-[5-(4-hydroxyphenyl)-3,6-dioxopiperazin-2-yl]- 5,5-dimethylthiazolidine-4-carboxylic acid

15 mg

New USP1031547 Amoxicillin Related Compound D (4S)-2-{[(R)-2-amino-2-(4-hydroxyphenyl)acetamido](carboxy)methyl}-5,5-dimethylthiazolidine-4-carboxylic acid, monosodium salt

50 mg

New USP1031558 Amoxicillin Related Compounds D and E Mixture 15 mg

New USP1031569 Amoxicillin Related Compound F 3-(4-Hydroxyphenyl)pyrazin-2-ol; phenylpyrazinediol

15 mg

New USP1031570 Amoxicillin Related Compound G (2S,5R,6R)-6-{(R)-2-[(R)-2-Amino-2-(4-hydroxyphenyl)acetamido]-2-(4-hydroxyphenyl)acetamido}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; D-hydroxyphenylglycylamoxicillin

15 mg

USP1031591 Amoxicillin Related Compound I (R)-2-Amino-2-(4-hydroxyphenyl)acetic acid

15 mg

New USP1031605 Amoxicillin Related Compound J Mixture of amoxicillin and amoxicillin related compound J (open ring dimer)

15 mg

USP1032007 Amphotericin B 125 mg

USP1033000 Ampicillin 200 mg

USP1033203 Ampicillin Sodium 125 mg

USP1033407 Ampicillin Trihydrate 200 mg



Code Product Unit

USP1034002 Amprolium 200 mg

USP1034308 Amrinone (Inamrinone) 500 mg

USP1034320 Amrinone Related Compound A 5-carboxamide[3,4'-bipyridin]-6(1H)-one (Inamrinone Related Compound A)

100 mg

USP1034341 Amrinone Related Compound B N-(1,6-dihydro-6-oxo-(3,4'-bipyridine)-5-yl)-2-hydroxypropanamide (Inamrinone Related Compound B)

100 mg

USP1034363 Amrinone Related Compound C 1,6-dihydro-6-oxo-(3,4'-bipyridine)-5-carbonitrile (Inamrinone Related Compound C)

50 mg

New USP1034738 Anagrelide HCl 100 mg

New USP1034749 Anagrelide Related Compound A ethyl 2-(6-amino-2,3-dichlorobenzylamino)acetate

25 mg

New USP1034750 Anagrelide Related Compound B (2-amino-5,6-dichloroquinazolin-3(4H)-yl)acetic acid

25 mg

New USP1034771 Anagrelide Related Compound C Ethyl 2-(5,6-dichloro-2-imino-1,2-dihydroquinazolin-3(4H)-yl)acetate

25 mg

USP1034807 Anastrozole 200 mg

USP1034818 Anastrozole Related Compound A 2,2'-(5-methyl-1,3-phenylene)bis(2-methylpropanenitrile)

20 mg

USP1034862 Andrographolide 50 mg

USP1034873 Powdered Andrographis Extract 500 mg

USP1034909 Anecortave Acetate 200 mg

USP1034910 Anecortave Acetate Related Compound A 9(11)-dehydrocortisol

20 mg

USP1035005 Anethole (AS) 2 mL

USP1035300 1,6-Anhydro-D-glucose 50 mg

USP1036008 Anileridine HCl Controlled Substance CII 250 mg

USP1036507 3-Anilino-2-(3,4,5-trimethoxybenzyl)acrylonitrile (AS) 25 mg

USP1037011 Anisole 3x1.2 mL

USP1038003 Antazoline Phosphate 200 mg

USP1039006 Anthralin 200 mg

USP1040005 Antipyrine 200 mg

USP1040683 Apigenin 30 mg

USP1040708 Apigenin-7-glucoside 30 mg

USP1041008 Apomorphine HCl 250 mg

USP1041609 Apraclonidine HCl 100 mg

New USP1041904 Aprepitant 50 mg

New USP1041915 Aprepitant Related Compound A 3-[[(2R,3R)-2-[(R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholino]methyl]-1H-1,2,4-triazol-5(4H)-one

10 mg

New USP1041926 Aprepitant Related Compound B 3-[[(2S,3R)-2-[(S)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholino]methyl-1H-1,2,4-triazol-5(4H)-one

10 mg

USP1042102 L-Arabinitol 500 mg

USP1042500 L-Arginine 200 mg

New USP1042554 Arginine Ethyl Ester Dihydrochloride 250 mg

USP1042601 Arginine HCl 125 mg

USP1042703 Arsanilic Acid 25 mg

USP1042780 Artemether 100 mg

USP1042791 Artemether Related Compound A (3R,5aS,6R,8aS,9R,12R,12aR)-Decahydro-10-hydroxy-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin

15 mg

USP1042805 Artemether Related Compound B (3R,5aS,6R,8aS,9R,10R,12R,12aR)-Decahydro-10-methoxy-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin

15 mg

USP1042850 Artesunate 200 mg

USP1042907 Articaine 40 mg



Code Product Unit

USP1042918 Articaine HCl 125 mg

USP1042929 Articaine Related Compound A Methyl 4-methyl-3-[2-propylamino) acetamido)thiophene-2-carboxylate

40 mg

New USP1042930 Articaine Related Compound B 4-methyl-3-{[2-(propylamino)propanoy]amino}thiophene-2-carboxylic acid

25 mg

USP1042962 Articaine Related Compound E Methyl 3-[2-(isopropylamino)propanamido]-4-methylthiophene-2-carboxylate

40 mg

USP1043003 Ascorbic Acid (Vitamin C) 1 g

USP1043105 Ascorbyl Palmitate (AS) 2 g

USP1043309 Powdered Ashwagandha Extract 1 g

New USP1043331 Asiaticoside 30 mg

USP1043502 Asparagine Anhydrous 200 mg

USP1043513 Asparagine Monohydrate 200 mg

USP1043706 Aspartame 200 mg

USP1043750 Aspartame Acesulfame 200 mg

USP1043728 Aspartame Related Compound A 5-Benzyl-3,6-dioxo-2-piperazineacetic Acid

25 mg

USP1043819 Aspartic Acid 100 mg

USP1044006 Aspirin 500 mg

USP1044301 Astemizole 200 mg

USP1044403 Atenolol 200 mg

New USP1044469 Atomoxetine HCl 100 mg

New USP1044470 Atomoxetine Related Compound A 3-(Methylamino)-1-phenylpropan-1ol

10 mg

USP1044488 Atomoxetine Related Compound B N-Methyl-3-phenyl-3-(m-tolyloxy)propan-1-amine HCl

10 mg

New USP1044491 Atomoxetine Related Compound C N-methyl-3-phenyl-3-(p-tolyloxy)propan-1-amine HCl

10 mg

New USP1044913 Atomoxetine S-Isomer (S)-N-Methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine HCl

10 mg

USP1044516 Atorvastatin Calcium 100 mg

USP1044527 Atorvastatin Related Compound A Desfluoro impurity, or (3R,5R)-7-[3-(phenylcarbamoyl)-2-isopropyl-4,5-diphenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid calcium salt

20 mg

USP1044538 Atorvastatin Related Compound B 3S,5R isomer,or (3S,5R)-7-[3-(phenylcarbamoyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid calcium salt

20 mg

USP1044549 Atorvastatin Related Compound C Difluoro impurity, or (3R,5R)-7-[3-(phenylcarbamoyl)-4,5-bis(4-fluorophenyl)-2-isopropyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptcnoic acid calcium salt

20 mg

USP1044550 Atorvastatin Related Compound D Epoxide impurity, or 3-(4-Fluorobenzoyl)-2-isobutyryl-3-phenyl-oxirane-2-carboxylic acid phenylamide

20 mg

USP1044571 Atorvastatin Related Compound E 3S,5S enantiomer of Atorvastatin Calcium

10 mg

New USP1044582 Atorvastatin Related Compound H 5-(4-Fluorophenyl)-1-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-2-isopropyl-N,4-diphenyl-1H-pyrrole-3-carboxamide

20 mg

USP1044593 Atorvastatin Related Compound I tert-Butyl 2-((4R,6R)-6-{2-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-phenylcarbamoyl)-1H-pyrrol-1-yl)]ethyl}-2,2-dimetyl-1,3-dioxan-4-yl)acetate

20 mg

USP1044651 Atovaquone 200 mg

USP1044662 Atovaquone Related Compound A cis-2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone

25 mg

USP1044800 Atracurium Besylate 100 mg

USP1045009 Atropine Sulfate 500 mg

USP1045508 Aurothioglucose 100 mg

USP1045337 Avobenzone 500 mg



Code Product Unit

USP1045600 Azaerythromycin A 9-Deoxo-9a-aza-9a-homoerythromycin A

100 mg

USP1045756 Azaperone 200 mg

USP1045803 Azatadine Maleate 200 mg

USP1046001 Azathioprine 200 mg

USP1046056 Azithromycin 100 mg

USP1046067 Azithromycin Identity 75 mg

New USP1046012 Azithromycin Identification Mixture 75 mg

USP1046090 Azithromycin N-Oxide 15 mg

USP1046045 Azithromycin Related Compound F 3'-N-demethyl-3'-N-formylazithromycin

25 mg

New USP1046023 Azithromycin Related Compound H 3'-N-[[4-(acetylamino)phenyl]sulfonyl]-3'-N-demethylazithromycin

15 mg

USP1046147 Azo-Aminoglutethimide 100 mg

USP1046205 Aztreonam 200 mg

USP1046307 Aztreonam E-Isomer 50 mg

USP1046409 Open Ring Aztreonam 15 mg

USP1047300 Bacampicillin HCl 200 mg

USP1047503 Bacitracin AS (Susceptibility disk standard) 1 g

USP1048007 Bacitracin Zinc 200 mg

USP1048200 Baclofen 350 mg

USP1048222 Baclofen Related Compound A 4-(4-Chlorophenyl)-2-pyrrolidinone

50 mg

New USP1048244 Powdered Bacopa Extract 500 mg

New USP1048233 Bacoside A3 15 mg

USP1048255 Balsalazide Disodium 200 mg

USP1048266 Balsalazide Related Compound A (E)-5-[(p-carboxyphenyl)azo]-2-salicylic acid, disodium salt

100 mg

USP1048277 Balsalazide Related Compound B (E)-5-((m-[(2-carboxyethyl)carbamoyl]phenyl)azo)-2-salicylic acid

25 mg

USP1048506 Beclomethasone Dipropionate 200 mg

USP1048550 Behenoyl Polyoxylglycerides 500 mg

USP1048572 Bemotrizinol 200 mg

USP1048583 Bemotrizinol Impurity Mixture 100 mg

USP1048619 Benazepril HCl 125 mg

USP1048620 Benazepril Related Compound A (3R)-3-[[(1R)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-1H-1-benazapine-1-acetic acid, monohydrochloride

15 mg

USP1048630 Benazepril Related Compound B (3S)-3-[[(1R)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-1H-1-benazapine-1-acetic acid, monohydrochloride

15 mg

USP1048641 Benazepril Related Compound C (3S)-3-[[(1S)-1-(carboxy)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-1H-1-benazepine]-1-acetic acid

50 mg

USP1048652 Benazepril Related Compound D 3-(1-Ethoxycarbonyl-3-cyclohexyl-(1S)-propyl)amino-2,3,4,5-tetrahydro-2-oxo-1H-1-(3S)-benzazepine-1-acetic acid monohydrochloride

15 mg

USP1048663 Benazepril Related Compound E 3-amino-2,3,4,5-tetrahydro-2-oxo-1H-1-(3S)-benzazepine-1-acetic acid, monohydrochloride

25 mg

USP1048674 Benazepril Related Compound F 3-Amino-2,3,4,5-tetrahydro-2-oxo-1H-1-(3S)-benzazepine-1-acetic acid, tert-butyl ester

15 mg

USP1048685 Benazepril Related Compound G 3-(1-Ethoxycarbonyl-3-phenyl-(1S)-propyl)amino-2,3,4,5-tetrahydro-2-oxo-1H-1-(3S)-benzazepine-1-acetic acid, ethyl ester

15 mg

USP1049000 Bendroflumethiazide 200 mg

USP1050009 Benoxinate HCl 200 mg

USP1050905 Benzaldehyde 2x1 mL



Code Product Unit

USP1051001 Benzalkonium Chloride 5 mL

USP1051500 Benzethonium Chloride 500 mg

USP1054000 Benzocaine 500 mg

USP1055002 Benzoic Acid 300 mg

USP1056005 Benzonatate 1 g

USP1056504 1,4-Benzoquinone 200 mg

USP1057507 Benzothiadiazine Related Compound A 4-Amino-6-chloro-1,3-benzenedisulfonamide

100 mg

USP1059003 Benzphetamine HCl Controlled Substance CIII 200 mg

USP1061005 Benztropine Mesylate 200 mg

USP1061901 Benzyl Alcohol 500 mg

USP1062008 Benzyl Benzoate 5 g

USP1064003 1-Benzyl-3-methyl-5-aminopyrazole HCl 25 mg

USP1065006 Bephenium Hydroxynaphthoate 500 mg

USP1065210 Berberine Chloride 50 mg

New USP1048288 Beta Glucan Beta Glucan from Baker's Yeast Saccharomyces cerevisiae

1 g

USP1065618 Betahistine HCl 200 mg

USP1065695 Betaine 1 g

USP1065709 Betaine HCl 200 mg

USP1066009 Betamethasone 200 mg

USP1067001 Betamethasone Acetate 500 mg

USP1067307 Betamethasone Benzoate 200 mg

USP1067704 Betamethasone Dipropionate 125 mg

USP1068004 Betamethasone Sodium Phosphate 500 mg

USP1069007 Betamethasone Valerate 200 mg

USP1069018 Betamethasone Valerate Related Compound A Betamethasone 21-valerate (AS)

50 mg

USP1069903 Betaxolol HCl 200 mg

USP1070006 Betazole HCl 200 mg

USP1071009 Bethanechol Chloride 200 mg

USP1071202 Bicalutamide 200 mg

USP1071213 Bicalutamide Related Compound A N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfinyl]-2-hydroxy-2- methyl-propanamide

25 mg

USP1071224 Bicalutamide Related Compound B (RS)-N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(3-fluorophenylsulfonyl)- 2-hydroxy-2-methylpropanamide

10 mg

USP1071268 Powdered Bilberry Extract 500 mg

USP1071304 Bile Salts 10 g

USP1071439 Positive Bioreaction 3 strips

USP1071508 Biotin 200 mg

USP1072001 Biperiden 200 mg

USP1073004 Biperiden HCl 200 mg

USP1074007 Bisacodyl 125 mg

New USP1074030 Bisacodyl Related Compound A 4,4'-(Pyridin-2-ylmethylene)diphenol

20 mg

New USP1074042 Bisacodyl Related Compound B 2,4'-(Pyridin-2-ylmethylene)diphenol

20 mg

New USP1074051 Bisacodyl Related Compound C 4-[(4-Hydroxyphenyl)(pyridin)-2-yl)methyl]phenyl acetate

20 mg

New USP1074073 Bisacodyl Related Compound E 2-[(4-Acetoxyphenyl)(pyridin-2-yl)methyl]phenyl acetate

20 mg

USP1074700 2,5-Bis-(D-arabino-1,2,3,4-tetrahydroxybutyl)pyrazine 25 mg



Code Product Unit

USP1075203 Bis(2-ethylhexyl)maleate 2 mL

USP1075305 Bisdesmethoxycurcumin 30 mg

USP1075509 p-Bis(di-n-propyl)carbamylbenzenesulfonamide 50 mg

USP1075531 Bismuth Citrate 100 mg

USP1075600 Bismuth Subcarbonate (AS) 1 g

USP1075622 Bismuth Subgallate (AS) 2 g

USP1075644 Bismuth Subnitrate (AS) 1.5 g

USP1075553 Bismuth Subsalicylate 100 mg

USP1075677 Bisoctrizole 200 mg

USP1075688 Bisoctrizole Related Compound A 2-(2H-Benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl) phenol

25 mg

USP1075699 Bisoctrizole Resolution Mixture 50 mg

USP1075757 Bisoprolol Fumarate 200 mg

USP1076206 Powdered Black Cohosh Extract 1.5 g

USP1076308 Bleomycin Sulfate 15 mg

USP1076341 Boric Acid (AS) 1 g

USP1076250 Boswellia Serrata Extract 1 g

USP1076261 3-Acetyl-11-Keto-Beta-Boswellic Acid 20 mg

USP1076352 Bretylium Tosylate 200 mg

USP1076363 Brinzolamide 200 mg

USP1076374 Brinzolamide Related Compound A (S)-(-)-4-ethylamino-2,3-dihydro-2-(3-methoxypropyl)-4H-thieno-[3,2,e]-thiazine-6-sulfonamide-1,1-dioxide

50 mg

USP1076385 Brinzolamide Related Compound B (R)-4-amino-2,3-dihydro-2-(3-methoxypropyl)-4H-thieno-[3,2,e]-thiazine-6-sulfonamide-1,1-dioxide ethanedioate

50 mg

USP1076465 Bromazepam (AS) Controlled Substance CIV 100 mg

USP1076501 Bromocriptine Mesylate 150 mg

USP1077005 Bromodiphenhydramine HCl 200 mg

USP1077708 8-Bromotheophylline 400 mg

USP1077887 Bromperidol Decanoate 15 mg

USP1078008 Brompheniramine Maleate 125 mg

USP1078201 Budesonide 200 mg

USP1078303 Bumetanide 250 mg

USP1078325 Bumetanide Related Compound A 3-Amino-4-phenoxy-5-sulfamoylbenzoic Acid

10 mg

USP1078336 Bumetanide Related Compound B 3-Nitro-4-phenoxy-5-sulfamoylbenzoic Acid

25 mg

USP1078507 Bupivacaine HCl 500 mg

USP1078518 Bupivacaine Related Compound A 6-(butylamino)-N-(2,6-dimethylphenyl)hexanamide (AS)

50 mg

USP1078529 Bupivacaine Related Compound B (2RS)-N-(2,6-dimethylphenyl)piperidine-2-carboxamide (AS)

50 mg

USP1078700 Buprenorphine HCl Controlled Substance CIII 50 mg

USP1078711 Buprenorphine Related Compound A 21-[3-(1-propenyl)]7-alpha-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine Controlled Substance CII

25 mg

USP1078733 Bupropion HCl 200 mg

USP1078744 Bupropion HCl Related Compound A 2-(tert-butylamino)-4'-chloropropiophenone hydrochloride

15 mg

USP1078755 Bupropion HCl Related Compound B 2-(tert-butylamino)-3'-bromopropiophenone hydrochloride

15 mg

USP1078766 Bupropion HCl Related Compound C 1-(3-chlorophenyl)-2-hydroxy-1-propanone

40 mg

USP1078799 Bupropion HCl Related Compound F 1-(3-chlorophenyl)-1-hydroxy-2-propanone

30 mg



Code Product Unit

USP1078802 Buspirone HCl 200 mg

USP1079000 Butabarbital Controlled Substance CIII 200 mg

USP1080000 Butacaine Sulfate 600 mg

USP1081002 Butalbital Controlled Substance CIII 200 mg

USP1081501 Butamben 200 mg

USP1081807 1-Butanol 3x1.2 mL

USP1081829 2-Butanol 3x1.2 mL

USP1082300 Butoconazole Nitrate 200 mg

USP1082504 Butorphanol Tartrate Controlled Substance CIV 350 mg

USP1082606 Butyl Acetate 3x1.2 mL

USP1082708 Butylated Hydroxytoluene 500 mg

USP1082901 Butyl 3-(butylamino)-4-phenoxy-5-sulfamoylbenzoate 25 mg

USP1083008 2-tert-Butyl-4-hydroxyanisole 200 mg

USP1083100 3-tert-Butyl-4-hydroxyanisole 200 mg

USP1083303 tert-Butylmethyl ether 3x1.2 mL

USP1084000 Butylparaben 200 mg

USP1065550 Betadex Sulfobutyl Ether Sodium 500 mg

USP1084306 Cabergoline 125 mg

USP1085003 Caffeine 200 mg

USP1086006 Caffeine Melting Point Standard (Approximately 236°C) 1 g

USP1086108 Calcifediol 75 mg

New USP1086200 Calcitonin Salmon 20 mg

New USP1086210 Calcitonin Salmon Related Compound A N-acetyl-Cys(1)-calcitonin salmon

20 mg

USP1086301 Calcitriol 10 mg

USP1086312 Calcitriol Solution 5 mL

USP1086334 Calcium Acetate (AS) 1 g

USP1086356 Calcium Ascorbate 200 mg

New USP1086378 Calcium Benzoate 200 mg

USP1086403 Calcium Carbonate (AS) 1 g

USP1086436 Calcium Chloride (AS) 1 g

New USP1086447 Calcium Cyclamate 200 mg

USP1086800 Calcium Gluceptate 200 mg

USP1086855 Calcium Hydroxide (AS) 1 g

New USP1086866 Calcium(-)-Hydroxycitrate 150 mg

USP1086888 Calcium Lactate 1 g

USP1086902 Calcium Lactobionate 200 mg

USP1086935 Calcium Levulinate (AS) 1 g

USP1087009 Calcium Pantothenate (Vitamin B5) 200 mg

USP1087031 Tribasic Calcium Phosphate (AS) 1 g

USP1087202 Calcium Saccharate 200 mg

USP1087359 Calcium Stearate (AS) 2 g

USP1087406 Calcium Sulfate (AS) 1 g

USP1087508 Camphor 1 g

USP1087701 Candelilla Wax 250 mg

New USP1087803 Candesartan Cilexetil 100 mg

USP1088001 Candicidin 200 mg

USP1090706 Capecitabine 200 mg

USP1090717 Capecitabine Related Compound A 5'-deoxy-5-fluorocytidine

10 mg

USP1090728 Capecitabine Related Compound B 5'-deoxy-5-fluorouridine

20 mg



Code Product Unit

USP1090739 Capecitabine Related Compound C 2',3'-O-carbonyl-5'-deoxy-5-fluoro-N4-(pentyloxycarbonyl) cytidine

20 mg

USP1091006 Capreomycin Sulfate 250 mg

USP1091040 Caprylic Acid 300 mg

USP1091505 Caprylocaproyl Polyoxylglycerides 200 mg

USP1091108 Capsaicin 100 mg

USP1091200 Captopril 200 mg

USP1091221 Captopril Disulfide 100 mg

USP1092009 Carbachol 200 mg

USP1093001 Carbamazepine (CRM) 100 mg

USP1093012 Carbamazepine Related Compound A 10,11-dihydrocarbamazepine

50 mg

USP1093023 Carbamazepine Related Compound B Iminostilbene

50 mg

USP1093205 Carbarsone 200 mg

USP1093500 Carbenicillin Indanyl Sodium 300 mg

USP1094004 Carbenicillin Monosodium Monohydrate 200 mg

USP1095506 Carbidopa 400 mg

USP1095517 Carbidopa Related Compound A 3-O-Methylcarbidopa

25 mg

USP1096000 Carbinoxamine Maleate 200 mg

USP1096407 Carboplatin 100 mg

USP1096509 Carboprost Tromethamine 25 mg

USP1096531 Carboxymethylcellulose Calcium (AS) 1.5 g

USP1096553 Carboxymethylcellulose Sodium 1.5 g

USP1096600 Carisoprodol 1 g

USP1096611 Carmellose 500 mg

USP1096724 Carmustine 75 mg

USP1096735 Carmustine Related Compound A 1,3-bis(2-chloroethyl)urea

10 mg

USP1096699 Carprofen 200 mg

USP1096702 Carprofen Related Compound A Carbazole

50 mg

USP1096757 Carteolol HCl 200 mg

USP1096622 Carvedilol 200 mg

USP1096633 Carvedilol Related Compound A 1-(4-(2-hydroxy-3-(2-(2-methoxyphenoxy)ethylamino)propoxy)-9H-carbazol-9-yl)-3-(2-(2-methoxyphenoxy)ethylamino)propan-2-ol

15 mg

USP1096644 Carvedilol Related Compound B 3,3'-(2-(2-methoxyphenoxy)ethylazanediyl)bis(1-(9H-carbazol-4-yloxy)propan-2-ol)

15 mg

USP1096655 Carvedilol Related Compound C 1-(9H-Carbazol-4-yloxy)-3-(benzyl(2-(2-methoxyphenoxy)ethyl)amino)propan-2-ol

20 mg

USP1096666 Carvedilol Related Compound D 4-(Oxiran-2-ylmethoxy)-9H-carbazole

15 mg

USP1096677 Carvedilol Related Compound E 2-(2-methoxyphenoxy)ethylamine

15 mg

USP1096688 Carvedilol System Suitability Mixture carvedilol spiked with carvedilol related compound F

25 mg

USP1096779 Casticin 25 mg

USP1096790 (+)-Catechin 25 mg

USP1096804 Cathinone HCl alpha-Aminopropiophenone HCl Controlled Substance CI

50 mg

USP1096848 Powdered Cat's Claw Extract 1 g

USP1096906 Cefaclor 400 mg

USP1096917 Cefaclor, Delta-3-Isomer 30 mg

USP1097104 Cefadroxil 200 mg



Code Product Unit

USP1097308 Cefamandole Lithium 200 mg

USP1097400 Cefamandole Nafate 250 mg

USP1097603 Cefazolin 400 mg

USP1097614 Cefdinir 200 mg

USP1097625 Cefdinir Related Compound A 2(R)-2-[(Z)-2-(2-aminothiazol-4-yl)-2-(hydroxyimino)acetamido]-2-[(2RS,5RS)-5-methyl-7-oxo-2,4,5,7-tetrahydro-1H-furo[3,4-d][1,3]thiazin-2-yl]acetic acid

10 mg

USP1097589 Cefdinir Related Compound B (6R,7R)-7-[2-(2-amino-4-thiazolyl)acetamido]-8-oxo-3-vinyl-5-thia-1-azabicyclo[4,2,0]-oct-2-ene-2-carboxylic acid

10 mg

USP1097590 Cefditoren Pivoxil 350 mg

USP1097636 Cefepime HCl 500 mg

USP1097647 Cefepime HCl System Suitability 25 mg

USP1097658 Cefixime 500 mg

USP1097771 Cefmenoxime HCl 350 mg

USP1097782 Cefmetazole 200 mg

USP1097750 Cefonicid Sodium 1 g

USP1097705 Cefoperazone Dihydrate 200 mg

USP1097807 Ceforanide 200 mg

USP1097909 Cefotaxime Sodium 350 mg

USP1097975 Cefotetan 500 mg

USP1098005 Cefotiam HCl 325 mg

USP1098107 Cefoxitin 500 mg

USP1098118 Cefpiramide 300 mg

USP1098027 Cefpodoxime Proxetil 350 mg

USP1098049 Cefprozil (E)-Isomer 50 mg

USP1098050 Cefprozil (Z)-Isomer 200 mg

USP1098129 Ceftazidime, Delta-3-Isomer 10 mg

USP1098130 Ceftazidime Pentahydrate 300 mg

USP1098082 Ceftiofur Sodium 100 mg

USP1098173 Ceftizoxime 350 mg

USP1098184 Ceftriaxone Sodium 350 mg

USP1098195 Ceftriaxone Sodium E-Isomer 25 mg

USP1098209 Cefuroxime Sodium 200 mg

USP1098220 Cefuroxime Axetil 500 mg

USP1098231 Cefuroxime Axetil Delta-3-Isomers 15 mg

USP1098322 Cellaburate (Cellulose Acetate Butyrate) 350 mg

USP1098355 Cellacefate (Cellulose Acetate Phthalate) 125 mg

USP1098300 Cellulose Acetate 125 mg

USP1098388 Microcystalline Cellulose (AS) 1 g

USP1098399 Silicified Microcystalline Cellulose 1 g

USP1098402 Powdered Cellulose (AS) 1 g

New USP1297770 Powdered Centella Asiatica Extract 1 g

USP1098708 Cephaeline HBr 200 mg

USP1099008 Cephalexin 400 mg

USP1102000 Cephalothin Sodium 200 mg

USP1102408 Cephapirin Benzathine 100 mg

USP1102500 Cephapirin Sodium 500 mg

USP1102805 Cephradine 200 mg

USP1102929 Cetirizine Hydrochloride 250 mg

USP1102930 Cetirizine Related Compound A (RS)-2-[2-[4-[(4-chlorophenyl)phenylmethyl]piperazin-1-yl]ethoxy]acetic acid ethyl ester

20 mg

USP1102974 Cetrimonium Bromide 1 g



Code Product Unit

USP1103003 Cetyl Alcohol 100 mg

USP1103105 Cetyl Palmitate 50 mg

USP1104006 Cetylpyridinium Chloride 500 mg

USP1105009 Powdered Chaste Tree Extract 1.5 g

New USP1105508 Chitosan 500 mg

USP1107004 Chloramphenicol 200 mg

USP1107300 Chloramphenicol Palmitate 200 mg

USP1107401 Chloramphenicol Palmitate Nonpolymorph A 200 mg

USP1107503 Chloramphenicol Palmitate Polymorph A 100 mg

USP1109000 Chlordiazepoxide Controlled Substance CIV 200 mg

USP1110009 Chlordiazepoxide HCl Controlled Substance CIV 200 mg

USP1110020 Chlordiazepoxide Related Compound A 7-Chloro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one 4-Oxide

25 mg

USP1111001 Chlorhexidine 200 mg

USP1111103 Chlorhexidine Acetate 200 mg

USP1111307 Chlorhexidine Related Compounds 50 mg

USP1111908 p-Chloroaniline 200 mg

USP1112503 Chlorobutanol 200 mg

USP1115545 Chlorogenic Acid 50 mg

USP1115556 β-Chlorogenin 20 mg

New USP1115705 Chloromethyl Isopropyl Carbonate 100 mg

USP1117008 Chloroprocaine HCl 200 mg

USP1118000 Chloroquine Phosphate 500 mg

New USP1118317 Chloroquine Sulfate 500 mg

USP1118328 Chloroquine Related Compound A 4,7-dichloroquinoline

25 mg

USP1121005 Chlorothiazide 200 mg

USP1122700 Chloroxylenol 125 mg

USP1122722 Chloroxylenol Related Compound A 2-chloro-3,5-dimethylphenol

25 mg

USP1123000 Chlorpheniramine Maleate 125 mg

USP1123102 Chlorpheniramine Maleate Extended-Release Tablets Drug Release Calibrator, Single Unit

60 tablets

USP1124003 Chlorphenoxamine HCl 200 mg

USP1125006 Chlorpromazine HCl 200 mg

USP1126009 Chlorpropamide 200 mg

USP1129007 Chlortetracycline HCl 200 mg

USP1130006 Chlorthalidone 200 mg

USP1119309 Chlorthalidone Related Compound A 4'-Chloro-3'-sulfamoyl-2-benzophenone Carboxylic Acid

10 mg

USP1130505 Chlorzoxazone 350 mg

USP1130527 Chlorzoxazone Related Compound A 2-Amino-4-chlorophenol

50 mg

USP1131009 Cholecalciferol (Vitamin D3) 5x30 mg

USP1131803 Delta-4,6-cholestadienol 30 mg

USP1132001 Cholesteryl Caprylate 200 mg

USP1133004 Cholestyramine Resin 500 mg

USP1133503 Cholic Acid (AS) 2 g

USP1133536 Choline Bitartrate 200 mg

USP1133547 Choline Chloride 200 mg

USP1133570 Chondroitin Sulfate Sodium 300 mg

USP1133580 Oversulfated Chondroitin Sulfate 10 mg

USP1133638 Chromium Picolinate 100 mg



Code Product Unit

USP1134007 Chymotrypsin 300 mg

USP1134018 Ciclopirox 50 mg

USP1134030 Ciclopirox Olamine 125 mg

USP1134029 Ciclopirox Related Compound A 3-Cyclohexyl-4,5-dihydro-5-methyl-5-isoxayzolyl acetic acid

25 mg

USP1134040 Ciclopirox Related Compound B 6-Cyclohexyl-4-methyl-2-pyrone

25 mg

New USP1134084 Ciclopirox Related Compound C 6-Cyclohexyl-4-metylpyridin-2(1H)-one

10 mg

USP1134051 Cilistatin Ammonium Salt 100 mg

USP1134153 Cilostazol 200 mg

USP1134164 Cilostazol Related Compound A 6-hydroxy-3,4-dihydro-1H-quinolin-2-one

50 mg

USP1134175 Cilostazol Related Compound B 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-1H-quinolin-2-one

50 mg

USP1134186 Cilostazol Related Compound C 1-(4-(5-Cyclohexyl-1H-tetrazol-1-yl)butyl)-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one

50 mg

USP1134062 Cimetidine 200 mg

USP1134073 Cimetidine HCl 200 mg

USP1134109 Cinoxacin 200 mg

USP1134313 Ciprofloxacin 200 mg

USP1134324 Ciprofloxacin Ethylenediamine Analog 1-Cyclopropyl-6-fluoro-1, 4-dihydro-4-oxo-7-[(2-aminoethyl)-amino]-3-quinoline-carboxylic acid hydrochloride

25 mg

USP1134459 Ciprofloxacin Formamide 125 mg

USP1134335 Ciprofloxacin HCl 400 mg

USP1134346 Ciprofloxacin Related Compound A 7-Chloro-1-cyclopropyl-4-oxo-6-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid hydrochloride salt (AS)

25 mg

USP1134120 Cisapride 200 mg

USP1134357 Cisplatin 100 mg

USP1134233 Citalopram HBr 200 mg

USP1134142 R-Citalopram Oxalate R-(-)-1-[3-(dimethylamino)propyl]-1-(p-fluorophenyl)-5-phthalancarbonitrile oxalate

10 mg

USP1134244 Citalopram Related Compound A 1-(3-(dimethyl)propyl)-1-(4'-fluorophenyl)-1,3-dihydroisobenzofuran-5-carboxamide

25 mg

USP1134255 Citalopram Related Compound B 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3-hydroxy-1,3-dihydroisobenzofuran-5-carbonitrile oxylate

25 mg

USP1134266 Citalopram Related Compound C 3-[3-(dimethylamino)-1-propyl](4-fluorophenyl)-6-cyano-1(3H)-isobenzofuranone oxalate

25 mg

USP1134277 Citalopram Related Compound D 1-(4'-fluorophenyl)-1-(3-(methylamino)propyl)-1,3-dihydroisobenzofuran-5-carbonitrile hydrochloride

15 mg

USP1134288 Citalopram Related Compound E 1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile-N-oxide hydrochloride

25 mg

USP1134299 Citalopram Related Compound F dimethyl-(1-methyl-3,3-diphenyl-allyl)-amine hydrochloride

200 mg

USP1134197 Citalopram Related Compound G 1-(4'-fluorophenyl)-1-(3-dimethylaminopropyl)-5-chlorophthalane hydrobromide

25 mg

USP1134222 Citalopram Related Compound H 1-(4'-fluorophenyl)-1-(3-dimethylaminopropyl)-5-bromophthalane hydrobromide

25 mg

USP1134368 Citric Acid 200 mg

USP1134200 Cladribine 200 mg

USP1134211 Cladribine Related Compound A 2-methoxy-2'-deoxyadenosine

20 mg

USP1134379 Clarithromycin 100 mg



Code Product Unit

USP1134390 Clarithromycin Identity 20 mg

USP1134380 Clarithromycin Related Compound A 6,11-di-O-methylerythromycin A

50 mg

USP1134619 Clarithromycin Impurity D N-desmethyl clarithromycin

10 mg

USP1134620 Clarithromycin Impurity H N-formyl clarithromycin

10 mg

USP1134631 Clarithromycin Impurity Q N-oxide clarithromycin

10 mg

USP1134642 Clarithromycin Impurity R N-desmethyl erythromycin A

10 mg

USP1134404 Clavam-2-carboxylate Potassium 3.5 µg

USP1134426 Clavulanate Lithium 200 mg

USP1134506 Clemastine Fumarate 250 mg

USP1134674 Clenbuterol HCl 100 mg

USP1134696 Clenbuterol Related Compound B 1-(4-amino-3,5-dichlorophenyl)-2-tert-butylaminoethanone HCl

10 mg

USP1135000 Clidinium Bromide 500 mg

USP1135021 Clidinium Bromide Related Compound A 3-Hydroxy-1-methylquinuclidinium Bromide

250 mg

USP1135600 Climbazole 400 mg

USP1136002 Clindamycin HCl 200 mg

USP1137005 Clindamycin Palmitate HCl 500 mg

USP1138008 Clindamycin Phosphate 250 mg

USP1138201 Clioquinol 500 mg

USP1138405 Clobetasol Propionate 200 mg

USP1138427 Clobetasol Propionate Related Compound A 9-alpha-fluoro-11-beta-hydroxy-16-beta-methyl-3-oxo-androsta-1,4-diene-17(R)-spiro-2'- [4'-chloro-5'-ethylfuran-3'(2'H)-one]

50 mg

USP1138507 Clocortolone Pivalate 200 mg

USP1138904 Clofazimine 200 mg

USP1139000 Clofibrate 1 g

USP1140000 Clomiphene Citrate 500 mg

USP1140101 Clomiphene Related Compound A (E,Z)-2-[4-(1,2-diphenylethenyl)phenoxy]-N,N-diethylethanamine hydrochloride

100 mg

USP1140247 Clomipramine HCl 200 mg

USP1140305 Clonazepam Controlled Substance CIV 200 mg

USP1140327 Clonazepam Related Compound A 3-Amino-4-(2-chlorophenyl)-6-nitrocarbostyril

25 mg

USP1140338 Clonazepam Related Compound B 2-Amino-2'-chloro-5-nitrobenzophenone

25 mg

USP1140349 Clonazepam Related Compound C 2-Bromo-2'-(2-chlorobenzoyl)-4'-nitroacetanilide

25 mg

USP1140393 Clonidine 200 mg

USP1140407 Clonidine HCl 200 mg

USP1140418 Clonidine Related Compound A Acetylclonidine

25 mg

USP1140429 Clonidine Related Compound B 2-[(E)-2,6-Dichlorophenylimino]-1-(1-{2-[(E)-2,6-dichlorophenylimino]-imidazolidin-1-yl}-ethyl)-imidazolidine

25 mg

USP1140430 Clopidogrel Bisulfate 125 mg

USP1140586 Clopidogrel Related Compound A (S)-(o-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5-(4H)- acetic acid, hydrochloride

20 mg

USP1140597 Clopidogrel Related Compound B (Methyl(+/-)-(o-chlorophenyl)-4,5-dihydrothienol[2,3-c]pyridine-6(7H)-acetate, hydrochloride

20 mg



Code Product Unit

USP1140600 Clopidogrel Related Compound C methyl(-)-(R)-(o-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)- acetate,hydrogen sulfate

20 mg

USP1140666 Cloprostenol Sodium 400 mg

USP1140509 Clorazepate Dipotassium Controlled Substance CIV 125 mg

USP1140702 Clorsulon 200 mg

USP1141002 Clotrimazole 200 mg

USP1141024 Clotrimazole Related Compound A (o-chlorophenyl)diphenylmethanol

25 mg

USP1141909 Cloxacillin Benzathine 200 mg

USP1142005 Cloxacillin Sodium 200 mg

USP1142107 Clozapine 100 mg

USP1142108 Clozapine Resolution Mixture 30 mg

USP1143008 Cocaine HCl Controlled Substance CII 250 mg

USP1145207 Cod Liver Oil 1 g

USP1143802 Codeine N-Oxide Controlled Substance CI 50 mg

USP1144000 Codeine Phosphate Controlled Substance CII 100 mg

USP1145003 Codeine Sulfate Controlled Substance CII 250 mg

USP1146006 Colchicine 350 mg

USP1146505 Colestipol HCl 200 mg

USP1147009 Colistimethate Sodium 200 mg

USP1148001 Colistin Sulfate 200 mg

USP1148500 Copovidone 100 mg

USP1148806 Corn Oil (AS) 1 g

USP1149004 Corticotropin 5 vials

USP1150003 Cortisone Acetate 150 mg

USP1150207 Cottonseed Oil (AS) 1 g

USP1150353 Creatinine 100 mg

USP1150502 Cromolyn Sodium 500 mg

USP1150513 Cromolyn Sodium Related Compound A 1,3-Bis-(2-acetyl-3-hydroxyphenoxy)-2-propanol (AS)

25 mg

USP1150706 Crospovidone 100 mg

USP1151006 Crotamiton 200 mg

USP1151709 Cumene 3x1.2 mL

USP1151855 Curcumin 30 mg

USP1151866 Curcuminoids 300 mg

USP1151924 Cyanidin Chloride 25 mg

USP1151935 Cyanidin-3-O-glucoside Chloride 15 mg

USP1152009 Cyanocobalamin (Vitamin B12) 1.5 g

USP1152701 Cyclandelate 200 mg

USP1154004 Cyclizine HCl 200 mg

USP1154503 Cyclobenzaprine HCl 200 mg

USP1154558 Alpha Cyclodextrin 500 mg

USP1154569 Beta Cyclodextrin 250 mg

USP1154591 Gamma Cyclodextrin 200 mg

USP1154605 Cyclohexylmethanol 2x1 mL

USP1154707 Cyclomethicone 4 200 mg



USP1156000 Cyclopentolate HCl 300 mg

USP1157013 Cyclophosphamide Related Compound A bis(2-chloroethyl)amine HCl

25 mg



Code Product Unit

USP1157024 Cyclophosphamide Related Compound B 3-(2-chloroethyl)-2-oxo-2-hydroxy-1,3,6,2-oxadiazaphosphonane

25 mg

USP1157035 Cyclophosphamide Related Compound C (3-aminopropyl dihydrogen phosphate

25 mg

USP1157046 Cyclophosphamide Related Compound D 3-[2-(2-chloroethylamino)ethylamino]propyl dihydrogen phosphate dihydrochloride

25 mg

USP1157501 2-Cyclopropylmethylamino-5-chlorobenzophenone 50 mg

USP1158005 Cycloserine 250 mg

USP1158504 Cyclosporine 50 mg

USP1158650 Cyclosporine Resolution Mixture 25 mg

USP1159008 Cyclothiazide (AS) 200 mg

USP1161000 Cyproheptadine HCl 500 mg

USP1161010 Cyproheptadine Related Compound A 5H-dibenzo[a,d]cycloheptene (AS)

40 mg

USP1161203 Cyromazine 200 mg

USP1161509 L-Cysteine HCl 200 mg

USP1161586 Cystine 200 mg

USP1162002 Cytarabine 250 mg

USP1162126 5'-Cytidylic Acid 500 mg

USP1162148 Cytosine 100 mg

USP1162308 Dacarbazine 125 mg

USP1162320 Dacarbazine Related Compound A 5-aminoimidazole-4-carboxamide HCl

50 mg

USP1162330 Dacarbazine Related Compound B 2-azahypoxanthine

50 mg

USP1162400 Dactinomycin 50 mg

USP1162421 Daidzein 25 mg

USP1162432 Daidzin 30 mg

USP1162501 Danazol 200 mg

USP1163140 Dantrolene 200 mg

USP1163151 Dantrolene Sodium 100 mg

USP1163162 Dantrolene Related Compound A 5-(4-nitrophenyl)-2-furaldehyde azine

50 mg

USP1163173 Dantrolene Related Compound B 5-(4-nitrophenyl)-2-furaldehyde-(2-carboxymethyl)semicarbazone

50 mg

USP1163184 Dantrolene Related Compound C (5-(4-nitrophenyl)-2-furancarboxyaldehyde

50 mg

USP1164008 Dapsone 125 mg

USP1164700 Daunorubicin HCl 200 mg

USP1165408 Decoquinate 200 mg

USP1166003 Deferoxamine Mesylate 500 mg

USP1166309 Dehydroacetic Acid 200 mg

USP1166400 Dehydrocarteolol HCl 100 mg

USP1166502 Dehydrocholic Acid 200 mg

USP1169001 Demecarium Bromide 250 mg

USP1170000 Demeclocycline HCl 200 mg

USP1046089 N-Demethylazithromycin 15 mg

USP1171003 Denatonium Benzoate 200 mg

USP1171207 23-EPI-26-Deoxyactein 20 mg

USP1171251 2-Deoxy-D-Glucose (AS) 100 mg

USP1171455 Dermatan Sulfate 25 mg

USP1171706 Desacetyl Diltiazem HCl 50 mg

USP1171900 Desflurane 0.5 mL

USP1171910 Desflurane Related Compound A bis-(1,2,2,2-tetrafluoroethyl) ether

0.1 mL



Code Product Unit

USP1172006 Desipramine HCl 125 mg

USP1173009 Deslanoside 100 mg

USP1173100 Desmethoxycurcumin 30 mg

USP1173202 Desmopressin Acetate 1.91 mg

USP1173235 Desogestrel 50 mg

USP1173246 Desogestrel Related Compound A 13-ethyl-11-methylene-18,19-dinor-5alpha, 17alpha-pregn-3-en-20-yl-17-ol, desogestrel delta-3 isomer

15 mg

USP1173257 Desogestrel Related Compound B 3-Hydroxy-desogestrel

15 mg

USP1173268 Desogestrel Related Compound C 3-Keto-desogestrel

25 mg

USP1046078 Desosaminylazithromycin 15 mg

USP1173508 Desoximetasone 200 mg

USP1174001 Desoxycorticosterone Acetate 200 mg

USP1175004 Desoxycorticosterone Pivalate 125 mg

USP1176007 Dexamethasone 125 mg

USP1176506 Dexamethasone Acetate 200 mg

USP1177000 Dexamethasone Phosphate 200 mg

USP1178002 Dexbrompheniramine Maleate 200 mg

USP1179005 Dexchlorpheniramine Maleate 300 mg

USP1179504 Dexpanthenol 500 mg

USP1179628 Dextran 1 50 mg



USP1179854 Dextran 4 Calibration 100 mg



USP1179720 Dextran 40 System Suitability 200 mg


USP1179763 Dextran 70 System Suitability 200 mg


USP1179650 Dextran T-10 200 mg

USP1179800 Dextran Vo Marker 100 mg

USP1180004 Dextroamphetamine Sulfate Controlled Substance CII 500 mg

USP1180015 Dextroamphetamine Related Compound A 1-Phenyl-2-propanol

25 mg

USP1180026 Dextroamphetamine Related Compound B Phenyl acetone Controlled Substance CII

25 mg

USP1180503 Dextromethorphan 2 g

USP1181007 Dextromethorphan HBr (CRM) 500 mg

USP1181302 Dextrose 500 mg

USP1181506 Diacetylated Monoglycerides 200 mg

USP1182000 Diacetylfluorescein 200 mg

USP1183002 Diacetylmorphine HCl (Heroin HCl) (AS) Controlled Substance CI 25 mg

USP1184005 Diatrizoic Acid 100 mg

USP1184027 Diatrizoic Acid Related Compound A 5-Acetamido-3-amino-2,4,6-triiodobenzoic Acid

50 mg

USP1185008 Diazepam Controlled Substance CIV 100 mg

USP1185020 Diazepam Related Compound A 2-Methyl-amino-5-chlorobenzophenone

25 mg

USP1023403 Diazepam Related Compound B 3-Amino-6-chloro-1-methyl-4-phenylcarbostyril

25 mg

USP1186000 Diazoxide 200 mg



Code Product Unit

USP1187003 Dibucaine HCl 500 mg

USP1187080 Dibutyl Phthalate 200 mg

USP1187091 Dibutyl Sebacate (AS) 1 mL

USP1187207 Dichloralphenazone Controlled Substance CIV 200 mg

USP1187954 2,4-Dichlorophenol 100 mg

USP1188006 Dichlorphenamide 200 mg

USP1188301 Dichlorvos 2,2-dichlorovinyl dimethyl phosphate (AS)

150 mg

USP1188560 Diclazuril 200 mg

USP1188571 Diclazuril System Suitability Mixture 50 mg

USP1188709 Diclofenac Potassium 200 mg

USP1188800 Diclofenac Sodium 200 mg

USP1188811 Diclofenac Related Compound A N-(2,6-dichlorophenyl)indolin-2-one

25 mg

USP1189009 Dicloxacillin Sodium 500 mg

USP1190008 Dicumarol 200 mg

USP1190904 Dicyclohexyl 2x2 mL

USP1191000 Dicyclomine HCl 125 mg

USP1191204 Didanosine 200 mg

USP1191226 Didanosine Related Compound A Hypoxanthine

25 mg

USP1191237 Didanosine Related Compound B 2',3'-dideoxyadenosine

25 mg

USP1191215 Didanosine System Suitability Mixture 10 mg

USP1192003 Dienestrol 125 mg

USP1192808 Diethanolamine 3 mL

USP1193006 Diethylcarbamazine Citrate 200 mg

USP1193265 Diethylene Glycol 0.5 mL

USP1193301 Diethylene Glycol Monoethyl Ether 0.5 mL

USP1193505 Diethyl Phthalate 200 mg

USP1194009 Diethylpropion HCl Controlled Substance CIV 200 mg

USP1194803 Diethyl Sebacate 1 mL

USP1195001 Diethylstilbestrol 200 mg

USP1197007 Diethyltoluamide 3 g

USP1197302 Diflorasone Diacetate 200 mg

USP1197506 Diflunisal 200 mg

USP1198000 Digitalis 3 g

USP1199002 Digitoxin 200 mg

USP1200000 Digoxin 250 mg

USP1200600 Dihydrocapsaicin 25 mg

USP1200804 Dihydrocodeine Bitartrate Controlled Substance CII 200 mg

USP1201002 17α-Dihydroequilin 50 mg

USP1202005 Dihydroergotamine Mesylate 500 mg

USP1203008 Dihydrostreptomycin Sulfate 200 mg

USP1204000 Dihydrotachysterol 4x30 mg

USP1204102 Dihydroxyacetone 250 mg

USP1204805 Diloxanide Furoate 200 mg

USP1205003 Diltiazem HCl 200 mg

USP1205014 Diltiazem Related Compound A (AS) trans-diltiazem hydrochloride

25 mg

USP1206006 Dimenhydrinate 200 mg

USP1208001 Dimethisoquin HCl 2 g

USP1211006 Dimethyl Sulfoxide 3 g



Code Product Unit

USP1213001 Dinoprost Tromethamine 50 mg

USP1213103 Dinoprostone 50 mg

USP1214004 Dioxybenzone 150 mg

USP1217909 Diphenhydramine Citrate 200 mg

USP1218005 Diphenhydramine HCl 200 mg

New USP1218016 Diphenhydramine Related Compound A 2-(Diphenylmethoxy)-N-methylethanamine HCl

15 mg

USP1219008 Diphenoxylate HCl Controlled Substance CII 200 mg

USP1220302 Dipivefrin HCl 200 mg

USP1220506 Dipyridamole 200 mg

USP1220700 Dirithromycin 200 mg

USP1221000 Disodium Guanylate 350 mg

USP1222002 Disodium Inosinate 500 mg

USP1222400 Disodium 5'-Uridylate 500 mg

USP1222501 Disopyramide Phosphate 200 mg

USP1223005 2,4-Disulfamyl-5-trifluoromethylaniline 30 mg

USP1224008 Disulfiram 200 mg

USP1224201 Divalproex Sodium 200 mg

USP1224507 Dobutamine HCl 600 mg

USP1224551 Docetaxel 200 mg

USP1224562 Docetaxel Identification 50 mg

USP1224620 Docosahexaenoic Acid Ethyl Ester 500 mg

USP1224664 Docosyl Ferulate 50 mg

USP1224700 Docusate Calcium 500 mg

USP1224904 Docusate Potassium 100 mg

USP1224802 Docusate Sodium 500 mg

USP1224824 Docusate Sodium Related Compound B Disodium mono (2-ethylhexyl) sulfosuccinate

40 mg

USP1224937 Dofetilide 200 mg

USP1224948 Dofetilide Related Compound A N-[4-(2-(2-[4-(methanesulfonamido)phenoxy]ethyl)amino)phenyl] methanesulfonamide

25 mg

USP1224959 Dolasetron Mesylate 200 mg

USP1224960 Dolasetron Mesylate Related Compound A Hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-one HCl

25 mg

USP1224981 Donepezil HCl 200 mg

USP1224992 Donepezil Related Compound A (E)-2-[(1-benzylpiperidin-4-yl)methylene]-5,6-dimethoxyindan-1-one

25 mg

USP1225204 Dopamine HCl 200 mg

USP1225281 Dorzolamide HCl 200 mg

USP1225292 Dorzolamide Hydrochloride Related Compound A (4R,6R)-4-(ethylamino)-5,6-dihydro-6-methyl-4H-thieno [2,3-b]thiopyran-2-sulfonamide 7,7-dioxide, monohydrochloride

20 mg

USP1225000 Doxapram HCl 200 mg

USP1225419 Doxazosin Mesylate 200 mg

USP1225420 Doxazosin Related Compound A N-(1,4-benzodioxane-2-carbonyl)piperazine hydrochloride

20 mg

USP1225441 Doxazosin Related Compound B 6,7-dimethoxyquinazoline-2,4-dione

20 mg

USP1225452 Doxazosin Related Compound C 2-chloro-4-amino-6,7-dimethoxyquinazoline

20 mg

USP1225463 Doxazosin Related Compound D 1,4-benzodioxane-2-carboxylic acid

20 mg

USP1225474 Doxazosin Related Compound E 2,4-dichloro-6,7-dimethoxyquinazoline

20 mg



Code Product Unit

USP1225485 Doxazosin Related Compound F N,N'-bis(1,4-benzodioxane-2-carbonyl)piperazine

15 mg

USP1225500 Doxepin HCl 500 mg

USP1225511 Doxepin Related Compound A dibenzo[b,e]oxepin-11(6H)-one

50 mg

USP1225522 Doxepin Related Compound B (11RS)-11-[3-(dimethylamino)propyl]-6,11-dihydrodibenzo[b,e]oxepin-11-ol

50 mg

USP1225533 Doxepin Related Compound C (E-3-(dibenzo[b,e]oxepin-11(6H)-ylidene)-N-methylpropan-1-amine HCl

25 mg

USP1225703 Doxorubicin HCl 50 mg

USP1226003 Doxycycline Hyclate 200 mg

USP1226014 Doxycycline Related Compound A 6-epidoxycycline

10 mg

USP1227006 Doxylamine Succinate 300 mg

New USP1228009 Drometrizole 2-(2H-Benzotriazol-2-yl)-p-cresol

25 mg

New USP1228010 Drometrizole Trisiloxane 2-(2H-Benzotriazol-2-yl)-6-{3-[bis(trimethylsiloxy)methylsilyl]isobutyl}-p-cresol

200 mg

New USP1228029 Drometrizole Trisiloxane Related Compound A 2-(2H-Benzotriazol-2-yl)-6-(isobuten-1-yl)-p-cresol

25 mg

New USP1228031 Drometrizole Trisiloxane Related Compound B 2-(2H-Benzotriazol-2-yl)-6-(isobuten-3-yl)-p-cresol

25 mg

New USP1228042 Drometrizole Trisiloxane Related Compound C 2-(2H-Benzotriazol-2-yl)-6-(isobuten-1-yl)O1-[bis(trimethylsiloxy)methylsilyl]-p-cresol

150 mg

New USP1228053 Drometrizole Trisiloxane Related Compound D 2-(2H-Benzothiazol-2-yl)-6-isobutyl-p-cresol

25 mg

New USP1228064 Drometrizole Trisiloxane Related Compound E 2-(2H-Benzotriazol-2-yl)-6-{3-[bis(trimethylsiloxy)methylsilyl]isobutyl}-O1-[bis(trimethylsiloxy)methylsilyl]-p-cresol

150 mg

New USP1228075 Heptamethyl Trisiloxane 1,1,1,3,5,5,5-Heptamethyltrisiloxane

150 mg

USP1229001 Droperidol 250 mg

USP1229409 Drospirenone 200 mg

USP1229410 Drospirenone Related Compound A 17-Hydroxy-6beta,7beta:15beta,16beta-dimethylene-3-oxo-17beta-pregn-4-ene-21-carboxylic acid, gamma-lactone

15 mg

New USP1229817 Duloxetine HCl 100 mg

New USP1229828 Duloxetine Related Compound A 5-Chloro-2-(3-chloromethyl-4H-1,2,4-triazol-4-yl)-benzophenone

10 mg

New USP1229872 Duloxetine Related Compound F (S)-N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-3-yl)propan-1-amine HCl

10 mg

New USP1229883 Duloxetine Related Compound H (S)-4-(Methyl[3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propyl]amino)-4-oxobutanoic acid

10 mg

USP1230000 Dyclonine HCl 200 mg

USP1231003 Dydrogesterone 200 mg

USP1231502 Dyphylline 200 mg

USP1231580 Ecamsule Solution 0.5 mL

USP1231604 Ecamsule Triethanolamine 200 mg

USP1231615 Ecamsule Related Compound A 1,4-Phenylenedimethanol

50 mg

USP1231626 Ecamsule Related Compound B 4-(hydroxymethyl)benzoic acid

50 mg

USP1231637 Ecamsule Related Compound C terephthalic acid

50 mg

USP1231648 Ecamsule Related Compound D ((1SR,4RS)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonic acid

50 mg

USP1231659 Ecamsule Related Compound E sodium ((1SR,4SR,E)-3-(4-(hydroxymethyl)benzylidene)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonate

25 mg



Code Product Unit

USP1231660 Ecamsule Related Compound F 4-((E)-((1SR,4SR)-7,7-dimethyl-3-oxo-4-(sulfomethyl)bicyclo[2.2.1]heptan-2-ylidene)methyl)benzoic acid

25 mg

USP1231681 Ecamsule Related Compound G 4-((E)-((1SR,4SR)-7,7-dimethyl-3-oxo-4-(sulfomethyl)bicyclo[2.2.1]heptan-2-ylidene)methyl)benzaldehydre, sodium salt

25 mg

USP1231706 Powdered Echinacea Angustifolia Extract 1 g

USP1231717 Powdered Echinacea Pallida Extract 1 g

USP1231728 Powdered Echinacea Purpurea Extract 1 g

USP1231808 Econazole Nitrate 200 mg

USP1232006 Edetate Calcium Disodium 200 mg

USP1233009 Edetate Disodium 200 mg

USP1233508 Edetic Acid 200 mg

USP1234001 Edrophonium Chloride 200 mg

USP1234103 Efavirenz 200 mg

USP1234114 Efavirenz Racemic (+/-)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)- 2H-3,1-benzoxazin-2-one

20 mg

USP1234125 Efavirenz Related Compound A (S)-2-(2-amino-5-chlorophenyl)-4-cyclopropyl-1,1,1-trifluorobut-3-yn-2-ol)

20 mg

USP1234147 Efavirenz Related Compound B (S,E)-6-Chloro-4-(2-Cyclopropylvinyl)-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one

15 mg

USP1234136 Efavirenz Related Compound C 6-chloro-2-cyclopropyl-4-(trifluoromethyl)quinoline

20 mg

USP1234307 Eicosapentaenoic Acid Ethyl Ester 500 mg

USP1234668 Eleutheroside B (Syringin) 15 mg

USP1234680 Eleutheroside E (Syringaresinol diglucoside) 15 mg

USP1234704 Powdered Eleuthero Extract 1.5 g

USP1234806 Emedastine Difumarate 100 mg

USP1235004 Emetine HCl 300 mg

USP1235106 Emtricitabine 200 mg

USP1235128 Emtricitabine System Suitability Mixture A 15 mg

USP1235139 Emtricitabine System Suitability Mixture B 15 mg

USP1235274 Enalaprilat 300 mg

USP1235300 Enalapril Maleate 200 mg

USP1235503 Endotoxin unit

USP1235809 Enflurane 1 mL

USP1235820 Enoxaparin Sodium 300 mg

USP1235842 Enoxaparin Sodium Solution for Bioassays 1 mL

USP1235853 Enoxaparin Sodium Molecular Weight Calibrant A 6 mg

USP1235864 Enoxaparin Sodium Molecular Weight Calibrant B 6 mg

USP1235900 Enrofloxacin 200 mg

USP1235911 Enrofloxacin Related Compound Mixture 50 mg

USP1235933 Entacapone 150 mg

USP1235944 Entacapone Related Compound A (Z)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide

25 mg

USP1236007 Ephedrine Sulfate Drug Precursor 200 mg

USP1236506 4-Epianhydrotetracycline HCl 50 mg

USP1236700 (-)-Epigallocatechin-3-O-gallate 20 mg

USP1236801 Epilactose 200 mg

USP1237000 Epinephrine Bitartrate 200 mg

USP1237382 Epirubicin HCl 200 mg

USP1237509 Epitetracycline HCl (AS) 200 mg

USP1238002 Equilin 25 mg

USP1239005 Ergocalciferol (Vitamin D2) 5x30 mg



Code Product Unit

USP1239504 Ergoloid Mesylates 300 mg

USP1240004 Ergonovine Maleate Drug Precursor 100 mg

USP1241007 Ergosterol 50 mg

USP1241506 Ergotamine Tartrate Drug Precursor 150 mg

USP1241550 Ergotaminine Drug Precursor 100 mg

USP1241823 Erythorbic Acid 50 mg

USP1241903 Erythritol 200 mg

USP1242000 Erythromycin 250 mg

USP1242010 Erythromycin B 100 mg

USP1242021 Erythromycin C 50 mg

USP1242032 Erythromycin Related Compound N N-Demethylerythromycin A

50 mg

USP1243002 Erythromycin Estolate 200 mg

USP1245008 Erythromycin Ethylsuccinate 200 mg

USP1246000 Erythromycin Gluceptate 200 mg

USP1247003 Erythromycin Lactobionate 200 mg

USP1248006 Erythromycin Stearate 200 mg

USP1249202 Escin 350 mg

USP1249406 Escitalopram Oxalate 200 mg

USP1249417 Escitalopram Related Compound A (-)4-[(4-dimethylamino)-1-(4-fluorophenyl)-1-(hydroxybutyl)]-3-(hydroxymethyl)benzonitrile

10 mg

New USP1249701 Esmolol HCl 100 mg

USP1249789 Esomeprazole Magnesium 10 mg

New USP1249905 Estazolam Controlled Substance CIV 100 mg

New USP1249916 Estazolam Related Compound A 5-Chloro-2-(3-chloromethyl-4H-1,2,4-triazol-4-yl)-benzophenone

10 mg

USP1250008 Estradiol 500 mg

USP1250020 Estradiol Related Compound B 1,3,5(10),6-estratetraen-3,17beta-diol

10 mg

USP1250041 Estradiol Related Compound C 1,3,5(10)estratrien-3,17beta-diol-6-one

15 mg

USP1251000 Estradiol Benzoate (AS) 250 mg

USP1252003 Estradiol Cypionate 200 mg

USP1254009 Estradiol Valerate 100 mg

USP1254508 Estriol 100 mg

USP1255001 Estrone 200 mg

USP1255500 Estropipate 500 mg

USP1256004 Ethacrynic Acid 200 mg

USP1257007 Ethambutol HCl 200 mg

USP1257018 Ethambutol Related Compound A (2R,2'S)-2,2'-[ethane-1,2-diylbis(azanediyl)]dibutan-1-ol

15 mg

USP1257029 Ethambutol Related Compound B ((2R,2'R)-2,2'-[ethane-1,2-diylbis(azanediyl]dibutan-1-ol)HCl

15 mg

USP1258305 Ethchlorvynol Controlled Substance CIV 0.7 mL

USP1260001 Ethinyl Estradiol 150 mg

USP1260012 Ethinyl Estradiol Related Compound A 6-Keto-ethinyl estradiol

20 mg

New USP1260023 Ethinyl Estradiol Related Compound B 19-Nor-17alpha-pregna-1,3,5(10),9(11)-tetraen-20-yne-3,17-diol

10 mg

USP1261004 Ethionamide 200 mg

USP1262801 Ethopabate 125 mg

USP1262823 Ethopabate Related Compound A Methyl-4-acetamido-2-hydroxybenzoate

25 mg

USP1264002 Ethosuximide 500 mg

USP1264501 Ethotoin 200 mg



Code Product Unit

USP1265005 Ethoxzolamide 200 mg

USP1265402 Ethyl Acetate 3x1.2 mL

USP1265424 Ethyl Acrylate and Methyl Metacrylate Copolymer Dispersion 1.5 g

USP1265457 Ethylbenzene 3x0.5 mL

USP1265504 Ethylcellulose 1 g

USP1265515 Ethylene Glycol 0.5 mL

USP1265592 Ethylene Glycol and Vinyl Alcohol Graft Copolymer 1 g

USP1265606 Ethyl Formate 3x1.2 mL

USP1265526 2-Ethylhexan-1-ol 1.5 mL

USP1265537 Ethylhexyl Triazone 200 mg

USP1265548 Ethylhexyl Triazone Related Compound A 2-ethylhexyl 4-aminobenzoate

20 mg

USP1265559 Ethylhexyl Triazone Related Compound B 4-(4,6-bis(4-((2-ethylhexyloxy)carbonyl)phenylamino)-1,3,5-triazin-2-ylamino)benzoic acid

20 mg

USP1265560 Ethylhexyl Triazone Related Compound C bis(2-ethylhexyl)4,4'-(6-(4-(ethyoxycarbonyl)phenylamino)-1,3,5-triazine-2,4-diyl)bis(azanediyl)dibenzoate

20 mg

USP1265752 Ethyl Laurate 500 mg

USP1266008 Ethyl Maltol 1 g

USP1266507 Ethylnorepinephrine HCl 200 mg

USP1267000 Ethylparaben 200 mg

USP1266802 N-Ethylpiperazine 0.5 mL

USP1267500 Ethyl Vanillin 200 mg

USP1268003 Ethynodiol Diacetate 200 mg

USP1268502 Etidronate Disodium 200 mg

USP1268513 Etidronate Disodium Related Compound A Sodium phosphite dibasic pentahydrate

300 mg

USP1268604 Etidronic Acid Monohydrate 1 g

USP1268706 Etodolac 400 mg

USP1268728 Etodolac Related Compound A (+/-)-8-ethyl-1-methyl-1,3,4,9-tetrahydropyrano[3,4-b]-indole-1-acetic acid

25 mg

New USP1268750 Etomidate 200 mg

USP1268808 Etoposide 300 mg

USP1268852 Etoposide Resolution Mixture 30 mg

USP1268965 Eugenol 500 mg

New USP1269050 Exemestane 150 mg

New USP1269061 Exemestane Related Compound A 6-Methyleneandrosta-4-ene-3,17-dione

15 mg

New USP1269072 Exemestane Related Compound B 6-hydroxymethylandrostra-1,4-diene-3,17-dione

15 mg

New USP1269083 Exemestane Related Compound C androsta-1,4-diene-3,17-dione Controlled Substance CIII

15 mg

New USP1269094 Exemestane System Suitability Mixture 25 mg

USP1269152 Famciclovir 200 mg

USP1269163 Famciclovir System Suitability Mixture Mixture of Famciclovir, Propionylfamciclovir and 6-Chlorofamciclovir

20 mg

USP1269174 Famciclovir Related Compound A 2-[2-(2-Amino-9H-purin-9-yl)ethyl]propane-1,3-diol hydrochloride

20 mg

USP1269185 Famciclovir Related Compound B 4-(2-Amino-9H-purin-9-yl)-2-(hydroxymethyl)butyl acetate

20 mg

New USP1269119 FAME Standard Mixture 100 mg

USP1269200 Famotidine 125 mg

USP1269221 Famotidine Related Compound B 3,5-bis[2-[[[2-[(diaminomethylene)amino]thiazol-4-yl]methyl]sulphany]ethyl]-4H-1,2,4,6-thiatriazine1,1-dioxide (AS)

25 mg



Code Product Unit

New USP1269232 Famotidine Related Compound C 3-[[2-(diaminomethyleneamino)thiazol-4-yl]methylthio]-N-sulfamoylpropanamide HCl

25 mg

New USP1269243 Famotidine Related Compound D 3-[[2-(diaminomethyleneamino)thiazol-4-yl]methylthio]propanamide

25 mg

New USP1269254 Famotidine Related Compound E 2,2'-[4,4'-disulfanediylbis(methylene)bis(thiazole-4,2-diyl)]diguanidine

25 mg

New USP1269265 Famotidine Related Compound F 3-[[2-(diaminomethyleneamino)thiazol-4-yl]methylthio]propanoic acid

25 mg

New USP1269298 Famotidine Sulfoxide 3-[[2-(diaminomethyleneamino)thiazol-4-yl]methylsulfinyl]-N'-sulfamoylpropanimidamide

25 mg

New USP1269312 Felbamate 250 mg

New USP1269323 Felbamate Related Compound A 3-Hydroxy-2-phenylpropyl carbamate

25 mg

New USP1269334 Felbamate Related Compound B Phenethyl carbamate

25 mg

USP1269389 Felodipine 300 mg

USP1269390 Felodipine Related Compound A ethyl methyl 4-(2,3-dichlorophenyl)-2,6-dimethylpyridine-3,5-dicarboxylate

15 mg

USP1269403 Fenbendazole 100 mg

USP1269414 Fenbendazole Related Compound A Methyl(1H-benzimidazole-2-yl)carbamate

30 mg

USP1269425 Fenbendazole Related Compound B Methyl[5(6)-chlorobenzimidazole-2-yl]carbamate

30 mg

USP1269447 Fenofibrate 200 mg

USP1269607 Fenofibrate Related Compound A (4-chlorophenyl)(4-hydroxyphenyl) methanone

25 mg

USP1269618 Fenofibrate Related Compound B 2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropanoic acid

25 mg

USP1269629 Fenofibrate Related Compound C 1-methylethyl 2-[[2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoyl]oxy]-2-methylpropanoate

25 mg

USP1269458 Fenoldopam Mesylate 200 mg

USP1269469 Fenoldopam Related Compound A N-Methyl-6-chloro-2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-1H-3-benzazepine-7,8-diol HCl

20 mg

USP1269470 Fenoldopam Related Compound B 1H-3-Benzazapine-7,8-diol, 2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-, methanesulfonate

20 mg

USP1269505 Fenoprofen Calcium 500 mg

USP1269550 Fenoprofen Sodium 500 mg

USP1269902 Fentanyl Controlled Substance CII 100 mg

USP1270005 Fentanyl Citrate Controlled Substance CII 100 mg

USP1269913 Fentanyl Related Compound A (2-bromoethyl)benzene

100 mg

USP1269924 Fentanyl Related Compound B 4-Anilinopiperidine

10 mg

USP1269946 Fentanyl Related Compound D N-Phenyl-1-(phenylmethyl)-4-piperidinamine

10 mg

USP1269957 Fentanyl Related Compound E N-Phenyl-1-(2-phenylethyl)-4-piperidinamine Controlled Substance CII

10 mg

USP1269979 Fentanyl Related Compound G Acetyl fentanyl

10 mg

USP1270355 Ferrous Sulfate (AS) 1.5 g

USP1270311 Ferulic Acid trans-4-hydroxy-3-methoxycinnamic acid

25 mg

USP1270377 Fexofenadine HCl 200 mg

USP1270388 Fexofenadine Related Compound A 4-[1-oxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]butyl]-alpha,alpha-dimethyl benzeneacetic acid

25 mg



Code Product Unit

USP1270399 Fexofenadine Related Compound B 3-[1-hydroxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]butyl]-alpha,alpha-dimethyl benzeneacetic acid hydrochloride

25 mg

USP1270446 Fexofenadine Related Compound C (+)-4-[1-hydroxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-butyl]-isopropylbenzene (AS)

15 mg

USP1270402 Finasteride 200 mg

USP1270424 Fish Oil 1 g

USP1270708 Flavoxate HCl 200 mg

USP1270719 Flavoxate Related Compound A 3-methylflavone-8-carboxylic acid

25 mg

USP1270720 Flavoxate Related Compound B 3-Methylflavone-8-carboxylic acid methyl ester

20 mg

USP1270731 Flavoxate Related Compound C 3-Methylflavone-8-carboxylic acid ethyl ester

20 mg

USP1270800 Flecainide Acetate 200 mg

USP1270821 Flecainide Related Compound A 3-[2,5-bis(2,2,2-trifluoroethoxy) phenyl]-1,5,6,7,8,8a-hexahydroimidazo-[1,5a]pyridine HCl

75 mg

USP1271008 Floxuridine 250 mg

USP1271700 Fluconazole 200 mg

USP1271711 Fluconazole Related Compound A 2-[2-fluoro-4-(1H-1,2,4-triazol-1-yl)phenyl]-1,3-bis(1H-1,2,4-triazol-1-yl)-propan-2-ol

10 mg

USP1271722 Fluconazole Related Compound B 2-(4-fluorophenyl)-1,3-bis(1H-1,2,4-triazol-1-yl)-propan-2-ol

10 mg

USP1271733 Fluconazole Related Compound C 1,1'-(1,3-phenylene)di(1H-1,2,4-triazole)

10 mg

USP1272000 Flucytosine 200 mg

USP1272204 Fludarabine Phosphate 300 mg

USP1272907 Fludeoxyglucose 100 mg

USP1272918 Fludeoxyglucose Related Compound A 4,7,13,16,21,24-hexaoxa-1,10-diazabicyclo[8.8.8.]hexacosane

15 mg

USP1272929 Fludeoxyglucose Related Compound B 2-chloro-2-deoxy-D-glucose

10 mg

USP1273003 Fludrocortisone Acetate 250 mg

USP1273808 Flumazenil 200 mg

USP1273819 Flumazenil Related Compound A 8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazol-[1,5-alpha] [1,4]benzodiazepine-3-carboxylic acid

20 mg

USP1273820 Flumazenil Related Compound B Ethyl 8-hydroxy-5,6-dihydro-5-methyl-6-oxo-4H-imidazol-[1,5-alpha] [1,4]benzodiazepine-3-carboxylate

20 mg

USP1273841 Flumazenil Related Compound C N,N-Dimethylformamide diethyl acetal

500 mg

USP1274006 Flumethasone Pivalate 200 mg

USP1274505 Flunisolide 200 mg

USP1274607 Flunixin Meglumine 300 mg

USP1275009 Fluocinolone Acetonide 100 mg

USP1276001 Fluocinonide 100 mg

USP1277004 Fluorescein 200 mg

USP1277252 Fluoride Dentifrice: Sodium Fluoride/Silica 4.6 oz

USP1277274 Fluoride Dentifrice: Sodium Fluoride/Sodium Bicarbonate Powder 4 oz

USP1277300 Fluoride Dentifrice: Sodium Monofluorophosphate - Calcium Carbonate 4.6 oz

USP1277354 Fluoride Dentifrice: Sodium Monofluorophosphate/Dicalcium Phosphate 4.6 oz

USP1277401 Fluoride Dentifrice: Sodium Monofluorophosphate (1000 ppm)/Silica 5.25 oz

USP1277423 Fluoride Dentifrice: Sodium Monofluorophosphate (1500 ppm)/Silica 5.25 oz

USP1277456 Fluoride Dentifrice: Stannous Fluoride-Silica 4 oz

USP1278007 Fluorometholone 200 mg

USP1278109 Fluorometholone Acetate 200 mg



Code Product Unit

USP1278302 Fluoroquinolonic Acid 150 mg

USP1279000 Fluorouracil 250 mg

USP1279804 Fluoxetine HCl 200 mg

USP1279815 Fluoxetine Related Compound A N-methyl-3-phenyl-3-[(alpha,alpha,alpha-(trifluoro-m-tolyl)oxy]propylamine HCl

15 mg

USP1279826 Fluoxetine Related Compound B N-methyl-3-phenylpropylamine Controlled Substance

5 mL

USP1279837 Fluoxetine Related Compound C N-Methyl-N-[3-phenyl-3-(4-trifluoromethyl-phenoxy)-propyl] succinamic acid

15 mg

USP1280009 Fluoxymesterone Controlled Substance CIII 200 mg

USP1280803 Fluphenazine Decanoate Dihydrochloride 500 mg

USP1281001 Fluphenazine Enanthate Dihydrochloride 125 mg

USP1282004 Fluphenazine HCl 125 mg

USP1284000 Flurandrenolide 100 mg

USP1285002 Flurazepam HCL Controlled Substance CIV 200 mg

USP1285308 Flurazepam Related Compound C 5-chloro-2-(2-diethylaminoethyl(amino)-2'-fluorobenzophenone HCl

50 mg

USP1285603 Flurazepam Related Compound F 7-chloro-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepine-2-one)

50 mg

USP1285750 Flurbiprofen 200 mg

USP1285760 Flurbiprofen Related Compound A 2-(4-Biphenylyl)propionic Acid

100 mg

USP1285807 Flurbiprofen Sodium 200 mg

USP1285851 Flutamide 200 mg

USP1285862 o-Flutamide 50 mg

USP1285873 Fluticasone Propionate 100 mg

USP1285910 Fluticasone Propionate Nasal Spray Resolution Mixture 25 mg

USP1285840 Fluticasone Propionate Related Compounds Mixture 25 mg

USP1285884 Fluticasone Propionate Resolution Mixture 25 mg

USP1285895 Fluticasone Propionate System Suitability Mixture Fluticasone Propionate and Fluticasone Propionate Related Compounds B, C and D

25 mg

USP1285931 Fluvastatin Sodium 350 mg

USP1285964 Fluvastatin Related Compound B [R*,S*-E](+/-)-7-[3-(4-fluorophenyl)-1-methylethyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid 1,1-dimethylethyl ester

15 mg

USP1285942 Fluvastatin for System Suitability Fluvastatin sodium and fluvastatin sodium anti-isomer ([R*,R*-E](+/-)-7-[3-(4-fluorophenyl)-1-(methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid monosodium salt

25 mg

USP1285909 Fluvoxamine Maleate 200 mg

USP1286005 Folic Acid (Vitamin M or Vitamin Bc) 500 mg

USP1286027 Folic Acid Related Compound A Calcium Formyltetrahydrofolate

50 mg

USP1283200 Formic Acid 3x1.2 mL

USP1286060 Formononetin 50 mg

USP1286107 Formoterol Fumarate 100 mg

USP1286129 Formoterol Fumarate Resolution Mixture 20 mg

USP1286118 Formoterol Fumarate System Suitability Mixture 20 mg

USP1286300 10-Formylfolic Acid 25 mg

New USP1283244 Forskolin 7Beta-acetoxy-8,13-epoxy-1alpha,6Beta,9alpha-trihydroxy-labd-14-en-11-one

40 mg

New USP1283255 Powdered Forskohlii Extract 500 mg

USP1283302 Foscarnet Sodium 50 mg

USP1283313 Foscarnet Related Compound B Disodium (Ethoxyoxidophosphanyl) formate

10 mg

USP1283324 Foscarnet Related Compound D O,O-diethyl ethoxycarbonylphosphonate

0.27 mL



Code Product Unit

New USP1286322 Fosfomycin Tromethamine 800 mg

USP1283404 Fosinopril Sodium 200 mg

USP1283415 Fosinopril Related Compound A (4S)-4-cyclohexyl-[(4-phenylbutyl)phosphinyl]-acetyl-L-proline

25 mg

USP1283426 Fosinopril Related Compound B ((4S)-4-Cyclohexyl-1-[(R)-[(S)-1-hydroxy-2-methylpropoxy](4-phenylbutyl)phosphinyl]acetyl-D-proline propionate (ester), hemibarium salt, sesquihydrate)

15 mg

USP1283437 Fosinopril Related Compound C (4S)-4-cyclohexyl-1-[(RS)-1-hydroxy-2-methylpropoxy](4-phenylbutyl)phosphinyl]-acetyl-L-proline propionate (ester),sodium salt

15 mg

USP1283448 Fosinopril Related Compound D (4R)-4-cyclohexyl-1-[(R)-[(S]-1-hydroxy-2-methylpropoxy](4-phenylbutyl)phosphinyl]acetyl-L-proline propionate (ester), sodium salt

15 mg

USP1283459 Fosinopril Related Compound E (4S)-4-phenyl-1-[(R)-[(S)-1-hydroxy-2-methyl-propoxy](4-phenylbutyl]phospinyl]acetyl-L-proline propionate (ester), sodium salt

15 mg

USP1283460 Fosinopril Related Compound F (4S)-4-cyclohexyl-1-[(R)-[(S)-1-hydroxypropoxy](4-phenylbutyl)phospinyl]acetyl-L-proline propionate (ester),sodium salt

15 mg

USP1283470 Fosinopril Related Compound G (4-phenylbutyl)phosphinyl acetic acid, disodium salt

15 mg

USP1283481 Fosinopril Related Compound H 4-phenylbutyl phosphonic acid

25 mg

USP1286366 Fosphenytoin Sodium 250 mg

USP1286504 Fructose 125 mg

USP1286606 L-Fucose (AS) 200 mg

USP1286650 Fulvestrant 150 mg

USP1286661 Fulvestrant System Suitability Mixture 15 mg

USP1286708 Fumaric Acid 200 mg

USP1286800 Furazolidone 200 mg

USP1287008 Furosemide 200 mg

USP1287020 Furosemide Related Compound A 2-Chloro-4-N-furfurylamino-5-sulfamoylbenzoic Acid

50 mg

USP1287030 Furosemide Related Compound B 4-Chloro-5-sulfamoylanthranilic Acid

100 mg

USP1287303 Gabapentin 250 mg

USP1287325 Gabapentin Related Compound A 3,3-pentamethylene-5-butyrolactam

50 mg

USP1287347 Gabapentin Related Compound B (1-cyanocyclohexyl)acetic acid

30 mg

USP1287358 Gabapentin Related Compound D (1-(3-oxo-2-aza-spiro[4,5]dec-2-ylmethyl)-cyclohexyl)acetic acid

10 mg

USP1287369 Gabapentin Related Compound E carboxymethyl-cyclohexanecarboxylic Acid

10 mg

USP1287507 Gadodiamide 500 mg

USP1287518 Gadodiamide Related Compound A gadolinium sodium diethylenetriamine pentaacetic acid monomethylamide

50 mg

USP1287529 Gadodiamide Related Compound B gadolinium disodium diethylenetriamine pentaacetic Acid

50 mg

USP1287609 Gadopentetate Monomeglumine 500 mg

USP1287631 Gadoteridol 500 mg

USP1287642 Gadoteridol Related Compound A 10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclodedodecane-1,4,7-triaacetic Acid

50 mg

USP1287653 Gadoteridol Related Compound B 1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid, monogadolinium salt

50 mg

USP1287664 Gadoteridol Related Compound C 1,4,7,10-Tetraaza-11-oxo-bicylco[8.2.2]tetradecan-4,7-diacetic Acid

50 mg

USP1287675 Gadoversetamide 200 mg



Code Product Unit

USP1287686 Gadoversetamide Related Compound A Hydrogen[8,11,14-tris(carboxymethyl)-6-oxo-2-oxa-5,8,11,14-tetraazahexadecan-16-oato (4-)]gadolinium

200 mg

USP1287711 Galactitol 500 mg

USP1287722 Galactosamine HCl 300 mg

USP1287700 Galactose 200 mg

USP1287755 Galantamine HBr 200 mg

USP1287766 Galantamine HBr Racemic 15 mg

USP1287777 Galantamine HBr Related Compounds Mixture 25 mg

USP1288000 Gallamine Triethiodide 200 mg

USP1288306 Ganciclovir 200 mg

USP1288317 Ganciclovir Related Compound A (RS)-2-Amino-9-(2,3-dihydroxy-propoxymethyl)-1,9-dihydropurin-6-one

15 mg

USP1288339 Ganciclovir Mono-N-methyl Valinate 2-(RS)-[(guanin-9-yl)methoxy]-3-hydroxypropyl N-methyl-L-valinate hydrochloride

10 mg

USP1288408 Gatifloxacin 300 mg

New USP1288340 Powdered Garcinia Hydroxycitrate Extract 500 mg

USP1288463 Gemcitabine Hydrochloride 200 mg

USP1288500 Gemfibrozil 200 mg

USP1288510 Gemfibrozil Related Compound A 2,2-dimethyl-5-[2,5-dimethyl-4-propene-1-yl)phenoxy]valeric acid

20 mg

USP1288816 Genistein 15 mg

USP1288805 Genistin 30 mg

USP1289003 Gentamicin Sulfate 200 mg

USP1290002 Gentian Violet 650 mg

USP1291005 Gibberellic Acid 200 mg

USP1291504 Powdered Ginger 500 mg

USP1291446 Ginger Constituent Mixture 6-gingerol and 6-shogaol

0.2 mg

USP1291559 Ginkgo Terpene Lactones 50 mg

USP1291548 Ginkgolic Acids 10 mg

USP1291683 Powdered American Ginseng Extract 1.5 g

USP1291708 Powdered Asian Ginseng Extract 1.5 g

USP1292008 Gitoxin 50 mg

USP1292303 Glimepiride 200 mg

USP1292314 Glimepiride Related Compound A Glimepiride cis-isomer

20 mg

USP1292325 Glimepiride Related Compound B Glimepiride Sulfonamide

20 mg

USP1292336 Glimepiride Related Compound C Glimepiride urethane

20 mg

USP1292347 Glimepiride Related Compound D Glimepiride-3-isomer

20 mg

USP1292507 Glipizide 125 mg

USP1292609 Glipizide Related Compound A N-{2-[(4-aminosulfonyl)phenyl]ethyl}-5-methyl-pyrazinecarboxamide

25 mg

USP1292610 Glipizide Related Compound B 6-methyl-N-[2-(4-sulphamoylphenyl)ethyl]pyrazine-2-carboxamide

15 mg

USP1292631 Glipizide Related Compound C 1-cyclohexyl-3-[[4-[2-[[(6-methylpyrazin-2-yl)carbonyl]amino]ethyl]phenyl]sulfonyl]urea

15 mg

USP1294207 Glucosamine HCl 200 mg

USP1294976 Glutamic Acid 200 mg

USP1294987 L-Glutamic Acid HCl 100 mg

USP1294808 Glutamine 100 mg

New USP1294820 Glutathione 300 mg

USP1294848 gamma-Glutamyl-(S)-allyl-L-cysteine 25 mg



Code Product Unit

USP1295505 Glyburide 200 mg

USP1295516 Glyburide Related Compound A 5-chloro-2-methoxy-N-[2-(4-sulfamoylphenyl)ethyl]benzamide

25 mg

USP1295527 Glyburide Related Compound B methyl-[[4-[2-[5(-chloro-2-methoxybenzoyl)-amino]ethyl]phenyl]sulfonyl]carbamate (AS)

25 mg

USP1295607 Glycerin 2 mL

USP1295709 Glyceryl Behenate 200 mg

USP1295724 Glyceryl Distearate 500 mg

USP1295731 Glyceryl Monolinoleate 500 mg

USP1295753 Glyceryl Monooleate 40% 500 mg

USP1295742 Glyceryl Monooleate 90% 250 mg

USP1295800 Glycine 200 mg

USP1295844 Glycitein 15 mg

USP1295855 Glycitin 15 mg

USP1294284 N-Glycolylneuraminic Acid 200 mg

USP1296009 Glycopyrrolate 200 mg

New USP1296010 Glycopyrrolate Erythro Isomer (RS)-3-[(RS)-2-cyclopentyl-2-hydroxy-2-phenylacetoxy]-1,1-dimethylpyrrolidinium bromide

25 mg

New USP1296029 Glycopyrrolate Related Compound A 5-Nitrobenzene-1,3-dicarboxylic acid

50 mg

New USP1296031 Glycopyrrolate Related Compound B 1-Metyhlpyrrolidin-3-yl 2-cyclopentyl-2-hydroxy-2-phenylacetate

75 mg

New USP1296042 Glycopyrrolate Related Compound C 2-Cyclopentyl-2-hydroxy-2-phenylacetic acid

25 mg

USP1295888 Glycyrrhizic Acid 25 mg

USP1296756 Gonadorelin Acetate 50 mg

USP1296767 Gonadorelin Acetate Related Compound A Gonadorelin free acid trifluoroacetate salt

10 mg

USP1297205 Goserelin Acetate 100 mg

USP1297216 Goserelin Related Compound A 4-D-Serine Goserelin

2 mg

USP1297001 Human Chorionic Gonadotropin - 5,760 USP units per package vial

USP1298004 Gramicidin 200 mg

USP1298106 Granisetron HCl 150 mg

USP1298117 Granisetron Related Compound A 2-methyl-N-[(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-2H-indazole-3-carboxamide

15 mg

USP1298128 Granisetron Related Compound B N-[(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3-carboxamide

15 mg

USP1298139 Granisetron Related Compound C N-[(1R,3r,5S)-9-azabicyclo[3.3.1]non-3-yl]-1-methyl-1H-indazole-3-carboxamide HCl

15 mg

USP1298140 Granisetron Related Compound D 1-methyl-1H-indazole-3-carboxylic acid

15 mg

USP1298150 Granisetron Related Compound E (1R,3r,5S)-9-azabicyclo[3.3.1]nonan-3-amine acetate

15 mg

USP1298208 Grape Seeds Oligomeric Proanthocyanidins 500 mg

USP1298219 Purified Grape Seeds Oligomeric Proanthocyanidins

500 mg

USP1298401 Powdered Decaffeinated Green Tea Extract 300 mg

USP1299007 Griseofulvin 200 mg

USP1299200 Griseofulvin Permeability Diameter 2 g

USP1300004 Guaiacol 1 g

USP1301007 Guaifenesin 200 mg

USP1301404 Guanabenz Acetate 200 mg

USP1301608 Guanadrel Sulfate 200 mg

USP1301801 Guanethidine Monosulfate 200 mg

USP1302101 Guanfacine HCl 125 mg



Code Product Unit

USP1302156 Guanine 100 mg

USP1302203 Purified Guggul Extract 500 mg

USP1302214 Guggulsterone Z 25 mg

USP1302305 Halazepam (AS) Controlled Substance CIV 200 mg

USP1302509 Halcinonide 200 mg

USP1302906 Halobetasol Propionate 200 mg

USP1303002 Haloperidol 200 mg

USP1303057 Haloperidol Decanoate 200 mg

USP1303013 Haloperidol Related Compound A 4,4'-Bis[4-(p-chlorophenyl)-4-hydroxy-piperidino]-butyrophenone

10 mg

USP1303501 Halothane 1 mL

USP1304005 Heparin Sodium 10x1 mL

USP1304016 Heparin Sodium for Assays 9.5 mg

USP1304038 Heparin Sodium Identification 50 mg

USP1304049 Heparin Sodium System Suitability 50 mg

USP1304050 Heparin Sodium with Oversulfated Chondroitin Sulfate 8.8 mg

USP1304209 Heptane 3x1.2 mL

USP1305008 Hexachlorophene 500 mg

USP1305303 Hexacosanol 100 mg

USP1305507 2E,4E-Hexadienoic Acid Isobutylamide 25 mg

USP1307003 Hexobarbital Controlled Substance CIII 500 mg

USP1308006 Hexylcaine HCl 1 g

USP1308200 Hexylene Glycol 125 mg

USP1308307 Hexylresorcinol 200 mg

USP1308505 L-Histidine 200 mg

USP1309009 Histamine Dihydrochloride 250 mg

USP1310008 Homatropine HBr 200 mg

USP1311000 Homatropine Methylbromide 250 mg

USP1311306 Homopolymer Polypropylene 3 strips

USP1311408 Homosalate 500 mg

USP1313006 Hydralazine HCl 200 mg

USP1313210 Hydrastine 10 mg

USP1314009 Hydrochlorothiazide 200 mg

USP1315001 Hydrocodone Bitartrate Controlled Substance CII 100 mg

USP1315012 Hydrocodone Bitartrate Related Compound A Morphinan-6-one, 4-hydroxy-3-methoxy-17-methyl Controlled Substance CII

70 mg

USP1316004 Hydrocortisone 200 mg

USP1317007 Hydrocortisone Acetate 200 mg

USP1317302 Hydrocortisone Butyrate 200 mg

USP1318000 Hydrocortisone Cypionate 200 mg

USP1319002 Hydrocortisone Hemisuccinate 200 mg

USP1320001 Hydrocortisone Phosphate Triethylamine 200 mg

USP1321004 Hydrocortisone Valerate 200 mg

USP1322007 Hydroflumethiazide 200 mg

USP1323000 Hydromorphone HCl Controlled Substance CII 50 mg

USP1323019 Hydromorphone N-Oxide HCl Controlled Substance CII 15 mg

USP1323021 Hydromorphone Related Compound A Controlled Substance CII 7,8-didehydro-4,5alpha-epoxy-3-hydroxy-17-methylmorphinan-6-one hydrochloride

10 mg

USP1324002 Hydroquinone 500 mg

USP1325005 Hydroxyamphetamine HBr 200 mg

USP1327000 Hydroxychloroquine Sulfate 200 mg

New USP1327408 6-Hydroxynicotinic Acid 50 mg



Code Product Unit

USP1329006 Hydroxyprogesterone Caproate 200 mg

USP1329709 Hydroxypropyl Betadex 200 mg

USP1329800 Hydroxypropyl Cellulose 500 mg

USP1331008 12-Hydroxystearic Acid 200 mg

USP1332000 Hydroxyurea 200 mg

USP1333003 Hydroxyzine HCl 500 mg

USP1333058 Hydroxyzine Related Compound A p-Chlorobenzhydrylpiperazine

25 mg

USP1334006 Hydroxyzine Pamoate 500 mg

USP1335009 Hyoscyamine Sulfate 125 mg

USP1335010 Hyoscyamine Related Compound A Norhyoscyamine Sulfate

10 mg

USP1335202 Hyperoside 50 mg

USP1330005 Hypromellose (Hydroxypropyl Methylcellulose) 250 mg

USP1335279 Hypromellose Acetate Succinate 100 mg

USP1335304 Hypromellose Phthalate 100 mg

New USP1335428 Ibandronate Related Compound A 3-[Methyl(pentyl)amino]propanoic acid HCl

25 mg

USP1335508 Ibuprofen 750 mg

USP1335541 Ibuprofen Related Compound C 4-isobutylacetophenone

3x0.2 mL

USP1335701 Idarubicin HCl 50 mg

USP1336001 Idoxuridine 250 mg

USP1336205 Ifosfamide 500 mg

USP1336500 Imidazole 200 mg

USP1336806 Imidurea 200 mg

USP1337004 Iminodibenzyl 25 mg

USP1337809 Imipenem Monohydrate 100 mg

USP1338007 Imipramine HCl 200 mg

New USP1338313 Imiquimod 200 mg

New USP1338324 Imiquimod Related Compound A 1-Isobutyl-1H-imidazo[4,5-c]quinoline

25 mg

New USP1338346 Imiquimod Related Compound C 4-Chloro-1-isobutyl-1H-imidazo[4,5-c]quinolone)

25 mg

New USP1338357 Imiquimod Related Compound D 1-Propyl-1H-imidazo[4,5-c]quinolin-4-amine

25 mg

New USP1338368 Imiquimod Related Compound E N4-Isobutylquinoline-3,4-diamine

25 mg

USP1338801 Indapamide 250 mg

USP1338812 Indapamide Related Compound A 4-Chloro-N-(2-methyl-indol-1-yl)-3-sulfamoylbenzamide (AS)

50 mg

USP1339000 Indigotindisulfonate Sodium 500 mg

USP1339178 Indinavir 100 mg

USP1339189 Indinavir System Suitability 100 mg

USP1340009 Indocyanine Green 200 mg

USP1341001 Indomethacin 200 mg

USP1340960 Inositol 500 mg

USP1342004 Insulin 100 mg

USP1342106 Insulin Human 100 mg

USP1342150 High Molecular Weight Insulin Human 8.4 mg

USP1342208 Insulin (Beef) 100 mg

USP1342321 Insulin Lispro 5.97 mg

USP1342300 Insulin (Pork) 100 mg

USP1343007 Iodipamide 200 mg



Code Product Unit

USP1343517 Iodixanol 200 mg

USP1343540 Iodixanol Related Compound C 5-Acetyl[3-[[3,5-bis[[2,3-dihydroxypropyl) amino]carbonyl]-2,4,6-triiodophenyl]amino]-2-hydroxypropyl]amino]-N,N'-bis- (2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide

25 mg

USP1343550 Iodixanol Related Compound D 5-[Acetyl(2-hydroxy-3-methylpropyl)amino]-N,N'-bis(2,3-dihydroxypropyl) 2,4,6-triiodo-1,3-benzenedicarboxamide

50 mg

USP1343561 Iodixanol Related Compound E 5-[[3-[[3-[[(2,3-Dihydoxypropyl)amino]carbonyl]-5-[[amino]carbonyl]-2,4,6-triiodophenyl](acetylimino)]-2-hydroxypropyl]-(acetylimino)]-N,N'-bis(2,3-dihydoxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide

25 mg

USP1344305 o-Iodohippuric Acid 100 mg

USP1344509 Iodoquinol 100 mg

USP1344600 Iohexol 200 mg

USP1344622 Iohexol Related Compound A 5-(acetylamino)-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide

100 mg

USP1344644 Iohexol Related Compound B 5-amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide

50 mg

USP1344666 Iohexol Related Compound C N,N'-bis(2,3-dihydroxypropyl)-5-nitro-1,3-benzenedicarboxamide

50 mg

USP1344702 Iopamidol 200 mg

USP1344724 Iopamidol Related Compound A N,N'Bis-(1,3-dihydroxy-2-propyl)5-amino-2,4,6-triiodoiso-phthalamide

50 mg

USP1344735 Iopamidol Related Compound B 5-Glycolamido-N,N'-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-2,4,6-triiodoisophthalamide

100 mg

USP1344746 Iopamidol Related Compound C 4-chloro-N1,N3-bis(1,3-dihydroxypropan-2-yl)-5-(S)-lactamido-2,6-diiodoisophthalamide

40 mg

USP1344804 Iopromide 400 mg

USP1344826 Iopromide Related Compound A 5-Amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-N-methyl-1,3-benzenedicarboxamide

50 mg

USP1344837 Iopromide Related Compound B 5-(Acetylamino)-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-N-methyl-1,3-benzenedicarboxamide

50 mg

USP1345002 Iothalamic Acid 200 mg

USP1345104 Ioversol 200 mg

USP1345115 Ioversol Related Compound A 5-Amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide

50 mg

USP1345126 Ioversol Related Compound B N,N'-bis(2,3-dihydroxypropyl)-5-[(N-(2-hydroxyethyl)-carbonyl)methoxy]- 2,4,6-triiodoisophthalamide

50 mg

USP1345159 Ioxaglic Acid 100 mg

USP1345206 Ioxilan 400 mg

USP1345228 Ioxilan Related Compound A 5-amino-2,4,6-triiodo-3 N-(2-hydroxyethyl)carbamoyl benzoic Acid

100 mg

USP1347008 Ipodate Sodium 200 mg

USP1347507 Ipratropium Bromide 100 mg

USP1347518 Ipratropium Bromide Related Compound A endo-3-Hydroxy-8-isopropyl-8-methyl-8-azoniabicyclo[3.2.1]octane bromide

10 mg

USP1347529 Ipratropium Bromide Related Compound B (1R,3r,5S,8s)-3-[[(2RS)-3-hydroxy-2-phenylpropanoyl]oxy]-8-methyl-8-(1-methylethyl)-8-azoniabicyclo[3.2.1]octane, bromide

10 mg

USP1347530 Ipratropium Bromide Related Compound C (2-RS)-3-hydroxy-2-phenylpropanoic acid

15 mg

USP1347700 Irbesartan 200 mg

USP1347711 Irbesartan Related Compound A 1-pentanoylamino-cyclopentanecarboxylic acid[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amide

25 mg

USP1347609 Irinotecan Hydrochloride 100 mg



Code Product Unit

USP1347610 Irinotecan Related Compound A (S)-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione

10 mg

USP1347631 Irinotecan Related Compound B (S)-4,11-diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione

10 mg

USP1347642 Irinotecan Related Compound C (S)-9-[(1,4'-bipiperidine)-1'-carbonyloxy]-4-methyl-11-ethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1Hpyrano[3',4':6,7]indolizino[1,2-b]quinoline hydrochloride

10 mg

USP1347653 Irinotecan Related Compound D [1,4'-Bipiperidine]-1'-carboxylic acid,4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl ester, monohydrochloride,trihydrate, (R)

15 mg

USP1347755 Isoamyl Methoxycinnamate 750 mg

USP1347802 Isobutyl acetate 3x1.2 mL

USP1348000 Isocarboxazid 200 mg

USP1348500 Isoetharine HCl 250 mg

USP1348907 Isoflupredone Acetate 200 mg

USP1349003 Isoflurane 1 mL

USP1349014 Isoflurane Related Compound A 1-chloro-2,2,2-trifluoroethyl chlorodifluoromethyl ether

0.1 mL

USP1349025 Isoflurane Related Compound B 2,2,2-Trifluoroethyldifluoromethyl ether

0.1 mL

USP1349502 L-Isoleucine 200 mg

USP1349604 Isomalathion 50 mg

USP1349626 Isomalt 200 mg

USP1349637 Isomaltulose 5 g

USP1349659 Isometheptene Mucate 200 mg

USP1349706 Isoniazid 200 mg

USP1350002 Isopropamide Iodide 200 mg

USP1350104 Isopropyl Acetate 3x1.2 mL

USP1350400 Isopropyl Myristate 500 mg

USP1350603 Isopropyl Palmitate 500 mg

USP1351005 Isoproterenol HCl 125 mg

USP1351107 Isopteropodine 20 mg

New USP1351800 Isorhamnetin 15 mg

USP1352008 Isosorbide (75% solution) 1 g

USP1353000 Diluted Isosorbide Dinitrate 500 mg

USP1353102 Diluted Isosorbide Mononitrate 350 mg

USP1353113 Diluted Isosorbide Mononitrate Related Compound A 1,4:3,6-dianhydro-D-glucitol 2-nitrate

100 mg

USP1353500 Isotretinoin 200 mg

USP1354003 Isoxsuprine HCl 200 mg

USP1354207 Isradipine 200 mg

USP1354218 Isradipine Related Compound A Isopropyl methyl 4-(4-benzofurazanyl)-2,6-dimethyl-3,5-pyridinecarboxylate

15 mg

USP1354251 Itraconazole 100 mg

New USP1354262 Itraconazole System Suitability Mixture 25 mg

USP1354309 Ivermectin 200 mg

New USP1354900 Kaempferol 15 mg

USP1355006 Kanamycin Sulfate 200 mg

USP1355709 Powdered Kava Extract 1 g

USP1355753 Kawain 200 mg

USP1354852 KDN 3-Deoxy-D-glycero-D-galacto-2-nonulosonic acid

100 mg

USP1356009 Ketamine HCl Controlled Substance CIII 250 mg

USP1356020 Ketamine Related Compound A 1-[(2-Chlorophenyl)(methylimino)methyl]cylcopentanol

50 mg



Code Product Unit

USP1356508 Ketoconazole 200 mg

USP1356632 Ketoprofen 200 mg

USP1356643 Ketoprofen Related Compound A alpha-Methyl-3-(4-methylbenzoyl) benzeneacetic Acid (AS)

25 mg

USP1356552 Ketoprofen Related Compound C (2-(3-carboxyphenyl)propionic acid)

20 mg

USP1356563 Ketoprofen Related Compound D 3-acetylbenzophenone

20 mg

New USP1356315 Ketorolac Related Compound A 5-benzoyl-N-(1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl)-2,3-dihydro-1H-pyrroliine-1-carboxamide

20 mg

New USP1356326 Ketorolac Related Compound B 5-benzoyl-2,3-dihydro-1H-pyrrolizin-1-ol

20 mg

New USP1356337 Ketorolac Related Compound C 5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-one

20 mg

New USP1356348 Ketorolac Related Compound D 5-benzoyl-2,3-dihydro-1H-pyrrolizine

20 mg

New USP1356665 Ketorolac Tromethamine 200 mg

USP1356654 Labetalol HCl 200 mg

New USP1013909 Alpha-Lactalbumin 400 mg

USP1356698 Lactase 200 mg

USP1356734 Lactic Acid (AS) 3x1.5 mL

USP1356687 Lactitol 500 mg

USP1356825 Lactobionic Acid 200 mg

USP1356676 Anhydrous Lactose 100 mg

USP1356701 Lactose Monohydrate 500 mg

USP1356803 Lactulose 750 mg

USP1356836 Lamivudine 200 mg

USP1356847 Lamivudine Resolution Mixture A 10 mg

USP1356858 Lamivudine Resolution Mixture B 10 mg

USP1356756 Lamotrigine 100 mg

USP1356778 Lamotrigine Related Compound B 2,3-dichlorobenzoic acid

20 mg

USP1356789 Lamotrigine Related Compound C 3-amino-6-(2,3-dichlorophenyl)1,2,4-triazin-5(4H)-one

10 mg

USP1356790 Lamotrigine Related Compound D N-[5-amino-6-(2,3-dichlorophenyl)-1,2,4-triazin-3-yl]-2,3-dichlorobenzamide

10 mg

USP1356880 Lanolin 20 g

USP1356905 Lanolin Alcohols 5 g

USP1356916 Lansoprazole 150 mg

USP1356927 Lansoprazole Related Compound A 2-[[[3-methyl-4-(2,2,2-triflouroethoxy)-2-pyridyl]methyl]sulfonyl]benzimidazole

25 mg

USP1356931 Lansoprazole Related Compound B 2-[[[3-methyl-4-(2,2,2-trifluroethoxy)-pyridin-2-yl]methyl]sulfanyl]-1H-benzimidazole

25 mg

USP1356949 Lauric Acid 500 mg

New USP1356945 Lauroyl Arginine (S)-2-dodecanamido-5-guanidinopentanoic acid HCl

100 mg

USP1356950 Lauroyl Polyoxylglycerides 500 mg

USP1356960 Leflunomide 200 mg

USP1357045 Leflunomide Related Compound A 4-trifluoromethyl)aniline

50 mg

USP1357056 Leflunomide Related Compound B 2-Cyano-3-hydroxy-N-(4'-trifluoromethylphenyl)-crotone amide

10 mg

USP1357067 Leflunomide Related Compound C N-(3'-Trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide

10 mg

USP1356971 Letrozole 200 mg



Code Product Unit

USP1356982 Letrozole Related Compound A 4,4'-(1H-1,3,4-triazol-1-ylmethylene)dibenzonitrile

25 mg

USP1357001 L-Leucine 200 mg

USP1358004 Leucovorin Calcium 500 mg

USP1358503 Leuprolide Acetate 200 mg

USP1358784 Levalbuterol HCl 200 mg

USP1358795 Levalbuterol Related Compound A 4-(2-tert-butylamino-ethyl)-2-hydroxymethyl-phenol

30 mg

USP1358809 Levalbuterol Related Compound B alpha-[{(1,1-Dimethylethyl)amino}methyl]-4-hydroxy-3-methyl-benzenemethanol

20 mg

USP1358810 Levalbuterol Related Compound C alpha-[{(1,1-Dimethylethyl)amino}methyl]-4-hydroxy-3-(methoxymethyl)-benzenemethanol

30 mg

USP1358820 Levalbuterol Related Compound D 5-[2-{(1,1-dimethylethyl)amino}-1-hydroxyethyl]-2-hydroxy-benzaldehyde benzenesulfonic acid salt

30 mg

USP1358831 Levalbuterol Related Compound E alpha-[{(1,1-Dimethylethyl)amino}methyl]-3-(ethoxy-methyl)-4-hydroxy-benzenemethanol

30 mg

USP1358842 Levalbuterol Related Compound F alpha-[{(1,1-Dimethylethyl)amino}methyl}-4-(phenylmethoxy)-1,3-benzenedimethanol

30 mg

USP1358853 Levalbuterol Related Compound G alpha[{(1,1-Dimethylethyl)amino}methyl]-4,5-dihydroxy-1,3-benzenedimethanol

20 mg

USP1358864 Levalbuterol Related Compound H 4-[2-(tert-butylamino)-1-methoxyethyl]-2-(hydroxymethyl)phenol

5 mg

USP1359302 Levamisole HCl 125 mg

USP1359404 Levetiracetam 200 mg

USP1359415 Levetiracetam Racemic Mixture 15 mg

USP1359426 Levetiracetam Related Compound A (S)-N(1-amino-1-oxobutan-2-yl)-4-chlorobutanamide

20 mg

USP1359437 Levetiracetam Related Compound B (S)-2-aminobutanamide HCl

20 mg

USP1359506 Levmetamfetamine Controlled Substance CII 75 mg

USP1359801 Levobunolol HCl 200 mg

USP1359856 Levocabastine HCl 50 mg

USP1359867 Levocabastine Related Compound A 1-[cis-4-cyano-4-(4-fluorophenyl)cyclohexyl]-4-phenylpiperidine-4-carboxylic acid hydrochloride

50 mg

USP1359903 Levocarnitine 400 mg

USP1359925 Levocarnitine Related Compound A 2-propen-1-aminium, 3-carboxy-N,N,N-trimethyl-,chloride

100 mg

USP1361009 Levodopa 200 mg

USP1361010 Levodopa Related Compound A 3-(3,4,6-Trihydroxyphenyl)-alanine

50 mg

USP1420006 Levodopa Related Compound B 3-Methoxytyrosine

50 mg

USP1362103 Levofloxacin 350 mg

USP1362114 Levofloxacin Related Compound A (S)-9-fluoro-3-methyl-10-(piperazin-1-yl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid

25 mg

USP1362125 Levofloxacin Related Compound B (S)-9,10,difluro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid

35 mg

USP1362307 Levomenol 100 mg

USP1362500 Levonordefrin 200 mg

USP1362602 Levonorgestrel 200 mg

USP1363004 Levopropoxyphene Napsylate 300 mg

USP1364007 Levorphanol Tartrate Controlled Substance CII 500 mg

USP1365000 Levothyroxine 500 mg



Code Product Unit

USP1365021 Levothyroxine for Peak Identification levothyroxine sodium spiked with liothyronine, triiodothyroacetic acid, tetraiodothyroacetic acid

15 mg

USP1366002 Lidocaine 250 mg

USP1367005 Lincomycin HCl 200 mg

USP1367504 Lindane 200 mg

USP1367708 Linoleoyl Polyoxylglycerides 100 mg

USP1368008 Liothyronine 250 mg

USP1368201 Alpha Lipoic Acid 500 mg

USP1368609 Lisinopril 300 mg

USP1368610 Lisinopril Related Compound A ((S)-2-{(3S,8aS)-3-(4-aminobutyl)-1,4-dioxohexahydropyrrolo[1,2-a]pyrazin-2(1H)-yl}-4-phenylbutanoic acid

15 mg

USP1369000 Lithium Carbonate 300 mg

USP1370000 Loperamide HCl 200 mg

USP1370101 Lopinavir 350 mg

USP1370156 Lopinavir System Suitability Mixture 10 mg

USP1370203 Loracarbef 200 mg

USP1370225 Loracarbef L-Isomer 25 mg

USP1370270 Loratadine 200 mg

USP1370280 Loratadine Related Compound A 8-chloro-6,11-dihydro-11(4-piperidinylidene)-5H-benzo[5,6]cyclohepta [1,2-b]pyridine

15 mg

USP1370291 Loratadine Related Compound B 8-chloro-6,11-dihydro-11-(N-methyl-4-piperidinylidene)-5H-benzo[5,6]cyclohepta [1,2-b]pyridine

15 mg

USP1370269 Loratadine Related Compound C 8-Chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-one

15 mg

USP1370305 Lorazepam Controlled Substance CIV 200 mg

USP1370327 Lorazepam Related Compound A 7-Chloro-5-(o-chlorophenyl)-1,3-dihydro-3-acetoxy-2H-1,4-benzodiazepine-2-one Controlled Substance

25 mg

USP1370338 Lorazepam Related Compound B 2-Amino-2',5-dichlorobenzophenone

25 mg

USP1370349 Lorazepam Related Compound C 6-Chloro-4-(o-chlorophenyl)-2-quinazolinecarboxaldehyde

25 mg

USP1370350 Lorazepam Related Compound D 6-Chloro-4-(o-chlorophenyl)-2-quinazolinecarboxylic Acid

25 mg

USP1370360 Lorazepam Related Compound E 6-Chloro-4-(o-chlorophenyl)-2-quinazoline Methanol

25 mg

USP1370462 Losartan Potassium 250 mg

USP1370600 Lovastatin 125 mg

USP1370611 Lovastatin Related Compound A Dihydro-lovastatin

20 mg

USP1370702 Loxapine Succinate 125 mg

New USP1370713 Loxapine Related Compound A 3-Chloro-11-(4-methylpiperazine-1-yl)dibenzo[b,f][1,4]oxazepine

20 mg

USP1370746 Lumefantrine 100 mg

USP1370757 Lumefantrine Related Compound A (RS,Z)-2-(Dibutylamino)-2-(2,7-dichloro-9-(4-chlorobenzylidene)-9H-fluoren-4-yl)ethanol

25 mg

USP1370804 Lutein 1 mL

USP1370860 Lycopene 500 mg

USP1370906 Lynestrenol 20 mg

USP1711133 Lypressin 8-L-lysine vasopressin

2.2 mg

USP1371002 Lysergic Acid Diethylamide Tartrate (AS) (LSD) Controlled Substance CI 10 mg

USP1371501 L-Lysine Acetate 200 mg

USP1372005 L-Lysine HCl 200 mg



Code Product Unit

USP1372050 Lysophosphatidylcholine 350 mg

USP1373008 Mafenide Acetate 400 mg

USP1286209 Mafenide Related Compound A 4-Formylbenzenesulfonamide

50 mg

USP1374000 Magaldrate 200 mg

USP1374226 Magnesium Carbonate (AS) 2 g

USP1374248 Magnesium Chloride (AS) 1 g

USP1374260 Magnesium Hydroxide (AS) 1 g

USP1374292 Magnesium Phosphate (AS) 2 g

USP1374306 Magnesium Salicylate 200 mg

USP1374340 Magnesium Stearate (AS) 5 g

USP1374361 Magnesium Sulfate (AS) 1 g

New USP1374383 Powdered Malabar-Nut-Tree Leaf Extract 1 g

USP1374408 Malathion 500 mg

USP1374500 Maleic Acid 300 mg

USP1374601 Malic Acid 500 mg

USP1374907 Maltitol 200 mg

USP1375003 Maltol (FCC) 4 g

USP1375025 Maltose Monohydrate 500 mg

USP1375058 Mandelic Acid (AS) 500 mg

USP1375069 Mangafodipir Trisodium 200 mg

USP1375070 Mangafodipir Related Comound A Manganese (II) dipyridoxyl monophosphate sodium salt

15 mg

USP1375080 Mangafodipir Related Comound B Manganese (II) dipyridoxyl diphosphate mono-overalkylated sodium salt

15 mg

USP1375091 Mangafodipir Related Comound C Manganese (III) dipyridoxyl diphosphate sodium salt

15 mg

USP1375127 Manganese Chloride (AS) 1 g

USP1375149 Manganese Sulfate (AS) 1 g

USP1375105 Mannitol 200 mg

USP1375160 Mannosamine HCl 300 mg

USP1375182 Mannose 300 mg

USP1375207 Maprotiline HCl 200 mg

New USP1539803 Maritime Pine Extract 2 g

USP1375309 Mazindol Controlled Substance CIV 350 mg

USP1375502 Mebendazole 200 mg

USP1375706 Mebrofenin 100 mg

USP1376006 Mecamylamine HCl 200 mg

USP1376017 Mecamylamine Related Compound A N,1,7,7-tetramethyl bicyclo[2.2.1]heptan-2-amine hydrochloride

10 mg

USP1377009 Meclizine HCl 500 mg

USP1377508 Meclocycline Sulfosalicylate 300 mg

USP1377803 Meclofenamate Sodium 500 mg

USP1378001 Medroxyprogesterone Acetate 200 mg

USP1378012 Medroxyprogesterone Acetate Related Compound A 4,5-beta-Dihydromedroxyprogesterone acetate

25 mg

USP1379004 Medrysone 500 mg

USP1379605 Mefenamic Acid 200 mg

USP1379059 Mefloquine Hydrochloride 100 mg

USP1379060 Mefloquine Related Compound A threo-mefloquine

20 mg

USP1379106 Megestrol Acetate 500 mg

USP1379140 Meglumine (AS) 500 mg



Code Product Unit

USP1379183 Melamine 2,4,6-Triamino-1,3,5-triazine

250 mg

USP1380105 Melatonin (AS) 100 mg

USP1379254 Melengestrol Acetate 125 mg

USP1379265 Melengestrol Acetate Related Compound A 17-hydroxy-16-methylenepregna-4-ene-3,20-dione 17-acetate

25 mg

USP1379276 Melengestrol Acetate Related Compound B 6,16-dimethylene-17-hydroxypregna-4-ene-3,20-dione 17-acetate

25 mg

USP1379401 Meloxicam 400 mg

USP1379412 Meloxicam Related Compound A ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate-1,1-dioxide

25 mg

USP1379423 Meloxicam Related Compound B 2-Amino-5-methyl-thiazole

25 mg

USP1379434 Meloxicam Related Compound C Isopropyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate-1,1-dioxide

30 mg

USP1379445 Meloxicam Related Compound D 4-Methoxy-2-methyl-(5-methyl-1,3-thiazol-2yl)-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide

30 mg

USP1381006 Menadione (Vitamin K3) 200 mg

USP1381709 Menthol 250 mg

USP1381742 Menthyl Anthranilate 500 mg

USP1382009 Mepenzolate Bromide 200 mg

USP1383001 Meperidine HCl Controlled Substance CII 200 mg

USP1385007 Mephenytoin 250 mg

USP1386000 Mephobarbital Controlled Substance CIV 250 mg

USP1387002 Mepivacaine HCl 200 mg

USP1388005 Meprednisone 200 mg

USP1389008 Meprobamate Controlled Substance CIV 200 mg

USP1390007 Meprylcaine HCl 200 mg

USP1391000 3-Mercapto-2-methylpropanoic Acid 1,2-Diphenylethylamine Salt 75 mg

USP1392002 Mercaptopurine 500 mg

USP1392454 Meropenem 300 mg

USP1392705 Mesalamine 200 mg

USP1392807 Mesna 200 mg

USP1392818 Mesna Related Compound A 2-(Acetylsulfanyl)ethanesulfonic acid

50 mg

USP1392829 Mesna Related Compound B (2,2-(Disulfanediyl)bis(ethanesulfonic acid))

50 mg

USP1393005 Mesoridazine Besylate 250 mg

USP1394008 Mestranol 200 mg

USP1395500 Metaproterenol Sulfate 200 mg

USP1396003 Metaraminol Bitartrate 200 mg

USP1396309 Metformin HCl 200 mg

USP1396310 Metformin Related Compound A 1-Cyanoguanidine

30 mg

USP1396331 Metformin Related Compound B 1-Methylbiguanide hydrochloride

25 mg

USP1396342 Metformin Related Compound C N,N-Dimethyl-[1,3,5]triazine-2,4,6-triamine

25 mg

USP1396364 Methacholine Chloride (AS) 500 mg

USP1396400 Methacrylic Acid Copolymer Type A 200 mg

USP1396502 Methacrylic Acid Copolymer Type B 200 mg

USP1396604 Methacrylic Acid Copolymer Type C 200 mg

New USP1396659 Partially-Neutralized Methacrylic Acid and Ethyl Acrylate Copolymer (1:1) 1 g

USP1397006 Methacycline HCl 200 mg

USP1398009 Methadone HCl Controlled Substance CII 200 mg



Code Product Unit

USP1399001 Methamphetamine HCl Controlled Substance CII 125 mg

USP1401001 Methantheline Bromide 200 mg

USP1402004 Methapyrilene Fumarate 200 mg

USP1405002 Metharbital Controlled Substance CIII 200 mg

USP1406005 Methazolamide 500 mg

USP1408000 Methdilazine HCl 200 mg

USP1409003 Methenamine 500 mg

USP1409502 Methenamine Hippurate 200 mg

USP1409604 Methenamine Mandelate 200 mg

USP1410002 Methicillin Sodium (AS) 500 mg

USP1411005 Methimazole 200 mg

USP1411504 L-Methionine 200 mg

USP1412008 Methocarbamol 200 mg

USP1413000 Methohexital Controlled Substance CIV 500 mg

New USP1413988 R-Methotrexate (R)-2-(4-{[(2,4-diaminopteridin-6-yl)methyl](methyl)amino}benzamido)pentanedioic acid

5 mg

New USP1413999 Methotrexate System Suitability Mixture 5 mg

USP1414003 Methotrexate 500 mg

USP1414025 Methotrexate Related Compound B (S)-2-{4-[2,4-diaminopteridin-6yl)methylamino]benzoamido}pentanedioic acid

75 mg

USP1414036 Methotrexate Related Compound C (S)-2-(4{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl](methyl)amino}benzamido)pentanedioic acid

50 mg

USP1414058 Methotrexate Related Compound E 4-{[(2,4-Diaminopteridin-6-yl)methyl](methyl)amino}benzoic acid, hemihydrochloride

50 mg

USP1415006 Methotrimeprazine 200 mg

USP1416009 Methoxamine HCl 200 mg

USP1417001 Methoxsalen 200 mg

USP1418004 Methoxyflurane 1 mL

USP1418650 Methoxymethylguanine 20 mg

USP1421009 Methscopolamine Bromide 200 mg

USP1422001 Methsuximide 500 mg

USP1424007 Methyclothiazide 200 mg

USP1424018 Methyclothiazide Related Compound A 4-amino-6-chloro-N-3-methyl-m-benzenedisulfonamide

100 mg

USP1424051 Methyl Acetate 3x1.2 mL

USP1424109 Methyl Alcohol 3x1.5 mL

USP1424211 Methylbenzethonium Chloride 500 mg

USP1424222 Methyl Benzylidene Camphor 200 mg

USP1424153 3-Methyl-1-butanol 3x1.2 mL

USP1424233 Methyl Caprate 300 mg

USP1424244 Methyl Caproate 300 mg

USP1424255 Methyl Caprylate 300 mg

USP1424506 Methylcellulose (AS) 1 g

USP1425000 4-Methyl-2,5-dimethoxyamphetamine HCl (STP) (AS) Controlled Substance CI 25 mg

USP1426002 Methyldopa 500 mg

USP1427005 Methyldopate HCl 200 mg

USP1428008 Methylene Blue 250 mg

USP1429000 Methylenedioxy-3,4-amphetamine HCl (MDA) (AS) Controlled Substance CI 25 mg

USP1430000 Methylergonovine Maleate 50 mg

USP1430101 Methyl Ethyl Ketone 3x1.2 mL

USP1430203 Methyl Isobutyl Ketone 3x1.2 mL

USP1430305 Methyl Laurate 500 mg



Code Product Unit

USP1430327 Methyl Linoleate 5x50 mg

USP1430349 Methyl Linolenate 5x50 mg

USP1430509 3-O-Methylmethyldopa 50 mg

USP1431501 Methyl Myristate 300 mg

USP1431556 Methyl Oleate 500 mg

USP1431603 Methyl Palmitate 300 mg

USP1431625 Methyl Palmitoleate 300 mg

USP1432005 Methylparaben 125 mg

USP1433008 Methylphenidate HCl Controlled Substance CII 125 mg

USP1434011 Methylphenidate HCl Erythro Isomer Solution Controlled Substance CII 0.5 mL

USP1434022 Methylphenidate Related Compound A alpha-Phenyl-2-piperidineacetic Acid HCl

50 mg

USP1435003 Methylprednisolone 200 mg

USP1436006 Methylprednisolone Acetate 200 mg

USP1437009 Methylprednisolone Hemisuccinate 200 mg

USP1437202 Methylpyrrolidone 2 g

USP1437053 2-Methyl-1-propanol 3x1.2 mL

USP1437450 Methyl Salicylate (AS) 2 mL

USP1437508 Methyl Stearate 300 mg

USP1437600 Methylsulfonylmethane 200 mg

USP1438001 Methyltestosterone Controlled Substance CIII 200 mg

USP1438205 Methyl Tricosanoate 200 mg

USP1440003 Methysergide Maleate 350 mg

USP1440808 Metoclopramide HCl 500 mg

USP1441200 Metolazone 200 mg

New USP1268772 Metomidate HCl methyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate hydrochloride

50 mg

USP1441287 Metoprolol Fumarate 200 mg

USP1441232 Metoprolol Related Compound A (+/-)1-(ethylamino)-3-[4-(2-methoxyethyl)phenoxy]-propan-2-ol

20 mg

USP1441243 Metoprolol Related Compound B (+/-)1-Chloro-2-hydroxy-3-[4-(2-methoxyethyl)phenoxy]propane

50 mg

USP1441254 Metoprolol Related Compound C (+/-)4-[2-Hydroxy-3-(1-methylethyl)aminopropoxy]benzaldehyde

20 mg

USP1441265 Metoprolol Related Compound D (+/-)N,N-bis-[2-hydroxy-3-[4-(2-methoxyethyl)phenoxy]propyl] (1-methylethyl)amine hydrochloride

50 mg

USP1441298 Metoprolol Succinate 200 mg

USP1441301 Metoprolol Tartrate 200 mg

USP1441505 Metrizamide 500 mg

USP1442009 Metronidazole 100 mg

USP1442100 Metronidazole Benzoate 100 mg

USP1443001 Metyrapone 200 mg

USP1443205 Metyrosine 200 mg

USP1443250 Mexiletine HCl 200 mg

USP1443307 Mezlocillin Sodium 350 mg

USP1443362 Mibolerone Controlled Substance CIII 200 mg

USP1443409 Miconazole 200 mg

USP1443500 Miconazole Nitrate 200 mg

USP1443599 Midazolam Controlled Substance CIV 300 mg

USP1443602 Midazolam HCl (AS) Controlled Substance CI 200 mg

USP1443704 Midodrine HCl 200 mg

USP1443715 Midodrine Related Compound A 2-amino-1-(2,5-dimethoxyphenyl)ethanol

40 mg



Code Product Unit

USP1443759 Mifepristone 200 mg

USP1443806 Milbemycin Oxime 200 mg

USP1443850 Powdered Milk Thistle Extract 250 mg

USP1443908 Milrinone 500 mg

USP1443919 Milrinone Related Compound A 1,6-Dihydro-2-methyl-6-oxo(3,4'-bipyridine)-5-carboxamide

50 mg

USP1443952 Mineral Oil 1.5 mL

USP1444004 Minocycline HCl 350 mg

USP1444208 Minoxidil 125 mg

USP1444279 Mirtazapine 350 mg

USP1444285 Mirtazapine Related Compound A 1,2,3,4,10,14b-hexahydropyrazino[2,1-a}pyrido[2,3-c][2]benzazepine

15 mg

New USP1444235 Mirtazapine Related Compound B 1,2,3,4,10,14b-Hexahydro-2-methylpyrazino[2,1-a]pyrido[2,3-c][2]benzazepine 2-oxide monohydrate

25 mg

New USP1444241 Mirtazapine Related Compound C 2-Methyl-3,4,10,14b-tetrahydrobenzo[c]pyrazino[1,2-a]pyrido[3,2-f]azepin-1(2H)-one

50 mg

New USP1444252 Mirtazapine Related Compound D 2-Methyl-1,2,3,4-tetrahydrobenzo[c]pyrazino[1,2-a]pyrido[3,2-f]azepin-10(14bH)-one

50 mg

USP1444296 Mirtazapine Resolution Mixture 25 mg

USP1444300 Misoprostol 100 mg

USP1444707 Mitomycin 50 mg

USP1445007 Mitotane 500 mg

USP1445200 Mitoxantrone HCl 400 mg

USP1445211 Mitoxantrone System Suitability Mixture 0.3 mg

USP1445404 Modafinil Controlled Substance CIV 200 mg

USP1445346 Modafinil Related Compound A 2-[(diphenylmethyl)sulfinyl]acetic acid

20 mg

USP1445357 Modafinil Related Compound B 2-[diphenylmethyl)sulfonyl]acetamide

20 mg

USP1445368 Modafinil Related Compound C 2-[(diphenylmethyl)sulfenyl]acetamide

20 mg

USP1445379 Modafinil Related Compound D Bis (diphenylmethyl)ether

20 mg

USP1445380 Modafinil Related Compound E Bis(diphenylmethyl)disulfide

20 mg

USP1445459 Molindone HCl 500 mg

USP1445470 Mometasone Furoate 200 mg

USP1445481 Monensin Sodium 200 mg

USP1445506 Monobenzone 200 mg

USP1445925 Monoethanolamine 1 mL

USP1446000 Monoglycerides 125 mg

USP1446600 Monosodium Glutamate (AS) 1 g

USP1446804 Monostearyl Maleate 100 mg

New USP1446815 Montelukast Dicyclohexylamine 150 mg

New USP1446837 Montelukast for Peak Identification 20 mg

New USP1446848 Montelukast Racemate 20 mg

New USP1446859 Montelukast Sodium 150 mg

USP1446906 Morantel Tartrate 100 mg

USP1446950 Moricizine HCl 250 mg

USP1447002 Morphine Monohydrate (AS) Controlled Substance CII 50 mg

USP1448005 Morphine Sulfate Controlled Substance CII 500 mg

USP1448016 Morphine Sulfate Related Compound A Morphine N-Oxide Controlled Substance CI

20 mg

USP1448027 Morphine Sulfate Related Compound B Pseudomorphine Controlled Substance CII

20 mg



Code Product Unit

USP1448606 Moxifloxacin HCl 200 mg

USP1448617 Moxifloxacin Related Compound A 1-cyclopropyl-6,8-difluoro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

25 mg

USP1448901 Mupirocin 50 mg

USP1448912 Mupirocin Calcium 200 mg

USP1448923 Mupirocin Lithium 100 mg

USP1448956 Mycophenolate Mofetil 200 mg

USP1448967 Mycophenolate Mofetil Related Compound A 2-morpholinoethyl-(E)-6-(1,3-dihydro-4,6-dihydroxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate

15 mg

USP1448978 Mycophenolate Mofetil Related Compound B [(RS)-7-hydroxy-5-methoxy-4-methyl-6-[2-(5-methyl-2-oxo-tetrahydrofuran-5-yl)ethyl]-3H-isobenzofuranyl-1-one]

15 mg

USP1448990 Myristic Acid 200 mg

USP1449008 Myristyl Alcohol 1 g

USP1449518 Nabumetone 200 mg

USP1449530 Nabumetone Related Compound A 1-(6-methoxy-2-naphthyl)-but-1-en-3-one

15 mg

USP1449700 Nadolol 200 mg

USP1450007 Nafcillin Sodium 200 mg

USP1450404 Naftifine HCl 200 mg

USP1451000 Nalidixic Acid 200 mg

USP1452002 Nalorphine HCl Controlled Substance CIII 250 mg

USP1453005 Naloxone 125 mg

USP1453504 Naltrexone 200 mg

USP1453526 Naltrexone Related Compound A N-(3-butenyl)-noroxymorphone HCl Controlled Substance CII

30 mg

USP1454008 Nandrolone Controlled Substance CIII 50 mg

USP1455000 Nandrolone Decanoate Controlled Substance CIII 250 mg

USP1456003 Nandrolone Phenpropionate Controlled Substance CIII 250 mg

USP1457006 Naphazoline HCl 200 mg

USP1457083 Naphthalene 200 mg

USP1457301 Naproxen 200 mg

USP1457403 Naproxen Sodium 200 mg

USP1457458 Narasin 125 mg

USP1457469 Naratriptan HCl 125 mg

USP1457491 Naratriptan Resolution Mixture 20 mg

USP1457505 Natamycin 200 mg

USP1457607 Nateglinide 200 mg

USP1457618 Nateglinide Related Compound A trans-4-isopropylcyclohexanecarboxylic acid

10 mg

USP1457629 Nateglinide Related Compound B N-(trans-4-isopropylcyclohexanecarbonyl)-L-phenylalanine

10 mg

USP1457630 Nateglinide Related Compound C N-(cis-4-isopropylcyclohexanecarbonyl)-D-phenylalanine

5 mg

USP1457844 Near IR System Suitability unit

USP1457902 Nefazodone HCl 200 mg

USP1457913 Nefazodone Related Compound A 1-(3-chlorophenyl)-4-(3-chloropropyl)-piperazine hydrochloride

25 mg

USP1457924 Nefazodone Related Compound B 2-[3-[4-(4-chlorophenyl)-1-piperazinyl]propyl]-5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-3H-1,2,4-triazol-3-one hydrochloride

25 mg

New USP1457968 Nelfinavir Mesylate 200 mg



Code Product Unit

USP1457979 Nelfinavir Related Compound A (3S,4aS,8aS)-N-tert-Butyl-2-[(2R,3R)-2-hydroxy-3-(3-hydroxy-2-methylbenzamido)-4-(phenylsulfinyl)butyl]decahydroisoquinoline-2-carboxymide

15 mg

USP1458009 Neomycin Sulfate 200 mg

USP1459001 Neostigmine Bromide 200 mg

USP1460000 Neostigmine Methylsulfate 200 mg

USP1460204 Neotame 200 mg

USP1460215 Neotame Related Compound A N-[N-(3-3-dimethylbutyl)-L-alpha-aspartyl]-L-phenylalanine

15 mg

USP1460500 Netilmicin Sulfate 500 mg

USP1460703 Nevirapine Anhydrous 100 mg

USP1460714 Nevirapine Hemihydrate 100 mg

USP1460725 Nevirapine Related Compound A 5,11-Dihydro-4-methyl-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one

15 mg

USP1460736 Nevirapine Related Compound B 5,11-Dihydro-4-methyl-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one

15 mg

USP1461003 Niacin 200 mg

USP1462006 Niacinamide (Vitamin B3) 500 mg

USP1463304 Nicotine Bitartrate Dihydrate 500 mg

USP1463508 Nifedipine 125 mg

USP1463600 Nifedipine Nitrophenylpyridine Analog 25 mg

USP1463701 Nifedipine Nitrosophenylpyridine Analog 25 mg

USP1463858 Nimodipine 125 mg

USP1463870 Nimodipine Related Compound A 2-methoxyethyl-1-methylethyl-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate

50 mg

USP1463869 Nimodipine Related Compound B bis(2-methoxyethyl) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate (AS)

50 mg

USP1463960 Nitazoxanide 200 mg

USP1463971 Niltazoxanide Related Compound A 2-Amino-5-nitrothiazole

25 mg

USP1463950 Nitrilotriacetic Acid 50 mg

USP1464001 Nitrofurantoin 500 mg

USP1021703 Nitrofurantoin Related Compound A N-(Aminocarbonyl)-N-[([5-nitro-2-furanyl]-methylene)-amino]-glycine

20 mg

USP1465004 Nitrofurazone 200 mg

USP1466007 Nitrofurazone Related Compound A 5-Nitro-2-furfuraldazine

500 mg

USP1465503 Nitrofurfural Diacetate 100 mg

USP1466506 Diluted Nitroglycerin 5 ampules

USP1467804 Nizatidine 200 mg

USP1467950 Nonoxynol 9 0.5 mL

USP1468002 Nonoxynol 10 200 mg

USP1468400 Nordazepam Controlled Substance CIV 7-Chloro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one

50 mg

USP1468501 Norepinephrine Bitartrate 125 mg

USP1469005 Norethindrone 200 mg

USP1470004 Norethindrone Acetate 100 mg

USP1471506 Norfloxacin 200 mg

USP1471914 Norgestimate 200 mg

USP1471925 Norgestimate Related Compound A Levonorgestrel Acetate

25 mg

USP1471958 Deacetylnorgestimate (E)- and (Z)-17-deacetyl norgestimate mixture

25 mg

USP1472000 Norgestrel 125 mg

USP1473002 Noroxymorphone HCl Controlled Substance CII 50 mg



Code Product Unit

USP1473206 Norphenylephrine Hydrochloride 25 mg

USP1474005 Nortriptyline HCl 200 mg

USP1474504 Noscapine 100 mg

USP1475008 Novobiocin 200 mg

USP1476000 Nylidrin HCl 200 mg

USP1477003 Nystatin 200 mg

USP1477900 Octinoxate (Octyl Methoxycinnamate) 500 mg

USP1477943 Octisalate (Octyl Salicylate) 400 mg

USP1477411 Octocrylene 500 mg

USP1477502 Octoxynol 9 200 mg

USP1477808 Octyldodecanol 200 mg

USP1478108 Ofloxacin 200 mg

USP1478119 Ofloxacin Related Compound A (RS)-9-fluoro-2,3-dihydro-3-methyl-7-oxo-10-(piperazin-1-yl)-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid

25 mg

USP1478301 Olanzapine 200 mg

USP1478312 Olanzapine Related Compound A 5-Methyl-2-((2-nitrophenyl)amino)-3-thiophenecarbonitrile

25 mg

USP1478323 Olanzapine Related Compound B 2-methyl-10H-thieno-[2,3-b][1,5]benzodiazepin-4[5H]-one

25 mg

USP1478334 Olanzapine Related Compound C 2-methyl-4-(4-methylpiperazin-1-yl)-10H-benzo[b]thieno[2,3-e][1,4]diazepine 4'-N-oxide

15 mg

USP1478130 Oleic Acid 1 g

USP1478152 Oleoyl Polyoxylglycerides 100 mg

USP1478200 Oley Oleate 0.5 mL

USP1478254 Olive Oil (AS) 1 g

New USP1478378 Olmesartam Medoxomil Related Compound A 1-{[2'-(1H-Tetrazol-5-yl)biphenyl-4-yl]methyl}-4,4-dimethyl-2-propyl-1H-furo[3,4-d]imidazol-6(4H)-one

20 mg

USP1478403 Olopatadine HCl 150 mg

USP1478425 Olopatadine Related Compound B (Z)-3-{2-(carboxymethyl)dibenzo[b,e]oxepin-11(6H)-ylidene}-N,N-dimethylpropan-1-amine oxide

35 mg

USP1478436 Olopatadine Related Compound C (11-oxo-6,11-dihydrodibenzo[b,e]oxepin-2-yl)acetic acid

35 mg

USP1478505 Omeprazole 200 mg

USP1478549 Omeprazole Magnesium 10 mg

USP1478516 Omeprazole Related Compound A Omeprazole Sulfone (AS)

15 mg

USP1478571 Ondansetron 300 mg

USP1478582 Ondansetron HCl 300 mg

USP1478593 Ondansetron Related Compound A 3[(Dimethylamino)methyl]-1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one hydrochloride

50 mg

USP1478618 Ondansetron Related Compound C 1,2,3,9-Tetrahydro-9-methyl-4H-carbazol-4-one

30 mg

USP1478629 Ondansetron Related Compound D 1,2,3,9-Tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one

30 mg

USP1478630 Ondansetron Resolution Mixture 50 mg

USP1478673 Orbifloxacin 350 mg

USP1478800 Orlistat 200 mg

USP1478811 Orlistat Related Compound A (3S,4S)3-hexyl-4-[(R)-2-hydroxytridecyl]-2-oxetanone

25 mg

USP1478822 Orlistat Related Compound B diisopropyl bicarbamate

10 mg

USP1478833 Orlistat Related Compound C Triphenylphosphine oxide

25 mg



Code Product Unit

USP1478844 Orlistat Related Compound D N-formyl-L-leucine (3S,4R,6S)-tetrahydro-3-hexyl-2-oxo-6-undecyl-2H-pyran-4-yl ester

10 mg

USP1478855 Orlistat Related Compound E N-formyl-S-isoleucin-(S)-1-[[(2S, 3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester

10 mg

USP1479009 Orphenadrine Citrate 200 mg

USP1479010 Orphenadrine Related Compound A (RS)-N,N-dimethyl-2-[(3-methylphenyl)-phenylmethoxy]ethanamine citrate (AS)

50 mg

USP1479020 Orphenadrine Related Compound B N-ethyl-N,N-dimethyl[2-[2-methylbenzhydryloxy)ethyl]ammonium chloride

20 mg

USP1479031 Orphenadrine Related Compound C N-methyl-[2-(2-methylbenhydryloxy)ethyl]amine hydrochloride

20 mg

USP1479304 Oseltamivir Phosphate 200 mg

USP1479315 Oseltamivir Related Compound A (3S,4R,5S)-ethyl 4-acetamido-5-amino-2-azido-3-(penta-3-yloxy)cyclohexanecarboxylate

10 mg

USP1481000 Oxacillin Sodium 200 mg

USP1481204 Oxaliplatin 125 mg

USP1481215 Oxaliplatin Related Compound A Oxalic acid dihydrate

100 mg

USP1481226 Oxaliplatin Related Compound B [SP-4-2-(1R-trans-)]-(1,2-cyclohexanediamine-N,N')dinitratoplatinum (II)

15 mg

USP1481237 Oxaliplatin Related Compound C [1R-trans-(1,2-cyclohexanediamine-N,N')]-trans-dihydroxido-[oxalate(2-)-O,O']platinum (IV)

20 mg

USP1481248 Oxaliplatin Related Compound D cis[(1S,2S)-1,2-cyclohexanediamine-N,N'][oxalato(2-)-O,O']platinum

10 mg

USP1481260 Oxaliplatin Related Compound F [SP-4-2-(1R-trans)]-(1,2-cyclohexanediamine-N-N')diiodidoplatinum(II)

25 mg

USP1481306 Oxaliplatin System Suitability [SP-4-2-(1R-trans)]-(1,2-cyclohexanediamine-N,N')dichloridoplatinum (II)

25 mg

USP1482003 Oxandrolone Controlled Substance CIII 50 mg

USP1482014 Oxandrolone Related Compound A 17beta-hydroxy-17alpha-methyl-2-oxa-5alpha-androst-7-en-3-one Controlled Substance CIII

20 mg

USP1482025 Oxandrolone Related Compound B 17 beta-hydroxy-17-alpha-methyl-4-oxa-5 alpha-androsta-3-one Controlled Substance CIII

20 mg

USP1482036 Oxandrolone Related Compound C 17,17-dimethyl-18-nor-2-oxa-5alpha-androst-13-en-3-one Controlled Substance CIII

20 mg

USP1482207 Oxaprozin 200 mg

USP1483006 Oxazepam Controlled Substance CIV 200 mg

USP1483152 Oxcarbazepine 100 mg

New USP1483185 Oxcarbazepine Related Compound C Acridin-9(10H)-one

10 mg

USP1483301 Oxfendazole 200 mg

USP1483505 Oxprenolol HCl 200 mg

USP1484009 Oxtriphylline 500 mg

USP1485001 Oxybenzone 150 mg

USP1485103 Oxybutynin Chloride 200 mg

USP1485114 Oxybutynin Related Compound A Phenylcyclohexylglycolic Acid

100 mg

USP1485125 Oxybutynin Related Compound B Cyclohexyl mandelic acid methyl ester

20 mg

USP1485136 Oxybutynin Related Compound C 4-(Ethylmethylamino)but-2-ynyl(+/-)-2-cyclohexyl-2-hydroxy-2-phenylacetate hydrochloride

20 mg

USP1485191 Oxycodone Controlled Substance CII 200 mg

USP1485205 Oxycodone Hydrochloride Controlled Substance CII 1 g

USP1485216 Oxycodone Related Compound A 14-hydroxycodeinone Controlled Substance CII

10 mg



Code Product Unit

USP1485227 Oxycodone Related Compound B Oxycodone N-oxide Controlled Substance CII

15 mg

USP1485238 Oxycodone Related Compound C Codeinone Controlled Substance CII

15 mg

USP1486004 Oxymetazoline HCl 200 mg

USP1487007 Oxymetholone Controlled Substance CIII 200 mg

USP1488000 Oxymorphone Controlled Substance CII 500 mg

USP1490103 Oxyquinoline Sulfate 200 mg

USP1491004 Oxytetracycline 200 mg

USP1491015 Oxytetracycline HCl 200 mg

USP1491300 Oxytocin 5 vials

USP1491296 Oxytocin Identification 15 mg

USP1491332 Paclitaxel 200 mg

USP1491365 Paclitaxel Impurity Mixture 10 mg

USP1491343 Paclitaxel Related Compound A Cephalomannine

20 mg

USP1491354 Paclitaxel Related Compound B 10-Deacetyl-7-epipaclitaxel

20 mg

USP1491503 Padimate O 300 mg

USP1492040 Palm Oil (AS) 1 g

USP1492007 Palmitic Acid 500 mg

USP1492801 Pamidronate Disodium 100 mg

USP1493000 Pamoic Acid 250 mg

USP1494057 Pancreatin Amylase and Protease 2 g

USP1494079 Pancreatin Lipase 2 g

USP1494217 Pancuronium Bromide 200 mg

USP1494501 Panthenol, Racemic 200 mg

USP1494807 Pantolactone 500 mg

USP1494895 Pantoprazole Sodium 250 mg

USP1494909 Pantoprazole Related Compound A 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfonyl]-1H-benzimidazole

25 mg

USP1494910 Pantoprazole Related Compound B 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]thio]1-H-benzimidazole

20 mg

USP1494920 Pantoprazole Related Compound C 5-(difluoromethoxy)-1H-benzimidazole-2-thiol

20 mg

USP1494931 Pantoprazole Related Compounds D and F Mixture 20 mg

USP1494942 Pantoprazole Related Compound E 6,6'-bis(difluoromethoxy)-2,2'-bis[[(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl]-1H,1'H-5,5'-bibenzimidazolyl

20 mg

USP1495005 Papain 1 g

USP1496008 Papaverine HCl 200 mg

USP1496802 Parachlorophenol 500 mg

USP1496904 Paraffin 1 g

USP1497000 Paramethadione 500 mg

USP1498003 Paramethasone Acetate 200 mg

USP1498706 Parbendazole 200 mg

USP1499006 Pargyline HCl 200 mg

USP1499403 Paricalcitol 10 mg

USP1499414 Paricalcitol Solution 3 mL

USP1500003 Paromomycin Sulfate 125 mg

USP1500218 Paroxetine HCl 350 mg

USP1500230 Paroxetine Related Compound B trans-4-phenyl-3-([(3,4-methylenedioxy)phenoxymethyl]piperidine HCl

15 mg

USP1500240 Paroxetine Related Compound C (+)-trans-Paroxetine HCl

15 mg



Code Product Unit

USP1500251 Paroxetine Related Compound D cis-Paroxetine HCl (AS)

10 mg

USP1500262 Paroxetine Related Compound E Mixture 1-Methyl-4-(p-fluorophenyl)-1,2,3,6-tetrahydropyridine in Paroxetine Hydrochloride Matrix

25 mg

USP1500273 Paroxetine Related Compound F trans(-)-1-methyl-3-[(1,3-benzodioxol-5-yloxy)Methyl]-4-(4-fluorophenyl)piperidine

10 mg

USP1500284 Paroxetine Related Compound G (+/-)trans-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4''-fluorophenyl-4'-phenyl)piperidine HCl

10 mg

USP1500353 Paroxetine System Suitability Mixture A 50 mg

USP1500400 Parthenolide 25 mg

USP1500502 Particle Count Set unit

USP1500557 Peanut Oil (AS) 1 g

USP1500808 Penbutolol Sulfate 200 mg

USP1501006 Penicillamine 200 mg

USP1501108 Penicillamine Disulfide 200 mg

USP1502009 Penicillin G Benzathine 200 mg

USP1502508 Penicillin G Potassium 200 mg

USP1502552 Penicillin G Procaine 200 mg

USP1502701 Pencillin G Sodium 150 mg

USP1504489 Penicillin V 200 mg

USP1504503 Penicillin V Potassium 200 mg

USP1504900 Pentamidine Isethionate 200 mg

USP1504933 Pentane 3x1.2 mL

USP1504955 1-Pentanol 3x1.2 mL

USP1505007 Pentazocine Controlled Substance CIV 500 mg

USP1505506 Pentetic Acid 100 mg

USP1507002 Pentobarbital Controlled Substance CII 200 mg

USP1508901 Pentoxifylline 200 mg

USP1510801 Perflubron 0.5 mL

USP1510845 Pergolide Mesylate 200 mg

USP1510867 Pergolide Sulfoxide 50 mg

USP1511000 Perphenazine 200 mg

USP1511203 Perphenazine Sulfoxide 100 mg

USP1513005 Phenacetin 500 mg

USP1514008 Phenacetin Melting Point Standard (Approximately 135°C) 500 mg

USP1515000 Phenazopyridine HCl 200 mg

USP1516003 Phencyclidine HCl (AS) Controlled Substance CII 25 mg

USP1516502 Phendimetrazine Tartrate Controlled Substance CIII 350 mg

USP1517006 Phenelzine Sulfate 200 mg

USP1520000 Phenformin HCl 200 mg

USP1522006 Phenindione 250 mg

USP1522301 Pheniramine Maleate 150 mg

USP1523009 Phenmetrazine HCl Controlled Substance CII 200 mg

USP1524001 Phenobarbital Controlled Substance CIV 200 mg

USP1524806 Phenol 500 mg

USP1524908 Phenolphthalein 250 mg

USP1525004 Phenolsulfonphthalein 100 mg

USP1525707 Phenothiazine 500 mg

USP1526007 Phenoxybenzamine HCl 250 mg

USP1526200 Phenoxyethanol 2-Phenoxyethanol

500 mg

USP1528002 Phensuximide 500 mg

USP1528501 Phentermine HCl Controlled Substance CIV 200 mg



Code Product Unit

USP1529005 Phentolamine HCl 300 mg

USP1530004 Phentolamine Mesylate 200 mg

USP1530503 L-Phenylalanine 200 mg

USP1530809 Ensulizole Phenylbenzimidazole Sulfonic Acid

200 mg

USP1531007 Phenylbutazone 250 mg

USP1533002 Phenylephrine HCl 125 mg

USP1533250 Phenylethyl Alcohol 1 mL

USP1533308 5-Phenylhydantoin 100 mg

USP1533851 Phenylpropanediol 100 mg

USP1533909 Phenylpropanolamine Bitartrate Drug Precursor 100 mg

USP1534005 Phenylpropanolamine HCl Drug Precursor 250 mg

USP1534209 Phenyl Salicylate Melting Point Standard (Approximately 41°C) 500 mg

USP1534402 Phenyltoloxamine Citrate 100 mg

USP1534413 Phenyltoloxamine Related Compound A 2-(2-benzylphenoxy)ethylmethylamine hydrochloride

50 mg

USP1535008 Phenytoin (CRM) 200 mg

USP1535019 Phenytoin Related Compound A 2,2-Diphenylglycine

50 mg

USP1535020 Phenytoin Related Compound B alpha-((aminocarbonyl)amino)-alpha-phenyl benzeneacetic acid

50 mg

USP1535507 Phenytoin Sodium 200 mg

USP1535700 Phosphated Riboflavin 100 mg

USP1535733 Phosphatidylcholine 350 mg

USP1535744 Phosphatidylethanolamine 100 mg

USP1535802 Phosphoric Acid (AS) 3x1.5 mL

New USP1536509 Phyllanthin 15 mg

New USP1536510 Powdered Phyllanthus Amarus Extract 1 g

USP1537003 Physostigmine Salicylate 200 mg

USP1538006 Phytonadione (Vitamin K1) 500 mg

USP1538505 Pilocarpine 300 mg

USP1538902 Pilocarpine HCl 200 mg

USP1539009 Pilocarpine Nitrate 200 mg

USP1539508 Pimozide 200 mg

USP1539701 Pindolol 200 mg

USP1539905 Pioglitazone HCl 50 mg

USP1541000 Piperacetazine 250 mg

USP1541500 Piperacillin 500 mg

USP1541601 Piperazine 200 mg

USP1541703 Piperazine Adipate 200 mg

USP1541805 Piperazine Citrate 200 mg

USP1541907 Piperazine Dihydrochloride 200 mg

USP1542003 Piperazine Phosphate 200 mg

USP1543006 Piperidolate HCl 200 mg

USP1544304 Pirbuterol Acetate (AS) 200 mg

USP1544406 Piroctone Olamine 200 mg

USP1544417 Piroctone Related Compound A (2-[5-methyl-3-(2,4,4-trimethylpentyl)-4,5-dihydroisoxazol-5-yl] acetic acid)2-aminoethanol salt

15 mg

USP1544428 Piroctone Related Compound B 4-methyl-6-(2,4,4-trimethylpentyl)-2H-pyran-2-one

25 mg

USP1544508 Piroxicam 200 mg

USP1545205 Plicamycin 50 mg

USP1545409 Polacrilex Resin 100 mg



Code Product Unit

USP1545500 Polacrilin Potassium 200 mg

USP1546106 Poloxalene 500 mg

USP1546150 Poloxamer Liquid 1 mL

USP1546161 Poloxamer Solid 1 g

USP1546285 Polydextrose 200 mg

USP1546300 Polydimethylsiloxane 500 mg

USP1546401 Polyethylene Glycol 200 1 g















USP1546707 Polyethylene, High Density 3 strips

USP1546809 Polyethylene, Low Density 3 strips

USP1546853 Polyethylene Oxide 100 mg

USP1546900 Polyethylene Terephthalate (PET) 3 strips

USP1546922 Polyethylene Terephthalate G (PETG) 3 strips

New USP1546933 Polyglyceryl 3 Dioleate 1 g

New USP1546944 Polyglyceryl 3 Diisostearate 1,2,3-Propanetriol, homopolymer, diisoactadecanoate

1 mL

New USP1546955 Polyglyceryl 6 Dioleate 1 g

USP1546966 Polyisobutylene 1 g

USP1547007 Polymyxin B Sulfate 200 mg

USP1547200 Polyoxyl 35 Castor Oil 1 g

USP1547801 Polyoxyl 20 Cetostearyl Ether 100 mg

USP1547255 Polyoxyl 15 Hydroxystearate 500 mg

USP1372402 Polyoxyl Lauryl Ether 500 mg

New USP1372424 Polyoxyl 4 Lauryl Ether 1 mL

New USP1372468 Polyoxyl 23 Lauryl Ether 0.5 g

USP1372504 Polyoxyl Oleate 500 mg

USP1547302 Polyoxyl 10 Oleyl Ether 1 mL

USP1372606 Polyoxyl 10 Stearyl Ether 1 g

USP1547903 Polyoxyl 40 Stearate 200 mg

USP1547404 Polyoxyl 50 Stearate 200 mg

USP1547346 Polyoxyl 2 Stearyl Ether (AS) 1 g

USP1547368 Polyoxyl 20 Stearyl Ether 1 g

USP1547925 Polysorbate 20 (AS) 2 g




USP1548032 Polyvinyl Acetate 1 g

USP1548043 Polyvinyl Acetate Dispersion 1 g

USP1548065 Polyvinyl Alcohol 100 mg



Code Product Unit

USP1549807 Potassium Acetate (AS) 500 mg

USP1548101 Potassium Benzoate (AS) 1 g

USP1548134 Potassium Bicarbonate (AS) 1 g

USP1549840 Potassium Bitartrate (AS) 3 g

USP1548167 Potassium Carbonate (AS) 1 g

USP1548190 Potassium Chloride (AS) 1 g

USP1548225 Potassium Citrate (AS) 1 g

USP1550001 Potassium Gluconate 200 mg

USP1551004 Potassium Guaiacolsulfonate 500 mg

USP1548280 Potassium Iodide (AS) 1 g

USP1548349 Potassium Nitrate (AS) 5 g

USP1551128 Dibasic Potassium Phosphate (AS) 5 g

USP1551139 Monobasic Potassium Phosphate (AS) 5 g

USP1551140 Potassium Sodium Tartrate (AS) 2 g

USP1548407 Potassium Sorbate (AS) 1 g

USP1551150 Potassium Sucrose Octasulfate 300 mg

USP1551300 Potassium Trichloroammineplatinate 20 mg

USP1551503 Povidone 100 mg

USP1553000 Pralidoxime Chloride 200 mg

USP1553859 Pramipexole Dihydrochloride Monohydrate 200 mg

USP1553768 Pramipexole Related Compound A (S)-4,5,6,7-Tetrahydrobenzothiazole-2,6-diamine

15 mg

USP1553815 Pramipexole Related Compound D (R)-2-Amino-4,5,6,7-tetrahydro-6-(propylamino)benzothiazole

25 mg

USP1554002 Pramoxine HCl 500 mg

USP1554206 Pravastatin Sodium 50 mg

USP1554192 Pravastatin 1,1,3,3-Tetramethylbutylamine 200 mg

USP1554217 Pravastatin Related Compound A Sodium(3R,5R)-3,5-dihydroxy-7-[(1S,2S,3S,8S,8aR)-3-hydroxy-2methyl-8-[[(2S)-2-methylbutanoyl]oxy]-1,2,3,7,8,8a-hexahydronaphthalen-1-yl]heptanoate

15 mg

USP1554228 Pravastatin Related Compound B sodium (3R,5R)-3,5-dihydroxy-7-[(1S,2S,6R,8S,8aR)-6-hydroxy-2-methyl-8-[[(2S)-2-methylbutanoyl]oxy]1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoate

20 mg

USP1554501 Prazepam Controlled Substance CIV 500 mg

USP1554603 Praziquantel 200 mg

USP1554658 Praziquantel Related Compound A 2-benzoyl-1,2,3,6,7,11b-hexahydro-4 H-pyrazino[2,1-a]isoquinolin-4-one

50 mg

USP1554669 Praziquantel Related Compound B 2-(cyclohexylcarbonyl)-2,3,6,7-tetrahydro-4H-pyrazino[2,1-a]isoquinolin-4-one

50 mg

USP1554670 Praziquantel Related Compound C 2-(N-formylhexahydrohippuroyl-1,2,3,4-tetrahydroisoquinolin-1-one

50 mg

USP1554705 Prazosin HCl 500 mg

USP1554909 Prednicarbate 200 mg

USP1554910 Prednicarbate Related Compound A 1,2-dihydroprednicarbate

20 mg

USP1554920 Prednicarbate Related Compound B prednisolone-17-ethylcarbonate

20 mg

USP1554931 Prednicarbate Related Compound C prednisolone-21-propionate

20 mg

USP1555005 Prednisolone 200 mg

USP1556008 Prednisolone Acetate 200 mg

USP1556507 Prednisolone Hemisuccinate 125 mg

USP1557000 Prednisolone Sodium Phosphate 500 mg

USP1558003 Prednisolone Tebutate 200 mg

USP1559006 Prednisone 250 mg



Code Product Unit

USP1559505 Prednisone Tablets Dissolution calibrator tablets,Disintegrating

30 tablets

USP1560990 Prilocaine 200 mg

USP1561008 Prilocaine HCl 200 mg

USP1561019 Prilocaine Related Compound A o-toluidine hydrochloride

100 mg

USP1561020 Prilocaine Related Compound B (RS)-N-(4-methylphenyl)-2-(propylamino)propanamide

50 mg

USP1561507 Primaquine Phosphate 200 mg

New USP1561518 Primaquine Related Compound A 8-[(4-Aminopentyl)amino]-6-methoxyquinoline

15 mg

USP1562000 Primidone 200 mg

USP1562011 Primidone Related Compound A 2-ethyl-2-phenylmalonamide

20 mg

USP1562033 Primidone Related Compound C 2-phenylbutyramide

20 mg

USP1563003 Probenecid 200 mg

USP1563309 Probucol 200 mg

USP1563320 Probucol Related Compound A 2,2',6,6'-tetra-tert-butyldiphenoquinone

25 mg

USP1563331 Probucol Related Compound B 4,4'-dithio-bis(2,6-di-tert-butylphenol)

25 mg

USP1563342 Probucol Related Compound C 4-[(3,5-di-tert-butyl-2-hydroxyphenylthio)isopropylidenethio]-2,6-di-tert-butylphenol

25 mg

USP1563502 Procainamide HCl 200 mg

USP1564006 Procaine HCl 200 mg

USP1565009 Procarbazine HCl 200 mg

USP1566001 Prochlorperazine Maleate 200 mg

USP1567004 Procyclidine HCl 200 mg

USP1568007 Progesterone 200 mg

USP1568040 Proguanil HCl 200 mg

USP1568051 Proguanil Related Compound C 1,5-bis(4-chlorophenyl)biguanide hydrochloride

25 mg

USP1568062 Proguanil Related Compound D 1,5-bis(1-methylethyl)biguanide hydrochloride

25 mg

USP1568506 L-Proline 200 mg

USP1569000 Promazine HCI 200 mg

USP1570009 Promethazine HCl 500 mg

USP1570304 Propafenone HCl 200 mg

USP1570326 Propafenone Related Compound B (2E)-1-[2-[(2RS)-2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenylprop-2-en-1-one

50 mg

New USP1570483 1,3-Propanediol 1 mL

USP1570406 1-Propanol 3x1.2 mL

USP1570428 2-Propanol 3x1.2 mL

USP1570439 2-Propanol System Suitability 3x1 mL

USP1570450 Propanolamine 3-aminopropan-1-ol

100 mg

USP1570508 Propantheline Bromide 200 mg

USP1329505 Propantheline Bromide Related Compound A 9-Hydroxypropantheline Bromide

50 mg

USP1571001 Proparacaine HCl 200 mg

USP1572208 Propionic Acid (AS) 3x1.5 mL

USP1572503 Propofol 200 mg

USP1572536 Propofol Related Compound A 3,3',5,5'-Tetraisopropyldiphenol

10 mg



Code Product Unit

USP1572547 Propofol Related Compound B 2,6-diisopropylbenzoquinone

25 mg

USP1572558 Propofol Related Compound C 2,6-diisopropylphenyl isopropylether

50 mg

USP1572525 Propofol Resolution Mixture Propofol;2,6-diisopropylphenyl isopropylether, and 2-isopropyl-6-n-propylphenol

100 mg

USP1573007 Propoxycaine HCl 200 mg

USP1574000 Propoxyphene HCl Controlled Substance CII 1 g

USP1575002 Propoxyphene Napsylate Controlled Substance CII 1 g

USP1575206 Propoxyphene Related Compound A alpha-d-4-dimethylamino-1,2-diphenyl-3-methyl-2-butanol HCl

50 mg

USP1008002 Propoxyphene Related Compound B alpha-d-2-Acetoxy-4-dimethylamino-1,2-diphenyl-3-methylbutane

50 mg

USP1576005 Propranolol HCl 200 mg

USP1576402 Propyl Acetate 3x1.2 mL

USP1576800 Propyl Gallate 200 mg

USP1576504 Propylene Carbonate 200 mg

USP1576708 Propylene Glycol 1 mL

USP1576683 Propylene Glycol Dicaprylate/Dicaprate 1 mL

USP1576763 Propylene Glycol Dilaurate 500 mg

USP1576661 Propylene Glycol Monocaprylate Type I 1 g

USP1576672 Propylene Glycol Monocaprylate Type II 1 g

USP1576785 Propylene Glycol Monolaurate Type I 500 mg

USP1576796 Propylene Glycol Monolaurate Type II 500 mg

USP1576945 Propylene Oxide 5x0.1mL

USP1577008 Propylparaben 200 mg

USP1578000 Propylthiouracil 200 mg

USP1578500 Prostaglandin A1 25 mg

USP1578554 Prostaglandin B1 (13E,15S,)-15-Hydroxy-9-oxoprosta-8(12),13-dien-1-oic Acid

25 mg

USP1578816 rProtein A 2x250 µL

USP1578827 rProtein A, C-Cys 2x250 µL

USP1579310 Protocatechuic Acid 3,4-dihydroxybenzoic acid

25 mg

USP1580002 Protriptyline HCl 200 mg

USP1581005 Pseudoephedrine HCl Drug Precursor 125 mg

USP1581504 Pseudoephedrine Sulfate Drug Precursor 200 mg

USP1583805 Pygeum Extract 150 mg

USP1584003 Pyrantel Pamoate 500 mg

USP1584014 Pyrantel Related Compound A 1-methyl-2-[(Z)-2-(thiophen-2-yl)ethenyl]-1,4,5,6-tetrahydropyrimidine Pamoate

25 mg

USP1585006 Pyrazinamide 200 mg

USP1585505 Pyrethrum Extract 100 mg

USP1586009 Pyridostigmine Bromide 200 mg

USP1587001 Pyridoxine HCl (Vitamin B6) 200 mg

USP1588004 Pyrilamine Maleate 200 mg

USP1589007 Pyrimethamine 200 mg

USP1589109 Pyruvic Acid 500 mg

USP1592001 Pyrvinium Pamoate 500 mg

USP1592205 Quazepam Controlled Substance CIV 200 mg

USP1592227 Quazepam Related Compount A 7-Chloro-1-(2,2,2-trifluoroethyl)-5-(2-fluorophenyl)-1,3-dihydro- 2H-1,4-benzodiazepine-2-one

30 mg

USP1592409 Quercetin 500 mg

USP1593004 Quinacrine HCl 200 mg



Code Product Unit

USP1593401 Quinapril HCl 400 mg

USP1593412 Quinapril Related Compound A Ethyl[3S-[2(R*),3a,11a beta]]-1,3,4,6,11,11a-hexahydro-3-methyl-1,4-dioxo- alpha-(2-phenylethyl)-2H-pyrazino[1,2-b]isoquinoline-2-acetate

50 mg

USP1593423 Quinapril Related Compound B 3-Isoquinolinecarboxylic acid, 2-[2-[(1-carboxy-3-phenylpropyl)amino]- 1-oxopropyl]-1,2,3,4-tetrahydro-,[3S-[2[R*(R*)],3R*]]-

50 mg

USP1594007 Quinethazone 1.5 g

USP1594506 Quinic Acid 200 mg

USP1595000 Quinidine Gluconate 200 mg

USP1595509 Quinidine Sulfate 500 mg

USP1596807 Quinine HCl Dihydrate 1 g

USP1597005 Quinine Sulfate 500 mg

USP1597504 Quininone 50 mg

New USP1643292 Racemethionine 200 mg

USP1598100 Ractopamine HCl 200 mg

USP1598201 Raloxifene HCl 200 mg

New USP1598234 Raloxifene Related Compound C 2-(2-({4-[6-hydroxy-2-(4-hydroxyphenyl)benzothiophene-3-carbonyl]phenoxy}-ethyl)piperidine 1-oxide

20 mg

USP1598303 Ramipril 125 mg

USP1598314 Ramipril Related Compound A (2S,3aS,6aS)-1-[(S)2-[[(S)-1-(methoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-octahydrocyclopenta[b]pyrrole-2-carboxylic acid

30 mg

USP1598323 Ramipril Related Compound B Ramipril Isopropylester

20 mg

USP1598338 Ramipril Related Compound C Hexahydroramipil HCl

20 mg

USP1598347 Ramipril Related Compound D Ramipril Diketopiperazine

20 mg

USP1598405 Ranitidine HCl 200 mg

USP1598507 Ranitidine Related Compound A 5-[[(2-aminoethyl)thio]methyl]-N,N-dimethyl-2-furanmethanamine hemifumarate

50 mg

USP1598609 Ranitidine Related Compound B N,N'-bis[2-[[[5-[(dimethylamino)methyl]-2-furanyl]methyl]thio]ethyl]-2-nitro-1,1-ethenediamine

50 mg

USP1598700 Ranitidine Related Compound C N-[2-[[[5-[(dimethylamino)methyl]-2-furanyl]methyl]sulfinyl]ethyl]-N-methyl-2-nitro-1,1-ethenediamine

50 mg

USP1598450 Ranitidine Resolution Mixture 20 mg

USP1598802 Raspberry Alcohol 4-(3-Hydroxybutyl)phenol

50 mg

USP1598813 Raspberry Ketone 4-(4-hydroxyphenyl)-2-butanone

100 mg

USP1599000 Rauwolfia Serpentina 15 g

USP1600121 Rebaudioside A 300 mg

USP1599500 Powdered Red Clover Extract 500 mg

USP1600813 Repaglinide 200 mg

USP1600824 Repaglinide Related Compound A (S)-3-Methyl-1-[2-(1-piperidinyl)phenyl]butylamine, N-acetyl-L-glutamate Salt

25 mg

USP1600835 Repaglinide Related Compound B 3-Ethoxy-4-ethoxycarbonyl-phenylacetic Acid

50 mg

USP1600846 Repaglinide Related Compound C (S)-2-Ethoxy-4-[2-[[2-phenyl-1-[2-(1-piperidinyl)phenyl]ethyl]amino]-2-oxoethyl]benzoic Acid

25 mg

USP1601000 Reserpine 200 mg

USP1601102 Residual Solvent Mixture - Class 1 3x1.2 mL

USP1601146 Residual Solvent Class 1 - Benzene 3x1.2 mL

USP1601168 Residual Solvent Class 1 - Carbon Tetrachloride 3x1.2 mL

USP1601180 Residual Solvent Class 1 - 1,2-Dichloroethane 3x1.2 mL



Code Product Unit

USP1601204 Residual Solvent Class 1 - 1,1-Dichloroethene 3x1.2 mL

USP1601226 Residual Solvent Class 1 - 1,1,1-Trichloroethane 3x1.2 mL

USP1601281 Residual Solvent Class 2 - Mixture A 3x1.2 mL

USP1601292 Residual Solvent Class 2 - Mixture B 3x1.2 mL

USP1601306 Residual Solvent Class 2 - Mixture C 3x1.2 mL

USP1601340 Residual Solvent Class 2 - Acetonitrile 3x1.2 mL

USP1601361 Residual Solvent Class 2 - Chlorobenzene 3x1.2 mL

USP1601383 Residual Solvent Class 2 - Chloroform 3x1.2 mL

USP1601408 Residual Solvent Class 2 - Cyclohexane 3x1.2 mL

USP1601420 Residual Solvent Class 2 - 1,2-Dichloroethene 3x1.2 mL

USP1601463 Residual Solvent Class 2 - 1,2-Dimethoxyethane 3x1.2 mL

USP1601485 Residual Solvent Class 2 - N,N-Dimethylacetamide 3x1.2 mL

USP1601500 Residual Solvent Class 2 - N,N-Dimethylformamide 3x1.2 mL

USP1601521 Residual Solvent Class 2 - 1,4-Dioxane 3x1.2 mL

USP1601543 Residual Solvent Class 2 - 2-Ethoxyethanol 3x1.2 mL

USP1601565 Residual Solvent Class 2 - Ethylene Glycol 3x1.2 mL

USP1601587 Residual Solvent Class 2 - Formamide 3x1.2 mL

USP1601601 Residual Solvent Class 2 - Hexane 3x1.2 mL

USP1601623 Residual Solvent Class 2 - Methanol 3x1.2 mL

USP1601645 Residual Solvent Class 2 - 2-Methoxyethanol 3x1.2 mL

USP1601667 Residual Solvent Class 2 - Methylbutylketone 3x1.2 mL

USP1601689 Residual Solvent Class 2 - Methylcyclohexane 3x1.2 mL

USP1601441 Residual Solvent Class 2 - Methylene Chloride 3x1.2 mL

USP1601703 Residual Solvent Class 2 - N-Methylpyrrolidone 3x1.2 mL

USP1601725 Residual Solvent Class 2 - Nitromethane 3x1.2 mL

USP1601747 Residual Solvent Class 2 - Pyridine 3x1.2 mL

USP1601769 Residual Solvent Class 2 - Sulfolane 3x1.2 mL

USP1601770 Residual Solvent Class 2 - Tetrahydrofuran 3x1.2 mL

USP1601780 Residual Solvent Class 2 - Tetralin 3x1.2 mL

USP1601805 Residual Solvent Class 2 - Toluene 3x1.2 mL

USP1601827 Residual Solvent Class 2 - Trichloroethylene 3x1.2 mL

USP1601849 Residual Solvent Class 2 - Xylenes 3x1.2 mL

USP1602003 Resorcinol 200 mg

USP1602502 Retinyl Palmitate 200 mg

USP1602706 Ribavirin 200 mg

USP1603006 Riboflavin (Vitamin B2) 500 mg

USP1603108 Ribose 300 mg

USP1603800 Rifabutin 50 mg

USP1604009 Rifampin 300 mg

USP1604202 Rifampin Quinone 25 mg

USP1604337 Riluzole 200 mg

USP1604348 Riluzole Related Compound A 4-trifluoromethoxyaniline

25 mg

USP1604508 Rimantadine HCl 300 mg

USP1604600 Rimexolone 100 mg

USP1604610 Risedronate Sodium 350 mg

USP1604621 Risedronate Related Compound A [1-hydroxy-2-(2-pyridinyl)ethylidene]bis(phosphonic acid)

20 mg

USP1604632 Risedronate Related Compound B [3,6-bis[(3-pyridinyl)methyl]-2,5-dihydroxy-2,5-dioxido-1,4,2,5-dioxadiphosphorinane-3,6-diyl]bis[phosphonic acid]disodium tetrahydrate salt

20 mg

USP1604643 Risedronate Related Compound C [2-(3-pyridinyl)ethylidene-1,1]bis(phosphonic acid)

20 mg



Code Product Unit

USP1604654 Risperidone 200 mg

USP1604676 Risperidone Related Compounds Mixture 25 mg

USP1604665 Risperidone System Suitability Mixture 10 mg

USP1604701 Ritodrine HCl 200 mg

USP1604803 Ritonavir 200 mg

USP1604814 Ritonavir Related Compounds Mixture 50 mg

New USP1604836 Rivastigmine 0.1 mL

USP1604858 Rivastigmine Tartrate 200 mg

USP1604847 Rivastigmine Tartrate R-Isomer (R)-3-[1-(Dimethylamino)ethyl]phenyl ethylmethylcarbamate, hydrogen tartrate

20 mg

USP1604869 Rivastigmine Related Compound A (+)-Di-p-toluoyl-D-(+)-tartaric acid

15 mg

USP1604870 Rivastigmine Related Compound B (R,S)-3-[1-(Dimethylamino)ethyl]phenyl dimethylcarbamate

15 mg

New USP1604880 Rizatriptan Benzoate 200 mg

New USP1604891 Rizatriptan Benzoate System Suitability Mixture 15 mg

USP1604905 Rocuronium Bromide 250 mg

USP1604916 Rocuronium Peak Identification Mixture rocuronium bromide spiked with rocuronium related compounds A,B,C,D,E,F,G and H

25 mg

USP1605205 Ropinirole HCl 200 mg

USP1605216 Ropinirole Related Compound A 4-(2-hydroxyethyl)indolin-2-one

50 mg

USP1605227 Ropinirole Related Compound B 4-[2-(Dipropylamino)ethyl]indoline-2,3-dione HCl

50 mg

USP1605497 Ropivacaine 200 mg

USP1605500 Ropivacaine HCl 200 mg

USP1605512 Ropivacaine Related Compound A 2,6-dimethylaniline hydrochloride

25 mg

USP1605523 Ropivacaine Related Compound B (R)-(+)-1-Propylpiperidine-2-carboxylic acid (2,6-dimethylphenyl)- amide hydrochloride monohydrate

50 mg

New USP1605817 Rosiglitazone Maleate 200 mg

New USP1605828 Rosiglitazone Related Compound A (5Z)-5-{[4-({2-[methyl(2-pyridinyl)amino]ethyl}oxy)phenyl]methylidene}-1,3-thiazolidine-2,4-dione

25 mg

USP1606208 Roxarsone 200 mg

USP1606503 Rutin 100 mg

USP1607007 Saccharin 200 mg

USP1607029 Saccharin Calcium 100 mg

USP1607040 Saccharin Sodium 100 mg

USP1608000 Salicylamide 200 mg

USP1609002 Salicylic Acid 125 mg

USP1609013 Salicylic Acid Related Compound A 4-hydroxybenzoic acid

100 mg

USP1609024 Salicylic Acid Related Compound B 4-hydroxyisophthalic acid

100 mg

USP1609501 Salicylic Acid Tablets Dissolution Calibrator, Non-disintegrating

30 tablets

USP1609603 Salmeterol Xinafoate 150 mg

USP1609614 Salmeterol Related Compound A 4-[1-Hydroxy-2-(4-phenylbutylamino)ethyl]-2-(hydroxymethyl)phenol

10 mg

USP1609625 Salmeterol Related Compound B 4-{1-Hydroxy-2-[6-(4-phenylbutan-2-yloxy)hexylamino]ethyl}2-(hydroxymethyl)phenol

10 mg

USP1609807 Salsalate 150 mg

USP1609829 Saquinavir Mesylate 200 mg



Code Product Unit

USP1609831 Saquinavir Related Compound A N-tert-butyl-decahydro-2-[2(R)-hydroxy-4-phenyl-3(S)-[[N-(2-quinolylcarbonyl)-D-asparaginyl]amino]butyl]-(4aS,8aS)-isoquinoline-3(S)-carboxamide

25 mg

USP1610001 Scopolamine HBr 250 mg

USP1610090 Scopoletin 20 mg

USP1611004 Secobarbital Controlled Substance CII 200 mg

USP1611900 Selegiline HCl 200 mg

USP1611955 Selenomethionine 100 mg

USP1612007 Sennosides 500 mg

USP1612018 Sennoside A 20 mg

USP1612029 Sennoside B 20 mg

USP1612506 L-Serine 200 mg

USP1612539 Sertraline HCl 100 mg

USP1612517 Sertraline HCl Racemic Mixture 1:1 mixture of (1S,4S) and (1R, 4R)-4-(3,4-dichlorophenyl)- N-methyl-1,2,3,4-tetrahydro-1-naphthylamine HCl

25 mg

USP1612528 Sertraline HCl Related Compound A 1:1 mixture of (1R, 4S) and (1S, 4R)-4-(3,4-dichlorophenyl)- N-methyl-1,2,3,4-tetrahydro-1-naphthylamine hydrochloride

25 mg

USP1612404 Sesame Oil (AS) 2x1 mL

USP1612415 Sesame Oil Related Compound A 1,2-dilinoleoyl-3-oleoyl-rac-glycerol

3x6 mg

USP1612426 Sesame Oil Related Compound B 1,2-dilinoleoyl-3-palmitoyl-rac-glycerol, PLL

3x6 mg

USP1612540 Sevoflurane 1 mL

USP1612550 Sevoflurane Related Compound A 1,1,3,3,3-Pentafluoroisopropenyl fluoromethyl ether

0.2 mL

USP1612572 Sevoflurane Related Compound B 1,1,1,3,3,3-hexafluoro-2-methoxypropane

0.2 mL

USP1612594 Sevoflurane Related Compound C 1,1,1,3,3,3-hexafluoro-2-propanol

0.2 mL

USP1612845 Sibutramine HCl Controlled Substance CIV 125 mg

USP1612856 Sibutramine Related Compound A N-{1-[1-(2-chlorophenyl)cyclobutyl]-3-methylbutyl}-N,N-dimethylamine HCl

20 mg

USP1612867 Sibutramine Related Compound B N-{1-[1-(3-chlorophenyl)cyclobutyl]-3-methylbutyl}-N,N-dimethylamine HCl

20 mg

USP1612878 Sibutramine Related Compound C N-{1-[1-(4-chlorophenyl)cyclobutyl]pentyl}-N,N-dimethylamine HCl

20 mg

USP1612889 Sibutramine Related Compound D N-{1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl}-N-methylamine hydrochloride

20 mg

USP1612608 Silver Sulfadiazine 200 mg

USP1612630 Silybin 50 mg

USP1612641 Silydianin 20 mg

USP1612652 Simethicone 50 g

USP1612700 Simvastatin 200 mg

USP1612801 Sisomicin Sulfate 500 mg

USP1612947 Beta-Sitosterol 300 mg

USP1613407 Sodium Acetate (AS) 1 g

USP1613509 Sodium Ascorbate 200 mg

USP1613564 Sodium Benzoate 1 g

USP1613655 Sodium Bicarbonate (AS) 3 g

USP1613597 Sodium Bromide 1 g

USP1613600 Sodium Butyrate 25 mg

USP1613757 Sodium Carbonate Anhydrous (AS) 1 g

USP1613804 Sodium Chloride 1 g

USP1613859 Sodium Citrate (AS) 1 g



Code Product Unit

New USP1613860 Sodium Cyclamate 200 mg

USP1614239 Sodium Iron EDTA 200 mg

USP1614308 Sodium Lactate 200 mg

USP1614363 Sodium Lauryl Sulfate (AS) 1 g

USP1614396 Sodium Metabisulfite (AS) 1 g

USP1614454 Sodium Nitrite (AS) 1 g

USP1614501 Sodium Nitroprusside 500 mg

USP1614578 Sodium Picosulfate 50 mg

USP1614589 Sodium Picosulfate Related Compound A 4-[(pyridin-2-yl)(4-hydroxyphenyl)methyl]phenyl sodium sulfate

20 mg

USP1614603 Sodium Propionate 200 mg

USP1614636 Sodium Salicylate 500 mg

USP1614669 Sodium Starch Glycolate Type A 400 mg

USP1614670 Sodium Starch Glycolate Type B 400 mg

USP1614705 Sodium Stearyl Fumarate 200 mg

USP1614807 Sodium Sulfate Anhydrous (AS) 1 g

USP1614909 Sodium Tartrate Dihydrate 4x500 mg

USP1615107 Sodium Thiosulfate (AS) 1 g

USP1615708 Somatropin unit

USP1615956 Sorbic Acid (AS) 1 g

USP1616008 1,4-Sorbitan 300 mg

USP1617000 Sorbitol 125 mg

USP1617408 Sotalol HCl 300 mg

USP1617419 Sotalol Related Compound A N-[4-[[(1-Methylethyl)amino]acetyl]phenyl]methanesulfonamide monohydrochloride

50 mg

USP1617420 Sotalol Related Compound B N(4-Formylphenyl)methanesulfonamide

50 mg

USP1617430 Sotalol Related Compound C N-[4-[2-[(1-Methylethyl)amino]ethyl]phenyl]methanesulfonamide HCl

50 mg

USP1617474 Defatted Powdered Soy 2.5 g

USP1618003 Spectinomycin HCl 200 mg

USP1619006 Spironolactone 125 mg

USP1619017 Spironolactone Related Compound A Canrenone (3-Oxo-17-alpha-pregna-4,6-diene-21,17-carbolactone) (AS)

100 mg

USP1619505 Squalane 500 mg

USP1607506 Powdered St. John's Wort Extract 600 mg

USP1620005 Stanozolol Controlled Substance CIII 200 mg

USP1620209 Stavudine 250 mg

USP1620220 Stavudine System Suitability Mixture 10 mg

USP1621008 Stearic Acid 500 mg

USP1621507 Stearoyl Polyoxyglycerides 100 mg

USP1622000 Stearyl Alcohol 125 mg

USP1622408 Stevioside 30 mg

USP1623003 Streptomycin Sulfate 200 mg

USP1623411 Succinic Acid 100 mg

USP1623502 Succinylcholine Chloride 500 mg

USP1623604 Succinylmonocholine Chloride 125 mg

USP1623626 Sucralose 400 mg

New USP1623659 Sucromalt 200 mg

USP1623637 Sucrose 100 mg

USP1623615 Sucrose Octaacetate 500 mg

USP1623648 Sufentanil Citrate Controlled Substance CII 25 mg

USP1623670 Sulbactam 250 mg



Code Product Unit

USP1623681 Sulconazole Nitrate 200 mg

USP1623706 Sulfabenzamide 200 mg

USP1623808 Sulfacetamide 300 mg

USP1624006 Sulfacetamide Sodium 500 mg

USP1624505 Sulfachlorpyridazine 200 mg

USP1625009 Sulfadiazine 200 mg

USP1626001 Sulfadimethoxine 200 mg

USP1626500 Sulfadoxine 200 mg

USP1628007 Sulfamerazine 500 mg

USP1629000 Sulfamethazine 1 g

USP1630009 Sulfamethizole 200 mg

USP1631001 Sulfamethoxazole 200 mg

USP1631500 Sulfamethoxazole N4-glucoside 25 mg

USP1632004 Sulfanilamide 5 g

USP1633007 Sulfanilamide Melting Point Standard (Approximately 165°C) 500 mg

USP1633506 Sulfanilic Acid 200 mg

USP1634000 Sulfapyridine 200 mg

USP1635002 Sulfapyridine Melting Point Standard (Approximately 191°C) 1 g

USP1635206 Sulfaquinoxaline 200 mg

USP1635228 Sulfaquinoxaline Related Compound A N1-N2-diquinoxalin-2-ylsulfanilamide

25 mg

USP1636005 Sulfasalazine 125 mg

USP1636504 Sulfathiazole 350 mg

USP1637008 Sulfinpyrazone 200 mg

USP1638000 Sulfisoxazole 200 mg

USP1639003 Sulfisoxazole Acetyl 200 mg

USP1642008 Sulindac 200 mg

USP1642019 Sulindac Related Compound A trans-sulindac

20 mg

USP1642100 Sulisobenzone 500 mg

USP1642154 Sumatriptan 50 mg

USP1642201 Sumatriptan Succinate 200 mg

USP1642212 Sumatriptan Succinate Related Compound A [3-[2-(dimethylamino)ethyl]-2-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-1H-indol-5-yl]-N-methylmethansulfonamide, succinate Salt

15 mg

USP1642223 Sumatriptan Succinate Related Compound C [3-[2-(dimethylamino)ethyl]-1-(hydroxymethyl)-1H-indol-5-yl]- N-methylmethanesulfonamide succinate salt

50 mg

USP1642256 Sumatriptan Succinate Related Impurities 25 mg

USP1642507 Suprofen 200 mg

USP1642700 Tacrine HCl 500 mg

USP1642802 Tacrolimus 150 mg

USP1642813 Tacrolimus Related Compound A (E)-17-ethyl-1,14-dihydroxy-12[(E)-2-(4-hydroxy-3-methoxycyclohexyl)-1-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0super4,9]octacos-18-ene-2,3,10,16-tetrone

15 mg

New USP1642857 Tacrolimus System Suitability Mixture 10 mg

USP1642904 Tagatose 200 mg

USP1643306 Tamoxifen Citrate 200 mg

USP1643260 Tamsulosin HCl 200 mg

USP1643281 Racemic Tamsulosin HCl 50 mg

USP1643328 Tannic Acid (AS) 2 g

USP1643340 Tartaric Acid 1 g

USP1643361 Taurine 100 mg



Code Product Unit

USP1643383 Tazobactam 200 mg

USP1643394 Tazobactam Related Compound A 2-amino-3-methyl-3-sulfino-4-(1H-1,2,3-triazol-1-yl)butyric acid

20 mg

USP1643419 Telmisartan 150 mg

USP1643420 Telmisartan Related Compound A 1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzo[d]imidazole

20 mg

USP1643437 Telmisartan Related Compound B 4'-[(1,7'-dimethyl-2'-propyl-1H,1'H-2,5'-bibenzo[d]imidazol-1'-yl)methyl]biphenyl-2-carboxylic acid

15 mg

USP1643408 Temazepam Controlled Substance CIV 200 mg

New USP1644319 Temazepam Related Compound A 5-chloro-2-methylaminobenzophenone

15 mg

New USP1644364 Temazepam Related Compound F 7-chloro-1-methyl-5-phenyl-4,5-dihydro-1H-1,4-benzodiazepine-2,3-dione

15 mg

New USP1646375 Temazepam Related Compound G 7-Chloro-1,4-dimethyl-5-phenyl-4,5-dihydro-1H-1,4-benzodiazepine-2,3-dione

15 mg

USP1643543 Temozolomide 200 mg

USP1643554 Temozolomide Related Compound A 4-diazo-4H-imidazole-5-carboxamide

15 mg

USP1643565 Temozolomide Related Compound B 3-methyl-1,1-dihenylurea

15 mg

USP1643576 Temozolomide Related Compound C diphenylcarbamic chloride

15 mg

USP1643601 Tenofovir 15 mg

New USP1643612 Tenofovir Disoproxil Related Compound A (S)-5-[[2-(6-Amino-9H-purin-9-yl)-1-methylethoxy]methyl]-2,4,6,8-tetraoxa-5-phosphanonanedioic acid, bis(1-methylethyl)ester,5-oxide, (E)-2-butenedioate (1:1)

10 mg

New USP1643623 Tenofovir Disoproxil Related Compound B (E)-9-(Prop-1-enyl)9H-purin-6-amine

10 mg

USP1643656 Tenofovir Disoproxil Fumarate 200 mg

USP1643452 Terazosin HCl 200 mg

USP1643463 Terazosin Related Compound A 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)piperazine dihydrochloride

50 mg

USP1643474 Terazosin Related Compound B 1-(4-hydroxy-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]piperazine

50 mg

USP1643485 Terazosin Related Compound C 1,4-bis(4-amino-6,7-dimethoxy-2-quinazolinyl)piperazine dihydrochloride

25 mg

USP1643496 Terbinafine HCl 200 mg

USP1643500 Terbutaline Sulfate 125 mg

USP1643510 Terbutaline Related Compound A tert-butylamino-3,5-dihydroxyacetophenone sulfate

50 mg

USP1643703 Terconazole 200 mg

USP1643805 Terfenadine 200 mg

USP1643907 Terfenadine Related Compound A 1-[4-(1,1-dimethylethyl)phenyl]-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-butanone

100 mg

USP1643929 Terfenadine Related Compound B Terfenadine-N-oxide

50 mg

USP1644003 Terpin Hydrate 750 mg

USP1645006 Testolactone Controlled Substance CIII 125 mg

USP1646009 Testosterone Controlled Substance CIII 125 mg

USP1647001 Testosterone Cypionate Controlled Substance CIII 200 mg

USP1648004 Testosterone Enanthate Controlled Substance CIII 200 mg

USP1649007 Testosterone Propionate Controlled Substance CIII 200 mg

USP1650006 Tetracaine HCl 200 mg

USP1651009 Tetracycline HCl 200 mg

USP1651621 Delta-9-Tetrahydrocannabinol Controlled Substance 1 mL

USP1090014 Exo-tetrahydrocannabinol Controlled Substance 1 mL



Code Product Unit

USP1652001 Tetrahydrozoline HCl 200 mg

USP1652500 Thalidomide 200 mg

New USP1652704 L-Theanine 200 mg

USP1653004 Theophylline (CRM) 200 mg

USP1653117 Theophylline Melting Point Standard (Approximately 271°C) 500 mg

USP1655000 Thiabendazole 100 mg

USP1656002 Thiamine HCl (Vitamin B1 HCl) 500 mg

USP1657005 Thiethylperazine Malate 200 mg

USP1658008 Thiethylperazine Maleate 200 mg

USP1659000 Thimerosal 500 mg

USP1660000 Thioguanine 200 mg

USP1661002 Thiopental Controlled Substance CIII 250 mg

USP1662504 Thioridazine 200 mg

USP1663008 Thioridazine HCl 200 mg

USP1663700 Thiostrepton 200 mg

USP1664000 Thiotepa 500 mg

USP1665003 Thiothixene 250 mg

USP1666006 (E)-Thiothixene 100 mg

USP1667100 Thonzonium Bromide 200 mg

USP1667202 L-Threonine 200 mg

USP1667213 Thymol 500 mg

USP1667280 Tiagabine Hydrochloride 300 mg

USP1667235 Racemic Tiagabine Hydrochloride Mixture (S)-(+),(R)-(-)-1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]nipecotic acid, HCl

25 mg

USP1667224 Tiagabine Related Compound A (R)-ethyl 1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]-3-piperidinecarboxylate, HCl

15 mg

USP1667355 Tiamulin 100 mg

USP1667290 Tiamulin Fumarate 250 mg

USP1667337 Tiamulin Related Compound A Tosyl pleuromutilin

50 mg

USP1667304 Ticarcillin Monosodium Monohydrate 350 mg

USP1667144 Ticlopidine HCl 150 mg

USP1667155 Ticlopidine Related Compound A 4-oxo-4,5,6,7-tetrahydrothieno-[3,2-c]pyridine

20 mg

USP1667166 Ticlopidine Related Compound B 5-(2-chlorobenzyl)4-oxo-4,5,6,7-tetrahydrothieno-[3,2-c]pyridine

20 mg

USP1667359 Tiletamine HCl 200 mg

USP1667370 Tilmicosin 250 mg

USP1667406 Timolol Maleate 200 mg

USP1667520 Tinidazole 200 mg

USP1667530 Tinidazole Related Compound A 2-methyl-5-nitroimidazole

100 mg

USP1667541 Tinidazole Related Compound B (1-(2-ethyl-sulfonylethyl)-2-methyl-4-nitroimidazole)

20 mg

USP1667439 Tioconazole 200 mg

USP1667450 Tioconazole Related Compound A 1-[2,4-Dichloro-beta-[(3-thenyl)-oxy]phenethyl]imidazole HCl

25 mg

USP1667461 Tioconazole Related Compound B 1-[2,4-Dichloro-beta-[(2,5-dichloro-3-thenyl)oxy]phenethyl]imidazole HCl

25 mg

USP1667472 Tioconazole Related Compound C 1-[2,4-Dichloro-beta-[(5-bromo-2-chloro-3-thenyl)-oxy]-phenethyl]imidazole HCl

25 mg

USP1667585 Titanium Dioxide (AS) 1 g

USP1667905 Tizanidine Hydrochloride 200 mg

USP1667916 Tizanidine Related Compound A 4-amino-5-chloro-2,1,3-benzothiadiazole

50 mg



Code Product Unit

USP1667924 Tizanidine Related Compound B N-acetyltizanidine

50 mg

USP1667938 Tizanidine Related Compound C 1-acetylimidazolidine-2-thione

50 mg

USP1667508 Tobramycin 350 mg

USP1667552 Tocainide HCl 125 mg

USP1667600 Alpha Tocopherol (Vitamin E Alcohol) 250 mg

USP1667701 Alpha Tocopheryl Acetate (Vitamin E Acetate) 250 mg

USP1667803 Alpha Tocopheryl Acid Succinate (Vitamin E Succinate) 250 mg

USP1668001 Tolazamide 200 mg

USP1669004 Tolazoline HCl 300 mg

USP1670003 Tolbutamide 200 mg

USP1670207 Tolcapone 200 mg

USP1670218 Tolcapone Related Compound A 4'-methyl-3,4-dihydroxybenzophenone

25 mg

USP1670229 Tolcapone Related Compound B 4-hydroxy-3-methoxy-4'-methyl-5-nitrobenzophenone

25 mg

USP1670502 Tolmetin Sodium 500 mg

USP1671006 Tolnaftate 200 mg

USP1672010 o-Toluenesulfonamide 200 mg

USP1672020 p-Toluenesulfonamide 200 mg

USP1672100 Tomato Extract Containing Lycopene 1 g

USP1672206 Topiramate 150 mg

USP1672210 Topiramate Related Compound A 2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose

25 mg

USP1672304 Torsemide 200 mg

USP1672315 Torsemide Related Compound A 4-[(3-methylphenyl)amino]-3-pyridinesulfonamide

75 mg

USP1672326 Torsemide Related Compound B N-[(n-butylamino)carbonyl]-4-[(3-methylphenyl)amino]-3-pyridinesulfonamide

75 mg

USP1672337 Torsemide Related Compound C N-[(ethylamino)carbonyl]-4-[(3-methylphenyl)amino]-3-pyridinesulfonamide

30 mg

USP1672600 Tramadol HCl 100 mg

USP1672610 Tramadol Related Compound A (+/-)-trans-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol hydrochloride

25 mg

USP1672621 Tramadol Related Compound B 2-(dimethylaminomethyl)-1-cyclohexanone hydrochloride

25 mg

USP1672687 Trandolapril 125 mg

USP1672701 Trandolapril Related Compound C (2S,3aR,7aS)-1-[N-[(S)-1-Carboxy-3-cyclohexylpropyl]-L-alanyl]hexahydro-2-indolinecarboxylic acid 1-ethyl ester HCl

25 mg

USP1672712 Trandolapril Related Compound D (S)-ethyl 2-[(3S,5aS,9aR,10aS)-3-methyl-1,4-dioxodecahydropyrazino[1,2-a]indol-2(1H)-yl]-4-phenylbutanoate

25 mg

USP1672745 Tranexamic Acid 200 mg

USP1672756 Tranexamic Acid Related Compound C (RS)-4-(aminomethyl)cyclohex-1-enecarboxylic acid

15 mg

USP1672803 Transplatin 25 mg

USP1672905 Tranylcypromine Sulfate 125 mg

USP1672916 Tranylcypromine Related Compound A (+/-)-cis-2-phenylcyclopropanamine HCl; cis-tranylcypromine HCl

40 mg

USP1672927 Tranylcypromine Related Compound B trans-3-phenylallylamine hydrochloride; cinnamylamine hydrochloride

40 mg

USP1673001 Travoprost 3 mL

USP1673012 Travoprost Related Compound A (5Z,13E)-(9S,11R,15R)-9,11,15-trihydroxy-16-(m-trifluoromethylphenoxy)-17,18,19,20-tetranor-5,13-prostadienoic acid

1.5 mL



Code Product Unit

USP1673500 Trazodone HCl 200 mg

USP1673715 Trehalose 400 mg

USP1673806 Trenbolone Controlled Substance CIII 50 mg

USP1673828 Trenbolone Acetate Controlled Substance CIII 200 mg

USP1673839 Trenbolone Acetate System Suitability Mixture Controlled Substance CIII 30 mg

USP1674004 Tretinoin 5x30 mg

USP1675007 Triacetin 1 g

USP1676000 Triamcinolone 250 mg

USP1677002 Triamcinolone Acetonide 500 mg

USP1678005 Triamcinolone Diacetate 350 mg

USP1679008 Triamcinolone Hexacetonide 200 mg

USP1680007 Triamterene 200 mg

USP1680018 Triamterene Related Compound A 2,4,6-triamino-5-nitrosopyrimidine

50 mg

USP1680029 Triamterene Related Compound B 2,7-diamino-4-hydroxy-6-phenylpteridine

50 mg

USP1680030 Triamterene Related Compound C 2,4,diamino-7-hydroxy-6-phenylpteridine

50 mg

USP1680506 Triazolam Controlled Substance CIV 200 mg

USP1680608 Tributyl Citrate 500 mg

USP1680685 Tributyl Phosphine Oxide 25 mg

USP1680801 Trichlorfon 200 mg

USP1681000 Trichlormethiazide 200 mg

USP1682206 Triclosan 200 mg

USP1682217 Triclosan Related Compounds Mixture A 3x1.2 mL

USP1683005 Tridihexethyl Chloride 200 mg

USP1683504 Trientine HCl 200 mg

New USP1683559 Triethylamine N,N-diethylethanamine

4x2 mL

USP1683606 Triethyl Citrate 500 mg

USP1685000 Trifluoperazine HCl 200 mg

USP1685500 2-[N-(2,2,2-Trifluoro-ethyl)amino-5]-chlorobenzophenone 25 mg

USP1686003 Triflupromazine HCI 200 mg

USP1686309 Trifluridine 200 mg

USP1686310 Trifluridine Related Compound A 5-Carboxy-2'-deoxyuridine

20 mg

USP1687006 Trihexyphenidyl HCl 200 mg

USP1689001 Trimeprazine Tartrate 200 mg

USP1690000 Trimethadione 200 mg

USP1692006 Trimethobenzamide HCl 500 mg

USP1692505 Trimethoprim 300 mg

USP1692516 Trimethoprim Related Compound A 4-amino-5-(3,4,5-trimethoxybenzyl)pyrimidin-2-ol (AS)

25 mg

USP1692527 Trimethoprim Related Compound B (2,4-diaminopyrimidin-5-yl)(3,4,5-trimethoxyphenyl)methanone (AS)

25 mg

USP1692709 Trimipramine Maleate 50 mg

USP1692710 Trimipramine Related Compound A dehydro trimipramine

25 mg

USP1693009 Trioxsalen 200 mg

USP1695004 Tripelennamine HCl 200 mg

USP1696007 Triprolidine HCl 500 mg

USP1696109 Triprolidine HCl Z-Isomer 50 mg

USP1696200 Trisalicylic Acid 100 mg

New USP1696153 Tritricosanoin 50 mg



Code Product Unit

USP1696958 Trolamine 3 mL

USP1697000 Troleandomycin 250 mg

USP1698002 Tromethamine 125 mg

USP1699005 Tropicamide 200 mg

New USP1699300 Trospium Chloride 100 mg

New USP1699311 Trospium Chloride Related Compound A Benzillic Acid

20 mg

New USP1699322 Trospium Chloride Related Compound B (1R,3r,5S)-8-azabicyclo[3.2.1]octan-3-yl-hydroxydiphenylacetate

20 mg

New USP1699333 Trospium Chloride Related Compound C Azoniaspironortropanol chloride

20 mg

USP1700002 Trypsin Crystallized 300 mg

USP1700501 L-Tryptophan 200 mg

USP1700512 Tryptophan Related Compound A 1,1'-ethylidene-bis-(L-tryptophan)

15 mg

USP1700523 Tryptophan Related Compound B N-Acetyl-L-Tryptophan

25 mg

USP1702008 Tubocurarine Chloride 250 mg

USP1703805 Tylosin 250 mg

USP1703850 Tylosin Tartrate 100 mg

USP1704003 Tyloxapol 600 mg

USP1705006 L-Tyrosine 500 mg

USP1705301 Ubidecarenone 200 mg

USP1705323 Ubidecarenone Related Compound A Coenzyme Q 9

15 mg

USP1705312 Ubidecarenone for System Suitability 25 mg

USP1705505 Undecylenic Acid 200 mg

USP1705800 Uracil Arabinoside 50 mg

USP1706698 Urea 200 mg

USP1706701 Urea C 13 150 mg

USP1707806 Ursodiol 125 mg

USP1707839 Valacyclovir HCl 200 mg

USP1707855 Valacyclovir Related Compound C 2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl N-methyl-L-valinate HCl

10 mg

USP1707861 Valacyclovir Related Compound D 2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl N-ethyl-L-valinate

15 mg

USP1707872 Valacyclovir Related Compound E 2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl N-[(benzyloxy]carbonyl]-L-valinate

25 mg

USP1707883 Valacyclovir Related Compound F 2-hydroxyethyl valinate pratoluenesulfonate salt

25 mg

USP1707894 Valacyclovir Related Compound G N,N-dimethylpyridin-4-amine

50 mg

USP1707908 Valerenic Acid 15 mg

USP1708004 Valganciclovir HCl 500 mg

USP1708015 D-Valganciclovir 2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)-methoxy]-3-hydroxypropyl D-valine ester monohydrochloride

10 mg

USP1708503 L-Valine 200 mg

USP1708707 Valproic Acid 500 mg

USP1708729 Valproic Acid Related Compound A Diallylacetic Acid

0.25 mL

USP1708718 Valproic Acid Related Compound B (2RS)-2-(1-methylethyl) pentanoic acid (AS)

50 mg

USP1708730 Valrubicin 100 mg

USP1708751 Valrubicin Resolution Mixture Valrubicin spiked with seven related substance

25 mg



Code Product Unit

USP1708762 Valsartan 350 mg

USP1708773 Valsartan Related Compound A (R)-N-Valeryl-N-([2'-(1-H-tetrazole)-5-yl)-biphenyl-4-yl]-methyl)-valine

10 mg

USP1708784 Valsartan Related Compound B (S)-N-butyryl-N-{[2'-(1-H-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine

10 mg

USP1708795 Valsartan Related Compound C (S)-N-Valeryl-N-([2'-(1-H-tetrazole)-5-yl)-biphenyl-4-yl]-methyl)-valine benzyl ester

10 mg

USP1709007 Vancomycin HCl 4 vials

USP1709018 Vancomycin B with Monodechlorovancomycin 350 mg

USP1710006 Vanillin 200 mg

USP1711009 Vanillin Melting Point Standard (Approximately 82°C) 1 g

USP1711100 Vasopressin 8-L-arginine vasopressin

1.71 mg

USP1711155 Vecuronium Bromide 50 mg

USP1711166 Vecuronium Bromide Related Compound A 3alpha, 17beta-diacetyl-oxy-2beta, 16beta-bispiperidinyl-5alpha-androstan

25 mg

USP1711177 Vecuronium Bromide Related Compound B Piperidinium,1-[(2beta, 3alpha, 5alpha, 16beta, 17beta)-3-acetyloxy-17-hydroxy-2-(1-piperidinyl)androstan-16-yl]-1-methyl bromide

15 mg

USP1711188 Vecuronium Bromide Related Compound C [Piperidinium,1-[(2beta,3alpha,5alpha,16beta,17beta)-3,17-dihydroxy-2-(1-piperidinyl)androstan-16-yl]-1-methyl bromide]

15 mg

USP1711224 Vecuronium Bromide Related Compound F Piperidinium,1-[(2beta,3alpha,5alpha,16beta,17beta)-17-acetyloxy-3-hydroxy-2-(1-piperidinyl)androstan-16-yl]-1-methyl bromide

15 mg

USP1711268 Venlafaxine HCl 100 mg

USP1711279 Venlafaxine Related Compound A 1-(1-(4-Methoxyphenyl)-2-(methylamino)ethyl)cyclohexanol hydrochloride

10 mg

USP1711202 Verapamil HCl 200 mg

USP1711304 Verapamil Related Compound A 3,4-Dimethoxy-alpha-[3-(methylamino)propyl]-alpha-(1-methylethyl)- benzeneacetonitrile monoHCl

50 mg

USP1711406 Verapamil Related Compound B alpha-[2-[[2-(3,4-dimethoxyphenyl)-ethyl]methylamino]ethyl]-3,4-dimethoxy- alpha-(1-methylethyl)-benzeneacetonitrile monohydrochloride

50 mg

USP1711428 Verapamil Related Compound D 5,5'-[[2-(3,4)dimethoxyphenyl)ethyl]imino]bis[2-(3,4-dimethoxyphenyl)-2-(1-methylethyl)pentanenitrile]hydrochloride

50 mg

USP1711439 Verapamil Related Compound E 3,4-dimethoxybenzaldehyde

50 mg

USP1711440 Verapamil Related Compound F 3,4-Dimethoxybenzyl alcohol

150 mg

USP1711461 Verteporfin 200 mg

USP1711472 Verteporfin Related Compound A (+/-)18-Ethenyl-4,4a-dihydro-3,4-bis(methoxycarbonyl)-4a,8,14,19-tetramethyl-23H,25H-benzo[b]prophine-9,13-dipropanoic Acid

50 mg

USP1711508 Vidarabine 200 mg

USP1713004 Vinblastine Sulfate 50 mg

USP1714007 Vincristine Sulfate 50 mg

New USP1714018 Vincristine Sulfate (Assay) 29.8 mg/vial

USP1714506 Vinorelbine Tartrate 200 mg

USP1714528 Vinorelbine Related Compound A 4-O-Deacetylvinorelbine Tartrate

25 mg

USP1714608 Vinpocetine 100 mg

USP1714619 Vinpocetine Related Compound A Ethyl(12RS,13aSR,13bSR)-13a-ethyl-12-hydroxy-2,3,5,6,12,13,13a,13b-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate

30 mg

USP1714620 Vinpocetine Related Compound B Methyl(13aS,13bS)-13a-ethyl-9-methoxy-2,3,5,6,13a,13bhexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate

30 mg



Code Product Unit

USP1714641 Vinpocetine Related Compound C Ethyl(13aS,13bS)-13a-ethyl-10-methoxy-2,3,5,6,13a,13b-hexahydro-1Hindolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate

30 mg

USP1714652 Vinpocetine Related Compound D Ethyl(12RS,13aRS,13bRS)-13a-ethyl-2,3,5,6,12,13,13a,13boctahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate

30 mg

USP1715000 Viomycin Sulfate 200 mg

USP1716002 Vitamin A unit

USP1717504 Vitamin D Assay System Suitability 1.5 g

USP1717708 Vitexin 25 mg

New USP1718008 Voriconazole 100 mg

USP1718019 Voriconazole Related Compound A (2RS, 3RS)-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol

10 mg

New USP1718020 Voriconazole Related Compound B (2S,3R)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol

10 mg

New USP1718063 Voriconazole Related Compound F {(1RS,4SR)-7,7-Dimethyl-2-oxobicyclo[2.2.1]hept-1yl}methanesulphonic acid

50 mg

USP1719000 Warfarin 200 mg

USP1719102 Warfarin Related Compound A 3-(o-hydroxyphenyl)-5-phenyl-2-cyclohexen-1-one

50 mg

USP1719500 Withanolide A 15 mg

USP1719532 Withanoside IV 15 mg

USP1720000 Xanthanoic Acid 100 mg

USP1720203 Xanthone 100 mg

USP1720407 Xylazine 200 mg

USP1720429 Xylazine HCl 200 mg

USP1720600 Xylitol 1 g

USP1721002 Xylometazoline HCl 250 mg

USP1722005 Xylose 1 g

USP1724000 Yohimbine HCl 200 mg

USP1724306 Zalcitabine 200 mg

New USP1724350 Zaleplon Controlled Substance CIV 200 mg

New USP1724361 Zaleplon Related Compound A (E)-N-(3-[3-(dimethylamino)acryloyl]phenyl)-N-ethylacetamide Controlled Substance CIV

15 mg

New USP1724372 Zaleplon Related Compund B N-[3-(3-Cyanopyrazolo[1,5-alpha]pyrimidin-5-yl)phenyl]-N-ethylacetamide Controlled Substance CIV

15 mg

USP1724317 Zalcitabine Related Compound A 2',3'-Didehydro-2',3'-dideoxycytidine

50 mg

USP1724500 Zidovudine 400 mg

USP1724521 Zidovudine Related Compound B 3'-chloro-3'-deoxythymidine

25 mg

USP1724532 Zidovudine Related Compound C thymine

100 mg

USP1724543 Zidovudine Related Compound D [1-(2-Deoxy-beta-D-ribofuranosyl)]thymine)methylsilyl]-p-cresol

50 mg

USP1724656 Zileuton 150 mg

USP1724667 Zileuton Related Compound A N-(1-Benzo[b]thien-2-ylethyl)urea

50 mg

USP1724678 Zileuton Related Compound B 2-(Benzo[b]thien-2-oyl)benzo[b]thiophene

50 mg

USP1724689 Zileuton Related Compound C 1-Benzo[b]thien-2-ylethanone

50 mg

USP1724747 Zinc Oxide (AS) 2 g

USP1724769 Zinc Sulfate (AS) 1 g

USP1724408 Ziprasidone HCl 200 mg



Code Product Unit

USP1724419 Ziprasidone Related Compound A 3-(Piperazin-1-yl)benzo[d]isothiazole monohydrochloride

10 mg

USP1724420 Ziprasidone Related Compound B 5-(2-(4-(Benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloroindoline-2,3-dione

10 mg

USP1724441 Ziprasidone Related Compound C 5,5'-Bis(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6,6'-dichloro-3-hydroxy-3,3'-biindoline-2,2'-dione

10 mg

USP1724452 Ziprasidone Related Compound D 3-(Benzo[d]isothiazol-3-yl)-5-(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloroindolin-2-one

10 mg

USP1724805 Zolazepam HCl 500 mg

New USP1724827 Zoledronic Acid 150 mg

New USP1724838 Zoledronic Acid Related Compound A 2-(1H-Imidazol-1-yl)acetic acid

30 mg

New USP1727009 Zolmitriptan 150 mg

New USP1727018 Zolmitriptan R-Isomer (R)-4-({3-[2-(Dimethylamino)ethyl]indol-5-yl}methyl)oxazolidin-2-one

20 mg

New USP1727020 Zolmitriptan Related Compound A (S)-4-({3-[2-(Methylamino)ethyl]-1H-indol-5-yl}methyl)oxazolidin-2-one

20 mg

New USP1727031 Zolmitriptan Related Compound B (S)-2-Amino-3-{3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}propan-1-ol

20 mg

New USP1727053 Zolmitriptan Related Compound D (S)-Ethyl 3-[2-(dimethylamino)ethyl]-5-[(2-oxooxazolidin-4-yl)methyl]-1H-indole-2-carboxylate

20 mg

USP1724893 Zolpidem Controlled Substance CIV 10 mg

USP1724951 Zolpidem Impurities Mixture Controlled Substance CIV

15 mg

USP1724907 Zolpidem Tartrate Controlled Substance CIV 200 mg

USP1724918 Zolpidem Related Compound A N,N-Dimethyl-2-[7-methyl-2-p-tolylimidazo[1,2-a]pyridin-3-yl]acetamide Controlled Substance CIV

15 mg

USP1725003 Zonisamide 200 mg

USP1725014 Zonisamide Related Compound A 1,2-benzisoxazole-3-methanesulfonic acid sodium salt

20 mg

USP1725036 Zonisamide Related Compound C N'-(benzisoxazol-3-ylmethylsulfonyl)-N,N-dimethylformimidamide

20 mg

New USP1729118 Zopiclone R-Isomer Controlled Substance CIV (-)-(5R)-6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo{3,4-b]pyrazin-5-yl 4-methylpiperazine-1-carboxylate

10 mg




programme. As Europe’s only officially authorized distributor of ATCC® cultures, LGC Standards can supply all ATCC organisms specified in the pharmacopoeia. ATCC maintains the highest standards for its biological materials, employing stringent quality control procedures to produce cultures which are well characterized and have low passage numbers. Long-term subculturing of biological materials can have adverse effects on the culture population, including genetic drift, unwanted selection, contamination, and varied cell responses. ATCC quality control cultures sold by LGC Standards are never subcultured or transferred in any way from ATCC’s strains and our European stock-holding means orders are usually filled within 3-5 working days. So whether it is quality control strains, genomic DNA, media or growth supplements, antibiotics for selection, or a huge selection of organisms, take the time and guesswork out of ordering your microbiology supplies with authentic, high-quality ATCC materials – exclusively from LGC Standards.

US Pharmacopeia 34, monographs and general chapters

Code Product Unit

Chondroitin sulfate sodium Monograph ATCC-11437 Clostridium sporogenes amp.

Oil- and water-soluble vitamins with minerals tablets Monograph ATCC-7830 Lactobacillus delbrueckii ss. lactis (as L.Leichmannii) amp.

ATCC-8014 Lactobacillus plantarum 17-5 amp.

Penicillamine Monograph ATCC-9341 Kocuria rhizophila amp.

Penicillin G Procaine and novobiocin sodium intramammary infusion ATCC-12692 Staphylococcus aureus ss.aureus amp.

Sargraostim Monograph ATCC-CRL-2003 TF-1 Cells amp.

Tetracycline hydrochloride and novobiocin sodium tablets Monograph ATCC-10536 Escherichia coli amp.

Water-soluble vitamins capsules Monograph ATCC-8042 Pediococcus acidilactici amp.

<51> Antimicrobial effectiveness testing ATCC-16404 Aspergillus niger amp.





<55> Biological indicator for dry-heat sterilization, paper carrier ATCC-9372** Bacillus subtilis amp.

<55> Biological indicator for ethylene oxide sterilization, paper carrier ATCC-9372** Bacillus subtilis amp.

<55> Biological indicator for steam sterilization, paper carrier ATCC-7953** Bacillus stearothermophilus amp.

ATCC-12980 Bacillus stearothermophilus amp.

<55> Biological indicator for steam sterilization, self contained ATCC-7953** Bacillus stearothermophilus amp.

ATCC-12980 Bacillus stearothermophilus amp.

<71> Sterility tests ATCC-16404 Aspergillus niger amp.


ATCC-8482 Bacteroides vulgatus amp.

US Pharmacopeia 34, monographs and general chapters


Code Product Unit




ATCC-9341 Kocuria rhizophila amp.



<81> Antibiotics assays ATCC-6633 Bacillus subtilis amp.


ATCC-10541 Enterococcus hirae (as Streptococcus faecalis) amp.


ATCC-10031 Klebsiella pneumoniae ss. pneumoniae amp.

ATCC-9341 Kocuria rhizophila amp.









<87> Biological reactivity tests, in-vitro amp ATCC-CCL-1 L-929 mammalian fibroblasts NCTC Clone 929 amp.

<91> Calcium pantothenate assay ATCC-8014 Lactobacillus plantarum 17-5 amp.

<115> Dexpanthenol assay ATCC-8042 Pediococcus acidilactici amp.

<171> Vitamin B12 activity assay ATCC-7830 Lactobacillus delbrueckii ss. lactis (as L.Leichmannii) amp.

<441> Niacin or niacinamide assay ATCC-8014 Lactobacillus plantarum 17-5 amp.

<1046> Analytical methodologies ATCC-VR-1448 Hybrid Moloney Amphotropic murine leukemia virus amp.

ATCC-VR-1450 Hybrid Moloney Amphotropic murine leukemia virus amp.

<1211> Sterilization and sterility assurance of compendial articles ATCC-27142** Bacillus pumilus amp.

ATCC-7953** Bacillus stearothermophilus amp.

ATCC-9372** Bacillus subtilis amp.

ATCC-19146 Brevendimonas diminuta (as Pseudomonas diminuta) amp.

ATCC-14756 Serratia marcescens amp.

<2021> Microbial enumeration tests - Dietary supplements ATCC-16404 Aspergillus niger amp.




ATCC-13311 Salmonella choleraesuis ss. choleraesuis serotype typhimurium (as Salmonella typhimurium) amp.

ATCC-6538 Staphylococcus aureus ss. aureus amp. **=Alternative strain

All care has been taken in compiling catalogue numbers, however users should consult the Pharmacopeia directly to confirm the testing requirements and recommended organisms before ordering or undertaking the testing procedures as described in the Pharmacopeia.

Secondarystandards

Reference materialsfor particle size fromWhitehouse Scientific

LGC Standards is pleased to offer particle size standardsfrom Whitehouse Scientific.

Whitehouse Scientific produces a wide range of precisionmicrospheres for calibrating all types of particle sizeinstruments, from sieve to laser diffraction analysers,as well as measuring the pore sizes in filters.

Founded 25 years ago, Whitehouse Scientific are thehighest ranking European certification laboratory forprimary methods of particle size analysis. Nearly all thereference standards are NIST and NPL traceable.

Particle size measurements are crucial in ensuring thequality of products in a wide variety of sectors:

� Food

� Industry

� Environmental

� Pharmaceutical

For further information or to place an order, pleasecontact your local office.

Polydisperse standards

Monodisperse standards

Image analysis standards

Sieve calibration standards

General purpose glassmicrospheres

General purpose basaltmicrospheres

www.lgcstandards.com Standards

Excellence through measurement

FINE dividers x 12 v6_SS:Layout 1 08/08/2011 11:27 Page 1

Secondary Reference Standards traceable to USP, EP and BP


Secondary Reference Standards traceable to USP, EP and BP Background

The concept of secondary standards derived by direct comparison with pharmacopoeial reference standards is a proven one and recognised by all major regulation agencies and pharmacopoeias. Normally such secondary standards are established by the laboratory that uses them afterwards. To source them from a dedicated provider instead is a new concept and offers significant advantages.

Efficiency: You can focus your resources on value producing activities, rather than the routine. Risk Mitigation: These standards are supplied by an independent 3rd party Reference Material Producer working according to acknowledged ISO standards. Economical savings: Attractively priced over pharmacopeial reference standards or in-house standards. Generous Quantities: Product contains 2-20x the amount offered by the Pharmacopeias, allowing multiple uses.

Certification

The Certificate of Analysis provided with the products in this catalogue section complies with the requirements of ISO Guide 31 and is traceable to the available United States, European, and British Pharmacopeial Reference Standard.

Furthermore, every current Secondary Reference Standard from this catalogue section is re-certified after new pharmacopoeial lot or batch releases. Please contact your local LGC Standards office to obtain updated certificates for the materials purchased via us.

About RTC

The certified reference materials displayed in this catalogue section are manufactured by RTC, the Research Technology Corporation with headquarters in Laramie (WY) in the United States of America. We are proud to offer them conveniently to you in mainland Europe.

RTC maintains the highest level of accreditation available in the industry like accreditation to ISO Guide 34 and ISO 17025.

Code Product Unit Price

RTC-PHR-1028 1,4-Benzoquinone 1 g AR

RTC-PHR-1072 2-Propanol 3x1.2 mL AR

RTC-PHR-1048 4-Hydroxybenzoic Acid 1 g AR

RTC-PHR-1005 Acetaminophen (Paracetamol) 1 g AR

RTC-PHR-1086 Acetanilide Melting Point Standard 1 g AR

RTC-PHR-1053 Albuterol Sulfate 1 g AR

RTC-PHR-1008 Ascorbic Acid 2 g BR

RTC-PHR-1003 Aspirin (Acetylsalicylic acid) 1 g AR

RTC-PHR-1073 Avobenzone 1 g AR

RTC-PHR-1088 Azithromycin 1 g BR

RTC-PHR-1050 Benzoic Acid 1 g AR

RTC-PHR-1019 Benzyl Alchohol 1 g AR

RTC-PHR-1022 Butylparaben (Butyl parahydroxybenzoate) 1 g AR

RTC-PHR-1009 Caffeine 1 g AR

RTC-PHR-1095 Caffeine Melting Point Standard 1 g AR

RTC-PHR-1067 Carbamazepine 1 g AR

RTC-PHR-1016 Chlorpheniramine Maleate 500 mg AR

RTC-PHR-1075 Cimetidine 1 g AR

RTC-PHR-1089 Cimetidine Hydrochloride 1 g AR

RTC-PHR-1044 Ciprofloxacin Hydrochloride 1g BR

RTC-PHR-1071 Citric Acid 1 g AR

RTC-PHR-1038 Clarithromycin 500 mg BR

RTC-PHR-1021 Clindamycin Phosphate 1 g BR

RTC-PHR-1058 Clotrimazole 1 g AR




RTC-PHR-1092 Cyclosporine 500 mg ER

RTC-PHR-1070 Dehydrated Alcohol 5x1.2 mL AR

RTC-PHR-1018 Dextromethorphan Hydrobromide 500 mg BR

RTC-PHR-1000 Dextrose (D-Glucose) 1 g AR

RTC-PHR-1045 Diethylene Glycol 1 g AR

RTC-PHR-1015 Diphenhydramine Hydrochloride 1 g AR

RTC-PHR-1090 Dopamine Hydrochloride 1 g AR

RTC-PHR-1068 Edetate Disodium 1 g AR

RTC-PHR-1039 Erythromycin 500 mg CR

RTC-PHR-1046 Ethylene Glycol 1 g AR

RTC-PHR-1011 Ethylparaben (Ethyl parahydroxybenzoate) 1 g AR

RTC-PHR-1055 Famotidine 1 g AR

RTC-PHR-1035 Folic Acid 1 g AR

RTC-PHR-1002 Fructose 1 g AR

RTC-PHR-1057 Furosemide 1 g BR

RTC-PHR-1049 Gabapentin 1 g CR

RTC-PHR-1020 Glycerin (Glycerol) 5 g AR

RTC-PHR-1027 Guaifenesin 1 g AR

RTC-PHR-1085 Homosalate 1 g AR

RTC-PHR-1032 Hydrochlorothiazide 1 g BR

RTC-PHR-1014 Hydrocortisone 500 mg BR

RTC-PHR-1004 Ibuprofen 1 g AR

RTC-PHR-1025 Lactose (anhydrous) 1 g AR

RTC-PHR-1024 Lactose monohydrate 1 g AR

RTC-PHR-1034 Lidocaine 1g AR

RTC-PHR-1007 Mannitol 1 g AR

RTC-PHR-1060 Mesalamine 1 g AR

RTC-PHR-1084 Metformin Hydrochloride 500 mg AR

RTC-PHR-1012 Methylparaben (Methyl parahydroxybenzoate) 1 g AR

RTC-PHR-1076 Metoprolol Tartrate 1 g AR

RTC-PHR-1052 Metronidazole 1 g AR

RTC-PHR-1040 Naproxen 500 mg CR

RTC-PHR-1033 Niacinamide (Nicotinamide) 1 g AR

RTC-PHR-1080 Octinoxate 1 g AR

RTC-PHR-1081 Octisalate 1 g AR

RTC-PHR-1083 Octocrylene 1 g AR

RTC-PHR-1059 Omeprazole 1 g BR

RTC-PHR-1074 Oxybenzone 1 g AR

RTC-PHR-1094 Phenacetin Melting Point Standard 1 g AR

RTC-PHR-1017 Phenylephrine Hydrochloride 500 mg AR

RTC-PHR-1078 Phytonadione 1 g AR

RTC-PHR-1043 Prednisolone 500 mg BR

RTC-PHR-1042 Prednisone 1 g BR

RTC-PHR-1051 Propylene Glycol 1.5 g AR

RTC-PHR-1010 Propylparaben (Propyl parahydroxybenzoate) 1 g AR

RTC-PHR-1036 Pyridoxine Hydrochloride 500 mg AR

RTC-PHR-1026 Ranitidine Hydrochloride 500 mg CR

RTC-PHR-1063 Residual Solvents Mixture - Class I 3x1.2 mL DR




RTC-PHR-1064 Residual Solvents Mixture - Class IIA 3x1.2 mL DR

RTC-PHR-1065 Residual Solvents Mixture - Class IIB 3x1.2 mL DR

RTC-PHR-1066 Residual Solvents Mixture - Class IIC 3x1.2 mL DR

RTC-PHR-1054 Riboflavin 1 g AR

RTC-PHR-1013 Salicylic Acid 1 g AR

RTC-PHR-1006 Sorbitol 1 g AR

RTC-PHR-1001 Sucrose 1 g AR

RTC-PHR-1093 Sulfanilamide Melting Point Standard 1 g AR

RTC-PHR-1087 Sulfapyridine Melting Point Standard 1 g AR

RTC-PHR-1041 Tetracycline Hydrochloride 500 mg BR

RTC-PHR-1023 Theophylline 1 g AR

RTC-PHR-1037 Thiamine Hydrochloride 1 g CR

RTC-PHR-1056 Trimethoprim 1 g AR

RTC-PHR-1061 Valproic Acid 1 g AR

RTC-PHR-1091 Vanillin Melting Point Standard 1 g AR

RTC-PHR-1031 α-Tocopherol 500 mg AR

RTC-PHR-1030 α-Tocopheryl Acetate 500 mg AR

RTC-PHR-1029 α-Tocopheryl Acid Succinate 500 mg AR

RTC-PHR-1096 L-Lysine Acetate 1 g AR

RTC-PHR-1097 L-Tyrosine 1 g AR

RTC-PHR-1098 N-Acetyl-L-Cysteine 1 g AR

RTC-PHR-1099 L-Isoleucine 1 g AR

RTC-PHR-1100 L-Phenylalanine 1 g AR

RTC-PHR-1105 L-Leucine 1 g AR




Institute of Dyes andOrganic Products

Refractive indexCRMs

Reference materials for sports drugs analysis from NMIANational Measurement Institute of Australia (NMIA) produces some 200

state-of-the-art certified reference materials for sports drugs applications.

• Synthetic steroids and their metabolites

• Endogenous steroids and their metabolites

• Prohormones and their metabolites

• Growth promotants and their metabolites

• Various other substances of interest

NMIA has a third party accreditation as a

reference materials producer operating to

ISO Guide 34. Its reference materials are

supplied with a comprehensive analysis report

that includes:

• Certified property values with uncertainty statements

• Homogeneity and stability studies on all materials

• Traceability of assigned values to the international system of units


Institute of Dyes and Organic Products


Institute of Dyes and Organic Products The use of colouring agents in pharmaceutical preparations and dose forms is widespread. In most

cases food colouring materials are used.

The following standards of dyes, used in the pharmaceutical and food industry, are listed with common description, E code and colour index number (C.I.) for an easy assignment.

The IBPO is accredited by the Polish Centre for Testing and Certification according to the standard PN-EN 45001 and ISO/IEC Guide 25:1990.

Each colour reference standard is supplied with a detailed certificate of analysis, which includes dye content value determined by spectrophotometry and values of impurities.

Black Code Product Unit

IBPO010 Brilliant Black PN (E 151) 1 g

Blue IBPO015 Brilliant Blue FCF (E 133) 1 g

IBPO002 Indigotine (E 132) 1 g

IBPO012 Patent Blue V (E 131) 1 g

Brown IBPO017 Brown HT(E 155) 1 g

Green IBPO016 Brilliant Green BS (E 142) 1 g

Red IBPO014 Allura Red AC (E 129) 1 g

IBPO005 Amaranth (E 123) 1 g

IBPO003 Azorubin (E 122) 1 g

IBPO011 Erythrosine (E 127) 1 g

IBPO004 Ponceau 4R (E 124) 1 g

IBPO013 Red 2 G (E 128) 1 g

Yellow IBPO007 Quinoline Yellow (E 104) 1 g

IBPO009 Sunset Yellow FCF (E 110)

1 g

IBPO008 Tartrazine (E 102) 1 g

Refractive index CRMs


Refractive index CRMs The revised EP general method 2.2.6 replaces CRS reference liquids with certified reference materials

available from suppliers of chemical reagents or materials certified for metrology.

11 liquid CRMs, certified by the Physical Chemistry Division of the Central Office of Measures (GUM), Warsaw in Poland, cover the wide range of refractive index from 1,333 (water) to 1,657 (1-bromonaphthalene).

These CRMs are intended for calibration and checking refractive index scales of laboratory refractometers of an uncertainty expected not less than ±0,00005.

The n values we determined on a Pulfrich refractometer, previously calibrated with solid class 1 CRMs, for which values were established using goniometric procedures.

All CRMs are supplied with a certificate. Certified values to 5 significant figures for the refractive index at λ = 589.3 nm t = 20°C and associated uncertainties are given.

Reference liquids are packed in glass ampoules or plastic drop-bottles.

Code Product Unit

PRG 7.21 Water Refractive index ................................. 1.333 at 20 °C

10 mL

PRG 7.1 2,2,4-Trimethylpentane Refractive index ................................. 1.391 at 20 °C

10 mL

PRG 7.11 Methylsilicone oil Refractive index ................................. 1.405 at 20 °C

10 mL

PRG 7.2 Methylcyclohexane Refractive index ................................. 1.423 at 20 °C

10 mL

PRG 7.12 Silicone oil DC 556 Refractive index ................................. 1.462 at 20 °C

10 mL

PRG 7.20 Paraffin oil Refractive index ................................. 1.475 at 20 °C

10 mL

PRG 7.5 Toluene Refractive index ................................. 1.496 at 20 °C

10 mL

PRG 7.6 Chlorobenzene Refractive index ................................. 1.524 at 20 °C

10 mL

PRG 7.8 1-Bromonaphthalene Refractive index ................................. 1.657 at 20 °C

10 mL

PRG 7.9 1-Iodonaphthalene Refractive index ................................. 1.702 at 20 °C

10 mL

Publicationsandsubscriptions

Microbiology catalogue including useful technical resource.

Available now from LGC Standards.

A comprehensive directory of ATCC® organisms essential for:

• Pharmaceutical applications

• Food and Water analysis

Contact your local LGC Standards office for your copy

www.lgcstandards-atcc.org

Microbiologycatalogue

ATCC microbiology cat new.qxp:Layout 1 17/8/11 16:20 Page 1

NEW

© LGC Limited 2011. All rights reserved. 3032/CF/0811

BLS micro ad.indd 1 17/08/2011 16:31

Publications and subscriptions


Publications and subscriptions Code Product Unit

Printed versions USP USP2340001 1 year subscription:

USP34-NF29 [2011 Print Subscription]; (2011 book + Supplement 1 & 2)

unit

Electronic versions USP USP2100000 USP-NF Online, 365 days access per user

USP2330009 1 year subscription: USP34-NF29 CD-ROM [2011 Single-user subscription]

unit

Printed versions EP EPPUB110001 EP 2011 Book Subscription 7th Edition English (7.0-7.2) unit

EPPUB120002 EP 2011 Book Subscription 7th Edition French (7.0-7.2) unit

EPPUB200000 EP 2012 Book Subscription 7th Edition English (7.3-7.5) unit

EPPUB200001 EP 2012 Book Subscription 7th Edition French (7.3-7.5) unit

Electronic versions EP EPPUB100003 EP 2011 USB stick Subscription 7th Edition (7.0-7.2) Bilingual unit

EPPUB200004 EP 2012 USB stick Subscription 7th Edition (7.3-7.5) Bilingual unit

EPPUB100004 EP 2011 Online subscription 7th Edition (7.0-7.2) Bilingual per user

EPPUB100006 EP 2012 Online subscription 7th Edition (7.3-7.5) Bilingual per user

British Pharmacopoeia BP 2011 British Pharmacopoeia 2011 Multimedia Package [2011 book (6 volumes), single user CD-

ROM or Password for one user for Online access) unit

BP 2012 British Pharmacopoeia 2012 Multimedia Package [2012 book (6 volumes), single user CD-ROM or Password for one user for Online access)

unit

Publications and subscriptions

402 Promotional message - even page Edition 2004/2005


High Purity Solvents

Reference materials for physical properties

LGC Standards, Europe‘s most comprehensive single source of reference materials, offers over 750 reference materials for physical properties. For manufacturers the determination of the physical pro-perties of their product can be one of the most important steps in quality assurance.

Our range covers many physical properties including thermal, surface properties, particle shape and size, ion activity, viscosity, electrical and polimeric properties. Of particular interest are the products for determination of optical properties such as molecular absorption, lumine-scence, colour measurement and refractive index.

• Materials and standards from commercial sources and international bodies• Fast delivery of high quality materials• Expert local customer service and technical support

To receive a copy of our catalogue 'Reference materials for physical properties' please contact your local office or download a PDF on http://www.lgcstandards.com/media/2010638350.pdf.


Thermal properties

Optical properties

Surface properties

Particle shape and size

Ion activity

Viscosity

Electrical properties

Polymeric properties

Standards

Excellence through measurement

Content

Edition 2011/2012 Promochem® is a trademark of LGC Standards 405

Introduction Picograde® solvents for residue analysis

Picograde® solvents form the heart of the LGC Standards solvent range. Each batch undergoes rigorous testing in order to meet the demanding requirements of organic trace analysis every time.

Environmental analysts are now expected to detect trace levels of an increasingly wide range of organic environmental contaminants including pesticides, PAHs, PCBs, PCDDs/PCDFs etc. with the highest possible accuracy. Consequently even the lowest levels of impurity in the solvent can affect the precision of analytical results. Picograde® solvents are specifically tailored to this application.

Carefully selected raw materials are chemically pre-treated and then fractionated in glass in the absence of air. Distillation and filling are similarly carried out in air free conditions. The glass bottles are sterile and dust free and are rinsed with the appropriate solvent prior to filling. Caps used to seal the bottles are subjected to the same stringent cleaning processes. The specification of the solvent includes the determination of water content, residue on evaporation and a comprehensive gas chromatographic analysis.

To confirm the absence of contaminants samples of the solvent are concentrated to varying degrees and then analysed by gas chromatography. Flame ionisation and electron capture detectors (ECD) are used for the quantification of the contaminants. The specification of the Picograde® solvent guarantees that no signal due to contamination will be larger than the internal standard peak (10 pg/mL heptachlor-epoxide) in the retention time window from 1,4-dichlorobenzene to decachlorobiphenyl. The very high specification of the Picograde® solvents allows them to be used for residue analysis of trace quantities of organic contaminants right down to ppb and ppt levels.

Optigrade® - High purity solvents for HPLC

High performance liquid chromatography is now an essential analytical tool especially in the areas of research and development, pharmaceutical quality control and analysis in the food and environmental sectors. This technique demands the highest quality solvents to allow reproducible separations. The basic requirements include a high UV-transmission factor, low particle levels, slight acidity and alkalinity coupled with low levels of water and other non-volatile components. In addition there must be consistency between batches.

Solvents for isocratic analytical HPLC together with gradient grade quality solvents are included in the HPLC range. Gradient grade has the highest purity and is specially designed for use with gradient elution HPLC using reversed phase materials and UV or fluorescence detection. Quality assurance procedures allow LGC Standards to offer a consistently premium quality product. Each batch is checked to make sure that the solvent has the required high level of UV-transmission in the wavelength range 190-350 nm.

Solvents for LC/MS The presence of alkali and alkaline earth metals in the mobile phase when using LC/MS can make the interpretation of the mass spectrum very difficult. LGC Standards offers solvents designed for this technique with extremely low levels of these metals, at 0.1 ppm and less.

Solvents for Ultra HPLC (UHPLC) ULTRA HPLC (UHPLC) requires solvents of superior quality. This range of high purity Optigrade® solvents from LGC Standards has been designed to allow high resolution and sensitivity. Such Ultra HPLC solvents combine the highest specification for: UV, low gradient shift, minimal peak impurities and lowest ionic background for MS detection. All Ultra HPLC solvents are micro filtered at 0.1 µm, have a residue following evaporation of max 1 ppm and are packed under inert gas for improved shelf life. Also available are selected buffers for mobile phase preparation and several blends of water and acetonitrile with formic acid, acetic acid and trifluoroacetic acid are offered.

Introduction

406 Promochem® is a trademark of LGC Standards Edition 2011/2012

Specialist solvents

Solvents for VOCs and aromatic hydrocarbons It has become increasingly necessary to be able to determine a range of organic compounds in environmental samples including volatile organic compounds (VOCs) and BTEX-aromatics. Various extraction techniques are used for the separation and concentration of organic trace constituents from the sample matrix and it is essential to use solvents with very low levels of contamination. LGC Standards can provide the solvents to meet these exacting requirements.

Solvents for GC headspace techniques Analysis of volatile organic impurities using the GC headspace technique, has become an important quality control tool in pharmaceutical and food related industries. The International Conference on Harmonization of technical requirements for registration of pharmaceuticals for Human use (ICH) has issued recommendationsconcerning the safe levels of residual solvents in pharmaceutical compounds. These solvents are divided into 3 classes according to their toxicity. Limit values of residual solvents in pharmaceutical products are specified by the United States and European Pharmacopeia. The quality of the solvent used to dissolve the sample is of prime importance. It must be of the highest purity and show virtually no background signal with both polar and non polar GC capillary columns. These headspace solvents are high boiling point solvents, specifically developed, analysed and packed for the headspace analysis of volatile solvent impurities.

Solvents for the analysis of nitrosamines When extracting trace levels of nitrosamines in samples it is important to use a solvent that is free of nitrosamine contamination. For this application LGC Standards has solvents with a maximum level of 0.1ppb of specific nitrosamines.

Solvents for the tobacco industry

High purity acids

LGC Standards offers the most frequently used mineral acids for trace analysis: hydrochloric acid, nitric acid, hydrofluoric acid, sulfuric acid, perchloric acid and acetic acid. These are produced by sub-boiling distillation of very pure starting materials. This purification results in most metallic impurities reduced to (or bellow) ppb ranges. The acids are delivered in special bottles (long - term leached borosilicate glass or modified HDPE) which ensure minimum contamination of the acid from the material of the bottle.

Important note: Element concentrations are at the point of bottling. Concentrations of some elements may increase due to the storage container.

Trademarks

Promochem®, Optigrade®, Cyclotainer®, Picograde® - LGC Standards GmbH FLORISIL® - U.S.SILICA COMPANY

Reagents / Sorbents


Reagents / Sorbents Code Product Unit

SC-4592-A005 ICN-Alumina A - Super I (acid) (50 - 200 µm) 500 g

SC-4568-A005 ICN Alumina B - Super I (basic) (50 - 200 µm) 500 g

SC-4569-A005 ICN-Alumina B - Super I (50 - 200 µm) for dioxin analysis 500 g

SC-4181-B005 Florisil® (Standard), 60 - 100 mesh (150 - 250 µm) 500 g

SC-4181-S010 Florisil® (Standard), 60 - 100 mesh (150 - 250 µm) 10 kg

SC-4182-B005 Florisil® PR for residue analysis, 60 - 100 mesh (150 - 250 µm) 500 g

SC-4182-S010 Florisil® PR for residue analysis, 60 - 100 mesh (150 - 250 µm) 10 kg

SC-4182-S020 Florisil® PR for residue analysis, 60 - 100 mesh (150 - 250 µm) 20 kg

SC-9700-B005 Florisil® (Standard), 60 - 100 mesh (suitable for ISO 9377-2/H53) 500 g

SC-4183-B005 Florisil® (Standard), 100-200 mesh 500 g

SC-4183-S010 Florisil® (Standard), 100-200 mesh 10 kg

SC-4183-S020 Florisil® (Standard), 100-200 mesh 20 kg

SC-9982-B010 Silica gel 60 (63 - 200 µm) 1 kg

SC-9950-B005 Sodium sulfate anhydrous, for analysis (ACS), powder 500 g

SC-9950-B025 Sodium sulfate anhydrous, for analysis (ACS), powder 2.5 kg

SC-8024-B005 Sodium sulfate anhydrous, for analysis, in granular form 500 g

SC-8024-B025 Sodium sulfate anhydrous, for analysis, in granular form 2.5 kg

SC-8024-S025 Sodium sulfate anhydrous, for analysis, in granular form 25 kg

SC-1024-B005 Sodium sulfate Picograde® anhydrous, for residue analysis (ACS), in granular form 500 g

SC-1024-B025 Sodium sulfate Picograde® anhydrous, for residue analysis (ACS), in granular form 2.5 kg

Ion pair reagents Code Product Unit

SC-5330-F025 1-Butanesulfonic acid sodium salt for HPLC 25 g

SC-5330-F100 1-Butanesulfonic acid sodium salt for HPLC 100 g

SC-5650-F025 1-Decanesulfonic acid sodium salt for HPLC 25 g

SC-5650-F100 1-Decanesulfonic acid sodium salt for HPLC 100 g

SC-5430-F025 1-Dodecanesulfonic acid sodium salt for HPLC 25 g

SC-5430-F100 1-Dodecanesulfonic acid sodium salt for HPLC 100 g

SC-5230-F025 1-Heptanesulfonic acid sodium salt for HPLC 25 g

SC-5230-F100 1-Heptanesulfonic acid sodium salt for HPLC 100 g

SC-5550-F025 1-Hexanesulfonic acid sodium salt for HPLC 25 g

SC-5550-F100 1-Hexanesulfonic acid sodium salt for HPLC 100 g

SC-5150-F025 1-Octanesulphonic acid sodium salt for HPLC 25 g

SC-5150-F100 1-Octanesulphonic acid sodium salt for HPLC 100 g

SC-5730-F025 1-Pentanesulfonic acid sodium salt for HPLC 25 g

SC-5730-F100 1-Pentanesulfonic acid sodium salt for HPLC 100 g

LC-MS additives


LC-MS additives Code Product Unit

SO-9685-B001 Ammonium acetate UHPLC-MS Optigrade® CAS number 631-61-8

Assay (GC, on anhydrous basis) .............. 99 % min.

Water (KF) .............................................. 0.1 % max.

Filter test (1M in water) ........................... Passes test

pH (1M in water) ............................................. 6.0-7.5

Transmission

at 260 nm (1M in water) .................................... 96 % at 280 nm (1M in water) .................................... 98 %

Chloride (Cl) ....................................... 0.0005% max. Sulfate (SO4) ........................................... 001% max.

Al ............................................................ 1 ppm max. Ca .......................................................... 5 ppm max. Fe ........................................................... 1 ppm max. K ............................................................. 5 ppm max. Mg .......................................................... 1 ppm max. Na .......................................................... 5 ppm max.

100 g

SO-9679-B001 Formic acid UHPLC-MS Optigrade® UN 1779

CAS number 64-18-6

Assay (T, on anhydrous basis) ............................... 99 % min.

Water (KF) .............................................................. 1 % max.

Residue after evaporation .......................... 0.001 %w/w max.

Color (APHA) ............................................................ 10 max.

Gradient specification

HPLC gradient at 254 nm - H. Peak 0.005 AU max. HPLC gradient at 254 nm - Drift 0.02 AU max.

Transmission

at 260 nm ............................................................... 15 % min. at 270 nm ................................................................ 83% min. at 280 nm ............................................................... 90 % min. at 300 nm ................................................................ 97% min. at 320 nm ................................................................ 98% min.

100 mL

SO-9668-B001 Trifluoroacetic acid UHPLC-MS Optigrade® UN 2699

CAS-Nr. 76-05-1

Assay (T) ................................................................... 99.95-100 %

Water (KF) ...................................................................... 0-0.02 %

Residue after evaporation ....................................... 0-0.001 %w/w

Color (APHA) ......................................................................... 0-10


HPLC gradient 254 nm - H. Peak ............................... 0-0.002 AU HPLC gradient at 254 nm - Drift.................................. 0-0.010 AU

Fluorescence at 254 nm (25%, as quinine) ...................... 0-1 ppb Fluorescence at 365 nm (25%, as quinine) ...................... 0-1 ppb

Transmission

at 260 nm ....................................................................... 10-100 % at 270 nm ....................................................................... 79-100 % at 280 nm ....................................................................... 93-100 % at 300 nm ...................................................................... 95-100 % at 320 nm ....................................................................... 96-100 %

100 mL

High purity solvents and acids


High purity solvents and acids Acetic acid Code Product Unit

HPA-0050-B010 Acetic acid for trace analysis min 99.5 % (glass bottle) UN 2789

Assay .......................................................... > 99.5 % Chloride ..................................................... < 0.4 ppm Colour (APHA) ................................................... < 10 Phosphate ................................................. < 0.5 ppm Residue ........................................................ < 2 ppm Sulfate ....................................................... < 0.4 ppm

Ag................................ < 0.1 ppb Cr .................................< 0.1 ppb Ni................................. < 0.1 ppb Al ................................. < 0.1 ppb Cu ................................< 0.1 ppb Pb................................ < 0.1 ppb As ................................ < 0.1 ppb Fe ................................< 0.5 ppb Se................................ < 0.5 ppb Ba................................ < 0.1 ppb K ..................................< 0.1 ppb Sn................................ < 0.1 ppb Be................................ < 0.1 ppb Li ..................................< 0.1 ppb Sr ................................ < 0.1 ppb Bi ................................. < 0.1 ppb Mg................................< 0.1 ppb Th ................................ < 0.1 ppb Ca ............................... < 0.5 ppb Mn................................< 0.1 ppb Ti ................................. < 0.1 ppb Cd ............................... < 0.1 ppb Mo................................< 0.1 ppb V.................................. < 0.1 ppb Co ............................... < 0.1 ppb Na ................................< 0.5 ppb Zn ................................ < 0.5 ppb

Hydrochloric acid stored in glass bottles will see a rise in: Al, B, Ca, K, Mg, Mn, Na and Si.

1 L

Acetone SO-2435-B010 Acetone HPLC Optigrade® 1 L

SO-2435-B025 Acetone HPLC Optigrade® 2.5 L

SO-2435-B040 Acetone HPLC Optigrade® UN 1090

CAS-Nr. 67-64-1

C3H6O

Assay ...................................................... 99.5% min.

Water ....................................................... 0.5% max.

Non-volatile matter ............................. 0.0005% max.

Filtered through 0.2 µm 1 L = 0.792 kg (at 20°C)

Specification

Transmission

at 330 nm ................................................... 10% min. at 340 nm ................................................... 79% min. at 350 nm ................................................... 89% min. at 370 nm ................................................... 98% min.

4 L

SO-1142-B010 Acetone Picograde® for residue analysis 1 L

SO-1142-B025 Acetone Picograde® for residue analysis 2.5 L

SO-1142-B040 Acetone Picograde® for residue analysis UN 1090

CAS number 67-64-1

C3H6O

Assay ...................................................... 99.0% min.

Water ....................................................... 0.5% max.


1 L = 0.792 kg (at 20°C)

Specification

GC/ECD In the GC-ECD chromatogram there are no interfering single signals in the retention time interval between 1,4-dichlorobenzene and decachlorobiphenyl, by a 500-fold concentration greater than that, given by 10 pg/mL heptachlor-epoxide.

GC/FID In the GC-FID chromatogram there are no interfering single signals in the retention time interval between n-octane (C8) and n-tetracontane (C40), by a 500-fold concentration greater than that, given by 50 ng/mL n-undecane (C11).

4 L

Acetonitrile SO-9128-B010 Acetonitrile HPLC Optigrade® Gradient Grade 1 L

SO-9128-B025 Acetonitrile HPLC Optigrade® Gradient Grade 2.5 L



Code Product Unit

SO-9128-B040 Acetonitrile HPLC Optigrade® Gradient Grade UN 1648

CAS-Nr. 75-05-8

C2H3N

Assay ..................................................... 99.8% min.

Water ..................................................... 0.02% max.


Gradientspecification (210 nm) .......... 3.0 mAU max.

Fluorescence (as Quinine at 254 nm) ..... 1 ppb max.

Filtered through 0.2 µm

1 L = 0.783 kg (at 20°C)

Specification

Transmission

at 190 nm .................................................... 20% min at 193 nm .................................................... 62% min at 195 nm .................................................... 76% min at 210 nm .................................................... 89% min at 220 nm .................................................... 98% min at 230 nm .................................................... 99% min

This solvent in glass bottles fulfills the specifications according to chapter 4 of the European Pharmacopoeia.

4 L

SO-9154-B010 Acetonitrile HPLC Optigrade® Super Gradient Grade 1 L

SO-9154-B025 Acetonitrile HPLC Optigrade® Super Gradient Grade UN 1648

CAS-Nr. 75-05-8

C2H3N

Assay ...................................................... 99.8% min.

Water ..................................................... 0.02% max.


Gradient specification (210 nm) ..........3.0 mAE max.

Fluorescence (as Quinine at 254 nm) ..... 1 ppb max.

Filtered through 0.2 µm 1 L = 0.783 kg (at 20°C)

Specification

Transmission

at 190 nm 40% min at 191 nm 50% min at 193 nm 66% min at 195 nm 83% min at 200 nm 95% min at 215 nm 98% min at 230 nm 99% min


2.5 L

SO-2856-B010 Acetonitrile HPLC Optigrade® 1 L

SO-2856-B025 Acetonitrile HPLC Optigrade® 2.5 L

SO-2856-B040 Acetonitrile HPLC Optigrade® UN 1648

CAS-Nr. 75-05-8

C2H3N

Assay ...................................................... 99.8% min.

Water ..................................................... 0.02% max.



1 L = 0.783 kg (at 20°C)

Specification

Transmission

at 190 nm ................................................... 10% min. at 200 nm ................................................... 79% min. at 210 nm ................................................... 89% min. at 220 nm ................................................... 95% min. at 230 nm ................................................... 98% min. at 235 nm ................................................... 99% min.

4 L

SO-9184-B010 Acetonitrile HPLC Optigrade® (for analysis of PAHs and pesticides) 1 L



Code Product Unit

SO-9184-B025 Acetonitrile HPLC Optigrade® (for analysis of PAHs and pesticides) UN 1648

CAS-Nr. 75-05-8

C2H3N

Assay ....................................................... 99.8% min

Water ..................................................... 0.02% max.



1 L = 0,783 kg (at 20°C)

Specification

Transmission


2.5 L

SO-9340-B010 Acetonitrile für LC-MS Optigrade® 1 L

SO-9340-B025 Acetonitrile für LC-MS Optigrade® UN 1648

CAS-Nr. 75-05-8

C2H3N

Assay ....................................................... 99.8% min

Water ..................................................... 0.02% max.



1 L = 0.783 kg (at 20°C)

Specification

Ca ........................................................0.1 ppm max. K...........................................................0.1 ppm max. Mg ........................................................0.1 ppm max. Na ........................................................0.1 ppm max.

Transmission

at 195 nm .................................................. 78 % min. at 200 nm .................................................. 95 % min. at 220 nm .................................................. 98 % min. at 240 nm .................................................. 99 % min.

2.5 L

SO-9640-B010 Acetonitrile UHPLC-MS Optigrade® 1 L

SO-4680-B025 Acetonitrile 0.1 % formic acid UHPLC-MS Optigrade® UN 1648

CAS number 75-05-8

C2H3N

Assay ..................................................................... 0.095-0.105 %

Water (KF) ................................................................ 0.02 % max.

Purity of ACN (GC) .................................................. 99.97 % min.

Purity of formic acid .................................................... 99.0% min.


HPLC gradient at 254 nm - H. Peak ...................... 0.002 AU max.

Fluorescence at 254 nm (as quinine) ....................... 0.5 ppb max. Fluorescence at 365 nm (as quinine) ....................... 0.5 ppb max.

Transmission

at 210 nm ........................................................................ 5 % min. at 230 nm ...................................................................... 15 % min. at 254 nm ...................................................................... 90 % min.

Al ............................................................................... 30 ppb max. Ca ............................................................................. 100 ppb min. Fe ................................................................................ 50 ppb min. K................................................................................ 100 ppb min. Mg ............................................................................... 30 ppb min. Na ............................................................................. 100 ppb min.

Microfiltered through 0.1 µm/bottled under inert gas

2.5 L



Code Product Unit

SO-4686-B025 Acetonitrile 0.1 % acetic acid UHPLC-MS Optigrade® UN 1648

CAS number 75-05-8

C2H3N

Assay ..................................................................... 0.095-0.105 %

Purity of ACN (GC) ................................................... 99.97% min.

Purity of acetic acid (GC) ............................................ 99.9% min.


HPLC gradient at 254 nm - H. Peak ..................... 0.002 AU max. HPLC gradient at 254 nm - Drift............................ 0.010 AU max.

Fluorescence at 254 nm (as quinine) ........................0.5 ppb max. Fluorescence at 365 nm (as quinine) ........................0.5 ppb max.

Transmission

at 210 nm ...................................................................... 20 % min. at 230 nm ...................................................................... 50 % min. at 254 nm ...................................................................... 98 % min.

Al ...............................................................................30 ppb max. Ca ............................................................................100 ppb max. Fe ...............................................................................50 ppb max. K ...............................................................................100 ppb max. Mg ..............................................................................30 ppb max. Na ............................................................................100 ppb max.


2.5 L

SO-4692-B025 Acetonitrile 0.1 % trifluoroacetic acid UHPLC-MS Optigrade® UN 1648

CAS number 75-05-8

C2H3N

Assay ..................................................................... 0.095-0.105 %

Water (KF) ................................................................ 0.02 % max.

Purity of ACN (GC) .................................................. 99.97 % min.

Purity of trifluoroacetic acid ...................................... 99.95 % min.


HPLC gradient at 254 nm - H. Peak ................... 0.0002 AU max.


Transmission




2.5 L

SO-9186-B025 Acetonitrile DNA. max. 0.001% water UN 1648

CAS-Nr. 75-05-8

C2H3N

Assay ...................................................... 99.9% min.

Water by Karl Fischer titration.............. 0.001% max.


1 L = 0.783 kg (at 20°C)

2.5 L

SO-9180-B025 Acetonitrile DNA. max. 0.003% water UN 1648

CAS-Nr. 75-05-8

C2H3N

Assay ...................................................... 99.9% min.

Water by Karl Fischer titration.............. 0.003% max.


1 L = 0.783 kg (at 20°C)

2.5 L

SO-1151-B010 Acetonitrile Picograde® for residue analysis 1 L

SO-1151-B025 Acetonitrile Picograde® for residue analysis 2.5 L



Code Product Unit

SO-1151-B040 Acetonitrile Picograde® for residue analysis UN 1648

CAS-Nr. 75-05-8

C2H3N

Assay ...................................................... 99.5% min.

Water ..................................................... 0.02% max.

Non-volatile matter ............................... 0.001% max.

1 L = 0.783 kg (at 20°C)

Specification



4 L

Ammonia solution HPA-0070-B010 Ammonia solution for trace analysis (glass bottle)

UN 2672

Assay ............................................................. > 21 % Chloride ..................................................... < 500 ppb Colour (Hazen) ................................................... < 10 Phosphate ................................................... < 50 ppb Carbonate .................................................. < 10 ppm Sulfate ....................................................... < 500 ppb

Al ................................. < 0.5 ppb Cu ................................< 0.5 ppb Se................................ < 0.1 ppb As ................................ < 0.1 ppb Fe ................................< 0.5 ppb Ag................................ < 0.1 ppb Ba................................ < 0.1 ppb Pb ................................< 0.1 ppb Na ............................... < 0.5 ppb Be................................ < 0.1 ppb Li ..................................< 0.1 ppb Sr ................................ < 0.1 ppb Bi ................................. < 0.1 ppb Mg................................< 0.2 ppb Th ................................ < 0.1 ppb Cd ............................... < 0.1 ppb Mn................................< 0.1 ppb Sn................................ < 0.1 ppb Ca ............................... < 0.5 ppb Mo................................< 0.1 ppb Ti ................................. < 0.1 ppb Cr ................................ < 0.1 ppb Ni .................................< 0.1 ppb V.................................. < 0.1 ppb Co ............................... < 0.1 ppb K ..................................< 0.2 ppb Zn ................................ < 0.2 ppb

1 L

Benzene SO-1163-B010 Benzene Picograde® for residue analysis 1 L

SO-1163-B025 Benzene Picograde® for residue analysis UN 1114

CAS-Nr.71-43-2

C6H6

Assay ...................................................... 99.0% min.

Water ..................................................... 0.05% max.


1 L = 0.871 kg (at 20°C)

Specification



2.5 L

Benzyl alcohol SO-9505-B005 Benzyl alcohol for the analysis of highly volatile halogenated compounds and EOX

CAS-Nr. 100-51-6

C7H8O

Assay ...................................................... 99.0% min.

Water ....................................................... 0.1% max.

Non-volatile matter ................................. 0.05% max.

1 L = 1.05 kg (at 20°C)

Specification

Highly volatile halogenated hydrocarbons In the GC/ECD chromatogram there are no interfering single signals in the retention time interval between 1,1-dichloroethene and tribromomethane greater than that, given by 5 µg/L parathion-methyl.

BTEX for FID In the GC-FID chromatogram the sum of the signals of BTEX-compounds is not greater than the signal, given by 10 µg/L n-Decane.

Coulometric determination of EOX gives a halogen content as chloride of less than 0.3 mg/L.

500 mL



Code Product Unit

Carbon disulfide SO-9056-B005 Carbon disulfide free from aromatic hydrocarbons

UN 1131

CAS-Nr. 75-15-0

CS2

Assay ...................................................... 99.8% min.

Water ..................................................... 0.03% max.


1 L = 1.261 kg (at 20°C)

Specification


500 mL

Chloroform SO-4443-B010 Chloroform HPLC Optigrade® (alcohol-free. stabilised with amylene) 1 L

SO-4443-B025 Chloroform HPLC Optigrade® (alcohol-free. stabilised with amylene) 2.5 L

SO-4443-B040 Chloroform HPLC Optigrade® (alcohol-free. stabilised with amylene) UN 1888

CAS-Nr. 67-66-3

CHCl3

Assay ...................................................... 99.9% min.

Water ..................................................... 0.03% max.



1 L = 1.475 kg (at 20°C)

stabilized with 50 - 200 ppm Amylen

Specification

Transmission

at 245 nm ................................................... 10% min. at 255 nm ................................................... 70% min. at 260 nm ................................................... 89% min. at 270 nm ................................................... 96% min. at 290 nm ................................................... 98% min.

4 L

SO-1174-B010 Chloroform Picograde® for residue analysis (stabilised with 0.2-1.8 % ethanol) 1 L

SO-1174-B025 Chloroform Picograde® for residue analysis (stabilised with 0.2-1.8 % ethanol) 2.5 L

SO-1174-B040 Chloroform Picograde® for residue analysis (stabilised with 0.2-1.8 % ethanol) UN 1888

CAS-Nr. 67-66-3

CHCl3

Assay ...................................................... 99.8% min.

Acid and phosgene (as HCI) .............. 0.0005% max.


1 L = 1.475 kg (at 20°C)

stabilized with 0.2 - 1.8% Ethanol

Specification



4 L



Code Product Unit

Cyclohexane SO-9052-B010 Cyclohexane HPLC Optigrade® 1 L

SO-9052-B025 Cyclohexane HPLC Optigrade® UN 1145

CAS-Nr. 110-82-7

C6H12

Assay ...................................................... 99,5% min.

Water ..................................................... 0,02% max.

Non-volatile matter ............................. 0,0003% max.


1 L = 0,779 kg (at 20°C)

Specification

Transmission


2.5 L

SO-1179-B010 Cyclohexane Picograde® for residue analysis 1 L

SO-1179-B025 Cyclohexane Picograde® for residue analysis 2.5 L

SO-1179-B040 Cyclohexane Picograde® for residue analysis UN 1145

CAS-Nr. 110-82-7

C6H12

Assay ...................................................... 99.0% min.

Water ..................................................... 0.01% max.


1 L = 0.779 kg (at 20°C)

Specification



4 L

Cyclopentane SO-6157-B010 Cyclopentane HPLC Optigrade®

UN 1146

CAS-Nr. 287-92-3

C5H10

Assay ......................................................... 75% min.

Water ................................................... 0.005% max.



1 L = 0.751 kg (at 20°C)

Specification

Transmission


1 L



Code Product Unit

n-Decane SO-1182-B010 n-Decane Picograde® for residue analysis

UN 2247

CAS-Nr. 124-18-5

CH3(CH2)8CH3

Assay ...................................................... 97,0% min.

Water ..................................................... 0,01% max.


1 L = 0,731 kg (at 20°C)

Specification



1 L

Dichloromethane SO-4879-B010 Dichloromethane HPLC Optigrade® (stabilised with amylene) 1 L

SO-4879-B025 Dichloromethane HPLC Optigrade® (stabilised with amylene) 2.5 L

SO-4879-B040 Dichloromethane HPLC Optigrade® (stabilised with amylene) UN 1593

CAS-Nr. 75-09-2

CH2Cl2

Assay ...................................................... 99.8% min.

Water ..................................................... 0.02% max.



1 L = 1.335 kg (at 20°C)

stabilized with 60 - 100 ppm Amylene

Specification

Transmission


4 L

SO-1185-B010 Dichloromethane Picograde® for residue analysis (stabilised with amylene) 1 L

SO-1185-B025 Dichloromethane Picograde® for residue analysis (stabilised with amylene) 2.5 L

SO-1185-B040 Dichloromethane Picograde® for residue analysis (stabilised with amylene) UN 1593

CAS-Nr. 75-09-2

CH2Cl2

Assay ...................................................... 99.5% min.

Water ..................................................... 0.02% max.


1 L = 1.335 kg (at 20°C)

stabilized with 60 - 100 ppm amylene

Specification

GC/ECD In the GC-ECD chromatogram there are no interfering single signals in the retention time interval between 1.4-dichlorobenzene and decachlorobiphenyl. by a 500-fold concentration greater than that, given by 10 pg/mL heptachlor-epoxide.

GC/FID In the GC-FID chromatogram there are no interfering single signals in the retention time interval between n-octane (C8) and n-tetracontane (C40). by a 500-fold concentration greater than that, given by 50 ng/mL n-undecane (C11).

4 L



Code Product Unit

SO-9800-B025 Dichloromethane nitrosamine-free Specification

N-Nitrosodimethylamine ............................ 0.1 ppb max. N-Nitrosodiethylamine................................ 0.1 ppb max. N-Nitrosodi-n-propylamine ......................... 0.1 ppb max. N-Nitrosodi-i-propylamine .......................... 0.1 ppb max. N-Nitrosodi-n-butylamine ........................... 0.1 ppb max. N-Nitrosopiperidine .................................... 0.1 ppb max. N-Nitrosopyrrolidine ................................... 0.1 ppb max. N-Nitrosomorpholine .................................. 0.1 ppb max.

2.5 L

Diethyl ether SO-9012-B010 Diethyl ether HPLC Optigrade® (stabilised with ethanol) 1 L

SO-9012-B025 Diethyl ether HPLC Optigrade® (stabilised with ethanol) UN 1155

CAS-Nr. 60-29-7

C4H10O

Assay ...................................................... 99.0% min.

Water ..................................................... 0.01% max.


Peroxide ..................................................5 ppm max.


1 L = 0.713 kg (at 20°C)

stabilized with 2% Ethanol

Specification

Transmission


2.5 L

SO-2854-B010 Diethyl ether HPLC Optigrade® (not stabilised) 1 L

SO-2854-B025 Diethyl ether HPLC Optigrade® (not stabilised) UN 1155

CAS-Nr. 60-29-7

C4H10O

Assay ...................................................... 99.0% min.

Water ..................................................... 0.01% max.


Peroxide ..................................................5 ppm max.


1 L = 0.713 kg (at 20°C)

not stabilized

Specification

Transmission

at 215 nm ................................................... 10% min. at 254 nm ................................................... 83% min. at 280 nm ................................................... 95% min.

2.5 L

SO-1187-B010 Diethyl ether Picograde® for residue analysis (stabilised with 1.5-2.5 % ethanol) 1 L



Code Product Unit

SO-1187-B025 Diethyl ether Picograde® for residue analysis (stabilised with 1.5-2.5 % ethanol) UN 1155

CAS-Nr. 60-29-7

C4H10O

Assay ...................................................... 99.0% min.

Water ........................................................ 0.1%max.

Non-volatile matter ................................ 0.001%max.

Peroxide ................................................. 5 ppm max.

1 L = 0.6502 kg (at 20°C)

stabilized with 1.5 - 2.5% Ethanol

Specification



2.5 L

N,N-Dimethylacetamide SO-5407-B025 N,N-Dimethylacetamide HPLC Optigrade® 2.5 L

SO-5407-B040 N,N-Dimethylacetamide HPLC Optigrade® CAS-Nr. 127-19-5

C4H9NO

Assay ...................................................... 99.0% min.

Water ..................................................... 0.03% max.



1 L = 0.937 kg (at 20°C)

Specification

Transmission


4 L

SO-3240-B010 N,N-Dimethylacetamide Headspace Grade CAS number 127-19-5

C4H9NO

Assay (GC, on anhydrous basis) ......... 99.99 % min.

Acidity (as acetic acid) .......................... 0.05 % max.

Water (KF) ............................................ 0.03 % max.

UV cutoff wavelength ............................. 190-268 nm

Transmission

at 268 nm .................................................. 10 % min. at 275 nm .................................................. 55 % min. at 300 nm .................................................. 85 % min. at 350 nm .................................................. 98 % min. at 400 nm .................................................. 99 % min.

Headspace test for O.V.I. ........................ passes test

1 L



Code Product Unit

N,N-Dimethylformamide SO-5356-B025 N,N-Dimethylformamide HPLC Optigrade®

UN 2265

CAS-Nr. 68-12-2

C3H7NO

Assay ...................................................... 99.7% min.

Water ..................................................... 0.05% max.



1 L = 0.951 kg (at 20°C)

Specification

Transmission


2.5 L

SO-1189-B010 N,N-Dimethylformamide Picograde® 1 L

SO-1189-B025 N,N-Dimethylformamide Picograde® UN 2265

CAS-Nr. 68-12-2

C3H7NO

Assay ...................................................... 99.0% min.

Water ....................................................... 0.2% max.


1 L = 0.951 kg (at 20°C)

Specification



2.5 L

SO-3230-B010 N,N-Dimethylformamide Headspace Grade UN 2265

CAS number 68-12-2

C3H7NO


Refractive index (20 °C) ......................... 1.430-1.440

Water (KF) ............................................ 0.03 % max.


Transmission


Headspace test for O.V.I........................... passes test

1 L

1,3-Dimethyl-2-imidazolidinone (N,N'-Dimethylethyleneurea) SO-3260-B005 1,3-Dimethyl-2-imidazolidinone (DMI) Headspace Grade

Assay (GC, on anhydrous basis) ........... 99.5 % min.

Refractive index (20 °C) .......................... 1.470-1473

Water (KF) .............................................. 0.1 % max.


Transmission

at 275 nm .................................................. 40 % min. at 300 nm .................................................. 85 % min. at 325 nm .................................................. 95 % min. at >350 nm ................................................ 98 % min.

Headspace test for O.V.I......................... passes test

500 mL



Code Product Unit

Dimethylsulfoxide (DMSO) SO-3210-B010 Dimethylsulfoxide Headspace Grade

CAS-Nr 67-68-5


Refractive index (20 °C) ......................... 1.477-1.480

Water (KF) ............................................ 0.04 % max.


Transmission

at 268 nm .................................................. 30 % min. at 275 nm .................................................. 60 % min. at 300 nm .................................................. 85 % min. at 350 nm .................................................. 95 % min. at 400 nm .................................................. 98 % min.

Headspace test for O.V.I. ........................ passes test

1 L

1,4-Dioxane SO-9002-B010 1,4-Dioxane HPLC Optigrade® (not stabilised) 1 L

SO-9002-B025 1,4-Dioxane HPLC Optigrade® (not stabilised) UN 1165

CAS-Nr. 123-91-1

C4H8O2

Assay ...................................................... 99.5% min.

Water ..................................................... 0.05% max.



1 L = 1.034 kg (at 20°C)

not stabilized

Specification

Transmission


2.5 L

Ethanol SO-9063-B010 Ethanol HPLC Optigrade® 1 L

SO-9063-B025 Ethanol HPLC Optigrade® UN 1170

CAS-Nr. 64-17-5

C2H5OH

Assay ...................................................... 99.7% min.

Water ....................................................... 0.1% max.



1 L = 0.789 kg (at 20°C)

Specification

Transmission


2.5 L



Code Product Unit

2-Ethoxyethanol SO-2925-B025 2-Ethoxyethanol HPLC Optigrade®

UN 1171

CAS-Nr. 110-80-5

C4H10O2

Assay ...................................................... 99.5% min.

Water ..................................................... 0.08% max.



1 L = 0.932 kg (at 20°C)

Specification

Transmission


2.5 L

Ethyl acetate SO-3442-B010 Ethyl acetate HPLC Optigrade® 1 L

SO-3442-B025 Ethyl acetate HPLC Optigrade® 2.5 L

SO-3442-B040 Ethyl acetate HPLC Optigrade® UN 1173

CAS-Nr. 141-78-6

CH3COOC2H5

Assay ...................................................... 99.5% min.

Water ..................................................... 0.05% max.



1 L = 0.897 kg (at 20°C)

Specification

Transmission


4 L

SO-9345-B010 Ethyl acetate for LC-MS Optigrade® 1 L

SO-9345-B025 Ethyl acetate for LC-MS Optigrade® UN 1173

CAS-Nr. 141-78-6

CH3COOC2H5

Assay ...................................................... 99,5% min.

Water ..................................................... 0,05% max.



1 L = 0,897 kg (at 20°C)

Specification

Ca ........................................................0,1 ppm max. K...........................................................0,1 ppm max. Mg ........................................................0,1 ppm max. Na ........................................................0,1 ppm max.

Transmission

at 260 nm .................................................. 70 % min. at 280 nm .................................................. 99 % min.

2.5 L

SO-1191-B010 Ethyl acetate Picograde® for residue analysis 1 L

SO-1191-B025 Ethyl acetate Picograde® for residue analysis 2.5 L



Code Product Unit

SO-1191-B040 Ethyl acetate Picograde® for residue analysis UN 1173

CAS-Nr. 141-78-6

CH3COOC2H5

Assay ...................................................... 99.0% min.

Water ..................................................... 0.05% max.


1 L = 0.897 kg (at 20°C)

Specification



4 L

n-Heptane SO-5139-B010 n-Heptane HPLC Optigrade® 1 L

SO-5139-B025 n-Heptane HPLC Optigrade® 2.5 L

SO-5139-B040 n-Heptane HPLC Optigrade® UN 1206

CAS-Nr. 142-82-5

C7H16

Assay ...................................................... 95.0% min.

Water ..................................................... 0.02% max.



1 L = 0.685 kg (at 20°C)

Specification

Transmission


4 L

SO-1210-B025 n-Heptane Picograde® for residue analysis UN 1206

CAS-Nr. 142-82-5

C7H16

Assay ...................................................... 97.0% min.

Water ..................................................... 0.01% max.


1 L = 0.682 kg (at 20°C)

Specification

GC/ECD In the GC-ECD chromatogram there are no interfering single signals in the retention time interval between 1,4 dichlorobenzene and decachlorobiphenyl, by a 500 fold concentration greater than that, given by 10 pg/mL heptachlor-epoxide.

GC/FID In the GC-FID chromatogram there are no interfering single signals in the retention time interval between n-octane (C8) and n-tetracontane (C40), by a 500 fold concentration greater than that, given by 50 ng/mL n-undecane (C11).

2.5 L

n-Hexane SO-5167-B010 n-Hexane HPLC Optigrade® 1 L

SO-5167-B025 n-Hexane HPLC Optigrade® 2.5 L



Code Product Unit

SO-5167-B040 n-Hexane HPLC Optigrade® UN 1208

CAS-Nr. 110-54-3

C6H14

Assay (of C6-isomers) ............................. 99.8% min.

Water ....................................................... 0.1% max.



1 L = 0.659 kg (at 20°C)

Specification

Transmission


4 L

SO-1244-B010 n-Hexane Picograde® for residue analysis 1 L

SO-1244-B025 n-Hexane Picograde® for residue analysis 2.5 L

SO-1244-B040 n-Hexane Picograde® for residue analysis UN 1208

CAS-Nr. 110-54-3

C6H14


Water ..................................................... 0.01% max.


PCBs (#28,52,77,81,101,105,114, ......... passes test 118,123,126,138,153,156,157,167, 169,180,189)

1 L = 0.659 kg (at 20°C)

Specification



4 L

SO-9500-B010 n-Hexane for the analysis of highly volatile halogenated hydrocarbons and EOX 1 L

SO-9500-B025 n-Hexane for the analysis of highly volatile halogenated hydrocarbons and EOX UN 1208

CAS-Nr. 110-54-3

C6H14


Wasser/Water ........................................ 0.01% max.


1 L = 0.651 kg (at 20°C)

Specification

Highly volatile halogenated hydrocarbons/EOX In the GC/ECD chromatorgram there are no interfering single signals in the retention time interval between 1,1-dichloroethene and tribromomethane greater than that, given by 5 µg/L parathion-methyl.


2.5 L



Code Product Unit

Iso-Hexane SO-9043-B025 Iso-Hexane HPLC Optigrade®

UN 1208

CAS-Nr. 107-83-5

C6H14

Assay of C6-isomers ................................ 95.0% min.

Water ..................................................... 0.01% max.


1 L = 0.653 kg (at 20°C)

Specification

Transmission

at 195nm .................................................... 10% min. at 210nm .................................................... 56% min. at 217nm .................................................... 63% min. at 220nm .................................................... 75% min. at 245nm .................................................... 95% min.

2.5 L

SO-1251-B025 Iso-Hexane Picograde® for residue analysis UN 1208

CAS-Nr. 107-83-5

C6H14

Gehalt/Assay (of C6-isomers) .................. 95.0% min.

Water ..................................................... 0.01% max.


1 L = 0.653 kg (at 20°C)

Specification



2.5 L

Hydrochloric acid HPA-0010-B010 Hydrochloric acid for trace analysis min. 36 % (glass bottle)

UN 1789

Assay ............................................................. > 36 % free chlorine............................................... < 0.5 ppm Residue ........................................................ < 3 ppm Phosphate ............................................... < 0.05 ppm Colour (APHA) ................................................... < 10 Sulfite ........................................................ < 0.5 ppm Bromide ...................................................... < 50 ppm Sulfate ....................................................... < 0.5 ppm

Ag ................................ < 0.1 ppb Cu ............................... < 0.1 ppb Sb ................................ < 0.1 ppb Al ................................. < 0.5 ppb Fe .................................. < 1 ppb Se ................................ < 0.1 ppb As ................................ < 0.1 ppb Hg ............................... < 0.2 ppb Sn ................................ < 0.1 ppb B ..................................... < 1 ppb K ................................. < 0.1 ppb Sr ................................ < 0.1 ppb Ba ................................ < 0.1 ppb Li ................................. < 0.1 ppb Th ................................ < 0.1 ppb Be ................................ < 0.1 ppb Mg ............................... < 0.5 ppb Ti ................................. < 0.1 ppb Bi ................................. < 0.1 ppb Mn ............................... < 0.1 ppb U ................................. < 0.1 ppb Ca ............................... < 0.5 ppb Mo ............................... < 0.1 ppb V .................................. < 0.1 ppb Cd ............................... < 0.1 ppb Na ............................... < 0.5 ppb Zn ................................ < 0.5 ppb Co ............................... < 0.1 ppb Ni ................................ < 0.1 ppb Zr ................................. < 0.1 ppb Cr ................................ < 0.1 ppb Pb ............................... < 0.1 ppb

Hydrochloric acid stored in glass bottles will see a rise in: Al, B, Ca, K, Mg, Mn, Na and Si.

1 L



Code Product Unit

Hydrofluoric acid HPA-0030-B010 Hydrofluoric acid for trace analysis min. 48 % ( HDPE bottle)

UN 1790

Assay ............................................................. > 48 % Phosphate ................................................. < 0.1 ppm Colour (HAZEN) ................................................. < 10 Sulfate ....................................................... < 0.5 ppm Chloride........................................................ < 1 ppm Hexafluorosilicate ....................................... < 20 ppm

Ag................................... < 1 ppb Cu ...................................< 1 ppb Pb................................... < 1 ppb Al .................................... < 1 ppb Fe ...................................< 1 ppb Se................................... < 1 ppb As ................................... < 1 ppb Hg ...................................< 1 ppb Si .................................... < 1 ppb Ba................................... < 1 ppb K .....................................< 1 ppb Sn................................... < 1 ppb Be................................... < 1 ppb Li .....................................< 1 ppb Sr ................................... < 1 ppb Bi .................................... < 1 ppb Mg...................................< 1 ppb Ti .................................... < 1 ppb Ca .................................. < 1 ppb Mn...................................< 1 ppb V..................................... < 1 ppb Cd .................................. < 1 ppb Mo...................................< 1 ppb Zn ................................... < 1 ppb Co .................................. < 1 ppb Na ...................................< 1 ppb Cr ................................... < 1 ppb Ni ....................................< 1 ppb

Hydrofluoric acid stored in polyethylene bottles will see a rise in: Al, Ca, Fe, Na and Zn.

1 L

Methanol SO-9510-B010 Methanol Purge & Trap

UN 1230

CAS-Nr. 67-56-1

CH3OH

Assay ...................................................... 99,9% min.

Water ............................................................. < 0.1%

Non-volatile matter ....................................... < 0,10%

2-Butanone (GC/MS; P&T) ......................... < 10 µg/l

Other volatile impurities ........................ passes tests

1 L = 0,792 kg (at 20°C)

1 L

SO-9260-B010 Methanol HPLC Optigrade® Gradient Grade 1 L

SO-9260-B025 Methanol HPLC Optigrade® Gradient Grade UN 1230

CAS-Nr. 67-56-1

CH3OH

Assay ...................................................... 99.9% min.

Water ..................................................... 0.05% max.


Gradientspecification (235 nm) ..........0.002 AU max.

Gradientspecification (254 nm) ..........0.001 AU max.

Fluorescence (as Quinine at 254 nm) ...... 1 ppb max.


1 L = 0.792 kg (at 20°C)

Specification

Transmission



2.5 L

SO-3041-B010 Methanol HPLC Optigrade® 1 L

SO-3041-B025 Methanol HPLC Optigrade® 2.5 L



Code Product Unit

SO-3041-B040 Methanol HPLC Optigrade® UN 1230

CAS-Nr. 67-56-1

CH3OH

Assay ...................................................... 99.9% min.

Water ..................................................... 0.05% max.



1 L = 0.792 kg (at 20°C)

Specification

Transmission



4 L

SO-9658-B010 Methanol UHPLC-MS Optigrade® 1 L

SO-9658-B025 Methanol UHPLC-MS Optigrade® UN 1230

CAS number 67-56-1

CH3OH

Assay (GC, on anhydrous basis) ............................. 99.98 % min.

Water (KF) ................................................................. 0.03% max.

Residue after evaporation ............................... 0.0001 %w/w max.

Acidity (as acetic acid) ............................................ 0.002 % max.

Alkalinity (as ammonia) ......................................... 0.0001 % max.

Color (APHA) ......................................................................5 max.


HPLC gradient at 220 nm - Drift.............................. 0.01 AU max. HPLC gradient at 235 nm - Drift............................ 0.005 AU max. HPLC gradient at 220 nm - H. Peak ..................... 0.004 AU max. HPLC gradient at 235 nm - H. Peak ..................... 0.002 AU max.


1 L = 0.783 kg (at 20°C)

Transmission

at 210 nm ...................................................................... 40 % min. at 220 nm ...................................................................... 65 % min. at 230 nm ...................................................................... 80 % min. at 260 nm ...................................................................... 98 % min.

Al ................................................................................20 ppb max. Ca ............................................................................100 ppb max. Fe ...............................................................................20 ppb max. K .................................................................................50 ppb max. Mg ..............................................................................20 ppb max. Na ............................................................................100 ppb max.


2.5 L

SO-9356-B010 Methanol for LC-MS Optigrade® 1 L

SO-9356-B025 Methanol for LC-MS Optigrade® UN 1230

CAS number 67-56-1

CH3OH

Assay ...................................................... 99.9% min.

Water ..................................................... 0.05% max.



1 L = 0.792 kg (at 20°C)

Ca ....................................................... 0.1 ppm max. K .......................................................... 0.1 ppm max. Mg ....................................................... 0.1 ppm max. Na ....................................................... 0.1 ppm max.

Transmission


2.5 L

SO-1263-B010 Methanol Picograde® for residue analysis 1 L



Code Product Unit

SO-1263-B025 Methanol Picograde® for residue analysis 2.5 L

SO-1263-B040 Methanol Picograde® for residue analysis UN 1230

CAS-Nr. 67-56-1

CH3OH

Assay ...................................................... 99.0% min.

Water ....................................................... 0.1% max.


1 L = 0.792 kg (at 20°C)

Specification



4 L

2-Methoxyethanol SO-9509-B010 2-Methoxyethanol for the analysis of highly volatile halogenated hydrocarbons

UN 1188

CAS-Nr. 109-86-4

C3H8O2

Assay ...................................................... 99.7% min.

Water ..................................................... 0.08% max.


1 L = 0.961 kg (at 20°C)

Highly volatile halogenated hydrocarbons In the GC/ECD chromatorgram there are no interfering single signals in the retention time interval between 1,1-dichloroethene and tribromomethane greater than that, given by 5 µg/L parathion-methyl.

BTEX for FID In the GC-FID chromatogram the sum of the signals of BTEX-compounds is not greater than the signal, given by 10 µg/L n-decane.

1 L

Methyl-tert-butyl ether SO-5398-B025 Methyl-tert-butylether HPLC Optigrade®

UN 2398

CAS-Nr. 1634-04-4

C5H12O

Assay ...................................................... 99.7% min.

Water ..................................................... 0.05% max.



1 L = 0.742 kg (at 20°C)

Specification

Transmission


2.5 L

SO-1265-B010 Methyl-tert-butylether Picograde® 1 L

SO-1265-B025 Methyl-tert-butylether Picograde® UN 2398

CAS-Nr. 1634-04-4

C5H12O

Assay ...................................................... 99.8% min.

Water ..................................................... 0.05% max.


1 L = 0.742 kg (at 20°C)

Specification



2.5 L



Code Product Unit

Nitric acid HPA-0020-B010 Nitric acid for trace analysis min 67 % (glass bottle)

UN 2031

Assay ............................................................. > 67 % Phosphate ................................................. < 0.1 ppm Residue ........................................................ < 1 ppm Sulfate ....................................................... < 0.5 ppm Chloride ................................................... < 0.08 ppm

Ag ................................ < 0.1 ppb Cu ............................... < 0.1 ppb Pb ................................ < 0.1 ppb Al ................................. < 0.5 ppb Fe ............................... < 0.5 ppb Se ................................ < 0.1 ppb As ................................ < 0.1 ppb Hg ............................... < 0.2 ppb Sn ................................ < 0.1 ppb Ba ................................ < 0.1 ppb K ................................. < 0.2 ppb Sr ................................ < 0.1 ppb Be ................................ < 0.1 ppb Li ................................. < 0.1 ppb Th ................................ < 0.1 ppb Bi ................................. < 0.1 ppb Mg ............................... < 0.5 ppb Ti ................................. < 0.1 ppb Ca ............................... < 0.5 ppb Mn ............................... < 0.1 ppb V .................................. < 0.1 ppb Cd ............................... < 0.1 ppb Mo ............................... < 0.1 ppb Zn ................................ < 0.5 ppb Co ............................... < 0.1 ppb Na ............................... < 0.5 ppb Cr ................................ < 0.2 ppb Ni ................................ < 0.1 ppb

Nitric Acid stored in glass bottles will see a rise in: Al, B, Ca, K, Mg, Mn, Na and Si.

1 L

n-Nonane SO-4436-B010 n-Nonane HPLC Optigrade®

UN 1920

CAS-Nr. 111-84-2

C9H20

Assay ......................................................... 95% min.

Water ..................................................... 0.01% max.



1 L = 0.719 kg (at 20°C)

Specification

Transmission


1 L

SO-1271-B010 n-Nonane Picograde® for residue analysis 1 L

SO-1271-B025 n-Nonane Picograde® for residue analysis UN 1920

CAS-Nr. 111-84-2

C9H20

Assay ...................................................... 95.0% min.

Water ..................................................... 0.01% max.


1 L = 0.719 kg (at 20°C)

Specification


GC/FID In the GC-FID chromatogram there are no interfering single signals in the retention time interval between decane (C10) and n-tetracontane (C40), by a 500-fold concentration greater than that, given by 50 ng/mL n-undecane (C11).

2.5 L



Code Product Unit

n-Octane SO-1279-B010 n-Octane Picograde® for residue analysis

UN 1262

CAS-Nr. 111-65-9

CH3(CH2)6CH3

Assay ...................................................... 95.0% min.

Water ..................................................... 0.01% max.


1 L = 0.703 kg (at 20°C)

Specification



1 L

n-Pentane SO-9081-B010 n-Pentane HPLC Optigrade®

UN 1265

CAS-Nr. 109-66-0

C5H12

Assay ...................................................... 95.0% min.

Water ..................................................... 0.01% max.



1 L = 0.626 kg (at 20°C)

Specification

Transmission


1 L

SO-1282-B010 n-Pentane Picograde® for residue analysis 1 L

SO-1282-B025 n-Pentane Picograde® for residue analysis 2.5 L

SO-1282-B040 n-Pentane Picograde® for residue analysis UN 1265

CAS-Nr. 109-66-0

C5H12

Assay ...................................................... 98.0% min.

Water ..................................................... 0.01% max.


1 L = 0.626 kg (at 20°C)

Specification



4 L

SO-9501-B010 n-Pentane for the analysis of highly volatile halogenated hydrocarbons UN 1265

CAS-Nr. 109-66-0

C5H12

Assay ...................................................... 95.0% min.

Water ..................................................... 0.01% max.


1 L = 0.632 kg (at 20°C)

Specification

Highly volatile halogenated hydrocarbons In the GC/ECD chromatogram there are no interfering single signals in the retention time interval between 1,1-dichloroethene and tribromomethane greater than that, given by 5 µg/L parathion-methyl.

1 L



Code Product Unit

SO-9610-B005 n-Pentane for the analysis of highly volatile halogenated hydrocarbons, aromatic hydrocarbons and EOX UN 1265

CAS-Nr. 109-66-0

C5H12

Assay ...................................................... 98.0% min.

Water ..................................................... 0.01% max.


1 L = 0.626 kg (at 20°C)

Specification

Highly volatile halogenated hydrocarbons In the GC/ECD chromatorgram there are no interfering single signals in the retention time interval between 1,1-dichloroethene and tribromomethane greater than that, given by 5 µg/L parathion-methyl.



500 mL

Perchloric acid HPA-0060-B010 Perchloric acid for trace analysis min 68 % (glass bottle)

UN 1802

Assay ............................................................. > 68 % Sulfate .......................................................... < 5 ppm Colour (APHA) ................................................... < 10 Total nitrogen ............................................. < 10 ppm Phosphate ................................................. < 0.1 ppm

Ag ................................ < 0.1 ppb Cu ............................... < 0.1 ppb Ni ................................. < 0.1 ppb Al ................................. < 0.5 ppb Fe ............................... < 0.5 ppb Pb ................................ < 0.1 ppb Ba ................................ < 0.1 ppb K ................................. < 0.5 ppb Sn ................................ < 0.1 ppb Be ................................ < 0.1 ppb Li ................................. < 0.1 ppb Sr ................................ < 0.1 ppb Bi ................................. < 0.1 ppb Mg ............................... < 0.5 ppb Th ................................ < 0.1 ppb Ca ............................... < 0.5 ppb Mn ............................... < 0.1 ppb Tl ................................. < 0.1 ppb Cd ............................... < 0.1 ppb Mo ............................... < 0.1 ppb V .................................. < 0.5 ppb Co ............................... < 0.1 ppb Na ............................... < 0.5 ppb Zn ................................ < 0.5 ppb

Perchloric acid stored in glass bottles will see a rise in: Al, B, Ca, K, Mg, Mn, Na and Si.

1 L

Petroleum ether SO-1320-B010 Petroleum ether Picograde® for residue analysis (30 - 60°C) 1 L

SO-1320-B025 Petroleum ether Picograde® for residue analysis (30 - 60°C) 2.5 L

SO-1320-B040 Petroleum ether Picograde® for residue analysis (30 - 60°C) UN 1268

CAS-Nr. 8032-32-4

Boiling point range ............................. 30 - 60°C min.

Water ..................................................... 0.01% max.


1 L = 0.625...0.655 kg (at 20°C)

Specification



4 L

SO-9502-B010 Petroleum ether for the analysis of highly volatile halogenated hydrocarbons and EOX (40 - 60°C)

1 L

SO-9502-B025 Petroleum ether for the analysis of highly volatile halogenated hydrocarbons and EOX (40 - 60°C) UN 1268

CAS-Nr. 8032-32-4

Boiling point ....................................... 40 - 60°C min.

Water ..................................................... 0.01% max.


1 L = 0.625...0.655 kg (bei/at 20°C)

Specification

Highly volatile halogenated hydrocarbons/EOX In the GC/ECD chromatorgram there are no interfering single signals in the retention time interval between 1,1-dichloroethene and tribromomethane greater than that, given by 5 µg/L parathion-methyl.


2.5 L



Code Product Unit

Propan-1-ol SO-5351-B025 Propan-1-ol HPLC Optigrade®

UN 1274

CAS-Nr. 71-23-8

CH3CH2CH2OH

Assay ...................................................... 99.8% min.

Water ..................................................... 0.05% max.



1 L = 0.804 kg (at 20°C)

Specification

Transmission


2.5 L

Propan-2-ol SO-3043-B010 Propan-2-ol HPLC Optigrade® 1 L

SO-3043-B025 Propan-2-ol HPLC Optigrade® 2.5 L

SO-3043-B040 Propan-2-ol HPLC Optigrade® UN 1219

CAS-Nr. 67-63-0

C3H8O

Assay ...................................................... 99.5% min.

Water ..................................................... 0.05% max.



1 L = 0.786 kg (at 20°C)

Specification

Transmission


4 L

SO-9352-B010 Propan-2-ol for LC-MS Optigrade® 1 L

SO-9352-B025 Propan-2-ol for LC-MS Optigrade® UN 1219

CAS number 67-63-0

C3H8O

Assay ...................................................... 99.5% min.

Water ..................................................... 0.05% max.



1 L = 0.786 kg (at 20°C)


Transmission

at 220 nm .................................................. 60 % min. at 250 nm .................................................. 99 % min.

2.5 L

SO-1334-B010 Propan-2-ol Picograde® for residue analysis 1 L

SO-1334-B025 Propan-2-ol Picograde® for residue analysis 2.5 L



Code Product Unit

SO-1334-B040 Propan-2-ol Picograde® for residue analysis UN 1219

CAS-Nr. 67-63-0

C3H8O

Assay ..................................................... 99.5% min.

Water ....................................................... 0.2% max.


1 L = 0.786 kg (at 20°C)

Specification



4 L

SO-3044-B040 Propan-2-ol for the tobacco industry contains

n-Heptadecan ................. 0.3 g/L

Ethanol ............................ 2.0 g/L

4 L


n-Heptandecan ............... 0.8 g/L

Ethanol abs ..................... 4.0 g/L

Wasser .............................. 0.1 %

4 L


n-Heptandecan ............... 0.4 g/L

Ethanol abs. ................... 2.0 g/ L

4 L

Sulfuric acid HPA-0040-B010 Sulfuric acid min 95 % (glass bottle)

UN 1830

Assay ................................................................ 95 % Chloride ..................................................... < 0.1 ppm Density ...................................................... 1.83 g/mL Phosphate ................................................. < 0.5 ppm Colour (APHA) ................................................... < 10 Nitrate ...................................................... < 0.07 ppm Residue ........................................................ < 2 ppm

Ag ................................ < 0.1 ppb Fe ............................... < 0.5 ppb Se ................................... < 5 ppb Al ................................. < 0.5 ppb Hg .................................. < 1 ppb Sn ................................ < 0.1 ppb As ................................... < 1 ppb K ................................. < 0.5 ppb Sr ................................ < 0.1 ppb Ba ................................ < 0.1 ppb Li ................................. < 0.1 ppb Th ................................ < 0.1 ppb Be ................................ < 0.1 ppb Mg ............................... < 0.5 ppb Ti .................................... < 1 ppb Bi ................................. < 0.1 ppb Mn ............................... < 0.1 ppb U ................................. < 0.1 ppb Ca ............................... < 0.5 ppb Mo ............................... < 0.1 ppb V .................................. < 0.1 ppb Cd ............................... < 0.1 ppb Na ............................... < 0.5 ppb Zn ................................ < 0.1 ppb Co ............................... < 0.1 ppb Ni ................................ < 0.1 ppb Zr ................................. < 0.1 ppb Cr ................................ < 0.1 ppb Pb ............................... < 0.1 ppb Cu ............................... < 0.1 ppb Sb ............................... < 0.1 ppb

Sulfuric acid stored in glass bottles will see a rise in: Al, B, Ca, K, Mg, Mn, Na and Si.

1 L

Tetrahydrofuran SO-2858-B010 Tetrahydrofuran HPLC Optigrade® 1 L

SO-2858-B025 Tetrahydrofuran HPLC Optigrade® 2.5 L



Code Product Unit

SO-2858-B040 Tetrahydrofuran HPLC Optigrade® UN 2056

CAS-Nr. 109-99-9

C4H8O

Assay ...................................................... 99.8% min.

Water ..................................................... 0.03% max.



1 L = 0.887 kg (at 20°C)

not stabilized

Specification

Transmission


4 L

SO-9364-B010 Tetrahydrofuran for LC-MS Optigrade® 1 L

SO-9364-B025 Tetrahydrofuran for LC-MS Optigrade® UN 2056

CAS number 109-99-9

C4H8O

Assay ...................................................... 99.8% min.

Water ..................................................... 0.03% max.



1 L = 0.887 kg (at 20°C)

not stabilised


Transmission

at 250 nm .................................................. 80 % min. at 290 nm .................................................. 99 % min.

2.5 L

Toluene SO-4483-B010 Toluene HPLC Optigrade® 1 L

SO-4483-B025 Toluene HPLC Optigrade® 2.5 L

SO-4483-B040 Toluene HPLC Optigrade® UN 1294

CAS-Nr. 108-88-3

C7H8

Assay ...................................................... 99.7% min.

Water ..................................................... 0.03% max.



1 L = 0.866 kg (at 20°C)

Specification

Transmission


4 L

SO-1350-B010 Toluene Picograde® for residue analysis 1 L

SO-1350-B025 Toluene Picograde® for residue analysis 2.5 L



Code Product Unit

SO-1350-B040 Toluene Picograde® for residue analysis UN 1294

CAS-Nr. 108-88-3

C7H8

Assay ...................................................... 99.8% min.

Water ..................................................... 0.02% max.


1 L = 0.866 kg (at 20°C)

Specification



4 L

1,1,2-Trichloro-1,2,2-trifluoroethane SO-9145-B025 1,1,2-Trichloro-1,2,2-trifluoroethane for IR-Spectroscopy

UN 3082

CAS-Nr. 76-13-1

C2Cl3F3

Assay ...................................................... 99,8% min.

Non-volatile matter ................................ 2 mg/L max.

Water .................................................10 mg/kg max.

Hydrocarbons .......................................5 mg/kg max.

1 L = 1.57 kg (at 20°C)

2.5 L

2,2,4-Trimethylpentane SO-6043-B010 2,2,4-Trimethylpentane HPLC Optigrade® (Isooctane) 1 L

SO-6043-B025 2,2,4-Trimethylpentane HPLC Optigrade® (Isooctane) 2.5 L

SO-6043-B040 2,2,4-Trimethylpentane HPLC Optigrade® (Isooctane) UN 1262

CAS-Nr. 540-84-1

C8H18

Assay ...................................................... 99.5% min.

Water ..................................................... 0.02% max.



1 L = 0.690 kg (at 20°C)

Specification

Transmission


4 L

SO-1364-B010 2,2,4-Trimethylpentane (Isooctane) Picograde® for residue analysis 1 L

SO-1364-B025 2,2,4-Trimethylpentane (Isooctane) Picograde® for residue analysis 2.5 L

SO-1364-B040 2,2,4-Trimethylpentane (Isooctane) Picograde® for residue analysis UN 1262

CAS-Nr. 540-84-1

C8H18

Assay ...................................................... 95.0% min.

Water ..................................................... 0.02% max.


1 L = 0.690 kg (at 20°C)

Specification



4 L



Code Product Unit

Water SO-6795-B025 Water HPLC Optigrade® 2.5 L

SO-6795-B040 Water HPLC Optigrade® CAS-Nr. 7732-18-5

H2O

Specification

Fluorescence at 254 nm (as Quinine) ....................... 0.1 ppb max.

Fluorescence at 365 nm (as quinine) ....................... 0.1 ppb max.

Non-volatile matter .................................1 mg/L max.


pH ................................................................ 5,0 - 8,0


4 L

SO-9662-B010 Water UHPLC-MS Optigrade® 1 L

SO-9662-B025 Water UHPLC-MS Optigrade® CAS number 7732-18-5

H2O

Residue after evaporation ............................... 0.0001 %w/w max.

Acidity (as Acetic acid) ............................................ 0.002 % max.

Alkalinity (as Ammonia) ...................................... 0.00005 % max.

Resistivity (at manuf.) ................................... 18.2 Mohm*cm min.


HPLC gradient at 210 nm - H. Peak ...................... 0.002 AU max. HPLC gradient at 254 nm - H. Peak .................... 0.0005 AU max.

Fluorescence at 254 nm (as quinine) ....................... 0.5 ppb max. Fluorescence at 365 nm (as quinine) ....................... 0.5 ppb max.

TOC ........................................................................... 10 ppb max.

Filter test ..................................................................... Passes test

Ca ............................................................................ 0.1 ppm max. K............................................................................... 0.1 ppm max. Mg ............................................................................ 0.1 ppm max. Na ........................................................................... 0.1 ppm max.


2.5 L

SO-4661-B025 Water 0.1 % formic acid UHPLC-MS Optigrade® Assay ..................................................................... 0.095-0.105 %

Purity of formic acid (GC)........................................... 99.0 % min.


HPLC gradient at 254 nm - H. Peak ...................... 0.002 AU max. HPLC gradient at 254 nm - Drift ............................ 0.010 AU max.

Fluorescence at 254 nm (as quinine) ....................... 0.5 ppb max. Fluorescence at 365 nm (as quinine) ...................... 0.5 ppb max.

Transmission

at 210 nm ........................................................................ 5 % min. at 230 nm ....................................................................... 45% min. at 254 nm ....................................................................... 99% min.

Al ............................................................................... 30 ppb max. Ca ............................................................................ 100 ppb max. Fe ............................................................................... 50 ppb max. K............................................................................... 100 ppb max. Mg .............................................................................. 30 ppb max. Na ............................................................................ 100 ppb max.


2.5 L



Code Product Unit

SO-4667-B025 Water 0.1 % acetic acid UHPLC-MS Optigrade® Assay ..................................................................... 0.095-0.105 %

pH ...................................................................................... 3.2-3.4

Purity of acetic acid (GC) ........................................... 99.9 % min.




Transmission




2.5 L

SO-4673-B025 Water 0.1 % trifluoroacetic acid UHPLC-MS Optigrade® Assay ..................................................................... 0.095-0.105 %

Purity of trifluoroacetic acid (GC) .............................. 99.95% min.



Fluorescence at 254 nm (as quinine) ....................... 0.5 ppb max. Fluorescence at 365 nm (as quinine) ........................0.5 ppb max.

Transmission

at 210 nm ...................................................................... 25 % min. at 230 nm ....................................................................... 85% min. at 254 nm ....................................................................... 99% min.



2.5 L

SO-9368-B010 Water for LC-MS Optigrade® 1 L

SO-9368-B025 Water for LC-MS Optigrade® Specification

Fluorescence (as Quinine at 450 nm) . 1.10-7 g max.

Non-volatile matter ................................ 5 mg/L max.


pH ................................................................ 5,0 - 8,0 Ca ....................................................... 0.1 ppm max. K .......................................................... 0.1 ppm max. Mg ....................................................... 0.1 ppm max. Na ....................................................... 0.1 ppm max.

Transmission

at 200 nm - 400 nm ................................... 99 % min.

2.5 L

Solvent mixtures SO-9534-B040 Mixture Cyclohexane/Ethylacetate 1:1

Specification



4 L

Ordering Information


Ordering Information

Ordering Orders may be placed by mail, telephone, fax or email. All purchase orders should indicate the number of units required, catalogue numbers and description of the materials together with a purchase order number. Addresses for delivery and for invoicing should also be included.

Prices A separate price list is supplied.

Payment terms Payment of all invoices is expected within 30 days of receipt. In some circumstances payment in advance may be requested.

Conditions of sale The Standard Terms and Conditions of Sale of LGC Standards apply.

Notes


Our 7 truths ofimpurities and theirreference standardsLGC Standards produces over 2,700 pharmaceutical reference standards for impurities and related compounds. We also provide support to our customers on choosing the most appropriate material for their needs, and on the correct usage of reference standards.

To make your life easier, we would like to share our experience, by revealing our ‘7 truths of impurities and their reference standards’.

ICH guidelines Q3A and Q3B on impurities are to be applied to generic drugs as well

An incompletely characterised impurity reference standard might be cheap, but could result in a large amount of hidden costs

It is not correct to assume an assay of 100% for a USP reference standard when there is no assay information on the label

Pharmacopoeial monographs might change, and so might the supply of impurity reference standards

Our impurity reference standards can be used universally, and might be less expensive thanyou think

Regulators accept our impurity reference standards

Impurity descriptions from pharmacopoeias will not necessarily match each other

No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording or any retrieval system, without the written permission of the copyright holder. © LGC Limited, 2011. All rights reserved. 3028/SS/0811


To discover the truth about our reference standards and their usage, please [email protected] to receive each truth in full.


Our extensive range of catalogues:

Catalogues from LGC Standards







www

.lgcstandards.comwww

.lgcstandards.com


Documents

Pharmaceutical reference substances and impurities 2011/2012 · The 2011/2012 edition of the LGC Standards catalogue ‘Pharmaceutical reference substances and impurities’, replaces